рофессиональная
библиотека
библиотека
Актуальная литература с 2020 года
Клинические рекомендации C 69.2 «Ретинобластома» (ID КР 71.3). Одобрены Научно-практическим Советом Минздрава РФ. Год утверждения: 2025 год.
https://cr.minzdrav.gov.ru/preview-cr/71_3
Клинические рекомендации «Интраокулярная ретинобластома» (ID КР71/1). Одобрены Научно-практическим Советом Минздрава РФ. Год утверждения: 2020 год.
https://cr.minzdrav.gov.ru/recomend/71_1
https://cr.minzdrav.gov.ru/preview-cr/71_3
Клинические рекомендации «Интраокулярная ретинобластома» (ID КР71/1). Одобрены Научно-практическим Советом Минздрава РФ. Год утверждения: 2020 год.
https://cr.minzdrav.gov.ru/recomend/71_1
А
Алексеева Е.А., Бабенко О.В., Козлова В.М., Ушакова Т.Л., Казубская Т.П., Танас А.С., Карандашева К.И., Стрельников В.В., Залетаев Д.В. Преимущества высокопроизводительного параллельного секвенирования в выявлении соматического мозаицизма при спорадической ретинобластоме. Медицинская генетика. 2020. Т. 19. № 6 (215). С. 6-7.
https://www.elibrary.ru/item.asp?id=44127160
Алексеева Е.А., Карандашева К.О., Бабенко О.В., Козлова В.М., Ушакова Т.Л., Казубская Т.П., Танас А.С., Залетаев Д.В., Стрельников В.В. Соматический мозаицизм при спорадической ретинобластоме. Медицинская генетика. 2021. Т. 20. № 4(225). С. 9-18.
DOI: 10.25557/2073-7998.2021.04.9-18
Алексеева Е.А., Козлова В. М., Бабенко О.В., Ушакова Т.Л., Казубская Т.П., Чеснокова Г.Г., Танас А.С., Залетаев Д.В., Стрельников В.В. Спектр нарушений гена RB1 при ретинобластоме у российских пациентов // Медицинская генетика. 2021. Т. 20. № 8(229). С. 11-20.
DOI: 10.25557/2073-7998.2021.08.11-20
Алиев Т.З., Киргизов К.И., Мачнева Е.Б., Костарева И.О., Сергеенко К.А., Смирнова Д.С., Бурлака Н.А., Лозован Ю.В., Трушкова И.Ю., Елфимова А.Ю., Митраков К.В., Потемкина Т.И., Малова М.Д., Фатхуллин Р.Р., Степанян Н.Г., Капкова О.А., Сагоян Г.Б., Сулейманова А.М., Матинян Н.В., Муфтахова Г.М., Казанцев А.П., Романцова О.М., Рубанская М.В., Ушакова Т.Л., Родина А.Д., Жогов В.В., Ванесян В.Ш., Скворцова Ю.В., Казанцев И.В., Слинин А.С., Горбунова Т.В., Валиев Т.Т., Поляков В.Г., Варфоломеева С.Р. Осложнения высокодозной полихимиотерапии с последующей аутологичной трансплантацией гемопоэтических стволовых клеток у детей с солидными злокачественными новообразованиями: опыт одного Центра. Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2024;23(2):116-127. https://doi.org/10.24287/1726-1708-2024-23-2-116-127.
Аль Хатиб Н.С.А., Шклярук В.В., Одинаева К.Н. и др. Глазное протезирование у пациентов с анофтальмом и субатрофией. Эффективная фармакотерапия. 2022; 18 (45): 22–24.
DOI: 10.33978/2307-3586-2022-18-45-22-24
Артеменко Ю.В., Панферова Т.Р., Михайлова Е.В., Кюн Ю., Ушакова Т.Л., Поляков В.Г. Методы визуализации в дифференциальной диагностике ретинобластомы, болезни Коатса и первичного персистирующего гиперпластического стекловидного тела. Российский журнал детской гематологии и онкологии. 2022;9(1):11–20.
https://doi.org/10.21682/2311-1267-2022-9-1-11-20
Артеменко Ю.В., Панферова Т.Р., Ушакова Т.Л., Михайлова Е.В. Оценка информативности ультразвукового исследования в диагностике ретинобластомы. Российский журнал детской гематологии и онкологии. 2023;10(1):49–56
https://doi.org/10.21682/2311-1267-2023-10-1-49-56
Аубакирова А.С., Абикулова А.К., Есназарова Г.С., Исаев А.Б. Анализ осведомленности офтальмологов о ретинобластоме // Интернаука. 2025, № 16-2(380). С. 8-13. – EDN GGGAPX.
Алексеева Е.А., Бабенко О.В., Козлова В.М., Ушакова Т.Л., Казубская Т.П., Танас А.С., Карандашева К.И., Стрельников В.В., Залетаев Д.В. Преимущества высокопроизводительного параллельного секвенирования в выявлении соматического мозаицизма при спорадической ретинобластоме. Медицинская генетика. 2020. Т. 19. № 6 (215). С. 6-7.
https://www.elibrary.ru/item.asp?id=44127160
Алексеева Е.А., Карандашева К.О., Бабенко О.В., Козлова В.М., Ушакова Т.Л., Казубская Т.П., Танас А.С., Залетаев Д.В., Стрельников В.В. Соматический мозаицизм при спорадической ретинобластоме. Медицинская генетика. 2021. Т. 20. № 4(225). С. 9-18.
DOI: 10.25557/2073-7998.2021.04.9-18
Алексеева Е.А., Козлова В. М., Бабенко О.В., Ушакова Т.Л., Казубская Т.П., Чеснокова Г.Г., Танас А.С., Залетаев Д.В., Стрельников В.В. Спектр нарушений гена RB1 при ретинобластоме у российских пациентов // Медицинская генетика. 2021. Т. 20. № 8(229). С. 11-20.
DOI: 10.25557/2073-7998.2021.08.11-20
Алиев Т.З., Киргизов К.И., Мачнева Е.Б., Костарева И.О., Сергеенко К.А., Смирнова Д.С., Бурлака Н.А., Лозован Ю.В., Трушкова И.Ю., Елфимова А.Ю., Митраков К.В., Потемкина Т.И., Малова М.Д., Фатхуллин Р.Р., Степанян Н.Г., Капкова О.А., Сагоян Г.Б., Сулейманова А.М., Матинян Н.В., Муфтахова Г.М., Казанцев А.П., Романцова О.М., Рубанская М.В., Ушакова Т.Л., Родина А.Д., Жогов В.В., Ванесян В.Ш., Скворцова Ю.В., Казанцев И.В., Слинин А.С., Горбунова Т.В., Валиев Т.Т., Поляков В.Г., Варфоломеева С.Р. Осложнения высокодозной полихимиотерапии с последующей аутологичной трансплантацией гемопоэтических стволовых клеток у детей с солидными злокачественными новообразованиями: опыт одного Центра. Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2024;23(2):116-127. https://doi.org/10.24287/1726-1708-2024-23-2-116-127.
Аль Хатиб Н.С.А., Шклярук В.В., Одинаева К.Н. и др. Глазное протезирование у пациентов с анофтальмом и субатрофией. Эффективная фармакотерапия. 2022; 18 (45): 22–24.
DOI: 10.33978/2307-3586-2022-18-45-22-24
Артеменко Ю.В., Панферова Т.Р., Михайлова Е.В., Кюн Ю., Ушакова Т.Л., Поляков В.Г. Методы визуализации в дифференциальной диагностике ретинобластомы, болезни Коатса и первичного персистирующего гиперпластического стекловидного тела. Российский журнал детской гематологии и онкологии. 2022;9(1):11–20.
https://doi.org/10.21682/2311-1267-2022-9-1-11-20
Артеменко Ю.В., Панферова Т.Р., Ушакова Т.Л., Михайлова Е.В. Оценка информативности ультразвукового исследования в диагностике ретинобластомы. Российский журнал детской гематологии и онкологии. 2023;10(1):49–56
https://doi.org/10.21682/2311-1267-2023-10-1-49-56
Аубакирова А.С., Абикулова А.К., Есназарова Г.С., Исаев А.Б. Анализ осведомленности офтальмологов о ретинобластоме // Интернаука. 2025, № 16-2(380). С. 8-13. – EDN GGGAPX.
Б
Бабкина А.В., Кулыгин Б.Б. Современные представления о ретинобластоме у детей. Научный альманах. 2020, № 4-1 (66).
https://www.elibrary.ru/item.asp?id=43025221
Базарбаева А.А., Кәрімова М., Таубалдиева З.Е. Анализ результатов лечения ретинобластомы у детей. Педиатрия и детская хирургия. 2020. № 1 (99). С. 13-17.
https://www.elibrary.ru/download/elibrary_44063343_42129189.pdf
Белоусова Е.И., Матинян Н.В., Мартынов Л.А., Ушакова Т.Л., Гьокова Е.В. Эффективность и безопасность ретробульбарной блокады 0,5% ропивакаином при проведении операции энуклеации глазного яблока у детей. Детская хирургия. 2020. Т. 24. № S1. С. 25.
http://www.fesmu.ru/elib/Article.aspx?id=391153
Белоусова Е.И., Матинян Н.В., Ушакова Т.Л., Поляков В.Г. Ретробульбарная блокада при энуклеации глазного яблока у детей с ретинобластомой. Офтальмохирургия. 2021. № 2. С. 52-57.
DOI 10.25276/0235-4160-2021-2-52-57
Белоусова Е.И., Матинян Н.В., Цинцадзе А.А. [и др.] Регионарные блокады под ультразвуковой навигацией при энуклеации глазного яблока у детей с ретинобластомой // Российский журнал детской гематологии и онкологии. 2022. Т. 9. № 4. С. 37-43. doi: 10.21682/2311-1267-2022-9-4-37-43. – EDN VUJMSZ
Белоусова Е.И., Матинян Н.В., Цинцадзе А.А., Мартынов Л.А., Кузнецов Д.А., Ковалева Е.А., Ушакова Т.Л., Поляков В.Г. Ультразвуковая навигация при выполнении ретробульбарной блокады у детей с ретинобластомой при энуклеации глазного яблока. Регионарная анестезия и лечение острой боли. 2021. Т. 15. № 2. С. 127-136.
https://doi.org/10.17816/1993-6508-2021-15-2-127-136
https://rjraap.com/1993-6508/article/view/90096
Боброва Н.Ф., Сорочинская Т.А., Молчанюк Н.И., Братишко А.Ю.
Ультраструктурные изменения сетчатки кролика при однократном интравитреальном введении различных доз мелфалана.
Офтальмологический журнал. 2020. № 4 (495). С. 50-55.
https://www.elibrary.ru/item.asp?id=44155830
Боброва Н.Ф., Сорочинская Т.А., Тронина С.А., Братишко А.Ю. Новая методика органосохранного лечения ретинобластомы. Современные технологии в офтальмологии. 2021. № 1(36). С. 215-220.
DOI 10.25276/2312-4911-2021-1-215-220
Бровкина А.Ф., Яровая Г.А., Цыбикова Н.Д. МикроРНК в офтальмологии. Офтальмология. 2021. Т. 18. № 2. С. 188-197.
DOI 10.18008/1816-5095-2021-2-188-197
Бабкина А.В., Кулыгин Б.Б. Современные представления о ретинобластоме у детей. Научный альманах. 2020, № 4-1 (66).
https://www.elibrary.ru/item.asp?id=43025221
Базарбаева А.А., Кәрімова М., Таубалдиева З.Е. Анализ результатов лечения ретинобластомы у детей. Педиатрия и детская хирургия. 2020. № 1 (99). С. 13-17.
https://www.elibrary.ru/download/elibrary_44063343_42129189.pdf
Белоусова Е.И., Матинян Н.В., Мартынов Л.А., Ушакова Т.Л., Гьокова Е.В. Эффективность и безопасность ретробульбарной блокады 0,5% ропивакаином при проведении операции энуклеации глазного яблока у детей. Детская хирургия. 2020. Т. 24. № S1. С. 25.
http://www.fesmu.ru/elib/Article.aspx?id=391153
Белоусова Е.И., Матинян Н.В., Ушакова Т.Л., Поляков В.Г. Ретробульбарная блокада при энуклеации глазного яблока у детей с ретинобластомой. Офтальмохирургия. 2021. № 2. С. 52-57.
DOI 10.25276/0235-4160-2021-2-52-57
Белоусова Е.И., Матинян Н.В., Цинцадзе А.А. [и др.] Регионарные блокады под ультразвуковой навигацией при энуклеации глазного яблока у детей с ретинобластомой // Российский журнал детской гематологии и онкологии. 2022. Т. 9. № 4. С. 37-43. doi: 10.21682/2311-1267-2022-9-4-37-43. – EDN VUJMSZ
Белоусова Е.И., Матинян Н.В., Цинцадзе А.А., Мартынов Л.А., Кузнецов Д.А., Ковалева Е.А., Ушакова Т.Л., Поляков В.Г. Ультразвуковая навигация при выполнении ретробульбарной блокады у детей с ретинобластомой при энуклеации глазного яблока. Регионарная анестезия и лечение острой боли. 2021. Т. 15. № 2. С. 127-136.
https://doi.org/10.17816/1993-6508-2021-15-2-127-136
https://rjraap.com/1993-6508/article/view/90096
Боброва Н.Ф., Сорочинская Т.А., Молчанюк Н.И., Братишко А.Ю.
Ультраструктурные изменения сетчатки кролика при однократном интравитреальном введении различных доз мелфалана.
Офтальмологический журнал. 2020. № 4 (495). С. 50-55.
https://www.elibrary.ru/item.asp?id=44155830
Боброва Н.Ф., Сорочинская Т.А., Тронина С.А., Братишко А.Ю. Новая методика органосохранного лечения ретинобластомы. Современные технологии в офтальмологии. 2021. № 1(36). С. 215-220.
DOI 10.25276/2312-4911-2021-1-215-220
Бровкина А.Ф., Яровая Г.А., Цыбикова Н.Д. МикроРНК в офтальмологии. Офтальмология. 2021. Т. 18. № 2. С. 188-197.
DOI 10.18008/1816-5095-2021-2-188-197
PDQ Pediatric Treatment Editorial Board. Retinoblastoma Treatment (PDQ®): Health Professional Version. 2021 Sep 21. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389442.
https://www.ncbi.nlm.nih.gov/books/NBK66006/
PDQ Pediatric Treatment Editorial Board. Retinoblastoma Treatment (PDQ®): Patient Version. 2021 Oct 7. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389197.
https://pubmed.ncbi.nlm.nih.gov/26389197/
Retinoblastoma - Current Therapeutic Challenges and Promising New Approaches. Special Issue. Cancers 2021
https://www.mdpi.com/journal/cancers/special_issues/Retinoblastoma
https://www.ncbi.nlm.nih.gov/books/NBK66006/
PDQ Pediatric Treatment Editorial Board. Retinoblastoma Treatment (PDQ®): Patient Version. 2021 Oct 7. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389197.
https://pubmed.ncbi.nlm.nih.gov/26389197/
Retinoblastoma - Current Therapeutic Challenges and Promising New Approaches. Special Issue. Cancers 2021
https://www.mdpi.com/journal/cancers/special_issues/Retinoblastoma
В
Ваньжа Е.Н. Поздняя диагностика ретинобластомы. клиническое наблюдение. // В сб. Современный взгляд на диагностику и лечение офтальмологических заболеваний. Материалы межрегиональной научно-практической конференции по офтальмологии, посвященной 60-летию со дня образования Тюменского государственного медицинского университета. Тюмень, 2023. С. 24-26
Верещагина Е.С. Актуальность разработки протеза глазного яблока / Е. С. Верещагина // Международная научно-практическая конференции им. Д.И. Менделеева, посвященная 90-летию профессора Р.З. Магарила: Материалы конференции, Тюмень, 25–27 ноября 2021 года / Тюмень: Тюменский индустриальный университет, 2022. С. 97-98. – EDN RYQGCB.
Виноградова Е.В. Субботина И.Н. Клинический случай бинокулярной ретинобластомы у ребенка в возрасте 4 лет. // Сборник «Вопросы педиатрии». Материалы межрегиональной научно-практической конференции с международным участием. Пермь, 2023. С. 40-44.
Волков Е. Н., Аверкин А.Н., Ярушев С.А. К вопросу о разработке интерпретируемого программного решения для диагностики ретинобластомы // Информационно-телекоммуникационные технологии и математическое моделирование высокотехнологичных систем: Материалы Всероссийской конференции с международным участием. М.,: РУДН им. П. Лумумбы, 2024. С. 468-471. EDN STGNOR.
Володин Д.П., Котельникова А.В., Котова Е.С., Яровой А.А.
Дифференциальная диагностика ретинобластомы и симулирующих состояний (псевдоретинобластом)
Медицинский вестник Башкортостана. 2020. Т. 15. № 4 (88). С. 44-47.
DOI: https://doi.org/10.25276/2307-6658-2020-4-51-58
https://eyepress.ru/article.aspx?44174
Володин Д.П., Котова Е.С., Чочаева А.М., Котельникова А.В., Яровой А.А. Транспупиллярная лазерная термотерапия ретинобластомы. Российская детская офтальмология. 2021. № 3. С. 54-60.
DOI: https://doi.org/10.25276/2307-6658-2021-3-54-60
https://eyepress.ru/article.aspx?46269
Володин Д.П., Яровой А.А., Яровая В.А., Матяева А.Д. Факторы эффективности лазерной термотерапии ретинобластомы // Российская детская офтальмология. 2023. № 2. С. 5-13. EDN NGIODC.
DOI 10.25276/2307-6658-2023-2-5-13
Ваньжа Е.Н. Поздняя диагностика ретинобластомы. клиническое наблюдение. // В сб. Современный взгляд на диагностику и лечение офтальмологических заболеваний. Материалы межрегиональной научно-практической конференции по офтальмологии, посвященной 60-летию со дня образования Тюменского государственного медицинского университета. Тюмень, 2023. С. 24-26
Верещагина Е.С. Актуальность разработки протеза глазного яблока / Е. С. Верещагина // Международная научно-практическая конференции им. Д.И. Менделеева, посвященная 90-летию профессора Р.З. Магарила: Материалы конференции, Тюмень, 25–27 ноября 2021 года / Тюмень: Тюменский индустриальный университет, 2022. С. 97-98. – EDN RYQGCB.
Виноградова Е.В. Субботина И.Н. Клинический случай бинокулярной ретинобластомы у ребенка в возрасте 4 лет. // Сборник «Вопросы педиатрии». Материалы межрегиональной научно-практической конференции с международным участием. Пермь, 2023. С. 40-44.
Волков Е. Н., Аверкин А.Н., Ярушев С.А. К вопросу о разработке интерпретируемого программного решения для диагностики ретинобластомы // Информационно-телекоммуникационные технологии и математическое моделирование высокотехнологичных систем: Материалы Всероссийской конференции с международным участием. М.,: РУДН им. П. Лумумбы, 2024. С. 468-471. EDN STGNOR.
Володин Д.П., Котельникова А.В., Котова Е.С., Яровой А.А.
Дифференциальная диагностика ретинобластомы и симулирующих состояний (псевдоретинобластом)
Медицинский вестник Башкортостана. 2020. Т. 15. № 4 (88). С. 44-47.
DOI: https://doi.org/10.25276/2307-6658-2020-4-51-58
https://eyepress.ru/article.aspx?44174
Володин Д.П., Котова Е.С., Чочаева А.М., Котельникова А.В., Яровой А.А. Транспупиллярная лазерная термотерапия ретинобластомы. Российская детская офтальмология. 2021. № 3. С. 54-60.
DOI: https://doi.org/10.25276/2307-6658-2021-3-54-60
https://eyepress.ru/article.aspx?46269
Володин Д.П., Яровой А.А., Яровая В.А., Матяева А.Д. Факторы эффективности лазерной термотерапии ретинобластомы // Российская детская офтальмология. 2023. № 2. С. 5-13. EDN NGIODC.
DOI 10.25276/2307-6658-2023-2-5-13
Г
Гараев Т.И., Матненко Т.Ю., Кучкова Ю.Е. Заболеваемость ретинобластомой в Омской области по данным БУЗОО «КОБ им. В. П. Выходцева». В сборнике: Неделя молодежной науки - 2021. Материалы Всероссийского научного форума с международным участием, посвященного медицинским работникам, оказывающим помощь в борьбе с коронавирусной инфекцией. Тюмень, 2021. С. 257.
https://www.elibrary.ru/item.asp?id=45682805
Гришкова И.Н., Кузнецова Н.В., Гуля Н.Н., Братчикова А.Ю., Морозов В.П., Головина Ю.П. Экспертно-реабилитационный и клинический анализ контингента детей-инвалидов вследствие ретинобластомы в Кемеровской области – Кузбассе за период 2017-2021 гг. // Медико-социальные проблемы инвалидности. 2023. № 2. С. 76-82. EDN WGHZXO
Гурьянова И.Е., Любушкин А.В., Макаревич О.О., Литвинова Д.Ю., Вертёлко В.Р., Волочник Е.В., Полякова Е.А., Мигас А.А., Конопля Н.Е. Первые результаты проведения генетического скрининга и изучения генотип-фенотипических корреляций у пациентов с ретинобластомой из Беларуси // Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2022, Т. 21. № 2, С. 78-88.
doi 10.24287/1726-1708-2022-21-2-78-88
https://www.elibrary.ru/download/elibrary_48697428_53152596.pdf
Гурьянова И.Е., Макаревич О.О., Литвинова Д.Ю., Мигас А.А., Конопля Н.Е. Роль генетических нарушений гена RB1 в патогенезе ретинобластомы. Евразийский онкологический журнал. 2021. Т. 9. № 2. С. 113-126.
Д
Долгушин Б.И., Берников С.Н., Буйденок Ю.В., Валиев А.К., Виршке Э.Р., Григорьевская З.В., Карпова М.С., Косырев В.Ю., Кудашкин Н.Е., Кукушкин А.В., Лаптева М.Г., Макаров Е.С., Маринов Д.Т., Маркович А.А., Мартынов Л.А., Матинян Н.В., Наркевич Б.Я., Нечипай А.М., Перегудов Н.А., Петухова И.Н., Погребняков И.В., Понедельникова Н.В., Притула С.И., Сергеева О.Н., Стилиди И.С., Трофимов И.А., Тулин П.Е., Тюрин И.Е., Федорова А.В., Францев Д.Ю., Черкасов В.А., Шолохов В.Н. Интервенционная радиология в онкологии. ИД МГУ, 2022.
ISBN: 978-5-88429-265-9. Т. 3. С. 783-795.
Гараев Т.И., Матненко Т.Ю., Кучкова Ю.Е. Заболеваемость ретинобластомой в Омской области по данным БУЗОО «КОБ им. В. П. Выходцева». В сборнике: Неделя молодежной науки - 2021. Материалы Всероссийского научного форума с международным участием, посвященного медицинским работникам, оказывающим помощь в борьбе с коронавирусной инфекцией. Тюмень, 2021. С. 257.
https://www.elibrary.ru/item.asp?id=45682805
Гришкова И.Н., Кузнецова Н.В., Гуля Н.Н., Братчикова А.Ю., Морозов В.П., Головина Ю.П. Экспертно-реабилитационный и клинический анализ контингента детей-инвалидов вследствие ретинобластомы в Кемеровской области – Кузбассе за период 2017-2021 гг. // Медико-социальные проблемы инвалидности. 2023. № 2. С. 76-82. EDN WGHZXO
Гурьянова И.Е., Любушкин А.В., Макаревич О.О., Литвинова Д.Ю., Вертёлко В.Р., Волочник Е.В., Полякова Е.А., Мигас А.А., Конопля Н.Е. Первые результаты проведения генетического скрининга и изучения генотип-фенотипических корреляций у пациентов с ретинобластомой из Беларуси // Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2022, Т. 21. № 2, С. 78-88.
doi 10.24287/1726-1708-2022-21-2-78-88
https://www.elibrary.ru/download/elibrary_48697428_53152596.pdf
Гурьянова И.Е., Макаревич О.О., Литвинова Д.Ю., Мигас А.А., Конопля Н.Е. Роль генетических нарушений гена RB1 в патогенезе ретинобластомы. Евразийский онкологический журнал. 2021. Т. 9. № 2. С. 113-126.
Д
Долгушин Б.И., Берников С.Н., Буйденок Ю.В., Валиев А.К., Виршке Э.Р., Григорьевская З.В., Карпова М.С., Косырев В.Ю., Кудашкин Н.Е., Кукушкин А.В., Лаптева М.Г., Макаров Е.С., Маринов Д.Т., Маркович А.А., Мартынов Л.А., Матинян Н.В., Наркевич Б.Я., Нечипай А.М., Перегудов Н.А., Петухова И.Н., Погребняков И.В., Понедельникова Н.В., Притула С.И., Сергеева О.Н., Стилиди И.С., Трофимов И.А., Тулин П.Е., Тюрин И.Е., Федорова А.В., Францев Д.Ю., Черкасов В.А., Шолохов В.Н. Интервенционная радиология в онкологии. ИД МГУ, 2022.
ISBN: 978-5-88429-265-9. Т. 3. С. 783-795.
З
Завадский С. Л. Бионические глазные протезы как средство реабилитации при потере обоих глазных яблок. Вестник офтальмологии. 2021. Т. 137. № 1. С. 35-39.
DOI 10.17116/oftalma202113701135
Загидуллина А.А., Харбедия В. Х., Нисиченко Д. В. и др. Опыт лечения первично-множественных злокачественных опухолей (ретинобластомы и остеосаркомы): разбор клинического случая // Саркомы костей, мягких тканей и опухоли кожи. 2021. Т. 13. № 2. С. 36-43. EDN TCRVUH.
DOI 10.17650/2070-9781-2021-13-2-36-43
Зеленова Е.Е., Белышева Т.С., Семенова В.В., Баринова И.О., Шарапова Е.В., Козлова В.М., Клецкая И.С., Югай О.В., Волчек Д.А., Валиев Т.Т., Наседкина Т.В. Синдром Блоха–Сульцбергера в практике врача-детского онколога. Российский журнал детской гематологии и онкологии. 2024;11(3):78–86.
DOI 10.21682/2311-1267-2024-11-3-78-86
Зеленова Е.Е., Козлова В.М., Югай О.В., Кюн Ю.А., Ушакова Т.Л., Михайлова С.Н., Алексеева Е.А., Мусатова В.В. Особенности молекулярно-генетической диагностики ретинобластомы // Российский журнал детской гематологии и онкологии (РЖДГиО). 2023. Т. 10, № 2. С. 34-43. EDN NCBSVD.
DOI 10.21682/2311-1267-2023-10-2-34-43
И
Иванова С.В., Кулева С.А., Садовникова Н.Н., Комиссаров М.И., Чистякова М.Н., Хохлова А.В., Щеголева Н.А. Принципы терапии интраокулярной ретинобластомы. РМЖ. Клиническая офтальмология. 2020. Т. 20. № 4. С. 197-203.
doi: 10.32364/2311-7729-2020-20-4-197-203
https://www.elibrary.ru/item.asp?id=44326007
Иванова С.В., Кулева С.А., Садовникова Н.Н., Комиссаров М.И., Чистякова М.Н., Хохлова А.В., Щеголева Н.А. Ретинобластома. Часть 1. Клинико-диагностические аспекты. РМЖ. Клиническая офтальмология. 2020. Т. 20. № 3. С. 159-164.
https://www.rmj.ru/articles/oftalmologiya/Retinoblastoma_Chasty_1_Kliniko-diagnosticheskie_aspekty/
Завадский С. Л. Бионические глазные протезы как средство реабилитации при потере обоих глазных яблок. Вестник офтальмологии. 2021. Т. 137. № 1. С. 35-39.
DOI 10.17116/oftalma202113701135
Загидуллина А.А., Харбедия В. Х., Нисиченко Д. В. и др. Опыт лечения первично-множественных злокачественных опухолей (ретинобластомы и остеосаркомы): разбор клинического случая // Саркомы костей, мягких тканей и опухоли кожи. 2021. Т. 13. № 2. С. 36-43. EDN TCRVUH.
DOI 10.17650/2070-9781-2021-13-2-36-43
Зеленова Е.Е., Белышева Т.С., Семенова В.В., Баринова И.О., Шарапова Е.В., Козлова В.М., Клецкая И.С., Югай О.В., Волчек Д.А., Валиев Т.Т., Наседкина Т.В. Синдром Блоха–Сульцбергера в практике врача-детского онколога. Российский журнал детской гематологии и онкологии. 2024;11(3):78–86.
DOI 10.21682/2311-1267-2024-11-3-78-86
Зеленова Е.Е., Козлова В.М., Югай О.В., Кюн Ю.А., Ушакова Т.Л., Михайлова С.Н., Алексеева Е.А., Мусатова В.В. Особенности молекулярно-генетической диагностики ретинобластомы // Российский журнал детской гематологии и онкологии (РЖДГиО). 2023. Т. 10, № 2. С. 34-43. EDN NCBSVD.
DOI 10.21682/2311-1267-2023-10-2-34-43
И
Иванова С.В., Кулева С.А., Садовникова Н.Н., Комиссаров М.И., Чистякова М.Н., Хохлова А.В., Щеголева Н.А. Принципы терапии интраокулярной ретинобластомы. РМЖ. Клиническая офтальмология. 2020. Т. 20. № 4. С. 197-203.
doi: 10.32364/2311-7729-2020-20-4-197-203
https://www.elibrary.ru/item.asp?id=44326007
Иванова С.В., Кулева С.А., Садовникова Н.Н., Комиссаров М.И., Чистякова М.Н., Хохлова А.В., Щеголева Н.А. Ретинобластома. Часть 1. Клинико-диагностические аспекты. РМЖ. Клиническая офтальмология. 2020. Т. 20. № 3. С. 159-164.
https://www.rmj.ru/articles/oftalmologiya/Retinoblastoma_Chasty_1_Kliniko-diagnosticheskie_aspekty/
К
Касай Д.В., Лещенко С.Г. Аспекты коррекционной работы по преодолению оптической дисграфии у детей младшего школьного возраста с ретинобластомой. // Психолого-педагогическое сопровождение общего, специального и инклюзивного образования детей и взрослых. Сб. материалов III Всероссийской научно-практической конференции с международным участием. Чебоксары, 2023. С. 290-291.
Климов К.Ю. Анализ генов, ассоциированных с ретинобластомой, с помощью методов анализа биоинформатики // Digital Diagnostics. 2023. Т. 4, № 1 Supplement. C. 66–69.
https://doi.org/10.17816/DD430347
Ковалева Е.А., Белоусова Е.И., Матинян Н.В., Ушакова Т.Л. Клинические случаи успешного лечения жизнеугрожающих осложнений при селективной интраартериальной химиотерапии у детей с ретинобластомой. Российский журнал детской гематологии и онкологии (РЖДГиО). 2023;10(3):82-88.
https://doi.org/10.21682/2311-1267-2023-10-3-82-88
Ковалева Е.А., Матинян Н.В., Ушакова Т.Л. Особенности анестезиологического обеспечения при селективной интраартериальной химиотерапии при ретинобластоме. Литературный обзор. Российский журнал детской гематологии и онкологии. 2024;11(4):81–8.
doi: 10.21682/2311-1267-2024-11-4-81-88
Коробова Л.С., Матинян Н.В., Мартынов Л.А., Кузнецов Д.А., Цинцадзе А.А., Ковалева Е.А. Анестезиологическое обеспечение при энуклеации глазного яблока в педиатрической онкохирургии // Отражение. 2022, № 1(13). С. 55-59.
doi 10.25276/2686-6986-2022-1-55-59
https://eyepress.ru/article.aspx?47655
Котельникова А.В., Володин Д.П., Яровая В.А., Чочаева А.М., Яровой А.А. Окклюзионная терапия как метод улучшения зрительных функций у детей, перенесших лечение по поводу ретинобластомы. Российская детская офтальмология. 2021. №4. С. 42-46.
Котельникова А.В., Котова Е.С., Володин Д.П., Ушакова Т.Л., Яровой А.А.
Первичное эндопротезирование глазницы при энуклеации по поводу ретинобластомы. Российская детская офтальмология. 2021. № 1. С. 44-49.
doi: 10.25276/2307-6658-2021-l-44-49
https://www.elibrary.ru/item.asp?id=44888607
Котельникова А.В., Тарасенко А.В., Яровой А.А. Качество жизни пациентов с ретинобластомой и методы их поддержки и реабилитации. Российский журнал детской гематологии и онкологии. 2022;9(4):75—80
https://doi.org/10.21682/2311-1267-2022-9-4-75-80
Котельникова А.В., Яровая В.А., Ушакова Т.Л., Судакова Е.П., Матяева А.Д., Галбацова А.Г., Яровой А.А. Первичное эндопротезирование орбиты силиконовым имплантом у пациентов с ретинобластомой. Российский журнал детской гематологии и онкологии. 2023. Т. 10, № 2. С. 28-33. EDN UNWFVB.
DOI 10.21682/2311-1267-2023-10-2-28-33
Котова Е.С. Оптимизированная органосохраняющая технология брахитерапии интраокулярной ретинобластомы. Автореферат. 2022. OAI-PMH ID: oai:eyepress.ru:avtoreferat56135
Котова Е.С., Яровой А.А., Бузуртанов М.Б. Эффективность локального лечения ретинобластомы на крайней периферии глазного дна.
Современные технологии в офтальмологии. 2020. № 3 (34). С. 110-111.
doi: 10.25276/2312-4911-2020-3-110-111
https://eyepress.ru/article.aspx?43403
Котова Е.С., Яровой А.А., Володин Д.П., Котельникова А.В. Брахитерапия ретинобластомы (обзор литературы). Российский журнал детской гематологии и онкологии. 2021. Т. 8. № 1. С. 50-56.
doi: 10.21682/2311-1267-2021-8-1-50-56
https://www.elibrary.ru/item.asp?id=45081117
Котова Е.С., Яровой А.А., Голанов А.В., Ушакова Т.Л., Яровая В.А. Многопольная брахитерапия мультифокальной ретинобластомы. Вопросы онкологии. 2022. Т. 68. № 4. С. 481-488. EDN LWEWRU.
doi: 10.37469/0507-3758-2022-68-4-481-488
Курлина П.Р., Щурова А.В., Гаврилова Т.В. Проблема ретинобластомы в Пермском крае // Российский общенациональный офтальмологический форум. 2024. Т. 2. С. 598-599. EDN ZHYIVY.
Л
Левашов А.С., Серов Ю.А., Ушакова Т.Л., Зеленова Е.Е., Горовцова О.В., Югай О.В., Поляков В.Г., Рыжова М.В., Строганова А.М., Алексеева Е.А., Мусатова В.В., Горелышев С.К., Кадыров Ш.У., Григорьева М.В., Шершакова А.И., Михайлова Е.В., Кашанина А.Л., Григоренко В.А. Современный взгляд на феномен трилатеральной ретинобластомы с позиций офтальмоонкологии и нейроонкологии. Часть I. Обзор литературы // Российский журнал детской гематологии и онкологии. 2024. Т. 11, № 3. С. 46-59. EDN NWOCFM.
DOI 10.21682/2311-1267-2024-11-3-46-59
Лещенко С.Г. Коррекция оптической дисграфии у детей младшего школьного возраста с ретинобластомой в условиях стационара: особенности работы медицинского логопеда // Национальное здоровье. 2024. № 2. С. 65-71. EDN ILIWJP.
Касай Д.В., Лещенко С.Г. Аспекты коррекционной работы по преодолению оптической дисграфии у детей младшего школьного возраста с ретинобластомой. // Психолого-педагогическое сопровождение общего, специального и инклюзивного образования детей и взрослых. Сб. материалов III Всероссийской научно-практической конференции с международным участием. Чебоксары, 2023. С. 290-291.
Климов К.Ю. Анализ генов, ассоциированных с ретинобластомой, с помощью методов анализа биоинформатики // Digital Diagnostics. 2023. Т. 4, № 1 Supplement. C. 66–69.
https://doi.org/10.17816/DD430347
Ковалева Е.А., Белоусова Е.И., Матинян Н.В., Ушакова Т.Л. Клинические случаи успешного лечения жизнеугрожающих осложнений при селективной интраартериальной химиотерапии у детей с ретинобластомой. Российский журнал детской гематологии и онкологии (РЖДГиО). 2023;10(3):82-88.
https://doi.org/10.21682/2311-1267-2023-10-3-82-88
Ковалева Е.А., Матинян Н.В., Ушакова Т.Л. Особенности анестезиологического обеспечения при селективной интраартериальной химиотерапии при ретинобластоме. Литературный обзор. Российский журнал детской гематологии и онкологии. 2024;11(4):81–8.
doi: 10.21682/2311-1267-2024-11-4-81-88
Коробова Л.С., Матинян Н.В., Мартынов Л.А., Кузнецов Д.А., Цинцадзе А.А., Ковалева Е.А. Анестезиологическое обеспечение при энуклеации глазного яблока в педиатрической онкохирургии // Отражение. 2022, № 1(13). С. 55-59.
doi 10.25276/2686-6986-2022-1-55-59
https://eyepress.ru/article.aspx?47655
Котельникова А.В., Володин Д.П., Яровая В.А., Чочаева А.М., Яровой А.А. Окклюзионная терапия как метод улучшения зрительных функций у детей, перенесших лечение по поводу ретинобластомы. Российская детская офтальмология. 2021. №4. С. 42-46.
Котельникова А.В., Котова Е.С., Володин Д.П., Ушакова Т.Л., Яровой А.А.
Первичное эндопротезирование глазницы при энуклеации по поводу ретинобластомы. Российская детская офтальмология. 2021. № 1. С. 44-49.
doi: 10.25276/2307-6658-2021-l-44-49
https://www.elibrary.ru/item.asp?id=44888607
Котельникова А.В., Тарасенко А.В., Яровой А.А. Качество жизни пациентов с ретинобластомой и методы их поддержки и реабилитации. Российский журнал детской гематологии и онкологии. 2022;9(4):75—80
https://doi.org/10.21682/2311-1267-2022-9-4-75-80
Котельникова А.В., Яровая В.А., Ушакова Т.Л., Судакова Е.П., Матяева А.Д., Галбацова А.Г., Яровой А.А. Первичное эндопротезирование орбиты силиконовым имплантом у пациентов с ретинобластомой. Российский журнал детской гематологии и онкологии. 2023. Т. 10, № 2. С. 28-33. EDN UNWFVB.
DOI 10.21682/2311-1267-2023-10-2-28-33
Котова Е.С. Оптимизированная органосохраняющая технология брахитерапии интраокулярной ретинобластомы. Автореферат. 2022. OAI-PMH ID: oai:eyepress.ru:avtoreferat56135
Котова Е.С., Яровой А.А., Бузуртанов М.Б. Эффективность локального лечения ретинобластомы на крайней периферии глазного дна.
Современные технологии в офтальмологии. 2020. № 3 (34). С. 110-111.
doi: 10.25276/2312-4911-2020-3-110-111
https://eyepress.ru/article.aspx?43403
Котова Е.С., Яровой А.А., Володин Д.П., Котельникова А.В. Брахитерапия ретинобластомы (обзор литературы). Российский журнал детской гематологии и онкологии. 2021. Т. 8. № 1. С. 50-56.
doi: 10.21682/2311-1267-2021-8-1-50-56
https://www.elibrary.ru/item.asp?id=45081117
Котова Е.С., Яровой А.А., Голанов А.В., Ушакова Т.Л., Яровая В.А. Многопольная брахитерапия мультифокальной ретинобластомы. Вопросы онкологии. 2022. Т. 68. № 4. С. 481-488. EDN LWEWRU.
doi: 10.37469/0507-3758-2022-68-4-481-488
Курлина П.Р., Щурова А.В., Гаврилова Т.В. Проблема ретинобластомы в Пермском крае // Российский общенациональный офтальмологический форум. 2024. Т. 2. С. 598-599. EDN ZHYIVY.
Л
Левашов А.С., Серов Ю.А., Ушакова Т.Л., Зеленова Е.Е., Горовцова О.В., Югай О.В., Поляков В.Г., Рыжова М.В., Строганова А.М., Алексеева Е.А., Мусатова В.В., Горелышев С.К., Кадыров Ш.У., Григорьева М.В., Шершакова А.И., Михайлова Е.В., Кашанина А.Л., Григоренко В.А. Современный взгляд на феномен трилатеральной ретинобластомы с позиций офтальмоонкологии и нейроонкологии. Часть I. Обзор литературы // Российский журнал детской гематологии и онкологии. 2024. Т. 11, № 3. С. 46-59. EDN NWOCFM.
DOI 10.21682/2311-1267-2024-11-3-46-59
Лещенко С.Г. Коррекция оптической дисграфии у детей младшего школьного возраста с ретинобластомой в условиях стационара: особенности работы медицинского логопеда // Национальное здоровье. 2024. № 2. С. 65-71. EDN ILIWJP.
М
Макаревич О.О. Интравитреальные инъекции в лечении ретинобластомы. Вестник Витебского государственного медицинского университета. Том 19, номер 3.
doi: 10.22263/2312-4156.2020.3.7
https://www.elibrary.ru/item.asp?id=42992359
Макаревич О.О. Науменко Л.В., Кочубинский Д.В., Горбач М.А., Конопля Н.Е. Результаты лечения ретинобластомы в Республике Беларусь за период с 1997 – 2021 гг. Евразийский онкологический журнал. 2023. Т. 11. № 3. С. 198-211.
doi: 10.34883/PI.2023.11.3.014
Макаревич О.О. Ретинобластома: клинические проявления и особенности диагностики у детей. Педиатрия. Восточная Европа. 2020. Т. 8. № 2.
doi: 10.34883/PI.2020.8.2.010
https://elibrary.ru/item.asp?id=43154294
Макаревич О.О. Транспупиллярная термотерапия в лечении ретинобластомы. Евразийский онкологический журнал.
doi: 10.34883/PI.2020.8.1.019
https://elibrary.ru/item.asp?id=42705485
Макимбето Э.К., Талгат Т.У., Сорокин А.А., Аманкулова А.А., Тиллоев Т.А., Мамашов Н.М.Эпидемиология злокачественных новообразований у детей младшего возраста в Кыргызской Республике // Российский журнал детской гематологии и онкологии. 2024. Т. 11, №2. С. 54-60.
DOI: 10.21682/2311-1267-2024-11-2-54-60
Малахова А.А., Михайлова С.Н., Ушакова Т.Л., Поляков В.Г. Детерминанты несвоевременной диагностики и лечения детей с ретинобластомой. Аналитический обзор организационно-методического отдела НИИ детской онкологии и гематологии ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава России. Российский журнал детской гематологии и онкологии. 2021;8(4):20–30.
https://doi.org/10.21682/2311-1267-2021-8-4-20-30.
Мацеха Е.П., Каюкова Е.В., Кряжева О. И. и др. Региональные особенности онкологической заболеваемости у детей Забайкальского края // Забайкальский медицинский вестник. 2023. №2. С. 72-81. EDN PHHUGN.
DOI: 10.52485/19986173_2023_2_72
Мерабишвили В.М. Состояние онкологической помощи в России: дети (0–14 лет), заболеваемость, смертность, погодичная летальность (популяционное исследование на уровне федерального округа). Часть I. Российский журнал детской гематологии и онкологии (РЖДГиО). 2023. Т. 10, № 2. С. 34-43. EDN NCBSVD
https://journal.nodgo.org/jour/article/view/936
Мирхаликов Ф.Р., Юсупов А. Ф., Усманов Р.Х. Выбор параметров лазерного вмешательства при транспупиллярной термотерапии монофокальных ретинобластом. Передовая офтальмология. 2024;10(4): 124-127.
Млечко В.С., Науменко Л.В., Красный С.А., Михалевская Т.М., Киселев П.Г., Жиляева Е.П., Шиманец С.В. Сравнительный анализ выраженности некроза опухоли у пациентов с ретинобластомой после проведения полихимиотерапии, консолидирующих методов лечения и суперселективной интраартериальной химиотерапии // Журнал Гродненского государственного медицинского университета. 2025. Т. 23, № 2. С. 155-161.
https://doi.org/10.25298/2221-8785-2025-23-2-155-161
Мякошина Е.Б., Саакян С.В., Тацков Р.А., Цыганков А.Ю. Морфометрические исследования малых ретинобластом на фоне комбинированной химиотерапии. Вестник офтальмологии. 2025; 141(2):38‑43.
https://doi.org/10.17116/oftalma202514102138
Макаревич О.О. Интравитреальные инъекции в лечении ретинобластомы. Вестник Витебского государственного медицинского университета. Том 19, номер 3.
doi: 10.22263/2312-4156.2020.3.7
https://www.elibrary.ru/item.asp?id=42992359
Макаревич О.О. Науменко Л.В., Кочубинский Д.В., Горбач М.А., Конопля Н.Е. Результаты лечения ретинобластомы в Республике Беларусь за период с 1997 – 2021 гг. Евразийский онкологический журнал. 2023. Т. 11. № 3. С. 198-211.
doi: 10.34883/PI.2023.11.3.014
Макаревич О.О. Ретинобластома: клинические проявления и особенности диагностики у детей. Педиатрия. Восточная Европа. 2020. Т. 8. № 2.
doi: 10.34883/PI.2020.8.2.010
https://elibrary.ru/item.asp?id=43154294
Макаревич О.О. Транспупиллярная термотерапия в лечении ретинобластомы. Евразийский онкологический журнал.
doi: 10.34883/PI.2020.8.1.019
https://elibrary.ru/item.asp?id=42705485
Макимбето Э.К., Талгат Т.У., Сорокин А.А., Аманкулова А.А., Тиллоев Т.А., Мамашов Н.М.Эпидемиология злокачественных новообразований у детей младшего возраста в Кыргызской Республике // Российский журнал детской гематологии и онкологии. 2024. Т. 11, №2. С. 54-60.
DOI: 10.21682/2311-1267-2024-11-2-54-60
Малахова А.А., Михайлова С.Н., Ушакова Т.Л., Поляков В.Г. Детерминанты несвоевременной диагностики и лечения детей с ретинобластомой. Аналитический обзор организационно-методического отдела НИИ детской онкологии и гематологии ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава России. Российский журнал детской гематологии и онкологии. 2021;8(4):20–30.
https://doi.org/10.21682/2311-1267-2021-8-4-20-30.
Мацеха Е.П., Каюкова Е.В., Кряжева О. И. и др. Региональные особенности онкологической заболеваемости у детей Забайкальского края // Забайкальский медицинский вестник. 2023. №2. С. 72-81. EDN PHHUGN.
DOI: 10.52485/19986173_2023_2_72
Мерабишвили В.М. Состояние онкологической помощи в России: дети (0–14 лет), заболеваемость, смертность, погодичная летальность (популяционное исследование на уровне федерального округа). Часть I. Российский журнал детской гематологии и онкологии (РЖДГиО). 2023. Т. 10, № 2. С. 34-43. EDN NCBSVD
https://journal.nodgo.org/jour/article/view/936
Мирхаликов Ф.Р., Юсупов А. Ф., Усманов Р.Х. Выбор параметров лазерного вмешательства при транспупиллярной термотерапии монофокальных ретинобластом. Передовая офтальмология. 2024;10(4): 124-127.
Млечко В.С., Науменко Л.В., Красный С.А., Михалевская Т.М., Киселев П.Г., Жиляева Е.П., Шиманец С.В. Сравнительный анализ выраженности некроза опухоли у пациентов с ретинобластомой после проведения полихимиотерапии, консолидирующих методов лечения и суперселективной интраартериальной химиотерапии // Журнал Гродненского государственного медицинского университета. 2025. Т. 23, № 2. С. 155-161.
https://doi.org/10.25298/2221-8785-2025-23-2-155-161
Мякошина Е.Б., Саакян С.В., Тацков Р.А., Цыганков А.Ю. Морфометрические исследования малых ретинобластом на фоне комбинированной химиотерапии. Вестник офтальмологии. 2025; 141(2):38‑43.
https://doi.org/10.17116/oftalma202514102138
Н
Науменко Л.В., Малиновский Г.Ф., Красный С.А., Жиляева Е.П., Бараш А.Н., Жерко И.Ю. Использование аллотрансплантата из подкожно-жировой клетчатки с апоневрозом подошвы для формирования опорно-двигательной культи при энуклеации. Новости хирургии. 2021. Т. 29. № 2. С. 191-197.
doi: 10.18484/2305-0047.2021.2.191
https://www.elibrary.ru/item.asp?id=45746866
Науменко Л.В., Малиновский Г.Ф., Красный С.А., Жиляева Е.П., Бараш А.Н., Жерко И.Ю. Использование аллотрансплантата из подкожно-жировой клетчатки с апоневрозом подошвы для формирования опорно-двигательной культи при энуклеации. Новости хирургии. 2021. Т. 29. № 2. С. 191-197.
doi: 10.18484/2305-0047.2021.2.191
https://www.elibrary.ru/item.asp?id=45746866
П
Погребняков И.В., Ушакова Т.Л., Трофимов И.А., Горовцова О.В., Матинян Н.В., Виршке Э.Р., Поляков В.Г., Долгушин Б.И. Осложнения селективной интраартериальной химиотерапии у детей с интраокулярной ретинобластомой // Онкологический журнал: лучевая диагностика, лучевая терапия. 2021. Т.4. № 2. С. 69-83.
DOI 10.37174/2587-7593-2021-4-2-69-83.
https://www.elibrary.ru/item.asp?id=46181348
Погребняков И.В., Ушакова Т.Л., Трофимов И.А., Горовцова О.В., Матинян Н.В., Виршке Э.Р., Поляков В.Г., Долгушин Б.И. Осложнения селективной интраартериальной химиотерапии у детей с интраокулярной ретинобластомой // Онкологический журнал: лучевая диагностика, лучевая терапия. 2021. Т.4. № 2. С. 69-83.
DOI 10.37174/2587-7593-2021-4-2-69-83.
https://www.elibrary.ru/item.asp?id=46181348
Р
Ретинобластома. Covid-19. Российский журнал детской гематологии и онкологии (РЖДГиО). Специальный выпуск, 2020.
https://cloud.mail.ru/public/5zHE/3wR92vLQh
Реджепова А., Элясов Р. Клинико-диагностическая характеристика и сравнение информативных данных различных методов диагностики ретинобластомы. Международный журнал гуманитарных и естественных наук. 2024. № 9-3(96). С. 11-13. EDN JJRNPS.
DOI 10.24412/2500-1000-2024-9-3-11-13
Ретинобластома. Covid-19. Российский журнал детской гематологии и онкологии (РЖДГиО). Специальный выпуск, 2020.
https://cloud.mail.ru/public/5zHE/3wR92vLQh
Реджепова А., Элясов Р. Клинико-диагностическая характеристика и сравнение информативных данных различных методов диагностики ретинобластомы. Международный журнал гуманитарных и естественных наук. 2024. № 9-3(96). С. 11-13. EDN JJRNPS.
DOI 10.24412/2500-1000-2024-9-3-11-13
С
Саакян С.В., Иванова О.А., Тадевосян С.С., Цыганков А.Ю., Ольхова Л.В., Ушакова Т.Л., Поляков В.Г. Выживаемость больных ретинобластомой по данным когортного исследования двух центров РФ. Российский офтальмологический журнал. 2021; 14(1):47-55.
https://doi.org/10.21516/2072-0076-2021-14-1-47-55
Саакян С.В., Иванова О.А., Тадевосян С.С., Цыганков А.Ю., Ольхова Л.В., Ушакова Т.Л., Поляков В.Г. Результаты пятилетней выживаемости при комбинированном лечении больных ретинобластомой. Российский общенациональный офтальмологический форум. 2020. Т. 2. С. 342-345.
https://www.elibrary.ru/item.asp?id=44450844
Саакян С.В., Мякошина Е.Б., Исмаилова Д.М. Токсическое влияние цитостатиков на изменения морфометрических параметров сетчатки и хориоидеи на фоне химиотерапии ретинобластомы.
Эффективная фармакотерапия. 2021. Т. 17. № 8. С. 12-15.
doi: 10.33978/2307-3586-2021-17-8-12-15
https://www.elibrary.ru/item.asp?id=45049320
Саакян С.В., Мякошина Е.Б., Поляков В.Г., Ушакова Т.Л., Исмаилова Д. М. Оптическая когерентная томография в доклинической диагностике изменений диска зрительного нерва после химиотерапии у детей с ретинобластомой. Российский офтальмологический журнал. №2. 2020.
DOI: 10.21516/2072-0076-2020-13-2-53-58
https://roj.igb.ru/jour/article/view/431/294
Саакян С.В., Мякошина Е.Б., Тацков Р.А., Катаргина Л.А., Панова А.Ю. Ангиоархитектоника малых ретинобластом: роль оптической когерентной томографии-ангиографии // Вестник офтальмологии. 2023. Т. 139, № 4. С. 5-11. EDN ZYIYKT.
DOI: 10.17116/oftalma20231390415
Саакян С.В., Тадевосян С.С., А.Ю. Цыганков А.Ю. Анализ структуры заболеваемости ретинобластомой у детей. Российская педиатрическая офтальмология. 2020. Т.15, №4. С.5-10.
DOI: https://doi.org/10.17816/rpo2020-15-4-5-10
https://www.elibrary.ru/item.asp?id=45615985
Саакян С.В., Тадевосян С.С., Цыганков А.Ю., Иванова О.А. Вторые опухоли у больных ретинобластомой в отдаленном периоде наблюдения (серия клинических случаев). Head and Neck/Голова и шея. Российское издание. Журнал Общероссийской общественной организации Федерация специалистов по лечению заболеваний головы и шеи. 2021. Т. 9. № 1. С. 83-90.
DOI: 10.25792/HN.2021.9.1.83-90
https://www.elibrary.ru/item.asp?id=44945729
Саакян С.В., Тацков Р.А., Мякошина Е.Б., Цыганков А.Ю., Ушакова Т.Л. Эффективность применения транспупиллярной термотерапии на фоне комбинированной химиотерапии ретинобластом. Вестник офтальмологии. 2025; 141(3):13‑19.
https://doi.org/10.17116/oftalma202514103113
Саакян С.В., Хорошилова-Маслова И.П., Тадевосян С.С., Цыганков А.Ю.1, Захарова Г.П., Иванова О.А., Пантелеева О.Г., Жаруа А.А. Морфогенез ретинобластомы при локальном введении цитостатиков. Офтальмология. 2021. Т. 18. № 3.
DOI: 10.18008/1816-5095-2021-3-508-517
Саакян С.В., Цыганков А.Ю., Тадевосян С.С., Макарова А.А., Коголева Л.В., Тацков Р.А. Аметропии у детей с ретинобластомой. Офтальмология. 2020;17(1):76-80.
https://doi.org/10.18008/1816-5095-2020-1-76-80
Саакян С.В., Цыганков А.Ю., Хорошилова-Маслова И.П., Моисеева Н.И., Карамышева А.Ф., Жильцова М.Г., Амирян А.Г., Тадевосян С.С. Разработка модели внутриглазной ретинобластомы invivo // Бюллетень экспериментальной биологии и медицины. 2020, Т. 169, №3 (март).
https://www.elibrary.ru/item.asp?id=42518484
Саакян С.В., Хорошилова-Маслова И.П., Тадевосян С.С., Цыганков А.Ю., Захарова Г.П., Иванова О.А., Жаруа А.А. Клинико-морфологическое исследование ретинобластомы после локальной химиотерапии. Российский общенациональный офтальмологический форум. 2020. Т. 2. С. 346-350.
https://www.elibrary.ru/item.asp?id=44450845
Саакян С.В., Хорошилова-Маслова И.П., Тадевосян С.С., Цыганков А.Ю., Захарова Г.П., Иванова О.А., Жаруа А.А. Морфогенез ретинобластомы при локальном введении цитостатиков. Точка зрения. Восток - Запад. 2020. № 3.
doi: 10.25276/2410-1257-2020-3-68-70
https://eyepress.ru/article.aspx?42537
Садовникова Н.Н., Чистякова М.Н., Кулева С.А., Иванова С.В., Баранова Н.А. Ретинобластом. В книге "Неонатальная офтальмология: Руководство для врачей" / Н. А. Баранова, В. В. Бржеский, О. В. Дискаленко [и др.]. Москва, 2021. 288 с.
DOI: 10.33029/9704-6152-5-NOF-2021-1-288.
Сайдашева Э.И., Фомина Н.В., Иова А.С., Буяновская С.В. Ретинобластома у детей. Российская педиатрическая офтальмология. 2021. Т. 16. № 1. С. 47-52.
DOI: 10.17816/rpo2021-16-1-47-52
Сироткина И.А., Семенова Л.Е., Варданян Л.А. Конъюнктивиты при использовании глазного протеза. Профилактика и выбор эффективной терапии // Отражение. 2024. № 1(17). С. 37-41. EDN NAJQZF.
DOI: 10.25276/2686-6986-2024-1-37-41
Смарцев А.С., Назаренко А.О., Сидоренко Е.Е., Адуева У.Г. Совместная работа онкологов и офтальмологов при лечении агрессивной двусторонней ретинобластомы. Российский педиатрический журнал. 2021. Т. 24. № 4. С. 277.
Степанян Н.Г., Сидорова Н.В., Рубанская М.В., Тупицын Н.H., Матинян Н.В., Киргизов К.И., Варфоломеева С.Р. Оптимизация методов сбора периферических гемопоэтических стволовых клеток у детей с онкологическими заболеваниями: обзор литературы. Российский журнал детской гематологии и онкологии (РЖДГиО). 2020; 7(2):78-85.
https://doi.org/10.21682/2311-1267-2020-7-2-78-85
Саакян С.В., Иванова О.А., Тадевосян С.С., Цыганков А.Ю., Ольхова Л.В., Ушакова Т.Л., Поляков В.Г. Выживаемость больных ретинобластомой по данным когортного исследования двух центров РФ. Российский офтальмологический журнал. 2021; 14(1):47-55.
https://doi.org/10.21516/2072-0076-2021-14-1-47-55
Саакян С.В., Иванова О.А., Тадевосян С.С., Цыганков А.Ю., Ольхова Л.В., Ушакова Т.Л., Поляков В.Г. Результаты пятилетней выживаемости при комбинированном лечении больных ретинобластомой. Российский общенациональный офтальмологический форум. 2020. Т. 2. С. 342-345.
https://www.elibrary.ru/item.asp?id=44450844
Саакян С.В., Мякошина Е.Б., Исмаилова Д.М. Токсическое влияние цитостатиков на изменения морфометрических параметров сетчатки и хориоидеи на фоне химиотерапии ретинобластомы.
Эффективная фармакотерапия. 2021. Т. 17. № 8. С. 12-15.
doi: 10.33978/2307-3586-2021-17-8-12-15
https://www.elibrary.ru/item.asp?id=45049320
Саакян С.В., Мякошина Е.Б., Поляков В.Г., Ушакова Т.Л., Исмаилова Д. М. Оптическая когерентная томография в доклинической диагностике изменений диска зрительного нерва после химиотерапии у детей с ретинобластомой. Российский офтальмологический журнал. №2. 2020.
DOI: 10.21516/2072-0076-2020-13-2-53-58
https://roj.igb.ru/jour/article/view/431/294
Саакян С.В., Мякошина Е.Б., Тацков Р.А., Катаргина Л.А., Панова А.Ю. Ангиоархитектоника малых ретинобластом: роль оптической когерентной томографии-ангиографии // Вестник офтальмологии. 2023. Т. 139, № 4. С. 5-11. EDN ZYIYKT.
DOI: 10.17116/oftalma20231390415
Саакян С.В., Тадевосян С.С., А.Ю. Цыганков А.Ю. Анализ структуры заболеваемости ретинобластомой у детей. Российская педиатрическая офтальмология. 2020. Т.15, №4. С.5-10.
DOI: https://doi.org/10.17816/rpo2020-15-4-5-10
https://www.elibrary.ru/item.asp?id=45615985
Саакян С.В., Тадевосян С.С., Цыганков А.Ю., Иванова О.А. Вторые опухоли у больных ретинобластомой в отдаленном периоде наблюдения (серия клинических случаев). Head and Neck/Голова и шея. Российское издание. Журнал Общероссийской общественной организации Федерация специалистов по лечению заболеваний головы и шеи. 2021. Т. 9. № 1. С. 83-90.
DOI: 10.25792/HN.2021.9.1.83-90
https://www.elibrary.ru/item.asp?id=44945729
Саакян С.В., Тацков Р.А., Мякошина Е.Б., Цыганков А.Ю., Ушакова Т.Л. Эффективность применения транспупиллярной термотерапии на фоне комбинированной химиотерапии ретинобластом. Вестник офтальмологии. 2025; 141(3):13‑19.
https://doi.org/10.17116/oftalma202514103113
Саакян С.В., Хорошилова-Маслова И.П., Тадевосян С.С., Цыганков А.Ю.1, Захарова Г.П., Иванова О.А., Пантелеева О.Г., Жаруа А.А. Морфогенез ретинобластомы при локальном введении цитостатиков. Офтальмология. 2021. Т. 18. № 3.
DOI: 10.18008/1816-5095-2021-3-508-517
Саакян С.В., Цыганков А.Ю., Тадевосян С.С., Макарова А.А., Коголева Л.В., Тацков Р.А. Аметропии у детей с ретинобластомой. Офтальмология. 2020;17(1):76-80.
https://doi.org/10.18008/1816-5095-2020-1-76-80
Саакян С.В., Цыганков А.Ю., Хорошилова-Маслова И.П., Моисеева Н.И., Карамышева А.Ф., Жильцова М.Г., Амирян А.Г., Тадевосян С.С. Разработка модели внутриглазной ретинобластомы invivo // Бюллетень экспериментальной биологии и медицины. 2020, Т. 169, №3 (март).
https://www.elibrary.ru/item.asp?id=42518484
Саакян С.В., Хорошилова-Маслова И.П., Тадевосян С.С., Цыганков А.Ю., Захарова Г.П., Иванова О.А., Жаруа А.А. Клинико-морфологическое исследование ретинобластомы после локальной химиотерапии. Российский общенациональный офтальмологический форум. 2020. Т. 2. С. 346-350.
https://www.elibrary.ru/item.asp?id=44450845
Саакян С.В., Хорошилова-Маслова И.П., Тадевосян С.С., Цыганков А.Ю., Захарова Г.П., Иванова О.А., Жаруа А.А. Морфогенез ретинобластомы при локальном введении цитостатиков. Точка зрения. Восток - Запад. 2020. № 3.
doi: 10.25276/2410-1257-2020-3-68-70
https://eyepress.ru/article.aspx?42537
Садовникова Н.Н., Чистякова М.Н., Кулева С.А., Иванова С.В., Баранова Н.А. Ретинобластом. В книге "Неонатальная офтальмология: Руководство для врачей" / Н. А. Баранова, В. В. Бржеский, О. В. Дискаленко [и др.]. Москва, 2021. 288 с.
DOI: 10.33029/9704-6152-5-NOF-2021-1-288.
Сайдашева Э.И., Фомина Н.В., Иова А.С., Буяновская С.В. Ретинобластома у детей. Российская педиатрическая офтальмология. 2021. Т. 16. № 1. С. 47-52.
DOI: 10.17816/rpo2021-16-1-47-52
Сироткина И.А., Семенова Л.Е., Варданян Л.А. Конъюнктивиты при использовании глазного протеза. Профилактика и выбор эффективной терапии // Отражение. 2024. № 1(17). С. 37-41. EDN NAJQZF.
DOI: 10.25276/2686-6986-2024-1-37-41
Смарцев А.С., Назаренко А.О., Сидоренко Е.Е., Адуева У.Г. Совместная работа онкологов и офтальмологов при лечении агрессивной двусторонней ретинобластомы. Российский педиатрический журнал. 2021. Т. 24. № 4. С. 277.
Степанян Н.Г., Сидорова Н.В., Рубанская М.В., Тупицын Н.H., Матинян Н.В., Киргизов К.И., Варфоломеева С.Р. Оптимизация методов сбора периферических гемопоэтических стволовых клеток у детей с онкологическими заболеваниями: обзор литературы. Российский журнал детской гематологии и онкологии (РЖДГиО). 2020; 7(2):78-85.
https://doi.org/10.21682/2311-1267-2020-7-2-78-85
Т
Терлецкая Е.Н., Медведев Ю.А., Петрук П.С. Применение имплантатов из пористого никелида титана для формирования опорно-двигательной культи глазного яблока после эвисцерации. Голова и шея. Российский журнал = Head and neck. Russian Journal. 2022;10(2):19–24
doi: 10.25792/HN.2022.10.2.19–24
https://www.elibrary.ru/download/elibrary_48486668_99637124.pdf
У
Умарова Б.З. Анализ патологических изменений и их роль в ранней диагностике ретинобластомы. Новый день в медицине. 2020. № 4 (32). С. 452-454.
https://www.elibrary.ru/item.asp?id=45759436
Умарова Б.З. Скрининг в ранней диагностике ретинобластомы. Экономика и социум. №6-2 (73). Узбекистан.
https://www.elibrary.ru/item.asp?id=44002068
Умарова Б.З., Икрамов А.Ф., Исламов З.С. Содержание МДА в слёзной жидкости у больных ретинобластомой. Современные технологии в офтальмологии. 2020. № 3 (34). С. 45-46.
doi: 10.25276/2312-4911-2020-3-45-46
https://www.elibrary.ru/item.asp?id=44346105
Умарова Б.З., Исламов З.С., Икрамов А.Ф. Содержание общего белка в слезной жидкости у больных ретинобластомой. Современные технологии в офтальмологии. 2020. № 3 (34). С. 44-45.
doi: 10.25276/2312-4911-2020-3-44-45
https://eyepress.ru/article.aspx?43338
Ушакова Т.Л., Волкова А.В., Горовцова О.В., Яровой А.А., Яровая В.А., Котова Е.С., Мaтинян Н.В., Цинцадзе А.А., Трофимов И.А., Погребняков И.В., Долгушин Б.И., Поляков В.Г. Роль трехкомпонентной селективной интраартериальной химиотерапии при неудачах стандартного органосохраняющего лечения детей с интраокулярной ретинобластомой. Российский журнал детской гематологии и онкологии, выпуск №4, 2020.
https://doi.org/10.21682/2311-1267-2020-7-4-15-34
Ушакова Т.Л., Поляков В.Г., Родина А.Д., Власова В.Е., Бланкова Т.И., Артеменко Ю.В., Михайлова Е.В., Крылов А.С., Оджарова А.А., Григоренко В.А., Шириков Е.И., Козлов Н.А., Гаспарян Т.Г., Бекяшев А.Х., Докучаева Я.Ю., Варфоломеева С.Р. Экстраокулярная ретинобластома: обзор литературы и клинический случай (интракраниальная ретинобластома с вовлечением зрительных трактов). Российский журнал детской гематологии и онкологии. 2022. Т. 9. № 2. С. 93-105.
doi: https://doi.org/10.21682/2311-1267-2022-9-2-93-105
Ушакова Т.Л., Поляков В.Г., Югай О.В., Кюн Ю.А., Артеменко Ю.В., Панферова Т.Р., Малахова А.А., Варфоломеева С.Р. Анализ дифференциально-диагностических особенностей ретинобластомы и глазной патологии, имитирующей ретинобластому. Российский журнал детской гематологии и онкологии (РЖДГиО). 2024;11(2):28-39.
https://doi.org/10.21682/2311-1267-2024-11-2-28-39
Ушакова Т.Л., Тузова Е.А., Шутова А.Д., Горовцова О.В., Гаспарян Т.Г., Бекяшев А.Х., Поляков В.Г. Расширенные хирургические вмешательства у детей с ретинобластомой при инвазии зрительного нерва. Российский журнал детской гематологии и онкологии. 2021. Т. 8. № 2. С. 50-60.
DOI 10.21682/2311-1267-2021-8-2-50-60
Ф
Фам Т.З., Фролов М.А., Шклярук В.В., Мельниченко С.В. Реабилитация после перенесенной глазной онкологии. Обзор литературы. Вестник НМХЦ им. Н.И. Пирогова. 2024;19(4,supplement):115-118.
https://doi.org/10.25881/20728255_2024_19_4_S1_115
Х
Ходжаев Д.Х., Юсупов А.Ф. К вопросу классификации анофтальмической орбиты. Advanced Ophthalmology. 2024. Vol. 10, No. 4.
DOI 10.57231/j.ao.2024.10.4.057
Терлецкая Е.Н., Медведев Ю.А., Петрук П.С. Применение имплантатов из пористого никелида титана для формирования опорно-двигательной культи глазного яблока после эвисцерации. Голова и шея. Российский журнал = Head and neck. Russian Journal. 2022;10(2):19–24
doi: 10.25792/HN.2022.10.2.19–24
https://www.elibrary.ru/download/elibrary_48486668_99637124.pdf
У
Умарова Б.З. Анализ патологических изменений и их роль в ранней диагностике ретинобластомы. Новый день в медицине. 2020. № 4 (32). С. 452-454.
https://www.elibrary.ru/item.asp?id=45759436
Умарова Б.З. Скрининг в ранней диагностике ретинобластомы. Экономика и социум. №6-2 (73). Узбекистан.
https://www.elibrary.ru/item.asp?id=44002068
Умарова Б.З., Икрамов А.Ф., Исламов З.С. Содержание МДА в слёзной жидкости у больных ретинобластомой. Современные технологии в офтальмологии. 2020. № 3 (34). С. 45-46.
doi: 10.25276/2312-4911-2020-3-45-46
https://www.elibrary.ru/item.asp?id=44346105
Умарова Б.З., Исламов З.С., Икрамов А.Ф. Содержание общего белка в слезной жидкости у больных ретинобластомой. Современные технологии в офтальмологии. 2020. № 3 (34). С. 44-45.
doi: 10.25276/2312-4911-2020-3-44-45
https://eyepress.ru/article.aspx?43338
Ушакова Т.Л., Волкова А.В., Горовцова О.В., Яровой А.А., Яровая В.А., Котова Е.С., Мaтинян Н.В., Цинцадзе А.А., Трофимов И.А., Погребняков И.В., Долгушин Б.И., Поляков В.Г. Роль трехкомпонентной селективной интраартериальной химиотерапии при неудачах стандартного органосохраняющего лечения детей с интраокулярной ретинобластомой. Российский журнал детской гематологии и онкологии, выпуск №4, 2020.
https://doi.org/10.21682/2311-1267-2020-7-4-15-34
Ушакова Т.Л., Поляков В.Г., Родина А.Д., Власова В.Е., Бланкова Т.И., Артеменко Ю.В., Михайлова Е.В., Крылов А.С., Оджарова А.А., Григоренко В.А., Шириков Е.И., Козлов Н.А., Гаспарян Т.Г., Бекяшев А.Х., Докучаева Я.Ю., Варфоломеева С.Р. Экстраокулярная ретинобластома: обзор литературы и клинический случай (интракраниальная ретинобластома с вовлечением зрительных трактов). Российский журнал детской гематологии и онкологии. 2022. Т. 9. № 2. С. 93-105.
doi: https://doi.org/10.21682/2311-1267-2022-9-2-93-105
Ушакова Т.Л., Поляков В.Г., Югай О.В., Кюн Ю.А., Артеменко Ю.В., Панферова Т.Р., Малахова А.А., Варфоломеева С.Р. Анализ дифференциально-диагностических особенностей ретинобластомы и глазной патологии, имитирующей ретинобластому. Российский журнал детской гематологии и онкологии (РЖДГиО). 2024;11(2):28-39.
https://doi.org/10.21682/2311-1267-2024-11-2-28-39
Ушакова Т.Л., Тузова Е.А., Шутова А.Д., Горовцова О.В., Гаспарян Т.Г., Бекяшев А.Х., Поляков В.Г. Расширенные хирургические вмешательства у детей с ретинобластомой при инвазии зрительного нерва. Российский журнал детской гематологии и онкологии. 2021. Т. 8. № 2. С. 50-60.
DOI 10.21682/2311-1267-2021-8-2-50-60
Ф
Фам Т.З., Фролов М.А., Шклярук В.В., Мельниченко С.В. Реабилитация после перенесенной глазной онкологии. Обзор литературы. Вестник НМХЦ им. Н.И. Пирогова. 2024;19(4,supplement):115-118.
https://doi.org/10.25881/20728255_2024_19_4_S1_115
Х
Ходжаев Д.Х., Юсупов А.Ф. К вопросу классификации анофтальмической орбиты. Advanced Ophthalmology. 2024. Vol. 10, No. 4.
DOI 10.57231/j.ao.2024.10.4.057
Ч
Чочаева А.М., Володин Д.П., Котова Е.С., Яровой А.А. Осложнения локального лечения ретинобластомы и их лечение (обзор литературы). Российский журнал детской гематологии и онкологии. 2022;9(3):65–74.
https://doi.org/10.21682/2311-1267-2022-9-3-65-74
Ш
Шацких А.В. Морфологические особенности ретинобластомы – первичные и вторичные изменения глаз. Практические вопросы. Российский журнал детской гематологии и онкологии (РЖДГиО). 2024;11(1):44-51.
https://doi.org/10.21682/2311-1267-2024-11-1-44-51
Ширин А.Д., Баранова О.Ю. Общие представления о диагностике и лечении вторичных остеогенных сарком у детей. Перспективные направления терапии // Иммунология гемопоэза. 2023. Т. 21, № 1-2. С. 74-108. EDN GDXXGT
Ю
Юсупов А.Ф., Мирхаликов Ф.Р. Транспупиллярная термотерапия при системной ПХТ-резистентных ретинобластомах. Современные технологии в офтальмологии. 2022. № 1(41). С. 250-253.
doi: 10.25276/2312-4911-2022-1-250-253
Я
Яровой А.А., Володин Д.П., Алексеев А.С., Яровая В.А., Осокин И.Г., Горшков И.М. Интраокулярные хирургические вмешательства у детей, перенесших лечение по поводу ретинобластомы: отдаленные результаты. Клиническая офтальмология. 2025; 25 (спецвыпуск):116-122.
DOI: 10.32364/2311-7729-2025-25-Suppl-17
Яровой А.А., Володин Д.П., Логинов Р.А. Первый опыт транссклеральной термотерапии ретинобластомы. // Офтальмохирургия. 2023. № 1. С. 18-24.
DOI: https://doi.org/10.25276/0235-4160-2023-1-18-24
Яровой А.А., Володин Д.П., Яровая В.А., Котова Е.С., Чочаева А.М., Котельникова А.В. Роль метода транспупиллярной лазерной термотерапии в системе органосохраняющего лечения ретинобластомы // Лазерная медицина. 2021. Т. 25. № S3. С. 39.
DOI: 10.37895/2071-8004-2021-25-3S-39
Яровой А.А., Володин Д.П., Яровая В.А., Котова Е.С., Чочаева А.М., Котельникова А.В. Транспупиллярная лазерная термотерапия: эффективность в лечении кавитарной ретинобластомы Российская детская офтальмология. 2021. № 4. С. 11-17.
Яровой А.А., Володин Д.П., Яровая В.А., Ушакова Т.Л., Котова Е.С., Чочаева А.М. Криодеструкция ретинобластомы: 13-летний опыт применения. Российский журнал детской гематологии и онкологии. 2022; 9(3):48–55.
https://doi.org/10.21682/2311-1267-2022-9-3-48-55
Яровой А.А., Володин Д.П., Яровая В.А., Ушакова Т.Л., Котова Е.С., Чочаева А.М., Поляков В.Г. Лазерная транспупиллярная термотерапия ретинобластомы. Российский журнал детской гематологии и онкологии. 2021. №3. С. 50-60.
https://doi.org/10.21682/2311-1267-2021-8-3-43-49
Яровой А.А., Володин Д.П., Яровая В.А., Чочаева А.М. Неполная регрессия ретинобластомы после химиотерапии: возможно ли динамическое наблюдение без дополнительного лечения? Российская детская офтальмология. 2024. Т. 49, № 3. С. 22-29. EDN BVAPTW.
DOI: 10.25276/2307-6658-2024-3-22-29.
Яровой А.А., Володин Д.П., Яровая В.А., Чочаева А.М. Эффективность локального лечения на разных стадиях ретинобластомы. Российский журнал детской гематологии и онкологии 2024;11(1):19–26.
https://doi.org/10.21682/2311-1267-2024-11-1-19-26
Яровой А.А., Голанов А.В., Ушакова Т.Л., Костюченко В.В., Яровая В.А., Котова Е.С., Поляков В.Г. Стереотаксическая радиохирургия «Гамма-нож» при интраокулярной ретинобластоме: результаты пяти лет применения. Офтальмохирургия. 2021. № 1. С. 46-56.
doi: 10.25276/0235-4160-2021-1-39-45
https://www.elibrary.ru/item.asp?id=45538352
Яровой А.А., Горшков И.М., Ушакова Т.Л., Яровая В.А., Котова Е.С., Котельникова А.В. Хирургическое лечение гемофтальма с одновременной ирригацией мелфалана у пациентов с ретинобластомой. Российская детская офтальмология. № 2.
doi: 10.25276/2307-6658-2020-2-20-25
https://eyepress.ru/article.aspx?42554
Яровой А.А., Клеянкина С.С., Зубарева С.А., Ушакова Т.Л., Яровая В.А., Котельникова А.В., Котова Е.С. Ретробульбарная инфузионная терапия интраокулярных осложнений локального лечения ретинобластомы. Российская детская офтальмология. 2020. № 2.
doi: 10.25276/2307-6658-2020-2-26-30
https://eyepress.ru/article.aspx?42555
Яровой А.А., Козлова В.М., Яровая В.А., Котельникова А.В., Астарханова Д.С. Клинические особенности и течение ретиноцитомы. Российская детская офтальмология. 2020. № 1. С. 24-28.
https://doi.org/10.25276/2307-6658-2020-1-24-28
Яровой А.А., Котельникова А.В., Галбацова А.Г., Матяева А.Д. Малигнизация ретиноцитомы. // Российская детская офтальмология. 2023. № 3. С. 27-32. EDN HFUOKW.
DOI: 10.25276/2307-6658-2023-3-27-32
Яровой А.А., Котова Е.С., Котельникова А.В., Яровая В.А.
Дифференциальная диагностика ретинита Коатса и ретинобластомы
Медицинский вестник Башкортостана. 2020. Т. 15. № 4 (88). С. 44-47.
https://www.elibrary.ru/download/elibrary_44521850...
Яровой А.А., Ушакова Т.Л., Голубева О.В., Левашов И.А., Михайлова С.Н., Яровая В.А., Поляков В.Г. Ретинобластома: история одного пациента. Российский журнал детской гематологии и онкологии. 2020. Т. 7. № 2.
doi: 10.21682/2311-1267-2020-7-2-134-9
https://elibrary.ru/item.asp?id=43089362
Яровой А.А., Ушакова Т.Л., Иванова Н.В., Горовцова О.В., Котельникова А.В., Яровая В.А., Поляков В.Г. Первичное эндопротезирование орбиты как способ косметической реабилитации детей с ретинобластомой. Современные технологии в офтальмологии. 2020. № 4 (35). С. 175-176.
DOI: https://doi.org/10.25276/2312-4911-2020-4-175-176
https://eyepress.ru/article.aspx?43809
Яровой А.А., Яровая В.А., Володин Д.П., Котельникова А.В., Котова Е.С., Городецкая Ю.Б. Псевдоретинобластомы: спектр патологии и частота в различных возрастных группах. Анализ 14-летнего опыта. Российская детская офтальмология. 2021. № 2. С. 9-14.
DOI: 10.25276/2307-6658-2021-2-9-14
Яровой А.А., Яровая В.А., Котова Е.С. и др. Брахитерапия ретинобластомы: результаты 13 лет применения // Злокачественные опухоли. 2021; 11(2):5–12
doi: 10.18027/2224-5057-2021-11-2-5-12
Яровой А.А., Яровая В.А., Осокин И.Г., Котова Е.С., Володин Д.П. Результаты хирургии катаракты у детей с ретинобластомой. Офтальмохирургия. 2021. № 3.
DOI: 10.25276/0235-4160-2021-3-65-70.
https://eyepress.ru/article.aspx?46216
Чочаева А.М., Володин Д.П., Котова Е.С., Яровой А.А. Осложнения локального лечения ретинобластомы и их лечение (обзор литературы). Российский журнал детской гематологии и онкологии. 2022;9(3):65–74.
https://doi.org/10.21682/2311-1267-2022-9-3-65-74
Ш
Шацких А.В. Морфологические особенности ретинобластомы – первичные и вторичные изменения глаз. Практические вопросы. Российский журнал детской гематологии и онкологии (РЖДГиО). 2024;11(1):44-51.
https://doi.org/10.21682/2311-1267-2024-11-1-44-51
Ширин А.Д., Баранова О.Ю. Общие представления о диагностике и лечении вторичных остеогенных сарком у детей. Перспективные направления терапии // Иммунология гемопоэза. 2023. Т. 21, № 1-2. С. 74-108. EDN GDXXGT
Ю
Юсупов А.Ф., Мирхаликов Ф.Р. Транспупиллярная термотерапия при системной ПХТ-резистентных ретинобластомах. Современные технологии в офтальмологии. 2022. № 1(41). С. 250-253.
doi: 10.25276/2312-4911-2022-1-250-253
Я
Яровой А.А., Володин Д.П., Алексеев А.С., Яровая В.А., Осокин И.Г., Горшков И.М. Интраокулярные хирургические вмешательства у детей, перенесших лечение по поводу ретинобластомы: отдаленные результаты. Клиническая офтальмология. 2025; 25 (спецвыпуск):116-122.
DOI: 10.32364/2311-7729-2025-25-Suppl-17
Яровой А.А., Володин Д.П., Логинов Р.А. Первый опыт транссклеральной термотерапии ретинобластомы. // Офтальмохирургия. 2023. № 1. С. 18-24.
DOI: https://doi.org/10.25276/0235-4160-2023-1-18-24
Яровой А.А., Володин Д.П., Яровая В.А., Котова Е.С., Чочаева А.М., Котельникова А.В. Роль метода транспупиллярной лазерной термотерапии в системе органосохраняющего лечения ретинобластомы // Лазерная медицина. 2021. Т. 25. № S3. С. 39.
DOI: 10.37895/2071-8004-2021-25-3S-39
Яровой А.А., Володин Д.П., Яровая В.А., Котова Е.С., Чочаева А.М., Котельникова А.В. Транспупиллярная лазерная термотерапия: эффективность в лечении кавитарной ретинобластомы Российская детская офтальмология. 2021. № 4. С. 11-17.
Яровой А.А., Володин Д.П., Яровая В.А., Ушакова Т.Л., Котова Е.С., Чочаева А.М. Криодеструкция ретинобластомы: 13-летний опыт применения. Российский журнал детской гематологии и онкологии. 2022; 9(3):48–55.
https://doi.org/10.21682/2311-1267-2022-9-3-48-55
Яровой А.А., Володин Д.П., Яровая В.А., Ушакова Т.Л., Котова Е.С., Чочаева А.М., Поляков В.Г. Лазерная транспупиллярная термотерапия ретинобластомы. Российский журнал детской гематологии и онкологии. 2021. №3. С. 50-60.
https://doi.org/10.21682/2311-1267-2021-8-3-43-49
Яровой А.А., Володин Д.П., Яровая В.А., Чочаева А.М. Неполная регрессия ретинобластомы после химиотерапии: возможно ли динамическое наблюдение без дополнительного лечения? Российская детская офтальмология. 2024. Т. 49, № 3. С. 22-29. EDN BVAPTW.
DOI: 10.25276/2307-6658-2024-3-22-29.
Яровой А.А., Володин Д.П., Яровая В.А., Чочаева А.М. Эффективность локального лечения на разных стадиях ретинобластомы. Российский журнал детской гематологии и онкологии 2024;11(1):19–26.
https://doi.org/10.21682/2311-1267-2024-11-1-19-26
Яровой А.А., Голанов А.В., Ушакова Т.Л., Костюченко В.В., Яровая В.А., Котова Е.С., Поляков В.Г. Стереотаксическая радиохирургия «Гамма-нож» при интраокулярной ретинобластоме: результаты пяти лет применения. Офтальмохирургия. 2021. № 1. С. 46-56.
doi: 10.25276/0235-4160-2021-1-39-45
https://www.elibrary.ru/item.asp?id=45538352
Яровой А.А., Горшков И.М., Ушакова Т.Л., Яровая В.А., Котова Е.С., Котельникова А.В. Хирургическое лечение гемофтальма с одновременной ирригацией мелфалана у пациентов с ретинобластомой. Российская детская офтальмология. № 2.
doi: 10.25276/2307-6658-2020-2-20-25
https://eyepress.ru/article.aspx?42554
Яровой А.А., Клеянкина С.С., Зубарева С.А., Ушакова Т.Л., Яровая В.А., Котельникова А.В., Котова Е.С. Ретробульбарная инфузионная терапия интраокулярных осложнений локального лечения ретинобластомы. Российская детская офтальмология. 2020. № 2.
doi: 10.25276/2307-6658-2020-2-26-30
https://eyepress.ru/article.aspx?42555
Яровой А.А., Козлова В.М., Яровая В.А., Котельникова А.В., Астарханова Д.С. Клинические особенности и течение ретиноцитомы. Российская детская офтальмология. 2020. № 1. С. 24-28.
https://doi.org/10.25276/2307-6658-2020-1-24-28
Яровой А.А., Котельникова А.В., Галбацова А.Г., Матяева А.Д. Малигнизация ретиноцитомы. // Российская детская офтальмология. 2023. № 3. С. 27-32. EDN HFUOKW.
DOI: 10.25276/2307-6658-2023-3-27-32
Яровой А.А., Котова Е.С., Котельникова А.В., Яровая В.А.
Дифференциальная диагностика ретинита Коатса и ретинобластомы
Медицинский вестник Башкортостана. 2020. Т. 15. № 4 (88). С. 44-47.
https://www.elibrary.ru/download/elibrary_44521850...
Яровой А.А., Ушакова Т.Л., Голубева О.В., Левашов И.А., Михайлова С.Н., Яровая В.А., Поляков В.Г. Ретинобластома: история одного пациента. Российский журнал детской гематологии и онкологии. 2020. Т. 7. № 2.
doi: 10.21682/2311-1267-2020-7-2-134-9
https://elibrary.ru/item.asp?id=43089362
Яровой А.А., Ушакова Т.Л., Иванова Н.В., Горовцова О.В., Котельникова А.В., Яровая В.А., Поляков В.Г. Первичное эндопротезирование орбиты как способ косметической реабилитации детей с ретинобластомой. Современные технологии в офтальмологии. 2020. № 4 (35). С. 175-176.
DOI: https://doi.org/10.25276/2312-4911-2020-4-175-176
https://eyepress.ru/article.aspx?43809
Яровой А.А., Яровая В.А., Володин Д.П., Котельникова А.В., Котова Е.С., Городецкая Ю.Б. Псевдоретинобластомы: спектр патологии и частота в различных возрастных группах. Анализ 14-летнего опыта. Российская детская офтальмология. 2021. № 2. С. 9-14.
DOI: 10.25276/2307-6658-2021-2-9-14
Яровой А.А., Яровая В.А., Котова Е.С. и др. Брахитерапия ретинобластомы: результаты 13 лет применения // Злокачественные опухоли. 2021; 11(2):5–12
doi: 10.18027/2224-5057-2021-11-2-5-12
Яровой А.А., Яровая В.А., Осокин И.Г., Котова Е.С., Володин Д.П. Результаты хирургии катаракты у детей с ретинобластомой. Офтальмохирургия. 2021. № 3.
DOI: 10.25276/0235-4160-2021-3-65-70.
https://eyepress.ru/article.aspx?46216
A
Abdelazeem B., Abbas K.S., Shehata J. et al. Increased Risk of Subsequent Skin Melanoma in Patients with Retinoblastoma: SEER-Based Results. The Journal of investigative dermatology. 2022-10-25;142(11):3123-3125.
doi: 10.1016/j.jid.2022.04.013
Abdelazeem B., Abbas K.S., Shehata J. et al. Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed? Cancer medicine. 2022-12-08
doi: 10.1002/cam4.5406
Abdelbaki M.S., Abu-Arja M.H., Davidson T.B., Fangusaro J.R., Stanek J.R., Dunkel I.J., Dhall G, Gardner SL, Finlay JL. Pineoblastoma in children less than six years of age: The Head Start I, II, and III experience. // Pediatric Blood & Cancer. 2020 Mar 18.
doi: 10.1002/pbc.28252
Abramson D.H. Cell Free DNA (cfDNA) in the Blood of Retinoblastoma Patients The Robert M. Ellsworth Lecture. Ophthalmic Genet. 2022 Apr 5:1-5. Epub ahead of print.
PMID: 35382685.
doi: 10.1080/13816810.2021.2004433
Abramson D.H. et al. Ten things you learned in your residency about retinoblastoma that have changed the 2023 Victor T. Curtin Lecture. Ophthalmic genetics. 2023-03-30:1-6
doi: 10.1080/13816810.2023.2189948
Abramson D.H. et al. What have we learned about intraarterial chemotherapy (Ophthalmic Artery Chemosurgery) for retinoblastoma in the past 18 years? The third A. Linn Murphree Lecture. Ophthalmic genetics. 2024-12-02;45(6):551-557
doi: 10.1080/13816810.2024.2388579
Abramson D.H., Bian Y., Belinsky I., Francis J.H. An in-utero presentation of trilateral retinoblastoma. Ophthalmology. Retina. 2020 Dec 26:S2468-6530(20)30504-2.
doi: 10.1016/j.oret.2020.12.017
Abramson D.H., Bian Y., Belinsky I., Francis JH. An In Utero Presentation of Trilateral Retinoblastoma. Ophthalmol Retina. 2021 Aug;5(8):831-832.
doi: 10.1016/j.oret.2020.12.017
Abramson D.H., Dunkel I.J., Francis J.H. et al. Magnetic Resonance Imaging of Metastatic Retinoblastoma. Journal of pediatric ophthalmology and strabismus. 2022-08-08:1
doi: 10.3928/01913913-20220623-02
Abramson DH, Francis JH, Knopman J, Dunkel IJ, Gobin YP. Ophthalmic Artery Chemosurgery for Retinoblastoma Babies Less than 3 Months Old or under 6-kg Weight. Ophthalmol Retina. 2025 Mar 20:S2468-6530(25)00115-0. Epub ahead of print. PMID: 40120678.
doi: 10.1016/j.oret.2025.03.008
Abramson D.H., Francis J.H. et al. Intravitreal Topotecan 90 µg for Recurrent Solid Retinoblastoma Tumors Is Effective and Not Toxic. Journal of pediatric ophthalmology and strabismus. 2023-03-29;60(2):e16-e18
doi: 10.3928/01913913-20230110-01
Abramson D.H., Gaccione J., Bracken C. et al. How Much Time Do Focal Treatments for Retinoblastoma Add to Anesthetic Exposure? Ocular oncology and pathology. 2024-11-05;10(3):182-188
doi: 10.1159/000539488
Abramson D.H., Gobin Y.P., Dunkel I.J., Francis J.H. Successful Treatment of Massive Choroidal Invasion in Retinoblastoma with Intraarterial Chemotherapy (Ophthalmic Artery Chemosurgery). Ophthalmology. Retina. 2020 Dec 28:S2468-6530(20)30505-4.
doi: 10.1016/j.oret.2020.12.018
Abramson D.H., Gobin Y.P., Dunkel I.J., Francis J.H. Successful Treatment of Massive Choroidal Invasion in Retinoblastoma with Intra-arterial Chemotherapy (Ophthalmic Artery Chemosurgery). Ophthalmol Retina. 2021 Sep;5(9):936-939.
doi: 10.1016/j.oret.2020.12.018
Abramson D.H., Gobin Y.P., Francis J.H. et al. Good Vision in Retinoblastoma Treated With Intra-arterial Chemotherapy and Laser in the Papillomacular Bundle. Journal of pediatric ophthalmology and strabismus. 2022-08-08:1
doi: 10.3928/01913913-20220629-01
Abramson D.H., Gobin Y.P., Francis J.H. et al. Ophthalmic Artery Chemosurgery for Optic Nerve Invasion in Retinoblastoma. Journal of pediatric ophthalmology and strabismus. 2024-05-30:1
doi: 10.3928/01913913-20240508-09
Abramson D.H., Gobin Y.P., Francis J.H. Orbital Retinoblastoma Treated with Intra-arterial Chemotherapy. Ophthalmology. 2021 Oct;128(10):1437.
doi: 10.1016/j.ophtha.2021.03.018
Abramson D.H., Haque S., Francis J.H. Prelaminar and Postlaminar Invasion of Retinoblastoma. Ophthalmology. Retina. 2021 Apr;5(4):387.
doi: 10.1016/j.oret.2020.12.015.
Abramson D.H., Haque S., Francis J.H. Unilateral Retinoblastoma Metastatic to the Skull and Both Orbits. Ophthalmology Retina. 2020 Oct;4
doi: 10.1016/j.oret.2020.04.019
Abramson D.H., Liu T., Guarini E. et al. Improved method of dilating pupils for ophthalmic exams under anesthesia (faster and easier). Asia-Pacific journal of oncology nursing. 2024-08-31;11(8):100543
doi: 10.1016/j.apjon.2024.100543
Abramson D.H., Mandelker D.L., Brannon A.R. et al. Mutant-RB1 circulating tumor DNA in the blood of unilateral retinoblastoma patients: What happens during enucleation surgery: A pilot study. PloS one. 2023-03-27;18(2):e0271505
doi: 10.1371/journal.pone.0271505
Abramson D.H., Robbins M.A., Gobin Y.P. et al. Circulating Tumor DNA Posttreatment Measurements and Clinical Correlates in Retinoblastoma. JAMA ophthalmology. 2024-03-22;142(3):257-261
doi: 10.1001/jamaophthalmol.2023.6516
Abramson D.H., Shields C.L. et al. RE: Tomar et al; American Joint Committee on Cancer Ophthalmic Oncology Task Force. High-risk pathologic features based on presenting findings in advanced intraocular retinoblastoma: a multicenter, international data-sharing American Joint Committee on Cancer Study (Ophthalmology. 2022;129:923-932) and Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. Metastatic death based on presenting features and treatment for advanced intraocular retinoblastoma: a multicenter registry-based study. (Ophthalmology. 2022;129:933-945). Ophthalmology. 2022-11-28
doi: 10.1016/j.ophtha.2022.10.018
Abruzzo T., Abraham K., Karani K.B., Geller J.I., Vadivelu S., Racadio J.M., Zhang B., Correa Z.M. Correlation of Technical and Adjunctive Factors with Quantitative Tumor Reduction in Children Undergoing Selective Ophthalmic Artery Infusion Chemotherapy for Retinoblastoma. AJNR. American journal of neuroradiology. 2020 Dec 24
doi: 10.3174/ajnr.A6905
Abusayf M.M., Alkatan H.M., Elkhamary S., Almesfer S.A., Maktabi A.M.Y.
Histopathological assessment of optic nerve invasion guided by radiological findings in enucleated globes with retinoblastoma. BMC Ophthalmology. 2020 Sep 29
doi: 10.1186/s12886-020-01654-z
de Aguirre Neto J.C., Antoneli C.B., Ribeiro K.B., Castilho M.S., Novaes P.E., Chojniak M.M., Arias V. Retinoblastoma in children older than 5 years of age
Pediatric blood & cancer. 2007 Mar;48(3):292-5
doi: 10.1002/pbc.20931
Agarwal A., Tanna V., Vempuluru V.S. et al. Intravitreal Melphalan versus Topotecan for Vitreous Seeds in Retinoblastoma: A Comparative Study of 64 Asian Indian Eyes. Ophthalmol Retina. 2025 Jun;9(6):589-597. Epub 2024 Nov 19. PMID: 39566884.
doi: 10.1016/j.oret.2024.11.010
Agarwal A, Mishra DK, Kaliki S. Retinal pigment epithelial (RPE) adenoma mimicking retinoblastoma in a child. BMJ Case Rep. 2025 Apr 5;18(4):e260331.
doi: 10.1136/bcr-2024-260331. PMID: 40187765
Agarwal K., Vinekar A., Chandra P., Padhi T.R., Nayak S., Jayanna S., Panchal B., Jalali S., Das T. Imaging the pediatric retina: An overview. Indian J Ophthalmol. 2021 Apr;69(4):812-823. PMID: 33727440; PMCID: PMC8012979
doi: 10.4103/ijo.IJO_1917_20
Aggarwal R., Sharma M., Singh U. et al. Understanding the killer-cell immunoglobulin like receptor polymorphism in retinoblastoma. Ophthalmic genetics. 2023-01-03:1-5
doi: 10.1080/13816810.2022.2163404
Agrawal T., Maddileti S., Mariappan I. et al. Generation and characterization of three CRISPR/Cas9 edited RB1 null hiPSC lines for retinoblastoma disease modelling. Stem cell research. 2024-03-25;76(76):103373
doi: 10.1016/j.scr.2024.103373
Agrawal T., Maddileti S., Verma A. et al. Generation of an induced pluripotent stem cell line (LVPEIi002-A) with heterozygous RB1 mutation using peri-orbital fat derived mesenchymal cells of a patient with inherited retinoblastoma. Stem cell research. 2024-03-25;76(76):103329
doi: 10.1016/j.scr.2024.103329
Ahangar Davoodi N., Najafi S., Naderi Ghale-Noie Z. et al. Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression. Frontiers in cell and developmental biology. 2023-01-11;10(10):1065837
doi: 10.3389/fcell.2022.1065837
Ahmad S., Azarcon C.P., Hubbard G.B., Wells J.R. Unilateral Xanthocoria and Retinal Vascular Anomalies in a 3-Year-Old Boy: Retinoblastoma or Coats Disease? J Pediatr Ophthalmol Strabismus. 2022 May-Jun;59(3):e33-e34
doi: 10.3928/01913913-20220420-01
Ain-Nasyrah AS, Rahmat J, Ghani SA, Shatriah I. The survival outcomes of unilateral retinoblastoma in Malaysia. Med J Malaysia. 2025 Mar;80(2):113-117. PMID: 40145150.
Abdelazeem B., Abbas K.S., Shehata J. et al. Increased Risk of Subsequent Skin Melanoma in Patients with Retinoblastoma: SEER-Based Results. The Journal of investigative dermatology. 2022-10-25;142(11):3123-3125.
doi: 10.1016/j.jid.2022.04.013
Abdelazeem B., Abbas K.S., Shehata J. et al. Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed? Cancer medicine. 2022-12-08
doi: 10.1002/cam4.5406
Abdelbaki M.S., Abu-Arja M.H., Davidson T.B., Fangusaro J.R., Stanek J.R., Dunkel I.J., Dhall G, Gardner SL, Finlay JL. Pineoblastoma in children less than six years of age: The Head Start I, II, and III experience. // Pediatric Blood & Cancer. 2020 Mar 18.
doi: 10.1002/pbc.28252
Abramson D.H. Cell Free DNA (cfDNA) in the Blood of Retinoblastoma Patients The Robert M. Ellsworth Lecture. Ophthalmic Genet. 2022 Apr 5:1-5. Epub ahead of print.
PMID: 35382685.
doi: 10.1080/13816810.2021.2004433
Abramson D.H. et al. Ten things you learned in your residency about retinoblastoma that have changed the 2023 Victor T. Curtin Lecture. Ophthalmic genetics. 2023-03-30:1-6
doi: 10.1080/13816810.2023.2189948
Abramson D.H. et al. What have we learned about intraarterial chemotherapy (Ophthalmic Artery Chemosurgery) for retinoblastoma in the past 18 years? The third A. Linn Murphree Lecture. Ophthalmic genetics. 2024-12-02;45(6):551-557
doi: 10.1080/13816810.2024.2388579
Abramson D.H., Bian Y., Belinsky I., Francis J.H. An in-utero presentation of trilateral retinoblastoma. Ophthalmology. Retina. 2020 Dec 26:S2468-6530(20)30504-2.
doi: 10.1016/j.oret.2020.12.017
Abramson D.H., Bian Y., Belinsky I., Francis JH. An In Utero Presentation of Trilateral Retinoblastoma. Ophthalmol Retina. 2021 Aug;5(8):831-832.
doi: 10.1016/j.oret.2020.12.017
Abramson D.H., Dunkel I.J., Francis J.H. et al. Magnetic Resonance Imaging of Metastatic Retinoblastoma. Journal of pediatric ophthalmology and strabismus. 2022-08-08:1
doi: 10.3928/01913913-20220623-02
Abramson DH, Francis JH, Knopman J, Dunkel IJ, Gobin YP. Ophthalmic Artery Chemosurgery for Retinoblastoma Babies Less than 3 Months Old or under 6-kg Weight. Ophthalmol Retina. 2025 Mar 20:S2468-6530(25)00115-0. Epub ahead of print. PMID: 40120678.
doi: 10.1016/j.oret.2025.03.008
Abramson D.H., Francis J.H. et al. Intravitreal Topotecan 90 µg for Recurrent Solid Retinoblastoma Tumors Is Effective and Not Toxic. Journal of pediatric ophthalmology and strabismus. 2023-03-29;60(2):e16-e18
doi: 10.3928/01913913-20230110-01
Abramson D.H., Gaccione J., Bracken C. et al. How Much Time Do Focal Treatments for Retinoblastoma Add to Anesthetic Exposure? Ocular oncology and pathology. 2024-11-05;10(3):182-188
doi: 10.1159/000539488
Abramson D.H., Gobin Y.P., Dunkel I.J., Francis J.H. Successful Treatment of Massive Choroidal Invasion in Retinoblastoma with Intraarterial Chemotherapy (Ophthalmic Artery Chemosurgery). Ophthalmology. Retina. 2020 Dec 28:S2468-6530(20)30505-4.
doi: 10.1016/j.oret.2020.12.018
Abramson D.H., Gobin Y.P., Dunkel I.J., Francis J.H. Successful Treatment of Massive Choroidal Invasion in Retinoblastoma with Intra-arterial Chemotherapy (Ophthalmic Artery Chemosurgery). Ophthalmol Retina. 2021 Sep;5(9):936-939.
doi: 10.1016/j.oret.2020.12.018
Abramson D.H., Gobin Y.P., Francis J.H. et al. Good Vision in Retinoblastoma Treated With Intra-arterial Chemotherapy and Laser in the Papillomacular Bundle. Journal of pediatric ophthalmology and strabismus. 2022-08-08:1
doi: 10.3928/01913913-20220629-01
Abramson D.H., Gobin Y.P., Francis J.H. et al. Ophthalmic Artery Chemosurgery for Optic Nerve Invasion in Retinoblastoma. Journal of pediatric ophthalmology and strabismus. 2024-05-30:1
doi: 10.3928/01913913-20240508-09
Abramson D.H., Gobin Y.P., Francis J.H. Orbital Retinoblastoma Treated with Intra-arterial Chemotherapy. Ophthalmology. 2021 Oct;128(10):1437.
doi: 10.1016/j.ophtha.2021.03.018
Abramson D.H., Haque S., Francis J.H. Prelaminar and Postlaminar Invasion of Retinoblastoma. Ophthalmology. Retina. 2021 Apr;5(4):387.
doi: 10.1016/j.oret.2020.12.015.
Abramson D.H., Haque S., Francis J.H. Unilateral Retinoblastoma Metastatic to the Skull and Both Orbits. Ophthalmology Retina. 2020 Oct;4
doi: 10.1016/j.oret.2020.04.019
Abramson D.H., Liu T., Guarini E. et al. Improved method of dilating pupils for ophthalmic exams under anesthesia (faster and easier). Asia-Pacific journal of oncology nursing. 2024-08-31;11(8):100543
doi: 10.1016/j.apjon.2024.100543
Abramson D.H., Mandelker D.L., Brannon A.R. et al. Mutant-RB1 circulating tumor DNA in the blood of unilateral retinoblastoma patients: What happens during enucleation surgery: A pilot study. PloS one. 2023-03-27;18(2):e0271505
doi: 10.1371/journal.pone.0271505
Abramson D.H., Robbins M.A., Gobin Y.P. et al. Circulating Tumor DNA Posttreatment Measurements and Clinical Correlates in Retinoblastoma. JAMA ophthalmology. 2024-03-22;142(3):257-261
doi: 10.1001/jamaophthalmol.2023.6516
Abramson D.H., Shields C.L. et al. RE: Tomar et al; American Joint Committee on Cancer Ophthalmic Oncology Task Force. High-risk pathologic features based on presenting findings in advanced intraocular retinoblastoma: a multicenter, international data-sharing American Joint Committee on Cancer Study (Ophthalmology. 2022;129:923-932) and Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. Metastatic death based on presenting features and treatment for advanced intraocular retinoblastoma: a multicenter registry-based study. (Ophthalmology. 2022;129:933-945). Ophthalmology. 2022-11-28
doi: 10.1016/j.ophtha.2022.10.018
Abruzzo T., Abraham K., Karani K.B., Geller J.I., Vadivelu S., Racadio J.M., Zhang B., Correa Z.M. Correlation of Technical and Adjunctive Factors with Quantitative Tumor Reduction in Children Undergoing Selective Ophthalmic Artery Infusion Chemotherapy for Retinoblastoma. AJNR. American journal of neuroradiology. 2020 Dec 24
doi: 10.3174/ajnr.A6905
Abusayf M.M., Alkatan H.M., Elkhamary S., Almesfer S.A., Maktabi A.M.Y.
Histopathological assessment of optic nerve invasion guided by radiological findings in enucleated globes with retinoblastoma. BMC Ophthalmology. 2020 Sep 29
doi: 10.1186/s12886-020-01654-z
de Aguirre Neto J.C., Antoneli C.B., Ribeiro K.B., Castilho M.S., Novaes P.E., Chojniak M.M., Arias V. Retinoblastoma in children older than 5 years of age
Pediatric blood & cancer. 2007 Mar;48(3):292-5
doi: 10.1002/pbc.20931
Agarwal A., Tanna V., Vempuluru V.S. et al. Intravitreal Melphalan versus Topotecan for Vitreous Seeds in Retinoblastoma: A Comparative Study of 64 Asian Indian Eyes. Ophthalmol Retina. 2025 Jun;9(6):589-597. Epub 2024 Nov 19. PMID: 39566884.
doi: 10.1016/j.oret.2024.11.010
Agarwal A, Mishra DK, Kaliki S. Retinal pigment epithelial (RPE) adenoma mimicking retinoblastoma in a child. BMJ Case Rep. 2025 Apr 5;18(4):e260331.
doi: 10.1136/bcr-2024-260331. PMID: 40187765
Agarwal K., Vinekar A., Chandra P., Padhi T.R., Nayak S., Jayanna S., Panchal B., Jalali S., Das T. Imaging the pediatric retina: An overview. Indian J Ophthalmol. 2021 Apr;69(4):812-823. PMID: 33727440; PMCID: PMC8012979
doi: 10.4103/ijo.IJO_1917_20
Aggarwal R., Sharma M., Singh U. et al. Understanding the killer-cell immunoglobulin like receptor polymorphism in retinoblastoma. Ophthalmic genetics. 2023-01-03:1-5
doi: 10.1080/13816810.2022.2163404
Agrawal T., Maddileti S., Mariappan I. et al. Generation and characterization of three CRISPR/Cas9 edited RB1 null hiPSC lines for retinoblastoma disease modelling. Stem cell research. 2024-03-25;76(76):103373
doi: 10.1016/j.scr.2024.103373
Agrawal T., Maddileti S., Verma A. et al. Generation of an induced pluripotent stem cell line (LVPEIi002-A) with heterozygous RB1 mutation using peri-orbital fat derived mesenchymal cells of a patient with inherited retinoblastoma. Stem cell research. 2024-03-25;76(76):103329
doi: 10.1016/j.scr.2024.103329
Ahangar Davoodi N., Najafi S., Naderi Ghale-Noie Z. et al. Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression. Frontiers in cell and developmental biology. 2023-01-11;10(10):1065837
doi: 10.3389/fcell.2022.1065837
Ahmad S., Azarcon C.P., Hubbard G.B., Wells J.R. Unilateral Xanthocoria and Retinal Vascular Anomalies in a 3-Year-Old Boy: Retinoblastoma or Coats Disease? J Pediatr Ophthalmol Strabismus. 2022 May-Jun;59(3):e33-e34
doi: 10.3928/01913913-20220420-01
Ain-Nasyrah AS, Rahmat J, Ghani SA, Shatriah I. The survival outcomes of unilateral retinoblastoma in Malaysia. Med J Malaysia. 2025 Mar;80(2):113-117. PMID: 40145150.
Akabane M., Hashimoto M., Takazawa Y., Hattori D., Koyama R., Imamura T. Leiomyosarcoma of the splenic vein with a history of bilateral retinoblastoma: A case report and review of the literature. Mol Clin Oncol. 2022 Feb;16(2):35
doi: 10.3892/mco.2021.2468
Akaeda S., Hirota Y., Fukui Y., Aikawa S., Shimizu-Hirota R., Kaku T., Gebril M., Hirata T., Hiraoka T., Matsuo M., Haraguchi H., Saito-Kanatani M., Takeda N., Fujii T., Osuga Y. Retinoblastoma protein promotes uterine epithelial cell cycle arrest and necroptosis for embryo invasion. EMBO Rep. 2021 Feb 3;22(2):e50927. Epub 2021 Jan 5
doi: 10.15252/embr.202050927
Akdemir Aktaş H., Ergun K.M., Tatar İ., Arat A., Hayran K.M.
Evaluation of the anastomoses between the ophthalmic artery and the middle meningeal artery by superselective angiography. Surgical and radiologic anatomy : SRA. 2020 Aug 16
doi: 10.1007/s00276-020-02546-z
Akdeniz Odemis D., Kebudi R., Bayramova J. et al. RB1 gene mutations and genetic spectrum in retinoblastoma cases. Medicine. 2023-09-22;102(36):e35068
doi: 10.1097/MD.0000000000035068
Akkari F.G., Stathopoulos C., Puccinelli F. et al. Absorbable gelatin compressed sponge (Gelfoam) embolization of distal external carotid artery branches in intra-arterial chemotherapy for retinoblastoma. Journal of neurointerventional surgery. 2023-05-04
doi: 10.1136/jnis-2023-020206
Aktaş H.A., Balcı S., Tatar İ., Varan A., Kıratlı H., Arat A. Dual ophthalmic arteries: a new case. Surg Radiol Anat. 2022 May 22. Epub ahead of print. PMID: 35598200
doi: 10.1007/s00276-022-02959-y
Al-Haddad C., Wehbi Z., Slim A. et al. Retinoblastoma programme outcome over a 10-year period in Lebanon: assessment of potential impact of the pandemic and economic crisis. Eye (London, England). 2025 Mar;39(4):748-754. Epub 2024 Nov 19. PMID: 39562725; PMCID: PMC11885430.
doi: 10.1038/s41433-024-03465-8
Al-Hussaini M, Sharie SA, Sultan H, Mohammad M, Yousef YA. Retinocytoma: understanding pathogenesis, diagnosis, and treatment approaches. Int J Retina Vitreous. 2025 Feb 25;11(1):20. PMID: 40001157; PMCID: PMC11863914.
doi: 10.1186/s40942-025-00642-z
Alabi A.O., Alabi A.S., Sowunmi A.C. et al. Presentation and Management of Orbito-Ocular Malignancies in a Tertiary Institution in Southwest Nigeria. Journal of the West African College of Surgeons. 2023-10-31;13(1):1-5
doi: 10.4103/jwas.jwas_37_21
Alahmadi G., Maktabi A.M.Y., Sesma G. et al. Ocular Survival Following Intravitreal Melphalan as Adjuvant Treatment for Vitreous Retinoblastoma Seeding. Clinical ophthalmology (Auckland, N.Z.). 2023-07-01;17(17):1789-1800
doi: 10.2147/OPTH.S417370
Albuquerque M.L., Moreto R., Bergamo M. et al. ERG and OCT abnormalities in retinoblastoma after melphalan intravitreous injection. Arquivos brasileiros de oftalmologia. 2022-07-20
doi: 10.5935/0004-2749.2021-0037
Aldughayfiq B., Ashfaq F., Jhanjhi NZ. et al. Explainable AI for Retinoblastoma Diagnosis: Interpreting Deep Learning Models with LIME and SHAP. Diagnostics (Basel, Switzerland). 2023-06-12;13(11)
doi: 10.3390/diagnostics13111932
Alfaar AS, Halalsheh H, Shelil AE, Qaddoumi I. Nationwide incidence and survival of retinoblastoma in the USA between 1996 and 2018: a review of 5730 cases. Ophthalmic Genet. 2025 Apr;46(2):144-153. Epub 2025 Feb 10. PMID: 39927550.
doi: 10.1080/13816810.2024.2449086
Alefeld E., Haase A., Van Meenen D. et al. In vitro model of retinoblastoma derived tumor and stromal cells for tumor microenvironment (TME) studies. Cell death & disease. 2025-01-04;15(12):905
doi: 10.1038/s41419-024-07285-2
Alekseeva E.A., Babenko O.V., Kozlova V.M., Ushakova T.L., Kazubskaya T.P., Nemtsova M.V., Chesnokova G.G., Mikhaylenko D.S., Bure I.V., Kalinkin A.I., Kuznetsova E.B., Tanas A.S., Kutsev S.I., Zaletaev D.V., Strelnikov V.V. Parental Origin of the RB1 Gene Mutations in Families with Low Penetrance Hereditary Retinoblastoma. Cancers. 2021, № 13, P.5068.-72
https://doi.org/10.3390/cancers13205068
Al-Ghazzawi K., Wessolly M., Dalbah S. et al. PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma. Frontiers in oncology. 2023-12-25;13(13):1144951
doi: 10.3389/fonc.2023.1144951
Alghofaili R. S., Almesfer S. A. Bilateral Retinoblastoma Presenting in an in vitro Fertilization Infant with Retinopathy of Prematurity. Case reports in ophthalmology, 12(1), 306–310. 2021 Apr 30;12(1):306-310
doi: 10.1159/000513181
Alhasseny K.F., Mahmud H., Al-Samarraie M. et al. An Unexpected Response of Orbital Retinoblastoma to Inconsistent Systemic Chemotherapy Alone. Case reports in ophthalmology. 2024-10-30;15(1):769-774
doi: 10.1159/000541776
Ali M.S., Sinha R., Bhaskar G. et al. Demographic and Clinical Characteristics of Retinoblastoma Cases at a Tertiary Care Center in Eastern India. Cureus. 2024-08-17;16(7):e64659
doi: 10.7759/cureus.64659
Alkatan H.M., AlQahtani F.S., Maktabi A.M. Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC). International Ophthalmology. 2020 Mar 19.
doi: 10.1007/s10792-020-01342-3
Alkatan H.M., Almuzaini A., Helmi H.A. et al. A retrospective study on adjuvant chemotherapy in retinoblastoma: validation of the new recommendation against treatment for pT2a tumors based on the 8th AJCC classification. BMC ophthalmology. 2024-07-28;24(1):309
doi: 10.1186/s12886-024-03585-5
Alkatan H.M., Al-Dahmash S.A., Almesfer S.A., AlQahtani F.S., Maktabi A.M.Y.
High-risk features in primary versus secondary enucleated globes with advanced retinoblastoma: a retrospective histopathological study. International ophthalmology. 2020 Jul 6
doi: 10.1007/s10792-020-01472-8
Allaman-Pillet N., Schorderet D.F. Piperlongumine promotes death of retinoblastoma cancer cells. Oncotarget. 2021 Apr 27;12(9):907-916
doi: 10.18632/oncotarget.27947
Allphin M.T., Ramasubramanian A. et al. Bilateral familial retinoblastoma diagnosed via optical coherence tomography following a normal funduscopic exam. Familial cancer. 2024-12-16;24(1):12
doi: 10.1007/s10689-024-00424-w
AlQahtani G.M.S., Alkatan H.M., AlMesfer S. et al. A case of retinoblastoma masquerading as endophthalmitis: Unusual presentation and clinicopathological correlation. International journal of surgery case reports. 2024-09-28;123(123):110263
doi: 10.1016/j.ijscr.2024.110263
Alotaibi A., Karam M., Roto A. et al. The first retinoblastoma local experience in Kuwait: A retrospective case series. American journal of ophthalmology case reports. 2024-01-31;33(33):101988
doi: 10.1016/j.ajoc.2023.101988
Alruwais N., Obayya M., Al-Mutiri F. et al. Advancing retinoblastoma detection based on binary arithmetic optimization and integrated features. PeerJ. Computer science. 2023-12-11;9(9):e1681
doi: 10.7717/peerj-cs.1681
Al Saiegh F., Chalouhi N., Sweid A., Mazza J., Mouchtouris N., Khanna O., Tjoumakaris S., Gooch R, Shields CL, Rosenwasser R, Jabbour P. Intra-arterial chemotherapy for retinoblastoma via the transradial route: Technique, feasibility, and case series. Clinical Neurology and Neurosurgery. 2020 Apr 6
doi: 10.1016/j.clineuro.2020.105824
Alshahrani N.O., Aldhawi A., Feng Z.X. et al. Single- Versus Triple-Agent Intra-Arterial Chemotherapy for Retinoblastoma. American journal of ophthalmology. 2025 Jan;269:488-496. Epub 2024 Oct 10. PMID: 39395595.
doi: 10.1016/j.ajo.2024.09.037
Altamirano-Lamarque F., Gonzalez E., Oke I. et al. The association between race and age of diagnosis of retinoblastoma in United States children. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2024-06-06;28(3):103932
doi: 10.1016/j.jaapos.2024.103932
Altamirano-Lamarque F., Lim C., Shah A.S. et al. Association of Neighborhood Opportunity With Severity of Retinoblastoma at Presentation. American journal of ophthalmology. 2024-02-07;261(261):1-6
doi: 10.1016/j.ajo.2024.01.013
Alvarez-Suarez D.E., Tovar H., Hernández-Lemus E., Orjuela M., Sadowinski-Pine S., Cabrera-Muñoz L., Camacho J., Favari L., Hernández-Angeles A., Ponce-Castañeda M.V. Discovery of a transcriptomic core of genes shared in 8 primary retinoblastoma with a novel detection score analysis. J Cancer Res Clin Oncol. 2020 May 30
doi: 10.1007/s00432-020-03266-y
Amin S., AlJboor M., Toro M.D., Rejdak R., Nowomiejska K., Nazzal R., Mohammad M., Al-Hussaini M., Khzouz J., Banat S., AlJabari R., Jaradat I., Mehyar M., Sultan I., AlNawaiseh I., Yousef Y.A.
Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma. Clinical ophthalmology. 2021 Jan 7;15:65-72
doi: 10.2147/OPTH.S282741
El Amrani Z., Elalaoui S.C., Jdioui W., Sbiti A., Ratbi I., Liehr T., Sefiani A., Natiq A. Complex translocation leading to13q interstitial deletion in a Moroccan child with retinoblastoma and intellectual disability. Ophthalmic Genet. 2022 Jun 6:1-4. Epub ahead of print. PMID: 35658784
doi: 10.1080/13816810.2022.2083183
doi: 10.3892/mco.2021.2468
Akaeda S., Hirota Y., Fukui Y., Aikawa S., Shimizu-Hirota R., Kaku T., Gebril M., Hirata T., Hiraoka T., Matsuo M., Haraguchi H., Saito-Kanatani M., Takeda N., Fujii T., Osuga Y. Retinoblastoma protein promotes uterine epithelial cell cycle arrest and necroptosis for embryo invasion. EMBO Rep. 2021 Feb 3;22(2):e50927. Epub 2021 Jan 5
doi: 10.15252/embr.202050927
Akdemir Aktaş H., Ergun K.M., Tatar İ., Arat A., Hayran K.M.
Evaluation of the anastomoses between the ophthalmic artery and the middle meningeal artery by superselective angiography. Surgical and radiologic anatomy : SRA. 2020 Aug 16
doi: 10.1007/s00276-020-02546-z
Akdeniz Odemis D., Kebudi R., Bayramova J. et al. RB1 gene mutations and genetic spectrum in retinoblastoma cases. Medicine. 2023-09-22;102(36):e35068
doi: 10.1097/MD.0000000000035068
Akkari F.G., Stathopoulos C., Puccinelli F. et al. Absorbable gelatin compressed sponge (Gelfoam) embolization of distal external carotid artery branches in intra-arterial chemotherapy for retinoblastoma. Journal of neurointerventional surgery. 2023-05-04
doi: 10.1136/jnis-2023-020206
Aktaş H.A., Balcı S., Tatar İ., Varan A., Kıratlı H., Arat A. Dual ophthalmic arteries: a new case. Surg Radiol Anat. 2022 May 22. Epub ahead of print. PMID: 35598200
doi: 10.1007/s00276-022-02959-y
Al-Haddad C., Wehbi Z., Slim A. et al. Retinoblastoma programme outcome over a 10-year period in Lebanon: assessment of potential impact of the pandemic and economic crisis. Eye (London, England). 2025 Mar;39(4):748-754. Epub 2024 Nov 19. PMID: 39562725; PMCID: PMC11885430.
doi: 10.1038/s41433-024-03465-8
Al-Hussaini M, Sharie SA, Sultan H, Mohammad M, Yousef YA. Retinocytoma: understanding pathogenesis, diagnosis, and treatment approaches. Int J Retina Vitreous. 2025 Feb 25;11(1):20. PMID: 40001157; PMCID: PMC11863914.
doi: 10.1186/s40942-025-00642-z
Alabi A.O., Alabi A.S., Sowunmi A.C. et al. Presentation and Management of Orbito-Ocular Malignancies in a Tertiary Institution in Southwest Nigeria. Journal of the West African College of Surgeons. 2023-10-31;13(1):1-5
doi: 10.4103/jwas.jwas_37_21
Alahmadi G., Maktabi A.M.Y., Sesma G. et al. Ocular Survival Following Intravitreal Melphalan as Adjuvant Treatment for Vitreous Retinoblastoma Seeding. Clinical ophthalmology (Auckland, N.Z.). 2023-07-01;17(17):1789-1800
doi: 10.2147/OPTH.S417370
Albuquerque M.L., Moreto R., Bergamo M. et al. ERG and OCT abnormalities in retinoblastoma after melphalan intravitreous injection. Arquivos brasileiros de oftalmologia. 2022-07-20
doi: 10.5935/0004-2749.2021-0037
Aldughayfiq B., Ashfaq F., Jhanjhi NZ. et al. Explainable AI for Retinoblastoma Diagnosis: Interpreting Deep Learning Models with LIME and SHAP. Diagnostics (Basel, Switzerland). 2023-06-12;13(11)
doi: 10.3390/diagnostics13111932
Alfaar AS, Halalsheh H, Shelil AE, Qaddoumi I. Nationwide incidence and survival of retinoblastoma in the USA between 1996 and 2018: a review of 5730 cases. Ophthalmic Genet. 2025 Apr;46(2):144-153. Epub 2025 Feb 10. PMID: 39927550.
doi: 10.1080/13816810.2024.2449086
Alefeld E., Haase A., Van Meenen D. et al. In vitro model of retinoblastoma derived tumor and stromal cells for tumor microenvironment (TME) studies. Cell death & disease. 2025-01-04;15(12):905
doi: 10.1038/s41419-024-07285-2
Alekseeva E.A., Babenko O.V., Kozlova V.M., Ushakova T.L., Kazubskaya T.P., Nemtsova M.V., Chesnokova G.G., Mikhaylenko D.S., Bure I.V., Kalinkin A.I., Kuznetsova E.B., Tanas A.S., Kutsev S.I., Zaletaev D.V., Strelnikov V.V. Parental Origin of the RB1 Gene Mutations in Families with Low Penetrance Hereditary Retinoblastoma. Cancers. 2021, № 13, P.5068.-72
https://doi.org/10.3390/cancers13205068
Al-Ghazzawi K., Wessolly M., Dalbah S. et al. PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma. Frontiers in oncology. 2023-12-25;13(13):1144951
doi: 10.3389/fonc.2023.1144951
Alghofaili R. S., Almesfer S. A. Bilateral Retinoblastoma Presenting in an in vitro Fertilization Infant with Retinopathy of Prematurity. Case reports in ophthalmology, 12(1), 306–310. 2021 Apr 30;12(1):306-310
doi: 10.1159/000513181
Alhasseny K.F., Mahmud H., Al-Samarraie M. et al. An Unexpected Response of Orbital Retinoblastoma to Inconsistent Systemic Chemotherapy Alone. Case reports in ophthalmology. 2024-10-30;15(1):769-774
doi: 10.1159/000541776
Ali M.S., Sinha R., Bhaskar G. et al. Demographic and Clinical Characteristics of Retinoblastoma Cases at a Tertiary Care Center in Eastern India. Cureus. 2024-08-17;16(7):e64659
doi: 10.7759/cureus.64659
Alkatan H.M., AlQahtani F.S., Maktabi A.M. Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC). International Ophthalmology. 2020 Mar 19.
doi: 10.1007/s10792-020-01342-3
Alkatan H.M., Almuzaini A., Helmi H.A. et al. A retrospective study on adjuvant chemotherapy in retinoblastoma: validation of the new recommendation against treatment for pT2a tumors based on the 8th AJCC classification. BMC ophthalmology. 2024-07-28;24(1):309
doi: 10.1186/s12886-024-03585-5
Alkatan H.M., Al-Dahmash S.A., Almesfer S.A., AlQahtani F.S., Maktabi A.M.Y.
High-risk features in primary versus secondary enucleated globes with advanced retinoblastoma: a retrospective histopathological study. International ophthalmology. 2020 Jul 6
doi: 10.1007/s10792-020-01472-8
Allaman-Pillet N., Schorderet D.F. Piperlongumine promotes death of retinoblastoma cancer cells. Oncotarget. 2021 Apr 27;12(9):907-916
doi: 10.18632/oncotarget.27947
Allphin M.T., Ramasubramanian A. et al. Bilateral familial retinoblastoma diagnosed via optical coherence tomography following a normal funduscopic exam. Familial cancer. 2024-12-16;24(1):12
doi: 10.1007/s10689-024-00424-w
AlQahtani G.M.S., Alkatan H.M., AlMesfer S. et al. A case of retinoblastoma masquerading as endophthalmitis: Unusual presentation and clinicopathological correlation. International journal of surgery case reports. 2024-09-28;123(123):110263
doi: 10.1016/j.ijscr.2024.110263
Alotaibi A., Karam M., Roto A. et al. The first retinoblastoma local experience in Kuwait: A retrospective case series. American journal of ophthalmology case reports. 2024-01-31;33(33):101988
doi: 10.1016/j.ajoc.2023.101988
Alruwais N., Obayya M., Al-Mutiri F. et al. Advancing retinoblastoma detection based on binary arithmetic optimization and integrated features. PeerJ. Computer science. 2023-12-11;9(9):e1681
doi: 10.7717/peerj-cs.1681
Al Saiegh F., Chalouhi N., Sweid A., Mazza J., Mouchtouris N., Khanna O., Tjoumakaris S., Gooch R, Shields CL, Rosenwasser R, Jabbour P. Intra-arterial chemotherapy for retinoblastoma via the transradial route: Technique, feasibility, and case series. Clinical Neurology and Neurosurgery. 2020 Apr 6
doi: 10.1016/j.clineuro.2020.105824
Alshahrani N.O., Aldhawi A., Feng Z.X. et al. Single- Versus Triple-Agent Intra-Arterial Chemotherapy for Retinoblastoma. American journal of ophthalmology. 2025 Jan;269:488-496. Epub 2024 Oct 10. PMID: 39395595.
doi: 10.1016/j.ajo.2024.09.037
Altamirano-Lamarque F., Gonzalez E., Oke I. et al. The association between race and age of diagnosis of retinoblastoma in United States children. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2024-06-06;28(3):103932
doi: 10.1016/j.jaapos.2024.103932
Altamirano-Lamarque F., Lim C., Shah A.S. et al. Association of Neighborhood Opportunity With Severity of Retinoblastoma at Presentation. American journal of ophthalmology. 2024-02-07;261(261):1-6
doi: 10.1016/j.ajo.2024.01.013
Alvarez-Suarez D.E., Tovar H., Hernández-Lemus E., Orjuela M., Sadowinski-Pine S., Cabrera-Muñoz L., Camacho J., Favari L., Hernández-Angeles A., Ponce-Castañeda M.V. Discovery of a transcriptomic core of genes shared in 8 primary retinoblastoma with a novel detection score analysis. J Cancer Res Clin Oncol. 2020 May 30
doi: 10.1007/s00432-020-03266-y
Amin S., AlJboor M., Toro M.D., Rejdak R., Nowomiejska K., Nazzal R., Mohammad M., Al-Hussaini M., Khzouz J., Banat S., AlJabari R., Jaradat I., Mehyar M., Sultan I., AlNawaiseh I., Yousef Y.A.
Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma. Clinical ophthalmology. 2021 Jan 7;15:65-72
doi: 10.2147/OPTH.S282741
El Amrani Z., Elalaoui S.C., Jdioui W., Sbiti A., Ratbi I., Liehr T., Sefiani A., Natiq A. Complex translocation leading to13q interstitial deletion in a Moroccan child with retinoblastoma and intellectual disability. Ophthalmic Genet. 2022 Jun 6:1-4. Epub ahead of print. PMID: 35658784
doi: 10.1080/13816810.2022.2083183
Ancona-Lezama D., Dalvin L.A., Shields C.L. Modern treatment of retinoblastoma: A 2020 review. Indian journal of ophthalmology. 2020 Nov;68(11):2356-2365
doi: 10.4103/ijo.IJO_721_20
Ancona-Lezama D., Garza-Garza L.A., Ruiz-Lozano R.E., Shields C.L., Villagomez-Valdez L.G., De-Leija-Portilla J.O. Diffuse infiltrative retinoblastoma with retinal detachment in "cinnamon-roll" configuration: a case report. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus / American Association for Pediatric Ophthalmology and Strabismus. 2020 Dec 18:S1091-8531(20)30315-3
doi: 10.1016/j.jaapos.2020.10.004
Ansari M, Gupta C, Kulkarni YA, Singh K. Functionalization of polymeric nanomicelles and mixed nanomicelles for targeted retinal delivery in the management of retinoblastoma. Int J Pharm. 2025 Feb 25;671:125235. Epub 2025 Jan 16. PMID: 39826786.
doi: 10.1016/j.ijpharm.2025.125235
Ansari M, Kulkarni YA, Singh K. Ocular polymeric nanomicelles for the posterior eye segment in the management of retinoblastoma: formulation, optimization, in vitro and ex vivo evaluations. Pharm Dev Technol. 2025 Mar;30(3):246-258. Epub 2025 Feb 23. PMID: 39985152.
doi: 10.1080/10837450.2025.2469321
Ansari M., Kulkarni Y.A., Singh K. et al. Advanced Technologies of Drug Delivery to the Posterior Eye Segment Targeting Angiogenesis and Ocular Cancer. Critical reviews in therapeutic drug carrier systems. 2023-11-01;41(1):85-124
doi: 10.1615/CritRevTherDrugCarrierSyst.2023045298
Apumayta ED, Buitrago M, Rioja M, Alarcon S, Salvador J, Ruiz E. Liver metastasis of retinoblastoma. Ecancermedicalscience. 2025 Jan 15;19:1824. PMID: 40177152; PMCID: PMC11959138.
doi: 10.3332/ecancer.2025.1824
Arazi M., Baum A., Casavilca-Zambrano S. et al. Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral Retinoblastoma. American journal of ophthalmology. 2024-12-04;268(268):399-408
doi: 10.1016/j.ajo.2024.09.023
Arazi M, Didi Fabian I. Telemedicine in Retinoblastoma: A Review. Semin Ophthalmol. 2025 Mar 3:1-6. Epub ahead of print. PMID: 40132087.
doi: 10.1080/08820538.2025.2471989
Arazi M, Kfir J, Sediqi SM, Majeed AR, Chaudhry S, Baum A, Behjat S, Hamid SA, Foster A, Fabian ID. Afghanistan-Pakistan retinoblastoma "Silk Road" referral pathway. Eye (Lond). 2025 May 3. Epub ahead of print. PMID: 40319173.
doi: 10.1038/s41433-025-03823-0
Arshad R., Barani M., Rahdar A., Sargazi S., Cucchiarini M., Pandey S., Kang M. Multi-Functionalized Nanomaterials and Nanoparticles for Diagnosis and Treatment of Retinoblastoma. Biosensors. 2021 Mar 26;11(4):97 doi: 10.3390/bios11040097
Arslan-Carlon V., Walline M.C., Seier K., Tan K.S., Abramson D.H. Hemodynamic Changes Associated with Mydriatic Eye Drop Administration in Anesthetized Pediatric Patients. Ocular oncology and pathology. 2020 May, 6
doi: 10.1159/000500593
Asadi M.R., Moslehian M.S., Sabaie H. et al. CircRNA-Associated CeRNAs Regulatory Axes in Retinoblastoma: A Systematic Scoping Review. Frontiers in oncology. 2022-07-23;12(12):910470
doi: 10.3389/fonc.2022.910470
Aschero R., Ganiewich D., Lamas G. et al. Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma. Pediatric blood & cancer. 2023-11-24;71(1):e30717
doi: 10.1002/pbc.30717
Aschero R., Francis J.H., Ganiewich D., Gomez-Gonzalez S., Sampor C., Zugbi S., Ottaviani D., Lemelle L., Mena M., Winter U., Correa Llano G., Lamas G., Lubieniecki F., Szijan I., Mora J., Podhajcer O., Doz F., Radvanyi F., Abramson D.H., Llera A.S., Schaiquevich P.S., Lavarino C., Chantada G.L. Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma. Cancers (Basel). 2021 Feb 8;13(4):673
doi: 10.3390/cancers13040673
Aschero R, Simao M, Catala-Mora J, L Chantada G. Risk Factors for Extraocular Relapse in Retinoblastoma. Semin Ophthalmol. 2025 Jan 9:1-11. Epub ahead of print. PMID: 39789868.
doi: 10.1080/08820538.2025.2450682
Ashkenazy N., Diaz J.D., Hansen E.D. et al. Cyst-like recurrence of retinoblastoma diagnosed by multimodal imaging. American journal of ophthalmology case reports. 2022-08-23;27(27):101678
doi: 10.1016/j.ajoc.2022.101678
Assane Rachidou MHA, Vanniarajan A, Kim U, Devarajan B. Analysing Differential Alternative Splicing Events and Their Impact on Retinoblastoma Progression Using RNA-seq Metadata. Asian Pac J Cancer Prev. 2025 May 1;26(5):1781-1792. PMID: 40439392.
doi: 10.31557/APJCP.2025.26.5.1781
Atima-Ayeni E, Orugun AJ, Idakwo U, Komolafe O, Atima MO, Atanda AT, Dahiru WG, Owolabi SK, Shimizu E, Shintaro N, Balogun EO, Dingwoke EJ. Retinoblastoma in a Young Nigerian Girl: A Case Report From ECWA Eye Hospital, Kano. Case Rep Ophthalmol Med. 2025 Jun 8;2025:1733830. PMID: 40524702; PMCID: PMC12170086.
doi: 10.1155/crop/1733830
Atima M.O., Idakwo U., Komolafe O. et al. Presentation pattern and survival rate of retinoblastoma following chemotherapy: a prospective study. BMC pediatrics. 2023-11-03;23(1):538
doi: 10.1186/s12887-023-04347-w
Attem J., Narayana R.V.L., Manukonda R. et al. Small extracellular vesicles loaded with carboplatin effectively enhance the cytotoxicity of drug-resistant cells from Y79 cells-in vitro. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2024-03-27;173(173):116403
doi: 10.1016/j.biopha.2024.116403
Attem J, Vemuganti GK. The Role of Small Extracellular Vesicles in Retinoblastoma Development and Progression. Curr Eye Res. 2025 Feb 4:1-15. Epub ahead of print. PMID: 39905667.
doi: 10.1080/02713683.2025.2457102
Attiku Y., Rishi P. Miliary tuberculosis presenting as bilateral pseudo-retinoblastoma. GMS Ophthalmol Cases. 2021 Jul 28;11:Doc12
doi: 10.3205/oc000185
Atwine R., Laffita D., Birungi A. et al. Clinical and Histopathologic Predictors of Survival Among Children With Retinoblastoma From Two Tertiary Health Facilities in Uganda. Cureus. 2024-01-17;15(12):e50605
doi: 10.7759/cureus.50605
Aubry A., Pearson J.D., Charish J. et al. Deneddylation of ribosomal proteins promotes synergy between MLN4924 and chemotherapy to elicit complete therapeutic responses. Cell reports. 2023-09-06;42(8):112925
doi: 10.1016/j.celrep.2023.112925
Aubry A., Pearson J.D., Huang K., Livne-Bar I., Ahmad M., Jagadeesan M., Khetan V., Ketela T., Brown K.R., Yu T., Lu .S, Wrana J.L., Moffat J., Bremner R. Functional genomics identifies new synergistic therapies for retinoblastoma. ONCOGENE. 2020 Jun 22.
doi: 10.1038/s41388-020-1372-7
Aubry A., Yu T., Bremner R. Preclinical studies reveal MLN4924 is a promising new retinoblastoma therapy. Cell Death Discov. 2020 Jan 20;6:2
doi: 10.1038/s41420-020-0237-8
August AH, Curtis D, Eiger-Moscovich M, Yaghy A, Lally SE, Shields JA, Shields CL, Eagle RC Jr, Milman T. Evolving trends in retinoblastoma management: A 16-year clinicopathological analysis of enucleated eyes. Taiwan J Ophthalmol. 2025 Mar 6;15(1):88-102. PMID: 40213308; PMCID: PMC11981572.
doi: 10.4103/tjo.TJO-D-24-00107
Austein F., Huhndorf M., Papanagiotou P. et al. [Orbital tumors]. Radiologie (Heidelberg, Germany). 2024-02-22;64(3):196-203
doi: 10.1007/s00117-023-01257-x
Awounou D., Lacour B., Desandes E. et al. Seasonality of main childhood embryonal tumours and rhabdomyosarcoma, France, 2000-2015. Cancer medicine. 2023-02-02
doi: 10.1002/cam4.5624
Ayub A., Gupta A., Lomi N. et al. A retrospective analysis of anesthetic concerns and management of pediatric patients undergoing brachytherapy for retinoblastoma. Paediatric anaesthesia. 2024-12-09;35(1):79-81
doi: 10.1111/pan.15036
Azimi F., Mirshahi R., Naseripour M. et al. Review: New horizons in retinoblastoma treatment: an updated review article. Molecular vision. 2022-09-06;28(28):130-146
Azimi F., Naseripour M., Sedaghat A. et al. Association of RB1 rs9568036 and CDKN1A rs1801270 Polymorphisms with Retinoblastoma Susceptibility. Journal of current ophthalmology. 2023-01-17;34(3):328-332
doi: 10.4103/joco.joco_125_22
doi: 10.4103/ijo.IJO_721_20
Ancona-Lezama D., Garza-Garza L.A., Ruiz-Lozano R.E., Shields C.L., Villagomez-Valdez L.G., De-Leija-Portilla J.O. Diffuse infiltrative retinoblastoma with retinal detachment in "cinnamon-roll" configuration: a case report. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus / American Association for Pediatric Ophthalmology and Strabismus. 2020 Dec 18:S1091-8531(20)30315-3
doi: 10.1016/j.jaapos.2020.10.004
Ansari M, Gupta C, Kulkarni YA, Singh K. Functionalization of polymeric nanomicelles and mixed nanomicelles for targeted retinal delivery in the management of retinoblastoma. Int J Pharm. 2025 Feb 25;671:125235. Epub 2025 Jan 16. PMID: 39826786.
doi: 10.1016/j.ijpharm.2025.125235
Ansari M, Kulkarni YA, Singh K. Ocular polymeric nanomicelles for the posterior eye segment in the management of retinoblastoma: formulation, optimization, in vitro and ex vivo evaluations. Pharm Dev Technol. 2025 Mar;30(3):246-258. Epub 2025 Feb 23. PMID: 39985152.
doi: 10.1080/10837450.2025.2469321
Ansari M., Kulkarni Y.A., Singh K. et al. Advanced Technologies of Drug Delivery to the Posterior Eye Segment Targeting Angiogenesis and Ocular Cancer. Critical reviews in therapeutic drug carrier systems. 2023-11-01;41(1):85-124
doi: 10.1615/CritRevTherDrugCarrierSyst.2023045298
Apumayta ED, Buitrago M, Rioja M, Alarcon S, Salvador J, Ruiz E. Liver metastasis of retinoblastoma. Ecancermedicalscience. 2025 Jan 15;19:1824. PMID: 40177152; PMCID: PMC11959138.
doi: 10.3332/ecancer.2025.1824
Arazi M., Baum A., Casavilca-Zambrano S. et al. Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral Retinoblastoma. American journal of ophthalmology. 2024-12-04;268(268):399-408
doi: 10.1016/j.ajo.2024.09.023
Arazi M, Didi Fabian I. Telemedicine in Retinoblastoma: A Review. Semin Ophthalmol. 2025 Mar 3:1-6. Epub ahead of print. PMID: 40132087.
doi: 10.1080/08820538.2025.2471989
Arazi M, Kfir J, Sediqi SM, Majeed AR, Chaudhry S, Baum A, Behjat S, Hamid SA, Foster A, Fabian ID. Afghanistan-Pakistan retinoblastoma "Silk Road" referral pathway. Eye (Lond). 2025 May 3. Epub ahead of print. PMID: 40319173.
doi: 10.1038/s41433-025-03823-0
Arshad R., Barani M., Rahdar A., Sargazi S., Cucchiarini M., Pandey S., Kang M. Multi-Functionalized Nanomaterials and Nanoparticles for Diagnosis and Treatment of Retinoblastoma. Biosensors. 2021 Mar 26;11(4):97 doi: 10.3390/bios11040097
Arslan-Carlon V., Walline M.C., Seier K., Tan K.S., Abramson D.H. Hemodynamic Changes Associated with Mydriatic Eye Drop Administration in Anesthetized Pediatric Patients. Ocular oncology and pathology. 2020 May, 6
doi: 10.1159/000500593
Asadi M.R., Moslehian M.S., Sabaie H. et al. CircRNA-Associated CeRNAs Regulatory Axes in Retinoblastoma: A Systematic Scoping Review. Frontiers in oncology. 2022-07-23;12(12):910470
doi: 10.3389/fonc.2022.910470
Aschero R., Ganiewich D., Lamas G. et al. Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma. Pediatric blood & cancer. 2023-11-24;71(1):e30717
doi: 10.1002/pbc.30717
Aschero R., Francis J.H., Ganiewich D., Gomez-Gonzalez S., Sampor C., Zugbi S., Ottaviani D., Lemelle L., Mena M., Winter U., Correa Llano G., Lamas G., Lubieniecki F., Szijan I., Mora J., Podhajcer O., Doz F., Radvanyi F., Abramson D.H., Llera A.S., Schaiquevich P.S., Lavarino C., Chantada G.L. Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma. Cancers (Basel). 2021 Feb 8;13(4):673
doi: 10.3390/cancers13040673
Aschero R, Simao M, Catala-Mora J, L Chantada G. Risk Factors for Extraocular Relapse in Retinoblastoma. Semin Ophthalmol. 2025 Jan 9:1-11. Epub ahead of print. PMID: 39789868.
doi: 10.1080/08820538.2025.2450682
Ashkenazy N., Diaz J.D., Hansen E.D. et al. Cyst-like recurrence of retinoblastoma diagnosed by multimodal imaging. American journal of ophthalmology case reports. 2022-08-23;27(27):101678
doi: 10.1016/j.ajoc.2022.101678
Assane Rachidou MHA, Vanniarajan A, Kim U, Devarajan B. Analysing Differential Alternative Splicing Events and Their Impact on Retinoblastoma Progression Using RNA-seq Metadata. Asian Pac J Cancer Prev. 2025 May 1;26(5):1781-1792. PMID: 40439392.
doi: 10.31557/APJCP.2025.26.5.1781
Atima-Ayeni E, Orugun AJ, Idakwo U, Komolafe O, Atima MO, Atanda AT, Dahiru WG, Owolabi SK, Shimizu E, Shintaro N, Balogun EO, Dingwoke EJ. Retinoblastoma in a Young Nigerian Girl: A Case Report From ECWA Eye Hospital, Kano. Case Rep Ophthalmol Med. 2025 Jun 8;2025:1733830. PMID: 40524702; PMCID: PMC12170086.
doi: 10.1155/crop/1733830
Atima M.O., Idakwo U., Komolafe O. et al. Presentation pattern and survival rate of retinoblastoma following chemotherapy: a prospective study. BMC pediatrics. 2023-11-03;23(1):538
doi: 10.1186/s12887-023-04347-w
Attem J., Narayana R.V.L., Manukonda R. et al. Small extracellular vesicles loaded with carboplatin effectively enhance the cytotoxicity of drug-resistant cells from Y79 cells-in vitro. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2024-03-27;173(173):116403
doi: 10.1016/j.biopha.2024.116403
Attem J, Vemuganti GK. The Role of Small Extracellular Vesicles in Retinoblastoma Development and Progression. Curr Eye Res. 2025 Feb 4:1-15. Epub ahead of print. PMID: 39905667.
doi: 10.1080/02713683.2025.2457102
Attiku Y., Rishi P. Miliary tuberculosis presenting as bilateral pseudo-retinoblastoma. GMS Ophthalmol Cases. 2021 Jul 28;11:Doc12
doi: 10.3205/oc000185
Atwine R., Laffita D., Birungi A. et al. Clinical and Histopathologic Predictors of Survival Among Children With Retinoblastoma From Two Tertiary Health Facilities in Uganda. Cureus. 2024-01-17;15(12):e50605
doi: 10.7759/cureus.50605
Aubry A., Pearson J.D., Charish J. et al. Deneddylation of ribosomal proteins promotes synergy between MLN4924 and chemotherapy to elicit complete therapeutic responses. Cell reports. 2023-09-06;42(8):112925
doi: 10.1016/j.celrep.2023.112925
Aubry A., Pearson J.D., Huang K., Livne-Bar I., Ahmad M., Jagadeesan M., Khetan V., Ketela T., Brown K.R., Yu T., Lu .S, Wrana J.L., Moffat J., Bremner R. Functional genomics identifies new synergistic therapies for retinoblastoma. ONCOGENE. 2020 Jun 22.
doi: 10.1038/s41388-020-1372-7
Aubry A., Yu T., Bremner R. Preclinical studies reveal MLN4924 is a promising new retinoblastoma therapy. Cell Death Discov. 2020 Jan 20;6:2
doi: 10.1038/s41420-020-0237-8
August AH, Curtis D, Eiger-Moscovich M, Yaghy A, Lally SE, Shields JA, Shields CL, Eagle RC Jr, Milman T. Evolving trends in retinoblastoma management: A 16-year clinicopathological analysis of enucleated eyes. Taiwan J Ophthalmol. 2025 Mar 6;15(1):88-102. PMID: 40213308; PMCID: PMC11981572.
doi: 10.4103/tjo.TJO-D-24-00107
Austein F., Huhndorf M., Papanagiotou P. et al. [Orbital tumors]. Radiologie (Heidelberg, Germany). 2024-02-22;64(3):196-203
doi: 10.1007/s00117-023-01257-x
Awounou D., Lacour B., Desandes E. et al. Seasonality of main childhood embryonal tumours and rhabdomyosarcoma, France, 2000-2015. Cancer medicine. 2023-02-02
doi: 10.1002/cam4.5624
Ayub A., Gupta A., Lomi N. et al. A retrospective analysis of anesthetic concerns and management of pediatric patients undergoing brachytherapy for retinoblastoma. Paediatric anaesthesia. 2024-12-09;35(1):79-81
doi: 10.1111/pan.15036
Azimi F., Mirshahi R., Naseripour M. et al. Review: New horizons in retinoblastoma treatment: an updated review article. Molecular vision. 2022-09-06;28(28):130-146
Azimi F., Naseripour M., Sedaghat A. et al. Association of RB1 rs9568036 and CDKN1A rs1801270 Polymorphisms with Retinoblastoma Susceptibility. Journal of current ophthalmology. 2023-01-17;34(3):328-332
doi: 10.4103/joco.joco_125_22
B
Babu V.S., Mallipatna A., Dudeja G. et al. Depleted hexokinase1 and lack of AMPKα activation favor OXPHOS-dependent energetics in retinoblastoma tumors. Translational research : the journal of laboratory and clinical medicine. 2023-10-11;261(261):41-56
doi: 10.1016/j.trsl.2023.07.001
Babu V.S., Mallipatna A., Sa D., Dudeja G., Kannan R., Shetty R., Nair A.P., Gundimeda S., Chaurasia S.S., Verma N.K., Lakshminarayanan R., Heymans S., Barathi V.A., Guha N., Ghosh A. Integrated Analysis of Cancer Tissue and Vitreous Humor from Retinoblastoma Eyes Reveals Unique Tumor-Specific Metabolic and Cellular Pathways in Advanced and Non-Advanced Tumors. Cells. 2022 May 18;11(10):1668.
doi: 10.3390/cells11101668
Baccega F, Goldfarb Cyrino L, Picciarelli P, Vigga Alves E Silva P, Bonanomi MTBC. Retinoblastoma and Persistent Fetal Vasculature in the Same Eye: Case Report. Case Rep Oncol. 2024 Dec 10;18(1):55-60. PMID: 39980525; PMCID: PMC11729121.
doi: 10.1159/000542987
Bach A., Villegas V.M., Gold A.S. et al. Atypical Event Profiling of Intra-Arterial Chemotherapy. Journal of vitreoretinal diseases. 2023-05-22;6(3):251-254
doi: 10.1177/24741264221083411
Badalova NA, van Hoefen Wijsard M, Dommering CJ, van der Pas SL, Bosscha MI, Fabius AWM, Moll AC. At what age could screening for familial retinoblastoma be stopped? Revised dutch retrospective population based cohort study 1991-2019. Ophthalmology. 2025 May 20:S0161-6420(25)00311-2. Epub ahead of print. PMID: 40404102.
doi: 10.1016/j.ophtha.2025.05.013
Bai S., Shao J., Bi C. et al. β-asarone attenuates the proliferation, migration and enhances apoptosis of retinoblastoma through Wnt/β-catenin signaling pathway. International ophthalmology. 2022-11-13
doi: 10.1007/s10792-022-02566-1
Bai S., Wang H., Bai Y. et al. β-Asarone Inhibits Carboplatin Resistance in Retinoblastoma Cells Through the UCA1/miR-206/NRP1 Axis. Biochemical genetics. 2024-12-24
doi: 10.1007/s10528-024-10985-1
Bakal K., Raval V., Gattu S.K. et al. Primary Subretinal Seeding in Retinoblastoma: Clinical Presentation and Treatment Outcomes. Ocular oncology and pathology. 2024-02-21;9(1-2):32-39
doi: 10.1159/000530497
Baker A., Caton M.T., Smith E.R. et al. Evolving indications for pediatric neurointerventional radiology: A single institutional 25-year experience in infants less than one year of age and a brief historical review. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2023-02-10:15910199231154689
doi: 10.1177/15910199231154689
Bakhuizen J.J., Hopman S.M.J., Bosscha M.I. et al. Assessment of Cancer Predisposition Syndromes in a National Cohort of Children With a Neoplasm. JAMA network open. 2023-02-21;6(2):e2254157
doi: 10.1001/jamanetworkopen.2022.54157
Bakker M.A., Toom D.T., Damen T.H.C., Sleddens HFBM, Meijssen I.C., Deloose S., Kliffen M., Dinjens WNM. Anisometric Cell and Dysplastic Lipomas in a Retinoblastoma Patient. International journal of surgical pathology. 2020 May 4.
doi: 10.1177/1066896920917220
Balaji S., Santhi R., Kim U., Muthukkaruppan V., Priya C.G., Vanniarajan A. Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma. Current cancer drug targets. 2020 May 4
doi: 10.2174/1568009620666200504112711
Balaji S., Rao A., Saraswathi K.K. et al. Focused cancer pathway analysis revealed unique therapeutic targets in retinoblastoma. Medical oncology (Northwood, London, England). 2024-07-01;41(7):168
doi: 10.1007/s12032-024-02391-9
Bali Y., Kumar A., Singh R. et al. Precision in Prosthetics: Two Case Reports on Transformative Rehabilitation With Custom Ocular and Orbital Prostheses. Cureus. 2024-11-28;16(10):e72485
doi: 10.7759/cureus.72485
Banderali U., Jain M., Thakur S., Jayanthan A., Belke D.D., Giles W.R., Narendran A. The T-type Calcium Channel Cav3.1 in Y79 Retinoblastoma Cells is Regulated by the Epidermal Growth Factor Receptor via the MAPK Signaling Pathway. Curr Eye Res. 2021 Oct 21:1-10.
doi: 10.1080/02713683.2021.1988982
Bansal R., Aishwarya A., Rao R., Christy M.C., Sen M., Regani H., Bagai P., Reddy V.A., Mulay K., Bongoni P., Honavar S.G. Impact of COVID-19 nationwide lockdown on retinoblastoma treatment and outcome: A study of 476 eyes of 326 children. Indian J Ophthalmol. 2021 Oct;69(10):2617-2624.
doi: 10.4103/ijo.IJO_2243_21
Bao X.Y., Sun M., Peng T.T., Han D.M. TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by activating the AKT/mTOR signaling pathway. Cancer biomarkers : section A of Disease markers. 2021 Apr 21.
doi: 10.3233/CBM-200050
Barbosa A.C., Magalhães-Barbosa M.C., Colombini G.N.UI. et al. Clinical, epidemiological, and care profile of hospitalized patients with retinoblastoma in Brazil. Arquivos brasileiros de oftalmologia. 2024-08-07;88(1):e20230073
doi: 10.5935/0004-2749.2023-0073
Barbosa AC., de Magalhães-Barbosa M.C., Moreira J.P.L. et al. Incidence of retinoblastoma in children and adolescents in Brazil: A population-based study. Frontiers in pediatrics. 2022-12-21;10(10):1048792
doi: 10.3389/fped.2022.1048792
Barke M.R., Negretti G.S., Shields C.L. et al. Melphalan Versus Topotecan for Retinoblastoma Vitreous Seeds. Journal of pediatric ophthalmology and strabismus. 2022-09-14:1
doi: 10.3928/01913913-20220727-03
Barnett S., Malone S., Strelnikov J. et al. Reading level, acuity, and speed evaluation among retinoblastoma survivors: A prospective case series. Rare tumors. 2024-12-13;16(16):20363613241306191
doi: 10.1177/20363613241306191
Bali Y., Kumar A., Singh R. et al. Precision in Prosthetics: Two Case Reports on Transformative Rehabilitation With Custom Ocular and Orbital Prostheses. Cureus. 2024-11-28;16(10):e72485
doi: 10.7759/cureus.72485
Barzaga A.D.A., Perias G.A.S., Reyes L.A.E. et al. Molecular Biomarkers Detected Using Fluorescence in situ Hybridization in a Filipino with Retinoblastoma. Acta medica Philippina. 2024-06-29;58(10):99-107
doi: 10.47895/amp.vi0.7666
Bas Z., Dalvin L.A., Tadepalli S., Rao R., Shah A., Leahey A.M., Shields C.L. Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 Patients. Asia-Pacific journal of ophthalmology. 2021 Jan 19.
doi: 10.1097/APO.0000000000000360
Baskaran P., Maitray A., Kasilingam K. et al. Retinal Vascular Occlusion Postintraarterial Chemotherapy for Retinoblastoma. Ophthalmology. Retina. 2024-09-22
doi: 10.1016/j.oret.2024.08.020
Batu Oto B., Sarıcı A.M., Kızılkılıç O. Superselective intra-arterial chemotherapy treatment for retinoblastoma: clinical experience from a tertiary referral centre. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2020 Jun 8.
doi: 10.1016/j.jcjo.2020.04.009
Batu Oto B., Yilmaz Çebi A., Kiliçarslan O. et al. Multimodal imaging of a sporadic retinal astrocytic hamartoma simulating retinoblastoma in a newborn. GMS ophthalmology cases. 2022-08-02;12(12):Doc11
doi: 10.3205/oc000198
Bayraktar S., Acar A., Şekeroğlu M.A. et al. A Rare Association: Neovascular Glaucoma Accompanying Anterior Chamber Synchysis Scintillans. Turkish journal of ophthalmology. 2023-11-27
doi: 10.4274/tjo.galenos.2023.39016
Bello W, Hosotte C, Stampfli C, Pierrot A, Munier FL, Berger-Gryllaki M, Pezzatti J, Carrez L, Sadeghipour F. Stability study of topotecan in ophthalmic prefilled syringes for intravitreal delivery. Eur J Hosp Pharm. 2025 Jan 20:ejhpharm-2024-004346. Epub ahead of print. PMID: 39837598.
doi: 10.1136/ejhpharm-2024-004346
Belson P.J., Eastwood J.A., Brecht M.L., Kim J.W., Hays R.D., Pike N.A. Health-Related Quality of Life in Adolescent and Young Adult Retinoblastoma Survivors. J Pediatr Hematol Oncol Nurs. 2022 Jun 8:27527530221073766. Epub ahead of print. PMID: 35674414.
doi: 10.1177/27527530221073766
Belson P.J., Pike N.A., Eastwood J.A. et al. Vision-related quality of life compared to generic measures in retinoblastoma survivors. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation. 2022-12-17:1-11
doi: 10.1007/s11136-022-03315-8
Beniwal V., Maheshwari G., Beniwal S. et al. Retinoblastoma: A review of clinical profile at a regional cancer center in Northwest India. Journal of cancer research and therapeutics. 2022-11-23;18(6):1623-1628
doi: 10.4103/jcrt.JCRT_1263_20
Berdugo J., Rooper L.M., Chiosea SI. RB1, p16, and Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma. Head Neck Pathol. 2021 Dec;15(4):1109-1118.
doi: 10.1007/s12105-021-01317-5.
Bereimipour A., Karimi S., Faranoush M. et al. Identification of miR-20a as A Potential Discerning Biomarker for Non-Invasive versus Invasive Retinoblastoma. Cell journal. 2024-05-13;26(4):250-258
doi: 10.22074/cellj.2024.2019336.1479
Bereimipour A., Satarian L., Taleahmad S. Investigation of Key Signaling Pathways Associating miR-204 and Common Retinopathies. Biomed Res Int. 2021 Oct 4;2021:5568113.
doi: 10.1155/2021/5568113
Bernard A., Xia S.Z., Saleh S. et al. EyeScreen: Development and Potential of a Novel Machine Learning Application to Detect Leukocoria. Ophthalmology science. 2022-10-19;2(3):100158.
doi: 10.1016/j.xops.2022.100158
Berry J.L., Munier F.L., Gallie B.L., Polski A., Shah S., Shields C.L., Gombos D.S., Ruchalski K., Stathopoulos C., Shah R., Jubran R., Kim J.W., Mruthyunjaya P., Marr B.P., Wilson M.W., Brennan R.C., Chantada G.L., Chintagumpala M.M., Murphree A.L. Response criteria for intraocular retinoblastoma: RB-RECIST. Pediatric blood & cancer. 2021 May;68(5):e28964.
doi: 10.1002/pbc.28964
Berry J.L., Pike S. et al. Retinoblastoma Outcomes in the Americas: a prospective analysis of 491 children with retinoblastoma from 23 American countries. American journal of ophthalmology. 2023-11-10.
Berry J.L., Pike S., Shah R. et al. Aqueous Humor Liquid Biopsy as a Companion Diagnostic for Retinoblastoma: implications for diagnosis, prognosis and therapeutic options. Five years of Progress. American journal of ophthalmology. 2023-12-01.
doi: 10.1016/j.ajo.2023.11.020
Berry J., Traboulsi E.I., Munier F. et al. A. L. Murphree, MD: the Mississippi man who conquered retinoblastoma and changed the fate of patients and their families. Ophthalmic genetics. 2023-02-02;43(6):729-730
doi: 10.1080/13816810.2022.2138458
Babu V.S., Mallipatna A., Dudeja G. et al. Depleted hexokinase1 and lack of AMPKα activation favor OXPHOS-dependent energetics in retinoblastoma tumors. Translational research : the journal of laboratory and clinical medicine. 2023-10-11;261(261):41-56
doi: 10.1016/j.trsl.2023.07.001
Babu V.S., Mallipatna A., Sa D., Dudeja G., Kannan R., Shetty R., Nair A.P., Gundimeda S., Chaurasia S.S., Verma N.K., Lakshminarayanan R., Heymans S., Barathi V.A., Guha N., Ghosh A. Integrated Analysis of Cancer Tissue and Vitreous Humor from Retinoblastoma Eyes Reveals Unique Tumor-Specific Metabolic and Cellular Pathways in Advanced and Non-Advanced Tumors. Cells. 2022 May 18;11(10):1668.
doi: 10.3390/cells11101668
Baccega F, Goldfarb Cyrino L, Picciarelli P, Vigga Alves E Silva P, Bonanomi MTBC. Retinoblastoma and Persistent Fetal Vasculature in the Same Eye: Case Report. Case Rep Oncol. 2024 Dec 10;18(1):55-60. PMID: 39980525; PMCID: PMC11729121.
doi: 10.1159/000542987
Bach A., Villegas V.M., Gold A.S. et al. Atypical Event Profiling of Intra-Arterial Chemotherapy. Journal of vitreoretinal diseases. 2023-05-22;6(3):251-254
doi: 10.1177/24741264221083411
Badalova NA, van Hoefen Wijsard M, Dommering CJ, van der Pas SL, Bosscha MI, Fabius AWM, Moll AC. At what age could screening for familial retinoblastoma be stopped? Revised dutch retrospective population based cohort study 1991-2019. Ophthalmology. 2025 May 20:S0161-6420(25)00311-2. Epub ahead of print. PMID: 40404102.
doi: 10.1016/j.ophtha.2025.05.013
Bai S., Shao J., Bi C. et al. β-asarone attenuates the proliferation, migration and enhances apoptosis of retinoblastoma through Wnt/β-catenin signaling pathway. International ophthalmology. 2022-11-13
doi: 10.1007/s10792-022-02566-1
Bai S., Wang H., Bai Y. et al. β-Asarone Inhibits Carboplatin Resistance in Retinoblastoma Cells Through the UCA1/miR-206/NRP1 Axis. Biochemical genetics. 2024-12-24
doi: 10.1007/s10528-024-10985-1
Bakal K., Raval V., Gattu S.K. et al. Primary Subretinal Seeding in Retinoblastoma: Clinical Presentation and Treatment Outcomes. Ocular oncology and pathology. 2024-02-21;9(1-2):32-39
doi: 10.1159/000530497
Baker A., Caton M.T., Smith E.R. et al. Evolving indications for pediatric neurointerventional radiology: A single institutional 25-year experience in infants less than one year of age and a brief historical review. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2023-02-10:15910199231154689
doi: 10.1177/15910199231154689
Bakhuizen J.J., Hopman S.M.J., Bosscha M.I. et al. Assessment of Cancer Predisposition Syndromes in a National Cohort of Children With a Neoplasm. JAMA network open. 2023-02-21;6(2):e2254157
doi: 10.1001/jamanetworkopen.2022.54157
Bakker M.A., Toom D.T., Damen T.H.C., Sleddens HFBM, Meijssen I.C., Deloose S., Kliffen M., Dinjens WNM. Anisometric Cell and Dysplastic Lipomas in a Retinoblastoma Patient. International journal of surgical pathology. 2020 May 4.
doi: 10.1177/1066896920917220
Balaji S., Santhi R., Kim U., Muthukkaruppan V., Priya C.G., Vanniarajan A. Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma. Current cancer drug targets. 2020 May 4
doi: 10.2174/1568009620666200504112711
Balaji S., Rao A., Saraswathi K.K. et al. Focused cancer pathway analysis revealed unique therapeutic targets in retinoblastoma. Medical oncology (Northwood, London, England). 2024-07-01;41(7):168
doi: 10.1007/s12032-024-02391-9
Bali Y., Kumar A., Singh R. et al. Precision in Prosthetics: Two Case Reports on Transformative Rehabilitation With Custom Ocular and Orbital Prostheses. Cureus. 2024-11-28;16(10):e72485
doi: 10.7759/cureus.72485
Banderali U., Jain M., Thakur S., Jayanthan A., Belke D.D., Giles W.R., Narendran A. The T-type Calcium Channel Cav3.1 in Y79 Retinoblastoma Cells is Regulated by the Epidermal Growth Factor Receptor via the MAPK Signaling Pathway. Curr Eye Res. 2021 Oct 21:1-10.
doi: 10.1080/02713683.2021.1988982
Bansal R., Aishwarya A., Rao R., Christy M.C., Sen M., Regani H., Bagai P., Reddy V.A., Mulay K., Bongoni P., Honavar S.G. Impact of COVID-19 nationwide lockdown on retinoblastoma treatment and outcome: A study of 476 eyes of 326 children. Indian J Ophthalmol. 2021 Oct;69(10):2617-2624.
doi: 10.4103/ijo.IJO_2243_21
Bao X.Y., Sun M., Peng T.T., Han D.M. TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by activating the AKT/mTOR signaling pathway. Cancer biomarkers : section A of Disease markers. 2021 Apr 21.
doi: 10.3233/CBM-200050
Barbosa A.C., Magalhães-Barbosa M.C., Colombini G.N.UI. et al. Clinical, epidemiological, and care profile of hospitalized patients with retinoblastoma in Brazil. Arquivos brasileiros de oftalmologia. 2024-08-07;88(1):e20230073
doi: 10.5935/0004-2749.2023-0073
Barbosa AC., de Magalhães-Barbosa M.C., Moreira J.P.L. et al. Incidence of retinoblastoma in children and adolescents in Brazil: A population-based study. Frontiers in pediatrics. 2022-12-21;10(10):1048792
doi: 10.3389/fped.2022.1048792
Barke M.R., Negretti G.S., Shields C.L. et al. Melphalan Versus Topotecan for Retinoblastoma Vitreous Seeds. Journal of pediatric ophthalmology and strabismus. 2022-09-14:1
doi: 10.3928/01913913-20220727-03
Barnett S., Malone S., Strelnikov J. et al. Reading level, acuity, and speed evaluation among retinoblastoma survivors: A prospective case series. Rare tumors. 2024-12-13;16(16):20363613241306191
doi: 10.1177/20363613241306191
Bali Y., Kumar A., Singh R. et al. Precision in Prosthetics: Two Case Reports on Transformative Rehabilitation With Custom Ocular and Orbital Prostheses. Cureus. 2024-11-28;16(10):e72485
doi: 10.7759/cureus.72485
Barzaga A.D.A., Perias G.A.S., Reyes L.A.E. et al. Molecular Biomarkers Detected Using Fluorescence in situ Hybridization in a Filipino with Retinoblastoma. Acta medica Philippina. 2024-06-29;58(10):99-107
doi: 10.47895/amp.vi0.7666
Bas Z., Dalvin L.A., Tadepalli S., Rao R., Shah A., Leahey A.M., Shields C.L. Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 Patients. Asia-Pacific journal of ophthalmology. 2021 Jan 19.
doi: 10.1097/APO.0000000000000360
Baskaran P., Maitray A., Kasilingam K. et al. Retinal Vascular Occlusion Postintraarterial Chemotherapy for Retinoblastoma. Ophthalmology. Retina. 2024-09-22
doi: 10.1016/j.oret.2024.08.020
Batu Oto B., Sarıcı A.M., Kızılkılıç O. Superselective intra-arterial chemotherapy treatment for retinoblastoma: clinical experience from a tertiary referral centre. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2020 Jun 8.
doi: 10.1016/j.jcjo.2020.04.009
Batu Oto B., Yilmaz Çebi A., Kiliçarslan O. et al. Multimodal imaging of a sporadic retinal astrocytic hamartoma simulating retinoblastoma in a newborn. GMS ophthalmology cases. 2022-08-02;12(12):Doc11
doi: 10.3205/oc000198
Bayraktar S., Acar A., Şekeroğlu M.A. et al. A Rare Association: Neovascular Glaucoma Accompanying Anterior Chamber Synchysis Scintillans. Turkish journal of ophthalmology. 2023-11-27
doi: 10.4274/tjo.galenos.2023.39016
Bello W, Hosotte C, Stampfli C, Pierrot A, Munier FL, Berger-Gryllaki M, Pezzatti J, Carrez L, Sadeghipour F. Stability study of topotecan in ophthalmic prefilled syringes for intravitreal delivery. Eur J Hosp Pharm. 2025 Jan 20:ejhpharm-2024-004346. Epub ahead of print. PMID: 39837598.
doi: 10.1136/ejhpharm-2024-004346
Belson P.J., Eastwood J.A., Brecht M.L., Kim J.W., Hays R.D., Pike N.A. Health-Related Quality of Life in Adolescent and Young Adult Retinoblastoma Survivors. J Pediatr Hematol Oncol Nurs. 2022 Jun 8:27527530221073766. Epub ahead of print. PMID: 35674414.
doi: 10.1177/27527530221073766
Belson P.J., Pike N.A., Eastwood J.A. et al. Vision-related quality of life compared to generic measures in retinoblastoma survivors. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation. 2022-12-17:1-11
doi: 10.1007/s11136-022-03315-8
Beniwal V., Maheshwari G., Beniwal S. et al. Retinoblastoma: A review of clinical profile at a regional cancer center in Northwest India. Journal of cancer research and therapeutics. 2022-11-23;18(6):1623-1628
doi: 10.4103/jcrt.JCRT_1263_20
Berdugo J., Rooper L.M., Chiosea SI. RB1, p16, and Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma. Head Neck Pathol. 2021 Dec;15(4):1109-1118.
doi: 10.1007/s12105-021-01317-5.
Bereimipour A., Karimi S., Faranoush M. et al. Identification of miR-20a as A Potential Discerning Biomarker for Non-Invasive versus Invasive Retinoblastoma. Cell journal. 2024-05-13;26(4):250-258
doi: 10.22074/cellj.2024.2019336.1479
Bereimipour A., Satarian L., Taleahmad S. Investigation of Key Signaling Pathways Associating miR-204 and Common Retinopathies. Biomed Res Int. 2021 Oct 4;2021:5568113.
doi: 10.1155/2021/5568113
Bernard A., Xia S.Z., Saleh S. et al. EyeScreen: Development and Potential of a Novel Machine Learning Application to Detect Leukocoria. Ophthalmology science. 2022-10-19;2(3):100158.
doi: 10.1016/j.xops.2022.100158
Berry J.L., Munier F.L., Gallie B.L., Polski A., Shah S., Shields C.L., Gombos D.S., Ruchalski K., Stathopoulos C., Shah R., Jubran R., Kim J.W., Mruthyunjaya P., Marr B.P., Wilson M.W., Brennan R.C., Chantada G.L., Chintagumpala M.M., Murphree A.L. Response criteria for intraocular retinoblastoma: RB-RECIST. Pediatric blood & cancer. 2021 May;68(5):e28964.
doi: 10.1002/pbc.28964
Berry J.L., Pike S. et al. Retinoblastoma Outcomes in the Americas: a prospective analysis of 491 children with retinoblastoma from 23 American countries. American journal of ophthalmology. 2023-11-10.
Berry J.L., Pike S., Shah R. et al. Aqueous Humor Liquid Biopsy as a Companion Diagnostic for Retinoblastoma: implications for diagnosis, prognosis and therapeutic options. Five years of Progress. American journal of ophthalmology. 2023-12-01.
doi: 10.1016/j.ajo.2023.11.020
Berry J., Traboulsi E.I., Munier F. et al. A. L. Murphree, MD: the Mississippi man who conquered retinoblastoma and changed the fate of patients and their families. Ophthalmic genetics. 2023-02-02;43(6):729-730
doi: 10.1080/13816810.2022.2138458
Bhaduri A., Das S., Bansal S., Shree N. Smartphone Wide-Field Fundus Photography in Retinoblastoma With a Nasal Endoscope. Indian journal of ophthalmology. 2020 Jul.
doi: 10.4103/ijo.IJO_1666_19
Bhatter P, Parthasarathy R, Gupta V, Dusa SR, Aggarwal U, Das S, Kumar P. Do's and Don'ts" for intraarterial chemotherapy for retinoblastoma- What ophthalmologist and interventional radiologist need to know? Indian J Ophthalmol. 2025 Jun 1;73(6):916-919. Epub 2025 May 28. PMID: 40434466; PMCID: PMC12178373.
doi: 10.4103/IJO.IJO_2912_24
Biewald E., Kiefer T., Geismar D., Schlüter S., Manthey A., Westekemper H., Wulff J., Timmermann B., Ketteler P., Schönberger S., Metz K.A., Ting S., Göricke S., Bechrakis N.E., Bornfeld N. Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Cancers. 2021 Apr 13;13(8):1862.
doi: 10.3390/cancers13081862
Bilbeisi T., Almasry R., Obeidat M. et al. Causes of death and survival analysis for patients with retinoblastoma in Jordan. Frontiers in medicine. 2023-09-22;10(10):1244308
doi: 10.3389/fmed.2023.1244308
Bisht S., Chawla B., Kumar A. et al. Identification of novel genes by targeted exome sequencing in Retinoblastoma. Ophthalmic genetics. 2022-08-05:1-18
doi: 10.1080/13816810.2022.2106497
Black A.K., Kahn A.E., Lamy C. et al. The association between race and age of diagnosis of retinoblastoma in United States children. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2024-03-18;28(1):103810
doi: 10.1016/j.jaapos.2023.11.013
Blitzer A.L., Schechet S.A., Shah H.A., Blair M.P. Retinoblastoma presenting as pseudohypopyon and preserved visual acuity. Am J Ophthalmol Case Rep. 2021 Jun 23;23:101141.
doi: 10.1016/j.ajoc.2021.101141
Blixt M.K.E., Hellsand M., Konjusha D., Zhang H., Stenfelt S., Åkesson M., Rafati N., Tararuk T., Stålhammar G., All-Eriksson C., Ring H., Hallböök F. MYCN induces cell-specific tumorigenic growth in RB1-proficient human retinal organoid and chicken retina models of retinoblastoma. Oncogenesis. 2022 Jun 21;11(1):34. PMID: 35729105; PMCID: PMC9213451.
doi: 10.1038/s41389-022-00409-3
de Bloeme C.M., van Elst S., Galluzzi P. et al. MR Imaging of Adverse Effects and Ocular Growth Decline after Selective Intra-Arterial Chemotherapy for Retinoblastoma. Cancers. 2024-05-27;16(10)
doi: 10.3390/cancers16101899
de Bloeme C.M., Jansen R.W., Cardoen L. et al. Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case-control study. Scientific reports. 2024-10-26;14(1):25103
doi: 10.1038/s41598-024-76933-6
de Bloeme C.M., Jansen R.W., Göricke S. et al. Optic nerve thickening on high-spatial-resolution MRI predicts early-stage postlaminar optic nerve invasion in retinoblastoma. European radiology. 2023-12-12
doi: 10.1007/s00330-023-10471-z
de Bloeme C.M., Jansen R.W., de Haan J. et al. Follow-up of Cystic Pineal Glands in Retinoblastoma Patients Does Not Increase Detection of Pineal Trilateral Retinoblastoma. American journal of ophthalmology. 2024-08-30;268(268):199-211
doi: 10.1016/j.ajo.2024.07.005
Boddu D., Thankamony P., Prakasam R., Sugath S., Kumar A., Nair S. Successful Treatment of Late Isolated Bone Metastasis in a Patient with Bilateral Retinoblastoma Using an Unconventional Method. Ocul Oncol Pathol. 2021 Sep;7(4):262-266.
doi: 10.1159/000514620
Bogan C.M., Kaczmarek J.V., Pierce J.M., Chen S.C., Boyd K.L., Calcutt M.W., Bridges T.M., Lindsley C.W., Nadelmann J.B., Liao A., Hsieh T., Abramson D.H., Francis J.H., Friedman D.L., Richmond A., Daniels A.B. Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study. The British journal of ophthalmology. 2021 May 10:bjophthalmol-2020-318529.
doi: 10.1136/bjophthalmol-2020-318529
Bogan C.M., Pierce J.M., Doss S.D., Tao Y.K., Chen S.C., Boyd K.L., Liao A., Hsieh T., Abramson D.H., Francis J.H., Friedman D.L., Richmond A., Daniels A.B. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients. Experimental eye research. 2021 Jan 11;204:108439.
doi: 10.1016/j.exer.2021.108439
Bokun J., Popović-Vuković M., Stanić D. et al. Clinical Profile and Outcome of 806 Pediatric Oncology Patients Treated With Radiotherapy at the Serbian National Cancer Center. Journal of pediatric hematology/oncology. 2023-09-18;45(3):116-122
doi: 10.1097/MPH.0000000000002589
Bonanomi M.T.B.C., de Almeida M.T.A., Hollaender M.A. et al. Retinoblastoma treatment in a Brazilian population. Presentation and long-term results. Cancer medicine. 2024-03-04;13(3):e6683
doi: 10.1002/cam4.6683
Borah N.A., Mittal R., Sucharita S. et al. Aurora Kinase A Is Overexpressed in Human Retinoblastoma and Correlates with Histopathologic High-Risk Factors: Implications for Targeted Therapy. The American journal of pathology. 2024-08-30;194(9):1780-1798
doi: 10.1016/j.ajpath.2024.05.006
Borah N.A., Sradhanjali S., Barik M.R., Jha A., Tripathy D., Kaliki S., Rath S., Raghav S.K., Patnaik S., Mittal R., Reddy M.M. Aurora Kinase B Expression, Its Regulation and Therapeutic Targeting in Human Retinoblastoma. Investigative ophthalmology & visual science. 2021 Mar 1;62(3):16.
doi: 10.1167/iovs.62.3.16
Bornfeld N., Lohmann D., Bechrakis N.E., Biewald E. [Retinoblastoma]. // Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. Ophthalmologe. 2020 Mar 23.
doi: 10.1007/s00347-020-01081-x
Bossacoma F., Cuadrado-Vilanova M., Vinent J., Correa M.G., Gavrus D., Castillo-Ecija H., Catala-Mora J., Mora J., Schaiquevich P., Chantada G.L., Carcaboso AM. Optimizing the storage of chemotherapeutics for ophthalmic oncology: stability of topotecan solution for intravitreal injection. Ophthalmic genetics. 2020 Jun 3.
doi: 10.1080/13816810.2020.1776336
Botta L., Gatta G., Capocaccia R. et al. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study. The Lancet. Oncology. 2022-11-18
doi: 10.1016/S1470-2045(22)00637-4
Bouchoucha Y., Matet A., Berger A. et al. Retinoblastoma: From genes to patient care. European journal of medical genetics. 2022-12-22;66(1):104674
doi: 10.1016/j.ejmg.2022.104674
Bourkiza R., Cumberland P., Fabian I.D., Abeysekera H., Parulekar M., Sagoo M.S., Rahi J., Reddy M.A. Role of ethnicity and socioeconomic status (SES) in the presentation of retinoblastoma: findings from the UK. BMJ Open Ophthalmology. 2020 May 15.
doi: 10.1136/bmjophth-2019-000415
Bowman R.J.C., Foster A., Stacey A., Keren-Froim N., Bascaran C., Kivelä T.T., Munier F., Fabian I.D. International travel to obtain medical treatment for primary retinoblastoma: A global cohort study. International journal of cancer. 2021 Apr 15;148(8):1858-1866.
doi: 10.1002/ijc.33350.
Bravo-Gonzalez A., Domínguez-Ruiz P., González M. et al. The role of Intravitreal chemotherapy as an adjunctive treatment for retinoblastoma: a systematic review and single-arm meta-analysis. Am J Ophthalmol. 2025 May; 273:130-140. Epub 2024 Dec 17. PMID: 39701510.
doi: 10.1016/j.ajo.2024.12.012
Bubshait L., Alburayk K., Alabdulhadi H. et al. Retinocytoma: A Case Series. Cureus. 2023-09-06;15(8):e42958
doi: 10.7759/cureus.42958
Burges M., Qaddoumi I., Brennan R.C., Krull L., Sahr N., Rodriguez-Galindo C., Jeha S., Wilson M.W. Assessment of Retinoblastoma Capacity in the Middle East, North Africa, and West Asia Region. JCO Global Oncology. 2020 Oct; 6.
doi: 10.1200/GO.20.00321.
Busch M.A., Haase A., Alefeld E. et al. Trefoil Family Factor Peptide 1-A New Biomarker in Liquid Biopsies of Retinoblastoma under Therapy. Cancers. 2023-10-31;15(19)
doi: 10.3390/cancers15194828
Busch M., Miroschnikov N., Dankert J.T., Wiesehöfer M., Metz K., Stephan H., Dünker N. Impact of RARα and miR-138 on retinoblastoma etoposide resistance. Tumour Biol. 2021;43(1):11-26.
doi: 10.3233/TUB-200072.
Byroju V.V., Nadukkandy A.S., Cordani M. et al. Retinoblastoma: present scenario and future challenges. Cell communication and signaling : CCS. 2023-11-20;21(1):226
doi: 10.1186/s12964-023-01223-z
doi: 10.4103/ijo.IJO_1666_19
Bhatter P, Parthasarathy R, Gupta V, Dusa SR, Aggarwal U, Das S, Kumar P. Do's and Don'ts" for intraarterial chemotherapy for retinoblastoma- What ophthalmologist and interventional radiologist need to know? Indian J Ophthalmol. 2025 Jun 1;73(6):916-919. Epub 2025 May 28. PMID: 40434466; PMCID: PMC12178373.
doi: 10.4103/IJO.IJO_2912_24
Biewald E., Kiefer T., Geismar D., Schlüter S., Manthey A., Westekemper H., Wulff J., Timmermann B., Ketteler P., Schönberger S., Metz K.A., Ting S., Göricke S., Bechrakis N.E., Bornfeld N. Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Cancers. 2021 Apr 13;13(8):1862.
doi: 10.3390/cancers13081862
Bilbeisi T., Almasry R., Obeidat M. et al. Causes of death and survival analysis for patients with retinoblastoma in Jordan. Frontiers in medicine. 2023-09-22;10(10):1244308
doi: 10.3389/fmed.2023.1244308
Bisht S., Chawla B., Kumar A. et al. Identification of novel genes by targeted exome sequencing in Retinoblastoma. Ophthalmic genetics. 2022-08-05:1-18
doi: 10.1080/13816810.2022.2106497
Black A.K., Kahn A.E., Lamy C. et al. The association between race and age of diagnosis of retinoblastoma in United States children. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2024-03-18;28(1):103810
doi: 10.1016/j.jaapos.2023.11.013
Blitzer A.L., Schechet S.A., Shah H.A., Blair M.P. Retinoblastoma presenting as pseudohypopyon and preserved visual acuity. Am J Ophthalmol Case Rep. 2021 Jun 23;23:101141.
doi: 10.1016/j.ajoc.2021.101141
Blixt M.K.E., Hellsand M., Konjusha D., Zhang H., Stenfelt S., Åkesson M., Rafati N., Tararuk T., Stålhammar G., All-Eriksson C., Ring H., Hallböök F. MYCN induces cell-specific tumorigenic growth in RB1-proficient human retinal organoid and chicken retina models of retinoblastoma. Oncogenesis. 2022 Jun 21;11(1):34. PMID: 35729105; PMCID: PMC9213451.
doi: 10.1038/s41389-022-00409-3
de Bloeme C.M., van Elst S., Galluzzi P. et al. MR Imaging of Adverse Effects and Ocular Growth Decline after Selective Intra-Arterial Chemotherapy for Retinoblastoma. Cancers. 2024-05-27;16(10)
doi: 10.3390/cancers16101899
de Bloeme C.M., Jansen R.W., Cardoen L. et al. Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case-control study. Scientific reports. 2024-10-26;14(1):25103
doi: 10.1038/s41598-024-76933-6
de Bloeme C.M., Jansen R.W., Göricke S. et al. Optic nerve thickening on high-spatial-resolution MRI predicts early-stage postlaminar optic nerve invasion in retinoblastoma. European radiology. 2023-12-12
doi: 10.1007/s00330-023-10471-z
de Bloeme C.M., Jansen R.W., de Haan J. et al. Follow-up of Cystic Pineal Glands in Retinoblastoma Patients Does Not Increase Detection of Pineal Trilateral Retinoblastoma. American journal of ophthalmology. 2024-08-30;268(268):199-211
doi: 10.1016/j.ajo.2024.07.005
Boddu D., Thankamony P., Prakasam R., Sugath S., Kumar A., Nair S. Successful Treatment of Late Isolated Bone Metastasis in a Patient with Bilateral Retinoblastoma Using an Unconventional Method. Ocul Oncol Pathol. 2021 Sep;7(4):262-266.
doi: 10.1159/000514620
Bogan C.M., Kaczmarek J.V., Pierce J.M., Chen S.C., Boyd K.L., Calcutt M.W., Bridges T.M., Lindsley C.W., Nadelmann J.B., Liao A., Hsieh T., Abramson D.H., Francis J.H., Friedman D.L., Richmond A., Daniels A.B. Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study. The British journal of ophthalmology. 2021 May 10:bjophthalmol-2020-318529.
doi: 10.1136/bjophthalmol-2020-318529
Bogan C.M., Pierce J.M., Doss S.D., Tao Y.K., Chen S.C., Boyd K.L., Liao A., Hsieh T., Abramson D.H., Francis J.H., Friedman D.L., Richmond A., Daniels A.B. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients. Experimental eye research. 2021 Jan 11;204:108439.
doi: 10.1016/j.exer.2021.108439
Bokun J., Popović-Vuković M., Stanić D. et al. Clinical Profile and Outcome of 806 Pediatric Oncology Patients Treated With Radiotherapy at the Serbian National Cancer Center. Journal of pediatric hematology/oncology. 2023-09-18;45(3):116-122
doi: 10.1097/MPH.0000000000002589
Bonanomi M.T.B.C., de Almeida M.T.A., Hollaender M.A. et al. Retinoblastoma treatment in a Brazilian population. Presentation and long-term results. Cancer medicine. 2024-03-04;13(3):e6683
doi: 10.1002/cam4.6683
Borah N.A., Mittal R., Sucharita S. et al. Aurora Kinase A Is Overexpressed in Human Retinoblastoma and Correlates with Histopathologic High-Risk Factors: Implications for Targeted Therapy. The American journal of pathology. 2024-08-30;194(9):1780-1798
doi: 10.1016/j.ajpath.2024.05.006
Borah N.A., Sradhanjali S., Barik M.R., Jha A., Tripathy D., Kaliki S., Rath S., Raghav S.K., Patnaik S., Mittal R., Reddy M.M. Aurora Kinase B Expression, Its Regulation and Therapeutic Targeting in Human Retinoblastoma. Investigative ophthalmology & visual science. 2021 Mar 1;62(3):16.
doi: 10.1167/iovs.62.3.16
Bornfeld N., Lohmann D., Bechrakis N.E., Biewald E. [Retinoblastoma]. // Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. Ophthalmologe. 2020 Mar 23.
doi: 10.1007/s00347-020-01081-x
Bossacoma F., Cuadrado-Vilanova M., Vinent J., Correa M.G., Gavrus D., Castillo-Ecija H., Catala-Mora J., Mora J., Schaiquevich P., Chantada G.L., Carcaboso AM. Optimizing the storage of chemotherapeutics for ophthalmic oncology: stability of topotecan solution for intravitreal injection. Ophthalmic genetics. 2020 Jun 3.
doi: 10.1080/13816810.2020.1776336
Botta L., Gatta G., Capocaccia R. et al. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study. The Lancet. Oncology. 2022-11-18
doi: 10.1016/S1470-2045(22)00637-4
Bouchoucha Y., Matet A., Berger A. et al. Retinoblastoma: From genes to patient care. European journal of medical genetics. 2022-12-22;66(1):104674
doi: 10.1016/j.ejmg.2022.104674
Bourkiza R., Cumberland P., Fabian I.D., Abeysekera H., Parulekar M., Sagoo M.S., Rahi J., Reddy M.A. Role of ethnicity and socioeconomic status (SES) in the presentation of retinoblastoma: findings from the UK. BMJ Open Ophthalmology. 2020 May 15.
doi: 10.1136/bmjophth-2019-000415
Bowman R.J.C., Foster A., Stacey A., Keren-Froim N., Bascaran C., Kivelä T.T., Munier F., Fabian I.D. International travel to obtain medical treatment for primary retinoblastoma: A global cohort study. International journal of cancer. 2021 Apr 15;148(8):1858-1866.
doi: 10.1002/ijc.33350.
Bravo-Gonzalez A., Domínguez-Ruiz P., González M. et al. The role of Intravitreal chemotherapy as an adjunctive treatment for retinoblastoma: a systematic review and single-arm meta-analysis. Am J Ophthalmol. 2025 May; 273:130-140. Epub 2024 Dec 17. PMID: 39701510.
doi: 10.1016/j.ajo.2024.12.012
Bubshait L., Alburayk K., Alabdulhadi H. et al. Retinocytoma: A Case Series. Cureus. 2023-09-06;15(8):e42958
doi: 10.7759/cureus.42958
Burges M., Qaddoumi I., Brennan R.C., Krull L., Sahr N., Rodriguez-Galindo C., Jeha S., Wilson M.W. Assessment of Retinoblastoma Capacity in the Middle East, North Africa, and West Asia Region. JCO Global Oncology. 2020 Oct; 6.
doi: 10.1200/GO.20.00321.
Busch M.A., Haase A., Alefeld E. et al. Trefoil Family Factor Peptide 1-A New Biomarker in Liquid Biopsies of Retinoblastoma under Therapy. Cancers. 2023-10-31;15(19)
doi: 10.3390/cancers15194828
Busch M., Miroschnikov N., Dankert J.T., Wiesehöfer M., Metz K., Stephan H., Dünker N. Impact of RARα and miR-138 on retinoblastoma etoposide resistance. Tumour Biol. 2021;43(1):11-26.
doi: 10.3233/TUB-200072.
Byroju V.V., Nadukkandy A.S., Cordani M. et al. Retinoblastoma: present scenario and future challenges. Cell communication and signaling : CCS. 2023-11-20;21(1):226
doi: 10.1186/s12964-023-01223-z
C
Cai L., Liu B., Cao Y. et al. Unveiling the molecular structure and role of RBBP4/7: implications for epigenetic regulation and cancer research. Frontiers in molecular biosciences. 2023-12-01;10(10):1276612
doi: 10.3389/fmolb.2023.1276612
Calabresi K, Emrich J, Belko S, Pugliese R, Komarnicky-Kocher L, Mourtada F. 3D-printed template design to improve 125/I seed plaque assembly accuracy for uveal brachytherapy. Brachytherapy. 2025 May-Jun;24(3):420-430Epub 2025 Feb 17. PMID: 39966071.
doi: 10.1016/j.brachy.2025.01.004
Сaliş Karanfil F., Gündüz A.K., Atilla H. et al. Varied toxicity profile of intravitreal melphalan in two retinoblastoma eyes. Anti-cancer drugs. 2024-07-24.
doi: 10.1097/CAD.0000000000001646
Calotti M., Yaghy A., Shields C.L. Painful Glaucoma and Pseudohypopyon in a Child with Retinoblastoma. Ophthalmology. Glaucoma. 2020 Nov-Dec;3(6):480.
doi: 10.1016/j.ogla.2020.07.004
Cancela M.B., Zugbi S., Winter U., Martinez A.L., Sampor C., Sgroi M., Francis J.H., Garippa R., Abramson D.H., Chantada G., Schaiquevich P. A decision process for drug discovery in retinoblastoma. Investigational new drugs. 2020 Nov 16.
doi: 10.1007/s10637-020-01030-0
Cancela M.B., Winter U., Zugbi S. et al. Mimicking Retinoblastoma Treatment With Repeated Topotecan or Melphalan Develops Cross-Resistance to Classic Agents But Not to Repurposed Drugs. Investigative ophthalmology & visual science. 2024-12-08;65(14):14
doi: 10.1167/iovs.65.14.14
Cao M., Wang S., Zou J., Wang W. Bioinformatics analyses of retinoblastoma reveal the retinoblastoma progression subtypes. PeerJ. 2020 May 21.
doi: 10.7717/peerj.8873
Cao Y., Zhou M., Tian M., Lv H.B. The Safety and Effectiveness of Melphalan-Based Intra-Arterial Chemotherapy for Retinoblastoma: An Updated Single-Arm Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2022 Feb 14;2022:3156503. PMID: 35198033; PMCID: PMC8860512.
doi: 10.1155/2022/3156503
Carbone E. T-type calcium channels as therapeutic targets for treating "giant" retinoblastoma cancer cells. Pflugers Arch. 2021 Sep 7.
doi: 10.1007/s00424-021-02620-4
Carnevale J.A., Goldberg J., Kocharian G., Rivera M., Giantini L.A., Garton A., Ramos A., Francis J.H., Abramson D.H., Pierre Gobin Y. Intra-arterial chemotherapy for retinoblastoma. J Neurointerv Surg. 2022 May 18.
doi: 10.1136/neurintsurg-2022-018957
Casciano F., Zauli E., Busin M. et al. State of the Art of Pharmacological Activators of p53 in Ocular Malignancies. Cancers. 2023-07-31;15(14).
doi: 10.3390/cancers15143593
Casey A, Barliana JD. The incidence of secondary neoplasms in retinoblastoma survivors who underwent radiation therapy: A systematic review and meta-analysis. Taiwan J Ophthalmol. 2024 Feb 2;15(1):45-54. PMID: 40213296; PMCID: PMC11981579.
doi: 10.4103/tjo.TJO-D-23-00086
Cassoux N., Malaise D., Lumbroso-Le-Rouic L. et al. Diffuse Infiltrating Retinoblastoma with Anterior Chamber Involvement: Conservative Management and Identification of RB1 Alterations in Aqueous Humor. Ocular oncology and pathology. 2023-10-31;9(3-4):96-100.
doi: 10.1159/000531233
Castillo-Trejo B., Pérez-Pérez J.F., Aguilar-Morales K. et al. Coexistence of persistent fetal vasculature and retinoblastoma in the same eye. Boletin medico del Hospital Infantil de Mexico. 2023-07-31;80(Supl 1):53-57.
doi: 10.24875/BMHIM.22000104
Castela G., Providência J., Monteiro M. et al. Effectiveness of Intra-Arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma: Relevance of a Multidisciplinary Setting. Clinical ophthalmology (Auckland, N.Z.). 2023-02-10;17(17):487-496.
doi: 10.2147/OPTH.S398488
Castela G., Providência J., Monteiro M., Silva S., Brito M., Murta J.N., Correa Z., Castelo Branco M. Treatment of Advanced Retinoblastoma in Children Evacuated from Low-Income Countries: Experience from a National Referral Center in Portugal. Clin Ophthalmol. 2021 Dec 21;15:4765-4773.
doi: 10.2147/OPTH.S343919
Castela G., Providencia J., Monteiro M., Silva S., Brito M., Sá J., Oliveiros B., Murta J.N., Correa Z., Branco M.C. Characterization of the Portuguese population diagnosed with retinoblastoma. Sci Rep. 2022 Mar 14;12(1):4378. PMID: 35288594; PMCID: PMC8921246.
doi: 10.1038/s41598-022-08326-6
Castro-Magdonel B.E., Orjuela M., Alvarez-Suarez D.E., Camacho J., Cabrera-Muñoz L., Sadowinski-Pine S., Medina-Sanson A., Lara-Molina C., García-Vega D., Vázquez Y., Durán-Figueroa N., Orozco-Romero M.J., Hernández-Ángeles A., Ponce-Castañeda M.V. Circulating miRNome Detection Analysis Reveals 537 miRNAS in Plasma, 625 in Extracellular Vesicles and a Discriminant Plasma Signature of 19 miRNAs in Children With Retinoblastoma From Which 14 Are Also Detected in Corresponding Primary Tumors. PLoS One. 2020 Apr 14.
doi: 10.1371/journal.pone.0231394
Catlin J.P., Marziali L.N., Rein B., Yan Z., Feltri M.L., Schaner Tooley C.E. Age-related neurodegeneration and cognitive impairments of NRMT1 knockout mice are preceded by misregulation of RB and abnormal neural stem cell development. Cell Death Dis. 2021 Oct 28;12(11):1014.
doi: 10.1038/s41419-021-04316-0
Cerna-Chavez R., Rozanska A., Poretti G.L. et al. Retinal pigment epithelium exhibits gene expression and phagocytic activity alterations when exposed to retinoblastoma chemotherapeutics. Experimental eye research. 2023-10-23;233(233):109542.
doi: 10.1016/j.exer.2023.109542
Chahin S., Morse M., Qaddoumi I. et al. An exploratory study of sleep habits in school-aged survivors of retinoblastoma. Sleep medicine. 2023-03-30;103(103):123-130.
doi: 10.1016/j.sleep.2023.01.026
Chai P., Luo Y., Yu J., Li Y., Yang J., Zhuang A., Fan J., Han M., Jia R. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients. Experimental eye research. 2021 Apr;205:108456.
doi: 10.1016/j.exer.2021.108456
Chai P., Jia R., Li Y., Zhou C., Gu X., Yang L., Shi H., Tian H., Lin H., Yu J., Zhuang A., Ge S., Jia R., Fan X. Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma. Prog Retin Eye Res. 2021 Dec 1:101030.
doi: 10.1016/j.preteyeres.2021.101030
Chakumatha E., Weijers J., Banda K., Bailey S., Molyneux E., Chagaluka G., Israels T. Outcome at the end of treatment of patients with common and curable childhood cancer types in Blantyre, Malawi. Pediatric blood & cancer. 2020 May 11.
DOI: 10.1002/pbc.28322
Chan W.Y.K., Fu N.W., Fu E.CH. et al. Autologous hematopoietic stem cell transplantation followed by quadruple immunotherapy with dinutuximab beta, sargramostim, aldesleukin, and spironolactone for relapsed metastatic retinoblastoma. Pediatric blood & cancer. 2024-07-10;71(7):e31044.
doi: 10.1002/pbc.31044
Chandra K., Raval V., Reddy P. V.A. et al. Primary Macular Retinoblastoma: Clinical Presentation and Treatment Outcomes. Journal of vitreoretinal diseases. 2023-04-04;6(5):367-373.
doi: 10.1177/24741264221107757
Chandrabhatla A.S., Horgan T.M., Cotton C.C. et al. Clinical Applications of Machine Learning in the Management of Intraocular Cancers: A Narrative Review. Investigative ophthalmology & visual science. 2023-07-27;64(10):29.
doi: 10.1167/iovs.64.10.29
Chang E., Zhou Y., Musch D. et al. Comparing internal versus external carotid artery branch delivery of intraarterial chemotherapy for the treatment of retinoblastoma. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2023-04-03.
doi: 10.1007/s00417-023-06037-w
Chantada G.L. et al. Eye-preserving therapy for retinoblastoma: new evidence and future perspectives. The Lancet. Child & adolescent health. 2023-10-11;7(9):600-601.
doi: 10.1016/S2352-4642(23)00165-7
Chantada G.L., Ceciliano A. et al. Intra-arterial chemotherapy for retinoblastoma: Centralization of care is essential. Pediatric blood & cancer. 2024-01-02;71(2):e30768.
doi: 10.1002/pbc.30768
Chaudhary R., Tiwari T., Sharma R., Goyal S. Retinoblastoma with significant intravitreal haemorrhage: a rare presentation. BMJ Case Rep. 2021 Sep 17;14(9):e246288.
doi: 10.1136/bcr-2021-246288
Chaudhary S., Shah S., Lavaju P., Shrestha B.G., Pant A.R., Badhu B.P. Profile of Destructive Ocular Surgery and its Indications: A Twelve-Year Review from Eastern Nepal. J Nepal Health Res Counc. 2021 Sep 6;19(2):246-251.
doi: 10.33314/jnhrc.v19i2.3150
Chawla B., Bhaskaran K., Dada T., Bajaj M.S., Kashyap S., Shende D. Evaluation of the role of ultrasound biomicroscopy in advanced retinoblastoma: A prospective study on Asian Indian children. Ophthalmic Genetics. 2020 Mar 16.
doi: 10.1080/13816810.2020.1737946
Che S., Wu S., Yu P. Lupeol induces autophagy and apoptosis with reduced cancer stem-like properties in retinoblastoma via phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin inhibition. J Pharm The Journal of pharmacy and pharmacology. 2021 Apr 9:rgab060.
doi: 10.1093/jpp/rgab060
Chen J., Yang S., Wang H. et al. Case report: Genetic diagnoses in a pediatric patient with retinoblastoma and comorbid global developmental delay: three distinct entities diagnosed by whole exome sequencing in a single patient. Frontiers in neuroscience. 2024-08-08;18(18):1391596.
doi: 10.3389/fnins.2024.1391596
Chen J., Zeng B. et al. METTL14-Mediated m6a Modification of CDKN2A Promotes the Development of Retinoblastoma by Inhibiting the p53 Pathway. Critical reviews in immunology. 2024-03-01;44(3):89-98.
doi: 10.1615/CritRevImmunol.2023052059
Chen M., Zhao Z., Wu L. et al. E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma. Cell death & disease. 2022-09-15;13(9):784.
doi: 10.1038/s41419-022-05222-9
Chen M., He H., Cheng H. et al. EIF4A3-induced hsa_circ_0078136 inhibits the tumorigenesis of retinoblastoma via IL-17 signaling pathway. International ophthalmology. 2024-08-26;44(1):352.
doi: 10.1007/s10792-024-03276-6
Chen N.N., Chao D.L., Li X.G. Circular RNA has_circ_0000527 participates in proliferation, invasion and migration of retinoblastoma cells via miR-646/BCL-2 axis. Cell Biochemistry & Function. 2020 Apr 7.
doi: 10.1002/cbf.3535
Chen P.Y., Kao L.Y., Chao A.N., Wu W.C., Sun M.H., Su W.W., Liu C.H. Retinoblastoma in Taiwan: survival and clinical characteristics. Japanese journal of ophthalmology. 2021 May 4.
doi: 10.1007/s10384-021-00836-6
Chen Q., Zhang B., Dong Y., Mo X., Zhang L., Xia J., Zhang J., Zhang S. Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma. // Cancer Chemotherapy and Pharmacology. 2020 Mar 2.
doi: 10.1007/s00280-020-04036-w
Chen S., Chen X., Luo Q., Liu X., Wang X., Cui Z., He A., He S., Jiang Z., Wu N., Chen P., Yu K., Zhuang J. Retinoblastoma cell-derived exosomes promote angiogenesis of human vesicle endothelial cells through microRNA-92a-3p. Cell Death Dis. 2021 Jul 13;12(7):695.
doi: 10.1038/s41419-021-03986-0
Chen S., Chen X., Qiu J., Chen P., Han X., Wu Y., Zhuang J., Yang M., Wu C., Wu N., Yang Y., Ge J., Yu K., Zhuang J. Exosomes derived from retinoblastoma cells enhance tumour deterioration by infiltrating the microenvironment. Oncology reports. 2021 Jan;45(1):278-290.
doi: 10.3892/or.2020.7858
Chen S., Chen X., Zhang P. et al. Bioinformatics Analysis and Experimental Identification of Immune-Related Genes and Immune Cells in the Progression of Retinoblastoma. Investigative ophthalmology & visual science. 2022-11-08;63(11):28.
doi: 10.1167/iovs.63.11.28
Chen X., Ouyang L., Ke N. et al. Study on the role of MYCN in retinoblastoma by inhibiting p53 and activating wnt/βcatenin/Fra-1 signaling pathway by reducing DKK3. Drug development research. 2024-08-12;85(5):e22222.
doi: 10.1002/ddr.22222
Chen W.J., Sun C.X., Li W. Mechanism of FGF7 Gene Silencing in Regulating Viability, Apoptosis, Invasion of Retinoblastoma Cell Line HXO-Rb44 and Angiogenesis. European review for medical and pharmacological sciences. 2020 Apr 24.
doi: 10.26355/eurrev_202004_20814
Chen W., Yang W., Li D. et al. Value of the strain ratio in the differential diagnosis of intraocular tumors by elastosonography: A retrospective case-control study. Indian journal of ophthalmology. 2023-03-07;71(3):983-988.
doi: 10.4103/ijo.IJO_1397_22
Chen X., Chen S., Jiang Z., Gong Q., Tang D., Luo Q., Liu X., He S., He A., Wu Y., Qiu J., Li Y., Wang X., Yu K., Zhuang J. Ubiquitination-Related miRNA-mRNA Interaction Is a Potential Mechanism in the Progression of Retinoblastoma. Invest Ophthalmol Vis Sci. 2021 Aug 2;62(10):3.
doi: 10.1167/iovs.62.10.3
Chen Y., Lu B., Liu L., Pan X., Jiang C., Xu H. Long non-coding RNA PROX1-AS1 knockdown upregulates microRNA-519d-3p to promote chemosensitivity of retinoblastoma cells via targeting SOX2. Cell Cycle. 2021 Sep 29:1-12.
doi: 10.1080/15384101.2021.1971352
Chen Y., Mao J., Xiang Z. et al. Retinal microvasculature observations of fellow eyes after intra-arterial chemotherapy for unilateral retinoblastoma using optical coherence tomography angiography. Frontiers in medicine. 2023-02-02;9(9):1015301.
doi: 10.3389/fmed.2022.1015301
Chen Y., Paul KC., Walker DI. et al. Neonatal per- and polyfluoroalkyl substance exposure in relation to retinoblastoma. Environmental research. 2023-11-21;240(Pt 2):117435.
doi: 10.1016/j.envres.2023.117435
Chen Y., Zhu X., Wang K., Zou W., Zhou F. Tubeimoside II inhibits TGF-β1-induced metastatic progression of human retinoblastoma cells through suppressing redoxosome-dependent EGFR activation. Chem Biol Interact. 2021 Feb 1;335:109367. Epub 2021 Jan 4.
doi: 10.1016/j.cbi.2021.109367
Chévez-Barrios P., Chantada G.L., Wilson M.W. et al. Incidence and Survival Rates in European Children With Retinoblastoma. JAMA ophthalmology. 2024-10-10
doi: 10.1001/jamaophthalmol.2024.4268
Cai L., Liu B., Cao Y. et al. Unveiling the molecular structure and role of RBBP4/7: implications for epigenetic regulation and cancer research. Frontiers in molecular biosciences. 2023-12-01;10(10):1276612
doi: 10.3389/fmolb.2023.1276612
Calabresi K, Emrich J, Belko S, Pugliese R, Komarnicky-Kocher L, Mourtada F. 3D-printed template design to improve 125/I seed plaque assembly accuracy for uveal brachytherapy. Brachytherapy. 2025 May-Jun;24(3):420-430Epub 2025 Feb 17. PMID: 39966071.
doi: 10.1016/j.brachy.2025.01.004
Сaliş Karanfil F., Gündüz A.K., Atilla H. et al. Varied toxicity profile of intravitreal melphalan in two retinoblastoma eyes. Anti-cancer drugs. 2024-07-24.
doi: 10.1097/CAD.0000000000001646
Calotti M., Yaghy A., Shields C.L. Painful Glaucoma and Pseudohypopyon in a Child with Retinoblastoma. Ophthalmology. Glaucoma. 2020 Nov-Dec;3(6):480.
doi: 10.1016/j.ogla.2020.07.004
Cancela M.B., Zugbi S., Winter U., Martinez A.L., Sampor C., Sgroi M., Francis J.H., Garippa R., Abramson D.H., Chantada G., Schaiquevich P. A decision process for drug discovery in retinoblastoma. Investigational new drugs. 2020 Nov 16.
doi: 10.1007/s10637-020-01030-0
Cancela M.B., Winter U., Zugbi S. et al. Mimicking Retinoblastoma Treatment With Repeated Topotecan or Melphalan Develops Cross-Resistance to Classic Agents But Not to Repurposed Drugs. Investigative ophthalmology & visual science. 2024-12-08;65(14):14
doi: 10.1167/iovs.65.14.14
Cao M., Wang S., Zou J., Wang W. Bioinformatics analyses of retinoblastoma reveal the retinoblastoma progression subtypes. PeerJ. 2020 May 21.
doi: 10.7717/peerj.8873
Cao Y., Zhou M., Tian M., Lv H.B. The Safety and Effectiveness of Melphalan-Based Intra-Arterial Chemotherapy for Retinoblastoma: An Updated Single-Arm Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2022 Feb 14;2022:3156503. PMID: 35198033; PMCID: PMC8860512.
doi: 10.1155/2022/3156503
Carbone E. T-type calcium channels as therapeutic targets for treating "giant" retinoblastoma cancer cells. Pflugers Arch. 2021 Sep 7.
doi: 10.1007/s00424-021-02620-4
Carnevale J.A., Goldberg J., Kocharian G., Rivera M., Giantini L.A., Garton A., Ramos A., Francis J.H., Abramson D.H., Pierre Gobin Y. Intra-arterial chemotherapy for retinoblastoma. J Neurointerv Surg. 2022 May 18.
doi: 10.1136/neurintsurg-2022-018957
Casciano F., Zauli E., Busin M. et al. State of the Art of Pharmacological Activators of p53 in Ocular Malignancies. Cancers. 2023-07-31;15(14).
doi: 10.3390/cancers15143593
Casey A, Barliana JD. The incidence of secondary neoplasms in retinoblastoma survivors who underwent radiation therapy: A systematic review and meta-analysis. Taiwan J Ophthalmol. 2024 Feb 2;15(1):45-54. PMID: 40213296; PMCID: PMC11981579.
doi: 10.4103/tjo.TJO-D-23-00086
Cassoux N., Malaise D., Lumbroso-Le-Rouic L. et al. Diffuse Infiltrating Retinoblastoma with Anterior Chamber Involvement: Conservative Management and Identification of RB1 Alterations in Aqueous Humor. Ocular oncology and pathology. 2023-10-31;9(3-4):96-100.
doi: 10.1159/000531233
Castillo-Trejo B., Pérez-Pérez J.F., Aguilar-Morales K. et al. Coexistence of persistent fetal vasculature and retinoblastoma in the same eye. Boletin medico del Hospital Infantil de Mexico. 2023-07-31;80(Supl 1):53-57.
doi: 10.24875/BMHIM.22000104
Castela G., Providência J., Monteiro M. et al. Effectiveness of Intra-Arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma: Relevance of a Multidisciplinary Setting. Clinical ophthalmology (Auckland, N.Z.). 2023-02-10;17(17):487-496.
doi: 10.2147/OPTH.S398488
Castela G., Providência J., Monteiro M., Silva S., Brito M., Murta J.N., Correa Z., Castelo Branco M. Treatment of Advanced Retinoblastoma in Children Evacuated from Low-Income Countries: Experience from a National Referral Center in Portugal. Clin Ophthalmol. 2021 Dec 21;15:4765-4773.
doi: 10.2147/OPTH.S343919
Castela G., Providencia J., Monteiro M., Silva S., Brito M., Sá J., Oliveiros B., Murta J.N., Correa Z., Branco M.C. Characterization of the Portuguese population diagnosed with retinoblastoma. Sci Rep. 2022 Mar 14;12(1):4378. PMID: 35288594; PMCID: PMC8921246.
doi: 10.1038/s41598-022-08326-6
Castro-Magdonel B.E., Orjuela M., Alvarez-Suarez D.E., Camacho J., Cabrera-Muñoz L., Sadowinski-Pine S., Medina-Sanson A., Lara-Molina C., García-Vega D., Vázquez Y., Durán-Figueroa N., Orozco-Romero M.J., Hernández-Ángeles A., Ponce-Castañeda M.V. Circulating miRNome Detection Analysis Reveals 537 miRNAS in Plasma, 625 in Extracellular Vesicles and a Discriminant Plasma Signature of 19 miRNAs in Children With Retinoblastoma From Which 14 Are Also Detected in Corresponding Primary Tumors. PLoS One. 2020 Apr 14.
doi: 10.1371/journal.pone.0231394
Catlin J.P., Marziali L.N., Rein B., Yan Z., Feltri M.L., Schaner Tooley C.E. Age-related neurodegeneration and cognitive impairments of NRMT1 knockout mice are preceded by misregulation of RB and abnormal neural stem cell development. Cell Death Dis. 2021 Oct 28;12(11):1014.
doi: 10.1038/s41419-021-04316-0
Cerna-Chavez R., Rozanska A., Poretti G.L. et al. Retinal pigment epithelium exhibits gene expression and phagocytic activity alterations when exposed to retinoblastoma chemotherapeutics. Experimental eye research. 2023-10-23;233(233):109542.
doi: 10.1016/j.exer.2023.109542
Chahin S., Morse M., Qaddoumi I. et al. An exploratory study of sleep habits in school-aged survivors of retinoblastoma. Sleep medicine. 2023-03-30;103(103):123-130.
doi: 10.1016/j.sleep.2023.01.026
Chai P., Luo Y., Yu J., Li Y., Yang J., Zhuang A., Fan J., Han M., Jia R. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients. Experimental eye research. 2021 Apr;205:108456.
doi: 10.1016/j.exer.2021.108456
Chai P., Jia R., Li Y., Zhou C., Gu X., Yang L., Shi H., Tian H., Lin H., Yu J., Zhuang A., Ge S., Jia R., Fan X. Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma. Prog Retin Eye Res. 2021 Dec 1:101030.
doi: 10.1016/j.preteyeres.2021.101030
Chakumatha E., Weijers J., Banda K., Bailey S., Molyneux E., Chagaluka G., Israels T. Outcome at the end of treatment of patients with common and curable childhood cancer types in Blantyre, Malawi. Pediatric blood & cancer. 2020 May 11.
DOI: 10.1002/pbc.28322
Chan W.Y.K., Fu N.W., Fu E.CH. et al. Autologous hematopoietic stem cell transplantation followed by quadruple immunotherapy with dinutuximab beta, sargramostim, aldesleukin, and spironolactone for relapsed metastatic retinoblastoma. Pediatric blood & cancer. 2024-07-10;71(7):e31044.
doi: 10.1002/pbc.31044
Chandra K., Raval V., Reddy P. V.A. et al. Primary Macular Retinoblastoma: Clinical Presentation and Treatment Outcomes. Journal of vitreoretinal diseases. 2023-04-04;6(5):367-373.
doi: 10.1177/24741264221107757
Chandrabhatla A.S., Horgan T.M., Cotton C.C. et al. Clinical Applications of Machine Learning in the Management of Intraocular Cancers: A Narrative Review. Investigative ophthalmology & visual science. 2023-07-27;64(10):29.
doi: 10.1167/iovs.64.10.29
Chang E., Zhou Y., Musch D. et al. Comparing internal versus external carotid artery branch delivery of intraarterial chemotherapy for the treatment of retinoblastoma. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2023-04-03.
doi: 10.1007/s00417-023-06037-w
Chantada G.L. et al. Eye-preserving therapy for retinoblastoma: new evidence and future perspectives. The Lancet. Child & adolescent health. 2023-10-11;7(9):600-601.
doi: 10.1016/S2352-4642(23)00165-7
Chantada G.L., Ceciliano A. et al. Intra-arterial chemotherapy for retinoblastoma: Centralization of care is essential. Pediatric blood & cancer. 2024-01-02;71(2):e30768.
doi: 10.1002/pbc.30768
Chaudhary R., Tiwari T., Sharma R., Goyal S. Retinoblastoma with significant intravitreal haemorrhage: a rare presentation. BMJ Case Rep. 2021 Sep 17;14(9):e246288.
doi: 10.1136/bcr-2021-246288
Chaudhary S., Shah S., Lavaju P., Shrestha B.G., Pant A.R., Badhu B.P. Profile of Destructive Ocular Surgery and its Indications: A Twelve-Year Review from Eastern Nepal. J Nepal Health Res Counc. 2021 Sep 6;19(2):246-251.
doi: 10.33314/jnhrc.v19i2.3150
Chawla B., Bhaskaran K., Dada T., Bajaj M.S., Kashyap S., Shende D. Evaluation of the role of ultrasound biomicroscopy in advanced retinoblastoma: A prospective study on Asian Indian children. Ophthalmic Genetics. 2020 Mar 16.
doi: 10.1080/13816810.2020.1737946
Che S., Wu S., Yu P. Lupeol induces autophagy and apoptosis with reduced cancer stem-like properties in retinoblastoma via phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin inhibition. J Pharm The Journal of pharmacy and pharmacology. 2021 Apr 9:rgab060.
doi: 10.1093/jpp/rgab060
Chen J., Yang S., Wang H. et al. Case report: Genetic diagnoses in a pediatric patient with retinoblastoma and comorbid global developmental delay: three distinct entities diagnosed by whole exome sequencing in a single patient. Frontiers in neuroscience. 2024-08-08;18(18):1391596.
doi: 10.3389/fnins.2024.1391596
Chen J., Zeng B. et al. METTL14-Mediated m6a Modification of CDKN2A Promotes the Development of Retinoblastoma by Inhibiting the p53 Pathway. Critical reviews in immunology. 2024-03-01;44(3):89-98.
doi: 10.1615/CritRevImmunol.2023052059
Chen M., Zhao Z., Wu L. et al. E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma. Cell death & disease. 2022-09-15;13(9):784.
doi: 10.1038/s41419-022-05222-9
Chen M., He H., Cheng H. et al. EIF4A3-induced hsa_circ_0078136 inhibits the tumorigenesis of retinoblastoma via IL-17 signaling pathway. International ophthalmology. 2024-08-26;44(1):352.
doi: 10.1007/s10792-024-03276-6
Chen N.N., Chao D.L., Li X.G. Circular RNA has_circ_0000527 participates in proliferation, invasion and migration of retinoblastoma cells via miR-646/BCL-2 axis. Cell Biochemistry & Function. 2020 Apr 7.
doi: 10.1002/cbf.3535
Chen P.Y., Kao L.Y., Chao A.N., Wu W.C., Sun M.H., Su W.W., Liu C.H. Retinoblastoma in Taiwan: survival and clinical characteristics. Japanese journal of ophthalmology. 2021 May 4.
doi: 10.1007/s10384-021-00836-6
Chen Q., Zhang B., Dong Y., Mo X., Zhang L., Xia J., Zhang J., Zhang S. Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma. // Cancer Chemotherapy and Pharmacology. 2020 Mar 2.
doi: 10.1007/s00280-020-04036-w
Chen S., Chen X., Luo Q., Liu X., Wang X., Cui Z., He A., He S., Jiang Z., Wu N., Chen P., Yu K., Zhuang J. Retinoblastoma cell-derived exosomes promote angiogenesis of human vesicle endothelial cells through microRNA-92a-3p. Cell Death Dis. 2021 Jul 13;12(7):695.
doi: 10.1038/s41419-021-03986-0
Chen S., Chen X., Qiu J., Chen P., Han X., Wu Y., Zhuang J., Yang M., Wu C., Wu N., Yang Y., Ge J., Yu K., Zhuang J. Exosomes derived from retinoblastoma cells enhance tumour deterioration by infiltrating the microenvironment. Oncology reports. 2021 Jan;45(1):278-290.
doi: 10.3892/or.2020.7858
Chen S., Chen X., Zhang P. et al. Bioinformatics Analysis and Experimental Identification of Immune-Related Genes and Immune Cells in the Progression of Retinoblastoma. Investigative ophthalmology & visual science. 2022-11-08;63(11):28.
doi: 10.1167/iovs.63.11.28
Chen X., Ouyang L., Ke N. et al. Study on the role of MYCN in retinoblastoma by inhibiting p53 and activating wnt/βcatenin/Fra-1 signaling pathway by reducing DKK3. Drug development research. 2024-08-12;85(5):e22222.
doi: 10.1002/ddr.22222
Chen W.J., Sun C.X., Li W. Mechanism of FGF7 Gene Silencing in Regulating Viability, Apoptosis, Invasion of Retinoblastoma Cell Line HXO-Rb44 and Angiogenesis. European review for medical and pharmacological sciences. 2020 Apr 24.
doi: 10.26355/eurrev_202004_20814
Chen W., Yang W., Li D. et al. Value of the strain ratio in the differential diagnosis of intraocular tumors by elastosonography: A retrospective case-control study. Indian journal of ophthalmology. 2023-03-07;71(3):983-988.
doi: 10.4103/ijo.IJO_1397_22
Chen X., Chen S., Jiang Z., Gong Q., Tang D., Luo Q., Liu X., He S., He A., Wu Y., Qiu J., Li Y., Wang X., Yu K., Zhuang J. Ubiquitination-Related miRNA-mRNA Interaction Is a Potential Mechanism in the Progression of Retinoblastoma. Invest Ophthalmol Vis Sci. 2021 Aug 2;62(10):3.
doi: 10.1167/iovs.62.10.3
Chen Y., Lu B., Liu L., Pan X., Jiang C., Xu H. Long non-coding RNA PROX1-AS1 knockdown upregulates microRNA-519d-3p to promote chemosensitivity of retinoblastoma cells via targeting SOX2. Cell Cycle. 2021 Sep 29:1-12.
doi: 10.1080/15384101.2021.1971352
Chen Y., Mao J., Xiang Z. et al. Retinal microvasculature observations of fellow eyes after intra-arterial chemotherapy for unilateral retinoblastoma using optical coherence tomography angiography. Frontiers in medicine. 2023-02-02;9(9):1015301.
doi: 10.3389/fmed.2022.1015301
Chen Y., Paul KC., Walker DI. et al. Neonatal per- and polyfluoroalkyl substance exposure in relation to retinoblastoma. Environmental research. 2023-11-21;240(Pt 2):117435.
doi: 10.1016/j.envres.2023.117435
Chen Y., Zhu X., Wang K., Zou W., Zhou F. Tubeimoside II inhibits TGF-β1-induced metastatic progression of human retinoblastoma cells through suppressing redoxosome-dependent EGFR activation. Chem Biol Interact. 2021 Feb 1;335:109367. Epub 2021 Jan 4.
doi: 10.1016/j.cbi.2021.109367
Chévez-Barrios P., Chantada G.L., Wilson M.W. et al. Incidence and Survival Rates in European Children With Retinoblastoma. JAMA ophthalmology. 2024-10-10
doi: 10.1001/jamaophthalmol.2024.4268
Chigane D, Pandya D, Singh M, Brown B, Lin M, Xu L, Stacey AW, Bonnell AC, Hubbard GB 3rd, Grossniklaus H, Skalet AH, Bellsmith KN, Lally SE, Simão-Rafael M, Muñoz CJ, Català-Mora J, Malaise D, Lumbroso-Le Rouic L, Matet A, Chantada GL, Cassoux N, Shields CL, Berry JL. Safety Assessment of Aqueous Humor Liquid Biopsy in Retinoblastoma: A Multicenter Study of 1203 Procedures. Ophthalmology. 2025 Mar 19:S0161-6420(25)00180-0. Epub ahead of print. PMID: 40118155.
doi: 10.1016/j.ophtha.2025.03.018
Chintagumpala M., Piao J., Gombos D. et al. A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1). Pediatric blood & cancer. 2023-12-14;71(1):e30718
doi: 10.1002/pbc.30718
Chiranthan M., Meel R., Bakhshi S. et al. Baseline and Post-NACT Imaging in Retinoblastoma With Optic Nerve Involvement: Can MRI Predict Prognosis? Journal of pediatric ophthalmology and strabismus. 2023-08-24:1-8
doi: 10.3928/01913913-20230714-01
Chiranthan M., Meel R., Sharma S. et al. Can Enhancement Pattern in Normal-Sized Optic Nerves on Magnetic Resonance Imaging Better Predict Tumor Invasion in Retinoblastoma Eyes? Ocular oncology and pathology. 2023-10-31;9(3-4):107-114
doi: 10.1159/000531354
Chittavanich P., Saengwimol D., Roytrakul S. et al. Ceftriaxone exerts antitumor effects in MYCN-driven retinoblastoma and neuroblastoma by targeting DDX3X for translation repression. Molecular oncology. 2023-11-27
doi: 10.1002/1878-0261.13553
Cho C.S., Jo D.H., Kim J.H. et al. Establishment and Characterization of Carboplatin-Resistant Retinoblastoma Cell Lines. Molecules and cells. 2022-09-01
doi: 10.14348/molcells.2022.2014
Choi W.J., Jo D.H., Kang H.J., Shin H.Y., Yu Y.S., Kim J.H. Development of New Solitary Retinoblastoma Tumors during and after Chemotherapy. Korean journal of ophthalmology : KJO. 2021 Feb;35(1):73-79.
doi: 10.3341/kjo.2020.0115
Cho S.J., Kim J.H., Baik S.H., Sunwoo L., Bae Y.J., Choi B.S. Diagnostic performance of MRI of post-laminar optic nerve invasion detection in retinoblastoma: A systematic review and meta-analysis. Neuroradiology. 2021 Apr;63(4):499-509.
doi: 10.1007/s00234-020-02538-1
Choudhry H.S., Patel A.M., Nguyen H.N. et al. Significance of Social Determinants of Health in Tumor Presentation, Hospital Readmission, and Overall Survival in Ocular Oncology. American journal of ophthalmology. 2023-11-13
doi: 10.1016/j.ajo.2023.10.024
Chou J.F., Ford J.S., Kleinerman R.A., Abramson D.H., Francis J.H., Sklar C.A., Oeffinger K.C., Robison L.L., Dunkel I.J., Friedman D.N. General cancer screening practices among adult survivors of retinoblastoma: Results from the Retinoblastoma Survivor Study. Pediatric blood & cancer. 2021 Jan 26:e28873.
doi: 10.1002/pbc.28873
Chou J.F., Ford J.S., Kleinerman R.A., Abramson D.H., Francis J.H., Sklar C.A., Oeffinger K.C., Robison L.L., Dunkel I.J., Friedman D.N. General cancer screening practices among adult survivors of retinoblastoma: Results from the Retinoblastoma Survivor Study. Pediatric blood & cancer. 2021 Apr;68(4):e28873.
doi: 10.1002/pbc.28873
Cho Y.J., Jung D.E., Oh Y., Nam K., Lee H.C., Jeon Y., Cho Y.D., Kim T.K. Heart rate variability and oxygen reserve index during cardiorespiratory events in patients undergoing ophthalmic arterial chemotherapy: a prospective observational study. Journal of clinical monitoring and computing. 2021 Mar 18.
doi: 10.1007/s10877-021-00687-z
Chronopoulos A., Babst N., Schiemenz C. et al. A Narrative Review – Therapy Options and Therapy Failure in Retinoblastoma. Neuro-Signals. 2022-11-14;30(S1):39-58
doi: 10.33594/000000585
Chrząszcz M., Mackiewicz N., Pociej-Marciak W. et al. Diagnostic and Therapeutic Challenges in a Patient with Radiation Retinopathy Complicated by Corticosteroid-Induced Central Serous Chorioretinopathy. Medicina (Kaunas, Lithuania). 2022-07-31;58(7)
doi: 10.3390/medicina58070862
Cieślik K., Rogowska A., Danowska M. et al. Efficacy of intravitreal injections of melphalan in the treatment of retinoblastoma vitreous seeding. Advances in clinical and experimental medicine: official organ Wroclaw Medical University. 2023-06-01
doi: 10.17219/acem/166180
Clarissa A., Sutandi N., Fath A.A. Stem-Cell Therapy Following High-Dose Chemotherapy in Advanced Retinoblastoma: A Systematic Review. Asia-Pacific journal of ophthalmology. 2021 Jan 19.
doi: 10.1097/APO.0000000000000372
Cobbs L.V., Francis J.H., Dunkel I.J., Gobin Y.P., Brodie S.E., Abramson D.H. Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions. Pediatric blood & cancer. 2021 May;68(5):e28845.
doi: 10.1002/pbc.28845
Cobrinik D. et al. Retinoblastoma Origins and Destinations. The New England journal of medicine. 2024-05-30;390(15):1408-1419
doi: 10.1056/NEJMra1803083
Collin J., Queen R., Zerti D., Steel D.H., Bowen C., Parulekar M., Lako M. Dissecting the Transcriptional and Chromatin Accessibility Heterogeneity of Proliferating Cone Precursors in Human Retinoblastoma Tumors by Single Cell Sequencing-Opening Pathways to New Therapeutic Strategies?
Investigative ophthalmology & visual science. 2021 May 3;62(6):18.
doi: 10.1167/iovs.62.6.18
Conroy L.R., Dougherty S., Kruer T., Metcalf S., Lorkiewicz P., He L., Yin X., Zhang X., Arumugam S., Young LEA, Sun R.C., Clem B.F. Loss of Rb1 Enhances Glycolytic Metabolism in Kras-Driven Lung Tumors In Vivo. ancers (Basel). 2020 Jan 17;12(1). pii: E237.
DOI: 10.3390/cancers12010237
Cooper R.C., Wang J., Yang H. et al. Injectable Dendrimer Hydrogel Delivers Melphalan in Both Conjugated and Free Forms for Retinoblastoma. Biomacromolecules. 2024-09-09;25(9):5928-5937
doi: 10.1021/acs.biomac.4c00597
Croley CR., Pumarol J., Delgadillo B.E. et al. Signaling pathways driving ocular malignancies and their targeting by bioactive phytochemicals. Pharmacology & therapeutics. 2023-07-18;248(248):108479
doi: 10.1016/j.pharmthera.2023.108479
Cruz-Abrams O, Dodds Rojas R, Abramson DH. Machine learning demonstrates clinical utility in distinguishing retinoblastoma from pseudo retinoblastoma with RetCam images. Ophthalmic Genet. 2025 Apr;46(2):180-185.. Epub 2025 Jan 20. PMID: 39834033.
doi: 10.1080/13816810.2025.2455576
Cruz-Gálvez C.C., Ordaz-Favila J.C., Villar-Calvo V.M. et al. Retinoblastoma: Review and new insights. Frontiers in oncology. 2022-11-22;12(12):963780
doi: 10.3389/fonc.2022.963780
Cuadrado-Vilanova M., Burgueño V., Balaguer-Lluna L. et al. Follow-up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients. The journal of pathology. Clinical research. 2022-09-24
doi: 10.1002/cjp2.296
Cuadrado-Vilanova M., Liu J., Paco S., Aschero R., Burgueño V., Sirab N., Pascual-Pasto G., Correa G., Balaguer-Lluna L., Castillo-Ecija H., Perez-Jaume S., Muñoz-Aznar O., Roldan M., Suñol M., Schaiquevich P., Aerts I., Doz F., Cassoux N., Lubieniecki F., Benitez-Ribas D., Lavarino C., Mora J., Chantada G.L., Catala-Mora J, Radvanyi F, Carcaboso AM. Identification of immunosuppressive factors in retinoblastoma cell secretomes and aqueous humor from patients. J Pathol. 2022 Mar 7. Epub ahead of print. PMID: 35254670.
doi: 10.1002/path.5893
Cui X., Ji X., Shao Y. et al. The Optos 200Tx Scanning Laser Ophthalmoscope Application in Retinoblastoma Patients' Follow-Up. BioMed research international. 2022-08-23;2022(2022):5422360
doi: 10.1155/2022/5422360
Cui X., Liang T., Ji X., Shao Y., Zhao P., Li X. LINC00488 Induces Tumorigenicity in Retinoblastoma by Regulating microRNA-30a-5p/EPHB2 Axis. Ocul Immunol Inflamm. 2022 Apr 11:1-9. Epub ahead of print. PMID: 35404750.
doi: 10.1080/09273948.2022.2037659
doi: 10.1016/j.ophtha.2025.03.018
Chintagumpala M., Piao J., Gombos D. et al. A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1). Pediatric blood & cancer. 2023-12-14;71(1):e30718
doi: 10.1002/pbc.30718
Chiranthan M., Meel R., Bakhshi S. et al. Baseline and Post-NACT Imaging in Retinoblastoma With Optic Nerve Involvement: Can MRI Predict Prognosis? Journal of pediatric ophthalmology and strabismus. 2023-08-24:1-8
doi: 10.3928/01913913-20230714-01
Chiranthan M., Meel R., Sharma S. et al. Can Enhancement Pattern in Normal-Sized Optic Nerves on Magnetic Resonance Imaging Better Predict Tumor Invasion in Retinoblastoma Eyes? Ocular oncology and pathology. 2023-10-31;9(3-4):107-114
doi: 10.1159/000531354
Chittavanich P., Saengwimol D., Roytrakul S. et al. Ceftriaxone exerts antitumor effects in MYCN-driven retinoblastoma and neuroblastoma by targeting DDX3X for translation repression. Molecular oncology. 2023-11-27
doi: 10.1002/1878-0261.13553
Cho C.S., Jo D.H., Kim J.H. et al. Establishment and Characterization of Carboplatin-Resistant Retinoblastoma Cell Lines. Molecules and cells. 2022-09-01
doi: 10.14348/molcells.2022.2014
Choi W.J., Jo D.H., Kang H.J., Shin H.Y., Yu Y.S., Kim J.H. Development of New Solitary Retinoblastoma Tumors during and after Chemotherapy. Korean journal of ophthalmology : KJO. 2021 Feb;35(1):73-79.
doi: 10.3341/kjo.2020.0115
Cho S.J., Kim J.H., Baik S.H., Sunwoo L., Bae Y.J., Choi B.S. Diagnostic performance of MRI of post-laminar optic nerve invasion detection in retinoblastoma: A systematic review and meta-analysis. Neuroradiology. 2021 Apr;63(4):499-509.
doi: 10.1007/s00234-020-02538-1
Choudhry H.S., Patel A.M., Nguyen H.N. et al. Significance of Social Determinants of Health in Tumor Presentation, Hospital Readmission, and Overall Survival in Ocular Oncology. American journal of ophthalmology. 2023-11-13
doi: 10.1016/j.ajo.2023.10.024
Chou J.F., Ford J.S., Kleinerman R.A., Abramson D.H., Francis J.H., Sklar C.A., Oeffinger K.C., Robison L.L., Dunkel I.J., Friedman D.N. General cancer screening practices among adult survivors of retinoblastoma: Results from the Retinoblastoma Survivor Study. Pediatric blood & cancer. 2021 Jan 26:e28873.
doi: 10.1002/pbc.28873
Chou J.F., Ford J.S., Kleinerman R.A., Abramson D.H., Francis J.H., Sklar C.A., Oeffinger K.C., Robison L.L., Dunkel I.J., Friedman D.N. General cancer screening practices among adult survivors of retinoblastoma: Results from the Retinoblastoma Survivor Study. Pediatric blood & cancer. 2021 Apr;68(4):e28873.
doi: 10.1002/pbc.28873
Cho Y.J., Jung D.E., Oh Y., Nam K., Lee H.C., Jeon Y., Cho Y.D., Kim T.K. Heart rate variability and oxygen reserve index during cardiorespiratory events in patients undergoing ophthalmic arterial chemotherapy: a prospective observational study. Journal of clinical monitoring and computing. 2021 Mar 18.
doi: 10.1007/s10877-021-00687-z
Chronopoulos A., Babst N., Schiemenz C. et al. A Narrative Review – Therapy Options and Therapy Failure in Retinoblastoma. Neuro-Signals. 2022-11-14;30(S1):39-58
doi: 10.33594/000000585
Chrząszcz M., Mackiewicz N., Pociej-Marciak W. et al. Diagnostic and Therapeutic Challenges in a Patient with Radiation Retinopathy Complicated by Corticosteroid-Induced Central Serous Chorioretinopathy. Medicina (Kaunas, Lithuania). 2022-07-31;58(7)
doi: 10.3390/medicina58070862
Cieślik K., Rogowska A., Danowska M. et al. Efficacy of intravitreal injections of melphalan in the treatment of retinoblastoma vitreous seeding. Advances in clinical and experimental medicine: official organ Wroclaw Medical University. 2023-06-01
doi: 10.17219/acem/166180
Clarissa A., Sutandi N., Fath A.A. Stem-Cell Therapy Following High-Dose Chemotherapy in Advanced Retinoblastoma: A Systematic Review. Asia-Pacific journal of ophthalmology. 2021 Jan 19.
doi: 10.1097/APO.0000000000000372
Cobbs L.V., Francis J.H., Dunkel I.J., Gobin Y.P., Brodie S.E., Abramson D.H. Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions. Pediatric blood & cancer. 2021 May;68(5):e28845.
doi: 10.1002/pbc.28845
Cobrinik D. et al. Retinoblastoma Origins and Destinations. The New England journal of medicine. 2024-05-30;390(15):1408-1419
doi: 10.1056/NEJMra1803083
Collin J., Queen R., Zerti D., Steel D.H., Bowen C., Parulekar M., Lako M. Dissecting the Transcriptional and Chromatin Accessibility Heterogeneity of Proliferating Cone Precursors in Human Retinoblastoma Tumors by Single Cell Sequencing-Opening Pathways to New Therapeutic Strategies?
Investigative ophthalmology & visual science. 2021 May 3;62(6):18.
doi: 10.1167/iovs.62.6.18
Conroy L.R., Dougherty S., Kruer T., Metcalf S., Lorkiewicz P., He L., Yin X., Zhang X., Arumugam S., Young LEA, Sun R.C., Clem B.F. Loss of Rb1 Enhances Glycolytic Metabolism in Kras-Driven Lung Tumors In Vivo. ancers (Basel). 2020 Jan 17;12(1). pii: E237.
DOI: 10.3390/cancers12010237
Cooper R.C., Wang J., Yang H. et al. Injectable Dendrimer Hydrogel Delivers Melphalan in Both Conjugated and Free Forms for Retinoblastoma. Biomacromolecules. 2024-09-09;25(9):5928-5937
doi: 10.1021/acs.biomac.4c00597
Croley CR., Pumarol J., Delgadillo B.E. et al. Signaling pathways driving ocular malignancies and their targeting by bioactive phytochemicals. Pharmacology & therapeutics. 2023-07-18;248(248):108479
doi: 10.1016/j.pharmthera.2023.108479
Cruz-Abrams O, Dodds Rojas R, Abramson DH. Machine learning demonstrates clinical utility in distinguishing retinoblastoma from pseudo retinoblastoma with RetCam images. Ophthalmic Genet. 2025 Apr;46(2):180-185.. Epub 2025 Jan 20. PMID: 39834033.
doi: 10.1080/13816810.2025.2455576
Cruz-Gálvez C.C., Ordaz-Favila J.C., Villar-Calvo V.M. et al. Retinoblastoma: Review and new insights. Frontiers in oncology. 2022-11-22;12(12):963780
doi: 10.3389/fonc.2022.963780
Cuadrado-Vilanova M., Burgueño V., Balaguer-Lluna L. et al. Follow-up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients. The journal of pathology. Clinical research. 2022-09-24
doi: 10.1002/cjp2.296
Cuadrado-Vilanova M., Liu J., Paco S., Aschero R., Burgueño V., Sirab N., Pascual-Pasto G., Correa G., Balaguer-Lluna L., Castillo-Ecija H., Perez-Jaume S., Muñoz-Aznar O., Roldan M., Suñol M., Schaiquevich P., Aerts I., Doz F., Cassoux N., Lubieniecki F., Benitez-Ribas D., Lavarino C., Mora J., Chantada G.L., Catala-Mora J, Radvanyi F, Carcaboso AM. Identification of immunosuppressive factors in retinoblastoma cell secretomes and aqueous humor from patients. J Pathol. 2022 Mar 7. Epub ahead of print. PMID: 35254670.
doi: 10.1002/path.5893
Cui X., Ji X., Shao Y. et al. The Optos 200Tx Scanning Laser Ophthalmoscope Application in Retinoblastoma Patients' Follow-Up. BioMed research international. 2022-08-23;2022(2022):5422360
doi: 10.1155/2022/5422360
Cui X., Liang T., Ji X., Shao Y., Zhao P., Li X. LINC00488 Induces Tumorigenicity in Retinoblastoma by Regulating microRNA-30a-5p/EPHB2 Axis. Ocul Immunol Inflamm. 2022 Apr 11:1-9. Epub ahead of print. PMID: 35404750.
doi: 10.1080/09273948.2022.2037659
D
Daba KT, Hordofa DF, Mengesha AA. Challenges and Outcomes of Retinoblastoma Treatment in Ethiopia A Case of Jimma University Medical Center, Southwest Ethiopia. Ethiop J Health Sci. 2025 Mar;35(2):96-100. PMID: 40511273; PMCID: PMC12153061.
doi: 10.4314/ejhs.v35i2.5.
Dai C., Yu H., Bai Q. et al. MicroRNA-708 suppresses the proliferation, migration, and invasion of human retinoblastoma cells by targeting RAP2B, a member of the RAS oncogene family. Acta biochimica Polonica. 2022-11-29
doi: 10.18388/abp.2020_5872
Dai H., Zeng W., Zeng W., Yan M., Jiang P., Li Y., Zhang W., Ke M. HELZ2 promotes K63-linked polyubiquitination of c-Myc to induce retinoblastoma tumorigenesis. Med Oncol. 2021 Nov 10;39(1):11
doi: 10.1007/s12032-021-01603-w
Dai X.Z., Wang L.Y., Shan Y., Qian J., Xue K., Ye J. Clinicopathological analysis of 719 pediatric and adolescents' ocular tumors and tumor-like lesions: a retrospective study from 2000 to 2018 in China. International journal of ophthalmology. 2020 Dec 18;13(12):1961-1967
doi: 10.18240/ijo.2020.12.1
Dalvi N., Kleinerman R.A., Epelman S., Abramson D.H., Dunkel I.J. Low-grade glioma: A rare second tumor in retinoblastoma survivors. Pediatric blood & cancer. 2020 Oct 16
doi: 10.1002/pbc.28770
Dalvin L.A., Bas Z., Tadepalli S., Rao R., Vaidya S., Pacheco R., Shields C.L. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients. Journal of pediatric ophthalmology and strabismus. 2020 Jul 1
doi: 10.3928/01913913-20200417-01
Damodharan S., Monroe E. et al. Increased Incidence of Retinoblastoma in Wisconsin: Coincidence or Public Health Concern? WMJ : official publication of the State Medical Society of Wisconsin. 2024-09-17;123(2):76-77
Daniels A.B., Froehler M.T., Kaczmarek J.V., Bogan C.M., Santapuram P.R., Pierce J.M., Chen S.C., Schremp E.A., Boyd K.L., Tao Y.K., Calcutt M.W., Koyama T., Richmond A., Friedman D.L. Efficacy, Toxicity, and Pharmacokinetics of Intra-Arterial Chemotherapy Versus Intravenous Chemotherapy for Retinoblastoma in Animal Models and Patients. Transl Vis Sci Technol. 2021 Sep 1;10(11):10
doi: 10.1167/tvst.10.11.10
Daniels A.B., Patel S.N., Milam R.W., Kohanim S., Friedman D.L., Koyama T.
Effect of Intravenous Chemotherapy Regimen on Globe Salvage Success Rates for Retinoblastoma Based on Disease Class-A Meta-Analysis. Cancers (Basel). 2021;13(9):2216. 2021 May 6
doi:10.3390/cancers13092216
Daniels A.B., Pierce J.M., Chen S.C. Complete preclinical platform for intravitreal chemotherapy drug discovery for retinoblastoma: Assessment of pharmacokinetics, toxicity and efficacy using a rabbit model. MethodsX. 2021 Apr 20;8:101358
doi: 10.1016/j.mex.2021.101358
Daniels A.B., Sishtla K.L., Bogan C.M. et al. Aqueous VEGF-A Levels as a Liquid Biopsy Biomarker of Retinoblastoma Vitreous Seed Response to Therapy. Investigative ophthalmology & visual science. 2024-07-11;65(6):18
doi: 10.1167/iovs.65.6.18
Das A., Ranjan R., Shah P.K. Coexistent Retinoblastoma and Retinopathy of Prematurity in a Preterm Infant. Ophthalmic Surg Lasers Imaging Retina. 2020 Dec 1;51(12):732.
doi: 10.3928/23258160-20201202-09.
Das D., Bhattacharjee K., Barman M.J., Bhattacharjee H., Maity S., Bandyopadhyay D., Thakur S., Deshmukh S., Garg M., Deka A. Pathologic evidence of retinoblastoma seeds supported by field emission scanning electron microscopy and Raman spectroscopy. Indian J Ophthalmol. 2021 Dec;69(12):3612-3617
doi: 10.4103/ijo.IJO_436_21
Das D., Rehman O., Bhattacharjee K. et al. Post-chemotherapy changes in retinal pigment epithelium in retinoblastoma eyes. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024-01-19
doi: 10.1016/j.jcjo.2023.12.006
Das S., Varshney A. et al. Commentary: Can machine be taught to detect retinoblastoma? Indian journal of ophthalmology. 2023-02-07;71(2):432-433
doi: 10.4103/ijo.IJO_2283_22
Dave N., Vural A.S., Piras I.S., Winslow W., Surendra L., Winstone J.K., Beach T.G., Huentelman M.J., Velazquez R. Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer's disease and related tauopathies. Acta Neuropathol. 2021 Aug;142(2):279-294
doi: 10.1007/s00401-021-02323-1
Dave T.V., Nayak A., Palo M., Goud Y., Tripuraneni D., Gupta S. Custom ocular prosthesis-related concerns: patient feedback survey-based report vis-à-vis objective clinical grading scales. Orbit. 2021 Oct;40(5):357-363
doi: 10.1080/01676830.2020.1797826
Davies H.R., Broad K.D., Onadim Z., Price E.A., Zou X., Sheriff I., Karaa E.K., Scheimberg I., Reddy M.A., Sagoo M.S., Ohnuma S.I., Nik-Zainal S. Whole-Genome Sequencing of Retinoblastoma Reveals the Diversity of Rearrangements Disrupting RB1 and Uncovers a Treatment-Related Mutational Signature. Cancers. 2021 Feb 11;13(4):754
doi: 10.3390/cancers13040754
Davis M.E., Guarini E., O'Connor K. et al. Hearing Evaluations in Children With Retinoblastoma Treated With Intra-arterial Carboplatin Chemotherapy: A Single Institution Review. J Pediatr Ophthalmol Strabismus. 2025 Jan-Feb;62(1):27-32. Epub 2024 Sep 10. PMID: 39254185; PMCID: PMC11757066
doi: 10.3928/01913913-20240807-02
Deike-Hofmann K., von Lampe P., Eerikaeinen M., Ting S., Schlüter S., Schlemmer H.P., Bechrakis N.E., Forsting M., Radbruch A. Anterior chamber enhancement predicts optic nerve infiltration in retinoblastoma. Eur Radiol. 2022 May 7
doi: 10.1007/s00330-022-08778-4
Del Carmen Bernal-Díaz Z., Murillo-Maldonado M.A., Pérez-Villanueva H., Reyes-López A., Ramírez-Ortiz M.A. Ocular preservation in patients with bilateral retinoblastoma before chemotherapy in situ era: A report from a Mexican Retinoblastoma Reference Hospital. Pediatric blood & cancer. 2020 Aug 3
doi: 10.1002/pbc.28625
Delrish E., Jabbarvand M., Ghassemi F. et al. The Antitumor Effect of Topotecan Loaded Thiolated Chitosan-Dextran Nanoparticles for Intravitreal Chemotherapy: A Xenograft Retinoblastoma Model. Journal of ophthalmic & vision research. 2023-03-21;18(1):68-80
doi: 10.18502/jovr.v18i1.12727
Delrish E., Jabbarvand M., Ghassemi F., Amoli F.A., Atyabi F., Lashay A., Soleimani M., Aghajanpour L., Dinarvand R. Efficacy of topotecan nanoparticles for intravitreal chemotherapy of retinoblastoma.
Experimental eye research. 2021 Jan 13;204:108423.
doi: 10.1016/j.exer.2020.108423
Del Sole M.J., Clausse M., Nejamkin P., Cancela B., Del Río M., Lamas G., Lubieniecki F., Francis J.H., Abramson D.H., Chantada G., Schaiquevich P. Ocular and systemic toxicity of high-dose intravitreal topotecan in rabbits: Implications for retinoblastoma treatment. Exp Eye Res. 2022 Mar 8;218:109026. Epub ahead of print. PMID: 35276184.
doi: 10.1016/j.exer.2022.109026
Demirci H., Wang Y., Li Q., Lin C.M., Kotov N.A., Grisolia A.B.D., Guo J.L. Penetration of Carbon Nanotubes into the Retinoblastoma Tumor after Intravitreal Injection in LH BETA T AG Transgenic Mice Reti-noblastoma Model. Journal of ophthalmic & vision research. 2020 Oct 25;15(4):446-452.
doi: 10.18502/jovr.v15i4.7778
Deng X., Cheng Y., Zhu X.M., Linghu D.D., Zhao M.W., Liang J.H. [Evaluation the risk of optic nerve invasion associated with optic nerve obscuration in advanced retinoblastoma]. Chinese journal of ophthalmology. 2020 Sep 11.
doi: 10.3760/cma.j.cn112142-20200318-00197
DeYoung C., Barke M.R., Shields C.L. et al. Cavitary Retinoblastoma Imaged on Magnetic Resonance Imaging. Journal of pediatric ophthalmology and strabismus. 2023-02-02;60(1):e1-e4
doi: 10.3928/01913913-20221118-02
Dhandapani K., Nagarjun B.R., Shah R. et al. Retinoblastoma with Isolated Parotid Gland Metastasis: A Report of 2 Cases with Review of Literature. Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India. 2023-09-28;75(2):1315-1320.
doi: 10.1007/s12070-022-03287-8
Dhingra H., Arya D., Taluja A., Das S., Mahajan A. A study analyzing the health-related quality of life of retinoblastoma survivors in India. Indian journal of ophthalmology. 2021 Jun;69(6):1482-1486.
doi: 10.4103/ijo.IJO_2428_20
Diatewa B.M., Maneh N., Domingo A.S., Amouzou D., Gnansa K., Bawerima W., Ayikoue Y.F., Mewamba Wamba R. Le rétinoblastome au Centre Hospitalier Universitaire-Campus de Lomé, Togo, de 2014 à 2018 [Retinoblastoma at the Campus-University Teaching Hospital in Lomé, Togo, from 2014 to 2018]. J Fr Ophtalmol. 2022 Jun 23:S0181-5512(21)00592-1. French. Epub ahead of print. PMID: 35753853.
doi: 10.1016/j.jfo.2021.08.014
Dimaras H., Omweri B., Muema D. et al. Toward advances in retinoblastoma genetics in Kenya. Nature genetics. 2024-12-17;56(12):2585-2588
doi: 10.1038/s41588-024-01974-6
Ding J., Sun J., Ma R.Q. et al. Low expression of NR1D1 and NR2E3 is associated with advanced features of retinoblastoma. International ophthalmology. 2024-03-16;44(1):133
doi: 10.1007/s10792-024-03055-3
Ding J., Lu J., Zhang Q. et al. Camouflage Nanoparticles Enable in Situ Bioluminescence-Driven Optogenetic Therapy of Retinoblastoma. ACS nano. 2023-05-07;17(8):7750-7764.
doi: 10.1021/acsnano.3c00470
Ding F., Jiang K., Sheng Y., Li C., Zhu H. LncRNA MIR7-3HG executes a positive role in retinoblastoma progression via modulating miR-27a-3p/PEG10 axis. Exp Eye Res. 2020 Feb 5;193:107960.
doi: 10.1016/j.exer.2020.107960
Dittner-Moormann S., Reschke M., Abbink F.C.H., Aerts I., Atalay H.T., Fedorovna Bobrova N., Biewald E., Brecht IB, Caspi S, Cassoux N., Castela G., Diarra Y., Duncan C., Ebinger M., Garcia Aldana D., Hadjistilianou D., Kepák T., Klett A., Kiratli H., Maka E., Opocher E., Pawinska-Wasikowska K., Rascon J., Russo I., Rutynowska-Pronicka O., Sábado Álvarez C., Pacheco S.S.R., Svojgr K., Timmermann B., Vishnevskia-Dai V., Eggert A., Ritter-Sovinz P., Bechrakis N.E., Jenkinson H., Moll A., Munier F.L., Popovic M.B., Chantada G., Doz F., Ketteler P. Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG). Pediatric blood & cancer. 2021 Mar 15:e28963.
doi: 10.1002/pbc.28963
Dockery P.W., Ruben M., Duffner E.R. et al. Likelihood of germline mutation with solitary retinoblastoma based on tumour location at presentation. The British journal of ophthalmology. 2022-11-22
Doege A., Steens R., Dünker N., Busch M.A. Retinoblastoma Cell Growth In Vitro and Tumor Formation In Ovo-Influence of Different Culture Conditions. Methods Protoc. 2022 Mar 2;5(2):21. PMID: 35314658; PMCID: PMC8938814.
doi: 10.3390/mps5020021
Doghish A.S., Moustafa H.A.M., Elballal M.S. et al. miRNAs as potential game-changers in retinoblastoma: Future clinical and medicinal uses. Pathology, research and practice. 2023-05-22;247(247):154537
doi: 10.1016/j.prp.2023.154537
Do K.H., Pham C.T.M., Do T.C. et al. Clinical features and outcome of retinoblastoma at the Vietnam National Cancer Hospital. Pediatric blood & cancer. 2023-06-25:e30526
doi: 10.1002/pbc.30526
Domínguez-Varela I.A., Aguilera-Partida J.A., Dalvin L.A., Garza-Garza L.A., Thompson-García L.M., Barbosa-Quintana Á., Ancona-Lezama D. Retinoblastoma in an older Hispanic child masquerading as pars planitis: A case report.
European journal of ophthalmology. 2021 Feb 10:1120672121994487.
doi: 10.1177/1120672121994487
Dong Y., Wan G., Yan P., Qian C., Li F., Peng G. Long noncoding RNA LINC00324 promotes retinoblastoma progression by acting as a competing endogenous RNA for microRNA-769-5p, thereby increasing STAT3 expression. Aging. 2020 May 5
doi: 10.18632/aging.103075
Döpper H., Horstmann M., Menges J., Bozet M., Kanber D., Steenpass L. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines. Stem Cell Research. 2020 Mar 29;45:101779.
doi: 10.1016/j.scr.2020.101779
Drager O., Metz K., Busch M., Dunker N. Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets. Mol Oncol. 2022 Feb;16(4):957-981. PMID: 34228897; PMCID: PMC8847994.
doi: 10.1002/1878-0261.13054
Dubey D., Shanmugam M., Singh D. et al. Fundus fluorescein angiography in a macular retinocytoma. Indian journal of ophthalmology. 2022-09-27;70(7):2731-2732
doi: 10.4103/ijo.IJO_161_22
Duka E, Hashorva E, Kapllanaj M, Xhafa M, Godo A, Tandili A, Rustemi E, Petrela E, Arazi M, Fabian ID, Babameto A, Tabaku M, Shundi L, Bali D. Retinoblastoma in Albania: A 25-Year Retrospective Analysis. Turk Arch Pediatr. 2025 Mar 3;60(2):159-163. PMID: 40091765; PMCID: PMC11963307.
doi: 10.5152/TurkArchPediatr.2025.24203
Dunkel I.J., Piao J., Chantada G.L. et al. Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321). Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2022-08-20:JCO2102337
doi: 10.1200/JCO.21.02337
Dutra M.P., Rodrigues C.M., Peretz-Soroka H. et al. Radiation-induced sarcomas following childhood cancer - A Canadian Sarcoma Research and Clinical Collaboration Study (CanSaRCC). Cancer reports (Hoboken, N.J.). 2023-06-08;6(6):e1834
doi: 10.1002/cnr2.1834
Daba KT, Hordofa DF, Mengesha AA. Challenges and Outcomes of Retinoblastoma Treatment in Ethiopia A Case of Jimma University Medical Center, Southwest Ethiopia. Ethiop J Health Sci. 2025 Mar;35(2):96-100. PMID: 40511273; PMCID: PMC12153061.
doi: 10.4314/ejhs.v35i2.5.
Dai C., Yu H., Bai Q. et al. MicroRNA-708 suppresses the proliferation, migration, and invasion of human retinoblastoma cells by targeting RAP2B, a member of the RAS oncogene family. Acta biochimica Polonica. 2022-11-29
doi: 10.18388/abp.2020_5872
Dai H., Zeng W., Zeng W., Yan M., Jiang P., Li Y., Zhang W., Ke M. HELZ2 promotes K63-linked polyubiquitination of c-Myc to induce retinoblastoma tumorigenesis. Med Oncol. 2021 Nov 10;39(1):11
doi: 10.1007/s12032-021-01603-w
Dai X.Z., Wang L.Y., Shan Y., Qian J., Xue K., Ye J. Clinicopathological analysis of 719 pediatric and adolescents' ocular tumors and tumor-like lesions: a retrospective study from 2000 to 2018 in China. International journal of ophthalmology. 2020 Dec 18;13(12):1961-1967
doi: 10.18240/ijo.2020.12.1
Dalvi N., Kleinerman R.A., Epelman S., Abramson D.H., Dunkel I.J. Low-grade glioma: A rare second tumor in retinoblastoma survivors. Pediatric blood & cancer. 2020 Oct 16
doi: 10.1002/pbc.28770
Dalvin L.A., Bas Z., Tadepalli S., Rao R., Vaidya S., Pacheco R., Shields C.L. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients. Journal of pediatric ophthalmology and strabismus. 2020 Jul 1
doi: 10.3928/01913913-20200417-01
Damodharan S., Monroe E. et al. Increased Incidence of Retinoblastoma in Wisconsin: Coincidence or Public Health Concern? WMJ : official publication of the State Medical Society of Wisconsin. 2024-09-17;123(2):76-77
Daniels A.B., Froehler M.T., Kaczmarek J.V., Bogan C.M., Santapuram P.R., Pierce J.M., Chen S.C., Schremp E.A., Boyd K.L., Tao Y.K., Calcutt M.W., Koyama T., Richmond A., Friedman D.L. Efficacy, Toxicity, and Pharmacokinetics of Intra-Arterial Chemotherapy Versus Intravenous Chemotherapy for Retinoblastoma in Animal Models and Patients. Transl Vis Sci Technol. 2021 Sep 1;10(11):10
doi: 10.1167/tvst.10.11.10
Daniels A.B., Patel S.N., Milam R.W., Kohanim S., Friedman D.L., Koyama T.
Effect of Intravenous Chemotherapy Regimen on Globe Salvage Success Rates for Retinoblastoma Based on Disease Class-A Meta-Analysis. Cancers (Basel). 2021;13(9):2216. 2021 May 6
doi:10.3390/cancers13092216
Daniels A.B., Pierce J.M., Chen S.C. Complete preclinical platform for intravitreal chemotherapy drug discovery for retinoblastoma: Assessment of pharmacokinetics, toxicity and efficacy using a rabbit model. MethodsX. 2021 Apr 20;8:101358
doi: 10.1016/j.mex.2021.101358
Daniels A.B., Sishtla K.L., Bogan C.M. et al. Aqueous VEGF-A Levels as a Liquid Biopsy Biomarker of Retinoblastoma Vitreous Seed Response to Therapy. Investigative ophthalmology & visual science. 2024-07-11;65(6):18
doi: 10.1167/iovs.65.6.18
Das A., Ranjan R., Shah P.K. Coexistent Retinoblastoma and Retinopathy of Prematurity in a Preterm Infant. Ophthalmic Surg Lasers Imaging Retina. 2020 Dec 1;51(12):732.
doi: 10.3928/23258160-20201202-09.
Das D., Bhattacharjee K., Barman M.J., Bhattacharjee H., Maity S., Bandyopadhyay D., Thakur S., Deshmukh S., Garg M., Deka A. Pathologic evidence of retinoblastoma seeds supported by field emission scanning electron microscopy and Raman spectroscopy. Indian J Ophthalmol. 2021 Dec;69(12):3612-3617
doi: 10.4103/ijo.IJO_436_21
Das D., Rehman O., Bhattacharjee K. et al. Post-chemotherapy changes in retinal pigment epithelium in retinoblastoma eyes. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024-01-19
doi: 10.1016/j.jcjo.2023.12.006
Das S., Varshney A. et al. Commentary: Can machine be taught to detect retinoblastoma? Indian journal of ophthalmology. 2023-02-07;71(2):432-433
doi: 10.4103/ijo.IJO_2283_22
Dave N., Vural A.S., Piras I.S., Winslow W., Surendra L., Winstone J.K., Beach T.G., Huentelman M.J., Velazquez R. Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer's disease and related tauopathies. Acta Neuropathol. 2021 Aug;142(2):279-294
doi: 10.1007/s00401-021-02323-1
Dave T.V., Nayak A., Palo M., Goud Y., Tripuraneni D., Gupta S. Custom ocular prosthesis-related concerns: patient feedback survey-based report vis-à-vis objective clinical grading scales. Orbit. 2021 Oct;40(5):357-363
doi: 10.1080/01676830.2020.1797826
Davies H.R., Broad K.D., Onadim Z., Price E.A., Zou X., Sheriff I., Karaa E.K., Scheimberg I., Reddy M.A., Sagoo M.S., Ohnuma S.I., Nik-Zainal S. Whole-Genome Sequencing of Retinoblastoma Reveals the Diversity of Rearrangements Disrupting RB1 and Uncovers a Treatment-Related Mutational Signature. Cancers. 2021 Feb 11;13(4):754
doi: 10.3390/cancers13040754
Davis M.E., Guarini E., O'Connor K. et al. Hearing Evaluations in Children With Retinoblastoma Treated With Intra-arterial Carboplatin Chemotherapy: A Single Institution Review. J Pediatr Ophthalmol Strabismus. 2025 Jan-Feb;62(1):27-32. Epub 2024 Sep 10. PMID: 39254185; PMCID: PMC11757066
doi: 10.3928/01913913-20240807-02
Deike-Hofmann K., von Lampe P., Eerikaeinen M., Ting S., Schlüter S., Schlemmer H.P., Bechrakis N.E., Forsting M., Radbruch A. Anterior chamber enhancement predicts optic nerve infiltration in retinoblastoma. Eur Radiol. 2022 May 7
doi: 10.1007/s00330-022-08778-4
Del Carmen Bernal-Díaz Z., Murillo-Maldonado M.A., Pérez-Villanueva H., Reyes-López A., Ramírez-Ortiz M.A. Ocular preservation in patients with bilateral retinoblastoma before chemotherapy in situ era: A report from a Mexican Retinoblastoma Reference Hospital. Pediatric blood & cancer. 2020 Aug 3
doi: 10.1002/pbc.28625
Delrish E., Jabbarvand M., Ghassemi F. et al. The Antitumor Effect of Topotecan Loaded Thiolated Chitosan-Dextran Nanoparticles for Intravitreal Chemotherapy: A Xenograft Retinoblastoma Model. Journal of ophthalmic & vision research. 2023-03-21;18(1):68-80
doi: 10.18502/jovr.v18i1.12727
Delrish E., Jabbarvand M., Ghassemi F., Amoli F.A., Atyabi F., Lashay A., Soleimani M., Aghajanpour L., Dinarvand R. Efficacy of topotecan nanoparticles for intravitreal chemotherapy of retinoblastoma.
Experimental eye research. 2021 Jan 13;204:108423.
doi: 10.1016/j.exer.2020.108423
Del Sole M.J., Clausse M., Nejamkin P., Cancela B., Del Río M., Lamas G., Lubieniecki F., Francis J.H., Abramson D.H., Chantada G., Schaiquevich P. Ocular and systemic toxicity of high-dose intravitreal topotecan in rabbits: Implications for retinoblastoma treatment. Exp Eye Res. 2022 Mar 8;218:109026. Epub ahead of print. PMID: 35276184.
doi: 10.1016/j.exer.2022.109026
Demirci H., Wang Y., Li Q., Lin C.M., Kotov N.A., Grisolia A.B.D., Guo J.L. Penetration of Carbon Nanotubes into the Retinoblastoma Tumor after Intravitreal Injection in LH BETA T AG Transgenic Mice Reti-noblastoma Model. Journal of ophthalmic & vision research. 2020 Oct 25;15(4):446-452.
doi: 10.18502/jovr.v15i4.7778
Deng X., Cheng Y., Zhu X.M., Linghu D.D., Zhao M.W., Liang J.H. [Evaluation the risk of optic nerve invasion associated with optic nerve obscuration in advanced retinoblastoma]. Chinese journal of ophthalmology. 2020 Sep 11.
doi: 10.3760/cma.j.cn112142-20200318-00197
DeYoung C., Barke M.R., Shields C.L. et al. Cavitary Retinoblastoma Imaged on Magnetic Resonance Imaging. Journal of pediatric ophthalmology and strabismus. 2023-02-02;60(1):e1-e4
doi: 10.3928/01913913-20221118-02
Dhandapani K., Nagarjun B.R., Shah R. et al. Retinoblastoma with Isolated Parotid Gland Metastasis: A Report of 2 Cases with Review of Literature. Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India. 2023-09-28;75(2):1315-1320.
doi: 10.1007/s12070-022-03287-8
Dhingra H., Arya D., Taluja A., Das S., Mahajan A. A study analyzing the health-related quality of life of retinoblastoma survivors in India. Indian journal of ophthalmology. 2021 Jun;69(6):1482-1486.
doi: 10.4103/ijo.IJO_2428_20
Diatewa B.M., Maneh N., Domingo A.S., Amouzou D., Gnansa K., Bawerima W., Ayikoue Y.F., Mewamba Wamba R. Le rétinoblastome au Centre Hospitalier Universitaire-Campus de Lomé, Togo, de 2014 à 2018 [Retinoblastoma at the Campus-University Teaching Hospital in Lomé, Togo, from 2014 to 2018]. J Fr Ophtalmol. 2022 Jun 23:S0181-5512(21)00592-1. French. Epub ahead of print. PMID: 35753853.
doi: 10.1016/j.jfo.2021.08.014
Dimaras H., Omweri B., Muema D. et al. Toward advances in retinoblastoma genetics in Kenya. Nature genetics. 2024-12-17;56(12):2585-2588
doi: 10.1038/s41588-024-01974-6
Ding J., Sun J., Ma R.Q. et al. Low expression of NR1D1 and NR2E3 is associated with advanced features of retinoblastoma. International ophthalmology. 2024-03-16;44(1):133
doi: 10.1007/s10792-024-03055-3
Ding J., Lu J., Zhang Q. et al. Camouflage Nanoparticles Enable in Situ Bioluminescence-Driven Optogenetic Therapy of Retinoblastoma. ACS nano. 2023-05-07;17(8):7750-7764.
doi: 10.1021/acsnano.3c00470
Ding F., Jiang K., Sheng Y., Li C., Zhu H. LncRNA MIR7-3HG executes a positive role in retinoblastoma progression via modulating miR-27a-3p/PEG10 axis. Exp Eye Res. 2020 Feb 5;193:107960.
doi: 10.1016/j.exer.2020.107960
Dittner-Moormann S., Reschke M., Abbink F.C.H., Aerts I., Atalay H.T., Fedorovna Bobrova N., Biewald E., Brecht IB, Caspi S, Cassoux N., Castela G., Diarra Y., Duncan C., Ebinger M., Garcia Aldana D., Hadjistilianou D., Kepák T., Klett A., Kiratli H., Maka E., Opocher E., Pawinska-Wasikowska K., Rascon J., Russo I., Rutynowska-Pronicka O., Sábado Álvarez C., Pacheco S.S.R., Svojgr K., Timmermann B., Vishnevskia-Dai V., Eggert A., Ritter-Sovinz P., Bechrakis N.E., Jenkinson H., Moll A., Munier F.L., Popovic M.B., Chantada G., Doz F., Ketteler P. Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG). Pediatric blood & cancer. 2021 Mar 15:e28963.
doi: 10.1002/pbc.28963
Dockery P.W., Ruben M., Duffner E.R. et al. Likelihood of germline mutation with solitary retinoblastoma based on tumour location at presentation. The British journal of ophthalmology. 2022-11-22
Doege A., Steens R., Dünker N., Busch M.A. Retinoblastoma Cell Growth In Vitro and Tumor Formation In Ovo-Influence of Different Culture Conditions. Methods Protoc. 2022 Mar 2;5(2):21. PMID: 35314658; PMCID: PMC8938814.
doi: 10.3390/mps5020021
Doghish A.S., Moustafa H.A.M., Elballal M.S. et al. miRNAs as potential game-changers in retinoblastoma: Future clinical and medicinal uses. Pathology, research and practice. 2023-05-22;247(247):154537
doi: 10.1016/j.prp.2023.154537
Do K.H., Pham C.T.M., Do T.C. et al. Clinical features and outcome of retinoblastoma at the Vietnam National Cancer Hospital. Pediatric blood & cancer. 2023-06-25:e30526
doi: 10.1002/pbc.30526
Domínguez-Varela I.A., Aguilera-Partida J.A., Dalvin L.A., Garza-Garza L.A., Thompson-García L.M., Barbosa-Quintana Á., Ancona-Lezama D. Retinoblastoma in an older Hispanic child masquerading as pars planitis: A case report.
European journal of ophthalmology. 2021 Feb 10:1120672121994487.
doi: 10.1177/1120672121994487
Dong Y., Wan G., Yan P., Qian C., Li F., Peng G. Long noncoding RNA LINC00324 promotes retinoblastoma progression by acting as a competing endogenous RNA for microRNA-769-5p, thereby increasing STAT3 expression. Aging. 2020 May 5
doi: 10.18632/aging.103075
Döpper H., Horstmann M., Menges J., Bozet M., Kanber D., Steenpass L. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines. Stem Cell Research. 2020 Mar 29;45:101779.
doi: 10.1016/j.scr.2020.101779
Drager O., Metz K., Busch M., Dunker N. Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets. Mol Oncol. 2022 Feb;16(4):957-981. PMID: 34228897; PMCID: PMC8847994.
doi: 10.1002/1878-0261.13054
Dubey D., Shanmugam M., Singh D. et al. Fundus fluorescein angiography in a macular retinocytoma. Indian journal of ophthalmology. 2022-09-27;70(7):2731-2732
doi: 10.4103/ijo.IJO_161_22
Duka E, Hashorva E, Kapllanaj M, Xhafa M, Godo A, Tandili A, Rustemi E, Petrela E, Arazi M, Fabian ID, Babameto A, Tabaku M, Shundi L, Bali D. Retinoblastoma in Albania: A 25-Year Retrospective Analysis. Turk Arch Pediatr. 2025 Mar 3;60(2):159-163. PMID: 40091765; PMCID: PMC11963307.
doi: 10.5152/TurkArchPediatr.2025.24203
Dunkel I.J., Piao J., Chantada G.L. et al. Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321). Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2022-08-20:JCO2102337
doi: 10.1200/JCO.21.02337
Dutra M.P., Rodrigues C.M., Peretz-Soroka H. et al. Radiation-induced sarcomas following childhood cancer - A Canadian Sarcoma Research and Clinical Collaboration Study (CanSaRCC). Cancer reports (Hoboken, N.J.). 2023-06-08;6(6):e1834
doi: 10.1002/cnr2.1834
E
Echegaray J.J., Al-Zahrani Y.A., Singh A. Episcleral brachytherapy for retinoblastoma. Br J Ophthalmol 2020; 104(2):208–13.
doi: 10.1136/bjophthalmol-2019-313985
Eichholz T., Heubach F., Arendt A.M. et al. Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3. Cancer immunology, immunotherapy: CII. 2024-02-12;73(1):19
doi: 10.1007/s00262-023-03587-0
Eiger-Moscovich M., Ruben M., Dockery P.W. et al. Familial retinoblastoma: variations in clinical presentation and management based on paternal versus maternal inheritance. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2024-03-18;28(1):103804
doi: 10.1016/j.jaapos.2023.11.007
Eiset S.E., Funding M., Racher H., Heegaard S., Gallie B., Urbak S.F., Gregersen P.A. Metachronous, non-pineal, trilateral retinoblastoma in a patient with a seemingly reduced-expressivity RB1 germline deletion. Clin Case Rep. 2022 Mar 18;10(3):e05498. PMID: 35340648; PMCID: PMC8933631.
doi: 10.1002/ccr3.5498
Elahi A.H., Morales C.S., Xu X.L. et al. Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-Related cancers: A brief review of current status and future prospects. Advances in biological regulation. 2023-05-22;88(88):100964
doi: 10.1016/j.jbior.2023.100964
Elfalah M., Al Nawaiseh T., Atoum D, AlKhassawneh A., Mohammad M., AlNawaiseh I., Yousef YA. Improving Medical Students' Awareness About Retinoblastoma: A Practical Strategy. Clin Ophthalmol. 2022 Jun 7;16:1807-1814. PMID: 35698597; PMCID: PMC9188477.
doi: 10.2147/OPTH.S355876
El Hamichi S., Acon D., Kon Graversen V., Gold A.S., Berrocal A.M., Murray T.G.
Acute Orbital Compromise after Intra-Arterial Chemotherapy in a Complex Retinoblastoma Associated with 13q Deletion Syndrome. Pediatric Neurosurgery. 2020 Nov 11:1-4.
doi: 10.1159/000511019
El Hamichi S., Feria Anzaldo E., Gold A.S. et al. Retinoblastoma in the Presence of Persistent Fetal Vasculature. Journal of vitreoretinal diseases. 2023-05-14;6(6):491-496
doi: 10.1177/24741264221080383
El Mehdi T., Siham C., Imane K. et al. Pigmented medulloepithelioma of the optic nerve: A challenging diagnostic entity. Indian journal of pathology & microbiology. 2024-02-16;67(1):207-210
doi: 10.4103/ijpm.ijpm_116_22
Elst van S., de Bloeme C.M., Noteboom S. et al. Automatic segmentation and quantification of the optic nerve on MRI using a 3D U-Net. Journal of medical imaging (Bellingham, Wash.). 2023-05-19;10(3):034501
doi: 10.1117/1.JMI.10.3.034501
El Khatib O., Yahya Y., Mahfouz R. et al. Heritable cancer predisposition testing in pediatric cancer patients excluding retinoblastoma in a middle-income country. Pediatric blood & cancer. 2022-09-30;69(11):e29982
doi: 10.1002/pbc.29982
El Zomor H., Nour R., Saad A., Taha H., Shelil A.E., Aleieldin A., Saad Zaghloul M., Alfaar A.S. Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients. Eye. 2020 Nov 13.
doi: 10.1038/s41433-020-01275-2
Enrico T.P., Stallaert W., Wick E.T., Ngoi P., Wang X., Rubin S.M., Brown N.G., Purvis J.E., Emanuele M.J. Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2. Elife. 2021 Dec 1;10:e70691.
doi: 10.7554/eLife.70691
Erdoğan Ö.Ş., Ödemiş D.A., Kayım Z.Y. et al. Investigation of the methylation changes in the promoter region of RB1 gene in retinoblastoma: Unraveling the epigenetic puzzle in retinoblastoma. Pathology, research and practice. 2023-11-25;253(253):154939
doi: 10.1016/j.prp.2023.154939
Escudero A., Ferreras C., Rodriguez-Salas N., Corral D., Rodriguez L., Pérez-Martínez A. Cancer predisposing syndrome: a retrospective cohort analysis in a pediatric and multidisciplinary genetic cancer counseling unit. Int J Clin Oncol. 2022 Feb 21. Epub ahead of print. PMID: 35190929.
doi: 10.1007/s10147-022-02133-9
Eulo V., Lesmana H., Doyle L.A., Nichols K.E., Hirbe A.C. Secondary Sarcomas: Biology, Presentation, and Clinical Care. // American Society of Clinical Oncology. 2020 Mar.
doi: 10.1200/EDBK_280985. PMID: 32213089
Echegaray J.J., Al-Zahrani Y.A., Singh A. Episcleral brachytherapy for retinoblastoma. Br J Ophthalmol 2020; 104(2):208–13.
doi: 10.1136/bjophthalmol-2019-313985
Eichholz T., Heubach F., Arendt A.M. et al. Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3. Cancer immunology, immunotherapy: CII. 2024-02-12;73(1):19
doi: 10.1007/s00262-023-03587-0
Eiger-Moscovich M., Ruben M., Dockery P.W. et al. Familial retinoblastoma: variations in clinical presentation and management based on paternal versus maternal inheritance. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2024-03-18;28(1):103804
doi: 10.1016/j.jaapos.2023.11.007
Eiset S.E., Funding M., Racher H., Heegaard S., Gallie B., Urbak S.F., Gregersen P.A. Metachronous, non-pineal, trilateral retinoblastoma in a patient with a seemingly reduced-expressivity RB1 germline deletion. Clin Case Rep. 2022 Mar 18;10(3):e05498. PMID: 35340648; PMCID: PMC8933631.
doi: 10.1002/ccr3.5498
Elahi A.H., Morales C.S., Xu X.L. et al. Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-Related cancers: A brief review of current status and future prospects. Advances in biological regulation. 2023-05-22;88(88):100964
doi: 10.1016/j.jbior.2023.100964
Elfalah M., Al Nawaiseh T., Atoum D, AlKhassawneh A., Mohammad M., AlNawaiseh I., Yousef YA. Improving Medical Students' Awareness About Retinoblastoma: A Practical Strategy. Clin Ophthalmol. 2022 Jun 7;16:1807-1814. PMID: 35698597; PMCID: PMC9188477.
doi: 10.2147/OPTH.S355876
El Hamichi S., Acon D., Kon Graversen V., Gold A.S., Berrocal A.M., Murray T.G.
Acute Orbital Compromise after Intra-Arterial Chemotherapy in a Complex Retinoblastoma Associated with 13q Deletion Syndrome. Pediatric Neurosurgery. 2020 Nov 11:1-4.
doi: 10.1159/000511019
El Hamichi S., Feria Anzaldo E., Gold A.S. et al. Retinoblastoma in the Presence of Persistent Fetal Vasculature. Journal of vitreoretinal diseases. 2023-05-14;6(6):491-496
doi: 10.1177/24741264221080383
El Mehdi T., Siham C., Imane K. et al. Pigmented medulloepithelioma of the optic nerve: A challenging diagnostic entity. Indian journal of pathology & microbiology. 2024-02-16;67(1):207-210
doi: 10.4103/ijpm.ijpm_116_22
Elst van S., de Bloeme C.M., Noteboom S. et al. Automatic segmentation and quantification of the optic nerve on MRI using a 3D U-Net. Journal of medical imaging (Bellingham, Wash.). 2023-05-19;10(3):034501
doi: 10.1117/1.JMI.10.3.034501
El Khatib O., Yahya Y., Mahfouz R. et al. Heritable cancer predisposition testing in pediatric cancer patients excluding retinoblastoma in a middle-income country. Pediatric blood & cancer. 2022-09-30;69(11):e29982
doi: 10.1002/pbc.29982
El Zomor H., Nour R., Saad A., Taha H., Shelil A.E., Aleieldin A., Saad Zaghloul M., Alfaar A.S. Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients. Eye. 2020 Nov 13.
doi: 10.1038/s41433-020-01275-2
Enrico T.P., Stallaert W., Wick E.T., Ngoi P., Wang X., Rubin S.M., Brown N.G., Purvis J.E., Emanuele M.J. Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2. Elife. 2021 Dec 1;10:e70691.
doi: 10.7554/eLife.70691
Erdoğan Ö.Ş., Ödemiş D.A., Kayım Z.Y. et al. Investigation of the methylation changes in the promoter region of RB1 gene in retinoblastoma: Unraveling the epigenetic puzzle in retinoblastoma. Pathology, research and practice. 2023-11-25;253(253):154939
doi: 10.1016/j.prp.2023.154939
Escudero A., Ferreras C., Rodriguez-Salas N., Corral D., Rodriguez L., Pérez-Martínez A. Cancer predisposing syndrome: a retrospective cohort analysis in a pediatric and multidisciplinary genetic cancer counseling unit. Int J Clin Oncol. 2022 Feb 21. Epub ahead of print. PMID: 35190929.
doi: 10.1007/s10147-022-02133-9
Eulo V., Lesmana H., Doyle L.A., Nichols K.E., Hirbe A.C. Secondary Sarcomas: Biology, Presentation, and Clinical Care. // American Society of Clinical Oncology. 2020 Mar.
doi: 10.1200/EDBK_280985. PMID: 32213089
F
Fabian I.D., Khetan V., Stacey A.W., Allen Foster, Ademola-Popoola D.S., Berry J.L., Cassoux N., Chantada G.L., Hessissen L., Kaliki S., Kivela T.T., Luna-Fineman S., Munier F.L., Reddy M.A., Rojanaporn D., Blum S., Sherief S.T., Staffieri S.E., Theophile T., Waddell K., Ji X., Astbury N.J., Bascaran C., Burton M., Zondervan M., Bowman R.; Global Retinoblastoma Study Group. Sex, gender, and retinoblastoma: analysis of 4351 patients from 153 countries. Eye (Lond). 2021 Jul 16.
doi: 10.1038/s41433-021-01675-y
Fabian I.D., Stacey A.W., Bowman R., Khetan V., Blum S., Keren-Froim N., Staffieri S., Foster A.; Global Retinoblastoma Study Group. Retinoblastoma management during the COVID-19 pandemic: A report by the Global Retinoblastoma Study Group including 194 centers from 94 countries. Pediatric blood & cancer. 2020 Aug 6
doi: 10.1002/pbc.28584
Fabian I.D., Stacey A.W., Foster A., Kivelä T.T., Munier F.L. etc. Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries. The British journal of ophthalmology. 2020 Sep 15.
doi: 10.1136/bjophthalmol-2020-316613
Fabius A.W.M., van Hoefen Wijsard M., van Leeuwen F.E., Moll A.C. Subsequent Malignant Neoplasms in Retinoblastoma Survivors. Cancers. 2021 Mar 10;13(6):1200.
doi: 10.3390/cancers13061200
Fakeri M, Shakoul F, Yaghoubi SM, Koulaeizadeh S, Haghi M. Comprehensive insights into circular RNAs, miRNAs, and lncRNAs as biomarkers in retinoblastoma. Ophthalmic Genet. 2025 Apr;46(2):122-132. Epub 2025 Jan 23. PMID: 39849678.
doi: 10.1080/13816810.2025.2456607
Fang X., Chen J., Wang Y., Zhao M., Zhang X., Yang L., Ni X., Zhao J., Gallie B.L. RB1 germline mutation spectrum and clinical features in patients with unilateral retinoblastomas. Ophthalmic genetics. 2021 Jun 30:1-7.
doi: 10.1080/13816810.2021.1946703
Fang X., Chen J., Wang Y., Zhao M., Zhang X., Yang L., Ni X., Zhao J., Gallie B.L. RB1 germline mutation spectrum and clinical features in patients with unilateral retinoblastomas. Ophthalmic Genet. 2021 Oct;42(5):593-599.
doi: 10.1080/13816810.2021
Fang X., Wang H., Ma X., Guo Y., Yang W., Hu S., Qiu Y., Zhao J., Ni X. Clinical Features of Children with Retinoblastoma and Neuroblastoma. Journal of ophthalmology. 2020 Jul 10.
doi: 10.1155/2020/9315784
Fang X., Wang Y., Yin J., Guo Y., Jia L., Zhang C., Jin M., Ni X., Zhao J. Clinical features and survival of Chinese children with trilateral retinoblastoma during 2006-2019: A retrospective multicenter study. American journal of ophthalmology. 2020 Oct 10.
doi: 10.1016/j.ajo.2020.10.002
Fang Y., Li Q., Zhang C. et al. Incidental detection of retinoblastoma from accidental trauma in children. BMC ophthalmology. 2023-03-03;23(1):81
doi: 10.1186/s12886-023-02819-2
Faranoush M, Khesali F, Faranoush P, Foroughi-Gilvaee MR, Shams P, Sadighnia N, Ahmadi SAY, Fallah Azad D, Nekouian R. Insights into retinoblastoma pathogenesis: unraveling RB1, N-MYC and miRNA profiles. BMJ Open Ophthalmol. 2025 Jun 10;10(1):e002093. PMID: 40499938; PMCID: PMC12161405.
doi: 10.1136/bmjophth-2024-002093
Faranoush M., Mehrvar N., Tashvighi M., Fabian I.D., Zloto O., Bascaran C., Ghorbani R., Ghasemi F., Naseripour M., Sedaghat A., Alebouyeh M., Mehrvar A. Retinoblastoma presentation, treatment and outcome in a large referral centre in Tehran: a 10-year retrospective analysis. Eye. 2020 May 4
doi: 10.1038/s41433-020-0907-z
Faranoush M, Naseripour M, Faranoush P, Davoodi-Moghaddam Z, Jahandideh A, Sadighnia N, Daneshjou D, Shams P, Sedaghat A, Mirshahi R, Ravanbod S,Nasirnejad F, Elahinia A, Bashash D. Delving Into Retinoblastoma Genetics: Discovery of Novel Mutations and Their Clinical Impact: Retrospective Cohort Study. Cancer Med. 2025 May;14(9):e70922. PMID: 40317918; PMCID: PMC12046630.
doi: 10.1002/cam4.70922
Farhat W., Yeung V., Kahale F. et al. Doxorubicin-Loaded Extracellular Vesicles Enhance Tumor Cell Death in Retinoblastoma. Bioengineering (Basel, Switzerland). 2022-11-26;9(11)
doi: 10.3390/bioengineering9110671
Farhat W., Yeung V., Ross A. et al. Advances in biomaterials for the treatment of retinoblastoma. Biomaterials science. 2022-09-29;10(19):5391-5429
doi: 10.1039/d2bm01005d
Farouk Sait S., Bernot M.R., Klein E. et al. Lack of complete response pretransplant is not associated with inferior overall survival for stage 4a metastatic retinoblastoma. Pediatric blood & cancer. 2022-08-08:e29921
doi: 10.1002/pbc.29921
Farouk Sait S., Haque S., Karimi S., Rebeiz K.J., Francis J.H., Marr B.P., Abramson D.H., Souweidane M.M., Dunkel I.J. A Potential Role For Apparent Diffusion Coefficient in the Diagnosis of Trilateral Retinoblastoma. Journal of Pediatric Hematology/Oncology. 2020 Apr
DOI: 10.1097/MPH.0000000000001523
Feldman M., Grimaudo H., Roth S. et al. Angiographic analysis of ophthalmic artery flow direction in children undergoing chemosurgery for retinoblastoma compared to age-matched controls. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2023-11-29:15910199231174538
doi: 10.1177/15910199231174538
Feldman M., Grimaudo H., Roth S. et al. Angiographic analysis of ophthalmic artery flow direction in children undergoing chemosurgery for retinoblastoma compared to age-matched controls. Interventional neuroradiology: journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2023-05-22:15910199231174538
doi: 10.1177/15910199231174538
Feng H., Deng Y. et al. Human Papillomavirus and Retinoblastoma: Evidence From a Systematic Review and Meta-analysis of Cross-Sectional Studies. International journal of public health. 2023-07-28;68(68):1605284
doi: 10.3389/ijph.2023.1605284
Feng W., Zhu R., Ma J., Song H. LncRNA ELFN1-AS1 Promotes Retinoblastoma Growth and Invasion via Regulating miR-4270/SBK1 Axis. Cancer management and research. 2021 Feb 5;13:1067-1073.
doi: 10.2147/CMAR.S281536
Feng X., Gong J., Li Q., Xing C., Pan J., Zou R., Zheng L., Chen F. Identification and functional annotation of differentially expressed long noncoding RNAs in retinoblastoma. Exp Ther Med. 2021 Dec;22(6):1447. Epub 2021 Oct 14. 3.
doi: 10.3892/etm.2021.10882
Feng Y., Feng X., Lv Y. et al. Worldwide Burden of Retinoblastoma from 1990 to 2021. Ophthalmic research. 2024-12-08;67(1):672-682
doi: 10.1159/000542193
Feng Y., Zhou C., Jia R., Wang Y., Fan X.Quality of Life (QoL) and Psychosocial Outcomes in Adult Survivors of Unilateral Retinoblastoma (RB) in China. Journal of Ophthalmology. 2020 Mar 12
doi: 10.1155/2020/4384251
Feng ZX, Zhao J, D'Souza D, Zhang N, Jin M, Gallie B. Optic Nerve Invasion in Retinoblastoma: Impact of Eye Salvage and Adjuvant Chemotherapy. Invest Ophthalmol Vis Sci. 2025 Jun 2;66(6):65. PMID: 40548635; PMCID: PMC12186835.
doi: 10.1167/iovs.66.6.65
Feng Z.X., Zhao J., Zhang N. et al. Adjuvant Chemotherapy Improves Survival for Children With Massive Choroidal Invasion of Retinoblastoma. Investigative ophthalmology & visual science. 2023-08-25;64(11):27
doi: 10.1167/iovs.64.11.27
Fernandez J.P., Haider A.A., Vajzovic L., Ponugoti A., Kelly M.P., Materin M.A. Optical Coherence Tomography Angiography Microvascular Variations in Pre- and Posttreatment of Retinoblastoma Tumors. Ocul Oncol Pathol. 2021 Oct;7(5):330-339. doi: 10.1159/000515142. Epub 2021 Jun 2.
PMID: 34722489; PMCID: PMC8531827.
Field M.G., Kuznetsoff J.N., Zhang M.G. et al. RB1 loss triggers dependence on ESRRG in retinoblastoma. Science advances. 2022-08-28;8(33):eabm8466
doi: 10.1126/sciadv.abm8466
Figueiredo D., Marques I.A., Pires A.S. et al. Risk of Second Tumors in Retinoblastoma Survivors after Ionizing Radiation: A Review. Cancers. 2023-11-27;15(22)
doi: 10.3390/cancers15225336
Finger P.T., Tomar A.S. Retinoblastoma outcomes: a global perspective. Lancet Glob Health. 2022 Jan 27:S2214-109X(21)00598-2. Epub ahead of print.
doi: 10.1016/S2214-109X(21)00598-2
Fitoussi R., Stolowy N., Levy C., Beylerian M., Comet A., Lesueur A., Denis D. Rétinoblastome avec présentation initiale trompeuse chez une enfant de 7 ans [Retinoblastoma with misleading initial presentation in a 7-year-old child]. J Fr Ophtalmol. 2021 Aug 6:S0181-5512(21)00403-4. French.
doi: 10.1016/j.jfo.2021.03.018
Flegg K., Gelkopf M.J., Johnson S.A., Dimaras H.; Canadian Retinoblastoma Research Advisory Board Priority Setting Steering Committee. The top 10 retinoblastoma research priorities in Canada as determined by patients, clinicians and researchers: a patient-oriented priority-setting partnership. CMAJ open. 2020 Jun 9.
doi: 10.9778/cmajo.20190221
Forer S., Ben Simon G.J., Greenberg G. et al. Orbital Development in Children with Retinoblastoma: An Imaging-Based Study. Seminars in ophthalmology. 2024-02-29:1-7
doi: 10.1080/08820538.2024.2312968
Fowle H., Zhao Z., Xu Q., Wasserman J.S., Wang X., Adeyemi M., Feiser F., Kurimchak A.N., Atar D., McEwan B.C., Kettenbach A.N., Page R., Peti W., Dunbrack R.L. Jr., Graña X. PP2A/B55α substrate recruitment as defined by the retinoblastoma-related protein p107. Elife. 2021 Oct 18;10:e63181.
doi: 10.7554/eLife.63181
De Francesco S., Galluzzi P., Bracco S., Di Maggio A., Sgheri A., Hadijstilianou T.
Rescue intra-arterial chemotherapy in unilateral multirelapsed peripapillary retinoblastoma: Decision making and the role of MRI. European journal of ophthalmology. 2020 Sep 9.
doi: 10.1177/1120672120957586
De Francesco S., Sgheri A., Di Maggio A., Rana F., Anna Maria P., Alessandra R., Hadjistilianou T. Bilateral Retinoblastoma and Osteogenesis Imperfecta, a Very Rare Association: Two Cases. European Journal of Ophthalmology. 2020 Apr 21.
doi: 10.1177/1120672120919344
Francis J.H., Richards A.L., Mandelker D.L., Berger M.F., Walsh M.F., Dunkel I.J., Donoghue M.T.A, Abramson D.H. Molecular Changes in Retinoblastoma beyond RB1: Findings from Next-Generation Sequencing. Cancers. 2021 Jan 5;13(1):149.
doi: 10.3390/cancers13010149
Freire I., Falsitta LV., Sharma C. et al. Pineal gland ADC values in children aged 0 to 4 years: normative data and usefulness in the differential diagnosis with trilateral retinoblastoma. Neuroradiology. 2024-12-02;66(12):2291-2299
doi: 10.1007/s00234-024-03479-9
Friedman D.N., Hsu M., Moskowitz C.S., Francis J.H., Lis E., Fleischut M.H., Oeffinger K.C., Walsh M., Tonorezos E.S., Sklar C.A., Abramson D.H., Dunkel I. Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: An update. J. Pediatr Blood Cancer. 2020 Jul;67(7):e28389. Epub 2020 May 9.
doi: 10.1002/pbc.28389
Friedman E.L., Froehler M.T., Daniels A.B. Orbital Swelling in a Child With Retinoblastoma Following Intra-arterial Chemotherapy. JAMA Ophthalmology. 2021 Jan 21.
doi: 10.1001/jamaophthalmol.2020.4675
Froehler M.T., Feldman M.J., Poitras B., Daniels A.B. Angiographic investigation of orbital vascular variations in the rabbit and implications for endovascular intra-arterial chemotherapy models. Journal of neurointerventional surgery. 2020 Sep 11
doi: 10.1136/neurintsurg-2020-016460
Fu C., Wang S., Jin L., Zhang M., Li M. CircTET1 inhibits retinoblastoma progression via targeting miR-492 and miR-494-3p through Wnt/beta-catenin signaling pathway. Current eye research. 2020 Oct 27.
doi: 10.1080/02713683.2020.1843685.
Fu C., Wang S., Jin L., Zhang M., Li M. CircTET1 Inhibits Retinoblastoma Progression via Targeting miR-492 and miR-494-3p through Wnt/β-catenin Signaling Pathway. Current eye research. 2021 May 7:1-10.
doi: 10.1080/02713683.2020.1843685
Fu Z, Liu Y, Yang H, Xiong W, Yin X, Fang W, Li X, Wei X, Hu J. Comprehensive analysis of clinical phenotype and genetic characteristics of retinoblastoma caused by RB1 gene mutation: a case series. Am J Cancer Res. 2025 May 25;15(5):2332-2337. PMID: 40520882; PMCID: PMC12163462.
doi: 10.62347/GVHN8345
Fukushima H., Suzuki R., Hiraoka T. et al. A novel de-novo RB1 mutation identified in a patient with bilateral retinoblastoma. Japanese journal of clinical oncology. 2023-09-06;53(9):863-865
doi: 10.1093/jjco/hyad064
Fu K., Zhang K., Zhang X. LncRNA HOTAIR facilitates proliferation and represses apoptosis of retinoblastoma cells through the miR-20b-5p/RRM2/PI3K/AKT axis. Orphanet J Rare Dis. 2022 Mar 5;17(1):119.. PMID: 35248107; PMCID: PMC8898492.
doi: 10.1186/s13023-022-02206-y
Fabian I.D., Khetan V., Stacey A.W., Allen Foster, Ademola-Popoola D.S., Berry J.L., Cassoux N., Chantada G.L., Hessissen L., Kaliki S., Kivela T.T., Luna-Fineman S., Munier F.L., Reddy M.A., Rojanaporn D., Blum S., Sherief S.T., Staffieri S.E., Theophile T., Waddell K., Ji X., Astbury N.J., Bascaran C., Burton M., Zondervan M., Bowman R.; Global Retinoblastoma Study Group. Sex, gender, and retinoblastoma: analysis of 4351 patients from 153 countries. Eye (Lond). 2021 Jul 16.
doi: 10.1038/s41433-021-01675-y
Fabian I.D., Stacey A.W., Bowman R., Khetan V., Blum S., Keren-Froim N., Staffieri S., Foster A.; Global Retinoblastoma Study Group. Retinoblastoma management during the COVID-19 pandemic: A report by the Global Retinoblastoma Study Group including 194 centers from 94 countries. Pediatric blood & cancer. 2020 Aug 6
doi: 10.1002/pbc.28584
Fabian I.D., Stacey A.W., Foster A., Kivelä T.T., Munier F.L. etc. Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries. The British journal of ophthalmology. 2020 Sep 15.
doi: 10.1136/bjophthalmol-2020-316613
Fabius A.W.M., van Hoefen Wijsard M., van Leeuwen F.E., Moll A.C. Subsequent Malignant Neoplasms in Retinoblastoma Survivors. Cancers. 2021 Mar 10;13(6):1200.
doi: 10.3390/cancers13061200
Fakeri M, Shakoul F, Yaghoubi SM, Koulaeizadeh S, Haghi M. Comprehensive insights into circular RNAs, miRNAs, and lncRNAs as biomarkers in retinoblastoma. Ophthalmic Genet. 2025 Apr;46(2):122-132. Epub 2025 Jan 23. PMID: 39849678.
doi: 10.1080/13816810.2025.2456607
Fang X., Chen J., Wang Y., Zhao M., Zhang X., Yang L., Ni X., Zhao J., Gallie B.L. RB1 germline mutation spectrum and clinical features in patients with unilateral retinoblastomas. Ophthalmic genetics. 2021 Jun 30:1-7.
doi: 10.1080/13816810.2021.1946703
Fang X., Chen J., Wang Y., Zhao M., Zhang X., Yang L., Ni X., Zhao J., Gallie B.L. RB1 germline mutation spectrum and clinical features in patients with unilateral retinoblastomas. Ophthalmic Genet. 2021 Oct;42(5):593-599.
doi: 10.1080/13816810.2021
Fang X., Wang H., Ma X., Guo Y., Yang W., Hu S., Qiu Y., Zhao J., Ni X. Clinical Features of Children with Retinoblastoma and Neuroblastoma. Journal of ophthalmology. 2020 Jul 10.
doi: 10.1155/2020/9315784
Fang X., Wang Y., Yin J., Guo Y., Jia L., Zhang C., Jin M., Ni X., Zhao J. Clinical features and survival of Chinese children with trilateral retinoblastoma during 2006-2019: A retrospective multicenter study. American journal of ophthalmology. 2020 Oct 10.
doi: 10.1016/j.ajo.2020.10.002
Fang Y., Li Q., Zhang C. et al. Incidental detection of retinoblastoma from accidental trauma in children. BMC ophthalmology. 2023-03-03;23(1):81
doi: 10.1186/s12886-023-02819-2
Faranoush M, Khesali F, Faranoush P, Foroughi-Gilvaee MR, Shams P, Sadighnia N, Ahmadi SAY, Fallah Azad D, Nekouian R. Insights into retinoblastoma pathogenesis: unraveling RB1, N-MYC and miRNA profiles. BMJ Open Ophthalmol. 2025 Jun 10;10(1):e002093. PMID: 40499938; PMCID: PMC12161405.
doi: 10.1136/bmjophth-2024-002093
Faranoush M., Mehrvar N., Tashvighi M., Fabian I.D., Zloto O., Bascaran C., Ghorbani R., Ghasemi F., Naseripour M., Sedaghat A., Alebouyeh M., Mehrvar A. Retinoblastoma presentation, treatment and outcome in a large referral centre in Tehran: a 10-year retrospective analysis. Eye. 2020 May 4
doi: 10.1038/s41433-020-0907-z
Faranoush M, Naseripour M, Faranoush P, Davoodi-Moghaddam Z, Jahandideh A, Sadighnia N, Daneshjou D, Shams P, Sedaghat A, Mirshahi R, Ravanbod S,Nasirnejad F, Elahinia A, Bashash D. Delving Into Retinoblastoma Genetics: Discovery of Novel Mutations and Their Clinical Impact: Retrospective Cohort Study. Cancer Med. 2025 May;14(9):e70922. PMID: 40317918; PMCID: PMC12046630.
doi: 10.1002/cam4.70922
Farhat W., Yeung V., Kahale F. et al. Doxorubicin-Loaded Extracellular Vesicles Enhance Tumor Cell Death in Retinoblastoma. Bioengineering (Basel, Switzerland). 2022-11-26;9(11)
doi: 10.3390/bioengineering9110671
Farhat W., Yeung V., Ross A. et al. Advances in biomaterials for the treatment of retinoblastoma. Biomaterials science. 2022-09-29;10(19):5391-5429
doi: 10.1039/d2bm01005d
Farouk Sait S., Bernot M.R., Klein E. et al. Lack of complete response pretransplant is not associated with inferior overall survival for stage 4a metastatic retinoblastoma. Pediatric blood & cancer. 2022-08-08:e29921
doi: 10.1002/pbc.29921
Farouk Sait S., Haque S., Karimi S., Rebeiz K.J., Francis J.H., Marr B.P., Abramson D.H., Souweidane M.M., Dunkel I.J. A Potential Role For Apparent Diffusion Coefficient in the Diagnosis of Trilateral Retinoblastoma. Journal of Pediatric Hematology/Oncology. 2020 Apr
DOI: 10.1097/MPH.0000000000001523
Feldman M., Grimaudo H., Roth S. et al. Angiographic analysis of ophthalmic artery flow direction in children undergoing chemosurgery for retinoblastoma compared to age-matched controls. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2023-11-29:15910199231174538
doi: 10.1177/15910199231174538
Feldman M., Grimaudo H., Roth S. et al. Angiographic analysis of ophthalmic artery flow direction in children undergoing chemosurgery for retinoblastoma compared to age-matched controls. Interventional neuroradiology: journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2023-05-22:15910199231174538
doi: 10.1177/15910199231174538
Feng H., Deng Y. et al. Human Papillomavirus and Retinoblastoma: Evidence From a Systematic Review and Meta-analysis of Cross-Sectional Studies. International journal of public health. 2023-07-28;68(68):1605284
doi: 10.3389/ijph.2023.1605284
Feng W., Zhu R., Ma J., Song H. LncRNA ELFN1-AS1 Promotes Retinoblastoma Growth and Invasion via Regulating miR-4270/SBK1 Axis. Cancer management and research. 2021 Feb 5;13:1067-1073.
doi: 10.2147/CMAR.S281536
Feng X., Gong J., Li Q., Xing C., Pan J., Zou R., Zheng L., Chen F. Identification and functional annotation of differentially expressed long noncoding RNAs in retinoblastoma. Exp Ther Med. 2021 Dec;22(6):1447. Epub 2021 Oct 14. 3.
doi: 10.3892/etm.2021.10882
Feng Y., Feng X., Lv Y. et al. Worldwide Burden of Retinoblastoma from 1990 to 2021. Ophthalmic research. 2024-12-08;67(1):672-682
doi: 10.1159/000542193
Feng Y., Zhou C., Jia R., Wang Y., Fan X.Quality of Life (QoL) and Psychosocial Outcomes in Adult Survivors of Unilateral Retinoblastoma (RB) in China. Journal of Ophthalmology. 2020 Mar 12
doi: 10.1155/2020/4384251
Feng ZX, Zhao J, D'Souza D, Zhang N, Jin M, Gallie B. Optic Nerve Invasion in Retinoblastoma: Impact of Eye Salvage and Adjuvant Chemotherapy. Invest Ophthalmol Vis Sci. 2025 Jun 2;66(6):65. PMID: 40548635; PMCID: PMC12186835.
doi: 10.1167/iovs.66.6.65
Feng Z.X., Zhao J., Zhang N. et al. Adjuvant Chemotherapy Improves Survival for Children With Massive Choroidal Invasion of Retinoblastoma. Investigative ophthalmology & visual science. 2023-08-25;64(11):27
doi: 10.1167/iovs.64.11.27
Fernandez J.P., Haider A.A., Vajzovic L., Ponugoti A., Kelly M.P., Materin M.A. Optical Coherence Tomography Angiography Microvascular Variations in Pre- and Posttreatment of Retinoblastoma Tumors. Ocul Oncol Pathol. 2021 Oct;7(5):330-339. doi: 10.1159/000515142. Epub 2021 Jun 2.
PMID: 34722489; PMCID: PMC8531827.
Field M.G., Kuznetsoff J.N., Zhang M.G. et al. RB1 loss triggers dependence on ESRRG in retinoblastoma. Science advances. 2022-08-28;8(33):eabm8466
doi: 10.1126/sciadv.abm8466
Figueiredo D., Marques I.A., Pires A.S. et al. Risk of Second Tumors in Retinoblastoma Survivors after Ionizing Radiation: A Review. Cancers. 2023-11-27;15(22)
doi: 10.3390/cancers15225336
Finger P.T., Tomar A.S. Retinoblastoma outcomes: a global perspective. Lancet Glob Health. 2022 Jan 27:S2214-109X(21)00598-2. Epub ahead of print.
doi: 10.1016/S2214-109X(21)00598-2
Fitoussi R., Stolowy N., Levy C., Beylerian M., Comet A., Lesueur A., Denis D. Rétinoblastome avec présentation initiale trompeuse chez une enfant de 7 ans [Retinoblastoma with misleading initial presentation in a 7-year-old child]. J Fr Ophtalmol. 2021 Aug 6:S0181-5512(21)00403-4. French.
doi: 10.1016/j.jfo.2021.03.018
Flegg K., Gelkopf M.J., Johnson S.A., Dimaras H.; Canadian Retinoblastoma Research Advisory Board Priority Setting Steering Committee. The top 10 retinoblastoma research priorities in Canada as determined by patients, clinicians and researchers: a patient-oriented priority-setting partnership. CMAJ open. 2020 Jun 9.
doi: 10.9778/cmajo.20190221
Forer S., Ben Simon G.J., Greenberg G. et al. Orbital Development in Children with Retinoblastoma: An Imaging-Based Study. Seminars in ophthalmology. 2024-02-29:1-7
doi: 10.1080/08820538.2024.2312968
Fowle H., Zhao Z., Xu Q., Wasserman J.S., Wang X., Adeyemi M., Feiser F., Kurimchak A.N., Atar D., McEwan B.C., Kettenbach A.N., Page R., Peti W., Dunbrack R.L. Jr., Graña X. PP2A/B55α substrate recruitment as defined by the retinoblastoma-related protein p107. Elife. 2021 Oct 18;10:e63181.
doi: 10.7554/eLife.63181
De Francesco S., Galluzzi P., Bracco S., Di Maggio A., Sgheri A., Hadijstilianou T.
Rescue intra-arterial chemotherapy in unilateral multirelapsed peripapillary retinoblastoma: Decision making and the role of MRI. European journal of ophthalmology. 2020 Sep 9.
doi: 10.1177/1120672120957586
De Francesco S., Sgheri A., Di Maggio A., Rana F., Anna Maria P., Alessandra R., Hadjistilianou T. Bilateral Retinoblastoma and Osteogenesis Imperfecta, a Very Rare Association: Two Cases. European Journal of Ophthalmology. 2020 Apr 21.
doi: 10.1177/1120672120919344
Francis J.H., Richards A.L., Mandelker D.L., Berger M.F., Walsh M.F., Dunkel I.J., Donoghue M.T.A, Abramson D.H. Molecular Changes in Retinoblastoma beyond RB1: Findings from Next-Generation Sequencing. Cancers. 2021 Jan 5;13(1):149.
doi: 10.3390/cancers13010149
Freire I., Falsitta LV., Sharma C. et al. Pineal gland ADC values in children aged 0 to 4 years: normative data and usefulness in the differential diagnosis with trilateral retinoblastoma. Neuroradiology. 2024-12-02;66(12):2291-2299
doi: 10.1007/s00234-024-03479-9
Friedman D.N., Hsu M., Moskowitz C.S., Francis J.H., Lis E., Fleischut M.H., Oeffinger K.C., Walsh M., Tonorezos E.S., Sklar C.A., Abramson D.H., Dunkel I. Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: An update. J. Pediatr Blood Cancer. 2020 Jul;67(7):e28389. Epub 2020 May 9.
doi: 10.1002/pbc.28389
Friedman E.L., Froehler M.T., Daniels A.B. Orbital Swelling in a Child With Retinoblastoma Following Intra-arterial Chemotherapy. JAMA Ophthalmology. 2021 Jan 21.
doi: 10.1001/jamaophthalmol.2020.4675
Froehler M.T., Feldman M.J., Poitras B., Daniels A.B. Angiographic investigation of orbital vascular variations in the rabbit and implications for endovascular intra-arterial chemotherapy models. Journal of neurointerventional surgery. 2020 Sep 11
doi: 10.1136/neurintsurg-2020-016460
Fu C., Wang S., Jin L., Zhang M., Li M. CircTET1 inhibits retinoblastoma progression via targeting miR-492 and miR-494-3p through Wnt/beta-catenin signaling pathway. Current eye research. 2020 Oct 27.
doi: 10.1080/02713683.2020.1843685.
Fu C., Wang S., Jin L., Zhang M., Li M. CircTET1 Inhibits Retinoblastoma Progression via Targeting miR-492 and miR-494-3p through Wnt/β-catenin Signaling Pathway. Current eye research. 2021 May 7:1-10.
doi: 10.1080/02713683.2020.1843685
Fu Z, Liu Y, Yang H, Xiong W, Yin X, Fang W, Li X, Wei X, Hu J. Comprehensive analysis of clinical phenotype and genetic characteristics of retinoblastoma caused by RB1 gene mutation: a case series. Am J Cancer Res. 2025 May 25;15(5):2332-2337. PMID: 40520882; PMCID: PMC12163462.
doi: 10.62347/GVHN8345
Fukushima H., Suzuki R., Hiraoka T. et al. A novel de-novo RB1 mutation identified in a patient with bilateral retinoblastoma. Japanese journal of clinical oncology. 2023-09-06;53(9):863-865
doi: 10.1093/jjco/hyad064
Fu K., Zhang K., Zhang X. LncRNA HOTAIR facilitates proliferation and represses apoptosis of retinoblastoma cells through the miR-20b-5p/RRM2/PI3K/AKT axis. Orphanet J Rare Dis. 2022 Mar 5;17(1):119.. PMID: 35248107; PMCID: PMC8898492.
doi: 10.1186/s13023-022-02206-y
G
Galardi A., Colletti M., Lavarello C., Di Paolo V., Mascio P., Russo I., Cozza R., Romanzo A., Valente P., De Vito R., Pascucci L., Peinado H., Carcaboso A.M., Petretto A., Locatelli F., Di Giannatale A. Proteomic Profiling of Retinoblastoma-Derived Exosomes Reveals Potential. Biomarkers of Vitreous Seeding. Cancers. 2020 Jun 12.
doi: 10.3390/cancers12061555
Galardi A, Di Paolo V, Lavarello C, Russo I, Romanzo A, Miele E, Vito R, Longo D, Petretto A, Locatelli F, Di Giannatale A. Case Report: Proteomicanalysis of cerebrospinal fluid in a retinoblastoma patient. Front Oncol. 2025 Apr 24;15:1511594. PMID: 40342827; PMCID: PMC12058659.
doi: 10.3389/fonc.2025.1511594
Galardi A., Stathopoulos C., Colletti M. et al. Proteomics of Aqueous Humor as a Source of Disease Biomarkers in Retinoblastoma. International journal of molecular sciences. 2022-11-17;23(21) doi: 10.3390/ijms232113458
Gal C., Carelli F.N., Appert A., Cerrato C., Huang N., Dong Y., Murphy J., Frapporti A., Ahringer J. DREAM represses distinct targets by cooperating with different THAP domain proteins. Cell Rep. 2021 Oct 19;37(3):109835.
doi: 10.1016/j.celrep.2021.109835
Le Gall J., Dehainault C, Benoist C., Matet A., Lumbroso-Le Rouic L., Aerts I., Jiménez I., Schleiermacher G., Houdayer C., Radvanyi F., Frouin E., Renault V., Doz F., Stoppa-Lyonnet D., Gauthier-Villars M., Cassoux N., Golmard L. Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers. J Mol Diagn. 2021 Oct 15:S1525-1578(21)00323-8.
doi: 10.1016/j.jmoldx.2021.08.014
Le Gall J., Dehainault C., Benoist C, Matet A., Lumbroso-Le Rouic L., Aerts I., Jiménez I., Schleiermacher G., Houdayer C., Radvanyi F., Frouin E., Renault V., Doz F., Stoppa-Lyonnet D., Gauthier-Villars M., Cassoux N., Golmard L. Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers. J Mol Diagn. 2021 Dec;23(12):1714-1721.
doi: 10.1016/j.jmoldx.2021.08.014
Gallie B.L. et al. Let's achieve a fair world for all children affected by retinoblastoma. Clinical & experimental ophthalmology. 2024-04-18;52(3):256-257
doi: 10.1111/ceo.14382
Gallie BL, Flegg K, Truong T, Liu J, Gavrylyuk Y, Chau K, Kletke S, Malliipatna A, Sheikh F, Soroka S, Ozkurt ZG, Alshahran N, Jong A, Janusonis I. Digital retinoblastoma documentation supports care and research. Can JOphthalmol. 2025 Apr;60(2):100-106. Epub 2024 Jul 31. PMID: 39095033.
doi: 10.1016/j.jcjo.2024.06.007
Gallo R.A., Shoag J., Johnson T.E., Solomon D.A., Perry A., Podda A., Lee J.Y., Rong A. Eye-sparing Treatment of Localized Orbital Medulloepithelioma With Neoadjuvant Chemoradiation. J. Ophthalmic Plast Reconstr Surg. 2020 May 14. PMID: 32427730
doi: 10.1097/IOP.0000000000001703
Ganesan B., Parameswaran S., Sharma A., Krishnakumar S. Clinical relevance of B7H3 expression in retinoblastoma. Scientific reports. 2020 Jun 23.
doi: 10.1038/s41598-020-67101-7
Ganguly S., Bakhshi S. et al. Unique Challenges in the Management of Retinoblastoma in India - Need for Country-Specific Guidelines. Indian journal of pediatrics. 2024-06-03
doi: 10.1007/s12098-024-05184-0
Gao C, Patel J, Robbins M, Gedvilaite E, Bowman AS, Arora K, Vanderbilt C, Brannon AR, Friedman DN, Kennedy J, Fiala E, Ceyhan-Birsoy O, Dunkel IJ, Weigelt B, Francis JH, Reis-Filho JS, Abramson DH, Mandelker D. Detection and Characterization of RB1 Mosaicism in Patients With Retinoblastoma Receiving cfDNA Test. JAMA Ophthalmol. 2025 May 8:e251079. Epub ahead of print. PMID: 40338593; PMCID: PMC12062978.
doi: 10.1001/jamaophthalmol.2025.1079
Gao M., Cui Z., Zhao D., Zhang S., Cai Q. MicroRNA-9 inhibits proliferation and progression in retinoblastoma cells by targeting PTEN. Genes & genomics. 2021 Jun 15.
doi: 10.1007/s13258-021-01043-w
Gao M., Cui Z., Zhao D., Zhang S., Cai Q. MicroRNA-9 inhibits proliferation and progression in retinoblastoma cells by targeting PTEN. Genes Genomics. 2021 Sep;43(9):1023-1033.
doi: 10.1007/s13258-021-01043-w
Gao X., Fan X., Jiang K. et al. Intraocular siRNA Delivery Mediated by Penetratin Derivative to Silence Orthotopic Retinoblastoma Gene. Pharmaceutics. 2023-03-31;15(3)
doi: 10.3390/pharmaceutics15030745
Gao X., Jin Z., Tan X., Zhang C., Zou C., Zhang W., Ding J., Das B.C., Severinov K., Hitzeroth I.I., Debata P.R., He D., Ma X., Tian X., Gao Q., Wu J., Tian R., Cui Z., Fan W., Huang Z., Cao C., Bao Y., Tan S., Hu Z. Hyperbranched poly (β-amino ester) based polyplex nanopaticles for delivery of CRISPR/Cas9 system and treatment of HPV infection associated cervical cancer. J Control Release. 2020 Feb 27.
doi: 10.1016/j.jconrel.2020.02.045
Gao Y., Du P. et al. miR-4529-3p Promotes the Progression of Retinoblastoma by Inhibiting RB1 Expression and Activating the ERK Signaling Pathway. Molecular biotechnology. 2023-04-11
doi: 10.1007/s12033-023-00738-7
Gao Y., Luo X., Zhang J. LincRNA-ROR is activated by H3K27 acetylation and induces EMT in retinoblastoma by acting as a sponge of miR-32 to activate the Notch signaling pathway. Cancer gene therapy. 2020 May 22
doi: 10.1038/s41417-020-0181-z
Gao Y., Luo X., Zhang J. Sp1-mediated up-regulation of lnc00152 promotes invasion and metastasis of retinoblastoma cells via the miR-30d/SOX9/ZEB2 pathway. Cellular oncology (Dordrecht). 2020 Jun 1.
doi: 10.1007/s13402-020-00522-8
Gao Y.X., Gao H.X., Xu X.Y., Ding F.K. Effects of lncRNA MALAT1 and lncRNA NKILA on proliferation, invasion and apoptosis of retinoblastoma. European review for medical and pharmacological sciences. 2020 Aug;24
doi: 10.26355/eurrev_202008_22626
Gargallo P., Oltra S., Balaguer J., Barranco H., Yáñez Y., Segura V., Juan-Ribelles A., Calabria I., Llavador M., Castel V., Cañete A. Retinoblastoma and mosaic 13q deletion: a case report. Int J Retina Vitreous. 2021 Sep 3;7(1):50.
doi: 10.1186/s40942-021-00321-9
Garin J.P.L., Sampor C., Grigorovski N. et al. How we approach conservative treatment of retinoblastoma in South America in the era of local ocular treatments: A consensus of the Grupo America Latina de Oncologia Pediatrica (GALOP). Pediatric blood & cancer. 2023-05-25;70(7):e30352
doi: 10.1002/pbc.30352
Garrido-Hermosilla AM., Díaz-Ruiz MCC., Avilés-Prieto J. et al. Clinical outcomes and complications of a new high-density polyethylene-based spherical integrated porous orbital implant. International ophthalmology. 2024-09-26;44(1):371
doi: 10.1007/s10792-024-03282-8
Garza-Garza L.A., Ruiz-Lozano R.E., Rebolledo-Méndez G., Ibarra-Nava I., Morales-Garza H.J., Ancona-Lezama D. Challenge of Retinoblastoma in Mexico in 2020: Perspectives and Solutions. Journal of ophthalmology. 2020 Aug 10
doi: 10.1155/2020/1953602
Gelbard M.K., Munger K. et al. Human papillomaviruses: Knowns, mysteries, and unchartered territories. Journal of medical virology. 2023-10-29;95(10):e29191
doi: 10.1002/jmv.29191
Genemo I., Chala T.K., Hordofa D.F. et al. Cost and Cost-Effectiveness of Treating Childhood Cancer at Jimma Medical Center. ClinicoEconomics and outcomes research : CEOR. 2023-06-14;15(15):433-442
doi: 10.2147/CEOR.S395170
Geng W., Ren J., Shi H., Qin F., Xu X., Xiao S., Jiao Y., Wang A. RPL41 sensitizes retinoblastoma cells to chemotherapeutic drugs via ATF4 degradation. Journal of cellular physiology. 2020 Aug 11.
doi: 10.1002/jcp.30010
Gerrish A., Bowns B., Mashayamombe-Wolfgarten C., Young E., Court S., Bott J., McCalla M., Ramsden S., Parks M., Goudie D., Carless S., Clokie S., Cole T., Allen S. Non-Invasive Prenatal Diagnosis of Retinoblastoma Inheritance by Combined Targeted Sequencing Strategies. Journal of Clinical Medicine. 2020 Oct 30;9(11):3517.
doi: 10.3390/jcm9113517
Gerrish A., Jenkinson H., Cole T. The Impact of Cell-Free DNA Analysis on the Management of Retinoblastoma. Cancers. 2021 Mar 29;13(7):1570.
doi: 10.3390/cancers13071570
Gerrish A., Mashayamombe-Wolfgarten C., Stone E. et al. Genetic Diagnosis of Retinoblastoma Using Aqueous Humour-Findings from an Extended Cohort. Cancers. 2024-04-29;16(8)
doi: 10.3390/cancers16081565
Ghafouri-Fard S., Dashti S., Taheri M., Omrani M.D. TINCR: An lncRNA with dual functions in the carcinogenesis process. Non-coding RNA research. 2020 Jul 9.
doi: 10.1016/j.ncrna.2020.06.003
Gharbaran R., Shi C., Onwumere O., Redenti S. Plumbagin Induces Cytotoxicity via Loss of Mitochondrial Membrane Potential and Caspase Activation in Metastatic Retinoblastoma. Anticancer Res. 2021 Oct;41(10):4725-4732.
doi: 10.21873/anticanres
Ghassemi F., Rahimi M., Riazi-Esfahani H. et al. Massive Uveal Relapse of Retinoblastoma Presumed to Be Choroidal Tumorous Involvement: Case Series. Case reports in ophthalmology. 2023-12-24;14(1):340-347
doi: 10.1159/000531527
Gherardini L, Sharma A, Taranta M, Cinti C. Epigenetic Reprogramming by Decitabine in Retinoblastoma. Front Biosci (Landmark Ed). 2025 Apr 25;30(4):33386. PMID: 40302340.
doi: 10.31083/FBL33386
Ghose N., Agarwal P., Reddy Palkonda VA. et al. Retinoblastoma associated with total exudative retinal detachment: Treatment and outcomes. Retina (Philadelphia, Pa.). 2023-02-02
doi: 10.1097/IAE.0000000000003734
Ghose N., Kaliki S. Liquid biopsy in Retinoblastoma: A review. Semin Ophthalmol. 2022 May 23:1-7.
doi: 10.1080/08820538.2022.2078165
Gibbs D., Reynolds L., Shea Yates T. et al. Understanding the Experiences of Living With an Artificial Eye in Children With Retinoblastoma-Perspectives of Children and Their Parents. Journal of pediatric hematology/oncology nursing. 2022-09-14;39(4):250-263
doi: 10.1177/27527530211073688
Girolamo M.M., Hadjistilianou T., Lembo A. et al. Unusual anterior and posterior segment features of coats disease. European journal of ophthalmology. 2023-07-13:11206721231188996
doi: 10.1177/11206721231188996
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries. The Lancet. Global health. 2022-08-26;10(8):e1128-e1140
doi: 10.1016/S2214-109X(22)00250-9
Global Retinoblastoma Study Group. Global Retinoblastoma Presentation and Analysis by National Income Level. JAMA Oncology. Published Online: February 27, 2020.
doi:10.1001/jamaoncol.2019.6716
Gohari M., Moghimi M., Aarafi H., Shajari A., Jafari-Nedooshan J., Lookzadeh M.H., Mirjalili S.R., Neamatzadeh H. Association of MTHFR 677C > T, 1298A > C and MTR 2756A > G Polymorphisms with Susceptibility to Childhood Retinoblastoma: A Systematic Review and Met-Analysis. Fetal Pediatr Pathol. 2021 Dec;40(6):612-625.
doi: 10.1080/15513815.2020.1721738
Gomez-Mariano G, Hernandez-SanMiguel E, Fernandez-Prieto M, Ramos Del Saz S, Baladrón B, Mielu LM, Rivera D, Moneo V, Lopez L, Rodriguez-Martin C, Fernandez-Teijeiro Álvarez A, Sabado C, Bermejo E, Alonso FJ, Martinez-Delgado B. Mosaicism and intronic variants in RB1 gene revealed by next generation sequencing in a cohort of Spanish retinoblastoma patients. Exp Eye Res. 2025 Feb;251:110233. Epub 2025 Jan 6. PMID: 39778672.
doi: 10.1016/j.exer.2025.110233
Gómez-Romero L., Alvarez-Suarez D.E., Hernández-Lemus E., Ponce-Castañeda M.V., Tovar H. The regulatory landscape of retinoblastoma: a pathway analysis perspective. R Soc Open Sci. 2022 May 18;9(5):220031.
doi: 10.1098/rsos.220031
Goncalves L.F., Ramasubramanian A., Grebe T., Riemann M., Moncrief D., Cornejo P. Prenatal diagnosis of bilateral retinoblastomas by multimodality fetal imaging: case report and review of the literature. Clinical imaging. 2021 Mar 20;78:121-126.
doi: 10.1016/j.clinimag.2021.03.023
Gong J, Song Z, Pan J, Huang X, Feng X, Li Q. circSLC39A8 by sponging hsa-miR-11181-5p and direct binding to PIK3CA mRNA promotes retinoblastoma proliferation. J Cancer. 2025 Apr 21;16(8):2434-2448. PMID: 40535798; PMCID: PMC12170501.
doi: 10.7150/jca.99599
Gonzalez M.E., Gaviria M.L., Lopez M., Escudero P.A., Bravo A., Vargas S.A. Eye Salvage with Intra-Arterial and Intra-Vitreal Chemotherapy in Patients with Retinoblastoma: 8-Year Single-Institution Experience in Colombia. Ocul Oncol Pathol. 2021 Jun;7(3):215-223.
doi: 10.1159/000511980
Gopal L. et al. Commentary: Artificial intelligence and machine learning in ocular oncology: Retinoblastoma. Indian journal of ophthalmology. 2023-02-07;71(2):431-432
doi: 10.4103/ijo.IJO_2269_22
Graetz D.E., Velasquez T., Chitsike I. et al. Stigma in Pediatric Cancer: An Exploratory Study of Osteosarcoma and Retinoblastoma in Guatemala, Jordan, and Zimbabwe. JCO global oncology. 2024-01-04;10(10):e2400017
doi: 10.1200/GO.24.00017
Graff Z., Giron V., Miller K. et al. Toxicity and feasibility of vincristine, etoposide, and carboplatin alternating with vincristine, doxorubicin, and cyclophosphamide in children with advanced retinoblastoma in Guatemala. Pediatric blood & cancer. 2023-05-25;70(7):e30392
doi: 10.1002/pbc.30392
Gregersen P.A., Funding M., Alsner J. et al. Danish heritable retinoblastoma survivors' perspectives on reproductive choices: "It's important for me, not to pass on this condition". Journal of genetic counseling. 2022-07-25
doi: 10.1002/jgc4.1618
Gregersen P.A., Funding M., Alsner J. et al. Genetic testing in adult survivors of retinoblastoma in Denmark: A study of the experience and impact of genetic testing many years after initial diagnosis. European journal of medical genetics. 2022-08-10;65(9):104569
doi: 10.1016/j.ejmg.2022.104569
Gregersen P.A., Funding M., Alsner J., Olsen M.H., Overgaard J., Urbak S.F., Staffieri S.E., Lou S. Living with heritable retinoblastoma and the perceived role of regular follow-up at a retinoblastoma survivorship clinic: 'That is exactly what I have been missing'. BMJ Open Ophthalmol. 2021 Sep 12;6(1):e000760.
doi: 10.1136/bmjophth-2021-000760
Gregersen P.A., Jensen P.S., Christensen R. et al. Retinoblastoma caused by an RB1 variant with unusually low penetrance in a Danish family. European journal of medical genetics. 2024-09-09;70(70):104956
doi: 10.1016/j.ejmg.2024.104956
Gregersen P.A., Olsen M.H., Urbak S.F., Funding M., Dalton S.O., Overgaard J., Alsner J. Incidence and Mortality of Second Primary Cancers in Danish Patients With Retinoblastoma, 1943-2013. JAMA Network Open. 2020 Oct 1
doi: 10.1001/jamanetworkopen.2020.22126
Greig E.C., Rabiee R., Afshar A.R. et al. Pushing the limit: Globe salvage of Group D retinoblastoma with severe vitreous seeding with intra-arterial chemotherapy and 15 cycles of intravitreal chemotherapy. American journal of ophthalmology case reports. 2024-01-31;33(33):101987
doi: 10.1016/j.ajoc.2023.101987
Grümme L., Biewald E., Reschke M., Fischhuber K. etc. Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma. Pediatr Blood Cancer. 2021 Oct 4:e29362.
doi: 10.1002/pbc.29362
Gu H., Wang Y., Huang D., Zhang Y., Zhang W., Hu H., Zhang P., Zhou Y., Yi Y., Han S. Clinical features and imaging manifestations of retinoblastoma with hepatic metastasis. Pediatr Blood Cancer. 2021 Oct;68(10):e28959.
doi: 10.1002/pbc.28959
Gu Y, Suarez-Pizarro M, Chen CC, Wu J, Zocchi L, Suh S, Smith PJ, Cruz S, Tinoco R, Benavente CA. UHRF1 is critical for tumor-promoting inflammation and tumorigenesis in retinoblastoma. bioRxiv [Preprint]. 2025 Mar 7:2025.03.02.641083. PMID: 40093113; PMCID: PMC11908184.
doi: 10.1101/2025.03.02.641083
Gu X., Xie M., Jia R., Ge S. Publication Trends of Research on Retinoblastoma During 2001-2021: A 20-Year Bibliometric Analysis. Front Med (Lausanne). 2021 May 21;8:675703.
doi: 10.3389/fmed.2021.675703
Guevarra M.C.B., Eala M.A.B, Dee E.C., Mercado G.J.V., Collantes E.R.A. Looking through the scope: retinoblastoma in the Philippines. Eye (Lond). 2022 Apr 13. Epub ahead of print. PMID: 35418708.
doi: 10.1038/s41433-022-02069-4
Gui T., Zheng H., Liu M., Xia Z., Ji X., Yin Q., Wang D., Li Y., Chen S. Clinical and magnetic resonance imaging features of 14 patients with trilateral retinoblastoma. Quantitative imaging in medicine and surgery. Quantitative imaging in medicine and surgery. 2021 Apr;11(4):1458-1469.
doi: 10.21037/qims-20-605
Guihurt Santiago J., Burgos-Tirado N., Lafontaine D.D., Mendoza Sierra J.C., Camacho R.H., Vecchini Rodríguez C.M., Morales-Tirado V., Flores-Otero J. Adhesion G protein-coupled receptor, ELTD1, is a potential therapeutic target for retinoblastoma migration and invasion. BMC Cancer. 2021 Jan 11;21(1):53.
doi: 10.1186/s12885-020-07768-3
Guiying T., Yue L., Chao X., Jinhai Y., Qihua X. Retracted: Antitumor Effects of 8-Deoxylactucin in RB355 Human Retinoblastoma Cells Are Mediated via Apoptosis Induction, Reactive Oxygen Species Production, and Cell Cycle Arrest. Medical science monitor : international medical journal of experimental and clinical research. 2021 Mar 25;27:e932344.
doi: 10.12659/MSM.932344
Gulati K., Manukonda R., Kairamkonda M. et al. Serum Metabolomics of Retinoblastoma: Assessing the Differential Serum Metabolic Signatures of Unilateral and Bilateral Patients. ACS omega. 2023-12-25;8(50):48233-48250
doi: 10.1021/acsomega.3c07424
Gulati K., Poluri KM., Kaliki S. et al. Assessing the Metabolic Variations of Invasive and Noninvasive Unilateral Retinoblastoma Patients. ACS omega. 2024-10-01;9(38):40082-40094
doi: 10.1021/acsomega.4c06014
Gündüz A.K., Mirzayev I., Temel E., Ünal E., Taçyıldız N., Dinçaslan H., Köse S.K., Özalp Ateş F.S., Işık M.U. A 20-year audit of retinoblastoma treatment outcomes. Eye. 2020 May 6.
DOI: 10.1038/s41433-020-0898-9
Gunduz A.K., Mirzayev I., Dinçaslan H., Özalp Ateş F.S. Recurrence and new tumor development after frontline intravenous chemotherapy for retinoblastoma: Risk factors and treatment results. Eur J Ophthalmol. 2021 Jun 30:11206721211023311.
doi: 10.1177/11206721211023311
Gündüz A.K., Mirzayev I., Temel E., Ünal E., Taçyıldız N., Dinçaslan H., Köse S.K., Ateş F.S.Ö., Işık M.U. Correction: A 20-year audit of retinoblastoma treatment outcomes. Eye. 2020 Aug 5.
doi: 10.1038/s41433-020-1119-2
Gündüz A.K., Tetik D. et al. Follow-up of retinoblastoma using RetCam fluorescein angiography and correlation with clinical findings. European journal of ophthalmology. 2023-03-20:11206721231163619
doi: 10.1177/11206721231163619
Guo L., Bai Y., Ni T., Li Y., Cao R., Ji S., Li S. MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways. Int J Oncol. 2021 Jul;59(1):47. Epub 2021 May 26.
doi: 10.3892/ijo.2021.5227
Guo X., Wang L., Beeraka N.M. et al. Incidence Trends, Clinicopathologic Characteristics, and Overall Survival Prediction in Retinoblastoma Children: SEER Prognostic Nomogram Analysis. The oncologist. 2023-10-24
doi: 10.1093/oncolo/oyad286
Gupta A.K., Meena J.P., Seth R. Reasons for missed chemotherapy appointments in retinoblastoma patients undergoing chemotherapy: A report from a Tertiary Care Hospital from India. Cancer reports. 2020 Sep 3
doi: 10.1002/cnr2.1279
Gupta H., Kandalkar B. et al. Choroidal ganglioneuromas in Francois variant neurofibromatosis-1: A rare retinoblastoma mimic. Indian journal of ophthalmology. 2022-09-27;70(7):2602-2604
doi: 10.4103/ijo.IJO_3109_21
Gupta H., Malaichamy S., Mallipatna A., Murugan S., Jeyabalan N., Suresh Babu V., Ghosh A., Ghosh A., Santhosh S., Seshagiri S., Ramprasad V.L., Kumaramanickavel G. Retinoblastoma genetics screening and clinical management. BMC Med Genomics. 2021 Jul 22;14(1):188.
doi: 10.1186/s12920-021-01034-6
Gurney S.P., Abbott J., Millen G. et al. Intraocular Surgery for Retinoblastoma: An Evaluation of Current Evidence. Ocular oncology and pathology. 2024-12-12;10(4):234-246
doi: 10.1159/000538626
Guzman F, Fazeli Y, Khuu M, Salcido K, Singh S, Benavente CA.
Retinoblastoma Tumor Suppressor Protein Roles in Epigenetic Regulation. Cancers. 2020; 12(10):2807.
Galardi A., Colletti M., Lavarello C., Di Paolo V., Mascio P., Russo I., Cozza R., Romanzo A., Valente P., De Vito R., Pascucci L., Peinado H., Carcaboso A.M., Petretto A., Locatelli F., Di Giannatale A. Proteomic Profiling of Retinoblastoma-Derived Exosomes Reveals Potential. Biomarkers of Vitreous Seeding. Cancers. 2020 Jun 12.
doi: 10.3390/cancers12061555
Galardi A, Di Paolo V, Lavarello C, Russo I, Romanzo A, Miele E, Vito R, Longo D, Petretto A, Locatelli F, Di Giannatale A. Case Report: Proteomicanalysis of cerebrospinal fluid in a retinoblastoma patient. Front Oncol. 2025 Apr 24;15:1511594. PMID: 40342827; PMCID: PMC12058659.
doi: 10.3389/fonc.2025.1511594
Galardi A., Stathopoulos C., Colletti M. et al. Proteomics of Aqueous Humor as a Source of Disease Biomarkers in Retinoblastoma. International journal of molecular sciences. 2022-11-17;23(21) doi: 10.3390/ijms232113458
Gal C., Carelli F.N., Appert A., Cerrato C., Huang N., Dong Y., Murphy J., Frapporti A., Ahringer J. DREAM represses distinct targets by cooperating with different THAP domain proteins. Cell Rep. 2021 Oct 19;37(3):109835.
doi: 10.1016/j.celrep.2021.109835
Le Gall J., Dehainault C, Benoist C., Matet A., Lumbroso-Le Rouic L., Aerts I., Jiménez I., Schleiermacher G., Houdayer C., Radvanyi F., Frouin E., Renault V., Doz F., Stoppa-Lyonnet D., Gauthier-Villars M., Cassoux N., Golmard L. Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers. J Mol Diagn. 2021 Oct 15:S1525-1578(21)00323-8.
doi: 10.1016/j.jmoldx.2021.08.014
Le Gall J., Dehainault C., Benoist C, Matet A., Lumbroso-Le Rouic L., Aerts I., Jiménez I., Schleiermacher G., Houdayer C., Radvanyi F., Frouin E., Renault V., Doz F., Stoppa-Lyonnet D., Gauthier-Villars M., Cassoux N., Golmard L. Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers. J Mol Diagn. 2021 Dec;23(12):1714-1721.
doi: 10.1016/j.jmoldx.2021.08.014
Gallie B.L. et al. Let's achieve a fair world for all children affected by retinoblastoma. Clinical & experimental ophthalmology. 2024-04-18;52(3):256-257
doi: 10.1111/ceo.14382
Gallie BL, Flegg K, Truong T, Liu J, Gavrylyuk Y, Chau K, Kletke S, Malliipatna A, Sheikh F, Soroka S, Ozkurt ZG, Alshahran N, Jong A, Janusonis I. Digital retinoblastoma documentation supports care and research. Can JOphthalmol. 2025 Apr;60(2):100-106. Epub 2024 Jul 31. PMID: 39095033.
doi: 10.1016/j.jcjo.2024.06.007
Gallo R.A., Shoag J., Johnson T.E., Solomon D.A., Perry A., Podda A., Lee J.Y., Rong A. Eye-sparing Treatment of Localized Orbital Medulloepithelioma With Neoadjuvant Chemoradiation. J. Ophthalmic Plast Reconstr Surg. 2020 May 14. PMID: 32427730
doi: 10.1097/IOP.0000000000001703
Ganesan B., Parameswaran S., Sharma A., Krishnakumar S. Clinical relevance of B7H3 expression in retinoblastoma. Scientific reports. 2020 Jun 23.
doi: 10.1038/s41598-020-67101-7
Ganguly S., Bakhshi S. et al. Unique Challenges in the Management of Retinoblastoma in India - Need for Country-Specific Guidelines. Indian journal of pediatrics. 2024-06-03
doi: 10.1007/s12098-024-05184-0
Gao C, Patel J, Robbins M, Gedvilaite E, Bowman AS, Arora K, Vanderbilt C, Brannon AR, Friedman DN, Kennedy J, Fiala E, Ceyhan-Birsoy O, Dunkel IJ, Weigelt B, Francis JH, Reis-Filho JS, Abramson DH, Mandelker D. Detection and Characterization of RB1 Mosaicism in Patients With Retinoblastoma Receiving cfDNA Test. JAMA Ophthalmol. 2025 May 8:e251079. Epub ahead of print. PMID: 40338593; PMCID: PMC12062978.
doi: 10.1001/jamaophthalmol.2025.1079
Gao M., Cui Z., Zhao D., Zhang S., Cai Q. MicroRNA-9 inhibits proliferation and progression in retinoblastoma cells by targeting PTEN. Genes & genomics. 2021 Jun 15.
doi: 10.1007/s13258-021-01043-w
Gao M., Cui Z., Zhao D., Zhang S., Cai Q. MicroRNA-9 inhibits proliferation and progression in retinoblastoma cells by targeting PTEN. Genes Genomics. 2021 Sep;43(9):1023-1033.
doi: 10.1007/s13258-021-01043-w
Gao X., Fan X., Jiang K. et al. Intraocular siRNA Delivery Mediated by Penetratin Derivative to Silence Orthotopic Retinoblastoma Gene. Pharmaceutics. 2023-03-31;15(3)
doi: 10.3390/pharmaceutics15030745
Gao X., Jin Z., Tan X., Zhang C., Zou C., Zhang W., Ding J., Das B.C., Severinov K., Hitzeroth I.I., Debata P.R., He D., Ma X., Tian X., Gao Q., Wu J., Tian R., Cui Z., Fan W., Huang Z., Cao C., Bao Y., Tan S., Hu Z. Hyperbranched poly (β-amino ester) based polyplex nanopaticles for delivery of CRISPR/Cas9 system and treatment of HPV infection associated cervical cancer. J Control Release. 2020 Feb 27.
doi: 10.1016/j.jconrel.2020.02.045
Gao Y., Du P. et al. miR-4529-3p Promotes the Progression of Retinoblastoma by Inhibiting RB1 Expression and Activating the ERK Signaling Pathway. Molecular biotechnology. 2023-04-11
doi: 10.1007/s12033-023-00738-7
Gao Y., Luo X., Zhang J. LincRNA-ROR is activated by H3K27 acetylation and induces EMT in retinoblastoma by acting as a sponge of miR-32 to activate the Notch signaling pathway. Cancer gene therapy. 2020 May 22
doi: 10.1038/s41417-020-0181-z
Gao Y., Luo X., Zhang J. Sp1-mediated up-regulation of lnc00152 promotes invasion and metastasis of retinoblastoma cells via the miR-30d/SOX9/ZEB2 pathway. Cellular oncology (Dordrecht). 2020 Jun 1.
doi: 10.1007/s13402-020-00522-8
Gao Y.X., Gao H.X., Xu X.Y., Ding F.K. Effects of lncRNA MALAT1 and lncRNA NKILA on proliferation, invasion and apoptosis of retinoblastoma. European review for medical and pharmacological sciences. 2020 Aug;24
doi: 10.26355/eurrev_202008_22626
Gargallo P., Oltra S., Balaguer J., Barranco H., Yáñez Y., Segura V., Juan-Ribelles A., Calabria I., Llavador M., Castel V., Cañete A. Retinoblastoma and mosaic 13q deletion: a case report. Int J Retina Vitreous. 2021 Sep 3;7(1):50.
doi: 10.1186/s40942-021-00321-9
Garin J.P.L., Sampor C., Grigorovski N. et al. How we approach conservative treatment of retinoblastoma in South America in the era of local ocular treatments: A consensus of the Grupo America Latina de Oncologia Pediatrica (GALOP). Pediatric blood & cancer. 2023-05-25;70(7):e30352
doi: 10.1002/pbc.30352
Garrido-Hermosilla AM., Díaz-Ruiz MCC., Avilés-Prieto J. et al. Clinical outcomes and complications of a new high-density polyethylene-based spherical integrated porous orbital implant. International ophthalmology. 2024-09-26;44(1):371
doi: 10.1007/s10792-024-03282-8
Garza-Garza L.A., Ruiz-Lozano R.E., Rebolledo-Méndez G., Ibarra-Nava I., Morales-Garza H.J., Ancona-Lezama D. Challenge of Retinoblastoma in Mexico in 2020: Perspectives and Solutions. Journal of ophthalmology. 2020 Aug 10
doi: 10.1155/2020/1953602
Gelbard M.K., Munger K. et al. Human papillomaviruses: Knowns, mysteries, and unchartered territories. Journal of medical virology. 2023-10-29;95(10):e29191
doi: 10.1002/jmv.29191
Genemo I., Chala T.K., Hordofa D.F. et al. Cost and Cost-Effectiveness of Treating Childhood Cancer at Jimma Medical Center. ClinicoEconomics and outcomes research : CEOR. 2023-06-14;15(15):433-442
doi: 10.2147/CEOR.S395170
Geng W., Ren J., Shi H., Qin F., Xu X., Xiao S., Jiao Y., Wang A. RPL41 sensitizes retinoblastoma cells to chemotherapeutic drugs via ATF4 degradation. Journal of cellular physiology. 2020 Aug 11.
doi: 10.1002/jcp.30010
Gerrish A., Bowns B., Mashayamombe-Wolfgarten C., Young E., Court S., Bott J., McCalla M., Ramsden S., Parks M., Goudie D., Carless S., Clokie S., Cole T., Allen S. Non-Invasive Prenatal Diagnosis of Retinoblastoma Inheritance by Combined Targeted Sequencing Strategies. Journal of Clinical Medicine. 2020 Oct 30;9(11):3517.
doi: 10.3390/jcm9113517
Gerrish A., Jenkinson H., Cole T. The Impact of Cell-Free DNA Analysis on the Management of Retinoblastoma. Cancers. 2021 Mar 29;13(7):1570.
doi: 10.3390/cancers13071570
Gerrish A., Mashayamombe-Wolfgarten C., Stone E. et al. Genetic Diagnosis of Retinoblastoma Using Aqueous Humour-Findings from an Extended Cohort. Cancers. 2024-04-29;16(8)
doi: 10.3390/cancers16081565
Ghafouri-Fard S., Dashti S., Taheri M., Omrani M.D. TINCR: An lncRNA with dual functions in the carcinogenesis process. Non-coding RNA research. 2020 Jul 9.
doi: 10.1016/j.ncrna.2020.06.003
Gharbaran R., Shi C., Onwumere O., Redenti S. Plumbagin Induces Cytotoxicity via Loss of Mitochondrial Membrane Potential and Caspase Activation in Metastatic Retinoblastoma. Anticancer Res. 2021 Oct;41(10):4725-4732.
doi: 10.21873/anticanres
Ghassemi F., Rahimi M., Riazi-Esfahani H. et al. Massive Uveal Relapse of Retinoblastoma Presumed to Be Choroidal Tumorous Involvement: Case Series. Case reports in ophthalmology. 2023-12-24;14(1):340-347
doi: 10.1159/000531527
Gherardini L, Sharma A, Taranta M, Cinti C. Epigenetic Reprogramming by Decitabine in Retinoblastoma. Front Biosci (Landmark Ed). 2025 Apr 25;30(4):33386. PMID: 40302340.
doi: 10.31083/FBL33386
Ghose N., Agarwal P., Reddy Palkonda VA. et al. Retinoblastoma associated with total exudative retinal detachment: Treatment and outcomes. Retina (Philadelphia, Pa.). 2023-02-02
doi: 10.1097/IAE.0000000000003734
Ghose N., Kaliki S. Liquid biopsy in Retinoblastoma: A review. Semin Ophthalmol. 2022 May 23:1-7.
doi: 10.1080/08820538.2022.2078165
Gibbs D., Reynolds L., Shea Yates T. et al. Understanding the Experiences of Living With an Artificial Eye in Children With Retinoblastoma-Perspectives of Children and Their Parents. Journal of pediatric hematology/oncology nursing. 2022-09-14;39(4):250-263
doi: 10.1177/27527530211073688
Girolamo M.M., Hadjistilianou T., Lembo A. et al. Unusual anterior and posterior segment features of coats disease. European journal of ophthalmology. 2023-07-13:11206721231188996
doi: 10.1177/11206721231188996
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries. The Lancet. Global health. 2022-08-26;10(8):e1128-e1140
doi: 10.1016/S2214-109X(22)00250-9
Global Retinoblastoma Study Group. Global Retinoblastoma Presentation and Analysis by National Income Level. JAMA Oncology. Published Online: February 27, 2020.
doi:10.1001/jamaoncol.2019.6716
Gohari M., Moghimi M., Aarafi H., Shajari A., Jafari-Nedooshan J., Lookzadeh M.H., Mirjalili S.R., Neamatzadeh H. Association of MTHFR 677C > T, 1298A > C and MTR 2756A > G Polymorphisms with Susceptibility to Childhood Retinoblastoma: A Systematic Review and Met-Analysis. Fetal Pediatr Pathol. 2021 Dec;40(6):612-625.
doi: 10.1080/15513815.2020.1721738
Gomez-Mariano G, Hernandez-SanMiguel E, Fernandez-Prieto M, Ramos Del Saz S, Baladrón B, Mielu LM, Rivera D, Moneo V, Lopez L, Rodriguez-Martin C, Fernandez-Teijeiro Álvarez A, Sabado C, Bermejo E, Alonso FJ, Martinez-Delgado B. Mosaicism and intronic variants in RB1 gene revealed by next generation sequencing in a cohort of Spanish retinoblastoma patients. Exp Eye Res. 2025 Feb;251:110233. Epub 2025 Jan 6. PMID: 39778672.
doi: 10.1016/j.exer.2025.110233
Gómez-Romero L., Alvarez-Suarez D.E., Hernández-Lemus E., Ponce-Castañeda M.V., Tovar H. The regulatory landscape of retinoblastoma: a pathway analysis perspective. R Soc Open Sci. 2022 May 18;9(5):220031.
doi: 10.1098/rsos.220031
Goncalves L.F., Ramasubramanian A., Grebe T., Riemann M., Moncrief D., Cornejo P. Prenatal diagnosis of bilateral retinoblastomas by multimodality fetal imaging: case report and review of the literature. Clinical imaging. 2021 Mar 20;78:121-126.
doi: 10.1016/j.clinimag.2021.03.023
Gong J, Song Z, Pan J, Huang X, Feng X, Li Q. circSLC39A8 by sponging hsa-miR-11181-5p and direct binding to PIK3CA mRNA promotes retinoblastoma proliferation. J Cancer. 2025 Apr 21;16(8):2434-2448. PMID: 40535798; PMCID: PMC12170501.
doi: 10.7150/jca.99599
Gonzalez M.E., Gaviria M.L., Lopez M., Escudero P.A., Bravo A., Vargas S.A. Eye Salvage with Intra-Arterial and Intra-Vitreal Chemotherapy in Patients with Retinoblastoma: 8-Year Single-Institution Experience in Colombia. Ocul Oncol Pathol. 2021 Jun;7(3):215-223.
doi: 10.1159/000511980
Gopal L. et al. Commentary: Artificial intelligence and machine learning in ocular oncology: Retinoblastoma. Indian journal of ophthalmology. 2023-02-07;71(2):431-432
doi: 10.4103/ijo.IJO_2269_22
Graetz D.E., Velasquez T., Chitsike I. et al. Stigma in Pediatric Cancer: An Exploratory Study of Osteosarcoma and Retinoblastoma in Guatemala, Jordan, and Zimbabwe. JCO global oncology. 2024-01-04;10(10):e2400017
doi: 10.1200/GO.24.00017
Graff Z., Giron V., Miller K. et al. Toxicity and feasibility of vincristine, etoposide, and carboplatin alternating with vincristine, doxorubicin, and cyclophosphamide in children with advanced retinoblastoma in Guatemala. Pediatric blood & cancer. 2023-05-25;70(7):e30392
doi: 10.1002/pbc.30392
Gregersen P.A., Funding M., Alsner J. et al. Danish heritable retinoblastoma survivors' perspectives on reproductive choices: "It's important for me, not to pass on this condition". Journal of genetic counseling. 2022-07-25
doi: 10.1002/jgc4.1618
Gregersen P.A., Funding M., Alsner J. et al. Genetic testing in adult survivors of retinoblastoma in Denmark: A study of the experience and impact of genetic testing many years after initial diagnosis. European journal of medical genetics. 2022-08-10;65(9):104569
doi: 10.1016/j.ejmg.2022.104569
Gregersen P.A., Funding M., Alsner J., Olsen M.H., Overgaard J., Urbak S.F., Staffieri S.E., Lou S. Living with heritable retinoblastoma and the perceived role of regular follow-up at a retinoblastoma survivorship clinic: 'That is exactly what I have been missing'. BMJ Open Ophthalmol. 2021 Sep 12;6(1):e000760.
doi: 10.1136/bmjophth-2021-000760
Gregersen P.A., Jensen P.S., Christensen R. et al. Retinoblastoma caused by an RB1 variant with unusually low penetrance in a Danish family. European journal of medical genetics. 2024-09-09;70(70):104956
doi: 10.1016/j.ejmg.2024.104956
Gregersen P.A., Olsen M.H., Urbak S.F., Funding M., Dalton S.O., Overgaard J., Alsner J. Incidence and Mortality of Second Primary Cancers in Danish Patients With Retinoblastoma, 1943-2013. JAMA Network Open. 2020 Oct 1
doi: 10.1001/jamanetworkopen.2020.22126
Greig E.C., Rabiee R., Afshar A.R. et al. Pushing the limit: Globe salvage of Group D retinoblastoma with severe vitreous seeding with intra-arterial chemotherapy and 15 cycles of intravitreal chemotherapy. American journal of ophthalmology case reports. 2024-01-31;33(33):101987
doi: 10.1016/j.ajoc.2023.101987
Grümme L., Biewald E., Reschke M., Fischhuber K. etc. Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma. Pediatr Blood Cancer. 2021 Oct 4:e29362.
doi: 10.1002/pbc.29362
Gu H., Wang Y., Huang D., Zhang Y., Zhang W., Hu H., Zhang P., Zhou Y., Yi Y., Han S. Clinical features and imaging manifestations of retinoblastoma with hepatic metastasis. Pediatr Blood Cancer. 2021 Oct;68(10):e28959.
doi: 10.1002/pbc.28959
Gu Y, Suarez-Pizarro M, Chen CC, Wu J, Zocchi L, Suh S, Smith PJ, Cruz S, Tinoco R, Benavente CA. UHRF1 is critical for tumor-promoting inflammation and tumorigenesis in retinoblastoma. bioRxiv [Preprint]. 2025 Mar 7:2025.03.02.641083. PMID: 40093113; PMCID: PMC11908184.
doi: 10.1101/2025.03.02.641083
Gu X., Xie M., Jia R., Ge S. Publication Trends of Research on Retinoblastoma During 2001-2021: A 20-Year Bibliometric Analysis. Front Med (Lausanne). 2021 May 21;8:675703.
doi: 10.3389/fmed.2021.675703
Guevarra M.C.B., Eala M.A.B, Dee E.C., Mercado G.J.V., Collantes E.R.A. Looking through the scope: retinoblastoma in the Philippines. Eye (Lond). 2022 Apr 13. Epub ahead of print. PMID: 35418708.
doi: 10.1038/s41433-022-02069-4
Gui T., Zheng H., Liu M., Xia Z., Ji X., Yin Q., Wang D., Li Y., Chen S. Clinical and magnetic resonance imaging features of 14 patients with trilateral retinoblastoma. Quantitative imaging in medicine and surgery. Quantitative imaging in medicine and surgery. 2021 Apr;11(4):1458-1469.
doi: 10.21037/qims-20-605
Guihurt Santiago J., Burgos-Tirado N., Lafontaine D.D., Mendoza Sierra J.C., Camacho R.H., Vecchini Rodríguez C.M., Morales-Tirado V., Flores-Otero J. Adhesion G protein-coupled receptor, ELTD1, is a potential therapeutic target for retinoblastoma migration and invasion. BMC Cancer. 2021 Jan 11;21(1):53.
doi: 10.1186/s12885-020-07768-3
Guiying T., Yue L., Chao X., Jinhai Y., Qihua X. Retracted: Antitumor Effects of 8-Deoxylactucin in RB355 Human Retinoblastoma Cells Are Mediated via Apoptosis Induction, Reactive Oxygen Species Production, and Cell Cycle Arrest. Medical science monitor : international medical journal of experimental and clinical research. 2021 Mar 25;27:e932344.
doi: 10.12659/MSM.932344
Gulati K., Manukonda R., Kairamkonda M. et al. Serum Metabolomics of Retinoblastoma: Assessing the Differential Serum Metabolic Signatures of Unilateral and Bilateral Patients. ACS omega. 2023-12-25;8(50):48233-48250
doi: 10.1021/acsomega.3c07424
Gulati K., Poluri KM., Kaliki S. et al. Assessing the Metabolic Variations of Invasive and Noninvasive Unilateral Retinoblastoma Patients. ACS omega. 2024-10-01;9(38):40082-40094
doi: 10.1021/acsomega.4c06014
Gündüz A.K., Mirzayev I., Temel E., Ünal E., Taçyıldız N., Dinçaslan H., Köse S.K., Özalp Ateş F.S., Işık M.U. A 20-year audit of retinoblastoma treatment outcomes. Eye. 2020 May 6.
DOI: 10.1038/s41433-020-0898-9
Gunduz A.K., Mirzayev I., Dinçaslan H., Özalp Ateş F.S. Recurrence and new tumor development after frontline intravenous chemotherapy for retinoblastoma: Risk factors and treatment results. Eur J Ophthalmol. 2021 Jun 30:11206721211023311.
doi: 10.1177/11206721211023311
Gündüz A.K., Mirzayev I., Temel E., Ünal E., Taçyıldız N., Dinçaslan H., Köse S.K., Ateş F.S.Ö., Işık M.U. Correction: A 20-year audit of retinoblastoma treatment outcomes. Eye. 2020 Aug 5.
doi: 10.1038/s41433-020-1119-2
Gündüz A.K., Tetik D. et al. Follow-up of retinoblastoma using RetCam fluorescein angiography and correlation with clinical findings. European journal of ophthalmology. 2023-03-20:11206721231163619
doi: 10.1177/11206721231163619
Guo L., Bai Y., Ni T., Li Y., Cao R., Ji S., Li S. MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways. Int J Oncol. 2021 Jul;59(1):47. Epub 2021 May 26.
doi: 10.3892/ijo.2021.5227
Guo X., Wang L., Beeraka N.M. et al. Incidence Trends, Clinicopathologic Characteristics, and Overall Survival Prediction in Retinoblastoma Children: SEER Prognostic Nomogram Analysis. The oncologist. 2023-10-24
doi: 10.1093/oncolo/oyad286
Gupta A.K., Meena J.P., Seth R. Reasons for missed chemotherapy appointments in retinoblastoma patients undergoing chemotherapy: A report from a Tertiary Care Hospital from India. Cancer reports. 2020 Sep 3
doi: 10.1002/cnr2.1279
Gupta H., Kandalkar B. et al. Choroidal ganglioneuromas in Francois variant neurofibromatosis-1: A rare retinoblastoma mimic. Indian journal of ophthalmology. 2022-09-27;70(7):2602-2604
doi: 10.4103/ijo.IJO_3109_21
Gupta H., Malaichamy S., Mallipatna A., Murugan S., Jeyabalan N., Suresh Babu V., Ghosh A., Ghosh A., Santhosh S., Seshagiri S., Ramprasad V.L., Kumaramanickavel G. Retinoblastoma genetics screening and clinical management. BMC Med Genomics. 2021 Jul 22;14(1):188.
doi: 10.1186/s12920-021-01034-6
Gurney S.P., Abbott J., Millen G. et al. Intraocular Surgery for Retinoblastoma: An Evaluation of Current Evidence. Ocular oncology and pathology. 2024-12-12;10(4):234-246
doi: 10.1159/000538626
Guzman F, Fazeli Y, Khuu M, Salcido K, Singh S, Benavente CA.
Retinoblastoma Tumor Suppressor Protein Roles in Epigenetic Regulation. Cancers. 2020; 12(10):2807.
H
Haase A., Alefeld E., Yalinci F. et al. Gastric Inhibitory Polypeptide Receptor (GIPR) Overexpression Reduces the Tumorigenic Potential of Retinoblastoma Cells. Cancers. 2024-05-13;16(9)
doi: 10.3390/cancers16091656
Haase A., Miroschnikov N., Klein S. et al. New retinoblastoma (RB) drug delivery approaches: anti-tumor effect of atrial natriuretic peptide (ANP)-conjugated hyaluronic-acid-coated gold nanoparticles for intraocular treatment of chemoresistant RB. Molecular oncology. 2024-01-13
doi: 10.1002/1878-0261.13587
Hadjistilianou D., Barchitta M., Defrancesco S. Covid-19 and retinoblastoma: How we manage it. European journal of ophthalmology. 2020 Jun 19.
doi: 10.1177/1120672120936484
Hage El S., Wakim E., Daou L., El Masri J., Salameh P. Epidemiology and Incidence of Retinoblastoma in the Middle East: A Nationwide Study in Lebanon. Cureus. 2021 Oct 12;13(10):e18696.
doi: 10.7759/cureus.18696
Hamdy NM, Barakat BM, El-Sisi MG, Shaker FH, Sallam AM, Elazazy O, Darwish SF, Elmakromy GM, Ibrahim IH, Anwar MM. Comprehensive review and in silico analysis of the role of noncoding RNAs in retinoblastoma: A step-toward ncRNA precision. Int J Biol Macromol. 2025 Jun;311(Pt 4):144036. Epub 2025 May 7. PMID: 40345278.
doi: 10.1016/j.ijbiomac.2025.144036
Hamichi El S., Feria Anzaldo E., Gold A.S. et al. Retinoblastoma in the Presence of Persistent Fetal Vasculature. Journal of vitreoretinal diseases. 2023-05-14;6(6):491-496
doi: 10.1177/24741264221080383
Han J.W., Lee C.S., Hahn S.M., Ahn W.K., Kim H.S., Yun H., Lee S.C., Kim B.M., Kim D.J., Lyu C.J. The Efficacy of Alternate Systemic Intravenous Chemotherapy and Intra-Arterial Chemotherapy Approach for Eye Globe Salvage in Retinoblastoma. Cancer Res Treat. 2022 May 24.
doi: 10.4143/crt.2021.1537
Han S., Song L., Chen Y., Hou M., Wei X., Fan D. The long non-coding RNA ILF3-AS1 increases the proliferation and invasion of retinoblastoma through the miR-132-3p/SMAD2 axis. Experimental cell research. 2020 May 11.
doi: 10.1016/j.yexcr.2020.112087
Hanbazazh M., Dryja T.P. Molecular Genetics of Intraocular Tumors. Seminars in ophthalmology. 2020 Jun 7.
doi: 10.1080/08820538.2020.1776343
Handayani K., Indraswari B.W., Sitaresmi M.N., Mulatsih S., Widjajanto P.H., Kors W.A., Kaspers G.J., Mostert S. Treatment Outcome of Children with Retinoblastoma in a Tertiary Care Referral Hospital in Indonesia. Asian Pacific journal of cancer prevention : APJCP. 2021 May 1;22(5):1613-1621.
doi:10.31557/APJCP.2021.22.5.1613
Hanks J., Snyder S., Stoolman S. Retinoblastoma: Beyond the red reflex. Nurse Pract. 2021 Sep 1;46(9):10-12.
doi: 10.1097/01.NPR.0000769776.57850.9a
Hardatt D., Devi M., Vyas S. et al. Effect of Vitamin D on Retinoblastoma Protein in Prediabetic Individuals. Current diabetes reviews. 2023-05-02
doi: 10.2174/1573399819666230331083715
Hayat SC, Kebudi R, Sencer S, Peksayar G, Tuncer S. Clinical features and treatment outcomes in children with retinoblastoma at a single tertiary referral center in Turkey. J Fr Ophtalmol. 2025 May;48(5):104511. Epub 2025 Mar 27. PMID: 40153936.
doi: 10.1016/j.jfo.2025.104511
Hazarika M., Kumar G., Saikia B.J. et al. Clinicoepidemiological Profile and Treatment Outcomes in Children with Retinoblastoma: Experience from a Cancer Care Center in Northeast India. South Asian journal of cancer. 2023-01-11;11(3):269-273
doi: 10.1055/s-0041-1740326
He D., Huang X., Uppal K. et al. Biomarkers of maternal smoking and the risk of the retinoblastoma in offspring. Retina (Philadelphia, Pa.). 2023-03-03;43(3):481-489
doi: 10.1097/IAE.0000000000003678
He GQ, Zheng YC, Tan LJ, Shen CQ, Gao J, Xiong F, Guo X. Case Report: A novel germline donor splicing site mutation of RB1 gene in a Chinese Tibetan pedigree with familial retinoblastoma. Front Oncol. 2025 May 20;15:1525035. PMID: 40463882; PMCID: PMC12130007.
doi: 10.3389/fonc.2025.1525035
He J., Pei C., Ge X. et al. Analysis of clinical and pathological features of ciliary body medulloepithelioma. International journal of ophthalmology. 2023-03-21;16(3):382-387
doi: 10.18240/ijo.2023.03.08
He L.F., Mou P., Yang C.H. et al. Single-cell sequencing in primary intraocular tumors: understanding heterogeneity, the microenvironment, and drug resistance. Frontiers in immunology. 2023-07-01;14(14):1194590
doi: 10.3389/fimmu.2023.1194590
He M., Yang L., Jia S. et al. Does vitreous haemorrhage and calcification lead to increased risk of enucleation in advanced retinoblastoma? Acta ophthalmologica. 2023-07-11
doi: 10.1111/aos.15735
He X., Chai P., Li F., Zhang L., Zhou C., Yuan X., Li Y., Yang J., Luo Y., Ge S., Zhang H., Jia R., Fan X. A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3. Molecular cancer. 2020 Jul 15.
doi: 10.1186/s12943-020-01232-3
He X., Feng Y. MicroRNA hsa-miR-657 promotes retinoblastoma malignancy by inhibiting peroxisome proliferator-activated receptor alpha expression. Anticancer Drugs. 2022 Mar 23. Epub ahead of print. PMID: 35324527.
doi: 10.1097/CAD.0000000000001308
Hersi R.M., Naaman N.K., Alghamdi A.M. et al. Knowledge and attitude toward eye disorders in children among pediatricians and family physicians: a survey study. BMC ophthalmology. 2023-03-10;23(1):90
doi: 10.1186/s12886-023-02832-5
Hicks R.M., Ji X., Zou Y. et al. Differences in Childhood Growth Parameters Between Patients With Somatic and Heritable Retinoblastoma. Investigative ophthalmology & visual science. 2024-05-10;65(4):39
doi: 10.1167/iovs.65.4.39
Hoang C.Q., Duong H.Q., Nguyen N.T., Nguyen S.AH., Nguyen C., Nguyen B.D., Phung L.T., Nguyen D.T., Pham C.T.M., Le Doan T., Tran M.H. Clinical evaluation of RB1 genetic testing reveals novel mutations in Vietnamese patients with retinoblastoma. Mol Clin Oncol. 2021 Sep;15(3):182.
oi: 10.3892/mco.2021.2344
Hobzova R., Kodetova M., Pochop P., Uhlik J., Dunovska K., Svojgr K., Hrabeta J., Feriancikova B., Cocarta A.I., Sirc J. Hydrogel implants for transscleral diffusion delivery of topotecan: In vivo proof of concept in a rabbit eye model. International journal of pharmaceutics. 2021 Jun 24:120832.
doi: 10.1016/j.ijpharm.2021.120832
Hobzova R., Sirc J., Shrestha K. et al. Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment. Pharmaceutics. 2023-05-30;15(5)
doi: 10.3390/pharmaceutics15051398
Holmes L., Pollack E., Berice B.N. et al. Survival disadvantage of male children with retinoblastoma in the United States: Surveillance Epidemiology and End Results (2000-2017) Evidence. Cancer medicine. 2023-03-17;12(4):4626-4637
doi: 10.1002/cam4.3967
Honavar S.G. et al. Intraarterial chemotherapy for retinoblastoma in low and lower-middle-income countries - Can we break the barriers? Indian journal of ophthalmology. 2023-02-07;71(2):325-326
doi: 10.4103/IJO.IJO_227_23
Hopkins J., Asada K., Leung A. et al. PRELP Regulates Cell-Cell Adhesion and EMT and Inhibits Retinoblastoma Progression. Cancers. 2022-10-17;14(19).
doi: 10.3390/cancers14194926
Hoshina H., Taguchi S., Suyama H. et al. Surgical resection of retinoblastoma-associated bladder leiomyosarcoma during pregnancy: a case report. BMC urology. 2023-08-01;23(1):125
doi: 10.1186/s12894-023-01298-3
Hraib M., Mhanna A., Bayerly B., Ghanem A., Alshehabi Z. An atypical clinical/radiological presentation of Retinoblastoma in a 4-year-old child: A case report & educational lessons from Syria. Ann Med Surg (Lond). 2022 May 18;78:103830. PMID: 35734689; PMCID: PMC9206916.
doi: 10.1016/j.amsu.2022.103830
Hsieh J., Molusky M.M., McCabe K.M., Fotakis P., Xiao T., Tascau L., Zeana-Schliep L., DaSilva-Jardine P., Tall A.R. TTC39B destabilizes retinoblastoma protein promoting hepatic lipogenesis in a sex-specific fashion. J Hepatol. 2021 Sep 30:S0168-8278(21)02083-3.
doi: 10.1016/j.jhep.2021.09.021
Hsieh T., Liao A., Francis J.H., Lavery J.A., Mauguen A., Brodie S.E., Abramson D.H. Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma. PLoS One. 2020 Jul 1.
doi: 10.1371/journal.pone.0235016
Hu X., Zhang D., Huang L. et al. Construction of a Functional Nucleic Acid-Based Artificial Vesicle-Encapsulated Composite Nanoparticle and Its Application in Retinoblastoma-Targeted Theranostics. ACS biomaterials science & engineering. 2024-03-12;10(3):1830-1842
doi: 10.1021/acsbiomaterials.3c01972
Hu Y., Zhao M., Li L., Ding J., Gui Y.M., Wei T.W. miR-491-3p is Downregulated in Retinoblastoma and Inhibit Tumor Cells Growth and Metastasis by Targeting SNN. Biochemical genetics. 2020 Oct 23.
Huang J., Zhang L., Li Z., Lu X. Screening and identification of key biomarkers for retinoblastoma: Evidence from bioinformatics analysis. Medicine (Baltimore) 2020 May.
doi: 10.1097/MD.0000000000019952
Huang X., Wan J., Liu F., Liu Y., Wang L., Zhao S., Wu T., Sun F. P38 Mitogen-Activated Protein Kinase Protects Against Retinoblastoma Through Regulating USP22/SIRT1/SOST Axis. Front Oncol. 2022 Mar 9;12:781247. PMID: 35356205; PMCID: PMC8959650.
doi: 10.3389/fonc.2022.781247
Huang Y., Guo Y. et al. Quality of life among people with eye cancer: a systematic review from 2012 to 2022. Health and quality of life outcomes. 2024-03-30;22(1):3
doi: 10.1186/s12955-023-02219-6
Huang Y., Xue B., Pan J., Shen N. Circ-E2F3 acts as a ceRNA for miR-204-5p to promote proliferation, metastasis and apoptosis inhibition in retinoblastoma by regulating ROCK1 expression. Experimental and molecular pathology. 2021 Apr 18;120:104637.
doi: 10.1016/j.yexmp.2021.104637
Hudani A., Kimani K., Njambi L. et al. Navigating familial retinoblastoma in Kenya: A mother's journey. Pediatric blood & cancer. 2024-07-25;71(9):e31191
doi: 10.1002/pbc.31191
Huemmer S.E., Patnaik J.L., Ybarra S. et al. Teleophthalmology Through Online Mentorship Over a 20-Year Period: Education and Capacity Building. JCO global oncology. 2024-11-14;10(10):e2400297
doi: 10.1200/GO-24-00297
Hülsenbeck I., Frank M., Biewald E., Kanber D., Lohmann D.R., Ketteler P.
Introduction of a Variant Classification System for Analysis of Genotype-Phenotype Relationships in Heritable Retinoblastoma. Cancers. 2021 Mar 31;13(7):1605.
doi: 10.3390/cancers13071605
Hussain A.K., Rahul R.A., Carlos R.L., Francisco Z.M., María G.L., Flavia P., Chiara B., Davide B. Globe salvage treatment in group D and group E retinoblastoma. Rom J Ophthalmol. 2021 Jan-Mar;65(1):20-24.
doi: 10.22336/rjo.2021.5
Hussain MS., Gupta G., Afzal M. et al. Exploring the role of lncrna neat1 knockdown in regulating apoptosis across multiple cancer types: A review. Pathology, research and practice. 2023-12-05;252(252):154908
doi: 10.1016/j.prp.2023.154908
Hussain Z. Impact of Laterality on Cumulative Survival in Patients Diagnosed with Retinoblastoma: A Retrospective Cohort Analysis of 1925 Cases in the Surveillance, Epidemiology, and End Results (SEER) Program. Clinical ophthalmology. 2021 Mar 5;15:991-1001.
doi: 10.2147/OPTH.S298209. eCollection 2021
Hyun Park S., Young Park H., Kim H. et al. Hematological Second Primary Malignancy in Pediatric Retinoblastoma: A Case Report and Systematic Review. Ophthalmic plastic and reconstructive surgery. 2024-09-06;40(5):487-496
doi: 10.1097/IOP.0000000000002737
Haase A., Alefeld E., Yalinci F. et al. Gastric Inhibitory Polypeptide Receptor (GIPR) Overexpression Reduces the Tumorigenic Potential of Retinoblastoma Cells. Cancers. 2024-05-13;16(9)
doi: 10.3390/cancers16091656
Haase A., Miroschnikov N., Klein S. et al. New retinoblastoma (RB) drug delivery approaches: anti-tumor effect of atrial natriuretic peptide (ANP)-conjugated hyaluronic-acid-coated gold nanoparticles for intraocular treatment of chemoresistant RB. Molecular oncology. 2024-01-13
doi: 10.1002/1878-0261.13587
Hadjistilianou D., Barchitta M., Defrancesco S. Covid-19 and retinoblastoma: How we manage it. European journal of ophthalmology. 2020 Jun 19.
doi: 10.1177/1120672120936484
Hage El S., Wakim E., Daou L., El Masri J., Salameh P. Epidemiology and Incidence of Retinoblastoma in the Middle East: A Nationwide Study in Lebanon. Cureus. 2021 Oct 12;13(10):e18696.
doi: 10.7759/cureus.18696
Hamdy NM, Barakat BM, El-Sisi MG, Shaker FH, Sallam AM, Elazazy O, Darwish SF, Elmakromy GM, Ibrahim IH, Anwar MM. Comprehensive review and in silico analysis of the role of noncoding RNAs in retinoblastoma: A step-toward ncRNA precision. Int J Biol Macromol. 2025 Jun;311(Pt 4):144036. Epub 2025 May 7. PMID: 40345278.
doi: 10.1016/j.ijbiomac.2025.144036
Hamichi El S., Feria Anzaldo E., Gold A.S. et al. Retinoblastoma in the Presence of Persistent Fetal Vasculature. Journal of vitreoretinal diseases. 2023-05-14;6(6):491-496
doi: 10.1177/24741264221080383
Han J.W., Lee C.S., Hahn S.M., Ahn W.K., Kim H.S., Yun H., Lee S.C., Kim B.M., Kim D.J., Lyu C.J. The Efficacy of Alternate Systemic Intravenous Chemotherapy and Intra-Arterial Chemotherapy Approach for Eye Globe Salvage in Retinoblastoma. Cancer Res Treat. 2022 May 24.
doi: 10.4143/crt.2021.1537
Han S., Song L., Chen Y., Hou M., Wei X., Fan D. The long non-coding RNA ILF3-AS1 increases the proliferation and invasion of retinoblastoma through the miR-132-3p/SMAD2 axis. Experimental cell research. 2020 May 11.
doi: 10.1016/j.yexcr.2020.112087
Hanbazazh M., Dryja T.P. Molecular Genetics of Intraocular Tumors. Seminars in ophthalmology. 2020 Jun 7.
doi: 10.1080/08820538.2020.1776343
Handayani K., Indraswari B.W., Sitaresmi M.N., Mulatsih S., Widjajanto P.H., Kors W.A., Kaspers G.J., Mostert S. Treatment Outcome of Children with Retinoblastoma in a Tertiary Care Referral Hospital in Indonesia. Asian Pacific journal of cancer prevention : APJCP. 2021 May 1;22(5):1613-1621.
doi:10.31557/APJCP.2021.22.5.1613
Hanks J., Snyder S., Stoolman S. Retinoblastoma: Beyond the red reflex. Nurse Pract. 2021 Sep 1;46(9):10-12.
doi: 10.1097/01.NPR.0000769776.57850.9a
Hardatt D., Devi M., Vyas S. et al. Effect of Vitamin D on Retinoblastoma Protein in Prediabetic Individuals. Current diabetes reviews. 2023-05-02
doi: 10.2174/1573399819666230331083715
Hayat SC, Kebudi R, Sencer S, Peksayar G, Tuncer S. Clinical features and treatment outcomes in children with retinoblastoma at a single tertiary referral center in Turkey. J Fr Ophtalmol. 2025 May;48(5):104511. Epub 2025 Mar 27. PMID: 40153936.
doi: 10.1016/j.jfo.2025.104511
Hazarika M., Kumar G., Saikia B.J. et al. Clinicoepidemiological Profile and Treatment Outcomes in Children with Retinoblastoma: Experience from a Cancer Care Center in Northeast India. South Asian journal of cancer. 2023-01-11;11(3):269-273
doi: 10.1055/s-0041-1740326
He D., Huang X., Uppal K. et al. Biomarkers of maternal smoking and the risk of the retinoblastoma in offspring. Retina (Philadelphia, Pa.). 2023-03-03;43(3):481-489
doi: 10.1097/IAE.0000000000003678
He GQ, Zheng YC, Tan LJ, Shen CQ, Gao J, Xiong F, Guo X. Case Report: A novel germline donor splicing site mutation of RB1 gene in a Chinese Tibetan pedigree with familial retinoblastoma. Front Oncol. 2025 May 20;15:1525035. PMID: 40463882; PMCID: PMC12130007.
doi: 10.3389/fonc.2025.1525035
He J., Pei C., Ge X. et al. Analysis of clinical and pathological features of ciliary body medulloepithelioma. International journal of ophthalmology. 2023-03-21;16(3):382-387
doi: 10.18240/ijo.2023.03.08
He L.F., Mou P., Yang C.H. et al. Single-cell sequencing in primary intraocular tumors: understanding heterogeneity, the microenvironment, and drug resistance. Frontiers in immunology. 2023-07-01;14(14):1194590
doi: 10.3389/fimmu.2023.1194590
He M., Yang L., Jia S. et al. Does vitreous haemorrhage and calcification lead to increased risk of enucleation in advanced retinoblastoma? Acta ophthalmologica. 2023-07-11
doi: 10.1111/aos.15735
He X., Chai P., Li F., Zhang L., Zhou C., Yuan X., Li Y., Yang J., Luo Y., Ge S., Zhang H., Jia R., Fan X. A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3. Molecular cancer. 2020 Jul 15.
doi: 10.1186/s12943-020-01232-3
He X., Feng Y. MicroRNA hsa-miR-657 promotes retinoblastoma malignancy by inhibiting peroxisome proliferator-activated receptor alpha expression. Anticancer Drugs. 2022 Mar 23. Epub ahead of print. PMID: 35324527.
doi: 10.1097/CAD.0000000000001308
Hersi R.M., Naaman N.K., Alghamdi A.M. et al. Knowledge and attitude toward eye disorders in children among pediatricians and family physicians: a survey study. BMC ophthalmology. 2023-03-10;23(1):90
doi: 10.1186/s12886-023-02832-5
Hicks R.M., Ji X., Zou Y. et al. Differences in Childhood Growth Parameters Between Patients With Somatic and Heritable Retinoblastoma. Investigative ophthalmology & visual science. 2024-05-10;65(4):39
doi: 10.1167/iovs.65.4.39
Hoang C.Q., Duong H.Q., Nguyen N.T., Nguyen S.AH., Nguyen C., Nguyen B.D., Phung L.T., Nguyen D.T., Pham C.T.M., Le Doan T., Tran M.H. Clinical evaluation of RB1 genetic testing reveals novel mutations in Vietnamese patients with retinoblastoma. Mol Clin Oncol. 2021 Sep;15(3):182.
oi: 10.3892/mco.2021.2344
Hobzova R., Kodetova M., Pochop P., Uhlik J., Dunovska K., Svojgr K., Hrabeta J., Feriancikova B., Cocarta A.I., Sirc J. Hydrogel implants for transscleral diffusion delivery of topotecan: In vivo proof of concept in a rabbit eye model. International journal of pharmaceutics. 2021 Jun 24:120832.
doi: 10.1016/j.ijpharm.2021.120832
Hobzova R., Sirc J., Shrestha K. et al. Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment. Pharmaceutics. 2023-05-30;15(5)
doi: 10.3390/pharmaceutics15051398
Holmes L., Pollack E., Berice B.N. et al. Survival disadvantage of male children with retinoblastoma in the United States: Surveillance Epidemiology and End Results (2000-2017) Evidence. Cancer medicine. 2023-03-17;12(4):4626-4637
doi: 10.1002/cam4.3967
Honavar S.G. et al. Intraarterial chemotherapy for retinoblastoma in low and lower-middle-income countries - Can we break the barriers? Indian journal of ophthalmology. 2023-02-07;71(2):325-326
doi: 10.4103/IJO.IJO_227_23
Hopkins J., Asada K., Leung A. et al. PRELP Regulates Cell-Cell Adhesion and EMT and Inhibits Retinoblastoma Progression. Cancers. 2022-10-17;14(19).
doi: 10.3390/cancers14194926
Hoshina H., Taguchi S., Suyama H. et al. Surgical resection of retinoblastoma-associated bladder leiomyosarcoma during pregnancy: a case report. BMC urology. 2023-08-01;23(1):125
doi: 10.1186/s12894-023-01298-3
Hraib M., Mhanna A., Bayerly B., Ghanem A., Alshehabi Z. An atypical clinical/radiological presentation of Retinoblastoma in a 4-year-old child: A case report & educational lessons from Syria. Ann Med Surg (Lond). 2022 May 18;78:103830. PMID: 35734689; PMCID: PMC9206916.
doi: 10.1016/j.amsu.2022.103830
Hsieh J., Molusky M.M., McCabe K.M., Fotakis P., Xiao T., Tascau L., Zeana-Schliep L., DaSilva-Jardine P., Tall A.R. TTC39B destabilizes retinoblastoma protein promoting hepatic lipogenesis in a sex-specific fashion. J Hepatol. 2021 Sep 30:S0168-8278(21)02083-3.
doi: 10.1016/j.jhep.2021.09.021
Hsieh T., Liao A., Francis J.H., Lavery J.A., Mauguen A., Brodie S.E., Abramson D.H. Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma. PLoS One. 2020 Jul 1.
doi: 10.1371/journal.pone.0235016
Hu X., Zhang D., Huang L. et al. Construction of a Functional Nucleic Acid-Based Artificial Vesicle-Encapsulated Composite Nanoparticle and Its Application in Retinoblastoma-Targeted Theranostics. ACS biomaterials science & engineering. 2024-03-12;10(3):1830-1842
doi: 10.1021/acsbiomaterials.3c01972
Hu Y., Zhao M., Li L., Ding J., Gui Y.M., Wei T.W. miR-491-3p is Downregulated in Retinoblastoma and Inhibit Tumor Cells Growth and Metastasis by Targeting SNN. Biochemical genetics. 2020 Oct 23.
Huang J., Zhang L., Li Z., Lu X. Screening and identification of key biomarkers for retinoblastoma: Evidence from bioinformatics analysis. Medicine (Baltimore) 2020 May.
doi: 10.1097/MD.0000000000019952
Huang X., Wan J., Liu F., Liu Y., Wang L., Zhao S., Wu T., Sun F. P38 Mitogen-Activated Protein Kinase Protects Against Retinoblastoma Through Regulating USP22/SIRT1/SOST Axis. Front Oncol. 2022 Mar 9;12:781247. PMID: 35356205; PMCID: PMC8959650.
doi: 10.3389/fonc.2022.781247
Huang Y., Guo Y. et al. Quality of life among people with eye cancer: a systematic review from 2012 to 2022. Health and quality of life outcomes. 2024-03-30;22(1):3
doi: 10.1186/s12955-023-02219-6
Huang Y., Xue B., Pan J., Shen N. Circ-E2F3 acts as a ceRNA for miR-204-5p to promote proliferation, metastasis and apoptosis inhibition in retinoblastoma by regulating ROCK1 expression. Experimental and molecular pathology. 2021 Apr 18;120:104637.
doi: 10.1016/j.yexmp.2021.104637
Hudani A., Kimani K., Njambi L. et al. Navigating familial retinoblastoma in Kenya: A mother's journey. Pediatric blood & cancer. 2024-07-25;71(9):e31191
doi: 10.1002/pbc.31191
Huemmer S.E., Patnaik J.L., Ybarra S. et al. Teleophthalmology Through Online Mentorship Over a 20-Year Period: Education and Capacity Building. JCO global oncology. 2024-11-14;10(10):e2400297
doi: 10.1200/GO-24-00297
Hülsenbeck I., Frank M., Biewald E., Kanber D., Lohmann D.R., Ketteler P.
Introduction of a Variant Classification System for Analysis of Genotype-Phenotype Relationships in Heritable Retinoblastoma. Cancers. 2021 Mar 31;13(7):1605.
doi: 10.3390/cancers13071605
Hussain A.K., Rahul R.A., Carlos R.L., Francisco Z.M., María G.L., Flavia P., Chiara B., Davide B. Globe salvage treatment in group D and group E retinoblastoma. Rom J Ophthalmol. 2021 Jan-Mar;65(1):20-24.
doi: 10.22336/rjo.2021.5
Hussain MS., Gupta G., Afzal M. et al. Exploring the role of lncrna neat1 knockdown in regulating apoptosis across multiple cancer types: A review. Pathology, research and practice. 2023-12-05;252(252):154908
doi: 10.1016/j.prp.2023.154908
Hussain Z. Impact of Laterality on Cumulative Survival in Patients Diagnosed with Retinoblastoma: A Retrospective Cohort Analysis of 1925 Cases in the Surveillance, Epidemiology, and End Results (SEER) Program. Clinical ophthalmology. 2021 Mar 5;15:991-1001.
doi: 10.2147/OPTH.S298209. eCollection 2021
Hyun Park S., Young Park H., Kim H. et al. Hematological Second Primary Malignancy in Pediatric Retinoblastoma: A Case Report and Systematic Review. Ophthalmic plastic and reconstructive surgery. 2024-09-06;40(5):487-496
doi: 10.1097/IOP.0000000000002737
I
Im D.H., Pike S., Reid M.W. et al. A Multicenter Analysis of Nucleic Acid Quantification Using Aqueous Humor Liquid Biopsy in Retinoblastoma: Implications for Clinical Testing. Ophthalmology science. 2023-04-11;3(3):100289 doi: 10.1016/j.xops.2023.100289
Im S., Park H.S., Cho U. et al. Massive Retinal Gliosis Mistaken as a Malignant Intraocular Tumor in Phthisis Bulbi. Diagnostics (Basel, Switzerland). 2022-12-25;12(12)
doi: 10.3390/diagnostics12123090
Irvine T, Brundage M, Hudani A, Kabiru J, Kimani K, Njuguna F, Njambi L, Dimaras H. Development and preliminary evaluation of a genetics education booklet for retinoblastoma. J Genet Couns. 2025 Apr;34(2):e1944. Epub 2024 Aug 1. PMID: 39087554; PMCID: PMC11907173.
doi: 10.1002/jgc4.1944
Ishaq H., Patel B.C. Cancer, Retinoblastoma. 2020 Aug 10. StatPearls [Internet].
Ishaq H., Patel B.C. Retinoblastoma. 2021 Aug 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. PMID: 31424860
Ishaq H., Patel B.C. Retinoblastoma. 2021 Nov 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. PMID: 31424860
Istre-Wilz H., Ebert JJ., Augsburger JJ. et al. Retinal Gliovascular Proliferation Secondary to Retinoblastoma Treated With Radiotherapy. Ophthalmic surgery, lasers & imaging retina. 2024-12-16;55(12):714-720
doi: 10.3928/23258160-20240801-01
Im D.H., Pike S., Reid M.W. et al. A Multicenter Analysis of Nucleic Acid Quantification Using Aqueous Humor Liquid Biopsy in Retinoblastoma: Implications for Clinical Testing. Ophthalmology science. 2023-04-11;3(3):100289 doi: 10.1016/j.xops.2023.100289
Im S., Park H.S., Cho U. et al. Massive Retinal Gliosis Mistaken as a Malignant Intraocular Tumor in Phthisis Bulbi. Diagnostics (Basel, Switzerland). 2022-12-25;12(12)
doi: 10.3390/diagnostics12123090
Irvine T, Brundage M, Hudani A, Kabiru J, Kimani K, Njuguna F, Njambi L, Dimaras H. Development and preliminary evaluation of a genetics education booklet for retinoblastoma. J Genet Couns. 2025 Apr;34(2):e1944. Epub 2024 Aug 1. PMID: 39087554; PMCID: PMC11907173.
doi: 10.1002/jgc4.1944
Ishaq H., Patel B.C. Cancer, Retinoblastoma. 2020 Aug 10. StatPearls [Internet].
Ishaq H., Patel B.C. Retinoblastoma. 2021 Aug 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. PMID: 31424860
Ishaq H., Patel B.C. Retinoblastoma. 2021 Nov 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. PMID: 31424860
Istre-Wilz H., Ebert JJ., Augsburger JJ. et al. Retinal Gliovascular Proliferation Secondary to Retinoblastoma Treated With Radiotherapy. Ophthalmic surgery, lasers & imaging retina. 2024-12-16;55(12):714-720
doi: 10.3928/23258160-20240801-01
J
Jabbarli L., Göricke S., Stumbaum P. et al. Preoperative Detection of Local Tumor Extent in Patients with Advanced Retinoblastoma: Predictive Value of MRI and Clinical Findings. Klinische Monatsblatter fur Augenheilkunde. 2023-12-22
doi: 10.1055/a-2198-7630
Jabir A.R., Zaheer H.A., Zaheer M.A. et al. Detection and Diagnosis of Retinoblastoma: Can Mobile Devices Be the Next Step Toward Early Intervention? Cureus. 2022-11-17;14(10):e30074
doi: 10.7759/cureus.30074
Jahagirdar D., Jain R., Dandekar P. et al. In vitro triple culture model of retinoblastoma for pre-clinical investigations. Biotechnology journal. 2023-03-07:e2200518
doi: 10.1002/biot.202200518
Jakati S., Kaliki S. Aqueous seeding in retinoblastoma: Classification and clinicopathological correlation. Ophthalmol Retina. 2021 Dec 24:S2468-6530(21)00398-5.
doi: 10.1016/j.oret.2021.12.013
Jakati S., Patel A., Pathengay A., Kaliki S. Coincidental Retinal Dysplasia in Patients Presenting With Pseudohypopyon: A Series of Two Cases. BMJ Case Reports.
doi: 10.1136/bcr-2019-233922
Jakati S., Vempuluru V.S., Kaliki S. et al. Intraocular Cysticercosis Masquerading as Cavitary Retinoblastoma. Ophthalmology. 2024-06-15
doi: 10.1016/j.ophtha.2024.05.017
Jakati S., Vempuluru V.S., Mohamed A., K Mishra D., Kaliki S. Lenticular changes in eyes with advanced intraocular retinoblastoma: A histopathological study of 48 enucleated eyes. Semin Ophthalmol. 2021 Aug 12:1-5.
doi: 10.1080/08820538.2021.1962367
Janic A., Bowden S., Levy S., Stinson J., Dimaras H. Patient-reported outcome measures for retinoblastoma: a scoping review. Journal of patient-reported outcomes. 2020 Aug 8.
doi: 10.1186/s41687-020-00232-7
Janic A., Vincent A., Stinson J., Dimaras H. Values of Retinoblastoma Survivors and Parents Regarding Treatment Outcomes: A Qualitative Study. JCO Oncol Pract. 2022 Jan 5:OP2100474. Epub ahead of print.
doi: 10.1200/OP.21.00474
Jansen R.W., de Bloeme C.M., Brisse H.J., Galluzzi P., Cardoen L., Göricke S., Maeder P., Cassoux N., Gauthier A., Schlueter S., Hadjistilianou T., Munier F.L., Castelijns J.A., van der Valk P., Moll A.C., de Jong M.C., de Graaf P. MR Imaging Features to Differentiate Retinoblastoma from Coats' Disease and Persistent Fetal Vasculature. Cancers. 2020 Nov 30;12(12):3592.
doi: 10.3390/cancers12123592
Jansen R.W., de Bloeme C.M., Cardoen L. et al. MRI Features for Identifying MYCN-amplified RB1 Wild-type Retinoblastoma. Radiology. 2023-05-16:222264
doi: 10.1148/radiol.222264
Jansen R.W., van der Heide S., Cardoen L., Sirin S., de Bloeme C.M., Galluzzi P., Göricke S., Brisse H.J., Maeder P., Sen S., Biewald E., Castelijns J.A., Moll A.C., van der Valk P., de Jong M.C., de Graaf P.; European Retinoblastoma Imaging Collaboration. MRI can reliably differentiate optic nerve inflammation from tumor invasion in retinoblastoma with orbital cellulitis. Ophthalmology. 2022 Jun 22:S0161-6420(22)00445-6. Epub ahead of print. PMID: 35752210. doi: 10.1016/j.ophtha.2022.06.013
Jansen R.W., Roohollahi K., Uner O.E. et al. Correlation of gene expression with magnetic resonance imaging features of retinoblastoma: a multi-center radiogenomics validation study. European radiology. 2023-08-24
doi: 10.1007/s00330-023-10054-y
Jayabal P., Zhou F., Ma X. et al. Nitric oxide suppression by secreted frizzled-related protein 2 drives retinoblastoma. Cell reports. 2023-02-11;42(2):112103
doi: 10.1016/j.celrep.2023.112103
Jeyaprakash K., Kumaran M., Kim U. et al. Investigating druggable kinases for targeted therapy in retinoblastoma. Journal of human genetics. 2024-08-24;69(9):467-474
doi: 10.1038/s10038-024-01267-0
Jeyaprakash K., Shanthini T., Kim U., Muthukkaruppan V., Vanniarajan A. Human papillomavirus in retinoblastoma: A tertiary eye care center study from South India. Indian J Ophthalmol. 2021 Aug;69(8):2111-2115.
doi: 10.4103/ijo.IJO_106_21
Jeyaprakash K., Thirumalairaj K., Kim U. et al. RB1 transcript analysis detects novel splicing aberration in retinoblastoma. Pediatric blood & cancer. 2023-03-14:e30290
doi: 10.1002/pbc.30290
Jabbarli L., Göricke S., Stumbaum P. et al. Preoperative Detection of Local Tumor Extent in Patients with Advanced Retinoblastoma: Predictive Value of MRI and Clinical Findings. Klinische Monatsblatter fur Augenheilkunde. 2023-12-22
doi: 10.1055/a-2198-7630
Jabir A.R., Zaheer H.A., Zaheer M.A. et al. Detection and Diagnosis of Retinoblastoma: Can Mobile Devices Be the Next Step Toward Early Intervention? Cureus. 2022-11-17;14(10):e30074
doi: 10.7759/cureus.30074
Jahagirdar D., Jain R., Dandekar P. et al. In vitro triple culture model of retinoblastoma for pre-clinical investigations. Biotechnology journal. 2023-03-07:e2200518
doi: 10.1002/biot.202200518
Jakati S., Kaliki S. Aqueous seeding in retinoblastoma: Classification and clinicopathological correlation. Ophthalmol Retina. 2021 Dec 24:S2468-6530(21)00398-5.
doi: 10.1016/j.oret.2021.12.013
Jakati S., Patel A., Pathengay A., Kaliki S. Coincidental Retinal Dysplasia in Patients Presenting With Pseudohypopyon: A Series of Two Cases. BMJ Case Reports.
doi: 10.1136/bcr-2019-233922
Jakati S., Vempuluru V.S., Kaliki S. et al. Intraocular Cysticercosis Masquerading as Cavitary Retinoblastoma. Ophthalmology. 2024-06-15
doi: 10.1016/j.ophtha.2024.05.017
Jakati S., Vempuluru V.S., Mohamed A., K Mishra D., Kaliki S. Lenticular changes in eyes with advanced intraocular retinoblastoma: A histopathological study of 48 enucleated eyes. Semin Ophthalmol. 2021 Aug 12:1-5.
doi: 10.1080/08820538.2021.1962367
Janic A., Bowden S., Levy S., Stinson J., Dimaras H. Patient-reported outcome measures for retinoblastoma: a scoping review. Journal of patient-reported outcomes. 2020 Aug 8.
doi: 10.1186/s41687-020-00232-7
Janic A., Vincent A., Stinson J., Dimaras H. Values of Retinoblastoma Survivors and Parents Regarding Treatment Outcomes: A Qualitative Study. JCO Oncol Pract. 2022 Jan 5:OP2100474. Epub ahead of print.
doi: 10.1200/OP.21.00474
Jansen R.W., de Bloeme C.M., Brisse H.J., Galluzzi P., Cardoen L., Göricke S., Maeder P., Cassoux N., Gauthier A., Schlueter S., Hadjistilianou T., Munier F.L., Castelijns J.A., van der Valk P., Moll A.C., de Jong M.C., de Graaf P. MR Imaging Features to Differentiate Retinoblastoma from Coats' Disease and Persistent Fetal Vasculature. Cancers. 2020 Nov 30;12(12):3592.
doi: 10.3390/cancers12123592
Jansen R.W., de Bloeme C.M., Cardoen L. et al. MRI Features for Identifying MYCN-amplified RB1 Wild-type Retinoblastoma. Radiology. 2023-05-16:222264
doi: 10.1148/radiol.222264
Jansen R.W., van der Heide S., Cardoen L., Sirin S., de Bloeme C.M., Galluzzi P., Göricke S., Brisse H.J., Maeder P., Sen S., Biewald E., Castelijns J.A., Moll A.C., van der Valk P., de Jong M.C., de Graaf P.; European Retinoblastoma Imaging Collaboration. MRI can reliably differentiate optic nerve inflammation from tumor invasion in retinoblastoma with orbital cellulitis. Ophthalmology. 2022 Jun 22:S0161-6420(22)00445-6. Epub ahead of print. PMID: 35752210. doi: 10.1016/j.ophtha.2022.06.013
Jansen R.W., Roohollahi K., Uner O.E. et al. Correlation of gene expression with magnetic resonance imaging features of retinoblastoma: a multi-center radiogenomics validation study. European radiology. 2023-08-24
doi: 10.1007/s00330-023-10054-y
Jayabal P., Zhou F., Ma X. et al. Nitric oxide suppression by secreted frizzled-related protein 2 drives retinoblastoma. Cell reports. 2023-02-11;42(2):112103
doi: 10.1016/j.celrep.2023.112103
Jeyaprakash K., Kumaran M., Kim U. et al. Investigating druggable kinases for targeted therapy in retinoblastoma. Journal of human genetics. 2024-08-24;69(9):467-474
doi: 10.1038/s10038-024-01267-0
Jeyaprakash K., Shanthini T., Kim U., Muthukkaruppan V., Vanniarajan A. Human papillomavirus in retinoblastoma: A tertiary eye care center study from South India. Indian J Ophthalmol. 2021 Aug;69(8):2111-2115.
doi: 10.4103/ijo.IJO_106_21
Jeyaprakash K., Thirumalairaj K., Kim U. et al. RB1 transcript analysis detects novel splicing aberration in retinoblastoma. Pediatric blood & cancer. 2023-03-14:e30290
doi: 10.1002/pbc.30290
Jiang A., Wu W., Xu C., Mao L., Ao S., Guo H., Sun X., Tao J., Sang Y., Huang G. SP2509, a Selective Inhibitor of LSD1, Suppresses Retinoblastoma Growth by Downregulating β-catenin Signaling. Invest Ophthalmol Vis Sci. 2022 Mar 2;63(3):20. PMID: 35297943; PMCID: PMC8944386.
doi: 10.1167/iovs.63.3.20
Jiang G., Qu M., Kong L. et al. hsa_circ_0084811 Regulates Cell Proliferation and Apoptosis in Retinoblastoma through miR-18a-5p/miR-18b-5p/E2F5 Axis. BioMed research international. 2022-08-02;2022(2022):6918396
doi: 10.1155/2022/6918396
Jiang H, Jiang Y, Liu Z, Guo Y, Zhang J. Intra-arterial chemotherapy for treatment of very low birthweight infants with retinoblastoma: Two case reports. Medicine (Baltimore). 2021 May 14;100(19):e25870.
doi: 10.1097/MD.0000000000025870
Jiang H., Niu C., Guo Y. et al. Wedelolactone induces apoptosis and pyroptosis in retinoblastoma through promoting ROS generation. International immunopharmacology. 2022-09-14;111(111):108855
doi: 10.1016/j.intimp.2022.108855
Jiang K., Fan X., Hu Y., Yao S., Liu Y., Zhan C., Lu W., Wei G. Topical instillation of cell-penetrating peptide-conjugated melphalan blocks metastases of retinoblastoma. Biomaterials. 2022 Apr 1;284:121493. Epub ahead of print. PMID: 35395452.
doi: 10.1016/j.biomaterials.2022.121493
Jiang Y., Xiao F., Wang L., Wang T., Chen L. Circular RNA has_circ_0000034 accelerates retinoblastoma advancement through the miR-361-3p/ADAM19 axis. Molecular and cellular biochemistry. 2020 Aug 25.
doi: 10.1007/s11010-020-03886-5
Jiang Y., Xiao F., Wang L., Wang T., Chen L. Hsa_circ_0099,198 facilitates the progression of retinoblastoma by regulating miR-1287/LRP6 axis. Experimental eye research. 2021 Mar 4;206:108529.
doi: 10.1016/j.exer.2021.108529
Jiang Y., Yam J.C., Chu W.K. Poly ADP Ribose Polymerase Inhibitor Olaparib Targeting Microhomology End Joining in Retinoblastoma Protein Defective Cancer: Analysis of the Retinoblastoma Cell-Killing Effects by Olaparib after Inducing Double-Strand Breaks. Int J Mol Sci. 2021 Oct 1;22(19):10687.
doi: 10.3390/ijms221910687
Jiang Y., Zheng G., Sun X. et al. PRMT5 promotes retinoblastoma development. Human cell. 2022-11-04 doi: 10.1007/s13577-022-00807-0
Jiang Z, Allkanjari MS, Chung PED, Tran H, Ghanbari-Azarnier R, Wang DY, Lin DJ, Min JY, Ben-David Y, Zacksenhaus E. Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities. Cancers (Basel). 2025 Feb 20;17(5):720. PMID: 40075567; PMCID: PMC11898778.
doi: 10.3390/cancers17050720
Jiao G., Sommer C., Rai R.S. et al. Markedly Asymmetric Opsoclonus as the Initial Presentation of Trilateral Retinoblastoma and an Undifferentiated Metastatic Tumor. Journal of neuro-ophthalmology: the official journal of the North American Neuro-Ophthalmology Society. 2023-05-24
doi: 10.1097/WNO.0000000000001892
Jia S., Wen X., Yu J. et al. Risk factors for cataract in retinoblastoma management. The British journal of ophthalmology. 2023-04-17
doi: 10.1136/bjo-2022-321723
Jia S., Wen X., Zhou M., He X., Han M., Fan J., Jia R., Fan X. Comparison of Intra-Arterial Chemotherapy Efficacy Delivered Through the Ophthalmic Artery or External Carotid Artery in a Cohort of Retinoblastoma Patients. Frontiers in medicine. 2021 Jun 11;8:658305.
doi: 10.3389/fmed.2021.658305
Jiménez I., Frouin É., Chicard M., Dehainault C., Le Gall J., Benoist C., Gauthier A., Lapouble E., Houdayer C., Radvanyi F., Bernard V., Brisse H.J., Gauthier-Villars M., Stoppa-Lyonnet D., Baulande S., Cassoux N., Lumbroso L., Matet A., Aerts I., Renault V., Doz F., Golmard L., Delattre O., Schleiermacher G. Molecular diagnosis of retinoblastoma by circulating tumor DNA analysis. Eur J Cancer. 2021 Sep;154:277-287.
doi: 10.1016/j.ejca.2021.05.039
Jiménez I., Laé M, Tanguy M.L., Savignoni A., Gauthier-Villars M., Desjardins L., Cassoux N., Dendale R., Rodriguez J., Doz F., Brisse H.J., Aerts I. Craniofacial second primary tumors in patients with germline retinoblastoma previously treated with external beam radiotherapy: A retrospective institutional analysis. Pediatr Blood Cancer. 2020 Jan
doi: 10.1002/pbc.28158
Jin B., Lu K., Gao W. et al. Polydopamine-Based Targeted Nanosystem for Chemo/Photothermal Therapy of Retinoblastoma in a Mouse Orthotopic Model. International journal of nanomedicine. 2024-08-06;19(19):7799-7816
doi: 10.2147/IJN.S467949
Jin L., Ma X., Lei X., Tong J., Wang R. Cyclophosphamide inhibits Pax5 methylation to regulate the growth of retinoblastoma via the Notch1 pathway. Hum Exp Toxicol. 2021 Oct 18:9603271211051601.
doi: 10.1177/09603271211051601
Jo D.H., Lee S., Bak E., Cho C.S., Han Y.T., Kim K., Suh Y.G., Kim J.H. Anti-tumor Activity of Novel STAT3 Inhibitors on Retinoblastoma. Molecular Pharmacology. 2021 May 20:MOLPHARM-AR-2020-000231.
doi: 10.1124/molpharm.120.000231
de Jong M.C., Shaikh F., Gallie B., Kors W.A., Jansen R.W,. Dommering C., de Graaf P., Moll A.C., Dimaras H., Shroff M., Kivelä T.T., Soliman S.E. Asynchronous pineoblastoma is more likely after early diagnosis of retinoblastoma: a meta-analysis. Acta Ophthalmologica. 2021 May 3.
doi: 10.1111/aos.14855
de Jong M.C., Van Der Valk P., Jansen R.W., Abbink F., Bosscha M., Castelijns J.A., Moll A.C., de Graaf P. Full-width postlaminar optic nerve tumor invasion of retinoblastoma as risk-factor for leptomeningeal spread of retinoblastoma. A case report and review of the literature. Ophthalmic Genet. 2020 Feb 19:1-4.
doi:10.1080/13816810.2020.1727535
Joseph A.K., Guerin J.B., Eckel L.J., Dalvin L.A., Keating G.F., Liebo G.B., Benson J.C., Brinjikji W., Laack N.N., Silvera V.M. Imaging Findings of Pediatric Orbital Masses and Tumor Mimics. Radiographics. 2022 May-Jun;42(3):880-897.
doi: 10.1148/rg.210116
Joseph S., Pike S., Peng C.C. et al. Retinoblastoma with MYCN Amplification Diagnosed from Cell-Free DNA in the Aqueous Humor. Ocular oncology and pathology. 2024-06-28;10(1):15-24
doi: 10.1159/000533311
Jubran J.H., Luong H., Naik A. et al. Efficacy of a prolonged stability melphalan formulation for intra-arterial treatment of retinoblastoma. Journal of neurointerventional surgery. 2023-06-28
doi: 10.1136/jnis-2023-020170
Jubran R.F., Villablanca J.G., Krailo M., Piao J., Huang L., Murphree A.L., O'Brien J., Gombos D., Shields C.L., Meadows A., Chintagumpala M. A Single-Arm Study of Systemic and sub-Tenon Chemotherapy for Groups C and D Intraocular Retinoblastoma: A Children's Oncology Group Study (ARET 0231). Pediatric Blood & Cancer. 2020 June 26.
doi: 10.1002/pbc.28502
Jullien S. Vision screening in newborns and early childhood. BMC Pediatr. 2021 Sep 8;21(Suppl 1):306.
doi: 10.1186/s12887-021-02606-2
Jung E.M., Bunin G.R., Ganguly A. et al. The association between maternal nutrient intake during pregnancy and the risk of sporadic unilateral retinoblastoma among offspring. Cancer epidemiology. 2023-05-11;85(85):102376
doi: 10.1016/j.canep.2023.102376
doi: 10.1167/iovs.63.3.20
Jiang G., Qu M., Kong L. et al. hsa_circ_0084811 Regulates Cell Proliferation and Apoptosis in Retinoblastoma through miR-18a-5p/miR-18b-5p/E2F5 Axis. BioMed research international. 2022-08-02;2022(2022):6918396
doi: 10.1155/2022/6918396
Jiang H, Jiang Y, Liu Z, Guo Y, Zhang J. Intra-arterial chemotherapy for treatment of very low birthweight infants with retinoblastoma: Two case reports. Medicine (Baltimore). 2021 May 14;100(19):e25870.
doi: 10.1097/MD.0000000000025870
Jiang H., Niu C., Guo Y. et al. Wedelolactone induces apoptosis and pyroptosis in retinoblastoma through promoting ROS generation. International immunopharmacology. 2022-09-14;111(111):108855
doi: 10.1016/j.intimp.2022.108855
Jiang K., Fan X., Hu Y., Yao S., Liu Y., Zhan C., Lu W., Wei G. Topical instillation of cell-penetrating peptide-conjugated melphalan blocks metastases of retinoblastoma. Biomaterials. 2022 Apr 1;284:121493. Epub ahead of print. PMID: 35395452.
doi: 10.1016/j.biomaterials.2022.121493
Jiang Y., Xiao F., Wang L., Wang T., Chen L. Circular RNA has_circ_0000034 accelerates retinoblastoma advancement through the miR-361-3p/ADAM19 axis. Molecular and cellular biochemistry. 2020 Aug 25.
doi: 10.1007/s11010-020-03886-5
Jiang Y., Xiao F., Wang L., Wang T., Chen L. Hsa_circ_0099,198 facilitates the progression of retinoblastoma by regulating miR-1287/LRP6 axis. Experimental eye research. 2021 Mar 4;206:108529.
doi: 10.1016/j.exer.2021.108529
Jiang Y., Yam J.C., Chu W.K. Poly ADP Ribose Polymerase Inhibitor Olaparib Targeting Microhomology End Joining in Retinoblastoma Protein Defective Cancer: Analysis of the Retinoblastoma Cell-Killing Effects by Olaparib after Inducing Double-Strand Breaks. Int J Mol Sci. 2021 Oct 1;22(19):10687.
doi: 10.3390/ijms221910687
Jiang Y., Zheng G., Sun X. et al. PRMT5 promotes retinoblastoma development. Human cell. 2022-11-04 doi: 10.1007/s13577-022-00807-0
Jiang Z, Allkanjari MS, Chung PED, Tran H, Ghanbari-Azarnier R, Wang DY, Lin DJ, Min JY, Ben-David Y, Zacksenhaus E. Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities. Cancers (Basel). 2025 Feb 20;17(5):720. PMID: 40075567; PMCID: PMC11898778.
doi: 10.3390/cancers17050720
Jiao G., Sommer C., Rai R.S. et al. Markedly Asymmetric Opsoclonus as the Initial Presentation of Trilateral Retinoblastoma and an Undifferentiated Metastatic Tumor. Journal of neuro-ophthalmology: the official journal of the North American Neuro-Ophthalmology Society. 2023-05-24
doi: 10.1097/WNO.0000000000001892
Jia S., Wen X., Yu J. et al. Risk factors for cataract in retinoblastoma management. The British journal of ophthalmology. 2023-04-17
doi: 10.1136/bjo-2022-321723
Jia S., Wen X., Zhou M., He X., Han M., Fan J., Jia R., Fan X. Comparison of Intra-Arterial Chemotherapy Efficacy Delivered Through the Ophthalmic Artery or External Carotid Artery in a Cohort of Retinoblastoma Patients. Frontiers in medicine. 2021 Jun 11;8:658305.
doi: 10.3389/fmed.2021.658305
Jiménez I., Frouin É., Chicard M., Dehainault C., Le Gall J., Benoist C., Gauthier A., Lapouble E., Houdayer C., Radvanyi F., Bernard V., Brisse H.J., Gauthier-Villars M., Stoppa-Lyonnet D., Baulande S., Cassoux N., Lumbroso L., Matet A., Aerts I., Renault V., Doz F., Golmard L., Delattre O., Schleiermacher G. Molecular diagnosis of retinoblastoma by circulating tumor DNA analysis. Eur J Cancer. 2021 Sep;154:277-287.
doi: 10.1016/j.ejca.2021.05.039
Jiménez I., Laé M, Tanguy M.L., Savignoni A., Gauthier-Villars M., Desjardins L., Cassoux N., Dendale R., Rodriguez J., Doz F., Brisse H.J., Aerts I. Craniofacial second primary tumors in patients with germline retinoblastoma previously treated with external beam radiotherapy: A retrospective institutional analysis. Pediatr Blood Cancer. 2020 Jan
doi: 10.1002/pbc.28158
Jin B., Lu K., Gao W. et al. Polydopamine-Based Targeted Nanosystem for Chemo/Photothermal Therapy of Retinoblastoma in a Mouse Orthotopic Model. International journal of nanomedicine. 2024-08-06;19(19):7799-7816
doi: 10.2147/IJN.S467949
Jin L., Ma X., Lei X., Tong J., Wang R. Cyclophosphamide inhibits Pax5 methylation to regulate the growth of retinoblastoma via the Notch1 pathway. Hum Exp Toxicol. 2021 Oct 18:9603271211051601.
doi: 10.1177/09603271211051601
Jo D.H., Lee S., Bak E., Cho C.S., Han Y.T., Kim K., Suh Y.G., Kim J.H. Anti-tumor Activity of Novel STAT3 Inhibitors on Retinoblastoma. Molecular Pharmacology. 2021 May 20:MOLPHARM-AR-2020-000231.
doi: 10.1124/molpharm.120.000231
de Jong M.C., Shaikh F., Gallie B., Kors W.A., Jansen R.W,. Dommering C., de Graaf P., Moll A.C., Dimaras H., Shroff M., Kivelä T.T., Soliman S.E. Asynchronous pineoblastoma is more likely after early diagnosis of retinoblastoma: a meta-analysis. Acta Ophthalmologica. 2021 May 3.
doi: 10.1111/aos.14855
de Jong M.C., Van Der Valk P., Jansen R.W., Abbink F., Bosscha M., Castelijns J.A., Moll A.C., de Graaf P. Full-width postlaminar optic nerve tumor invasion of retinoblastoma as risk-factor for leptomeningeal spread of retinoblastoma. A case report and review of the literature. Ophthalmic Genet. 2020 Feb 19:1-4.
doi:10.1080/13816810.2020.1727535
Joseph A.K., Guerin J.B., Eckel L.J., Dalvin L.A., Keating G.F., Liebo G.B., Benson J.C., Brinjikji W., Laack N.N., Silvera V.M. Imaging Findings of Pediatric Orbital Masses and Tumor Mimics. Radiographics. 2022 May-Jun;42(3):880-897.
doi: 10.1148/rg.210116
Joseph S., Pike S., Peng C.C. et al. Retinoblastoma with MYCN Amplification Diagnosed from Cell-Free DNA in the Aqueous Humor. Ocular oncology and pathology. 2024-06-28;10(1):15-24
doi: 10.1159/000533311
Jubran J.H., Luong H., Naik A. et al. Efficacy of a prolonged stability melphalan formulation for intra-arterial treatment of retinoblastoma. Journal of neurointerventional surgery. 2023-06-28
doi: 10.1136/jnis-2023-020170
Jubran R.F., Villablanca J.G., Krailo M., Piao J., Huang L., Murphree A.L., O'Brien J., Gombos D., Shields C.L., Meadows A., Chintagumpala M. A Single-Arm Study of Systemic and sub-Tenon Chemotherapy for Groups C and D Intraocular Retinoblastoma: A Children's Oncology Group Study (ARET 0231). Pediatric Blood & Cancer. 2020 June 26.
doi: 10.1002/pbc.28502
Jullien S. Vision screening in newborns and early childhood. BMC Pediatr. 2021 Sep 8;21(Suppl 1):306.
doi: 10.1186/s12887-021-02606-2
Jung E.M., Bunin G.R., Ganguly A. et al. The association between maternal nutrient intake during pregnancy and the risk of sporadic unilateral retinoblastoma among offspring. Cancer epidemiology. 2023-05-11;85(85):102376
doi: 10.1016/j.canep.2023.102376
K
Kaczmarek J.V., Bogan C.M., Pierce J.M., Tao Y.K., Chen S.C., Liu Q., Liu X., Boyd K.L., Calcutt M.W., Bridges T.M., Lindsley C.W., Friedman D.L., Richmond A., Daniels A.B. Intravitreal HDAC Inhibitor Belinostat Effectively Eradicates Vitreous Seeds Without Retinal Toxicity In Vivo in a Rabbit Retinoblastoma Model. Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):8.
doi: 10.1167/iovs.62.14.8
Kaewkhaw R., Rojanaporn D. Retinoblastoma: Etiology, Modeling, and Treatment. Cancers. 2020 Aug 16
doi: 10.3390/cancers12082304
Kakarala C.L., Raval V.R., Mallu A. et al. Metastatic retinoblastoma at presentation: Clinical presentation, treatment, and outcomes. Oman journal of ophthalmology. 2023-12-08;16(3):524-528
doi: 10.4103/ojo.ojo_176_22
Kakkassery V., Gemoll T., Kraemer M.M., Sauer T., Tura A., Ranjbar M., Grisanti S., Joachim S.C., Mergler S., Reinhard J. Protein Profiling of WERI-RB1 and Etoposide-Resistant WERI-ETOR Reveals New Insights into Topoisomerase Inhibitor Resistance in Retinoblastoma. Int J Mol Sci. 2022 Apr 6;23(7):4058. PMID: 35409416; PMCID: PMC9000009.
doi: 10.3390/ijms23074058
Kalaiyarasan R., Shende D., Parthiban M., Lomi N. Comparison of peribulbar block and subtenon infiltration in pediatric enucleation for retinoblastoma. Indian J Ophthalmol. 2021 Aug;69(8):2106-2110.
doi: 10.4103/ijo.IJO_2829_20
Kaliki S. Aqueous seeding in intraocular retinoblastoma: A review. Clin Exp Ophthalmol. 2021 Aug;49(6):606-614.
doi: 10.1111/ceo.13964
Kaliki S., Gavara S., Patil G. et al. Secondary salvage intravenous chemotherapy for refractory / recurrent retinoblastoma: A Study of 41 Eyes. Retina (Philadelphia, Pa.). 2023-12-21;44(1):144-150
doi: 10.1097/IAE.0000000000003923
Kaliki S., Jakati S., Vempuluru V.S., Mallu A., Mishra D.K. Retinoblastoma associated with orbital pseudocellulitis and high-risk retinoblastoma: a study of 32 eyes. Int Ophthalmol. 2021 Aug 6.
doi: 10.1007/s10792-021-01993-w
Kaliki S., Ji X., Zou Y., Rashid R., Sultana S., Taju Sherief S., Cassoux N., Y Diaz Coronado R., Luis Garcia Leon J., López A.M.Z., Polyakov V.G., Ushakova T.L., Rani Roy S., Ahmad A., Al Harby L., Reddy M.A., Sagoo M.S., L. Berry J., Kim J., Polski A., Astbury N.J., Bascaran C., Blum S., Bowman R., Burton M.J., Foster A., Gomel N., Keren-Froim N., Madgar S., W. Stacey A., M. Steinberg D., Mohamed A., Zondervan M., Fabian I.D. Lag Time between Onset of First Symptom and Treatment of Retinoblastoma: An International Collaborative Study of 692 Patients from 10 Countries. Cancers. 2021 Apr 19;13(8):1956.
doi: 10.3390/cancers13081956.
Kaliki S., Maniar A., Kekunnaya R. Cataract surgery in treated retinoblastoma eyes: A study of 29 eyes. European journal of ophthalmology. 2020 Jun 25.
doi: 10.1177/1120672120938575
Kaliki S., Shields C.L., Cassoux N., Munier F.L., Chantada G., Grossniklaus H.E., Yoshikawa H., Fabian I.D., Berry J.L., McKenzie J.D., Kimani K., Reddy M.A., Parulekar M., Tanabe M., Furuta M., Grigorovski N., Chevez-Barrios P., Scanlan P., Eagle RC. Jr, Rashid R., Coronado R.D., Sultana S., Staffieri S., Frenkel S., Suzuki S., Ushakova T.L., Ji X. Defining High-Risk Retinoblastoma: A Multicenter Global Survey. JAMA Ophthalmol. 2021 Nov 11:e214732
doi: 10.1001/jamaophthalmol.2021.4732
Kaliki S., Shields C.L., Cassoux N., Munier F.L., Chantada G., Grossniklaus H.E., Yoshikawa H., Fabian I.D., Berry J.L., McKenzie J.D., Kimani K., Reddy M.A., Parulekar M., Tanabe M., Furuta M., Grigorovski N., Chevez-Barrios P., Scanlan P., Eagle R.C. Jr., Rashid R., Coronado R.D., Sultana S., Staffieri S., Frenkel S., Suzuki S., Ushakova T.L., Ji X. Defining High-risk Retinoblastoma: A Multicenter Global Survey. JAMA Ophthalmol. 2022 Jan 1;140(1):30-36.
doi: 10.1001/jamaophthalmol.2021.4732
Kaliki S, Vempuluru VS, Ahmad A, Berry JL, Diaz-Coronado R, Eiger-Moscovich M, Fabian ID, Grossniklaus H, Baker Hubbard G 3rd, Mohammad M, Pe'er J, Reddy MA, Sagoo MS, Shields CL, Staffieri SE, Tanabe M, Ushakova T, Yousef YA; High‐Risk Retinoblastoma Collaborative Study Group. Impact of Race on the Outcomes of Retinoblastoma Treated With Primary Enucleation: A Global Study of 1426 Patients. Clin Exp Ophthalmol. 2025 May-Jun;53(4):421-434. Epub 2024 Dec 28. PMID: 39731391; PMCID: PMC12129717.
doi: 10.1111/ceo.14488
Kaliki S., Vempuluru V.S., Bakal K.R. et al. High-Risk Histopathological Features of Retinoblastoma following Primary Enucleation: A Global Study of 1426 Patients from 5 Continents. Retina (Philadelphia, Pa.). 2024-08-16
doi: 10.1097/IAE.0000000000004250
Kaliki S, Vempuluru VS, Desai A, Ji X, Zou Y, Rashid R, Sultana S, Sherief ST, Cassoux N, Diaz Coronado RY, Garcia Leon JL, López AMZ, Polyakov VG, Ushakova TL, Yarovoy AA, Rani Roy S, Ahmad A, Al Harby L, Reddy MA, Sagoo MS, Berry JL, Kim J, Polski A, Astbury NJ, Bascaran C, Blum S, Gomel N, Bowman R, Burton MJ, Foster A, Stacey AW, Steinberg DM, Refaeli D, Zondervan M, Didi Fabian I. Lag Time Between Onset of First Symptom and Treatment ofRetinoblastoma: Outcomes at Three Years from Recruitment. Semin Ophthalmol. 2025 Apr 12:1-7. doi: 10.1080/08820538.2025.2491004. Epub ahead of print. PMID: 40219812.
Kaliki S, Vempuluru VS, Fabian ID; Global Retinoblastoma Study Group. Retinoblastoma with and without Extraocular Tumor Extension: A GlobalComparative Study of 3435 Patients. Ophthalmol Sci. 2024 Oct 30;5(2):100637. doi: 10.1016/j.xops.2024.100637. PMID: 39758129; PMCID: PMC11696820.
Kaliki S., Vempuluru V.S., Ghose N. et al. Artificial intelligence and machine learning in ocular oncology: Retinoblastoma. Indian journal of ophthalmology. 2023-02-07;71(2):424-430
doi: 10.4103/ijo.IJO_1393_22
Kaliki S., Vempuluru VS., Mohamed A. et al. Retinoblastoma in Asia: Clinical Presentation and Treatment Outcomes in 2112 Patients from 33 Countries. Ophthalmology. 2023-11-24
doi: 10.1016/j.ophtha.2023.10.015
Kaliki S., Vempuluru V.S., Priya Y., Mohamed A. Risk factors for recurrent retinoblastoma after intravenous chemotherapy. International ophthalmology. 2021 Feb 20.
doi: 10.1007/s10792-021-01759-4
Kalinaki A., Muwonge H., Balagadde-Kambugu J., Mulumba Y., Ntende J., Ssali G., Nakiyingi L., Nakanjako D., Nalukenge C., Ampaire A.M. Clinical presentation and outcomes in children with retinoblastoma managed at the Uganda Cancer Institute. J Cancer Epidemiol. 2022 Mar 8;2022:8817215. PMID: 35308301; PMCID: PMC8924608.
doi: 10.1155/2022/8817215
Kamarudin A.A., Sayuti N.H., Saad N., Razak NA.A., Esa N.M. Induction of apoptosis by Eleutherine bulbosa (Mill.) Urb. bulb extracted under optimised extraction condition on human retinoblastoma cancer cells (WERI-Rb-1). J Ethnopharmacol. 2021 Oct 21;284:114770. doi: 10.1016/j.jep.2021.114770. PMID: 34688803
Kamihara J, Schienda J, McGee RB, Friedman DN, Rednam SP, Brzezinski JJ, Kim SY, Becktell KD, Lupo PJ, Gallie BL, Greer MC, Hansford JR, Brodeur GM. Update on Retinoblastoma Predisposition and Surveillance Recommendations for Children. Clin Cancer Res. 2025 May 1;31(9):1573-1579. doi: 10.1158/1078-0432.CCR-24-3271. PMID: 39998650.
Kannan K., Jethva D., Parameswarappa D.C. et al. Electroretinographic changes in the inner and outer retinal layers before and after intravenous chemotherapy for retinoblastoma. Indian journal of ophthalmology. 2024-07-30;72(8):1168-1174
doi: 10.4103/IJO.IJO_2722_23
Kant N., Jayaraj P., Sen S. et al. Establishment of patient-derived xenografts of retinoblastoma and choroidal melanoma on the avian chorioallantoic membrane. Indian journal of ophthalmology. 2023-03-07;71(3):977-982
doi: 10.4103/ijo.IJO_1494_22
Kanukollu V.M., Tripathy K. Leukocoria. StatPearls [Internet]. 2020 Aug 16.
Karaca BÖ, Tellioğlu A. Assessment of the Quality, Reliability, and Popularity of Information About Retinoblastoma on YouTube. J Pediatr Ophthalmol Strabismus. 2025 Jan-Feb;62(1):33-38.. Epub 2024 Sep 10. PMID: 39254184.
doi: 10.3928/01913913-20240807-03
Karami Fath M., Pourbagher Benam S., Kouhi Esfahani N. et al. The functional role of circular RNAs in the pathogenesis of retinoblastoma: a new potential biomarker and therapeutic target? Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2023-03-31
doi: 10.1007/s12094-023-03144-2
Karimi S., Arabi A., Shahraki T., Ansari I., Safi S. Development of Progressive Chiari I Malformation in a Child with Unilateral Sporadic Retinoblastoma. J Curr Ophthalmol. 2021 Mar 26;33(1):88-90.
doi: 10.4103/JOCO.JOCO_166_20
Karimi S., Arabi A., Shahraki T., Safi S. Central Serous Chorioretinopathy in a Case of Regressed Familial Retinoblastoma. Journal of ophthalmic & vision research. 2020 Oct 25;15(4):559-564.
doi: 10.18502/jovr.v15i4.7802
Kasengaliev, A.M., Ermekova K.T. Analysis of improving the diagnosis and treatment of retinoblastoma in Kazakhstan // Устойчивое развитие науки и образования. 2023. No. 5(80). P. 6-9. EDN DNVBAX.
Kashyap S., Singh L., Kumar N., Singh M.K., Pushker N., Bakhshi S., Sen S., Lomi N., Meel R., Chawla B. Combined association of massive choroidal and optic nerve invasion as a prognostic relevance in primary retinoblastoma: A 10-year study. Asia-Pacific journal of clinical oncology. 2021 Apr;17(2):e100-e108.
doi: 10.1111/ajco.13348
Kassab A., Gupta I., Moustafa A.A. et al. Role of E2F transcription factor in oral cancer: Recent insight and advancements. Seminars in cancer biology. 2023-03-30;92(92):28-41
doi: 10.1016/j.semcancer.2023.03.004
Kaur K, Patel BC. Retinoblastoma. 2025 Feb 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424860.
Kaczmarek J.V., Bogan C.M., Pierce J.M., Tao Y.K., Chen S.C., Liu Q., Liu X., Boyd K.L., Calcutt M.W., Bridges T.M., Lindsley C.W., Friedman D.L., Richmond A., Daniels A.B. Intravitreal HDAC Inhibitor Belinostat Effectively Eradicates Vitreous Seeds Without Retinal Toxicity In Vivo in a Rabbit Retinoblastoma Model. Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):8.
doi: 10.1167/iovs.62.14.8
Kaewkhaw R., Rojanaporn D. Retinoblastoma: Etiology, Modeling, and Treatment. Cancers. 2020 Aug 16
doi: 10.3390/cancers12082304
Kakarala C.L., Raval V.R., Mallu A. et al. Metastatic retinoblastoma at presentation: Clinical presentation, treatment, and outcomes. Oman journal of ophthalmology. 2023-12-08;16(3):524-528
doi: 10.4103/ojo.ojo_176_22
Kakkassery V., Gemoll T., Kraemer M.M., Sauer T., Tura A., Ranjbar M., Grisanti S., Joachim S.C., Mergler S., Reinhard J. Protein Profiling of WERI-RB1 and Etoposide-Resistant WERI-ETOR Reveals New Insights into Topoisomerase Inhibitor Resistance in Retinoblastoma. Int J Mol Sci. 2022 Apr 6;23(7):4058. PMID: 35409416; PMCID: PMC9000009.
doi: 10.3390/ijms23074058
Kalaiyarasan R., Shende D., Parthiban M., Lomi N. Comparison of peribulbar block and subtenon infiltration in pediatric enucleation for retinoblastoma. Indian J Ophthalmol. 2021 Aug;69(8):2106-2110.
doi: 10.4103/ijo.IJO_2829_20
Kaliki S. Aqueous seeding in intraocular retinoblastoma: A review. Clin Exp Ophthalmol. 2021 Aug;49(6):606-614.
doi: 10.1111/ceo.13964
Kaliki S., Gavara S., Patil G. et al. Secondary salvage intravenous chemotherapy for refractory / recurrent retinoblastoma: A Study of 41 Eyes. Retina (Philadelphia, Pa.). 2023-12-21;44(1):144-150
doi: 10.1097/IAE.0000000000003923
Kaliki S., Jakati S., Vempuluru V.S., Mallu A., Mishra D.K. Retinoblastoma associated with orbital pseudocellulitis and high-risk retinoblastoma: a study of 32 eyes. Int Ophthalmol. 2021 Aug 6.
doi: 10.1007/s10792-021-01993-w
Kaliki S., Ji X., Zou Y., Rashid R., Sultana S., Taju Sherief S., Cassoux N., Y Diaz Coronado R., Luis Garcia Leon J., López A.M.Z., Polyakov V.G., Ushakova T.L., Rani Roy S., Ahmad A., Al Harby L., Reddy M.A., Sagoo M.S., L. Berry J., Kim J., Polski A., Astbury N.J., Bascaran C., Blum S., Bowman R., Burton M.J., Foster A., Gomel N., Keren-Froim N., Madgar S., W. Stacey A., M. Steinberg D., Mohamed A., Zondervan M., Fabian I.D. Lag Time between Onset of First Symptom and Treatment of Retinoblastoma: An International Collaborative Study of 692 Patients from 10 Countries. Cancers. 2021 Apr 19;13(8):1956.
doi: 10.3390/cancers13081956.
Kaliki S., Maniar A., Kekunnaya R. Cataract surgery in treated retinoblastoma eyes: A study of 29 eyes. European journal of ophthalmology. 2020 Jun 25.
doi: 10.1177/1120672120938575
Kaliki S., Shields C.L., Cassoux N., Munier F.L., Chantada G., Grossniklaus H.E., Yoshikawa H., Fabian I.D., Berry J.L., McKenzie J.D., Kimani K., Reddy M.A., Parulekar M., Tanabe M., Furuta M., Grigorovski N., Chevez-Barrios P., Scanlan P., Eagle RC. Jr, Rashid R., Coronado R.D., Sultana S., Staffieri S., Frenkel S., Suzuki S., Ushakova T.L., Ji X. Defining High-Risk Retinoblastoma: A Multicenter Global Survey. JAMA Ophthalmol. 2021 Nov 11:e214732
doi: 10.1001/jamaophthalmol.2021.4732
Kaliki S., Shields C.L., Cassoux N., Munier F.L., Chantada G., Grossniklaus H.E., Yoshikawa H., Fabian I.D., Berry J.L., McKenzie J.D., Kimani K., Reddy M.A., Parulekar M., Tanabe M., Furuta M., Grigorovski N., Chevez-Barrios P., Scanlan P., Eagle R.C. Jr., Rashid R., Coronado R.D., Sultana S., Staffieri S., Frenkel S., Suzuki S., Ushakova T.L., Ji X. Defining High-risk Retinoblastoma: A Multicenter Global Survey. JAMA Ophthalmol. 2022 Jan 1;140(1):30-36.
doi: 10.1001/jamaophthalmol.2021.4732
Kaliki S, Vempuluru VS, Ahmad A, Berry JL, Diaz-Coronado R, Eiger-Moscovich M, Fabian ID, Grossniklaus H, Baker Hubbard G 3rd, Mohammad M, Pe'er J, Reddy MA, Sagoo MS, Shields CL, Staffieri SE, Tanabe M, Ushakova T, Yousef YA; High‐Risk Retinoblastoma Collaborative Study Group. Impact of Race on the Outcomes of Retinoblastoma Treated With Primary Enucleation: A Global Study of 1426 Patients. Clin Exp Ophthalmol. 2025 May-Jun;53(4):421-434. Epub 2024 Dec 28. PMID: 39731391; PMCID: PMC12129717.
doi: 10.1111/ceo.14488
Kaliki S., Vempuluru V.S., Bakal K.R. et al. High-Risk Histopathological Features of Retinoblastoma following Primary Enucleation: A Global Study of 1426 Patients from 5 Continents. Retina (Philadelphia, Pa.). 2024-08-16
doi: 10.1097/IAE.0000000000004250
Kaliki S, Vempuluru VS, Desai A, Ji X, Zou Y, Rashid R, Sultana S, Sherief ST, Cassoux N, Diaz Coronado RY, Garcia Leon JL, López AMZ, Polyakov VG, Ushakova TL, Yarovoy AA, Rani Roy S, Ahmad A, Al Harby L, Reddy MA, Sagoo MS, Berry JL, Kim J, Polski A, Astbury NJ, Bascaran C, Blum S, Gomel N, Bowman R, Burton MJ, Foster A, Stacey AW, Steinberg DM, Refaeli D, Zondervan M, Didi Fabian I. Lag Time Between Onset of First Symptom and Treatment ofRetinoblastoma: Outcomes at Three Years from Recruitment. Semin Ophthalmol. 2025 Apr 12:1-7. doi: 10.1080/08820538.2025.2491004. Epub ahead of print. PMID: 40219812.
Kaliki S, Vempuluru VS, Fabian ID; Global Retinoblastoma Study Group. Retinoblastoma with and without Extraocular Tumor Extension: A GlobalComparative Study of 3435 Patients. Ophthalmol Sci. 2024 Oct 30;5(2):100637. doi: 10.1016/j.xops.2024.100637. PMID: 39758129; PMCID: PMC11696820.
Kaliki S., Vempuluru V.S., Ghose N. et al. Artificial intelligence and machine learning in ocular oncology: Retinoblastoma. Indian journal of ophthalmology. 2023-02-07;71(2):424-430
doi: 10.4103/ijo.IJO_1393_22
Kaliki S., Vempuluru VS., Mohamed A. et al. Retinoblastoma in Asia: Clinical Presentation and Treatment Outcomes in 2112 Patients from 33 Countries. Ophthalmology. 2023-11-24
doi: 10.1016/j.ophtha.2023.10.015
Kaliki S., Vempuluru V.S., Priya Y., Mohamed A. Risk factors for recurrent retinoblastoma after intravenous chemotherapy. International ophthalmology. 2021 Feb 20.
doi: 10.1007/s10792-021-01759-4
Kalinaki A., Muwonge H., Balagadde-Kambugu J., Mulumba Y., Ntende J., Ssali G., Nakiyingi L., Nakanjako D., Nalukenge C., Ampaire A.M. Clinical presentation and outcomes in children with retinoblastoma managed at the Uganda Cancer Institute. J Cancer Epidemiol. 2022 Mar 8;2022:8817215. PMID: 35308301; PMCID: PMC8924608.
doi: 10.1155/2022/8817215
Kamarudin A.A., Sayuti N.H., Saad N., Razak NA.A., Esa N.M. Induction of apoptosis by Eleutherine bulbosa (Mill.) Urb. bulb extracted under optimised extraction condition on human retinoblastoma cancer cells (WERI-Rb-1). J Ethnopharmacol. 2021 Oct 21;284:114770. doi: 10.1016/j.jep.2021.114770. PMID: 34688803
Kamihara J, Schienda J, McGee RB, Friedman DN, Rednam SP, Brzezinski JJ, Kim SY, Becktell KD, Lupo PJ, Gallie BL, Greer MC, Hansford JR, Brodeur GM. Update on Retinoblastoma Predisposition and Surveillance Recommendations for Children. Clin Cancer Res. 2025 May 1;31(9):1573-1579. doi: 10.1158/1078-0432.CCR-24-3271. PMID: 39998650.
Kannan K., Jethva D., Parameswarappa D.C. et al. Electroretinographic changes in the inner and outer retinal layers before and after intravenous chemotherapy for retinoblastoma. Indian journal of ophthalmology. 2024-07-30;72(8):1168-1174
doi: 10.4103/IJO.IJO_2722_23
Kant N., Jayaraj P., Sen S. et al. Establishment of patient-derived xenografts of retinoblastoma and choroidal melanoma on the avian chorioallantoic membrane. Indian journal of ophthalmology. 2023-03-07;71(3):977-982
doi: 10.4103/ijo.IJO_1494_22
Kanukollu V.M., Tripathy K. Leukocoria. StatPearls [Internet]. 2020 Aug 16.
Karaca BÖ, Tellioğlu A. Assessment of the Quality, Reliability, and Popularity of Information About Retinoblastoma on YouTube. J Pediatr Ophthalmol Strabismus. 2025 Jan-Feb;62(1):33-38.. Epub 2024 Sep 10. PMID: 39254184.
doi: 10.3928/01913913-20240807-03
Karami Fath M., Pourbagher Benam S., Kouhi Esfahani N. et al. The functional role of circular RNAs in the pathogenesis of retinoblastoma: a new potential biomarker and therapeutic target? Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2023-03-31
doi: 10.1007/s12094-023-03144-2
Karimi S., Arabi A., Shahraki T., Ansari I., Safi S. Development of Progressive Chiari I Malformation in a Child with Unilateral Sporadic Retinoblastoma. J Curr Ophthalmol. 2021 Mar 26;33(1):88-90.
doi: 10.4103/JOCO.JOCO_166_20
Karimi S., Arabi A., Shahraki T., Safi S. Central Serous Chorioretinopathy in a Case of Regressed Familial Retinoblastoma. Journal of ophthalmic & vision research. 2020 Oct 25;15(4):559-564.
doi: 10.18502/jovr.v15i4.7802
Kasengaliev, A.M., Ermekova K.T. Analysis of improving the diagnosis and treatment of retinoblastoma in Kazakhstan // Устойчивое развитие науки и образования. 2023. No. 5(80). P. 6-9. EDN DNVBAX.
Kashyap S., Singh L., Kumar N., Singh M.K., Pushker N., Bakhshi S., Sen S., Lomi N., Meel R., Chawla B. Combined association of massive choroidal and optic nerve invasion as a prognostic relevance in primary retinoblastoma: A 10-year study. Asia-Pacific journal of clinical oncology. 2021 Apr;17(2):e100-e108.
doi: 10.1111/ajco.13348
Kassab A., Gupta I., Moustafa A.A. et al. Role of E2F transcription factor in oral cancer: Recent insight and advancements. Seminars in cancer biology. 2023-03-30;92(92):28-41
doi: 10.1016/j.semcancer.2023.03.004
Kaur K, Patel BC. Retinoblastoma. 2025 Feb 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424860.
Ke F., Li J., Wang N. et al. Clinical characterization and long-term postoperative outcomes of retinoblastoma patients receiving enucleation and primary orbital implantation in early infancy: an observational study. BMC ophthalmology. 2024-08-24;24(1):360
doi: 10.1186/s12886-024-03641-0
Ke F., Wang N., Zhang X. et al. Enhancement of vincristine sensitivity in retinoblastoma through Janus kinase inhibition by ruxolitinib. Anti-cancer drugs. 2024-07-11;35(7):615-622
doi: 10.1097/CAD.0000000000001615
Kerrouche K., Boumedane A., Guerbouz R. et al. [Fatal outcome of a trilateral retinoblastoma: Case report]. Journal francais d'ophtalmologie. 2022-12-23
doi: 10.1016/j.jfo.2022.07.015
Ketteler P., Hülsenbeck I., Frank M., Schmidt B., Jöckel K.H., Lohmann D.R. The impact of RB1 genotype on incidence of second tumours in heritable retinoblastoma. European journal of cancer. 2020 May 17.
doi: 10.1016/j.ejca.2020.04.005
Khade O.S., Sasidharan S., Jain A. et al. Identification of dysregulation of sphingolipids in retinoblastoma using liquid chromatography-mass spectrometry. Experimental eye research. 2024-03-05;240(240):109798
doi: 10.1016/j.exer.2024.109798
Khanum A., Mochi Basavaraj T., Dudeja G. Ruptured retinoblastoma: management in a rare case scenario. BMJ Case Rep. 2022 Jun 6;15(6):e248830. PMID: 35667699; PMCID: PMC9171184.
doi: 10.1136/bcr-2022-248830
Kheir W.J., Slim A., Hadi D.E. et al. Treatment outcomes in retinoblastoma and the effect of tumor topography. Pediatric blood & cancer. 2024-10-23;71(12):e31334
doi: 10.1002/pbc.31334
Khetan V., Krishnakumar S., Maitra P. et al. Lens subluxation in retinoblastoma - Where does it fit in the classification of retinoblastoma. Indian journal of ophthalmology. 2024-12-02;72(12):1837-1838
doi: 10.4103/IJO.IJO_3164_23
Khoo S.A., Ong G.Y. Use of Ocular Point-of-Care Ultrasound in a Difficult Pediatric Examination: A Case Report of an Emergency Department Diagnosis of Retinoblastoma. // The Journal of Emergency Medicine. 2020 Mar.
doi: 10.1016/j.jemermed.2020.01.006
Kiefer T., Schlüter S., Bechrakis N.E., Bornfeld N., Göricke S., Ketteler P., Ting S., Geismar D., Biewald E. Intraarterial Chemotherapy for Retinoblastoma - Initial Experiences of a German Reference Centre. Klin Monbl Augenheilkd. 2021 Jul;238(7):788-796. English, German. Epub 2021 Aug 10.
doi: 10.1055/a-1508-6194
Kiernan M., Fabian I.D., Smith V., Sagoo M.S., Reddy M.A. Strabismus as a Presenting Sign in Retinoblastoma. J Pediatr Ophthalmol Strabismus. 2021 Sep-Oct;58(5):324-330.
doi: 10.3928/01913913-20210614-03
Kim C.H., Kim M.J., Park J., Kim J., Kim J.Y., An M.J., Shin G.S., Lee H.M., Kim J.W.
Bisphenol A Exposure Changes the Transcriptomic and Proteomic Dynamics of Human Retinoblastoma Y79 Cells. Genes. 2021 Feb 11;12(2):264.
doi: 10.3390/genes12020264
Kim D.I., Lee H., Kwon S.H., Sung Y.J., Song W.K., Park S. Bilayer Hydrogel Sheet-Type Intraocular Microrobot for Drug Delivery and Magnetic Nanoparticles Retrieval. Advanced healthcare materials. 2020 May 19.
DOI: 10.1002/adhm.202000118
Kim H.A., Yoon Y.H., Kim J.G., Lee J.Y. Clinical Features and Long-term Prognosis of Retinoblastoma according to Age at Diagnosis. Korean journal of ophthalmology : KJO. 2020 Jun.
doi: 10.3341/kjo.2019.0097
Kim H.J., Di Nicola M., Augsburger J.J., Williams B.K. Successful salvage intravenous chemotherapy after tandem selective ophthalmic artery infusion chemotherapy in bilateral retinoblastoma. Indian journal of ophthalmology. 2020 Nov;68(11):2618-2620.
doi: 10.4103/ijo.IJO_576_20
Kim M.E., Xu L., Prabakar R.K., Shen L., Peng C.C., Kuhn P., Gai X., Hicks J., Berry JL. Aqueous Humor as a Liquid Biopsy for Retinoblastoma: Clear Corneal Paracentesis and Genomic Analysis. J Vis Exp. 2021 Sep 7;(175).
doi: 10.3791/62939
Kim M.E., Polski A., Xu L., Prabakar R.K., Peng C.C., Reid M.W., Shah R., Kuhn P., Cobrinik D., Hicks J., Berry J.L. Comprehensive Somatic Copy Number Analysis Using Aqueous Humor Liquid Biopsy for Retinoblastoma. Cancers (Basel). 2021 Jul 3;13(13):3340.
doi: 10.3390/cancers13133340
Kim S., Guzman S.J., Jo D.H., Cho C.S., Kim J.H. Giant Y79 retinoblastoma cells contain functionally active T-type calcium channels. Pflugers Arch. 2021 Oct;473(10):1631-1639.
doi: 10.1007/s00424-021-02612-4
Kim S, Cho CS, Jang HY, Jo DH, Kim JH. Ca<sub>V</sub>3.3 T-type calcium channels contribute to carboplatin resistance in retinoblastoma. J Biol Chem. 2025 Feb;301(2):108199. doi: 10.1016/j.jbc.2025.108199. Epub 2025 Jan 16. Erratum in: J Biol Chem. 2025 May 22;301(6):108535. PMID: 39826688; PMCID: PMC11850143.
doi: 10.1016/j.jbc.2025.108535
Kim S.H., Choi T.H., Lee Y.S. et al. Rehabilitation of severe dentofacial deformity after early radiotherapy of retinoblastoma: a case report. Journal of medical case reports. 2023-03-13;17(1):103
doi: 10.1186/s13256-023-03761-z
Kim S., Song Y.K., Cho C.S. et al. Inhibition of protein arginine deiminase II suppresses retinoblastoma in orthotopic transplantation in mice. Oncology reports. 2023-07-01;50(1)
doi: 10.3892/or.2023.8583
Kim Y.J., Park H.S., Youk J. et al. Subset of retinoblastoma tumours is associated with BRCA1/2 mutations. The British journal of ophthalmology. 2023-10-13
doi: 10.1136/bjo-2023-323388
Kim Y., Park J.W., Cho H.S. et al. Does the Clinical Presentation of Secondary Osteosarcoma in Patients Who Survive Retinoblastoma Differ From That of Conventional Osteosarcoma and How Do We Detect Them? Clinical orthopaedics and related research. 2023-05-05
doi: 10.1097/CORR.0000000000002667
Kinch K., Roberts F. et al. Primary orbital sarcoma in adults: a case series with emphasis on post-irradiation sarcoma. Orbit (Amsterdam, Netherlands). 2023-01-09:1-12.
doi: 10.1080/01676830.2022.2160766
King B.A., Sahr N., Sykes A., Wilson M.W., Brennan R.C. Chemoreduction with topotecan and vincristine: Quantifying tumor response in bilateral retinoblastoma patients. Pediatric blood & cancer. 2021 Jan 28:e28882.
doi: 10.1002/pbc.28882
King B.A., Sahr N., Sykes A., Wilson M.W., Brennan R.C. Chemoreduction with topotecan and vincristine: Quantifying tumor response in bilateral retinoblastoma patients. Pediatric blood & cancer. 2021 Apr;68(4):e28882.
doi: 10.1002/pbc.28882
King B.A., Wilson M.W., Kaluzny T. et al. Intravitreal Carboplatin as Salvage Treatment for Progressive Vitreous Disease in Retinoblastoma: a Phase I Clinical Trial. Ophthalmology. Retina. 2022-11-13
doi: 10.1016/j.oret.2022.11.003
Kiratli H., Koç I., Öztürk E., Varan A., Akyüz C. Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma. Japanese journal of ophthalmology. 2020 May 23.
doi: 10.1007/s10384-020-00743-2
Kiray G., Westcott M., Sagoo M.S. et al. Genetics versus enviromental factors in pathogenesis of retinoblastoma. International journal of hygiene and environmental health. 2023-02-21:114121
doi: 10.1016/j.ijheh.2023.114121
Kirita M, Himoto Y, Kuriyama Matsumoto Y, Kurata Y, Kido A, Yamaoka Y, Yamanoi K, Mandai M, Minamiguchi S, Nakamoto Y. A case of uterine leiomyosarcoma in a survivor of hereditary retinoblastoma. Abdom Radiol (NY). 2025 May 5. Epub ahead of print. PMID: 40323381.
doi: 10.1007/s00261-025-04943-7
doi: 10.1186/s12886-024-03641-0
Ke F., Wang N., Zhang X. et al. Enhancement of vincristine sensitivity in retinoblastoma through Janus kinase inhibition by ruxolitinib. Anti-cancer drugs. 2024-07-11;35(7):615-622
doi: 10.1097/CAD.0000000000001615
Kerrouche K., Boumedane A., Guerbouz R. et al. [Fatal outcome of a trilateral retinoblastoma: Case report]. Journal francais d'ophtalmologie. 2022-12-23
doi: 10.1016/j.jfo.2022.07.015
Ketteler P., Hülsenbeck I., Frank M., Schmidt B., Jöckel K.H., Lohmann D.R. The impact of RB1 genotype on incidence of second tumours in heritable retinoblastoma. European journal of cancer. 2020 May 17.
doi: 10.1016/j.ejca.2020.04.005
Khade O.S., Sasidharan S., Jain A. et al. Identification of dysregulation of sphingolipids in retinoblastoma using liquid chromatography-mass spectrometry. Experimental eye research. 2024-03-05;240(240):109798
doi: 10.1016/j.exer.2024.109798
Khanum A., Mochi Basavaraj T., Dudeja G. Ruptured retinoblastoma: management in a rare case scenario. BMJ Case Rep. 2022 Jun 6;15(6):e248830. PMID: 35667699; PMCID: PMC9171184.
doi: 10.1136/bcr-2022-248830
Kheir W.J., Slim A., Hadi D.E. et al. Treatment outcomes in retinoblastoma and the effect of tumor topography. Pediatric blood & cancer. 2024-10-23;71(12):e31334
doi: 10.1002/pbc.31334
Khetan V., Krishnakumar S., Maitra P. et al. Lens subluxation in retinoblastoma - Where does it fit in the classification of retinoblastoma. Indian journal of ophthalmology. 2024-12-02;72(12):1837-1838
doi: 10.4103/IJO.IJO_3164_23
Khoo S.A., Ong G.Y. Use of Ocular Point-of-Care Ultrasound in a Difficult Pediatric Examination: A Case Report of an Emergency Department Diagnosis of Retinoblastoma. // The Journal of Emergency Medicine. 2020 Mar.
doi: 10.1016/j.jemermed.2020.01.006
Kiefer T., Schlüter S., Bechrakis N.E., Bornfeld N., Göricke S., Ketteler P., Ting S., Geismar D., Biewald E. Intraarterial Chemotherapy for Retinoblastoma - Initial Experiences of a German Reference Centre. Klin Monbl Augenheilkd. 2021 Jul;238(7):788-796. English, German. Epub 2021 Aug 10.
doi: 10.1055/a-1508-6194
Kiernan M., Fabian I.D., Smith V., Sagoo M.S., Reddy M.A. Strabismus as a Presenting Sign in Retinoblastoma. J Pediatr Ophthalmol Strabismus. 2021 Sep-Oct;58(5):324-330.
doi: 10.3928/01913913-20210614-03
Kim C.H., Kim M.J., Park J., Kim J., Kim J.Y., An M.J., Shin G.S., Lee H.M., Kim J.W.
Bisphenol A Exposure Changes the Transcriptomic and Proteomic Dynamics of Human Retinoblastoma Y79 Cells. Genes. 2021 Feb 11;12(2):264.
doi: 10.3390/genes12020264
Kim D.I., Lee H., Kwon S.H., Sung Y.J., Song W.K., Park S. Bilayer Hydrogel Sheet-Type Intraocular Microrobot for Drug Delivery and Magnetic Nanoparticles Retrieval. Advanced healthcare materials. 2020 May 19.
DOI: 10.1002/adhm.202000118
Kim H.A., Yoon Y.H., Kim J.G., Lee J.Y. Clinical Features and Long-term Prognosis of Retinoblastoma according to Age at Diagnosis. Korean journal of ophthalmology : KJO. 2020 Jun.
doi: 10.3341/kjo.2019.0097
Kim H.J., Di Nicola M., Augsburger J.J., Williams B.K. Successful salvage intravenous chemotherapy after tandem selective ophthalmic artery infusion chemotherapy in bilateral retinoblastoma. Indian journal of ophthalmology. 2020 Nov;68(11):2618-2620.
doi: 10.4103/ijo.IJO_576_20
Kim M.E., Xu L., Prabakar R.K., Shen L., Peng C.C., Kuhn P., Gai X., Hicks J., Berry JL. Aqueous Humor as a Liquid Biopsy for Retinoblastoma: Clear Corneal Paracentesis and Genomic Analysis. J Vis Exp. 2021 Sep 7;(175).
doi: 10.3791/62939
Kim M.E., Polski A., Xu L., Prabakar R.K., Peng C.C., Reid M.W., Shah R., Kuhn P., Cobrinik D., Hicks J., Berry J.L. Comprehensive Somatic Copy Number Analysis Using Aqueous Humor Liquid Biopsy for Retinoblastoma. Cancers (Basel). 2021 Jul 3;13(13):3340.
doi: 10.3390/cancers13133340
Kim S., Guzman S.J., Jo D.H., Cho C.S., Kim J.H. Giant Y79 retinoblastoma cells contain functionally active T-type calcium channels. Pflugers Arch. 2021 Oct;473(10):1631-1639.
doi: 10.1007/s00424-021-02612-4
Kim S, Cho CS, Jang HY, Jo DH, Kim JH. Ca<sub>V</sub>3.3 T-type calcium channels contribute to carboplatin resistance in retinoblastoma. J Biol Chem. 2025 Feb;301(2):108199. doi: 10.1016/j.jbc.2025.108199. Epub 2025 Jan 16. Erratum in: J Biol Chem. 2025 May 22;301(6):108535. PMID: 39826688; PMCID: PMC11850143.
doi: 10.1016/j.jbc.2025.108535
Kim S.H., Choi T.H., Lee Y.S. et al. Rehabilitation of severe dentofacial deformity after early radiotherapy of retinoblastoma: a case report. Journal of medical case reports. 2023-03-13;17(1):103
doi: 10.1186/s13256-023-03761-z
Kim S., Song Y.K., Cho C.S. et al. Inhibition of protein arginine deiminase II suppresses retinoblastoma in orthotopic transplantation in mice. Oncology reports. 2023-07-01;50(1)
doi: 10.3892/or.2023.8583
Kim Y.J., Park H.S., Youk J. et al. Subset of retinoblastoma tumours is associated with BRCA1/2 mutations. The British journal of ophthalmology. 2023-10-13
doi: 10.1136/bjo-2023-323388
Kim Y., Park J.W., Cho H.S. et al. Does the Clinical Presentation of Secondary Osteosarcoma in Patients Who Survive Retinoblastoma Differ From That of Conventional Osteosarcoma and How Do We Detect Them? Clinical orthopaedics and related research. 2023-05-05
doi: 10.1097/CORR.0000000000002667
Kinch K., Roberts F. et al. Primary orbital sarcoma in adults: a case series with emphasis on post-irradiation sarcoma. Orbit (Amsterdam, Netherlands). 2023-01-09:1-12.
doi: 10.1080/01676830.2022.2160766
King B.A., Sahr N., Sykes A., Wilson M.W., Brennan R.C. Chemoreduction with topotecan and vincristine: Quantifying tumor response in bilateral retinoblastoma patients. Pediatric blood & cancer. 2021 Jan 28:e28882.
doi: 10.1002/pbc.28882
King B.A., Sahr N., Sykes A., Wilson M.W., Brennan R.C. Chemoreduction with topotecan and vincristine: Quantifying tumor response in bilateral retinoblastoma patients. Pediatric blood & cancer. 2021 Apr;68(4):e28882.
doi: 10.1002/pbc.28882
King B.A., Wilson M.W., Kaluzny T. et al. Intravitreal Carboplatin as Salvage Treatment for Progressive Vitreous Disease in Retinoblastoma: a Phase I Clinical Trial. Ophthalmology. Retina. 2022-11-13
doi: 10.1016/j.oret.2022.11.003
Kiratli H., Koç I., Öztürk E., Varan A., Akyüz C. Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma. Japanese journal of ophthalmology. 2020 May 23.
doi: 10.1007/s10384-020-00743-2
Kiray G., Westcott M., Sagoo M.S. et al. Genetics versus enviromental factors in pathogenesis of retinoblastoma. International journal of hygiene and environmental health. 2023-02-21:114121
doi: 10.1016/j.ijheh.2023.114121
Kirita M, Himoto Y, Kuriyama Matsumoto Y, Kurata Y, Kido A, Yamaoka Y, Yamanoi K, Mandai M, Minamiguchi S, Nakamoto Y. A case of uterine leiomyosarcoma in a survivor of hereditary retinoblastoma. Abdom Radiol (NY). 2025 May 5. Epub ahead of print. PMID: 40323381.
doi: 10.1007/s00261-025-04943-7
Kleinerman R.A., Schonfeld S.J., Abramson D.H., Francis J.H., Seddon J.M., Morton L.M., Tucker M.A. Increased risk of skin cancer in 1851 long-term retinoblastoma survivors. The Journal of investigative dermatology. 2021 Jun 18:S0022-202X(21)01334-8.
doi: 10.1016/j.jid.2021.05.021
Kletke S.N., Mallipatna A., Mireskandari K., Gallie B.L., Ali A. Pediatric Cataract Surgery Following Treatment for Retinoblastoma: A Case Series and Systematic Review. Am J Ophthalmol. 2022 Feb 13:S0002-9394(22)00046-0. Epub ahead of print. PMID: 35172168.
doi: 10.1016/j.ajo.2022.02.001
Kletke S.N., Soliman S., Racher H. et al. Atypical anterior retinoblastoma: diagnosis by aqueous humor cell-free DNA analysis. Ophthalmic genetics. 2022-11-03:1-4
doi: 10.1080/13816810.2022.2141800
Kobashi H., Kobayashi M. 3D-printed eye model: Simulation of intraocular pressure. PLoS One. 2023 Mar 9;18(3):e0282911. PMID: 36893149; PMCID: PMC9997944
doi: 10.1371/journal.pone.0282911
Kocharian G., Gobin Y.P., Kharas N. et al. Advancements in super-selective catheterization and drug selection for intra-arterial chemotherapy for retinoblastoma: a 15-year evolution. Journal of neurointerventional surgery. 2023-05-17.
doi: 10.1136/jnis-2023-020109
Koç İ., Taylan Şekeroğlu H., Kıratlı H., Lotfisadigh S. Management of cataracts secondary to intravitreal chemotherapy injections for retinoblastoma seeding.European journal of ophthalmology. 2021 Jun 3:11206721211023317.
doi: 10.1177/11206721211023317
Kodetová M., Švojgr K., Širc J. et al. Therapy for Vitreous Seeding Caused by Retinoblastoma. A Review. Ceska a slovenska oftalmologie: casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti. 2024-03-29;80(Ahead of print):1001-1007
doi: 10.31348/2023/35
Kolyvas P., Mir A., Stirrat T. et al. Advanced Interventional Treatments in Retinoblastoma Management: A Comprehensive Review. Cardiovascular and interventional radiology. 2024-03-21
doi: 10.1007/s00270-024-03692-2
Kong L., Sun Y., Chen M., Dai Y., Liu Z. Downregulation of microRNA-320a inhibits proliferation and induces apoptosis of retinoblastoma cells via targeting TUSC3. Experimental and therapeutic medicine. 2020 Nov;20
doi: 10.3892/etm.2020.9137
Kong M., Han Y., Zhao Y., Zhang H. miR-512-3p Overcomes Resistance to Cisplatin in Retinoblastoma by Promoting Apoptosis Induced by Endoplasmic Reticulum Stress. Medical science monitor : international medical journal of experimental and clinical research. 2020 Jul 9.
doi: 10.12659/MSM.923817
Konishi K., Kamiya M., Ohira K. et al. Impact of Radiation Dose on Treatment of Maxillary Cancer With Superselective Intra-arterial Cisplatin With Radiotherapy. Anticancer research. 2023-05-31;43(6):2859-2864
doi: 10.21873/anticanres.16455
Koochakzadeh L., Yekta A., Hashemi H. et al. Epidemiological aspect of retinoblastoma in the world: a review of recent advance studies. International journal of ophthalmology. 2023-06-20;16(6):962-968
doi: 10.18240/ijo.2023.06.20
Kothari P., Marass F., Yang J.L., Stewart C.M., Stephens D., Patel J., Hasan M., Jing X., Meng F., Enriquez J., Huberman K., Viale A., Francis J.H., Berger M.F., Shukla N., Abramson D.H., Dunkel I.J., Tsui D.W.Y. Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience. Cancer medicine. 2020 Jul 7.
doi: 10.1002/cam4.3144
Krásný J., Šach J. et al. Forms of ocular larval toxocariasis in childhood. A review. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti. 2022-11-30;2(Ahead of Print):1001-1009
doi: 10.31348/2022/28
Krishnan B., Sanidas I., Dyson N.J. et al. Seeing is believing: the impact of RB on nuclear organization. Cell cycle (Georgetown, Tex.). 2023-12-13;22(11):1357-1366
doi: 10.1080/15384101.2023.2206352
Kritfuangfoo T., Rojanaporn D. et al. Update on chemotherapy modalities for retinoblastoma: Progress and challenges. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2024-04-28;13(2):100061
doi: 10.1016/j.apjo.2024.100061
Kruger M., van Elsland S.L., Davidson A. et al. Outcome of Retinoblastoma After Implementation of National Retinoblastoma Treatment Guidelines in South Africa. JCO global oncology. 2024-08-29;10(10):e2400034
doi: 10.1200/GO.24.00034
Kruglov A.A., Laplant J.F., Dryden S.C. et al. Longitudinal Comparison of Orbital Volumes from Enucleated Eyes with Hydroxyapatite Orbital Implant in Unilateral Retinoblastoma Patients. Ophthalmic plastic and reconstructive surgery. 2023-11-15
doi: 10.1097/IOP.0000000000002558
Kubo T., Sone M., Sugawara S. et al. Technical Feasibility and Safety of Central Venous Ports for Intravenous Chemotherapy in Infants With Retinoblastoma: A Retrospective Study. Cureus. 2024-02-15;16(1):e52231
doi: 10.7759/cureus.52231
Kugalingam N., De Silva D., Abeysekera H. et al. RB1 screening of retinoblastoma patients in Sri Lanka using targeted next generation sequencing (NGS) and gene ratio analysis copy enumeration PCR (GRACE-PCR). BMC medical genomics. 2023-11-28;16(1):279
doi: 10.1186/s12920-023-01721-6
Kugalingam N., de Silva D., Abeysekera H. et al. Retinoblastoma patients treated in Sri Lanka from 2014 to 2020: epidemiology, clinical status and correlates of lag time in seeking tertiary care services. BMC ophthalmology. 2024-07-20;24(1):292
doi: 10.1186/s12886-024-03541-3
Kulbay M, Tuli N, Mazza M, Jaffer A, Juntipwong S, Marcotte E, Tanya SM, Nguyen AX, Burnier MN Jr, Demirci H. Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances. Biomedicines. 2025 Jan 6;13(1):108. PMID: 39857692; PMCID: PMC11762644.
doi: 10.3390/biomedicines13010108
Kulsh J. et al. Biochemistry-Not Oncogenes-May Demystify and Defeat Cancer. Oncology and therapy. 2023-06-16;11(2):153-169
doi: 10.1007/s40487-023-00221-y
Kumari N., Jain N., Saboo S. et al. Intra-arterial chemotherapy in refractory and advanced intraocular retinoblastoma. Indian journal of ophthalmology. 2023-02-07;71(2):436-443
doi: 10.4103/ijo.IJO_1388_22
Kumar Panigrahi D. P. Correspondence on Turkoglu EB, Erol MK, Karaca BO, Coexistence of torpedo maculopathy and retinoblastoma: Differentiation the lesions with hand held optical coherence tomography, Photodiagnosis and photodynamic therapy 34 (2021) 102331. Photodiagnosis and photodynamic therapy, 102357. 26 May. 2021.
doi:10.1016/j.pdpdt.2021.102357
Kumar P., Suganthi D., Valarmathi K. et al. A Multi-Thresholding-Based Discriminative Neural Classifier for Detection of Retinoblastoma Using CNN Models. BioMed research international. 2023-02-17;2023(2023):5803661
doi: 10.1155/2023/5803661
Kumar S.V., Kumar V., Sati A. et al. Clinicodemographic profile, management, and treatment outcomes in advanced retinoblastoma at a tertiary care center in North India. Indian journal of ophthalmology. 2023-12-18
doi: 10.4103/IJO.IJO_1849_23
Kurian DE, Kaliki S, Shields CL; High-Risk Retinoblastoma Collaborative Group. High-Risk Retinoblastoma Based on International Classification Systems: Analysis of 1362 Eyes. Ophthalmol Retina. 2025 Feb 6:S2468-6530(25)00053-3. Epub ahead of print. PMID: 39922380.
doi: 10.1016/j.oret.2025.01.020
Kruger M., van Elsland S.L., Afungchwi G.M., Bardin R., Njodzeka B., Kouya F., Nfor P., Nana P., Wharin P., Hesseling P.B. Outcome of retinoblastoma treatment protocol in Cameroon as per SIOP-PODC recommendation for a low-income setting. Pediatr Blood Cancer. 2022 Apr 11:e29642. Epub ahead of print. PMID: 35403812.
doi: 10.1002/pbc.29642
doi: 10.1016/j.jid.2021.05.021
Kletke S.N., Mallipatna A., Mireskandari K., Gallie B.L., Ali A. Pediatric Cataract Surgery Following Treatment for Retinoblastoma: A Case Series and Systematic Review. Am J Ophthalmol. 2022 Feb 13:S0002-9394(22)00046-0. Epub ahead of print. PMID: 35172168.
doi: 10.1016/j.ajo.2022.02.001
Kletke S.N., Soliman S., Racher H. et al. Atypical anterior retinoblastoma: diagnosis by aqueous humor cell-free DNA analysis. Ophthalmic genetics. 2022-11-03:1-4
doi: 10.1080/13816810.2022.2141800
Kobashi H., Kobayashi M. 3D-printed eye model: Simulation of intraocular pressure. PLoS One. 2023 Mar 9;18(3):e0282911. PMID: 36893149; PMCID: PMC9997944
doi: 10.1371/journal.pone.0282911
Kocharian G., Gobin Y.P., Kharas N. et al. Advancements in super-selective catheterization and drug selection for intra-arterial chemotherapy for retinoblastoma: a 15-year evolution. Journal of neurointerventional surgery. 2023-05-17.
doi: 10.1136/jnis-2023-020109
Koç İ., Taylan Şekeroğlu H., Kıratlı H., Lotfisadigh S. Management of cataracts secondary to intravitreal chemotherapy injections for retinoblastoma seeding.European journal of ophthalmology. 2021 Jun 3:11206721211023317.
doi: 10.1177/11206721211023317
Kodetová M., Švojgr K., Širc J. et al. Therapy for Vitreous Seeding Caused by Retinoblastoma. A Review. Ceska a slovenska oftalmologie: casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti. 2024-03-29;80(Ahead of print):1001-1007
doi: 10.31348/2023/35
Kolyvas P., Mir A., Stirrat T. et al. Advanced Interventional Treatments in Retinoblastoma Management: A Comprehensive Review. Cardiovascular and interventional radiology. 2024-03-21
doi: 10.1007/s00270-024-03692-2
Kong L., Sun Y., Chen M., Dai Y., Liu Z. Downregulation of microRNA-320a inhibits proliferation and induces apoptosis of retinoblastoma cells via targeting TUSC3. Experimental and therapeutic medicine. 2020 Nov;20
doi: 10.3892/etm.2020.9137
Kong M., Han Y., Zhao Y., Zhang H. miR-512-3p Overcomes Resistance to Cisplatin in Retinoblastoma by Promoting Apoptosis Induced by Endoplasmic Reticulum Stress. Medical science monitor : international medical journal of experimental and clinical research. 2020 Jul 9.
doi: 10.12659/MSM.923817
Konishi K., Kamiya M., Ohira K. et al. Impact of Radiation Dose on Treatment of Maxillary Cancer With Superselective Intra-arterial Cisplatin With Radiotherapy. Anticancer research. 2023-05-31;43(6):2859-2864
doi: 10.21873/anticanres.16455
Koochakzadeh L., Yekta A., Hashemi H. et al. Epidemiological aspect of retinoblastoma in the world: a review of recent advance studies. International journal of ophthalmology. 2023-06-20;16(6):962-968
doi: 10.18240/ijo.2023.06.20
Kothari P., Marass F., Yang J.L., Stewart C.M., Stephens D., Patel J., Hasan M., Jing X., Meng F., Enriquez J., Huberman K., Viale A., Francis J.H., Berger M.F., Shukla N., Abramson D.H., Dunkel I.J., Tsui D.W.Y. Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience. Cancer medicine. 2020 Jul 7.
doi: 10.1002/cam4.3144
Krásný J., Šach J. et al. Forms of ocular larval toxocariasis in childhood. A review. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti. 2022-11-30;2(Ahead of Print):1001-1009
doi: 10.31348/2022/28
Krishnan B., Sanidas I., Dyson N.J. et al. Seeing is believing: the impact of RB on nuclear organization. Cell cycle (Georgetown, Tex.). 2023-12-13;22(11):1357-1366
doi: 10.1080/15384101.2023.2206352
Kritfuangfoo T., Rojanaporn D. et al. Update on chemotherapy modalities for retinoblastoma: Progress and challenges. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2024-04-28;13(2):100061
doi: 10.1016/j.apjo.2024.100061
Kruger M., van Elsland S.L., Davidson A. et al. Outcome of Retinoblastoma After Implementation of National Retinoblastoma Treatment Guidelines in South Africa. JCO global oncology. 2024-08-29;10(10):e2400034
doi: 10.1200/GO.24.00034
Kruglov A.A., Laplant J.F., Dryden S.C. et al. Longitudinal Comparison of Orbital Volumes from Enucleated Eyes with Hydroxyapatite Orbital Implant in Unilateral Retinoblastoma Patients. Ophthalmic plastic and reconstructive surgery. 2023-11-15
doi: 10.1097/IOP.0000000000002558
Kubo T., Sone M., Sugawara S. et al. Technical Feasibility and Safety of Central Venous Ports for Intravenous Chemotherapy in Infants With Retinoblastoma: A Retrospective Study. Cureus. 2024-02-15;16(1):e52231
doi: 10.7759/cureus.52231
Kugalingam N., De Silva D., Abeysekera H. et al. RB1 screening of retinoblastoma patients in Sri Lanka using targeted next generation sequencing (NGS) and gene ratio analysis copy enumeration PCR (GRACE-PCR). BMC medical genomics. 2023-11-28;16(1):279
doi: 10.1186/s12920-023-01721-6
Kugalingam N., de Silva D., Abeysekera H. et al. Retinoblastoma patients treated in Sri Lanka from 2014 to 2020: epidemiology, clinical status and correlates of lag time in seeking tertiary care services. BMC ophthalmology. 2024-07-20;24(1):292
doi: 10.1186/s12886-024-03541-3
Kulbay M, Tuli N, Mazza M, Jaffer A, Juntipwong S, Marcotte E, Tanya SM, Nguyen AX, Burnier MN Jr, Demirci H. Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances. Biomedicines. 2025 Jan 6;13(1):108. PMID: 39857692; PMCID: PMC11762644.
doi: 10.3390/biomedicines13010108
Kulsh J. et al. Biochemistry-Not Oncogenes-May Demystify and Defeat Cancer. Oncology and therapy. 2023-06-16;11(2):153-169
doi: 10.1007/s40487-023-00221-y
Kumari N., Jain N., Saboo S. et al. Intra-arterial chemotherapy in refractory and advanced intraocular retinoblastoma. Indian journal of ophthalmology. 2023-02-07;71(2):436-443
doi: 10.4103/ijo.IJO_1388_22
Kumar Panigrahi D. P. Correspondence on Turkoglu EB, Erol MK, Karaca BO, Coexistence of torpedo maculopathy and retinoblastoma: Differentiation the lesions with hand held optical coherence tomography, Photodiagnosis and photodynamic therapy 34 (2021) 102331. Photodiagnosis and photodynamic therapy, 102357. 26 May. 2021.
doi:10.1016/j.pdpdt.2021.102357
Kumar P., Suganthi D., Valarmathi K. et al. A Multi-Thresholding-Based Discriminative Neural Classifier for Detection of Retinoblastoma Using CNN Models. BioMed research international. 2023-02-17;2023(2023):5803661
doi: 10.1155/2023/5803661
Kumar S.V., Kumar V., Sati A. et al. Clinicodemographic profile, management, and treatment outcomes in advanced retinoblastoma at a tertiary care center in North India. Indian journal of ophthalmology. 2023-12-18
doi: 10.4103/IJO.IJO_1849_23
Kurian DE, Kaliki S, Shields CL; High-Risk Retinoblastoma Collaborative Group. High-Risk Retinoblastoma Based on International Classification Systems: Analysis of 1362 Eyes. Ophthalmol Retina. 2025 Feb 6:S2468-6530(25)00053-3. Epub ahead of print. PMID: 39922380.
doi: 10.1016/j.oret.2025.01.020
Kruger M., van Elsland S.L., Afungchwi G.M., Bardin R., Njodzeka B., Kouya F., Nfor P., Nana P., Wharin P., Hesseling P.B. Outcome of retinoblastoma treatment protocol in Cameroon as per SIOP-PODC recommendation for a low-income setting. Pediatr Blood Cancer. 2022 Apr 11:e29642. Epub ahead of print. PMID: 35403812.
doi: 10.1002/pbc.29642
L
Laasri K., El Houss S., Halfi I.M. et al. Coats' syndrome: A rare cause of infant leukocoria to keep in mind. Radiology case reports. 2023-10-27;19(1):7-11
doi: 10.1016/j.radcr.2023.09.046
Ladewig M.S., Jacobsen J.O.B., Wagner A.H. et al. GA4GH Phenopackets: A Practical Introduction. Advanced genetics (Hoboken, N.J.). 2023-03-14;4(1):2200016
doi: 10.1002/ggn2.202200016
Lai Y.H., Liu W.L., Lee T.Y. et al. Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo. Phytomedicine: international journal of phytotherapy and phytopharmacology. 2023-02-01;110(110):154597
doi: 10.1016/j.phymed.2022.154597
Lal P. Role of radiotherapy in retinoblastoma. Indian J Ophthalmol. 2021 Oct;69(10):2912-2913.
doi: 10.4103/ijo.IJO_1284_21
Lam C.G. et al. Retinoblastoma as a lens for correctable disparities worldwide. The Lancet. Global health. 2022-07-25;10(8):e1074-e1075
doi: 10.1016/S2214-109X(22)00290-X
Lam M., Suh D. et al. Screening, Diagnosis, and Treatment of Pediatric Ocular Diseases. Children (Basel, Switzerland). 2022-12-25;9(12)
doi: 10.3390/children9121939
Lamiot A.K., Trone M.C., Garcin T., Pommier B., Thuret G., Gain P. [Orbital leiomyosarcoma post-irradiated hereditary retinoblastoma: A case study].
Journal français d'ophtalmologie. 2020 Dec 3:S0181-5512(20)30510-6.
doi: 10.1016/j.jfo.2020.04.046
Lan X., Xu W., Tang X., Ye H., Song X., Lin L., Ren X., Yu G., Zhang H., Wu S. Spectrum of RB1 Germline Mutations and Clinical Features in Unrelated Chinese Patients With Retinoblastoma. // Frontiers in Genetics. 2020 Mar 11
DOI: 10.3389/fgene.2020.00142
Lande K., Gupta J., Ranjan R., Kiran M., Torres Solis L.F., Solís Herrera A., Aliev G., Karnati R. Exosomes: Insights from Retinoblastoma and Other Eye Cancers. International journal of molecular sciences. 2020 Sep 25
doi: 10.3390/ijms21197055
Lando L., Mallipatna A., Kletke S.N. et al. Orbital Complications and Cost Analysis of Enucleation by Myoconjunctival versus Conventional Techniques for Retinoblastoma. Ocular oncology and pathology. 2023-12-13;9(5-6):123-129
doi: 10.1159/000531871
Laplant J.F., Kornblau I.I., King B.A., Wilson M.W. (2022). Retinoblastoma. In: Lakhoo, K., Abdelhafeez, A.H., Abib, S. (eds) Pediatric Surgical Oncology. Springer, Cham. 22.12.2022 doi.org/10.1007/978-3-030-71113-9_101-1
Larkin H.D. et al. Retinoblastoma Especially Deadly in Children in Low-Income Countries. JAMA. 2022-08-19;328(7):611
doi: 10.1001/jama.2022.1326
Larrosa C, Simao-Rafael M, Salvador N, Muñoz JP, Lavarino C, Chantada G, Mora J. Case Report: Successful treatment of metastatic retinoblastoma with CNS involvement with anti-GD2 immunotherapy, intrathecal topotecan and reduced systemic chemotherapy. Front Pediatr. 2025 Jan 17;12:1509645. PMID: 39895987; PMCID: PMC11782212.
doi: 10.3389/fped.2024.1509645
Lavasidis G., Papaioannou K., Anagnostou N. et al. Evidence in Focus: The Sparse Landscape of Randomized Trials on Retinoblastoma Treatment. Ocular oncology and pathology. 2024-05-17;10(1):53-62
doi: 10.1159/000536410
Lavasidis G., Strongylis M., Tzamalis A. et al. Safety of intravitreal chemotherapy in the management of retinoblastoma: A systematic review of the literature. Critical reviews in oncology/hematology. 2024-07-16;200(200):104423
doi: 10.1016/j.critrevonc.2024.104423
Lazari K., Papageorgiou E., Tsironi E.E., Androudi S. Late-onset retinoblastoma in a 12-year-old girl. Postgrad Med J. 2022 Feb;98(e1):e43.
doi: 10.1136/postgradmedj-2020-139531
Leahey A.M. Let's Make Retinoblastoma a Zero-Death Cancer. Ophthalmology. Retina. 2020 Jun;4
doi: 10.1016/j.oret.2020.03.016
Leahey A.M., Shah A., Shields C.L. et al. Three vs 6 Cycles of Adjuvant Chemotherapy for Retinoblastoma. JAMA ophthalmology. 2024-12-19;142(12):1107-1108
doi: 10.1001/jamaophthalmol.2024.4859
Leahey A.M., Shields C.L. Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma. Oman J Ophthalmol. 2021 Oct 20;14(3):134-135.
doi: 10.4103/ojo.OJO_241_2021
Lebrón Gutiérrez K., Balendra S., Duncan C. et al. A diagnostic dilemma: suspected retinoblastoma in a child from Sierra Leone. Eye (London, England). 2023-09-19
doi: 10.1038/s41433-023-02729-z
Leclerc R., Olin J. An Overview of Retinoblastoma and Enucleation in Pediatric Patients // AORN J. Wiley-Blackwell, 2020. Vol. 111, № 1. P. 69–79.
Lee C., Kim J.K. Genome maintenance in retinoblastoma: Implications for therapeutic vulnerabilities. Oncol Lett. 2022 Jun;23(6):192. Epub 2022 Apr 29. PMID: 35527780; PMCID: PMC9073582.
doi: 10.3892/ol.2022.13312
Lee C., Kim J.K. Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications. Journal of cellular physiology. 2021 Apr;236(4):2318-2332.
doi: 10.1002/jcp.30022
Lee D.H., Donkor R., Parvus M.N. et al. Incidence and Risk Factors for Neutropenia After Intra-Arterial Chemotherapy for Retinoblastoma. JAMA ophthalmology. 2024-01-02;141(12):1133-1138
doi: 10.1001/jamaophthalmol.2023.4825
Lee D.H., Han J.W., Hahn S.M., Kim B.M., Lyu C.J., Lee S.C., Kim D.J., Lee C.S. Changes in Treatment Patterns and Globe Salvage Rate of Advanced Retinoblastoma in Korea: Efficacy of Intra-Arterial Chemotherapy. J Clin Med. 2021 Nov 20;10(22):5421.
doi: 10.3390/jcm10225421
Lee J.S., Kim J.Y., Jung C., Woo S.J. Iatrogenic Ophthalmic Artery Occlusion and Retinal Artery Occlusion. // Progress in Retinal and Eye Research. 2020 Mar 9.
DOI: 10.1016/j.preteyeres.2020.100848
Lee Y.J., Kim J.H., Lee S.Y. et al. A comprehensive genotype-phenotype study in 203 individuals with retinoblastoma. Experimental eye research. 2024-11-04;248(248):110102
doi: 10.1016/j.exer.2024.110102
Legg L.R., Ahmed Z.U., Solano A.K. et al. Rehabilitation of pediatric retinoblastoma patients with ocular prostheses and their subsequent modifications: A 15-year retrospective study. Journal of prosthodontics : official journal of the American College of Prosthodontists. 2023-03-23
doi: 10.1111/jopr.13681
Lemaitre S, Anguita R, Sagoo MS, Reddy MA. Medusa head vasculature in retinoblastoma. J Fr Ophtalmol. 2022 Jan 4:S0181-5512(21)00610-0. Epub ahead of print.
doi: 10.1016/j.jfo.2021.06.032
Lemaître S., Lévy-Gabriel C., Pacquement H., Cassoux N. Unilateral retinoblastoma with reactive orbital inflammation: A case report. Journal français d'ophtalmologie. 2020 Dec 11:S0181-5512(20)30556-8.
doi: 10.1016/j.jfo.2020.05.020
Leonini S., Bertelli E., Bracco S., Guasti A. Thoughts on "Estimation of radiation exposure of children undergoing superselective intra-arterial chemotherapy for retinoblastoma treatment: assessment of local diagnostic reference levels as a function of age, sex, and interventional success". Neuroradiology. 2020 Oct 19.
doi: 10.1007/s00234-020-02587-6
León-Ruiz J., Espinal-Centeno A., Blilou I. et al. RETINOBLASTOMA-RELATED interactions with key factors of the RNA-directed DNA methylation (RdDM) pathway and its influence on root development. Planta. 2023-05-02;257(6):105
doi: 10.1007/s00425-023-04135-x
Lewis M., Brown A., Riemann M. et al. Doppler Ultrasound Twinkling Artifact in Retinoblastoma. Retina (Philadelphia, Pa.). 2024-08-26
doi: 10.1097/IAE.0000000000004262
Lewis M., Riemann M., Goncalves L. et al. Microflow Imaging of Fetal Retinoblastoma. Journal of pediatric ophthalmology and strabismus. 2024-05-30:1
doi: 10.3928/01913913-20240425-01
Laasri K., El Houss S., Halfi I.M. et al. Coats' syndrome: A rare cause of infant leukocoria to keep in mind. Radiology case reports. 2023-10-27;19(1):7-11
doi: 10.1016/j.radcr.2023.09.046
Ladewig M.S., Jacobsen J.O.B., Wagner A.H. et al. GA4GH Phenopackets: A Practical Introduction. Advanced genetics (Hoboken, N.J.). 2023-03-14;4(1):2200016
doi: 10.1002/ggn2.202200016
Lai Y.H., Liu W.L., Lee T.Y. et al. Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo. Phytomedicine: international journal of phytotherapy and phytopharmacology. 2023-02-01;110(110):154597
doi: 10.1016/j.phymed.2022.154597
Lal P. Role of radiotherapy in retinoblastoma. Indian J Ophthalmol. 2021 Oct;69(10):2912-2913.
doi: 10.4103/ijo.IJO_1284_21
Lam C.G. et al. Retinoblastoma as a lens for correctable disparities worldwide. The Lancet. Global health. 2022-07-25;10(8):e1074-e1075
doi: 10.1016/S2214-109X(22)00290-X
Lam M., Suh D. et al. Screening, Diagnosis, and Treatment of Pediatric Ocular Diseases. Children (Basel, Switzerland). 2022-12-25;9(12)
doi: 10.3390/children9121939
Lamiot A.K., Trone M.C., Garcin T., Pommier B., Thuret G., Gain P. [Orbital leiomyosarcoma post-irradiated hereditary retinoblastoma: A case study].
Journal français d'ophtalmologie. 2020 Dec 3:S0181-5512(20)30510-6.
doi: 10.1016/j.jfo.2020.04.046
Lan X., Xu W., Tang X., Ye H., Song X., Lin L., Ren X., Yu G., Zhang H., Wu S. Spectrum of RB1 Germline Mutations and Clinical Features in Unrelated Chinese Patients With Retinoblastoma. // Frontiers in Genetics. 2020 Mar 11
DOI: 10.3389/fgene.2020.00142
Lande K., Gupta J., Ranjan R., Kiran M., Torres Solis L.F., Solís Herrera A., Aliev G., Karnati R. Exosomes: Insights from Retinoblastoma and Other Eye Cancers. International journal of molecular sciences. 2020 Sep 25
doi: 10.3390/ijms21197055
Lando L., Mallipatna A., Kletke S.N. et al. Orbital Complications and Cost Analysis of Enucleation by Myoconjunctival versus Conventional Techniques for Retinoblastoma. Ocular oncology and pathology. 2023-12-13;9(5-6):123-129
doi: 10.1159/000531871
Laplant J.F., Kornblau I.I., King B.A., Wilson M.W. (2022). Retinoblastoma. In: Lakhoo, K., Abdelhafeez, A.H., Abib, S. (eds) Pediatric Surgical Oncology. Springer, Cham. 22.12.2022 doi.org/10.1007/978-3-030-71113-9_101-1
Larkin H.D. et al. Retinoblastoma Especially Deadly in Children in Low-Income Countries. JAMA. 2022-08-19;328(7):611
doi: 10.1001/jama.2022.1326
Larrosa C, Simao-Rafael M, Salvador N, Muñoz JP, Lavarino C, Chantada G, Mora J. Case Report: Successful treatment of metastatic retinoblastoma with CNS involvement with anti-GD2 immunotherapy, intrathecal topotecan and reduced systemic chemotherapy. Front Pediatr. 2025 Jan 17;12:1509645. PMID: 39895987; PMCID: PMC11782212.
doi: 10.3389/fped.2024.1509645
Lavasidis G., Papaioannou K., Anagnostou N. et al. Evidence in Focus: The Sparse Landscape of Randomized Trials on Retinoblastoma Treatment. Ocular oncology and pathology. 2024-05-17;10(1):53-62
doi: 10.1159/000536410
Lavasidis G., Strongylis M., Tzamalis A. et al. Safety of intravitreal chemotherapy in the management of retinoblastoma: A systematic review of the literature. Critical reviews in oncology/hematology. 2024-07-16;200(200):104423
doi: 10.1016/j.critrevonc.2024.104423
Lazari K., Papageorgiou E., Tsironi E.E., Androudi S. Late-onset retinoblastoma in a 12-year-old girl. Postgrad Med J. 2022 Feb;98(e1):e43.
doi: 10.1136/postgradmedj-2020-139531
Leahey A.M. Let's Make Retinoblastoma a Zero-Death Cancer. Ophthalmology. Retina. 2020 Jun;4
doi: 10.1016/j.oret.2020.03.016
Leahey A.M., Shah A., Shields C.L. et al. Three vs 6 Cycles of Adjuvant Chemotherapy for Retinoblastoma. JAMA ophthalmology. 2024-12-19;142(12):1107-1108
doi: 10.1001/jamaophthalmol.2024.4859
Leahey A.M., Shields C.L. Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma. Oman J Ophthalmol. 2021 Oct 20;14(3):134-135.
doi: 10.4103/ojo.OJO_241_2021
Lebrón Gutiérrez K., Balendra S., Duncan C. et al. A diagnostic dilemma: suspected retinoblastoma in a child from Sierra Leone. Eye (London, England). 2023-09-19
doi: 10.1038/s41433-023-02729-z
Leclerc R., Olin J. An Overview of Retinoblastoma and Enucleation in Pediatric Patients // AORN J. Wiley-Blackwell, 2020. Vol. 111, № 1. P. 69–79.
Lee C., Kim J.K. Genome maintenance in retinoblastoma: Implications for therapeutic vulnerabilities. Oncol Lett. 2022 Jun;23(6):192. Epub 2022 Apr 29. PMID: 35527780; PMCID: PMC9073582.
doi: 10.3892/ol.2022.13312
Lee C., Kim J.K. Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications. Journal of cellular physiology. 2021 Apr;236(4):2318-2332.
doi: 10.1002/jcp.30022
Lee D.H., Donkor R., Parvus M.N. et al. Incidence and Risk Factors for Neutropenia After Intra-Arterial Chemotherapy for Retinoblastoma. JAMA ophthalmology. 2024-01-02;141(12):1133-1138
doi: 10.1001/jamaophthalmol.2023.4825
Lee D.H., Han J.W., Hahn S.M., Kim B.M., Lyu C.J., Lee S.C., Kim D.J., Lee C.S. Changes in Treatment Patterns and Globe Salvage Rate of Advanced Retinoblastoma in Korea: Efficacy of Intra-Arterial Chemotherapy. J Clin Med. 2021 Nov 20;10(22):5421.
doi: 10.3390/jcm10225421
Lee J.S., Kim J.Y., Jung C., Woo S.J. Iatrogenic Ophthalmic Artery Occlusion and Retinal Artery Occlusion. // Progress in Retinal and Eye Research. 2020 Mar 9.
DOI: 10.1016/j.preteyeres.2020.100848
Lee Y.J., Kim J.H., Lee S.Y. et al. A comprehensive genotype-phenotype study in 203 individuals with retinoblastoma. Experimental eye research. 2024-11-04;248(248):110102
doi: 10.1016/j.exer.2024.110102
Legg L.R., Ahmed Z.U., Solano A.K. et al. Rehabilitation of pediatric retinoblastoma patients with ocular prostheses and their subsequent modifications: A 15-year retrospective study. Journal of prosthodontics : official journal of the American College of Prosthodontists. 2023-03-23
doi: 10.1111/jopr.13681
Lemaitre S, Anguita R, Sagoo MS, Reddy MA. Medusa head vasculature in retinoblastoma. J Fr Ophtalmol. 2022 Jan 4:S0181-5512(21)00610-0. Epub ahead of print.
doi: 10.1016/j.jfo.2021.06.032
Lemaître S., Lévy-Gabriel C., Pacquement H., Cassoux N. Unilateral retinoblastoma with reactive orbital inflammation: A case report. Journal français d'ophtalmologie. 2020 Dec 11:S0181-5512(20)30556-8.
doi: 10.1016/j.jfo.2020.05.020
Leonini S., Bertelli E., Bracco S., Guasti A. Thoughts on "Estimation of radiation exposure of children undergoing superselective intra-arterial chemotherapy for retinoblastoma treatment: assessment of local diagnostic reference levels as a function of age, sex, and interventional success". Neuroradiology. 2020 Oct 19.
doi: 10.1007/s00234-020-02587-6
León-Ruiz J., Espinal-Centeno A., Blilou I. et al. RETINOBLASTOMA-RELATED interactions with key factors of the RNA-directed DNA methylation (RdDM) pathway and its influence on root development. Planta. 2023-05-02;257(6):105
doi: 10.1007/s00425-023-04135-x
Lewis M., Brown A., Riemann M. et al. Doppler Ultrasound Twinkling Artifact in Retinoblastoma. Retina (Philadelphia, Pa.). 2024-08-26
doi: 10.1097/IAE.0000000000004262
Lewis M., Riemann M., Goncalves L. et al. Microflow Imaging of Fetal Retinoblastoma. Journal of pediatric ophthalmology and strabismus. 2024-05-30:1
doi: 10.3928/01913913-20240425-01
Li C., Dong K., Zhuang Y. et al. ACOT7 promotes retinoblastoma resistance to vincristine by regulating fatty acid metabolism reprogramming. Heliyon. 2024-03-12;10(5):e27156
doi: 10.1016/j.heliyon.2024.e27156
Li C., Sun S., Zhuang Y. et al. CTSB Nuclear Translocation Facilitates DNA Damage and Lysosomal Stress to Promote Retinoblastoma Cell Death. Molecular biotechnology. 2023-12-30
doi: 10.1007/s12033-023-01042-0
Li C., Zhang L., Zhang J. et al. Global, regional and national burden due to retinoblastoma in children aged younger than 10 years from 1990 to 2021. BMC medicine. 2025-01-04;22(1):604
doi: 10.1186/s12916-024-03827-9
Li C., Zhao J., Sun W. microRNA-222-Mediated VHL Downregulation Facilitates Retinoblastoma Chemoresistance by Increasing HIF1α Expression. Investigative ophthalmology & visual science. 2020 Aug 3
doi: 10.1167/iovs.61.10.9
Li F., Yin Y.K., Zhang J.T. et al. Role of circular RNAs in retinoblastoma. Functional & integrative genomics. 2022-12-26;23(1):13
doi: 10.1007/s10142-022-00942-9
Li H., Fan D., Wang W., Zhang X., Song L., Huang Y. MiR-142-5p serves as a tumor suppressor in retinoblastoma cells by regulating MYCN. Biochem Biophys Res Commun. 2021 Oct 15;574:20-26.
doi: 10.1016/j.bbrc.2021.07.099
Li H.T., Xu L., Weisenberger D.J. et al. Characterizing DNA methylation signatures of retinoblastoma using aqueous humor liquid biopsy. Nature communications. 2022-09-24;13(1):5523
doi: 10.1038/s41467-022-33248-2
Li J., Min Y. Pre-clinical evidence that salinomycin is active against retinoblastoma via inducing mitochondrial dysfunction, oxidative damage and AMPK activation. J Bioenerg Biomembr. 2021 Oct;53(5):513-523.
doi: 10.1007/s10863-021-09915-2
Li J., Jing C., Hua X., Liang T., Li J., Zhao P., Ji X. Outcome of salvage intra-arterial chemotherapy for recurrent retinoblastoma. Eye (Lond). 2021 Oct 15.
doi: 10.1038/s41433-021-01693-w
Li K., Han F., Wu Y., Wang X. miR-340 Promotes Retinoblastoma Cell Proliferation, Migration and Invasion Through Targeting WIF1. Onco Targets Ther. 2021 Jun 4;14:3635-3648.
doi: 10.2147/OTT.S302800
Li L., He T., Su Y., Wu L., Chen C. The Results of Pars Plana Vitrectomy in the Treatment of Intraocular Retinoblastoma: A Retrospective Study and Literature Review. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211048634.
doi: 10.1177/15330338211048634
Li L., Li H., Zhang J. et al. Five novel RB1 gene mutations and genotype-phenotype correlations in Chinese children with retinoblastoma. International ophthalmology. 2022-08-12
doi: 10.1007/s10792-022-02341-2
Li L., Xu B., Li C.R., Zhang M.M., Wu S.J., Dang W.J., Liu J.C., Sun S.G., Zhao W. Anti-proliferation and apoptosis-inducing effects of sodium aescinate on retinoblastoma Y79 cells. International journal of ophthalmology. 2020, Oct 18.
doi: 10.18240/ijo.2020.10.06
Li L., Yang N., Sun JH. et al. IGF2BP3-dependent N6-methyladenosine modification of USP49 promotes carboplatin resistance in retinoblastoma by enhancing autophagy via regulating the stabilization of SIRT1. The Kaohsiung journal of medical sciences. 2024-12-07;40(12):1043-1056
doi: 10.1002/kjm2.12902
Li M., Yang J., Liu K., Yang J., Zhan X., Wang L., Shen X., Chen J., Mao Z. p16 promotes proliferation in cervical carcinoma cells through CDK6-HuR-IL1A axis. J Cancer. 2020 Jan 14;11(6):1457-1467.
doi: 10.7150/jca.35479. eCollection 2020.
Li N., Wang Y.Z., Zhang Y. et al. Characteristics of patients with recurrent retinoblastoma: a survival analysis. BMC cancer. 2024-03-07;24(1):287
doi: 10.1186/s12885-024-12058-3
Li T.G., Cao H.B., Gao X.Y. et al. Prenatal Ultrasound Diagnosis of Persistent Hyperplastic Primary Vitreous with Retinoblastoma. Fetal diagnosis and therapy. 2022-09-20
doi: 10.1159/000527062
Li W., He X.D., Yang Z.T. et al. De Novo Mutations Contributes Approximately 7% of Pathogenicity in Inherited Eye Diseases. Investigative ophthalmology & visual science. 2023-02-17;64(2):5
doi: 10.1167/iovs.64.2.5
Li W, Xu K, Chen F. Gene expression study in retinoblastoma patients with different anaplasias and lateralities. Sci Rep. 2025 Mar 22;15(1):9925. PMID: 40121244; PMCID: PMC11929801.
doi: 10.1038/s41598-025-94225-5
Li X, Chang Y, Zhao X, Liu X, Zhang Y, Wang X, Li J. Global health inequities in retinoblastoma: a 1990-2021 analysis across socio-demographic index regions. Front Public Health. 2025 Feb 21;13:1513526. PMID: 40061466; PMCID: PMC11885149.
doi: 10.3389/fpubh.2025.1513526
Li X.H., Shi A.J., Li J., Yuan H.F. Plasma miR-6089 as potential diagnostic biomarker for retinoblastoma. International ophthalmology. 2021 Mar 27.
doi: 10.1007/s10792-021-01808-y
Li X., Ma B., Zhang W. et al. The essential role of N6-methyladenosine RNA methylation in complex eye diseases. Genes & diseases. 2023-05-25;10(2):505-520
doi: 10.1016/j.gendis.2022.05.008
Li X., Wang Y., Zhang B. et al. Hsa_circ_0119412 Contributes to Development of Retinoblastoma by Targeting miR-186-5p/ELK4 Axis. Molecular biotechnology. 2023-01-30
doi: 10.1007/s12033-023-00660-y
Li Y, Han M, Song D, Li J, Liu Z, Zhang X, Wang L, Guo L. Intra-arterial chemotherapy for unilateral advanced intraocular retinoblastoma: A long-term review of a case series. J Cancer Res Ther. 2025 May 1;21(2):442-446. Epub 2025 May 2. PMID: 40317150.
doi: 10.4103/jcrt.jcrt_2375_24
Li Y.P., Wang Y.T., Wang W. et al. Second hit impels oncogenesis of retinoblastoma in patient-induced pluripotent stem cell-derived retinal organoids: direct evidence for Knudson's theory. PNAS nexus. 2023-02-02;1(4):pgac162
doi: 10.1093/pnasnexus/pgac162
Li Z., Guo J., Xu X., Wei W., Xian J. MRI-based radiomics model can improve the predictive performance of postlaminar optic nerve invasion in retinoblastoma. Br J Radiol. 2021 Nov 26:20211027.
doi: 10.1259/bjr.20211027
Li Z., Guo Z., Chu D., Feng H., Zhang J., Zhu L., Li J. Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles. Drug Deliv. 2020 Dec;27(1):358-366.
doi: 10.1080/10717544.2020.1730522
Li Z., Zhang L., Liu D., Yang Z., Xuan D., Zhang Y. Knockdown of NRMT enhances sensitivity of retinoblastoma cells to cisplatin through upregulation of the CENPA/Myc/Bcl2 axis. Cell Death Discov. 2022 Jan 10;8(1):14.
doi: 10.1038/s41420-021-00622-w
Liang T., Fan M., Meng Z., Sun B., Mi S., Gao X. Circ_0000527 Drives Retinoblastoma Progression by Regulating miR-1236-3p/SMAD2 Pathway. Curr Eye Res. 2021 Dec 29:1-10.
doi: 10.1080/02713683.2021.2007535
Liang T., Zhang X., Li J., Hua X., Zhao P., Ji X. Intra-Arterial Chemotherapy as Primary Treatment for Advanced Unilateral Retinoblastoma in China. Front Med (Lausanne). 2022 Apr 7;9:855661. PMID: 35462996; PMCID: PMC9021594.
doi: 10.3389/fmed.2022.855661
Liang T.Y., Zhu X.Y., Hua X.M., Ji X.D., Zhao P.Q. Combined intra-arterial chemotherapy and intravitreal melphalan for the treatment of advanced unilateral retinoblastoma. Int J Ophthalmol. 2020 Feb 18;13(2):257-262.
doi: 10.18240/ijo.2020.02.09
Liao A., Hsieh T., Francis J.H., Lavery J.A., Mauguen A., Brodie S.E., Abramson D.H. Toxicity and efficacy of intravitreal Melphalan for retinoblastoma: 25 µg Versus 30 µg.
doi:10.1097/IAE.0000000000002782
Liao E.T., Lin H.Y., Tsai C.Y. et al. Updated retinoblastoma incidence and outcome in children in Taiwan from 1980 to 2019: a 40-year nationwide study. Eye (London, England). 2024-02-02
doi: 10.1038/s41433-024-02946-0
Liao Q, Yang J, Shi H, Mengjiang R, Li Y, Zhang Q, Wen X, Ge S, Chai P, Fan X, Jia R, Fan J. Aurora A Kinase Inhibition Is Synthetic Lethal With theActivation of MYCN in Retinoblastoma. Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):20. PMID: 39918479; PMCID: PMC11809451.
doi: 10.1167/iovs.66.2.20
Liasis A., Paez-Escamilla M., Gruszewski J. et al. Melphalan toxicity following treatment of retinoblastoma identified by pattern electroretinogram. Ophthalmic genetics. 2022-11-04:1-4
doi: 10.1080/13816810.2022.2116652
Lim H., Im M., Seo E.S. et al. Tandem High-dose Chemotherapy Increases the Risk of Secondary Malignant Neoplasm in Pediatric Solid Tumors. Cancer research and treatment. 2023-11-24
doi: 10.4143/crt.2023.999
Lima M.F., Teixeira L.F., Teruya S.B.D.M. et al. Association of Lower Age and Cardiorespiratory Events during Intra-Arterial Chemotherapy for Retinoblastoma: A Prospective Observational Study. AJNR. American journal of neuroradiology. 2023-07-26;44(7):828-832
doi: 10.3174/ajnr.A7896
Lima RV, Arruda MP, Muniz MCR, Filho HNF, Ferrerira DMR, Pereira SM. Artificial intelligence methods in diagnosis of retinoblastoma based on fundus imaging: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2025 Feb;263(2):547-553. Epub 2024 Sep 18. PMID: 39289309.
doi: 10.1007/s00417-024-06643-2
Limbu B., Kafle P.A., Lamichanne D.H. et al. Epidemiological and Clinical Presentation of Retinoblastoma among Nepalese Children in 2019. South Asian journal of cancer. 2023-11-17;12(2):199-205
doi: 10.1055/s-0042-1757581
Lin F.Y., Chintagumpala M.M. Neonatal Retinoblastoma. Clinics in perinatology. 2021 Mar;48(1):53-70.
doi: 10.1016/j.clp.2020.12.001
Lin H.Y., Ho C.H., Lin Y.S. et al. Retinoblastoma Incidence in Taiwan Over a Recent 20-Year Period: A Comprehensive Nationwide Study. International journal of general medicine. 2024-03-14;17(17):909-917
doi: 10.2147/IJGM.S452277
Lin M, Liu X, Li J, Zou H, Wang J, Yan Z, Liu Y, Lyu Y, Feng N. Hybrid NIR-responsive liposome/hydrogel platform mediating chemo-photothermal therapy of retinoblastoma enhanced by quercetin as an adjuvant. Theranostics. 2025 Mar 10;15(9):3995-4015. PMID: 40213657; PMCID: PMC11980669.
doi: 10.7150/thno.108471
Lin S.Y., Yen K.G., Zhu H., Moisiuc A., Chilakapati M. Abnormal Red Reflex: Etiologies in a Pediatric Ophthalmology Population. Clinical pediatrics. 2020 Jul
doi: 10.1177/0009922820916892.
Lin Z., Tang L., Chen S. et al. EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target. Ophthalmic research. 2024-01-02;66(1):1014-1019
doi: 10.1159/000531530
Linh D.N.H., Van Huy N., Nguyen P.D. et al. Mutation spectrum of retinoblastoma patients in Vietnam. Molecular genetics & genomic medicine. 2023-11-27;11(11):e2244
doi: 10.1002/mgg3.2244
Lisek M., Tomczak J., Swiatek J. et al. Histone Deacetylases in Retinoblastoma. International journal of molecular sciences. 2024-07-15;25(13)
doi: 10.3390/ijms25136910
Liu A., Ray A. An unusual case of late recurrence of bilateral retinoblastoma. Bone Rep. 2021 Sep 30;15:101135.
doi: 10.1016/j.bonr.2021.101135
Liu B., Abraham N., Chitsike I. et al. Enhancing information on stage at diagnosis for childhood cancer in Africa. Pediatric blood & cancer. 2023-10-07;70(10):e30555
doi: 10.1002/pbc.30555
Liu B., Gao T., Wu H.Y., Wan M. Erb-B2 receptor tyrosine kinase 2 knockdown inhibits retinoblastoma progression via Wnt/beta-catenin signaling pathway in vitro. Journal of biological regulators and homeostatic agents. 2021 Jan 22;35(1).
doi: 10.23812/20-594-L
Liu C.C., Mohmood A., Hamzah N., Lau J.H., Khaliddin N., Rahmat J. Intra-arterial chemotherapy for retinoblastoma: Our first three-and-a-half years' experience in Malaysia. PloS one. 2020 May 1.
DOI: 10.1371/journal.pone.0232249
Liu H., Gan Q., Lai Y. et al. USP14 increases the sensitivity of retinoblastoma to cisplatin by mediating the ferroptosis. Naunyn-Schmiedeberg's archives of pharmacology. 2024-11-01;397(11):8671-8680
doi: 10.1007/s00210-024-03174-9
Liu H., Hua Z. Q., Jin Z. B. Modeling human retinoblastoma using embryonic stem cell-derived retinal organoids. STAR protocols, 2(2), 100444.
doi: 10.1016/j.xpro.2021.100444
Liu H., Liu Y., Chen Y. et al. Detection of Parotid Metastasis from Retinoblastoma by Revista espanola de medicina nuclear e imagen molecular. 2022-08-10;41 Suppl 1(41 Suppl 1):S8-S9
doi: 10.1016/j.remnie.2021.03.015
Liu H., Liu Y., Chen Y., Liu H. Detection of parotid metastasis from retinoblastoma by [18F]FDG PET/CT scan. Revista española de medicina nuclear e imagen molecular. 2021 Jul 31:S2253-654X(21)00028-7. English, Spanish. PMID: 34344630.
doi: 10.1016/j.remn.2021.02.003
Liu H., Xu J., Yang Y., Wang X., Wu E., Majerciak V., Zhang T., Steenbergen R.D.M., Wang H.K., Banerjee N.S., Li Y., Lu W., Meyers C., Zhu J., Xie X., Chow L.T., Zheng Z.M. Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1. Proc Natl Acad Sci U S A. 2021 Jan 19;118(3):e2014195118.
doi: 10.1073/pnas.2014195118
Liu H., Zhang Y., Zhang Y.Y., Li Y.P., Hua Z.Q., Zhang C.J., Wu K.C., Yu F., Zhang Y., Su J., Jin Z.B. Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin. Proceedings of the National Academy of Sciences of the United States of America. 2020 Dec 29;117(52):33628-33638.
doi: 10.1073/pnas.2011780117
Liu J., Ottaviani D., Sefta M., Desbrousses C., Chapeaublanc E., Aschero R., Sirab N., Lubieniecki F., Lamas G., Tonon L., Dehainault C., Hua C., Fréneaux P., Reichman S., Karboul N., Biton A., Mirabal-Ortega L., Larcher M., Brulard C., Arrufat S., Nicolas A., Elarouci N., Popova T., Némati F., Decaudin D., Gentien D., Baulande S., Mariani O., Dufour F., Guibert S., Vallot C., Rouic L.L., Matet A., Desjardins L., Pascual-Pasto G., Suñol M., Catala-Mora J., Llano G.C., Couturier J., Barillot E., Schaiquevich P., Gauthier-Villars M., Stoppa-Lyonnet D., Golmard L., Houdayer C., Brisse H., Bernard-Pierrot I., Letouzé E., Viari A., Saule S., Sastre-Garau X., Doz F., Carcaboso A.M., Cassoux N., Pouponnot C., Goureau O., Chantada G., de Reyniès A., Aerts I., Radvanyi F. A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression. Nat Commun. 2021 Sep 22;12(1):5578.
doi: 10.1038/s41467-021-25792-0
Liu J., Xu X., Yan J. et al. Diffusion-Weighted MR Imaging of the Optic Nerve Can Improve the Detection of Post-Laminar Optic Nerve Invasion from Retinoblastoma. Journal of magnetic resonance imaging : JMRI. 2022-09-15
doi: 10.1002/jmri.28429
Liu J.C., Zhang C.L., Dong K.Y. et al. Advances in the research of plant-derived natural products against retinoblastoma. International journal of ophthalmology. 2022-08-27;15(8):1391-1400
doi: 10.18240/ijo.2022.08.24
Liu J., Zhang C., Jia B., Dong K., Li M., Qiu D., Li L., Xu B., Sun S., Li C. Panax notoginseng saponins induce apoptosis in retinoblastoma Y79 cells via the PI3K/AKT signalling pathway. Exp Eye Res. 2022 Jan 21:108954. Epub ahead of print.
doi: 10.1016/j.exer.2022.108954
Liu K., Huang J., Liu J., Klionsky D.J., Kang R., Tang D. Induction of autophagy-dependent ferroptosis to eliminate drug-tolerant human retinoblastoma cells. Cell Death Dis. 2022 Jun 2;13(6):521. PMID: 35654783; PMCID: PMC9163041.
doi: 10.1038/s41419-022-04974-8
Liu K., Li H., Wang F. et al. Ferroptosis: mechanisms and advances in ocular diseases. Molecular and cellular biochemistry. 2023-01-08
doi: 10.1007/s11010-022-04644-5
Liu L., Xiao C., Sun Q. MiRNA-375 inhibits retinoblastoma progression through targeting ERBB2 and inhibiting MAPK1/MAPK3 signalling pathway. Cutan Ocul Toxicol. 2021 Oct 29:1-10.
doi: 10.1080/15569527.2021.1994587
Liu S., Wen C. miR-141-3p promotes retinoblastoma progression via inhibiting sushi domain-containing protein 2. Bioengineered. 2022 Mar;13(3):7410-7424. PMID: 35259051.
doi: 10.1080/21655979.2022.2048770
Liu W., Luo Y., Dai J., Yang L., Huang L., Wang R., Chen W., Huang Y., Sun S., Cao J., Wu J., Han M., Fan J., He M., Qian K., Fan X., Jia R. Monitoring Retinoblastoma by Machine Learning of Aqueous Humor Metabolic Fingerprinting. Small Methods. 2022 Jan;6(1):e2101220.
doi: 10.1002/smtd.202101220
Liu X., He J., Mao L., Zhang Y., Cui W., Duan S., Jiang A., Gao Y., Sang Y., Huang G.
EPZ015666, a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an antitumour effect in retinoblastoma. Experimental eye research. 2020 Oct 6.
doi: 10.1016/j.exer.2020.108286
Liu X., Li X., Li J. Long Non-coding RNA FEZF1-AS1 Promotes Growth and Reduces Apoptosis Through Regulation of miR-363-3p/PAX6 Axis in Retinoblastoma. Biochemical genetics. 2021 Jan 11.
doi: 10.1007/s10528-020-10026-7
Liu X.M., Li X.F., Li J.C. MiR-146a functions as a potential tumor suppressor in retinoblastoma by negatively regulate neuro-oncological ventral antigen-1. The Kaohsiung journal of medical sciences. 2020 Dec 19.
doi: 10.1002/kjm2.12337
Liu X.M., Li X.F., Li J.C. MiR-146a functions as a potential tumor suppressor in retinoblastoma by negatively regulate neuro-oncological ventral antigen-1.
The Kaohsiung journal of medical sciences. 2021 Apr;37(4):286-293.
doi: 10.1002/kjm2.12337
Liu Y., Han Y., Chen S., Liu J., Wang D., Huang Y. Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma. Acta Pharm Sin B. 2022 Jun;12(6):2731-2739. Epub 2021 Oct 22. PMID: 35755292; PMCID: PMC9214327.
doi: 10.1016/j.apsb.2021.10.009
Liu Y., Hu W., Xie Y. et al. Single-cell transcriptomics enable the characterization of local extension in retinoblastoma. Communications biology. 2024-02-02;7(1):11
doi: 10.1038/s42003-023-05732-y
Liu Y., Xie H., Zhao X. et al. Automated detection of nine infantile fundus diseases and conditions in retinal images using a deep learning system. The EPMA journal. 2024-03-12;15(1):39-51
doi: 10.1007/s13167-024-00350-y
Liu Z., Huang Y., Zhang F., Tang H., Wang Y. Autophagy-related gene 7 deficiency caused by miR-154-5p overexpression suppresses the cell viability and tumorigenesis of retinoblastoma by increasing cell apoptosis. Annals of translational medicine. 2020 Nov;8(21):1451.
doi: 10.21037/atm-20-6009
doi: 10.1016/j.heliyon.2024.e27156
Li C., Sun S., Zhuang Y. et al. CTSB Nuclear Translocation Facilitates DNA Damage and Lysosomal Stress to Promote Retinoblastoma Cell Death. Molecular biotechnology. 2023-12-30
doi: 10.1007/s12033-023-01042-0
Li C., Zhang L., Zhang J. et al. Global, regional and national burden due to retinoblastoma in children aged younger than 10 years from 1990 to 2021. BMC medicine. 2025-01-04;22(1):604
doi: 10.1186/s12916-024-03827-9
Li C., Zhao J., Sun W. microRNA-222-Mediated VHL Downregulation Facilitates Retinoblastoma Chemoresistance by Increasing HIF1α Expression. Investigative ophthalmology & visual science. 2020 Aug 3
doi: 10.1167/iovs.61.10.9
Li F., Yin Y.K., Zhang J.T. et al. Role of circular RNAs in retinoblastoma. Functional & integrative genomics. 2022-12-26;23(1):13
doi: 10.1007/s10142-022-00942-9
Li H., Fan D., Wang W., Zhang X., Song L., Huang Y. MiR-142-5p serves as a tumor suppressor in retinoblastoma cells by regulating MYCN. Biochem Biophys Res Commun. 2021 Oct 15;574:20-26.
doi: 10.1016/j.bbrc.2021.07.099
Li H.T., Xu L., Weisenberger D.J. et al. Characterizing DNA methylation signatures of retinoblastoma using aqueous humor liquid biopsy. Nature communications. 2022-09-24;13(1):5523
doi: 10.1038/s41467-022-33248-2
Li J., Min Y. Pre-clinical evidence that salinomycin is active against retinoblastoma via inducing mitochondrial dysfunction, oxidative damage and AMPK activation. J Bioenerg Biomembr. 2021 Oct;53(5):513-523.
doi: 10.1007/s10863-021-09915-2
Li J., Jing C., Hua X., Liang T., Li J., Zhao P., Ji X. Outcome of salvage intra-arterial chemotherapy for recurrent retinoblastoma. Eye (Lond). 2021 Oct 15.
doi: 10.1038/s41433-021-01693-w
Li K., Han F., Wu Y., Wang X. miR-340 Promotes Retinoblastoma Cell Proliferation, Migration and Invasion Through Targeting WIF1. Onco Targets Ther. 2021 Jun 4;14:3635-3648.
doi: 10.2147/OTT.S302800
Li L., He T., Su Y., Wu L., Chen C. The Results of Pars Plana Vitrectomy in the Treatment of Intraocular Retinoblastoma: A Retrospective Study and Literature Review. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211048634.
doi: 10.1177/15330338211048634
Li L., Li H., Zhang J. et al. Five novel RB1 gene mutations and genotype-phenotype correlations in Chinese children with retinoblastoma. International ophthalmology. 2022-08-12
doi: 10.1007/s10792-022-02341-2
Li L., Xu B., Li C.R., Zhang M.M., Wu S.J., Dang W.J., Liu J.C., Sun S.G., Zhao W. Anti-proliferation and apoptosis-inducing effects of sodium aescinate on retinoblastoma Y79 cells. International journal of ophthalmology. 2020, Oct 18.
doi: 10.18240/ijo.2020.10.06
Li L., Yang N., Sun JH. et al. IGF2BP3-dependent N6-methyladenosine modification of USP49 promotes carboplatin resistance in retinoblastoma by enhancing autophagy via regulating the stabilization of SIRT1. The Kaohsiung journal of medical sciences. 2024-12-07;40(12):1043-1056
doi: 10.1002/kjm2.12902
Li M., Yang J., Liu K., Yang J., Zhan X., Wang L., Shen X., Chen J., Mao Z. p16 promotes proliferation in cervical carcinoma cells through CDK6-HuR-IL1A axis. J Cancer. 2020 Jan 14;11(6):1457-1467.
doi: 10.7150/jca.35479. eCollection 2020.
Li N., Wang Y.Z., Zhang Y. et al. Characteristics of patients with recurrent retinoblastoma: a survival analysis. BMC cancer. 2024-03-07;24(1):287
doi: 10.1186/s12885-024-12058-3
Li T.G., Cao H.B., Gao X.Y. et al. Prenatal Ultrasound Diagnosis of Persistent Hyperplastic Primary Vitreous with Retinoblastoma. Fetal diagnosis and therapy. 2022-09-20
doi: 10.1159/000527062
Li W., He X.D., Yang Z.T. et al. De Novo Mutations Contributes Approximately 7% of Pathogenicity in Inherited Eye Diseases. Investigative ophthalmology & visual science. 2023-02-17;64(2):5
doi: 10.1167/iovs.64.2.5
Li W, Xu K, Chen F. Gene expression study in retinoblastoma patients with different anaplasias and lateralities. Sci Rep. 2025 Mar 22;15(1):9925. PMID: 40121244; PMCID: PMC11929801.
doi: 10.1038/s41598-025-94225-5
Li X, Chang Y, Zhao X, Liu X, Zhang Y, Wang X, Li J. Global health inequities in retinoblastoma: a 1990-2021 analysis across socio-demographic index regions. Front Public Health. 2025 Feb 21;13:1513526. PMID: 40061466; PMCID: PMC11885149.
doi: 10.3389/fpubh.2025.1513526
Li X.H., Shi A.J., Li J., Yuan H.F. Plasma miR-6089 as potential diagnostic biomarker for retinoblastoma. International ophthalmology. 2021 Mar 27.
doi: 10.1007/s10792-021-01808-y
Li X., Ma B., Zhang W. et al. The essential role of N6-methyladenosine RNA methylation in complex eye diseases. Genes & diseases. 2023-05-25;10(2):505-520
doi: 10.1016/j.gendis.2022.05.008
Li X., Wang Y., Zhang B. et al. Hsa_circ_0119412 Contributes to Development of Retinoblastoma by Targeting miR-186-5p/ELK4 Axis. Molecular biotechnology. 2023-01-30
doi: 10.1007/s12033-023-00660-y
Li Y, Han M, Song D, Li J, Liu Z, Zhang X, Wang L, Guo L. Intra-arterial chemotherapy for unilateral advanced intraocular retinoblastoma: A long-term review of a case series. J Cancer Res Ther. 2025 May 1;21(2):442-446. Epub 2025 May 2. PMID: 40317150.
doi: 10.4103/jcrt.jcrt_2375_24
Li Y.P., Wang Y.T., Wang W. et al. Second hit impels oncogenesis of retinoblastoma in patient-induced pluripotent stem cell-derived retinal organoids: direct evidence for Knudson's theory. PNAS nexus. 2023-02-02;1(4):pgac162
doi: 10.1093/pnasnexus/pgac162
Li Z., Guo J., Xu X., Wei W., Xian J. MRI-based radiomics model can improve the predictive performance of postlaminar optic nerve invasion in retinoblastoma. Br J Radiol. 2021 Nov 26:20211027.
doi: 10.1259/bjr.20211027
Li Z., Guo Z., Chu D., Feng H., Zhang J., Zhu L., Li J. Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles. Drug Deliv. 2020 Dec;27(1):358-366.
doi: 10.1080/10717544.2020.1730522
Li Z., Zhang L., Liu D., Yang Z., Xuan D., Zhang Y. Knockdown of NRMT enhances sensitivity of retinoblastoma cells to cisplatin through upregulation of the CENPA/Myc/Bcl2 axis. Cell Death Discov. 2022 Jan 10;8(1):14.
doi: 10.1038/s41420-021-00622-w
Liang T., Fan M., Meng Z., Sun B., Mi S., Gao X. Circ_0000527 Drives Retinoblastoma Progression by Regulating miR-1236-3p/SMAD2 Pathway. Curr Eye Res. 2021 Dec 29:1-10.
doi: 10.1080/02713683.2021.2007535
Liang T., Zhang X., Li J., Hua X., Zhao P., Ji X. Intra-Arterial Chemotherapy as Primary Treatment for Advanced Unilateral Retinoblastoma in China. Front Med (Lausanne). 2022 Apr 7;9:855661. PMID: 35462996; PMCID: PMC9021594.
doi: 10.3389/fmed.2022.855661
Liang T.Y., Zhu X.Y., Hua X.M., Ji X.D., Zhao P.Q. Combined intra-arterial chemotherapy and intravitreal melphalan for the treatment of advanced unilateral retinoblastoma. Int J Ophthalmol. 2020 Feb 18;13(2):257-262.
doi: 10.18240/ijo.2020.02.09
Liao A., Hsieh T., Francis J.H., Lavery J.A., Mauguen A., Brodie S.E., Abramson D.H. Toxicity and efficacy of intravitreal Melphalan for retinoblastoma: 25 µg Versus 30 µg.
doi:10.1097/IAE.0000000000002782
Liao E.T., Lin H.Y., Tsai C.Y. et al. Updated retinoblastoma incidence and outcome in children in Taiwan from 1980 to 2019: a 40-year nationwide study. Eye (London, England). 2024-02-02
doi: 10.1038/s41433-024-02946-0
Liao Q, Yang J, Shi H, Mengjiang R, Li Y, Zhang Q, Wen X, Ge S, Chai P, Fan X, Jia R, Fan J. Aurora A Kinase Inhibition Is Synthetic Lethal With theActivation of MYCN in Retinoblastoma. Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):20. PMID: 39918479; PMCID: PMC11809451.
doi: 10.1167/iovs.66.2.20
Liasis A., Paez-Escamilla M., Gruszewski J. et al. Melphalan toxicity following treatment of retinoblastoma identified by pattern electroretinogram. Ophthalmic genetics. 2022-11-04:1-4
doi: 10.1080/13816810.2022.2116652
Lim H., Im M., Seo E.S. et al. Tandem High-dose Chemotherapy Increases the Risk of Secondary Malignant Neoplasm in Pediatric Solid Tumors. Cancer research and treatment. 2023-11-24
doi: 10.4143/crt.2023.999
Lima M.F., Teixeira L.F., Teruya S.B.D.M. et al. Association of Lower Age and Cardiorespiratory Events during Intra-Arterial Chemotherapy for Retinoblastoma: A Prospective Observational Study. AJNR. American journal of neuroradiology. 2023-07-26;44(7):828-832
doi: 10.3174/ajnr.A7896
Lima RV, Arruda MP, Muniz MCR, Filho HNF, Ferrerira DMR, Pereira SM. Artificial intelligence methods in diagnosis of retinoblastoma based on fundus imaging: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2025 Feb;263(2):547-553. Epub 2024 Sep 18. PMID: 39289309.
doi: 10.1007/s00417-024-06643-2
Limbu B., Kafle P.A., Lamichanne D.H. et al. Epidemiological and Clinical Presentation of Retinoblastoma among Nepalese Children in 2019. South Asian journal of cancer. 2023-11-17;12(2):199-205
doi: 10.1055/s-0042-1757581
Lin F.Y., Chintagumpala M.M. Neonatal Retinoblastoma. Clinics in perinatology. 2021 Mar;48(1):53-70.
doi: 10.1016/j.clp.2020.12.001
Lin H.Y., Ho C.H., Lin Y.S. et al. Retinoblastoma Incidence in Taiwan Over a Recent 20-Year Period: A Comprehensive Nationwide Study. International journal of general medicine. 2024-03-14;17(17):909-917
doi: 10.2147/IJGM.S452277
Lin M, Liu X, Li J, Zou H, Wang J, Yan Z, Liu Y, Lyu Y, Feng N. Hybrid NIR-responsive liposome/hydrogel platform mediating chemo-photothermal therapy of retinoblastoma enhanced by quercetin as an adjuvant. Theranostics. 2025 Mar 10;15(9):3995-4015. PMID: 40213657; PMCID: PMC11980669.
doi: 10.7150/thno.108471
Lin S.Y., Yen K.G., Zhu H., Moisiuc A., Chilakapati M. Abnormal Red Reflex: Etiologies in a Pediatric Ophthalmology Population. Clinical pediatrics. 2020 Jul
doi: 10.1177/0009922820916892.
Lin Z., Tang L., Chen S. et al. EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target. Ophthalmic research. 2024-01-02;66(1):1014-1019
doi: 10.1159/000531530
Linh D.N.H., Van Huy N., Nguyen P.D. et al. Mutation spectrum of retinoblastoma patients in Vietnam. Molecular genetics & genomic medicine. 2023-11-27;11(11):e2244
doi: 10.1002/mgg3.2244
Lisek M., Tomczak J., Swiatek J. et al. Histone Deacetylases in Retinoblastoma. International journal of molecular sciences. 2024-07-15;25(13)
doi: 10.3390/ijms25136910
Liu A., Ray A. An unusual case of late recurrence of bilateral retinoblastoma. Bone Rep. 2021 Sep 30;15:101135.
doi: 10.1016/j.bonr.2021.101135
Liu B., Abraham N., Chitsike I. et al. Enhancing information on stage at diagnosis for childhood cancer in Africa. Pediatric blood & cancer. 2023-10-07;70(10):e30555
doi: 10.1002/pbc.30555
Liu B., Gao T., Wu H.Y., Wan M. Erb-B2 receptor tyrosine kinase 2 knockdown inhibits retinoblastoma progression via Wnt/beta-catenin signaling pathway in vitro. Journal of biological regulators and homeostatic agents. 2021 Jan 22;35(1).
doi: 10.23812/20-594-L
Liu C.C., Mohmood A., Hamzah N., Lau J.H., Khaliddin N., Rahmat J. Intra-arterial chemotherapy for retinoblastoma: Our first three-and-a-half years' experience in Malaysia. PloS one. 2020 May 1.
DOI: 10.1371/journal.pone.0232249
Liu H., Gan Q., Lai Y. et al. USP14 increases the sensitivity of retinoblastoma to cisplatin by mediating the ferroptosis. Naunyn-Schmiedeberg's archives of pharmacology. 2024-11-01;397(11):8671-8680
doi: 10.1007/s00210-024-03174-9
Liu H., Hua Z. Q., Jin Z. B. Modeling human retinoblastoma using embryonic stem cell-derived retinal organoids. STAR protocols, 2(2), 100444.
doi: 10.1016/j.xpro.2021.100444
Liu H., Liu Y., Chen Y. et al. Detection of Parotid Metastasis from Retinoblastoma by Revista espanola de medicina nuclear e imagen molecular. 2022-08-10;41 Suppl 1(41 Suppl 1):S8-S9
doi: 10.1016/j.remnie.2021.03.015
Liu H., Liu Y., Chen Y., Liu H. Detection of parotid metastasis from retinoblastoma by [18F]FDG PET/CT scan. Revista española de medicina nuclear e imagen molecular. 2021 Jul 31:S2253-654X(21)00028-7. English, Spanish. PMID: 34344630.
doi: 10.1016/j.remn.2021.02.003
Liu H., Xu J., Yang Y., Wang X., Wu E., Majerciak V., Zhang T., Steenbergen R.D.M., Wang H.K., Banerjee N.S., Li Y., Lu W., Meyers C., Zhu J., Xie X., Chow L.T., Zheng Z.M. Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1. Proc Natl Acad Sci U S A. 2021 Jan 19;118(3):e2014195118.
doi: 10.1073/pnas.2014195118
Liu H., Zhang Y., Zhang Y.Y., Li Y.P., Hua Z.Q., Zhang C.J., Wu K.C., Yu F., Zhang Y., Su J., Jin Z.B. Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin. Proceedings of the National Academy of Sciences of the United States of America. 2020 Dec 29;117(52):33628-33638.
doi: 10.1073/pnas.2011780117
Liu J., Ottaviani D., Sefta M., Desbrousses C., Chapeaublanc E., Aschero R., Sirab N., Lubieniecki F., Lamas G., Tonon L., Dehainault C., Hua C., Fréneaux P., Reichman S., Karboul N., Biton A., Mirabal-Ortega L., Larcher M., Brulard C., Arrufat S., Nicolas A., Elarouci N., Popova T., Némati F., Decaudin D., Gentien D., Baulande S., Mariani O., Dufour F., Guibert S., Vallot C., Rouic L.L., Matet A., Desjardins L., Pascual-Pasto G., Suñol M., Catala-Mora J., Llano G.C., Couturier J., Barillot E., Schaiquevich P., Gauthier-Villars M., Stoppa-Lyonnet D., Golmard L., Houdayer C., Brisse H., Bernard-Pierrot I., Letouzé E., Viari A., Saule S., Sastre-Garau X., Doz F., Carcaboso A.M., Cassoux N., Pouponnot C., Goureau O., Chantada G., de Reyniès A., Aerts I., Radvanyi F. A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression. Nat Commun. 2021 Sep 22;12(1):5578.
doi: 10.1038/s41467-021-25792-0
Liu J., Xu X., Yan J. et al. Diffusion-Weighted MR Imaging of the Optic Nerve Can Improve the Detection of Post-Laminar Optic Nerve Invasion from Retinoblastoma. Journal of magnetic resonance imaging : JMRI. 2022-09-15
doi: 10.1002/jmri.28429
Liu J.C., Zhang C.L., Dong K.Y. et al. Advances in the research of plant-derived natural products against retinoblastoma. International journal of ophthalmology. 2022-08-27;15(8):1391-1400
doi: 10.18240/ijo.2022.08.24
Liu J., Zhang C., Jia B., Dong K., Li M., Qiu D., Li L., Xu B., Sun S., Li C. Panax notoginseng saponins induce apoptosis in retinoblastoma Y79 cells via the PI3K/AKT signalling pathway. Exp Eye Res. 2022 Jan 21:108954. Epub ahead of print.
doi: 10.1016/j.exer.2022.108954
Liu K., Huang J., Liu J., Klionsky D.J., Kang R., Tang D. Induction of autophagy-dependent ferroptosis to eliminate drug-tolerant human retinoblastoma cells. Cell Death Dis. 2022 Jun 2;13(6):521. PMID: 35654783; PMCID: PMC9163041.
doi: 10.1038/s41419-022-04974-8
Liu K., Li H., Wang F. et al. Ferroptosis: mechanisms and advances in ocular diseases. Molecular and cellular biochemistry. 2023-01-08
doi: 10.1007/s11010-022-04644-5
Liu L., Xiao C., Sun Q. MiRNA-375 inhibits retinoblastoma progression through targeting ERBB2 and inhibiting MAPK1/MAPK3 signalling pathway. Cutan Ocul Toxicol. 2021 Oct 29:1-10.
doi: 10.1080/15569527.2021.1994587
Liu S., Wen C. miR-141-3p promotes retinoblastoma progression via inhibiting sushi domain-containing protein 2. Bioengineered. 2022 Mar;13(3):7410-7424. PMID: 35259051.
doi: 10.1080/21655979.2022.2048770
Liu W., Luo Y., Dai J., Yang L., Huang L., Wang R., Chen W., Huang Y., Sun S., Cao J., Wu J., Han M., Fan J., He M., Qian K., Fan X., Jia R. Monitoring Retinoblastoma by Machine Learning of Aqueous Humor Metabolic Fingerprinting. Small Methods. 2022 Jan;6(1):e2101220.
doi: 10.1002/smtd.202101220
Liu X., He J., Mao L., Zhang Y., Cui W., Duan S., Jiang A., Gao Y., Sang Y., Huang G.
EPZ015666, a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an antitumour effect in retinoblastoma. Experimental eye research. 2020 Oct 6.
doi: 10.1016/j.exer.2020.108286
Liu X., Li X., Li J. Long Non-coding RNA FEZF1-AS1 Promotes Growth and Reduces Apoptosis Through Regulation of miR-363-3p/PAX6 Axis in Retinoblastoma. Biochemical genetics. 2021 Jan 11.
doi: 10.1007/s10528-020-10026-7
Liu X.M., Li X.F., Li J.C. MiR-146a functions as a potential tumor suppressor in retinoblastoma by negatively regulate neuro-oncological ventral antigen-1. The Kaohsiung journal of medical sciences. 2020 Dec 19.
doi: 10.1002/kjm2.12337
Liu X.M., Li X.F., Li J.C. MiR-146a functions as a potential tumor suppressor in retinoblastoma by negatively regulate neuro-oncological ventral antigen-1.
The Kaohsiung journal of medical sciences. 2021 Apr;37(4):286-293.
doi: 10.1002/kjm2.12337
Liu Y., Han Y., Chen S., Liu J., Wang D., Huang Y. Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma. Acta Pharm Sin B. 2022 Jun;12(6):2731-2739. Epub 2021 Oct 22. PMID: 35755292; PMCID: PMC9214327.
doi: 10.1016/j.apsb.2021.10.009
Liu Y., Hu W., Xie Y. et al. Single-cell transcriptomics enable the characterization of local extension in retinoblastoma. Communications biology. 2024-02-02;7(1):11
doi: 10.1038/s42003-023-05732-y
Liu Y., Xie H., Zhao X. et al. Automated detection of nine infantile fundus diseases and conditions in retinal images using a deep learning system. The EPMA journal. 2024-03-12;15(1):39-51
doi: 10.1007/s13167-024-00350-y
Liu Z., Huang Y., Zhang F., Tang H., Wang Y. Autophagy-related gene 7 deficiency caused by miR-154-5p overexpression suppresses the cell viability and tumorigenesis of retinoblastoma by increasing cell apoptosis. Annals of translational medicine. 2020 Nov;8(21):1451.
doi: 10.21037/atm-20-6009
Lo-Cao E., Crofts S., Geering K. et al. Spectrum of ocular disease in children aged between 0 and 3 years at an Australian paediatric tertiary hospital. Clinical & experimental ophthalmology. 2023-05-06
doi: 10.1111/ceo.14237
Lo Giudice G., Angelini E., Bini S, Candian T, Crudeli C, Galan A. Outcome of cataract surgery in children affected by malignancies other than retinoblastoma with eye-lens radiation exposure. Eur J Ophthalmol. 2021 Apr 10:11206721211009445.
doi: 10.1177/11206721211009445
Lohmann D.R., Gallie B.L. Retinoblastoma. 2000 Jul 18 [updated 2018 Nov 21]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. PMID: 20301625.
Long K., Yang Y., Lv W., Jiang K., Li Y., Lo ACY, Lam W.C., Zhan C., Wang W. Green Light-Triggered Intraocular Drug Release for Intravenous Chemotherapy of Retinoblastoma. Adv Sci (Weinh). 2021 Aug 27:e2101754.
doi: 10.1002/advs.202101754
López J.P., Barriga M.M., Lecea D., Parada C., Stephens G. Ophthalmology examination during well-child visits in primary care health centres: Knowledge and difficulties experienced by health workers. Archivos de la Sociedad Española de Oftalmología. 2020 Oct 13
doi: 10.1016/j.oftal.2020.05.029
Loya A., Ayaz T., Gombos D.S. et al. Association of choroidal invasion with retinoblastoma survival rates. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2023-02-02 doi: 10.1016/j.jaapos.2022.11.014
Lueder G., Galli M., Cho J.C.C. et al. Pediatric Ophthalmology Scope of Practice. Journal of binocular vision and ocular motility. 2023-04-28;73(2):53-54
doi:
Ludwiczak S., Reinhard J., Reinach P.S. et al. Joint CB1 and NGF Receptor Activation Suppresses TRPM8 Activation in Etoposide-Resistant Retinoblastoma Cells. International journal of molecular sciences. 2024-02-23;25(3)
doi: 10.3390/ijms25031733
Lukamba R.M., Budiongo A.N., Monga B.B. et al. Treatment adherence in retinoblastoma: A retro-prospective cohort study in Ivory Coast and the Democratic Republic of Congo. Cancer reports (Hoboken, N.J.). 2023-12-26:e1949
doi: 10.1002/cnr2.1949
Lumbroso-Le Rouic L., Blanc R., Saint Martin C., Savignoni A., Brisse H.J., Pierrat N., Lévy-Gabriel C., Matet A., Doz F., Aerts I., Cassoux N. Selective Ophthalmic Artery Chemotherapy with Melphalan in the Management of Unilateral Retinoblastoma: A Prospective Study. Ophthalmol Retina. 2021 Aug;5(8):e30-e37.
doi: 10.1016/j.oret.2021.05.007
Luong H., Abruzzo T., Ramasubramanian A. et al. Low Penetrance Retinoblastoma. Journal of pediatric ophthalmology and strabismus. 2023-07-25:1
doi: 10.3928/01913913-20230427-03
Luo Y., Zhou C., He F., Fan J., Wen X., Ding Y. etc. Contemporary update of retinoblastoma in China: Three-decade changes in epidemiology, clinical features, treatments and outcomes. Am J Ophthalmol. 2021 Oct 6:S0002-9394(21)00498-0.
doi: 10.1016/j.ajo.2021.09.026
Luo Y., He M., Yang J. et al. A novel MYCN-YTHDF1 cascade contributes to retinoblastoma tumor growth by eliciting m Science China. Life sciences. 2023-03-23
doi: 10.1007/s11427-022-2288-4
Luo Y., Xu M., Yang L. et al. Correlating somatic copy number alteration in aqueous humour cfDNA with chemotherapy history, eye salvage and pathological features in retinoblastoma. The British journal of ophthalmology. 2023-03-30
doi: 10.1136/bjo-2022-322866
Lu X., Tu H., Tang D., Huang X., Sun F. miR-130a-3p Enhances the Chemosensitivity of Y79 Retinoblastoma Cells to Vincristine by Targeting PAX6 Expression. Curr Eye Res. 2021 Sep 30:1-8.
doi: 10.1080/02713683.2021.1984537
Ludwiczak S., Reinhard J., Reinach P.S. et al. Joint CB1 and NGF Receptor Activation Suppresses TRPM8 Activation in Etoposide-Resistant Retinoblastoma Cells. International journal of molecular sciences. 2024-02-23;25(3)
doi: 10.3390/ijms25031733
doi: 10.1111/ceo.14237
Lo Giudice G., Angelini E., Bini S, Candian T, Crudeli C, Galan A. Outcome of cataract surgery in children affected by malignancies other than retinoblastoma with eye-lens radiation exposure. Eur J Ophthalmol. 2021 Apr 10:11206721211009445.
doi: 10.1177/11206721211009445
Lohmann D.R., Gallie B.L. Retinoblastoma. 2000 Jul 18 [updated 2018 Nov 21]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. PMID: 20301625.
Long K., Yang Y., Lv W., Jiang K., Li Y., Lo ACY, Lam W.C., Zhan C., Wang W. Green Light-Triggered Intraocular Drug Release for Intravenous Chemotherapy of Retinoblastoma. Adv Sci (Weinh). 2021 Aug 27:e2101754.
doi: 10.1002/advs.202101754
López J.P., Barriga M.M., Lecea D., Parada C., Stephens G. Ophthalmology examination during well-child visits in primary care health centres: Knowledge and difficulties experienced by health workers. Archivos de la Sociedad Española de Oftalmología. 2020 Oct 13
doi: 10.1016/j.oftal.2020.05.029
Loya A., Ayaz T., Gombos D.S. et al. Association of choroidal invasion with retinoblastoma survival rates. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2023-02-02 doi: 10.1016/j.jaapos.2022.11.014
Lueder G., Galli M., Cho J.C.C. et al. Pediatric Ophthalmology Scope of Practice. Journal of binocular vision and ocular motility. 2023-04-28;73(2):53-54
doi:
Ludwiczak S., Reinhard J., Reinach P.S. et al. Joint CB1 and NGF Receptor Activation Suppresses TRPM8 Activation in Etoposide-Resistant Retinoblastoma Cells. International journal of molecular sciences. 2024-02-23;25(3)
doi: 10.3390/ijms25031733
Lukamba R.M., Budiongo A.N., Monga B.B. et al. Treatment adherence in retinoblastoma: A retro-prospective cohort study in Ivory Coast and the Democratic Republic of Congo. Cancer reports (Hoboken, N.J.). 2023-12-26:e1949
doi: 10.1002/cnr2.1949
Lumbroso-Le Rouic L., Blanc R., Saint Martin C., Savignoni A., Brisse H.J., Pierrat N., Lévy-Gabriel C., Matet A., Doz F., Aerts I., Cassoux N. Selective Ophthalmic Artery Chemotherapy with Melphalan in the Management of Unilateral Retinoblastoma: A Prospective Study. Ophthalmol Retina. 2021 Aug;5(8):e30-e37.
doi: 10.1016/j.oret.2021.05.007
Luong H., Abruzzo T., Ramasubramanian A. et al. Low Penetrance Retinoblastoma. Journal of pediatric ophthalmology and strabismus. 2023-07-25:1
doi: 10.3928/01913913-20230427-03
Luo Y., Zhou C., He F., Fan J., Wen X., Ding Y. etc. Contemporary update of retinoblastoma in China: Three-decade changes in epidemiology, clinical features, treatments and outcomes. Am J Ophthalmol. 2021 Oct 6:S0002-9394(21)00498-0.
doi: 10.1016/j.ajo.2021.09.026
Luo Y., He M., Yang J. et al. A novel MYCN-YTHDF1 cascade contributes to retinoblastoma tumor growth by eliciting m Science China. Life sciences. 2023-03-23
doi: 10.1007/s11427-022-2288-4
Luo Y., Xu M., Yang L. et al. Correlating somatic copy number alteration in aqueous humour cfDNA with chemotherapy history, eye salvage and pathological features in retinoblastoma. The British journal of ophthalmology. 2023-03-30
doi: 10.1136/bjo-2022-322866
Lu X., Tu H., Tang D., Huang X., Sun F. miR-130a-3p Enhances the Chemosensitivity of Y79 Retinoblastoma Cells to Vincristine by Targeting PAX6 Expression. Curr Eye Res. 2021 Sep 30:1-8.
doi: 10.1080/02713683.2021.1984537
Ludwiczak S., Reinhard J., Reinach P.S. et al. Joint CB1 and NGF Receptor Activation Suppresses TRPM8 Activation in Etoposide-Resistant Retinoblastoma Cells. International journal of molecular sciences. 2024-02-23;25(3)
doi: 10.3390/ijms25031733
M
Ma H., Nie C., Chen Y., Li J., Xie Y., Tang Z., Gao Y., Ai S., Mao Y., Sun Q., Lu R. Therapeutic targeting PLK1 by ON-01910.Na is effective in local treatment of retinoblastoma. Oncology research. 2021 Feb 11.
doi: 10.3727/096504021X16130322409507
Ma X., Jin L., Lei X., Tong J., Wang R. MicroRNA‑363‑3p inhibits cell proliferation and induces apoptosis in retinoblastoma cells via the Akt/mTOR signaling pathway by targeting PIK3CA.Oncology reports. 2020 May.
DOI: 10.3892/or.2020.7544
Ma X., Li X., Sun Q. et al. Molecular Biological Research on the Pathogenic Mechanism of Retinoblastoma. Current issues in molecular biology. 2024-06-28;46(6):5307-5321
doi: 10.3390/cimb46060317
Machakuri K., Kaliki S. et al. Bilateral enucleation for retinoblastoma: A study of 14 patients. Oman journal of ophthalmology. 2022-08-09;15(2):188-192
doi: 10.4103/ojo.ojo_272_21
Macke E.L., Miller A.R., Stonerock E. et al. A LINE-1 mediated deletion resulting in germline retinoblastoma predisposition. Neuro-oncology advances. 2024-01-13;6(1):vdad163
doi: 10.1093/noajnl/vdad163
Madan R., Goyal S., Dey T. et al. Profile of 193 pediatric cancer patients managed with radiation therapy: Challenges and lessons learned. Journal of cancer research and therapeutics. 2023-11-02;19(3):757-761
doi: 10.4103/jcrt.jcrt_2034_21
Madan R., Radhakrishnan V., Meel R. et al. Management of Extraocular Retinoblastoma: ICMR Consensus Guidelines. Indian journal of pediatrics. 2024-04-19
doi: 10.1007/s12098-024-05104-2
Maddy K., Luther E., Walker A. et al. Algorithm for evaluating ophthalmic artery pseudo-occlusion during intra-arterial chemotherapy for retinoblastoma. Interventional neuroradiology: journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2023-04-18:15910199231169843
doi: 10.1177/15910199231169843
Maheshwari A., Finger P.T. et al. Palladium-103 plaque brachytherapy for retinoblastoma: Long term follow up. American journal of ophthalmology case reports. 2022-07-16;27(27):101636
doi: 10.1016/j.ajoc.2022.101636
Maimaiti A, Jia Z, Feng Y, Pan L, Li Y, Yang W, Gao H, Zhou R, Zhong S, Turhon M, Wang X, Mijiti M, Fan G, Qin H, Wang Y. Global, regional, and national burden of brain and central nervous system cancer, with a secondary analysis of retinoblastoma, 1990-2021: analysis for the Global Burden of Disease Study. World Neurosurg. 2025 Jun 27:124228. Epub ahead of print. PMID: 40582503.
doi: 10.1016/j.wneu.2025.124228
Malabanan-Cabebe C.G.P., Santos-Gonzales M.A., Te A.V.R. et al. Retinoblastoma in the Southern Philippines: Clinical Outcomes of Retinoblastoma Patients in a Davao Tertiary Hospital. Acta medica Philippina. 2024-06-08;58(6):45-51
doi: 10.47895/amp.vi0.6754
Malik F., Cooper K. et al. Anisometric Cell/Dysplastic Lipomas in a Retinoblastoma Survivor: Report of a Case with Review of the Literature. International journal of surgical pathology. 2023-03-10:10668969231157779
doi: 10.1177/10668969231157779
Maloney S.M., Williams B.K. Jr., Shields C.L. Resolution of Nystagmus Following Treatment for Retinoblastoma. JAMA Ophthalmology. 2020 Apr 1
doi: 10.1001/jamaophthalmol.2019.0382
Mandal M., Banerjee I., Mandal M. et al. Nanoparticle-mediated gene therapy as a novel strategy for the treatment of retinoblastoma. Colloids and surfaces. B, Biointerfaces. 2022-11-01;220(220):112899.
doi: 10.1016/j.colsurfb.2022.112899
Mandigo A.C., Shafi A.A., McCann J.J., Yuan W., Laufer T.S., Bogdan D., Gallagher L., Dylgjeri E., Semenova G., Vasilevskaya I.A., Schiewer M.J., McNair C., de Bono J.S., Knudsen K.E. Novel oncogenic transcription factor cooperation in RB-deficient cancer. Cancer Res. 2021 Oct 8:canres.1159.2021.
doi: 10.1158/0008-5472.CAN-21-1159
Mandigo A.C., Tomlins S.A., Kelly W.K., Knudsen K.E. Relevance of pRB Loss in Human Malignancies. Clin Cancer Res. 2021 Aug 18.
doi: 10.1158/1078-0432.CCR-21-1565
Manukonda R., Jakati S., Attem J. et al. Identifying Treatment Resistance Related Pathways by Analyzing Serum Extracellular Vesicles of Patients With Resistant Versus Regressed Retinoblastoma. Investigative ophthalmology & visual science. 2023-08-25;64(11):26
doi: 10.1167/iovs.64.11.26
Manukonda R., Narayana R.V., Kaliki S. et al. Emerging therapeutic targets for retinoblastoma. Expert opinion on therapeutic targets. 2022-12-26:1-11
doi: 10.1080/14728222.2022.2158812
Manukonda R., Pujar A., Ramappa G., Vemuganti G.K., Kaliki S. Identification of novel RB1 genetic variants in Retinoblastoma patients and their impact on clinical outcome. Ophthalmic Genet. 2021 Oct 13:1-9.
doi: 10.1080/13816810.2021.1989602
Manukonda R., Yenuganti V.R., Nagar N. et al. Comprehensive Analysis of Serum Small Extracellular Vesicles-Derived Coding and Non-Coding RNAs from Retinoblastoma Patients for Identifying Regulatory Interactions. Cancers. 2022-09-13;14(17)
doi: 10.3390/cancers14174179
Mao J., Lu M., Lu S. et al. Retinoblastoma gene expression profiling based on bioinformatics analysis. BMC medical genomics. 2023-05-16;16(1):101
doi: 10.1186/s12920-023-01537-4
Mao Y., Nie Q., Yang Y., Mao G. Identification of co‑expression modules and hub genes of retinoblastoma via co‑expression analysis and protein‑protein interaction networks. Molecular medicine reports. 2020 Aug
doi: 10.3892/mmr.2020.11189
Mao Y., Sun Y., Wu Z., Zheng J., Zhang J., Zeng J., Lee C., Kim J.K. Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapy. Cell Death Dis. 2021 Dec 9;12(12):1141.
doi: 10.1038/s41419-021-04431-y
Maradani B.S., Parameswaran S., Subramanian K. et al. Development and characterization of DNA aptamer against Retinoblastoma by Cell-SELEX. Scientific reports. 2022-09-30;12(1):16178
doi: 10.1038/s41598-022-20660-3
Marasligiller S.A., Williams B.K., Vadivelu S. et al. Ocular survival after intra-arterial chemotherapy for retinoblastoma improves with accrual of experience and programmatic evolution. Pediatric blood & cancer. 2022-11-09:e30071
doi: 10.1002/pbc.30071
Marathe P.H., Dunkel I.J., Francis J.H. et al. Biochemical measures of ovarian function in female survivors of retinoblastoma treated with intra-arterial melphalan: an initial report. Ophthalmic genetics. 2023-02-02;43(6):806-808
doi: 10.1080/13816810.2022.2132516
Marathe S., Shadambikar G., Mehraj T., Sulochana S.P., Dudhipala N., Majumdar S. Development of α-Tocopherol Succinate-Based Nanostructured Lipid Carriers for Delivery of Paclitaxel. Pharmaceutics. 2022 May 11;14(5):1034. doi: 10.3390/pharmaceutics14051034
Maricic N., Schwermer M., Schramm A. et al. Zebrafish as an Orthotopic Tumor Model for Retinoblastoma Mimicking Routes of Human Metastasis. Cancers. 2022-12-20;14(23)
doi: 10.3390/cancers14235814
Marković L., Bukovac A., Varošanec A.M. et al. Genetics in ophthalmology: molecular blueprints of retinoblastoma. Human genomics. 2023-11-21;17(1):82
doi: 10.1186/s40246-023-00529-w
Marti B, Chaouch A, Puccinelli F, Rizzi M, Lemmel E, Maeder P, Dolci M, Stathopoulos C, Munier F, Beck-Popovic M. Extra-Ocular Vascular andCardiorespiratory Events During Intra-Arterial Chemotherapy in Children With Retinoblastoma: Incidence, Predictive Risk Factors, Management, and Impact on Further Treatment. Pediatr Blood Cancer. 2025 Jul;72(7):e31724. Epub 2025 Apr 16. PMID: 40241278.
doi: 10.1002/pbc.31724
Martínez-Sánchez M., Hernandez-Monge J., Rangel M., Olivares-Illana V. Retinoblastoma: from discovery to clinical management. The FEBS journal. 27 May. 2021
doi:10.1111/febs.16035
Martínez-Sánchez M., Moctezuma-Dávila M., Hernandez-Monge J., Rangel-Charqueño M., Olivares-Illana V. Analysis of the p53 pathway in peripheral blood of retinoblastoma patients; potential biomarkers. PloS one. Jun 5.
doi: 10.1371/journal.pone.0234337
Maryam D., Wu L.M., Su Y.C., Hsu M.T., Harianto S. The journey of embracing life: Mothers' perspectives of living with their children with retinoblastoma. J Pediatr Nurs. 2022 Jun 16:S0882-5963(22)00149-X. Epub ahead of print. PMID: 35718669.
doi: 10.1016/j.pedn.2022.06.004
Masoomian B., Pefkianaki M., Ghassemi F., Riazi-Esfahani H. A New Rapidly Growing Dome-Shaped Choroidal Lesion in an Eye with Treated Retinoblastoma. Case Rep Ophthalmol Med. 2021 Jun 14;2021:6678779.
doi: 10.1155/2021/6678779
Masoomian B., Shields C.L., Esfahani HR. et al. Strabismus management in retinoblastoma survivors. BMC ophthalmology. 2024-03-16;24(1):114
doi: 10.1186/s12886-024-03379-9
Matet A., Kaspi M., Garcin T. Multimodal imaging of a unilateral large retinoma. J Fr Ophtalmol. 2022 May;45(5):e227-e230.
doi: 10.1016/j.jfo.2021.06.019
Matsuda Y., Otani Y., Yasuhara T. et al. A Case of Radiation-Induced Osteosarcoma with RB1 Gene Alteration Treated by Skull Base Surgery and Craniofacial Reconstruction. Acta medica Okayama. 2023-03-06;77(1):85-90
doi: 10.18926/AMO/64367
Mattosinho C., Moura A.T., Grigorovski N., Araújo L.H., Ferman S., Ribeiro K. Socioeconomic status and retinoblastoma survival: Experience of a tertiary cancer center in Brazil. Pediatric Blood and Cancer. 2020 Oct 22.
doi: 10.1002/pbc.28757
Ma H., Nie C., Chen Y., Li J., Xie Y., Tang Z., Gao Y., Ai S., Mao Y., Sun Q., Lu R. Therapeutic targeting PLK1 by ON-01910.Na is effective in local treatment of retinoblastoma. Oncology research. 2021 Feb 11.
doi: 10.3727/096504021X16130322409507
Ma X., Jin L., Lei X., Tong J., Wang R. MicroRNA‑363‑3p inhibits cell proliferation and induces apoptosis in retinoblastoma cells via the Akt/mTOR signaling pathway by targeting PIK3CA.Oncology reports. 2020 May.
DOI: 10.3892/or.2020.7544
Ma X., Li X., Sun Q. et al. Molecular Biological Research on the Pathogenic Mechanism of Retinoblastoma. Current issues in molecular biology. 2024-06-28;46(6):5307-5321
doi: 10.3390/cimb46060317
Machakuri K., Kaliki S. et al. Bilateral enucleation for retinoblastoma: A study of 14 patients. Oman journal of ophthalmology. 2022-08-09;15(2):188-192
doi: 10.4103/ojo.ojo_272_21
Macke E.L., Miller A.R., Stonerock E. et al. A LINE-1 mediated deletion resulting in germline retinoblastoma predisposition. Neuro-oncology advances. 2024-01-13;6(1):vdad163
doi: 10.1093/noajnl/vdad163
Madan R., Goyal S., Dey T. et al. Profile of 193 pediatric cancer patients managed with radiation therapy: Challenges and lessons learned. Journal of cancer research and therapeutics. 2023-11-02;19(3):757-761
doi: 10.4103/jcrt.jcrt_2034_21
Madan R., Radhakrishnan V., Meel R. et al. Management of Extraocular Retinoblastoma: ICMR Consensus Guidelines. Indian journal of pediatrics. 2024-04-19
doi: 10.1007/s12098-024-05104-2
Maddy K., Luther E., Walker A. et al. Algorithm for evaluating ophthalmic artery pseudo-occlusion during intra-arterial chemotherapy for retinoblastoma. Interventional neuroradiology: journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2023-04-18:15910199231169843
doi: 10.1177/15910199231169843
Maheshwari A., Finger P.T. et al. Palladium-103 plaque brachytherapy for retinoblastoma: Long term follow up. American journal of ophthalmology case reports. 2022-07-16;27(27):101636
doi: 10.1016/j.ajoc.2022.101636
Maimaiti A, Jia Z, Feng Y, Pan L, Li Y, Yang W, Gao H, Zhou R, Zhong S, Turhon M, Wang X, Mijiti M, Fan G, Qin H, Wang Y. Global, regional, and national burden of brain and central nervous system cancer, with a secondary analysis of retinoblastoma, 1990-2021: analysis for the Global Burden of Disease Study. World Neurosurg. 2025 Jun 27:124228. Epub ahead of print. PMID: 40582503.
doi: 10.1016/j.wneu.2025.124228
Malabanan-Cabebe C.G.P., Santos-Gonzales M.A., Te A.V.R. et al. Retinoblastoma in the Southern Philippines: Clinical Outcomes of Retinoblastoma Patients in a Davao Tertiary Hospital. Acta medica Philippina. 2024-06-08;58(6):45-51
doi: 10.47895/amp.vi0.6754
Malik F., Cooper K. et al. Anisometric Cell/Dysplastic Lipomas in a Retinoblastoma Survivor: Report of a Case with Review of the Literature. International journal of surgical pathology. 2023-03-10:10668969231157779
doi: 10.1177/10668969231157779
Maloney S.M., Williams B.K. Jr., Shields C.L. Resolution of Nystagmus Following Treatment for Retinoblastoma. JAMA Ophthalmology. 2020 Apr 1
doi: 10.1001/jamaophthalmol.2019.0382
Mandal M., Banerjee I., Mandal M. et al. Nanoparticle-mediated gene therapy as a novel strategy for the treatment of retinoblastoma. Colloids and surfaces. B, Biointerfaces. 2022-11-01;220(220):112899.
doi: 10.1016/j.colsurfb.2022.112899
Mandigo A.C., Shafi A.A., McCann J.J., Yuan W., Laufer T.S., Bogdan D., Gallagher L., Dylgjeri E., Semenova G., Vasilevskaya I.A., Schiewer M.J., McNair C., de Bono J.S., Knudsen K.E. Novel oncogenic transcription factor cooperation in RB-deficient cancer. Cancer Res. 2021 Oct 8:canres.1159.2021.
doi: 10.1158/0008-5472.CAN-21-1159
Mandigo A.C., Tomlins S.A., Kelly W.K., Knudsen K.E. Relevance of pRB Loss in Human Malignancies. Clin Cancer Res. 2021 Aug 18.
doi: 10.1158/1078-0432.CCR-21-1565
Manukonda R., Jakati S., Attem J. et al. Identifying Treatment Resistance Related Pathways by Analyzing Serum Extracellular Vesicles of Patients With Resistant Versus Regressed Retinoblastoma. Investigative ophthalmology & visual science. 2023-08-25;64(11):26
doi: 10.1167/iovs.64.11.26
Manukonda R., Narayana R.V., Kaliki S. et al. Emerging therapeutic targets for retinoblastoma. Expert opinion on therapeutic targets. 2022-12-26:1-11
doi: 10.1080/14728222.2022.2158812
Manukonda R., Pujar A., Ramappa G., Vemuganti G.K., Kaliki S. Identification of novel RB1 genetic variants in Retinoblastoma patients and their impact on clinical outcome. Ophthalmic Genet. 2021 Oct 13:1-9.
doi: 10.1080/13816810.2021.1989602
Manukonda R., Yenuganti V.R., Nagar N. et al. Comprehensive Analysis of Serum Small Extracellular Vesicles-Derived Coding and Non-Coding RNAs from Retinoblastoma Patients for Identifying Regulatory Interactions. Cancers. 2022-09-13;14(17)
doi: 10.3390/cancers14174179
Mao J., Lu M., Lu S. et al. Retinoblastoma gene expression profiling based on bioinformatics analysis. BMC medical genomics. 2023-05-16;16(1):101
doi: 10.1186/s12920-023-01537-4
Mao Y., Nie Q., Yang Y., Mao G. Identification of co‑expression modules and hub genes of retinoblastoma via co‑expression analysis and protein‑protein interaction networks. Molecular medicine reports. 2020 Aug
doi: 10.3892/mmr.2020.11189
Mao Y., Sun Y., Wu Z., Zheng J., Zhang J., Zeng J., Lee C., Kim J.K. Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapy. Cell Death Dis. 2021 Dec 9;12(12):1141.
doi: 10.1038/s41419-021-04431-y
Maradani B.S., Parameswaran S., Subramanian K. et al. Development and characterization of DNA aptamer against Retinoblastoma by Cell-SELEX. Scientific reports. 2022-09-30;12(1):16178
doi: 10.1038/s41598-022-20660-3
Marasligiller S.A., Williams B.K., Vadivelu S. et al. Ocular survival after intra-arterial chemotherapy for retinoblastoma improves with accrual of experience and programmatic evolution. Pediatric blood & cancer. 2022-11-09:e30071
doi: 10.1002/pbc.30071
Marathe P.H., Dunkel I.J., Francis J.H. et al. Biochemical measures of ovarian function in female survivors of retinoblastoma treated with intra-arterial melphalan: an initial report. Ophthalmic genetics. 2023-02-02;43(6):806-808
doi: 10.1080/13816810.2022.2132516
Marathe S., Shadambikar G., Mehraj T., Sulochana S.P., Dudhipala N., Majumdar S. Development of α-Tocopherol Succinate-Based Nanostructured Lipid Carriers for Delivery of Paclitaxel. Pharmaceutics. 2022 May 11;14(5):1034. doi: 10.3390/pharmaceutics14051034
Maricic N., Schwermer M., Schramm A. et al. Zebrafish as an Orthotopic Tumor Model for Retinoblastoma Mimicking Routes of Human Metastasis. Cancers. 2022-12-20;14(23)
doi: 10.3390/cancers14235814
Marković L., Bukovac A., Varošanec A.M. et al. Genetics in ophthalmology: molecular blueprints of retinoblastoma. Human genomics. 2023-11-21;17(1):82
doi: 10.1186/s40246-023-00529-w
Marti B, Chaouch A, Puccinelli F, Rizzi M, Lemmel E, Maeder P, Dolci M, Stathopoulos C, Munier F, Beck-Popovic M. Extra-Ocular Vascular andCardiorespiratory Events During Intra-Arterial Chemotherapy in Children With Retinoblastoma: Incidence, Predictive Risk Factors, Management, and Impact on Further Treatment. Pediatr Blood Cancer. 2025 Jul;72(7):e31724. Epub 2025 Apr 16. PMID: 40241278.
doi: 10.1002/pbc.31724
Martínez-Sánchez M., Hernandez-Monge J., Rangel M., Olivares-Illana V. Retinoblastoma: from discovery to clinical management. The FEBS journal. 27 May. 2021
doi:10.1111/febs.16035
Martínez-Sánchez M., Moctezuma-Dávila M., Hernandez-Monge J., Rangel-Charqueño M., Olivares-Illana V. Analysis of the p53 pathway in peripheral blood of retinoblastoma patients; potential biomarkers. PloS one. Jun 5.
doi: 10.1371/journal.pone.0234337
Maryam D., Wu L.M., Su Y.C., Hsu M.T., Harianto S. The journey of embracing life: Mothers' perspectives of living with their children with retinoblastoma. J Pediatr Nurs. 2022 Jun 16:S0882-5963(22)00149-X. Epub ahead of print. PMID: 35718669.
doi: 10.1016/j.pedn.2022.06.004
Masoomian B., Pefkianaki M., Ghassemi F., Riazi-Esfahani H. A New Rapidly Growing Dome-Shaped Choroidal Lesion in an Eye with Treated Retinoblastoma. Case Rep Ophthalmol Med. 2021 Jun 14;2021:6678779.
doi: 10.1155/2021/6678779
Masoomian B., Shields C.L., Esfahani HR. et al. Strabismus management in retinoblastoma survivors. BMC ophthalmology. 2024-03-16;24(1):114
doi: 10.1186/s12886-024-03379-9
Matet A., Kaspi M., Garcin T. Multimodal imaging of a unilateral large retinoma. J Fr Ophtalmol. 2022 May;45(5):e227-e230.
doi: 10.1016/j.jfo.2021.06.019
Matsuda Y., Otani Y., Yasuhara T. et al. A Case of Radiation-Induced Osteosarcoma with RB1 Gene Alteration Treated by Skull Base Surgery and Craniofacial Reconstruction. Acta medica Okayama. 2023-03-06;77(1):85-90
doi: 10.18926/AMO/64367
Mattosinho C., Moura A.T., Grigorovski N., Araújo L.H., Ferman S., Ribeiro K. Socioeconomic status and retinoblastoma survival: Experience of a tertiary cancer center in Brazil. Pediatric Blood and Cancer. 2020 Oct 22.
doi: 10.1002/pbc.28757
McInnis-Smith K, Abruzzo T, Riemann M, Goncalves LF, Ramasubramanian A. Utility of color Doppler imaging in patients with retinoblastoma treated by intra-arterial chemotherapy. J AAPOS. 2025 Feb;29(1):104093. Epub 2024 Dec 30. PMID: 39742953.
doi: 10.1016/j.jaapos.2024.104093
McInnis-Smith K., Chen K., Klanderman M. et al. Quantity and duration of exposure to general anesthesia for pediatric patients with retinoblastoma. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2022-10-23.
doi: 10.1016/j.jaapos.2022.07.013
Meel R., Kashyap S., Bakhshi S., Singh Bajaj M., Wadhwani M. Retinoblastoma in Children Older than 6 Years of Age. Ocul Oncol Pathol. 2020 Dec;6(6):395-404.
doi: 10.1159/000509040
Meel R., Kulkarni S., Singh L. et al. Management of Intraocular Retinoblastoma: ICMR Consensus Guidelines. Indian journal of pediatrics. 2024-04-12
doi: 10.1007/s12098-024-05095-0
Meel R., Sangwan S K., Agrawal S. et al. Tumor DNA sampling from aqueous humor in retinoblastoma - A report from South Asia. Indian journal of ophthalmology. 2024-03-08
doi: 10.4103/IJO.IJO_234_23
Mehyar M., Mosallam M., Tbakhi A., Saab A., Sultan I., Deebajah R., Jaradat I., AlJabari R., Mohammad M., Al Nawaiseh I., Al-Hussaini M., Yousef Y.A. Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome. // Hematology/Oncology and Stem Cell Therapy. 2020 Mar 23
DOI: 10.1016/j.hemonc.2020.02.006
Mejia-Rodriguez F., Flores-Aldana M.E., Quezada-Sánchez A.D., Shamah-Levy T., Villalpando S., Contreras-Manzano A., Bhatt-Carreño S., Orjuela-Grimm M. Association between Predictors of Vitamin D Serum Levels and Risk of Retinoblastoma in Children: A Case-Control Study. Nutrients. 2021 Jul 23;13(8):2510.
doi: 10.3390/nu13082510
Meller L., Jagadeesh V., Oca M. et al. Cytomegalovirus Retinitis in an Eye with Unilateral Retinoblastoma: A Case Report. Case reports in ophthalmology. 2024-07-18;15(1):483-489
doi: 10.1159/000538738
Mendes TB, Oliveira ID, Gamba FT, Lima FT, Morales BFSC, Macedo CRD, Teixeira LF, de Toledo SRC. Retinoblastoma: Molecular Evaluation of Tumor Samples, Aqueous Humor, and Peripheral Blood Using a Next-Generation Sequence Panel. Int J Mol Sci. 2025 Apr 9;26(8):3523. PMID: 40332023; PMCID: PMC12027083.
doi: 10.3390/ijms26083523
Méndez-Cruz A.R., Félix-Bermúdez G.E., Aguilar-Escobar D.V. et al. Bloodstream infection by Rhodococcus corynebacterioides in a pediatric patient diagnosed with high-risk retinoblastoma. Revista Argentina de microbiologia. 2022-08-21.
doi: 10.1016/j.ram.2022.06.001
Mendonça V., Evangelista A.C., P Matta B., M Moreira M.Â., Faria P., Lucena E., Seuánez H.N. Molecular alterations in retinoblastoma beyond RB1. Exp Eye Res. 2021 Oct;211:108753.
doi: 10.1016/j.exer.2021.108753
Mendonça V., Pereira Sena P., Evangelista Dos Santos A.C. et al. Diverse mutational spectrum in the 13q14 chromosomal region in a Brazilian cohort of retinoblastoma. Experimental eye research. 2022-09-27;224(224):109211.
doi: 10.1016/j.exer.2022.109211
Meng N., Zhao Z., Shi C., Xia L. Inhibiting the Progression of Human Retinoblastoma Cell by Downregulation of MMP-2/MMP-9 Using Short Hairpin RNAs (shRNAs) In Vitro. Journal of ophthalmology. 2020 May 13.
doi: 10.1155/2020/4912347
Meng X., Zhang Y., Hu Y., Zhong J., Jiang C., Zhang H. LncRNA CCAT1 sponges miR-218-5p to promote EMT, cellular migration and invasion of retinoblastoma by targeting MTF2. Cell Signal. 2021 Oct;86:110088.
doi: 10.1016/j.cellsig.2021.110088
Meredith D.M., Charville G.W., Fletcher C.D.M., Hornick J.L. Distantly Metastatic Retinoblastoma to Soft Tissue and Bone: A Challenging Diagnosis Highlighting the Utility of CRX. The American journal of surgical pathology. 2020 Nov 5.
doi: 10.1097/PAS.0000000000001620
Meredith D.M., Charville G.W., Fletcher C.D.M., Hornick J.L. Distantly Metastatic Retinoblastoma to Soft Tissue and Bone: A Challenging Diagnosis Highlighting the Utility of CRX. The American journal of surgical pathology. 2021 Jun 1;45(6):820-824.
doi: 10.1097/PAS.0000000000001620
Meyer D.B., Larkins M.C., Klose C. et al. Radiation-induced myofibroblastoma within the nasal sinus requiring maxillectomy and ethmoidectomy: A case report and literature review. Clinical case reports. 2023-02-02;11(1):e6546
doi: 10.1002/ccr3.6546
Millen G.C., Lawford A., Duncan C. et al. Utility of carboplatin therapeutic drug monitoring for the treatment of neonate and infant retinoblastoma patients in the United Kingdom. British journal of cancer. 2024-08-08;131(3):491-497
doi: 10.1038/s41416-024-02728-1
Min Y., Ding Y., Huang Q. et al. Cordycepin inhibited the retinoblastoma cell proliferation, migration, and invasion as well as lung metastasis via modulating c-Myc/cyclin D1 pathway. Chemical biology & drug design. 2022-10-14.
doi: 10.1111/cbdd.14150
Miracco C., Toti P., Gelmi M.C., Aversa S., Baldino G., Galluzzi P., De Francesco S., Petrelli F., Sorrentino E., Belmonte G., Galimberti D., Bracco S., Hadjistilianou T. Retinoblastoma Is Characterized by a Cold, CD8+ Cell Poor, PD-L1- Microenvironment, Which Turns Into Hot, CD8+ Cell Rich, PD-L1+ After Chemotherapy. Investigative ophthalmology & visual science. 2021 Feb 1;62(2):6.
doi: 10.1167/iovs.62.2.6
Miroschnikov N., Dräger O., Van Meenen D. et al. Tumor Suppressor Role of INPP4B in Chemoresistant Retinoblastoma. Journal of oncology. 2023-03-31;2023(2023):2270097
doi: 10.1155/2023/2270097
Mirzayev I., Gündüz A.K., Biçer Ö., Tarlan B. The Final Diagnosis: Retinoblastoma or Pseudoretinoblastoma. Journal of pediatric ophthalmology and strabismus. May-Jun 2021;58(3):161-167.
doi:10.3928/01913913-20210108-01
Mirzayev I., Gündüz A.K., Özalp Ateş F.S., Tetik D. Pseudoretinoblastoma: Distribution based on gender, age, and laterality. Eur J Ophthalmol. 2022 May 16:11206721221100627.
doi: 10.1177/11206721221100627
Mirzayev I., Gündüz A.K., Yavuz K., Şekkeli M.Z., Özalp Ateş F.S., Ünal E., Taçyıldız N. Secondary intra-arterial chemotherapy and/or intravitreal chemotherapy as salvage treatment for retinoblastoma.
European journal of ophthalmology. 2020 Sep 22
doi: 10.1177/1120672120957587
Mishra C., Tripathy K. Fundus Camera. 2023 Feb 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan.
PMID: 36256758
doi: 10.1016/j.jaapos.2024.104093
McInnis-Smith K., Chen K., Klanderman M. et al. Quantity and duration of exposure to general anesthesia for pediatric patients with retinoblastoma. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2022-10-23.
doi: 10.1016/j.jaapos.2022.07.013
Meel R., Kashyap S., Bakhshi S., Singh Bajaj M., Wadhwani M. Retinoblastoma in Children Older than 6 Years of Age. Ocul Oncol Pathol. 2020 Dec;6(6):395-404.
doi: 10.1159/000509040
Meel R., Kulkarni S., Singh L. et al. Management of Intraocular Retinoblastoma: ICMR Consensus Guidelines. Indian journal of pediatrics. 2024-04-12
doi: 10.1007/s12098-024-05095-0
Meel R., Sangwan S K., Agrawal S. et al. Tumor DNA sampling from aqueous humor in retinoblastoma - A report from South Asia. Indian journal of ophthalmology. 2024-03-08
doi: 10.4103/IJO.IJO_234_23
Mehyar M., Mosallam M., Tbakhi A., Saab A., Sultan I., Deebajah R., Jaradat I., AlJabari R., Mohammad M., Al Nawaiseh I., Al-Hussaini M., Yousef Y.A. Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome. // Hematology/Oncology and Stem Cell Therapy. 2020 Mar 23
DOI: 10.1016/j.hemonc.2020.02.006
Mejia-Rodriguez F., Flores-Aldana M.E., Quezada-Sánchez A.D., Shamah-Levy T., Villalpando S., Contreras-Manzano A., Bhatt-Carreño S., Orjuela-Grimm M. Association between Predictors of Vitamin D Serum Levels and Risk of Retinoblastoma in Children: A Case-Control Study. Nutrients. 2021 Jul 23;13(8):2510.
doi: 10.3390/nu13082510
Meller L., Jagadeesh V., Oca M. et al. Cytomegalovirus Retinitis in an Eye with Unilateral Retinoblastoma: A Case Report. Case reports in ophthalmology. 2024-07-18;15(1):483-489
doi: 10.1159/000538738
Mendes TB, Oliveira ID, Gamba FT, Lima FT, Morales BFSC, Macedo CRD, Teixeira LF, de Toledo SRC. Retinoblastoma: Molecular Evaluation of Tumor Samples, Aqueous Humor, and Peripheral Blood Using a Next-Generation Sequence Panel. Int J Mol Sci. 2025 Apr 9;26(8):3523. PMID: 40332023; PMCID: PMC12027083.
doi: 10.3390/ijms26083523
Méndez-Cruz A.R., Félix-Bermúdez G.E., Aguilar-Escobar D.V. et al. Bloodstream infection by Rhodococcus corynebacterioides in a pediatric patient diagnosed with high-risk retinoblastoma. Revista Argentina de microbiologia. 2022-08-21.
doi: 10.1016/j.ram.2022.06.001
Mendonça V., Evangelista A.C., P Matta B., M Moreira M.Â., Faria P., Lucena E., Seuánez H.N. Molecular alterations in retinoblastoma beyond RB1. Exp Eye Res. 2021 Oct;211:108753.
doi: 10.1016/j.exer.2021.108753
Mendonça V., Pereira Sena P., Evangelista Dos Santos A.C. et al. Diverse mutational spectrum in the 13q14 chromosomal region in a Brazilian cohort of retinoblastoma. Experimental eye research. 2022-09-27;224(224):109211.
doi: 10.1016/j.exer.2022.109211
Meng N., Zhao Z., Shi C., Xia L. Inhibiting the Progression of Human Retinoblastoma Cell by Downregulation of MMP-2/MMP-9 Using Short Hairpin RNAs (shRNAs) In Vitro. Journal of ophthalmology. 2020 May 13.
doi: 10.1155/2020/4912347
Meng X., Zhang Y., Hu Y., Zhong J., Jiang C., Zhang H. LncRNA CCAT1 sponges miR-218-5p to promote EMT, cellular migration and invasion of retinoblastoma by targeting MTF2. Cell Signal. 2021 Oct;86:110088.
doi: 10.1016/j.cellsig.2021.110088
Meredith D.M., Charville G.W., Fletcher C.D.M., Hornick J.L. Distantly Metastatic Retinoblastoma to Soft Tissue and Bone: A Challenging Diagnosis Highlighting the Utility of CRX. The American journal of surgical pathology. 2020 Nov 5.
doi: 10.1097/PAS.0000000000001620
Meredith D.M., Charville G.W., Fletcher C.D.M., Hornick J.L. Distantly Metastatic Retinoblastoma to Soft Tissue and Bone: A Challenging Diagnosis Highlighting the Utility of CRX. The American journal of surgical pathology. 2021 Jun 1;45(6):820-824.
doi: 10.1097/PAS.0000000000001620
Meyer D.B., Larkins M.C., Klose C. et al. Radiation-induced myofibroblastoma within the nasal sinus requiring maxillectomy and ethmoidectomy: A case report and literature review. Clinical case reports. 2023-02-02;11(1):e6546
doi: 10.1002/ccr3.6546
Millen G.C., Lawford A., Duncan C. et al. Utility of carboplatin therapeutic drug monitoring for the treatment of neonate and infant retinoblastoma patients in the United Kingdom. British journal of cancer. 2024-08-08;131(3):491-497
doi: 10.1038/s41416-024-02728-1
Min Y., Ding Y., Huang Q. et al. Cordycepin inhibited the retinoblastoma cell proliferation, migration, and invasion as well as lung metastasis via modulating c-Myc/cyclin D1 pathway. Chemical biology & drug design. 2022-10-14.
doi: 10.1111/cbdd.14150
Miracco C., Toti P., Gelmi M.C., Aversa S., Baldino G., Galluzzi P., De Francesco S., Petrelli F., Sorrentino E., Belmonte G., Galimberti D., Bracco S., Hadjistilianou T. Retinoblastoma Is Characterized by a Cold, CD8+ Cell Poor, PD-L1- Microenvironment, Which Turns Into Hot, CD8+ Cell Rich, PD-L1+ After Chemotherapy. Investigative ophthalmology & visual science. 2021 Feb 1;62(2):6.
doi: 10.1167/iovs.62.2.6
Miroschnikov N., Dräger O., Van Meenen D. et al. Tumor Suppressor Role of INPP4B in Chemoresistant Retinoblastoma. Journal of oncology. 2023-03-31;2023(2023):2270097
doi: 10.1155/2023/2270097
Mirzayev I., Gündüz A.K., Biçer Ö., Tarlan B. The Final Diagnosis: Retinoblastoma or Pseudoretinoblastoma. Journal of pediatric ophthalmology and strabismus. May-Jun 2021;58(3):161-167.
doi:10.3928/01913913-20210108-01
Mirzayev I., Gündüz A.K., Özalp Ateş F.S., Tetik D. Pseudoretinoblastoma: Distribution based on gender, age, and laterality. Eur J Ophthalmol. 2022 May 16:11206721221100627.
doi: 10.1177/11206721221100627
Mirzayev I., Gündüz A.K., Yavuz K., Şekkeli M.Z., Özalp Ateş F.S., Ünal E., Taçyıldız N. Secondary intra-arterial chemotherapy and/or intravitreal chemotherapy as salvage treatment for retinoblastoma.
European journal of ophthalmology. 2020 Sep 22
doi: 10.1177/1120672120957587
Mishra C., Tripathy K. Fundus Camera. 2023 Feb 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan.
PMID: 36256758
Mndeme F.G., Mmbaga B.T, Kim M.J., Sinke L., Allen L., Mgaya E., Bastawrous A., MacLeod D., Burton M.J., Gilbert C., Bowman R. Red reflex examination in reproductive and child health clinics for early detection of paediatric cataract and ocular media disorders: cross-sectional diagnostic accuracy and feasibility studies from Kilimanjaro, Tanzania. Eye. 2020 Jun 16
doi: 10.1038/s41433-020-1019-5
Mohammad M., Mehyar M., Halalsheh H. et al. The Impact of Tumor Laterality (Unilateral vs. Bilateral) on Presentation and Management Outcome in Patients with Retinoblastoma. Journal of clinical medicine. 2024-04-25;13(7)
doi: 10.3390/jcm13072146
Mohammad M., Shehada R., Al-Nawaiseh I. et al. A comparison of high risk pathological features between primary and secondary enucleation for retinoblastoma. European journal of ophthalmology. 2023-02-10:11206721231155671
doi: 10.1177/11206721231155671
Mohan S., Subramanian K., Khetan V. et al. Retinoblastoma tumour cells in central retinal vessels. Indian journal of ophthalmology. 2022-09-27;70(7):2773
doi: 10.4103/ijo.IJO_1350_21
Mohanan A., Meel R., Venkatesh P., Kashyap S. Retinal tumour outcome with IVC in retinoblastoma. Eye. 2020 Jul 14
doi: 10.1038/s41433-020-1076-9
Mohren L., Doege A., Miroschnikov N. et al. Role of Protein Tyrosine Phosphatase Receptor Type E (PTPRE) in Chemoresistant Retinoblastoma. International journal of molecular sciences. 2024-05-21;25(8)
doi: 10.3390/ijms25084572
Moin M., Malik T.G., Siddiq L. et al. Clinical Patterns And Outcomes Of Retinoblastoma In A Tertiary Care Centre Of A Developing Country. JPMA. The Journal of the Pakistan Medical Association. 2023-11-01;73(9):1881-1883
doi: 10.47391/JPMA.7689
Mokánszki A., Chang Chien Y.C., Mótyán J.A., Juhász P., Bádon E.S., Madar L., Szegedi I., Kiss C., Méhes G. Novel RB1 and MET Gene Mutations in a Case with Bilateral Retinoblastoma Followed by Multiple Metastatic Osteosarcoma. Diagnostics. 2020 Dec 25;11(1):E28.
doi: 10.3390/diagnostics11010028
Mollick T., Darekar S., Dalarun B. et al. Retinoblastoma vulnerability to combined de novo and salvage pyrimidine ribonucleotide synthesis pharmacologic blockage. Heliyon. 2024-02-10;10(1):e23831
doi: 10.1016/j.heliyon.2023.e23831
Monroe E.J., Chick J.F.B., Stacey A.W., Millard N.E., Geyer J.R., Ramoso L.R., Ghodke B.V., Hallam D.K. Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecutive pediatric interventions using five distinct protocols.Pediatric radiology. 2020 Nov 24.
doi: 10.1007/s00247-020-04892-x
Monroe E.J., Chick J.F.B., Stacey A.W., Millard N.E., Geyer J.R., Ramoso L.R., Ghodke B.V., Hallam D.K. Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecutive pediatric interventions using five distinct protocols. Pediatric radiology. 2021 Apr;51(4):649-657.
doi: 10.1007/s00247-020-04892-x
Moolsuwan K., Permpoon T., Sae-Lee C. et al. Dopachrome tautomerase is a retinoblastoma-specific gene, and its proximal promoter is preferentially active in human retinoblastoma cells. Molecular vision. 2022-10-31;28(28):192-202
Moothedath A.W., Chopra K.K., Seth R. et al. Role of 18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Predicting Residual Disease Posttreatment Completion in Retinoblastoma Patients. Indian journal of nuclear medicine: IJNM : the official journal of the Society of Nuclear Medicine, India. 2022-08-20;37(2):142-146.
doi: 10.4103/ijnm.ijnm_145_21
Moradi S., Mokhtari-Dizaji M., Ghassemi F., Sheibani S., Asadi Amoli F. Increasing the efficiency of the retinoblastoma brachytherapy protocol with ultrasonic hyperthermia and gold nanoparticles: A rabbit model. International journal of radiation biology. 2020 Oct 19:1-34.
Moradi S., Mokhtari-Dizaji M., Ghassemi F., Sheibani S., Asadi Amoli F. Increasing the efficiency of the retinoblastoma brachytherapy protocol with ultrasonic hyperthermia and gold nanoparticles: a rabbit model. International journal of radiation biology. 2020 Nov 9:1-14.
doi: 10.1080/09553002.2020.1838657
Morales-de la Cruz X., Mandujano-Chávez A., Browne D.R., Devarenne T.P., Sánchez-Segura L., López M.G., Lozoya-Gloria E. In Silico and Cellular Differences Related to the Cell Division Process between the A and B Races of the Colonial Microalga Botryococcus braunii. Biomolecules. 2021 Oct 5;11(10):1463.
doi: 10.3390/biom11101463
Morozova E.V., Rudakova T.A., Vlasova J.J., et al. Pre- and post-transplantation factors associated with primary graft failure and severe poor graft function after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia. Cell Ther Transplant 2022; 11(1): 13-23.
doi:10.18620/ctt-1866-8836-2022-11-1-13-23
Morse M., Parris K., Qaddoumi I. et al. Psychosocial outcomes and quality of life among school-age survivors of retinoblastoma. Pediatric blood & cancer. 2022-11-19:e29983
doi: 10.1002/pbc.29983
Moses C., Flegg K., Dimaras H. Patient knowledge, experiences and preferences regarding retinoblastoma and research: A qualitative study.
Mostaghimi H., Ahmadabad F.G., Rezaei H. Super-selective intra-arterial platinum-based chemotherapy concurrent with low-dose-rate plaque brachytherapy in the treatment of retinoblastoma: A simulation study. Journal of cancer research and therapeutics. 2021 Jan-Mar;17(1):130-135.
doi: 10.4103/jcrt.JCRT_340_19
Mou J., Yang L., Zhao J. et al. The survival analysis and feasibility study of Pars Plana Vitrectomy (PPV) in the treatment of retinoblastoma. Journal of cancer research and clinical oncology. 2022-11-11
doi: 10.1007/s00432-022-04466-4
Mouawad R., Himadewi P., Kadiyala D., Arnosti D.N. Selective repression of the Drosophila cyclin B promoter by retinoblastoma and E2F proteins.Biochimica et Biophysica Acta - Gene Regulatory Mechanisms. 2020 Apr 7
DOI: 10.1016/j.bbagrm.2020.194549
Moulay Lakhdar I., Ferlazzo M.L., Al Choboq J., Berthel E., Sonzogni L., Devic C., Granzotto A., Thariat J., Foray N. Fibroblasts from Retinoblastoma Patients Show Radiosensitivity Linked to Abnormal Localization of the ATM Protein. Current eye research. 2020 Aug 30
doi: 10.1080/02713683.2020.1808998
Moulin A., Pica A., Munier F., Schalenbourg A., Nobile A., Asana A., Astaras C., Hamedani M. Proton Therapy of a Conjunctival Carcinoma in the Anophthalmic Socket, 41 Years after Enucleation for a Sporadic Retinoblastoma. A Case Report and Review of the Literature. Klin Monbl Augenheilkd. 2021 Apr;238(4):361-364. English.
doi: 10.1055/a-1384-1159.
Moulin A.P., Stathopoulos C., Marcelli F., Schoumans Pouw J., Beck-Popovic M., Munier F.L. Secondary enucleated retinoblastoma with MYCN amplification. Ophthalmic Genetics. 2021 Apr 19:1-6.
doi: 10.1080/13816810.2021.1897847
Mudigunda S.V., Pemmaraju D.B., Paradkar S., Puppala E.R., Gawali B., Upadhyayula S.M., Vegi Gangamodi N., Rengan A.K. Multifunctional Polymeric Nanoparticles for Chemo/Phototheranostics of Retinoblastoma. ACS Biomater Sci Eng. 2021 Dec 22.
doi: 10.1021/acsbiomaterials.1c01234
Mudigunda S.V., Pemmaraju D.B., Sankaranarayanan S.A. et al. Bioactive Polymeric Nanoparticles of Moringa oleifera Induced Phyto-Photothermal Sensitization for the Enhanced Therapy of Retinoblastoma. Pharmaceutics. 2023-03-01;15(2)
doi: 10.3390/pharmaceutics15020475
Mudrova B., Hrabakova K., Kozlik P. et al. A sensitive bioanalytical ultra-high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous quantitation of lactone and carboxylate forms of topotecan in plasma and vitreous. Journal of separation science. 2024-06-12;47(11):e2400181
doi: 10.1002/jssc.202400181
Müngen E, Koç İ, Kiratli H, Varan A. Second Malignant Neoplasms in Long-term Retinoblastoma Survivors: Retrospective Cohort Study of 491 Patients in Turkey. J Pediatr Hematol Oncol. 2025 Jul 1;47(5):e161-e167. Epub 2025 Apr 21. PMID: 40262045.
doi: 10.1097/MPH.0000000000003039
Munier F.L. et al. Special Issue of Cancers: "Retinoblastoma: Current Challenges and Promising New Approaches". Cancers. 2023-05-19;15(8)
doi: 10.3390/cancers15082293
Munier F.L., Beck-Popovic M., Chantada G.L., Cobrinik D., Kivelä T.T., Lohmann D., Maeder P., Moll A.C., Carcaboso A.M., Moulin A., Schaiquevich P., Bergin C., Dyson P.J., Houghton S., Puccinelli F., Vial Y., Gaillard M.C., Stathopoulos C. Corrigendum to "Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. "Alive, with good vision and no comorbidity"" [Prog. Retina Eye Res. 73 (2019) 100764] Progress in Retinal and Eye Research.. 2020 Apr 8
doi: 10.1016/j.preteyeres.2020.100857
Muniyandi A., Jensen N.R., Devanathan N. et al. The Potential of Aqueous Humor Sampling in Diagnosis, Prognosis, and Treatment of Retinoblastoma. Investigative ophthalmology & visual science. 2024-01-11;65(1):18
doi: 10.1167/iovs.65.1.18
Mustafi D., Waligorski N., Paulson V., Cole B., Crotty E.E., Stacey A.W. Pineoblastoma Without Retinal Tumors in a Patient With a Mosaic Retinoblastoma Pathogenic Variant. JAMA Ophthalmol. 2022 Mar 17. Epub ahead of print. PMID: 35297960.
doi: 10.1001/jamaophthalmol.2022.0170
Muthukumaran S., Sulochana K.N., Umashankar V. Structure based design of inhibitory peptides targeting ornithine decarboxylase dimeric interface and in vitro validation in human retinoblastoma Y79 cells. J Biomol Struct Dyn. 2021 Sep;39(14):5261-5275.
doi: 10.1080/07391102.2020.1785331
Mu Y.T., Feng H.H., Yu J.Q., Liu Z.K., Wang Y., Shao J., Li R.H., Li D.K. Correction to: Curcumin suppressed proliferation and migration of human retinoblastoma cells through modulating NF-κB pathway. International ophthalmology. 2021 Jun;41(6):2301.
doi: 10.1007/s10792-020-01675-z
Mu Y.T., Feng H.H., Yu J.Q., Liu Z.K., Wang Y., Shao J., Li R.H., Li D.K. Curcumin suppressed proliferation and migration of human retinoblastoma cells through modulating NF-κB pathway. International ophthalmology. 2020 May 12.
doi: 10.1007/s10792-020-01406-4
Mudrova B., Hrabakova K., Kozlik P. et al. A sensitive bioanalytical ultra-high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous quantitation of lactone and carboxylate forms of topotecan in plasma and vitreous. Journal of separation science. 2024-06-12;47(11):e2400181
doi: 10.1002/jssc.202400181
Myakoshina EB, Saakyan SV, Tatskov RA, Tsygankov AY. Morfometricheskie issledovaniya malykh retinoblastom na fone kombinirovannoi khimioterapii [Morphometric analysis of small retinoblastomas following combination chemotherapy]. Vestn Oftalmol. 2025;141(2):38-43. Russian. PMID: 40353539.
doi:10.17116/oftalma202514102138
doi: 10.1038/s41433-020-1019-5
Mohammad M., Mehyar M., Halalsheh H. et al. The Impact of Tumor Laterality (Unilateral vs. Bilateral) on Presentation and Management Outcome in Patients with Retinoblastoma. Journal of clinical medicine. 2024-04-25;13(7)
doi: 10.3390/jcm13072146
Mohammad M., Shehada R., Al-Nawaiseh I. et al. A comparison of high risk pathological features between primary and secondary enucleation for retinoblastoma. European journal of ophthalmology. 2023-02-10:11206721231155671
doi: 10.1177/11206721231155671
Mohan S., Subramanian K., Khetan V. et al. Retinoblastoma tumour cells in central retinal vessels. Indian journal of ophthalmology. 2022-09-27;70(7):2773
doi: 10.4103/ijo.IJO_1350_21
Mohanan A., Meel R., Venkatesh P., Kashyap S. Retinal tumour outcome with IVC in retinoblastoma. Eye. 2020 Jul 14
doi: 10.1038/s41433-020-1076-9
Mohren L., Doege A., Miroschnikov N. et al. Role of Protein Tyrosine Phosphatase Receptor Type E (PTPRE) in Chemoresistant Retinoblastoma. International journal of molecular sciences. 2024-05-21;25(8)
doi: 10.3390/ijms25084572
Moin M., Malik T.G., Siddiq L. et al. Clinical Patterns And Outcomes Of Retinoblastoma In A Tertiary Care Centre Of A Developing Country. JPMA. The Journal of the Pakistan Medical Association. 2023-11-01;73(9):1881-1883
doi: 10.47391/JPMA.7689
Mokánszki A., Chang Chien Y.C., Mótyán J.A., Juhász P., Bádon E.S., Madar L., Szegedi I., Kiss C., Méhes G. Novel RB1 and MET Gene Mutations in a Case with Bilateral Retinoblastoma Followed by Multiple Metastatic Osteosarcoma. Diagnostics. 2020 Dec 25;11(1):E28.
doi: 10.3390/diagnostics11010028
Mollick T., Darekar S., Dalarun B. et al. Retinoblastoma vulnerability to combined de novo and salvage pyrimidine ribonucleotide synthesis pharmacologic blockage. Heliyon. 2024-02-10;10(1):e23831
doi: 10.1016/j.heliyon.2023.e23831
Monroe E.J., Chick J.F.B., Stacey A.W., Millard N.E., Geyer J.R., Ramoso L.R., Ghodke B.V., Hallam D.K. Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecutive pediatric interventions using five distinct protocols.Pediatric radiology. 2020 Nov 24.
doi: 10.1007/s00247-020-04892-x
Monroe E.J., Chick J.F.B., Stacey A.W., Millard N.E., Geyer J.R., Ramoso L.R., Ghodke B.V., Hallam D.K. Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecutive pediatric interventions using five distinct protocols. Pediatric radiology. 2021 Apr;51(4):649-657.
doi: 10.1007/s00247-020-04892-x
Moolsuwan K., Permpoon T., Sae-Lee C. et al. Dopachrome tautomerase is a retinoblastoma-specific gene, and its proximal promoter is preferentially active in human retinoblastoma cells. Molecular vision. 2022-10-31;28(28):192-202
Moothedath A.W., Chopra K.K., Seth R. et al. Role of 18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Predicting Residual Disease Posttreatment Completion in Retinoblastoma Patients. Indian journal of nuclear medicine: IJNM : the official journal of the Society of Nuclear Medicine, India. 2022-08-20;37(2):142-146.
doi: 10.4103/ijnm.ijnm_145_21
Moradi S., Mokhtari-Dizaji M., Ghassemi F., Sheibani S., Asadi Amoli F. Increasing the efficiency of the retinoblastoma brachytherapy protocol with ultrasonic hyperthermia and gold nanoparticles: A rabbit model. International journal of radiation biology. 2020 Oct 19:1-34.
Moradi S., Mokhtari-Dizaji M., Ghassemi F., Sheibani S., Asadi Amoli F. Increasing the efficiency of the retinoblastoma brachytherapy protocol with ultrasonic hyperthermia and gold nanoparticles: a rabbit model. International journal of radiation biology. 2020 Nov 9:1-14.
doi: 10.1080/09553002.2020.1838657
Morales-de la Cruz X., Mandujano-Chávez A., Browne D.R., Devarenne T.P., Sánchez-Segura L., López M.G., Lozoya-Gloria E. In Silico and Cellular Differences Related to the Cell Division Process between the A and B Races of the Colonial Microalga Botryococcus braunii. Biomolecules. 2021 Oct 5;11(10):1463.
doi: 10.3390/biom11101463
Morozova E.V., Rudakova T.A., Vlasova J.J., et al. Pre- and post-transplantation factors associated with primary graft failure and severe poor graft function after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia. Cell Ther Transplant 2022; 11(1): 13-23.
doi:10.18620/ctt-1866-8836-2022-11-1-13-23
Morse M., Parris K., Qaddoumi I. et al. Psychosocial outcomes and quality of life among school-age survivors of retinoblastoma. Pediatric blood & cancer. 2022-11-19:e29983
doi: 10.1002/pbc.29983
Moses C., Flegg K., Dimaras H. Patient knowledge, experiences and preferences regarding retinoblastoma and research: A qualitative study.
Mostaghimi H., Ahmadabad F.G., Rezaei H. Super-selective intra-arterial platinum-based chemotherapy concurrent with low-dose-rate plaque brachytherapy in the treatment of retinoblastoma: A simulation study. Journal of cancer research and therapeutics. 2021 Jan-Mar;17(1):130-135.
doi: 10.4103/jcrt.JCRT_340_19
Mou J., Yang L., Zhao J. et al. The survival analysis and feasibility study of Pars Plana Vitrectomy (PPV) in the treatment of retinoblastoma. Journal of cancer research and clinical oncology. 2022-11-11
doi: 10.1007/s00432-022-04466-4
Mouawad R., Himadewi P., Kadiyala D., Arnosti D.N. Selective repression of the Drosophila cyclin B promoter by retinoblastoma and E2F proteins.Biochimica et Biophysica Acta - Gene Regulatory Mechanisms. 2020 Apr 7
DOI: 10.1016/j.bbagrm.2020.194549
Moulay Lakhdar I., Ferlazzo M.L., Al Choboq J., Berthel E., Sonzogni L., Devic C., Granzotto A., Thariat J., Foray N. Fibroblasts from Retinoblastoma Patients Show Radiosensitivity Linked to Abnormal Localization of the ATM Protein. Current eye research. 2020 Aug 30
doi: 10.1080/02713683.2020.1808998
Moulin A., Pica A., Munier F., Schalenbourg A., Nobile A., Asana A., Astaras C., Hamedani M. Proton Therapy of a Conjunctival Carcinoma in the Anophthalmic Socket, 41 Years after Enucleation for a Sporadic Retinoblastoma. A Case Report and Review of the Literature. Klin Monbl Augenheilkd. 2021 Apr;238(4):361-364. English.
doi: 10.1055/a-1384-1159.
Moulin A.P., Stathopoulos C., Marcelli F., Schoumans Pouw J., Beck-Popovic M., Munier F.L. Secondary enucleated retinoblastoma with MYCN amplification. Ophthalmic Genetics. 2021 Apr 19:1-6.
doi: 10.1080/13816810.2021.1897847
Mudigunda S.V., Pemmaraju D.B., Paradkar S., Puppala E.R., Gawali B., Upadhyayula S.M., Vegi Gangamodi N., Rengan A.K. Multifunctional Polymeric Nanoparticles for Chemo/Phototheranostics of Retinoblastoma. ACS Biomater Sci Eng. 2021 Dec 22.
doi: 10.1021/acsbiomaterials.1c01234
Mudigunda S.V., Pemmaraju D.B., Sankaranarayanan S.A. et al. Bioactive Polymeric Nanoparticles of Moringa oleifera Induced Phyto-Photothermal Sensitization for the Enhanced Therapy of Retinoblastoma. Pharmaceutics. 2023-03-01;15(2)
doi: 10.3390/pharmaceutics15020475
Mudrova B., Hrabakova K., Kozlik P. et al. A sensitive bioanalytical ultra-high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous quantitation of lactone and carboxylate forms of topotecan in plasma and vitreous. Journal of separation science. 2024-06-12;47(11):e2400181
doi: 10.1002/jssc.202400181
Müngen E, Koç İ, Kiratli H, Varan A. Second Malignant Neoplasms in Long-term Retinoblastoma Survivors: Retrospective Cohort Study of 491 Patients in Turkey. J Pediatr Hematol Oncol. 2025 Jul 1;47(5):e161-e167. Epub 2025 Apr 21. PMID: 40262045.
doi: 10.1097/MPH.0000000000003039
Munier F.L. et al. Special Issue of Cancers: "Retinoblastoma: Current Challenges and Promising New Approaches". Cancers. 2023-05-19;15(8)
doi: 10.3390/cancers15082293
Munier F.L., Beck-Popovic M., Chantada G.L., Cobrinik D., Kivelä T.T., Lohmann D., Maeder P., Moll A.C., Carcaboso A.M., Moulin A., Schaiquevich P., Bergin C., Dyson P.J., Houghton S., Puccinelli F., Vial Y., Gaillard M.C., Stathopoulos C. Corrigendum to "Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. "Alive, with good vision and no comorbidity"" [Prog. Retina Eye Res. 73 (2019) 100764] Progress in Retinal and Eye Research.. 2020 Apr 8
doi: 10.1016/j.preteyeres.2020.100857
Muniyandi A., Jensen N.R., Devanathan N. et al. The Potential of Aqueous Humor Sampling in Diagnosis, Prognosis, and Treatment of Retinoblastoma. Investigative ophthalmology & visual science. 2024-01-11;65(1):18
doi: 10.1167/iovs.65.1.18
Mustafi D., Waligorski N., Paulson V., Cole B., Crotty E.E., Stacey A.W. Pineoblastoma Without Retinal Tumors in a Patient With a Mosaic Retinoblastoma Pathogenic Variant. JAMA Ophthalmol. 2022 Mar 17. Epub ahead of print. PMID: 35297960.
doi: 10.1001/jamaophthalmol.2022.0170
Muthukumaran S., Sulochana K.N., Umashankar V. Structure based design of inhibitory peptides targeting ornithine decarboxylase dimeric interface and in vitro validation in human retinoblastoma Y79 cells. J Biomol Struct Dyn. 2021 Sep;39(14):5261-5275.
doi: 10.1080/07391102.2020.1785331
Mu Y.T., Feng H.H., Yu J.Q., Liu Z.K., Wang Y., Shao J., Li R.H., Li D.K. Correction to: Curcumin suppressed proliferation and migration of human retinoblastoma cells through modulating NF-κB pathway. International ophthalmology. 2021 Jun;41(6):2301.
doi: 10.1007/s10792-020-01675-z
Mu Y.T., Feng H.H., Yu J.Q., Liu Z.K., Wang Y., Shao J., Li R.H., Li D.K. Curcumin suppressed proliferation and migration of human retinoblastoma cells through modulating NF-κB pathway. International ophthalmology. 2020 May 12.
doi: 10.1007/s10792-020-01406-4
Mudrova B., Hrabakova K., Kozlik P. et al. A sensitive bioanalytical ultra-high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous quantitation of lactone and carboxylate forms of topotecan in plasma and vitreous. Journal of separation science. 2024-06-12;47(11):e2400181
doi: 10.1002/jssc.202400181
Myakoshina EB, Saakyan SV, Tatskov RA, Tsygankov AY. Morfometricheskie issledovaniya malykh retinoblastom na fone kombinirovannoi khimioterapii [Morphometric analysis of small retinoblastomas following combination chemotherapy]. Vestn Oftalmol. 2025;141(2):38-43. Russian. PMID: 40353539.
doi:10.17116/oftalma202514102138
N
Nadelmann J., Francis J.H., Brodie S.E., Muca E., Abramson D.H. Is intravitreal topotecan toxic to retinal function? The British journal of ophthalmology. 2020 Jul 14
doi: 10.1136/bjophthalmol-2020-316588
Nag A., Khetan V. et al. Retinoblastoma - A comprehensive review, update and recent advances. Indian journal of ophthalmology. 2024-07-11;72(6):778-788
doi: 10.4103/IJO.IJO_2414_23
Nair R.M., Revu N.V.L., Gali S., Kallamadi P.R., Prabhu V., Manukonda R., Nemani H., Kaliki S., Vemuganti G.K. A short-term chick embryo in vivo xenograft model to study retinoblastoma cancer stem cells. Indian J Ophthalmol. 2022 May;70(5):1703-1711.
doi: 10.4103/ijo.IJO_2348_21
Nakagawa N., Morimoto T., Miyamura T. et al. A case of retinoblastoma resulting in phthisis bulbi after proton beam radiation therapy. American journal of ophthalmology case reports. 2022-10-09;28(28):101715.
doi: 10.1016/j.ajoc.2022.101715
Nakamichi K., Stacey A., Mustafi D. et al. Targeted long-read sequencing allows for rapid identification of pathogenic disease-causing variants in retinoblastoma. Ophthalmic genetics. 2022-11-03:1-9
doi: 10.1080/13816810.2022.2141797
Nakamura S., Murakami N., Suzuki S., Ito K., Takemori M., Nakayama H., Kaga K., Chiba T., Iijima K., Takahashi K., Goka T., Itami J., Okamoto H., Igaki H. Monte Carlo simulation of tilted contact plaque brachytherapy placement for juxtapapillary retinoblastoma. Radiat Oncol. 2022 Jan 24;17(1):16.
doi: 10.1186/s13014-022-01986-8
Nandi S., Chhebbi M., Mandal A. et al. A Systematic Review Article on Orbital Exenteration: Indication, Complications and Reconstruction Methods. Indian journal of otolaryngology and head and neck surgery. 2022-12-02;74(Suppl 2):1183-1191
doi: 10.1007/s12070-020-02270-5
Narang S., Sindhu M., Jinagal J., Handa U., Kochhar S. Unusual presentation of Retinoblastoma. European journal of ophthalmology. 2020 Jul 2
doi: 10.1177/1120672120939388
Narayana R.V.L., Jana P., Tomar N., Prabhu V., Nair R.M., Manukonda R., Kaliki S., Coupland S.E., Alexander J., Kalirai H., Kondapi A.K., Vemuganti G.K. Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro. Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):13.
doi: 10.1167/iovs.62.14.13
Naser A.Y., Alrawashdeh H.M., Alwafi H., Alyami H.S., Dahmash E.Z., Ghoul I., Shishtawi A.A., Abdelwahab G.M., Qadus S., Taybeh E., Abuthawabeh R., Hassanin F., Alhartani Y.J., Alyami M.H., Salawati E.M., Alwan S.S. Knowledge and awareness of the general population and healthcare providers about retinoblastoma: it is time to know the glow. International journal of clinical practice. 2021 Apr 30:e14298.
doi: 10.1111/ijcp.14298
Naseripour M., Mirshahi R., Kasraei H. et al. Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes. OncoTargets and therapy. 2023-01-03;15(15):1545-1561.
doi: 10.2147/OTT.S370878
Naseripour M., Sedaghat A., Mirshahi R., Abdolalizadeh P., Koushki A., Faranoush M., Ghorbani M., Kashkouli M.B., Sadeghipour A., Chaibakhsh S., Mehrvar A. Targeted chemotherapy in retinoblastoma: A step forward from patient survival to globe survival. Eur J Ophthalmol. 2022 Apr 13:11206721221093018. Epub ahead of print. PMID: 35414292.
doi: 10.1177/11206721221093018
Nasrolahi A., Azizidoost S., Radoszkiewicz K. et al. Long non-coding RNAs involved in retinoblastoma. Journal of cancer research and clinical oncology. 2022-10-28.
doi: 10.1007/s00432-022-04398-z
Nasrolahi A., Khojasteh Pour F., Mousavi Salehi A. et al. Potential roles of lncRNA MALAT1-miRNA interactions in ocular diseases. Journal of cell communication and signaling. 2023-12-14;17(4):1203-1217
doi: 10.1007/s12079-023-00787-2
Navaratnam J., Faber R., Eide N. et al. Retinocytoma Undergoing Retinoblastoma Transformation in an Adult Patient. Case reports in ophthalmological medicine. 2023-08-03;2023(2023):8127245
doi: 10.1155/2023/8127245
Nazha B., Inal C., Owonikoko T.K. Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy. Frontiers in oncology. 2020 Jul 7
doi: 10.3389/fonc.2020.01000
Nadelmann J., Francis J.H., Brodie S.E., Muca E., Abramson D.H. Is intravitreal topotecan toxic to retinal function? The British journal of ophthalmology. 2020 Jul 14
doi: 10.1136/bjophthalmol-2020-316588
Nag A., Khetan V. et al. Retinoblastoma - A comprehensive review, update and recent advances. Indian journal of ophthalmology. 2024-07-11;72(6):778-788
doi: 10.4103/IJO.IJO_2414_23
Nair R.M., Revu N.V.L., Gali S., Kallamadi P.R., Prabhu V., Manukonda R., Nemani H., Kaliki S., Vemuganti G.K. A short-term chick embryo in vivo xenograft model to study retinoblastoma cancer stem cells. Indian J Ophthalmol. 2022 May;70(5):1703-1711.
doi: 10.4103/ijo.IJO_2348_21
Nakagawa N., Morimoto T., Miyamura T. et al. A case of retinoblastoma resulting in phthisis bulbi after proton beam radiation therapy. American journal of ophthalmology case reports. 2022-10-09;28(28):101715.
doi: 10.1016/j.ajoc.2022.101715
Nakamichi K., Stacey A., Mustafi D. et al. Targeted long-read sequencing allows for rapid identification of pathogenic disease-causing variants in retinoblastoma. Ophthalmic genetics. 2022-11-03:1-9
doi: 10.1080/13816810.2022.2141797
Nakamura S., Murakami N., Suzuki S., Ito K., Takemori M., Nakayama H., Kaga K., Chiba T., Iijima K., Takahashi K., Goka T., Itami J., Okamoto H., Igaki H. Monte Carlo simulation of tilted contact plaque brachytherapy placement for juxtapapillary retinoblastoma. Radiat Oncol. 2022 Jan 24;17(1):16.
doi: 10.1186/s13014-022-01986-8
Nandi S., Chhebbi M., Mandal A. et al. A Systematic Review Article on Orbital Exenteration: Indication, Complications and Reconstruction Methods. Indian journal of otolaryngology and head and neck surgery. 2022-12-02;74(Suppl 2):1183-1191
doi: 10.1007/s12070-020-02270-5
Narang S., Sindhu M., Jinagal J., Handa U., Kochhar S. Unusual presentation of Retinoblastoma. European journal of ophthalmology. 2020 Jul 2
doi: 10.1177/1120672120939388
Narayana R.V.L., Jana P., Tomar N., Prabhu V., Nair R.M., Manukonda R., Kaliki S., Coupland S.E., Alexander J., Kalirai H., Kondapi A.K., Vemuganti G.K. Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro. Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):13.
doi: 10.1167/iovs.62.14.13
Naser A.Y., Alrawashdeh H.M., Alwafi H., Alyami H.S., Dahmash E.Z., Ghoul I., Shishtawi A.A., Abdelwahab G.M., Qadus S., Taybeh E., Abuthawabeh R., Hassanin F., Alhartani Y.J., Alyami M.H., Salawati E.M., Alwan S.S. Knowledge and awareness of the general population and healthcare providers about retinoblastoma: it is time to know the glow. International journal of clinical practice. 2021 Apr 30:e14298.
doi: 10.1111/ijcp.14298
Naseripour M., Mirshahi R., Kasraei H. et al. Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes. OncoTargets and therapy. 2023-01-03;15(15):1545-1561.
doi: 10.2147/OTT.S370878
Naseripour M., Sedaghat A., Mirshahi R., Abdolalizadeh P., Koushki A., Faranoush M., Ghorbani M., Kashkouli M.B., Sadeghipour A., Chaibakhsh S., Mehrvar A. Targeted chemotherapy in retinoblastoma: A step forward from patient survival to globe survival. Eur J Ophthalmol. 2022 Apr 13:11206721221093018. Epub ahead of print. PMID: 35414292.
doi: 10.1177/11206721221093018
Nasrolahi A., Azizidoost S., Radoszkiewicz K. et al. Long non-coding RNAs involved in retinoblastoma. Journal of cancer research and clinical oncology. 2022-10-28.
doi: 10.1007/s00432-022-04398-z
Nasrolahi A., Khojasteh Pour F., Mousavi Salehi A. et al. Potential roles of lncRNA MALAT1-miRNA interactions in ocular diseases. Journal of cell communication and signaling. 2023-12-14;17(4):1203-1217
doi: 10.1007/s12079-023-00787-2
Navaratnam J., Faber R., Eide N. et al. Retinocytoma Undergoing Retinoblastoma Transformation in an Adult Patient. Case reports in ophthalmological medicine. 2023-08-03;2023(2023):8127245
doi: 10.1155/2023/8127245
Nazha B., Inal C., Owonikoko T.K. Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy. Frontiers in oncology. 2020 Jul 7
doi: 10.3389/fonc.2020.01000
Negretti G.S., Quhill H., Duncan C. et al. Ruthenium plaque radiotherapy in the current era of retinoblastoma treatment. Ophthalmic genetics. 2022-11-01:1-6
doi: 10.1080/13816810.2022.2141795
Negretti GS, Ushakova T, Yuri Serov, Vladimir Polyakov, Berry JL, Pike S, Shields CL, Hubbard GB 3rd, Eiger-Moscovich M, Pe'er J, Staffieri SE, Elder JE, McKenzie JD, Ahmad A, Hussain M, Casavilca-Zambrano S, Alarcon-Leon S, Yousef YA, Mohammad M, Tanabe M, Arazi M, Fabian ID, Goldstein S, Kaliki S, Sagoo MS, Reddy MA. Neovascular glaucoma as a predictor of a retinoblastoma high-risk histopathology in a international multicenter study. Retina. 2025 Mar 1;45(3):565-573. PMID: 39622251.
doi: 10.1097/IAE.0000000000004340
Nelson AJ, Park S, Nelson MD Jr, Berry JL. Aqueous Humor Liquid Biopsy to Exclude Retinoblastoma for a Child with an Intraocular Mass. Case Rep Ophthalmol. 2025 Apr 21;16(1):366-371. PMID: 40469936; PMCID: PMC12136566.
doi: 10.1159/000545924
Nguyen M., Blair K. Red Reflex. 2021 Sep 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 31985932
Nguyen M., Saunders J., Pacheco M.C., Stacey A.W. Progressive Preretinal Fibrosis with Late, Ossifying, Proliferative Retinopathy following Treatment for Retinoblastoma. Ocular oncology and pathology. 2021 Mar;7(1):44-47.
doi: 10.1159/000509809. Epub 2020 Sep 25
Ni H., Chai P., Yu J., Xing Y., Wang S., Fan J., Ge S., Wang Y., Jia R., Fan X. LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter. Cell death & disease. 2020 May 4.
doi: 10.1038/s41419-020-2524-y
Ni W., Li Z., Ai K. lncRNA ZFPM2-AS1 promotes retinoblastoma progression by targeting microRNA miR-511-3p/paired box protein 6 (PAX6) axis. Bioengineered. 2022 Jan;13(1):1637-1649.
doi: 10.1080/21655979.2021.2021346
Nie C., Ma H., Gao Y., Li J., Tang Z., Chen Y., Lu R. RNA Sequencing and Bioinformatic Analysis on Retinoblastoma Revealing Cell Cycle Deregulation being a Key Process in Retinoblastoma Tumorigenesis. // Acta Ophthalmologica. 2020 Mar 6.
doi: 10.1159/000506993
Nie J, Tang J, Zhang Z, Sun H, Wang X, Wang L, Wang M, Huang W, Gao Y, Li J, Cheng C, Su S, Chen S, Ai S, Mao Y, Zhang P, Liu Y, Lu R. SOX4 as a Key Oncogene Driving Tumor Invasion in Retinoblastoma. Invest Ophthalmol Vis Sci. 2025 May 1;66(5):24. PMID: 40402518; PMCID: PMC12110620.
doi: 10.1167/iovs.66.5.24
Nimonkar S.V., Belkhode V.M., Dahihandekar C., Nimonkar P.V., Pisulkar S. A narrative review on techniques of iris replication in an ocular prosthesis. J Indian Prosthodont Soc. 2023 Jan-Mar;23(1):4-11. PMID: 36588369
doi: 10.4103/jips.jips_252_22
Nindyastuti H., Rusmawatiningtyas D., Makrufardi F., Supriyadi E. Lag time to diagnosis as a predictor of mortality in children with extraocular retinoblastoma: Experience from a developing country. Asia Pac J Clin Oncol. 2022 Mar 28. Epub ahead of print. PMID: 35347866.
doi: 10.1111/ajco.13767
Ning Y, Qu X, Li X, Jin L, Liu J. Molecular mechanism of RB progression and Circ_0082415 inhibits MKLN1 translation to suppress retinoblastoma progression: Changes in mRNA and protein levels. Int J Biol Macromol. 2025 Jan;286:138524. Epub 2024 Dec 6. PMID: 39647744.
doi: 10.1016/j.ijbiomac.2024.138524
Nishath T., Li X., Chandramohan A. et al. Risk factors associated with abandonment of care in retinoblastoma: analysis of 692 patients from 10 countries. The British journal of ophthalmology. 2022-09-20.
doi: 10.1136/bjo-2022-321159
Nishath T., Stacey A.W., Steinberg D. et al. Retinoblastoma survival and enucleation outcomes in 41 countries from the African continent. The British journal of ophthalmology. 2024-08-17
doi: 10.1136/bjo-2023-324746
Nishida K., Morimoto T., Suzuki S., Iwahashi C., Imai H., Kuniyoshi K., Kusaka S. Pars plana vitrectomy for vitreoretinal complications in only seeing eyes after treatment for retinoblastoma. Am J Ophthalmol Case Rep. 2022 Feb 2;25:101367. PMID: 35243141; PMCID: PMC8859804.
doi: 10.1016/j.ajoc.2022.101367
Norrie J.L., Nityanandam A., Lai K., Chen X., Wilson M., Stewart E., Griffiths L., Jin H., Wu G., Orr B., Tran Q., Allen S., Reilly C., Zhou X., Zhang J., Newman K., Johnson D., Brennan R., Dyer M.A. Retinoblastoma from human stem cell-derived retinal organoids. Nature communications. 2021 Jul 27;12(1):4535. PMID: 34315877; PMCID: PMC8316454.
doi: 10.1038/s41467-021-24781-7
Nouhou Diori A., Laminou L., Youssoufou Souley A.S. et al. [Stage at diagnosis of retinoblastoma in Niger: Current situation and perspectives]. Journal francais d'ophtalmologie. 2024-08-30;47(9):104258
doi: 10.1016/j.jfo.2024.104258
Nowak M.S., Romanowska-Dixon B., Grabska-Liberek I., Żurek M. Incidence and Characteristics of Retinoblastoma in Poland: The First Nationwide Study 2010-2017. Int J Environ Res Public Health. 2021 Jun 17;18(12):6539.
doi: 10.3390/ijerph18126539
Nummi K., Kivelä T. Retinoblastoma in Finland, 1964-2014: incidence and survival. // British Journal of Ophthalmology. 2020 Mar 25
doi: 10.1136/bjophthalmol-2019-315744
Nummi K., Kivelä T.T. Retinoblastoma in Finland, 1964-2014: incidence and survival. Br J Ophthalmol. 2021 Jan;105(1):63-69.
doi: 10.1136/bjophthalmol-2019-315744
doi: 10.1080/13816810.2022.2141795
Negretti GS, Ushakova T, Yuri Serov, Vladimir Polyakov, Berry JL, Pike S, Shields CL, Hubbard GB 3rd, Eiger-Moscovich M, Pe'er J, Staffieri SE, Elder JE, McKenzie JD, Ahmad A, Hussain M, Casavilca-Zambrano S, Alarcon-Leon S, Yousef YA, Mohammad M, Tanabe M, Arazi M, Fabian ID, Goldstein S, Kaliki S, Sagoo MS, Reddy MA. Neovascular glaucoma as a predictor of a retinoblastoma high-risk histopathology in a international multicenter study. Retina. 2025 Mar 1;45(3):565-573. PMID: 39622251.
doi: 10.1097/IAE.0000000000004340
Nelson AJ, Park S, Nelson MD Jr, Berry JL. Aqueous Humor Liquid Biopsy to Exclude Retinoblastoma for a Child with an Intraocular Mass. Case Rep Ophthalmol. 2025 Apr 21;16(1):366-371. PMID: 40469936; PMCID: PMC12136566.
doi: 10.1159/000545924
Nguyen M., Blair K. Red Reflex. 2021 Sep 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 31985932
Nguyen M., Saunders J., Pacheco M.C., Stacey A.W. Progressive Preretinal Fibrosis with Late, Ossifying, Proliferative Retinopathy following Treatment for Retinoblastoma. Ocular oncology and pathology. 2021 Mar;7(1):44-47.
doi: 10.1159/000509809. Epub 2020 Sep 25
Ni H., Chai P., Yu J., Xing Y., Wang S., Fan J., Ge S., Wang Y., Jia R., Fan X. LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter. Cell death & disease. 2020 May 4.
doi: 10.1038/s41419-020-2524-y
Ni W., Li Z., Ai K. lncRNA ZFPM2-AS1 promotes retinoblastoma progression by targeting microRNA miR-511-3p/paired box protein 6 (PAX6) axis. Bioengineered. 2022 Jan;13(1):1637-1649.
doi: 10.1080/21655979.2021.2021346
Nie C., Ma H., Gao Y., Li J., Tang Z., Chen Y., Lu R. RNA Sequencing and Bioinformatic Analysis on Retinoblastoma Revealing Cell Cycle Deregulation being a Key Process in Retinoblastoma Tumorigenesis. // Acta Ophthalmologica. 2020 Mar 6.
doi: 10.1159/000506993
Nie J, Tang J, Zhang Z, Sun H, Wang X, Wang L, Wang M, Huang W, Gao Y, Li J, Cheng C, Su S, Chen S, Ai S, Mao Y, Zhang P, Liu Y, Lu R. SOX4 as a Key Oncogene Driving Tumor Invasion in Retinoblastoma. Invest Ophthalmol Vis Sci. 2025 May 1;66(5):24. PMID: 40402518; PMCID: PMC12110620.
doi: 10.1167/iovs.66.5.24
Nimonkar S.V., Belkhode V.M., Dahihandekar C., Nimonkar P.V., Pisulkar S. A narrative review on techniques of iris replication in an ocular prosthesis. J Indian Prosthodont Soc. 2023 Jan-Mar;23(1):4-11. PMID: 36588369
doi: 10.4103/jips.jips_252_22
Nindyastuti H., Rusmawatiningtyas D., Makrufardi F., Supriyadi E. Lag time to diagnosis as a predictor of mortality in children with extraocular retinoblastoma: Experience from a developing country. Asia Pac J Clin Oncol. 2022 Mar 28. Epub ahead of print. PMID: 35347866.
doi: 10.1111/ajco.13767
Ning Y, Qu X, Li X, Jin L, Liu J. Molecular mechanism of RB progression and Circ_0082415 inhibits MKLN1 translation to suppress retinoblastoma progression: Changes in mRNA and protein levels. Int J Biol Macromol. 2025 Jan;286:138524. Epub 2024 Dec 6. PMID: 39647744.
doi: 10.1016/j.ijbiomac.2024.138524
Nishath T., Li X., Chandramohan A. et al. Risk factors associated with abandonment of care in retinoblastoma: analysis of 692 patients from 10 countries. The British journal of ophthalmology. 2022-09-20.
doi: 10.1136/bjo-2022-321159
Nishath T., Stacey A.W., Steinberg D. et al. Retinoblastoma survival and enucleation outcomes in 41 countries from the African continent. The British journal of ophthalmology. 2024-08-17
doi: 10.1136/bjo-2023-324746
Nishida K., Morimoto T., Suzuki S., Iwahashi C., Imai H., Kuniyoshi K., Kusaka S. Pars plana vitrectomy for vitreoretinal complications in only seeing eyes after treatment for retinoblastoma. Am J Ophthalmol Case Rep. 2022 Feb 2;25:101367. PMID: 35243141; PMCID: PMC8859804.
doi: 10.1016/j.ajoc.2022.101367
Norrie J.L., Nityanandam A., Lai K., Chen X., Wilson M., Stewart E., Griffiths L., Jin H., Wu G., Orr B., Tran Q., Allen S., Reilly C., Zhou X., Zhang J., Newman K., Johnson D., Brennan R., Dyer M.A. Retinoblastoma from human stem cell-derived retinal organoids. Nature communications. 2021 Jul 27;12(1):4535. PMID: 34315877; PMCID: PMC8316454.
doi: 10.1038/s41467-021-24781-7
Nouhou Diori A., Laminou L., Youssoufou Souley A.S. et al. [Stage at diagnosis of retinoblastoma in Niger: Current situation and perspectives]. Journal francais d'ophtalmologie. 2024-08-30;47(9):104258
doi: 10.1016/j.jfo.2024.104258
Nowak M.S., Romanowska-Dixon B., Grabska-Liberek I., Żurek M. Incidence and Characteristics of Retinoblastoma in Poland: The First Nationwide Study 2010-2017. Int J Environ Res Public Health. 2021 Jun 17;18(12):6539.
doi: 10.3390/ijerph18126539
Nummi K., Kivelä T. Retinoblastoma in Finland, 1964-2014: incidence and survival. // British Journal of Ophthalmology. 2020 Mar 25
doi: 10.1136/bjophthalmol-2019-315744
Nummi K., Kivelä T.T. Retinoblastoma in Finland, 1964-2014: incidence and survival. Br J Ophthalmol. 2021 Jan;105(1):63-69.
doi: 10.1136/bjophthalmol-2019-315744
O
Oatess T.L., Chen P.H., Daniels A.B., Himmel L.E. Severe Periocular Edema after Intraarterial Carboplatin Chemotherapy for Retinoblastoma in a Rabbit (Oryctolagus cuniculus) Model. // Comparative Medicine. 2020 Mar 11.
doi: 10.30802/AALAS-CM-18-000146
O'Donnell N, Howell D, Morgan JE, Phillips B. "That's All Anyone Needs Really, Support": A Content Analysis of Retinoblastoma Survivors' Psychosocial Support Needs. Pediatr Blood Cancer. 2025 Aug;72(8):e31787. Epub 2025 May 12. PMID: 40353373.
doi: 10.1002/pbc.31787
O'Donnell N., Phillips B., Morgan J.E. et al. 'It's not meant to be for life, but it carries on': a qualitative investigation into the psychosocial needs of young retinoblastoma survivors. BMJ open. 2024-05-12;14(4):e082779
doi: 10.1136/bmjopen-2023-082779
Ohan H., Minassian G., Minassian H., Farooq T., Zdilla M.J. Retinoblastoma in Infancy with Subsequent Bladder Leiomyosarcoma in Adulthood: Genomic Considerations.Urology. 2020 Mar 19
doi: 10.1016/j.urology.2020.03.010
Oguro S., Chen Y.N., Yamane T. et al. Selective ophthalmic arterial injection using a balloon catheter for retinoblastoma: a seven-year clinical evaluation. Japanese journal of ophthalmology. 2024-08-27;68(4):346-354
doi: 10.1007/s10384-024-01067-1
Oke I., Diller L.R., Gonzalez E. Advanced retinoblastoma presenting with cataract in a child with limited access to primary care. J Pediatr. 2022 May 13:S0022-3476(22)00427-9.
doi: 10.1016/j.jpeds.2022.05.019
Oke I, Gonzalez E, Elze T, Miller JW, Lorch AC, Hunter DG, Yeh JM, Diller LR, Wu AC; IRIS® Registry Analytic Center Consortium. The Association of Race, Ethnicity, and Insurance Status with the Visual Acuity of Retinoblastoma Survivors in the IRIS® Registry. Ophthalmic Epidemiol. 2025 Feb;32(1):18-24. Epub 2024 Apr 5. PMID: 38578693.
doi: 10.1080/09286586.2024.2315075
Omais S., El Atie Y.E., Ghanem N. et al. Rb deficiency, neuronal survival and neurodegeneration: In search of the perfect mouse model. Current research in neurobiology. 2023-02-02;4(4):100074
doi: 10.1016/j.crneur.2023.100074
Omidakhsh N, Hansen J, Ritz B, Coleman AL, McKean-Cowdin R, Olsen J, Heck JE. Parental Occupation and Risk of Childhood Retinoblastoma in Denmark. J Occup Environ Med. 2021 Mar 1;63(3):256-261.
doi: 10.1097/JOM.0000000000002120
Omotoso B.R., Harrichandparsad R., Lazarus L. et al. Ophthalmic artery arising from the external carotid artery system: the middle meningeal artery in South African patients. BMC ophthalmology. 2023-05-31;23(1):238
doi: 10.1186/s12886-023-02996-0
Onishi T., Nishina S., Yokoi T. et al. Outcomes of five cases of retinoblastoma with optic nerve invasion on imaging. Japanese journal of ophthalmology. 2024-12-02;68(6):741-750
doi: 10.1007/s10384-024-01112-z
Onugwu A.L., Ugorji O.L., Ufondu C.A. et al. Nanoparticle-based delivery systems as emerging therapy in retinoblastoma: recent advances, challenges and prospects. Nanoscale advances. 2023-09-16;5(18):4628-4648
doi: 10.1039/d3na00462g
Ophthalmic surgery, lasers & imaging retina. 2020 Dec 1;51(12):732.
doi: 10.3928/23258160-20201202-09
Opitz M., Bos D., Deuschl C., Radbruch A., Zensen S., Sirin S., Forsting M., Bechrakis N., Biewald E., Bornfeld N., Ketteler P., Timmermann B., Stuschke M., Guberina M., Wetter A., Göricke S., Guberina N. Estimation of radiation exposure of children undergoing superselective intra-arterial chemotherapy for retinoblastoma treatment: assessment of local diagnostic reference levels as a function of age, sex, and interventional success. Neuroradiology. 2020 Aug 29.
doi: 10.1007/s00234-020-02540-7
Opitz M., Wetter A., Guberina N. Thoughts on "Estimation of radiation exposure of children undergoing superselective, intra-arterial chemotherapy for retinoblastoma treatment: Assessment of Local Diagnostic Reference Levels as a function of age, sex and interventional success". Neuroradiology. 2020 Nov 3.
doi: 10.1007/s00234-020-02594-7
Oporto J.I., Zúñiga P., Ossandón D., Zanolli M., Pérez V., López J.P., Stetcher X., Rodríguez A., Puentes Á., Rustom S., Lobos J. Intra-arterial chemotherapy for retinoblastoma treatment in Chile: experience and results 2013-2020.
Archivos de la Sociedad Española de Oftalmología. 2020 Dec 2:S0365-6691(20)30391-9.
doi: 10.1016/j.oftal.2020.10.002
Oporto J.I., Zúñiga P., Ossandón D., Zanolli M., Pérez V., López J.P., Stetcher X., Rodríguez A., Puentes Á., Rustom S., Lobos J. Intra-arterial chemotherapy for retinoblastoma treatment in Chile: Experience and results 2013-2020. Archivos de la Sociedad Española de Oftalmología. 2021 Jun;96(6):288-292.
doi: 10.1016/j.oftale.2020.10.003
Orman G., Huisman TAGM. et al. A descriptive neuroimaging study of retinoblastoma in children: magnetic resonance imaging features. Polish journal of radiology. 2022-08-19;87(87):e363-e368
doi: 10.5114/pjr.2022.118107
Oronowicz J., Reinhard J., Reinach P.S., Ludwiczak S., Luo H., Omar Ba Salem M.H., Kraemer M.M., Biebermann H., Kakkassery V., Mergler S. Ascorbate-induced oxidative stress mediates TRP channel activation and cytotoxicity in human etoposide-sensitive and -resistant retinoblastoma cells. Laboratory investigation; a journal of technical methods and pathology. 2020 Sep 18.
doi: 10.1038/s41374-020-00485-2
Orjuela-Grimm M., Carreño S.B., Liu X., Ruiz A., Medina P., Ramirez Ortiz M.A., Rendon J.R., Molina N.C.L., Pinilla H., Hinojosa D., Rodriguez L., Connor A.O., Rodriguez F.M., Castañeda M.V.P., Cabrera-Muñoz L. Sunlight exposure in infancy decreases risk of sporadic retinoblastoma, extent of intraocular disease.
Cancer Reports. 2021 May 7:e1409.
doi: 10.1002/cnr2.1409
Osuna-Marco M.P., López-Barahona M., López-Ibor B., Tejera Á.M. Ten Reasons Why People With Down Syndrome are Protected From the Development of Most Solid Tumors -A Review. Front Genet. 2021 Nov 5;12:749480.
doi: 10.3389/fgene.2021.749480
Outtaleb F.Z., Kora L., Jabrane G., Serbati N., El Maaloum L., Allali B., El Kettani A., Dehbi H. 13q interstitial deletion in a moroccan child with hereditary retinoblastoma and intellectual disability: A case report. Annals of medicine and surgery. 2020 Nov 7;60:334-337.
doi: 10.1016/j.amsu.2020.10.063
Özdemir Özdoğan G., Kaya H. Next-Generation Sequencing Data Analysis on Pool-Seq and Low-Coverage Retinoblastoma Data. Interdisciplinary sciences, computational life sciences. 2020 Jun 9.
doi: 10.1007/s12539-020-00374-8
Oatess T.L., Chen P.H., Daniels A.B., Himmel L.E. Severe Periocular Edema after Intraarterial Carboplatin Chemotherapy for Retinoblastoma in a Rabbit (Oryctolagus cuniculus) Model. // Comparative Medicine. 2020 Mar 11.
doi: 10.30802/AALAS-CM-18-000146
O'Donnell N, Howell D, Morgan JE, Phillips B. "That's All Anyone Needs Really, Support": A Content Analysis of Retinoblastoma Survivors' Psychosocial Support Needs. Pediatr Blood Cancer. 2025 Aug;72(8):e31787. Epub 2025 May 12. PMID: 40353373.
doi: 10.1002/pbc.31787
O'Donnell N., Phillips B., Morgan J.E. et al. 'It's not meant to be for life, but it carries on': a qualitative investigation into the psychosocial needs of young retinoblastoma survivors. BMJ open. 2024-05-12;14(4):e082779
doi: 10.1136/bmjopen-2023-082779
Ohan H., Minassian G., Minassian H., Farooq T., Zdilla M.J. Retinoblastoma in Infancy with Subsequent Bladder Leiomyosarcoma in Adulthood: Genomic Considerations.Urology. 2020 Mar 19
doi: 10.1016/j.urology.2020.03.010
Oguro S., Chen Y.N., Yamane T. et al. Selective ophthalmic arterial injection using a balloon catheter for retinoblastoma: a seven-year clinical evaluation. Japanese journal of ophthalmology. 2024-08-27;68(4):346-354
doi: 10.1007/s10384-024-01067-1
Oke I., Diller L.R., Gonzalez E. Advanced retinoblastoma presenting with cataract in a child with limited access to primary care. J Pediatr. 2022 May 13:S0022-3476(22)00427-9.
doi: 10.1016/j.jpeds.2022.05.019
Oke I, Gonzalez E, Elze T, Miller JW, Lorch AC, Hunter DG, Yeh JM, Diller LR, Wu AC; IRIS® Registry Analytic Center Consortium. The Association of Race, Ethnicity, and Insurance Status with the Visual Acuity of Retinoblastoma Survivors in the IRIS® Registry. Ophthalmic Epidemiol. 2025 Feb;32(1):18-24. Epub 2024 Apr 5. PMID: 38578693.
doi: 10.1080/09286586.2024.2315075
Omais S., El Atie Y.E., Ghanem N. et al. Rb deficiency, neuronal survival and neurodegeneration: In search of the perfect mouse model. Current research in neurobiology. 2023-02-02;4(4):100074
doi: 10.1016/j.crneur.2023.100074
Omidakhsh N, Hansen J, Ritz B, Coleman AL, McKean-Cowdin R, Olsen J, Heck JE. Parental Occupation and Risk of Childhood Retinoblastoma in Denmark. J Occup Environ Med. 2021 Mar 1;63(3):256-261.
doi: 10.1097/JOM.0000000000002120
Omotoso B.R., Harrichandparsad R., Lazarus L. et al. Ophthalmic artery arising from the external carotid artery system: the middle meningeal artery in South African patients. BMC ophthalmology. 2023-05-31;23(1):238
doi: 10.1186/s12886-023-02996-0
Onishi T., Nishina S., Yokoi T. et al. Outcomes of five cases of retinoblastoma with optic nerve invasion on imaging. Japanese journal of ophthalmology. 2024-12-02;68(6):741-750
doi: 10.1007/s10384-024-01112-z
Onugwu A.L., Ugorji O.L., Ufondu C.A. et al. Nanoparticle-based delivery systems as emerging therapy in retinoblastoma: recent advances, challenges and prospects. Nanoscale advances. 2023-09-16;5(18):4628-4648
doi: 10.1039/d3na00462g
Ophthalmic surgery, lasers & imaging retina. 2020 Dec 1;51(12):732.
doi: 10.3928/23258160-20201202-09
Opitz M., Bos D., Deuschl C., Radbruch A., Zensen S., Sirin S., Forsting M., Bechrakis N., Biewald E., Bornfeld N., Ketteler P., Timmermann B., Stuschke M., Guberina M., Wetter A., Göricke S., Guberina N. Estimation of radiation exposure of children undergoing superselective intra-arterial chemotherapy for retinoblastoma treatment: assessment of local diagnostic reference levels as a function of age, sex, and interventional success. Neuroradiology. 2020 Aug 29.
doi: 10.1007/s00234-020-02540-7
Opitz M., Wetter A., Guberina N. Thoughts on "Estimation of radiation exposure of children undergoing superselective, intra-arterial chemotherapy for retinoblastoma treatment: Assessment of Local Diagnostic Reference Levels as a function of age, sex and interventional success". Neuroradiology. 2020 Nov 3.
doi: 10.1007/s00234-020-02594-7
Oporto J.I., Zúñiga P., Ossandón D., Zanolli M., Pérez V., López J.P., Stetcher X., Rodríguez A., Puentes Á., Rustom S., Lobos J. Intra-arterial chemotherapy for retinoblastoma treatment in Chile: experience and results 2013-2020.
Archivos de la Sociedad Española de Oftalmología. 2020 Dec 2:S0365-6691(20)30391-9.
doi: 10.1016/j.oftal.2020.10.002
Oporto J.I., Zúñiga P., Ossandón D., Zanolli M., Pérez V., López J.P., Stetcher X., Rodríguez A., Puentes Á., Rustom S., Lobos J. Intra-arterial chemotherapy for retinoblastoma treatment in Chile: Experience and results 2013-2020. Archivos de la Sociedad Española de Oftalmología. 2021 Jun;96(6):288-292.
doi: 10.1016/j.oftale.2020.10.003
Orman G., Huisman TAGM. et al. A descriptive neuroimaging study of retinoblastoma in children: magnetic resonance imaging features. Polish journal of radiology. 2022-08-19;87(87):e363-e368
doi: 10.5114/pjr.2022.118107
Oronowicz J., Reinhard J., Reinach P.S., Ludwiczak S., Luo H., Omar Ba Salem M.H., Kraemer M.M., Biebermann H., Kakkassery V., Mergler S. Ascorbate-induced oxidative stress mediates TRP channel activation and cytotoxicity in human etoposide-sensitive and -resistant retinoblastoma cells. Laboratory investigation; a journal of technical methods and pathology. 2020 Sep 18.
doi: 10.1038/s41374-020-00485-2
Orjuela-Grimm M., Carreño S.B., Liu X., Ruiz A., Medina P., Ramirez Ortiz M.A., Rendon J.R., Molina N.C.L., Pinilla H., Hinojosa D., Rodriguez L., Connor A.O., Rodriguez F.M., Castañeda M.V.P., Cabrera-Muñoz L. Sunlight exposure in infancy decreases risk of sporadic retinoblastoma, extent of intraocular disease.
Cancer Reports. 2021 May 7:e1409.
doi: 10.1002/cnr2.1409
Osuna-Marco M.P., López-Barahona M., López-Ibor B., Tejera Á.M. Ten Reasons Why People With Down Syndrome are Protected From the Development of Most Solid Tumors -A Review. Front Genet. 2021 Nov 5;12:749480.
doi: 10.3389/fgene.2021.749480
Outtaleb F.Z., Kora L., Jabrane G., Serbati N., El Maaloum L., Allali B., El Kettani A., Dehbi H. 13q interstitial deletion in a moroccan child with hereditary retinoblastoma and intellectual disability: A case report. Annals of medicine and surgery. 2020 Nov 7;60:334-337.
doi: 10.1016/j.amsu.2020.10.063
Özdemir Özdoğan G., Kaya H. Next-Generation Sequencing Data Analysis on Pool-Seq and Low-Coverage Retinoblastoma Data. Interdisciplinary sciences, computational life sciences. 2020 Jun 9.
doi: 10.1007/s12539-020-00374-8
P
Pacheco R.R., Vaidya S., Shields C.L. Benefit of Patching Therapy to Minimize Amblyopia After Retinoblastoma Treatment. Ophthalmology. Retina. 2020 Jun;4.
doi: 10.1016/j.oret.2020.01.013
Padamandala K., Vemuganti G.K., Prasad M.S.D. et al. Quality of life of Retinoblastoma survivors in tertiary care eye hospital in South India. Indian journal of ophthalmology. 2024-11-20;72(10):1433-1441
doi: 10.4103/IJO.IJO_2857_23
Palkonda V.A.R., Ramachandran A., Adewara B.A. et al. Ruthenium-106 ( Brachytherapy. 2024-11-23
doi: 10.1016/j.brachy.2024.06.008
Pai V., Muthusami P., Ertl-Wagner B. et al. Diagnostic Imaging for Retinoblastoma Cancer Staging: Guide for Providing Essential Insights for Ophthalmologists and Oncologists. Radiographics : a review publication of the Radiological Society of North America, Inc. 2024-03-28;44(4):e230125
doi: 10.1148/rg.230125
Pai V, Parra-Fariñas C, Shaikh F, Mallipatna A, Zaarour C, Muthusami P. An updated review of intra-arterial chemotherapy for retinoblastoma. Radiologia (Engl Ed). 2025 Mar-Apr;67(2):162-175. Epub 2025 Mar 1. PMID: 40187809.
doi: 10.1016/j.rxeng.2025.02.001
Palkonda VAR, Ramachandran A, Adewara BA, Verma R, Raval V, Kaliki S. Ruthenium-106 (106Ru) plaque brachytherapy as salvage treatment for retinoblastoma following intravenous chemotherapy. Brachytherapy. 2025 Jan-Feb;24(1):76-85. Epub 2024 Nov 22. PMID: 39580311.
doi: 10.1016/j.brachy.2024.06.008
Pallavi R, Soni BL, Jha GK, Sanyal S, Fatima A, Kaliki S. Tumor heterogeneity in retinoblastoma: a literature review. Cancer Metastasis Rev. 2025 Apr 22;44(2):46. PMID: 40259075; PMCID: PMC12011974.
doi: 10.1007/s10555-025-10263-5
Palomar-Siles M., Yurevych V., Bykov V.J.N. et al. Pharmacological induction of translational readthrough of nonsense mutations in the retinoblastoma (RB1) gene. PloS one. 2023-11-06;18(11):e0292468
doi: 10.1371/journal.pone.0292468
Pan W., Chaudhary N., Sedig L. et al. Scleral ectasia stabilization following intra-arterial chemotherapy in an eye with recurrent retinoblastoma. American journal of ophthalmology case reports. 2023-11-03;32(32):101941
doi: 10.1016/j.ajoc.2023.101941
Panigrahi A., Singh A., Gupta S. et al. Diffuse infiltrating retinoblastoma: a panuveitis masquerade. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2023-11-21;58(6):e246-e247
doi: 10.1016/j.jcjo.2023.07.007
Panthagani J., Montecinos P., López J.P., Parulekar M. Cystoid macular edema following intravitreal chemotherapy treatment for retinoblastoma. Pediatric blood & cancer. 2020 Jul 7.
doi: 10.1002/pbc.28348
Pareek A., Kumar D., Pareek A. et al. Retinoblastoma: An update on genetic origin, classification, conventional to next-generation treatment strategies. Heliyon. 2024-07-09;10(12):e32844
doi: 10.1016/j.heliyon.2024.e32844
Pascual-Pasto G., McIntyre B., Giudice A.M. et al. Targeting GPC2 on Intraocular and CNS Metastatic Retinoblastomas with Local and Systemic Delivery of CAR T Cells. Clinical cancer research : an official journal of the American Association for Cancer Research. 2024-08-21;30(16):3578-3591
doi: 10.1158/1078-0432.CCR-24-0221
Passos Gibson V., Mouna Derbali R., Trong Phan H., Tahiri H., Allen C., Hardy P., Leblond Chain J. Survivin silencing improved the cytotoxicity of carboplatin and melphalan in Y79 and primary retinoblastoma cells. International journal of pharmaceutics. 2020 Aug 27
doi: 10.1016/j.ijpharm.2020.119824
Patel J.M., Goss A., Garber J.E., Torous V., Richardson E.T., Haviland M.J., Hacker M.R., Freeman G.J., Nalven T., Alexander B., Lee L., Collins L.C., Schnitt S.J., Tung N. Retinoblastoma protein expression and its predictors in triple-negative breast cancer. NPJ breast cancer. 2020 Jun 5.
doi: 10.1038/s41523-020-0160-4
Patel S., Vogel J., Bradley K., Chuba P.J., Buchsbaum J., Krasin M.J. Rare tumors: Retinoblastoma, nasopharyngeal cancer, and adrenocorticoid tumors. Pediatric blood & cancer. 2021 May;68 Suppl 2:e28253.
doi: 10.1002/pbc.28253
PDQ Pediatric Treatment Editorial Board. Retinoblastoma Treatment (PDQ®): Patient Version. 2021 Mar 22. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–.
PDQ Pediatric Treatment Editorial Board. Retinoblastoma Treatment (PDQ®): Health Professional Version. 2023 Apr 11. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. 2023 Apr. PMID: 26389442.
PDQ Pediatric Treatment Editorial Board. Retinoblastoma Treatment (PDQ®): Health Professional Version. 2025 Apr 3. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389442.
Peck T., Gervasio K.A., Zhang P.JL., Shields C.L., Lally S.E., Eagle R.C. Jr, Milman T. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma with Myxoid Stroma in a Hereditary Retinoblastoma Survivor. Ocular Oncology and Pathology. 2020 Mar 6
DOI: 10.1159/000501523
Peeler C.E., Gonzalez E. Retinoblastoma. N Engl J Med. 2022 Jun 23;386(25):2412. PMID: 35731655.
doi: 10.1056/NEJMicm2118356
Peña-Balderas AM, Martínez-Sánchez M, Olmos-Sánchez I, Calderón-González K, Moctezuma-Dávila M, Rangel-Charqueño M, Hernández-Monge J, Olivares-Illana V. Analysis of pathogenic variants in retinoblastoma reveals a potential gain of function mutation. Genes Cancer. 2025 Jan 20;16:1-15. PMID: 39845333; PMCID: PMC11748778.
doi: 10.18632/genesandcancer.239
Pendri P.R., Chantada G. et al. Controversies in the Management of Choroidal Invasion in Retinoblastoma. International ophthalmology clinics. 2022-09-30;62(4):27-37
doi: 10.1097/IIO.0000000000000425
Pereira S.M., Lima R.V., Bezerra Filho C.O.A. et al. Retinoblastoma in Ceara: An epidemiological study in a Brazilian pediatric oncology referral center. Arquivos brasileiros de oftalmologia. 2024-09-25;88(2):e20230265
doi: 10.5935/0004-2749.2023-0265
Pérez-Becerra J.J., Rodríguez-Machuca V.U., González-Rodríguez M.T.A. et al. De Novo RB1 Germline Variant in Retinoblastoma with Two Subsequent Independent Neoplasms: Case Report and Literature Review. International journal of molecular sciences. 2024-11-30;25(22)
doi: 10.3390/ijms252212338
Perrin EL., Porter RG. et al. Indocyanine green angiography guided photocoagulation of large microvascular abnormalities ("TelCaps") in a patient with persistent macula oedema in the context of radiation retinopathy. Retinal cases & brief reports. 2022-12-13
doi: 10.1097/ICB.0000000000001378
Persaud Y., Seddiq M., Wu Y.M., Robinson D.R., Poulik J., Altinok D., Roarty J.D., Mody R., Taub J.W. Unusual clinical behavior of a very late retinoblastoma relapse in a patient with a germline RB mutation. Pediatric blood & cancer. 2021 May 18:e29064.
doi: 10.1002/pbc.29064
Phan T.A.T., Derumigny A., Duong M.C. et al. Conservative treatment using laser diode and systemic chemotherapy for early-stage bilateral retinoblastoma: A 14-year prospective cohort study. Cancer reports (Hoboken, N.J.). 2023-10-18:e1919
doi: 10.1002/cnr2.1919
Pi X., Zhang Q., Wang X. et al. Retinoblastoma and polydactyly in a child with 46, XY, 15pstk+ karyotype-A case report and literature review. Molecular genetics & genomic medicine. 2024-03-20;12(3):e2414
doi: 10.1002/mgg3.2414
Pike S., Peng C.C., Neviani P. et al. CD63/81 Small Extracellular Vesicles in the Aqueous Humor are Retinoblastoma Associated. Investigative ophthalmology & visual science. 2023-11-16;64(10):5
doi: 10.1167/iovs.64.10.5
PLOS ONE Editors. Expression of Concern: RNAi Mediated Tiam1 Gene Knockdown Inhibits Invasion of Retinoblastoma. PLoS One. 2021 May 26;16(5):e0252495.
doi: 10.1371/journal.pone.0252495
Plousiou M., De Vita A., Miserocchi G. et al. Growth Inhibition of Retinoblastoma Cell Line by Exosome-Mediated Transfer of miR-142-3p. Cancer management and research. 2022-07-16;14(14):2119-2131
doi: 10.2147/CMAR.S351979
Polski A., Xu L., Prabakar R.K., Kim J.W., Shah R., Jubran R., Kuhn P., Cobrinik D., Hicks J., Berry J.L. Cell-Free DNA Tumor Fraction in the Aqueous Humor Is Associated With Therapeutic Response in Retinoblastoma Patients. Translational vision science & technology. 2020 Sep 30
doi: 10.1167/tvst.9.10.30
Polski A., Xu L., Prabakar R.K., Gai X., Kim J.W., Shah R., Jubran R., Kuhn P., Cobrinik D., Hicks J., Berry J.L. Variability in retinoblastoma genome stability is driven by age and not heritability. Genes, chromosomes & cancer. 2020 May 11.
doi: 10.1002/gcc.22859
Ponces Ramalhão J., Rodrigues D., Vieira B. et al. Giant Conjunctival Cyst of the Orbit in a Patient with Previous Enucleation. Case reports in ophthalmology. 2024-03-26;15(1):250-255
doi: 10.1159/000535598
Popovа V., Tomčíkovа D., Bušаnyovа B. et al. Late choroidal neovascular complications in a patient treated for a retinoblastoma. A case report. Ceska a slovenska oftalmologie: casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti. 2022-12-23;78(6):320-324
doi: 10.31348/2022/32
Portney D.S., Demirci H. et al. Spotlighting Turnover Costs for Pediatric Ocular Oncology Exams under Anesthesia. Ocular oncology and pathology. 2024-12-12;10(4):247-251
doi: 10.1159/000541659
Poudyal P., Hamal D., Shrestha P. et al. Orbital Tumors and Tumor like Lesions: A Hospital Based Study. Journal of Nepal Health Research Council. 2022-08-11;20(1):26-32
doi: 10.33314/jnhrc.v20i01.3727
Prajantawanich K., Sanpakit K., Narkbunnam N., Vathana N., Takpradit C., Phuakpet K., Pongtanakul B., Atchaneeyasakul L.O., Sinlapamongkolkul P., Buaboonnam J. Clinical Outcomes and Prognostic Factors of Thai Retinoblastoma Patients. Pediatrics international : official journal of the Japan Pediatric Society. 2020 Oct 6.
doi: 10.1111/ped.14498
Privitera F., Calonaci A., Doddato G., Papa F.T., Baldassarri M., Pinto A.M., Mari F., Longo I., Caini M., Galimberti D., Hadjistilianou T., De Francesco S., Renieri A., Ariani F. 13q Deletion Syndrome Involving RB1: Characterization of a New Minimal Critical Region for Psychomotor Delay. Genes (Basel). 2021 Aug 26;12(9):1318.
doi: 10.3390/genes12091318
Price E.A., Patel R., Scheimberg I., Kotiloglu Karaa E., Sagoo M.S,, Reddy M.A., Onadim Z. MYCN amplification levels in primary retinoblastoma tumors analyzed by Multiple Ligation-dependent Probe Amplification. Ophthalmic genetics. 2021 May 18:1-8.
doi: 10.1080/13816810.2021.1923038
Price E.A., Patel R., Scheimberg I., Kotiloglu Karaa E., Sagoo M.S., Reddy M.A., Onadim Z. MYCN amplification levels in primary retinoblastoma tumors analyzed by Multiple Ligation-dependent Probe Amplification. Ophthalmic Genet. 2021 Oct;42(5):604-611.
doi: 10.1080/13816810.2021.1923038
Price E.A., Sagoo M.S., Reddy M.A. et al. An overview of RB1 transcript alterations detected during retinoblastoma genetic screening. Ophthalmic genetics. 2023-11-06:1-11
doi: 10.1080/13816810.2023.2270570
Pacheco R.R., Vaidya S., Shields C.L. Benefit of Patching Therapy to Minimize Amblyopia After Retinoblastoma Treatment. Ophthalmology. Retina. 2020 Jun;4.
doi: 10.1016/j.oret.2020.01.013
Padamandala K., Vemuganti G.K., Prasad M.S.D. et al. Quality of life of Retinoblastoma survivors in tertiary care eye hospital in South India. Indian journal of ophthalmology. 2024-11-20;72(10):1433-1441
doi: 10.4103/IJO.IJO_2857_23
Palkonda V.A.R., Ramachandran A., Adewara B.A. et al. Ruthenium-106 ( Brachytherapy. 2024-11-23
doi: 10.1016/j.brachy.2024.06.008
Pai V., Muthusami P., Ertl-Wagner B. et al. Diagnostic Imaging for Retinoblastoma Cancer Staging: Guide for Providing Essential Insights for Ophthalmologists and Oncologists. Radiographics : a review publication of the Radiological Society of North America, Inc. 2024-03-28;44(4):e230125
doi: 10.1148/rg.230125
Pai V, Parra-Fariñas C, Shaikh F, Mallipatna A, Zaarour C, Muthusami P. An updated review of intra-arterial chemotherapy for retinoblastoma. Radiologia (Engl Ed). 2025 Mar-Apr;67(2):162-175. Epub 2025 Mar 1. PMID: 40187809.
doi: 10.1016/j.rxeng.2025.02.001
Palkonda VAR, Ramachandran A, Adewara BA, Verma R, Raval V, Kaliki S. Ruthenium-106 (106Ru) plaque brachytherapy as salvage treatment for retinoblastoma following intravenous chemotherapy. Brachytherapy. 2025 Jan-Feb;24(1):76-85. Epub 2024 Nov 22. PMID: 39580311.
doi: 10.1016/j.brachy.2024.06.008
Pallavi R, Soni BL, Jha GK, Sanyal S, Fatima A, Kaliki S. Tumor heterogeneity in retinoblastoma: a literature review. Cancer Metastasis Rev. 2025 Apr 22;44(2):46. PMID: 40259075; PMCID: PMC12011974.
doi: 10.1007/s10555-025-10263-5
Palomar-Siles M., Yurevych V., Bykov V.J.N. et al. Pharmacological induction of translational readthrough of nonsense mutations in the retinoblastoma (RB1) gene. PloS one. 2023-11-06;18(11):e0292468
doi: 10.1371/journal.pone.0292468
Pan W., Chaudhary N., Sedig L. et al. Scleral ectasia stabilization following intra-arterial chemotherapy in an eye with recurrent retinoblastoma. American journal of ophthalmology case reports. 2023-11-03;32(32):101941
doi: 10.1016/j.ajoc.2023.101941
Panigrahi A., Singh A., Gupta S. et al. Diffuse infiltrating retinoblastoma: a panuveitis masquerade. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2023-11-21;58(6):e246-e247
doi: 10.1016/j.jcjo.2023.07.007
Panthagani J., Montecinos P., López J.P., Parulekar M. Cystoid macular edema following intravitreal chemotherapy treatment for retinoblastoma. Pediatric blood & cancer. 2020 Jul 7.
doi: 10.1002/pbc.28348
Pareek A., Kumar D., Pareek A. et al. Retinoblastoma: An update on genetic origin, classification, conventional to next-generation treatment strategies. Heliyon. 2024-07-09;10(12):e32844
doi: 10.1016/j.heliyon.2024.e32844
Pascual-Pasto G., McIntyre B., Giudice A.M. et al. Targeting GPC2 on Intraocular and CNS Metastatic Retinoblastomas with Local and Systemic Delivery of CAR T Cells. Clinical cancer research : an official journal of the American Association for Cancer Research. 2024-08-21;30(16):3578-3591
doi: 10.1158/1078-0432.CCR-24-0221
Passos Gibson V., Mouna Derbali R., Trong Phan H., Tahiri H., Allen C., Hardy P., Leblond Chain J. Survivin silencing improved the cytotoxicity of carboplatin and melphalan in Y79 and primary retinoblastoma cells. International journal of pharmaceutics. 2020 Aug 27
doi: 10.1016/j.ijpharm.2020.119824
Patel J.M., Goss A., Garber J.E., Torous V., Richardson E.T., Haviland M.J., Hacker M.R., Freeman G.J., Nalven T., Alexander B., Lee L., Collins L.C., Schnitt S.J., Tung N. Retinoblastoma protein expression and its predictors in triple-negative breast cancer. NPJ breast cancer. 2020 Jun 5.
doi: 10.1038/s41523-020-0160-4
Patel S., Vogel J., Bradley K., Chuba P.J., Buchsbaum J., Krasin M.J. Rare tumors: Retinoblastoma, nasopharyngeal cancer, and adrenocorticoid tumors. Pediatric blood & cancer. 2021 May;68 Suppl 2:e28253.
doi: 10.1002/pbc.28253
PDQ Pediatric Treatment Editorial Board. Retinoblastoma Treatment (PDQ®): Patient Version. 2021 Mar 22. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–.
PDQ Pediatric Treatment Editorial Board. Retinoblastoma Treatment (PDQ®): Health Professional Version. 2023 Apr 11. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. 2023 Apr. PMID: 26389442.
PDQ Pediatric Treatment Editorial Board. Retinoblastoma Treatment (PDQ®): Health Professional Version. 2025 Apr 3. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389442.
Peck T., Gervasio K.A., Zhang P.JL., Shields C.L., Lally S.E., Eagle R.C. Jr, Milman T. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma with Myxoid Stroma in a Hereditary Retinoblastoma Survivor. Ocular Oncology and Pathology. 2020 Mar 6
DOI: 10.1159/000501523
Peeler C.E., Gonzalez E. Retinoblastoma. N Engl J Med. 2022 Jun 23;386(25):2412. PMID: 35731655.
doi: 10.1056/NEJMicm2118356
Peña-Balderas AM, Martínez-Sánchez M, Olmos-Sánchez I, Calderón-González K, Moctezuma-Dávila M, Rangel-Charqueño M, Hernández-Monge J, Olivares-Illana V. Analysis of pathogenic variants in retinoblastoma reveals a potential gain of function mutation. Genes Cancer. 2025 Jan 20;16:1-15. PMID: 39845333; PMCID: PMC11748778.
doi: 10.18632/genesandcancer.239
Pendri P.R., Chantada G. et al. Controversies in the Management of Choroidal Invasion in Retinoblastoma. International ophthalmology clinics. 2022-09-30;62(4):27-37
doi: 10.1097/IIO.0000000000000425
Pereira S.M., Lima R.V., Bezerra Filho C.O.A. et al. Retinoblastoma in Ceara: An epidemiological study in a Brazilian pediatric oncology referral center. Arquivos brasileiros de oftalmologia. 2024-09-25;88(2):e20230265
doi: 10.5935/0004-2749.2023-0265
Pérez-Becerra J.J., Rodríguez-Machuca V.U., González-Rodríguez M.T.A. et al. De Novo RB1 Germline Variant in Retinoblastoma with Two Subsequent Independent Neoplasms: Case Report and Literature Review. International journal of molecular sciences. 2024-11-30;25(22)
doi: 10.3390/ijms252212338
Perrin EL., Porter RG. et al. Indocyanine green angiography guided photocoagulation of large microvascular abnormalities ("TelCaps") in a patient with persistent macula oedema in the context of radiation retinopathy. Retinal cases & brief reports. 2022-12-13
doi: 10.1097/ICB.0000000000001378
Persaud Y., Seddiq M., Wu Y.M., Robinson D.R., Poulik J., Altinok D., Roarty J.D., Mody R., Taub J.W. Unusual clinical behavior of a very late retinoblastoma relapse in a patient with a germline RB mutation. Pediatric blood & cancer. 2021 May 18:e29064.
doi: 10.1002/pbc.29064
Phan T.A.T., Derumigny A., Duong M.C. et al. Conservative treatment using laser diode and systemic chemotherapy for early-stage bilateral retinoblastoma: A 14-year prospective cohort study. Cancer reports (Hoboken, N.J.). 2023-10-18:e1919
doi: 10.1002/cnr2.1919
Pi X., Zhang Q., Wang X. et al. Retinoblastoma and polydactyly in a child with 46, XY, 15pstk+ karyotype-A case report and literature review. Molecular genetics & genomic medicine. 2024-03-20;12(3):e2414
doi: 10.1002/mgg3.2414
Pike S., Peng C.C., Neviani P. et al. CD63/81 Small Extracellular Vesicles in the Aqueous Humor are Retinoblastoma Associated. Investigative ophthalmology & visual science. 2023-11-16;64(10):5
doi: 10.1167/iovs.64.10.5
PLOS ONE Editors. Expression of Concern: RNAi Mediated Tiam1 Gene Knockdown Inhibits Invasion of Retinoblastoma. PLoS One. 2021 May 26;16(5):e0252495.
doi: 10.1371/journal.pone.0252495
Plousiou M., De Vita A., Miserocchi G. et al. Growth Inhibition of Retinoblastoma Cell Line by Exosome-Mediated Transfer of miR-142-3p. Cancer management and research. 2022-07-16;14(14):2119-2131
doi: 10.2147/CMAR.S351979
Polski A., Xu L., Prabakar R.K., Kim J.W., Shah R., Jubran R., Kuhn P., Cobrinik D., Hicks J., Berry J.L. Cell-Free DNA Tumor Fraction in the Aqueous Humor Is Associated With Therapeutic Response in Retinoblastoma Patients. Translational vision science & technology. 2020 Sep 30
doi: 10.1167/tvst.9.10.30
Polski A., Xu L., Prabakar R.K., Gai X., Kim J.W., Shah R., Jubran R., Kuhn P., Cobrinik D., Hicks J., Berry J.L. Variability in retinoblastoma genome stability is driven by age and not heritability. Genes, chromosomes & cancer. 2020 May 11.
doi: 10.1002/gcc.22859
Ponces Ramalhão J., Rodrigues D., Vieira B. et al. Giant Conjunctival Cyst of the Orbit in a Patient with Previous Enucleation. Case reports in ophthalmology. 2024-03-26;15(1):250-255
doi: 10.1159/000535598
Popovа V., Tomčíkovа D., Bušаnyovа B. et al. Late choroidal neovascular complications in a patient treated for a retinoblastoma. A case report. Ceska a slovenska oftalmologie: casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti. 2022-12-23;78(6):320-324
doi: 10.31348/2022/32
Portney D.S., Demirci H. et al. Spotlighting Turnover Costs for Pediatric Ocular Oncology Exams under Anesthesia. Ocular oncology and pathology. 2024-12-12;10(4):247-251
doi: 10.1159/000541659
Poudyal P., Hamal D., Shrestha P. et al. Orbital Tumors and Tumor like Lesions: A Hospital Based Study. Journal of Nepal Health Research Council. 2022-08-11;20(1):26-32
doi: 10.33314/jnhrc.v20i01.3727
Prajantawanich K., Sanpakit K., Narkbunnam N., Vathana N., Takpradit C., Phuakpet K., Pongtanakul B., Atchaneeyasakul L.O., Sinlapamongkolkul P., Buaboonnam J. Clinical Outcomes and Prognostic Factors of Thai Retinoblastoma Patients. Pediatrics international : official journal of the Japan Pediatric Society. 2020 Oct 6.
doi: 10.1111/ped.14498
Privitera F., Calonaci A., Doddato G., Papa F.T., Baldassarri M., Pinto A.M., Mari F., Longo I., Caini M., Galimberti D., Hadjistilianou T., De Francesco S., Renieri A., Ariani F. 13q Deletion Syndrome Involving RB1: Characterization of a New Minimal Critical Region for Psychomotor Delay. Genes (Basel). 2021 Aug 26;12(9):1318.
doi: 10.3390/genes12091318
Price E.A., Patel R., Scheimberg I., Kotiloglu Karaa E., Sagoo M.S,, Reddy M.A., Onadim Z. MYCN amplification levels in primary retinoblastoma tumors analyzed by Multiple Ligation-dependent Probe Amplification. Ophthalmic genetics. 2021 May 18:1-8.
doi: 10.1080/13816810.2021.1923038
Price E.A., Patel R., Scheimberg I., Kotiloglu Karaa E., Sagoo M.S., Reddy M.A., Onadim Z. MYCN amplification levels in primary retinoblastoma tumors analyzed by Multiple Ligation-dependent Probe Amplification. Ophthalmic Genet. 2021 Oct;42(5):604-611.
doi: 10.1080/13816810.2021.1923038
Price E.A., Sagoo M.S., Reddy M.A. et al. An overview of RB1 transcript alterations detected during retinoblastoma genetic screening. Ophthalmic genetics. 2023-11-06:1-11
doi: 10.1080/13816810.2023.2270570
Q
Qahtani Al. M., AlMasfer S., Khandekar R. Health related quality of life of patients treated with bilateral enucleation for retinoblastoma. Eur J Ophthalmol. 2021 Aug16:11206721211035637.
doi: 10.1177/11206721211035637
Qin A. et al. An anti-cancer surveillance by the interplay between interferon-beta and retinoblastoma protein RB1. Frontiers in oncology. 2023-05-16;13(13):1173467
doi: 10.3389/fonc.2023.1173467
Quan L, Wang M, Wang Z, Du Z. LIFU (Low-Intensity Focused Ultrasound) Activated Tumor-Starvation/Oxidative-Stress Combined Therapy for Treating Retinoblastoma. Int J Nanomedicine. 2025 Apr 3;20:4085-4103. PMID: 40196026; PMCID: PMC11975011.
doi: 10.2147/IJN.S506179
Quintero-Estades J.A., Izquierdo N.J. et al. Determining the Incidence of Retinoblastoma and Survival Rate of Retinoblastoma Patients in Puerto Rico using the Cancer Registry of Puerto Rico (1985-2012). Puerto Rico health sciences journal. 2022-09-12;41(3):149-152
Qahtani Al. M., AlMasfer S., Khandekar R. Health related quality of life of patients treated with bilateral enucleation for retinoblastoma. Eur J Ophthalmol. 2021 Aug16:11206721211035637.
doi: 10.1177/11206721211035637
Qin A. et al. An anti-cancer surveillance by the interplay between interferon-beta and retinoblastoma protein RB1. Frontiers in oncology. 2023-05-16;13(13):1173467
doi: 10.3389/fonc.2023.1173467
Quan L, Wang M, Wang Z, Du Z. LIFU (Low-Intensity Focused Ultrasound) Activated Tumor-Starvation/Oxidative-Stress Combined Therapy for Treating Retinoblastoma. Int J Nanomedicine. 2025 Apr 3;20:4085-4103. PMID: 40196026; PMCID: PMC11975011.
doi: 10.2147/IJN.S506179
Quintero-Estades J.A., Izquierdo N.J. et al. Determining the Incidence of Retinoblastoma and Survival Rate of Retinoblastoma Patients in Puerto Rico using the Cancer Registry of Puerto Rico (1985-2012). Puerto Rico health sciences journal. 2022-09-12;41(3):149-152
R
Rabelo B.S., de Alvarenga K.A.F., Fernando Lopes L. et al. Strategies to improve diagnosis and access to treatment of retinoblastoma in low- and middle-income countries: A systematic review. Pediatric blood & cancer. 2024-05-25;71(7):e30987
doi: 10.1002/pbc.30987
Rader A.E., Bayarmagnai B., Frolov M.V. et al. Combined inactivation of RB and Hippo converts differentiating Drosophila photoreceptors into eye progenitor cells through derepression of homothorax. Developmental cell. 2023-11-14;58(21):2261-2274.e6
doi: 10.1016/j.devcel.2023.09.003
Raguraman R., Parameswaran S., Kanwar J.R., Vasudevan M., Chitipothu S., Kanwar R.K., Krishnakumar S. Gene expression profiling of tumor stroma interactions in retinoblastoma. Experimental eye research. 2020 June 22.
doi: 10.1016/j.exer.2020.108067
Rahdar A., Ahmadi M.J., Naseripour M. et al. Semi-supervised segmentation of retinoblastoma tumors in fundus images. Scientific reports. 2023-11-21;13(1):13010
doi: 10.1038/s41598-023-39909-6
Rajput S., Malviya R., Uniyal P. et al. Advancements in the diagnosis, prognosis, and treatment of retinoblastoma. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024-02-29
doi: 10.1016/j.jcjo.2024.01.018
Raizis A.M., Racher H.M., Foucal A., Dimaras H., Gallie B.L., George P.M. DNA hypermethylation/boundary control loss identified in retinoblastomas associated with genetic and epigenetic inactivation of the RB1 gene promoter. Epigenetics. 2020 Dec 1:1-15.
doi: 10.1080/15592294.2020.1834911
Raizis A.M., Racher H.M., Foucal A., Dimaras H., Gallie B.L., George P.M. DNA hypermethylation/boundary control loss identified in retinoblastomas associated with genetic and epigenetic inactivation of the RB1 gene promoter. Epigenetics. 2021 Sep;16(9):940-954.
doi: 10.1080/15592294.2020.1834911
Rajeshuni N., Whittemore A.S., Ludwig C.A., Mruthyunjaya P., Moshfeghi D.M. Reply to Comment on: Racial, Ethnic, and Socioeconomic Disparities in Retinoblastoma Enucleation: A Population-Based Study, SEER 18 2000-2014. American journal of ophthalmology. 2020 Jul 10.
doi: 10.1016/j.ajo.2020.04.038
Rakhshan R., Atashi H.A., Hoseinian M., Jafari A., Haghighi A., Ziyadloo F., Razizadeh N., Ghasemian H., Nia M.M.K., Sefidi A.B., Arani H.Z. The Synergistic Cytotoxic and Apoptotic Effect of Resveratrol and Naringenin on Y79 Retinoblastoma Cell Line. Anti-cancer agents in medicinal chemistry. 2021 Jan 12.
doi: 10.2174/1871520621666210112121051
Ramanujan A., Bansal S., Guha M., Pande N.T., Tiwari S. LxCxD motif of the APC/C coactivator subunit FZR1 is critical for interaction with the retinoblastoma protein. Exp Cell Res. 2021 Jul 15;404(2):112632. Epub 2021 May 8.
doi: 10.1016/j.yexcr.2021.112632
Ramanathan S., Vijayasekharan K. et al. Retinoblastoma: Poster-Child Tumor of the Low-Middle Income Countries (LMICs)!!! South Asian journal of cancer. 2023-02-10;11(4):279-280
doi: 10.1055/s-0042-1759848
Ramasubramanian A., Riemann M., Brown A. et al. Microvascular flow ultrasound imaging for retinoblastoma. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2024-03-18;28(1):103801
doi: 10.1016/j.jaapos.2023.10.003
Ramasubramanian A., Riemann M., Brown A. et al. Three-Dimensional Ultrasound Imaging of Retinoblastoma and Its Correlation With Pathology. Ophthalmic surgery, lasers & imaging retina. 2024-03-13;55(3):136-140
doi: 10.3928/23258160-20240116-02
Ramasubramanian A., Rehman N.S., Chauhan A. et al. Amniotic Membrane Augmentation for Enucleation After Chemotherapy in Retinoblastoma. Journal of pediatric ophthalmology and strabismus. 2024-07-24;61(4):291-295
doi: 10.3928/01913913-20240307-01
Rana N.A., Mahmood A., Robert H.M. et al. Laboratory Evaluation and Pathological Features of Bone Marrow Metastasis in Non-haematological Malignancies. Journal of the College of Physicians and Surgeons--Pakistan: JCPSP. 2022-10-11;32(10):1367-1369.
doi: 10.29271/jcpsp.2022.10.1367
Randhawa J.K., Kim M.E., Polski A., Reid M.W., Mascarenhas K., Brown B., Fabian I.D., Kaliki S., Stacey A.W., Burner E., Sayegh C.S., Poblete R.A., Ji X., Zou Y., Sultana S., Rashid R., Sherief S.T., Cassoux N., Garcia J., Coronado R.D., López A.M.Z., Ushakova T., Polyakov V.G., Roy S.R., Ahmad A., Reddy M.A., Sagoo M.S., Al Harby L., Astbury N.J., Bascaran C., Blum S., Bowman R., Burton M.J., Gomel N., Keren-Froim N., Madgar S., Zondervan M., Berry J.L. The Effects of Breastfeeding on Retinoblastoma Development: Results from an International Multicenter Retinoblastoma Survey. Cancers (Basel). 2021 Sep 24;13(19):4773.
doi: 10.3390/cancers13194773
Rangel-Charqueño M., Flores C.S., Sánchez Dra M.M. et al. The Bloom Syndrome and Retinoblastoma patient exhibits two RB1 gene mutations in the germline. Retinal cases & brief reports. 2024-11-11
doi: 10.1097/ICB.0000000000001691
Ransone E, May C, Silverstein E. Smartphone-Detected Physiologic Photoleukocoria With Visible Optic Nerve Details. Pediatrics. 2025 Apr 1;155(4):e2024068701. PMID: 40074014.
doi: 10.1542/peds.2024-068701
Rastogi N., Kapoor R., Yadav S.P. Haploidentical Hematopoietic Stem Cell Transplantation for Relapsed Metastatic Retinoblastoma. Journal of pediatric hematology/oncology. 2020 Nov;42(8):499.
doi: 10.1097/MPH.0000000000001955
Rathore S., Verma A., Ratna R. et al. Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies. Indian journal of ophthalmology. 2023-11-16;71(7):2662-2676
doi: 10.4103/IJO.IJO_3172_22
Rating P., Bornfeld N., Schlüter S. et al. Long-Term Results after Intraocular Surgery in Treated Retinoblastoma Eyes. Ocular oncology and pathology. 2023-03-21;8(3):161-167
doi: 10.1159/000524610
Ratna H. Heritable Retinoblastoma and Risk of Developing Second Primary Cancer. JAMA Network Open. 2020 Oct 1.
doi: 10.1001/jamanetworkopen.2020.22569
Raval V., Bowen R.C., Soto H., Singh A. Chemotherapy for Retinoblastoma: Impact of Intravitreal Chemotherapy. Asia-Pacific journal of ophthalmology. 2020 Sep 9.
doi: 10.1097/APO.0000000000000322
Raval V., Bowen R.C., Soto H., Singh A. Intravenous Chemotherapy for Retinoblastoma in the Era of Intravitreal Chemotherapy: A Systematic Review. Ocul Oncol Pathol. 2021 Mar;7(2):142-148. Epub 2020 Dec 16.
doi: 10.1159/000510506
Raval V., DeBenedictis M., Bowen R., Soto H., Davanzo J., Singh A. Retinoblastoma in twins: Risk assessment of genotypic variants. Indian journal of ophthalmology. 2021 May;69(5):1230-1233.
doi: 10.4103/ijo.IJO_2811_20
Raval V., Kaliki S. Cavitary retinoblastoma: A review of literature. Surv Ophthalmol. 2021 Oct 11:S0039-6257(21)00188-0.
doi: 10.1016/j.survophthal.2021.10.002
Raval V., Parulekar M., Singh A.D. et al. Emerging New Therapeutics for Retinoblastoma. Ocular oncology and pathology. 2023-03-21;8(3):149-155
doi: 10.1159/000524919
Raval V., Racher H., Wrenn J., Singh A.D. Aqueous humor as a surrogate biomarker for retinoblastoma tumor tissue. J AAPOS. 2022 May 13:S1091-8531(22)00102-1.
doi: 10.1016/j.jaapos.2022.03.005
Raval V., Singh A. et al. Management of retinoblastoma: are we there yet? Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024-03-20
doi: 10.1016/j.jcjo.2024.01.013
Ravindra S.G., Sagar S., Arora S.K. et al. Axillary Lymph Node in Extra-Ocular Retinoblastoma - Benign or Malignant? Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. 2023-12-05;38(3):305-306
doi: 10.4103/ijnm.ijnm_4_23
Ravishankar H., Mangani A.S., Phoebe Moses G.L., Mani S.P., Parameswaran S., Khetan V., Ganesan S., Krishnakumar S. Serum exosomal miRNA as biomarkers for Retinoblastoma.
Experimental eye research.. 2020 Aug 11
doi: 10.1016/j.exer.2020.108184
Rabelo B.S., de Alvarenga K.A.F., Fernando Lopes L. et al. Strategies to improve diagnosis and access to treatment of retinoblastoma in low- and middle-income countries: A systematic review. Pediatric blood & cancer. 2024-05-25;71(7):e30987
doi: 10.1002/pbc.30987
Rader A.E., Bayarmagnai B., Frolov M.V. et al. Combined inactivation of RB and Hippo converts differentiating Drosophila photoreceptors into eye progenitor cells through derepression of homothorax. Developmental cell. 2023-11-14;58(21):2261-2274.e6
doi: 10.1016/j.devcel.2023.09.003
Raguraman R., Parameswaran S., Kanwar J.R., Vasudevan M., Chitipothu S., Kanwar R.K., Krishnakumar S. Gene expression profiling of tumor stroma interactions in retinoblastoma. Experimental eye research. 2020 June 22.
doi: 10.1016/j.exer.2020.108067
Rahdar A., Ahmadi M.J., Naseripour M. et al. Semi-supervised segmentation of retinoblastoma tumors in fundus images. Scientific reports. 2023-11-21;13(1):13010
doi: 10.1038/s41598-023-39909-6
Rajput S., Malviya R., Uniyal P. et al. Advancements in the diagnosis, prognosis, and treatment of retinoblastoma. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024-02-29
doi: 10.1016/j.jcjo.2024.01.018
Raizis A.M., Racher H.M., Foucal A., Dimaras H., Gallie B.L., George P.M. DNA hypermethylation/boundary control loss identified in retinoblastomas associated with genetic and epigenetic inactivation of the RB1 gene promoter. Epigenetics. 2020 Dec 1:1-15.
doi: 10.1080/15592294.2020.1834911
Raizis A.M., Racher H.M., Foucal A., Dimaras H., Gallie B.L., George P.M. DNA hypermethylation/boundary control loss identified in retinoblastomas associated with genetic and epigenetic inactivation of the RB1 gene promoter. Epigenetics. 2021 Sep;16(9):940-954.
doi: 10.1080/15592294.2020.1834911
Rajeshuni N., Whittemore A.S., Ludwig C.A., Mruthyunjaya P., Moshfeghi D.M. Reply to Comment on: Racial, Ethnic, and Socioeconomic Disparities in Retinoblastoma Enucleation: A Population-Based Study, SEER 18 2000-2014. American journal of ophthalmology. 2020 Jul 10.
doi: 10.1016/j.ajo.2020.04.038
Rakhshan R., Atashi H.A., Hoseinian M., Jafari A., Haghighi A., Ziyadloo F., Razizadeh N., Ghasemian H., Nia M.M.K., Sefidi A.B., Arani H.Z. The Synergistic Cytotoxic and Apoptotic Effect of Resveratrol and Naringenin on Y79 Retinoblastoma Cell Line. Anti-cancer agents in medicinal chemistry. 2021 Jan 12.
doi: 10.2174/1871520621666210112121051
Ramanujan A., Bansal S., Guha M., Pande N.T., Tiwari S. LxCxD motif of the APC/C coactivator subunit FZR1 is critical for interaction with the retinoblastoma protein. Exp Cell Res. 2021 Jul 15;404(2):112632. Epub 2021 May 8.
doi: 10.1016/j.yexcr.2021.112632
Ramanathan S., Vijayasekharan K. et al. Retinoblastoma: Poster-Child Tumor of the Low-Middle Income Countries (LMICs)!!! South Asian journal of cancer. 2023-02-10;11(4):279-280
doi: 10.1055/s-0042-1759848
Ramasubramanian A., Riemann M., Brown A. et al. Microvascular flow ultrasound imaging for retinoblastoma. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2024-03-18;28(1):103801
doi: 10.1016/j.jaapos.2023.10.003
Ramasubramanian A., Riemann M., Brown A. et al. Three-Dimensional Ultrasound Imaging of Retinoblastoma and Its Correlation With Pathology. Ophthalmic surgery, lasers & imaging retina. 2024-03-13;55(3):136-140
doi: 10.3928/23258160-20240116-02
Ramasubramanian A., Rehman N.S., Chauhan A. et al. Amniotic Membrane Augmentation for Enucleation After Chemotherapy in Retinoblastoma. Journal of pediatric ophthalmology and strabismus. 2024-07-24;61(4):291-295
doi: 10.3928/01913913-20240307-01
Rana N.A., Mahmood A., Robert H.M. et al. Laboratory Evaluation and Pathological Features of Bone Marrow Metastasis in Non-haematological Malignancies. Journal of the College of Physicians and Surgeons--Pakistan: JCPSP. 2022-10-11;32(10):1367-1369.
doi: 10.29271/jcpsp.2022.10.1367
Randhawa J.K., Kim M.E., Polski A., Reid M.W., Mascarenhas K., Brown B., Fabian I.D., Kaliki S., Stacey A.W., Burner E., Sayegh C.S., Poblete R.A., Ji X., Zou Y., Sultana S., Rashid R., Sherief S.T., Cassoux N., Garcia J., Coronado R.D., López A.M.Z., Ushakova T., Polyakov V.G., Roy S.R., Ahmad A., Reddy M.A., Sagoo M.S., Al Harby L., Astbury N.J., Bascaran C., Blum S., Bowman R., Burton M.J., Gomel N., Keren-Froim N., Madgar S., Zondervan M., Berry J.L. The Effects of Breastfeeding on Retinoblastoma Development: Results from an International Multicenter Retinoblastoma Survey. Cancers (Basel). 2021 Sep 24;13(19):4773.
doi: 10.3390/cancers13194773
Rangel-Charqueño M., Flores C.S., Sánchez Dra M.M. et al. The Bloom Syndrome and Retinoblastoma patient exhibits two RB1 gene mutations in the germline. Retinal cases & brief reports. 2024-11-11
doi: 10.1097/ICB.0000000000001691
Ransone E, May C, Silverstein E. Smartphone-Detected Physiologic Photoleukocoria With Visible Optic Nerve Details. Pediatrics. 2025 Apr 1;155(4):e2024068701. PMID: 40074014.
doi: 10.1542/peds.2024-068701
Rastogi N., Kapoor R., Yadav S.P. Haploidentical Hematopoietic Stem Cell Transplantation for Relapsed Metastatic Retinoblastoma. Journal of pediatric hematology/oncology. 2020 Nov;42(8):499.
doi: 10.1097/MPH.0000000000001955
Rathore S., Verma A., Ratna R. et al. Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies. Indian journal of ophthalmology. 2023-11-16;71(7):2662-2676
doi: 10.4103/IJO.IJO_3172_22
Rating P., Bornfeld N., Schlüter S. et al. Long-Term Results after Intraocular Surgery in Treated Retinoblastoma Eyes. Ocular oncology and pathology. 2023-03-21;8(3):161-167
doi: 10.1159/000524610
Ratna H. Heritable Retinoblastoma and Risk of Developing Second Primary Cancer. JAMA Network Open. 2020 Oct 1.
doi: 10.1001/jamanetworkopen.2020.22569
Raval V., Bowen R.C., Soto H., Singh A. Chemotherapy for Retinoblastoma: Impact of Intravitreal Chemotherapy. Asia-Pacific journal of ophthalmology. 2020 Sep 9.
doi: 10.1097/APO.0000000000000322
Raval V., Bowen R.C., Soto H., Singh A. Intravenous Chemotherapy for Retinoblastoma in the Era of Intravitreal Chemotherapy: A Systematic Review. Ocul Oncol Pathol. 2021 Mar;7(2):142-148. Epub 2020 Dec 16.
doi: 10.1159/000510506
Raval V., DeBenedictis M., Bowen R., Soto H., Davanzo J., Singh A. Retinoblastoma in twins: Risk assessment of genotypic variants. Indian journal of ophthalmology. 2021 May;69(5):1230-1233.
doi: 10.4103/ijo.IJO_2811_20
Raval V., Kaliki S. Cavitary retinoblastoma: A review of literature. Surv Ophthalmol. 2021 Oct 11:S0039-6257(21)00188-0.
doi: 10.1016/j.survophthal.2021.10.002
Raval V., Parulekar M., Singh A.D. et al. Emerging New Therapeutics for Retinoblastoma. Ocular oncology and pathology. 2023-03-21;8(3):149-155
doi: 10.1159/000524919
Raval V., Racher H., Wrenn J., Singh A.D. Aqueous humor as a surrogate biomarker for retinoblastoma tumor tissue. J AAPOS. 2022 May 13:S1091-8531(22)00102-1.
doi: 10.1016/j.jaapos.2022.03.005
Raval V., Singh A. et al. Management of retinoblastoma: are we there yet? Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024-03-20
doi: 10.1016/j.jcjo.2024.01.013
Ravindra S.G., Sagar S., Arora S.K. et al. Axillary Lymph Node in Extra-Ocular Retinoblastoma - Benign or Malignant? Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. 2023-12-05;38(3):305-306
doi: 10.4103/ijnm.ijnm_4_23
Ravishankar H., Mangani A.S., Phoebe Moses G.L., Mani S.P., Parameswaran S., Khetan V., Ganesan S., Krishnakumar S. Serum exosomal miRNA as biomarkers for Retinoblastoma.
Experimental eye research.. 2020 Aug 11
doi: 10.1016/j.exer.2020.108184
Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma
DOI:https://doi.org/10.1016/j.ophtha.2020.05.024
Reddy M.A., Butt M., Hinds A.M., Duncan C., Price E.A., Sagoo M.S., Onadim Z. Prognostic information for known genetic carriers of RB1 pathogenic variants (germline and mosaic).
Ophthalmology. Retina. 2020 Aug 21
doi: 10.1016/j.oret.2020.08.010
Reedy-Cooper A., Scartozzi C., Yurkonis T. et al. Childhood Eye Examination in Primary Care. American family physician. 2023-11-16;108(1):40-50
Reinhard J., Wagner N., Krämer M.M., Jarocki M., Joachim S.C., Dick H.B., Faissner A., Kakkassery V. Expression Changes and Impact of the Extracellular Matrix on Etoposide Resistant Human Retinoblastoma Cell Lines. International journal of molecular sciences. 2020 Jun 17.
doi: 10.3390/ijms21124322
Ren H., Guo X., Li F., Xia Q., Chen Z., Xing Y. Four Autophagy-Related Long Noncoding RNAs Provide Coexpression and ceRNA Mechanisms in Retinoblastoma through Bioinformatics and Experimental Evidence. ACS Omega. 2021 Nov 29;6(49):33976-33984.
doi: 10.1021/acsomega.1c05259
Ren R., Gao L., Li G. et al. 2D, 3D-QSAR study and docking of vascular endothelial growth factor receptor 3 (VEGFR3) inhibitors for potential treatment of retinoblastoma. Frontiers in pharmacology. 2023-04-25;14(14):1177282
doi: 10.3389/fphar.2023.1177282
Reschke M.; Biewald E.; Bronstein L.; Brecht I.B.; Dittner-Moormann S.; Driever F.; Ebinger M.; Fleischhack G.; Grabow D.; Geismar D. et al. Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria. Special Issue Retinoblastoma - Current Therapeutic Challenges and Promising New Approaches. Cancers 2021, 13, 1876.
Retinoblastoma Treatment (PDQ®): Health Professional Version.
https://pubmed.ncbi.nlm.nih.gov/26389442
Requejo F., Opezzo J., Vater A. et al. Pharmacokinetics of Orbital Topotecan After Ophthalmic Artery Chemosurgery and Intravenous Infusion in the Swine Model. Investigative ophthalmology & visual science. 2023-11-21;64(12):3
doi: 10.1167/iovs.64.12.3
Reynolds M., Lueder G., Gordon M., Hayashi R.J. Developmental Delay and School Performance Among Retinoblastoma Survivors: Development/school morbidity among retinoblastoma survivors. American journal of ophthalmology. 2021 May 6:S0002-9394(21)00224-5.
doi: 10.1016/j.ajo.2021.04.025
Reynolds M.M., Sein J., Hayashi R., Lueder G. Treatment of small and medium retinoblastoma tumors with Iris diode laser. European journal of ophthalmology. 2021 Feb 2:1120672121991390.
doi: 10.1177/1120672121991390
Reynolds M., Wise J., Wu T. et al. Characterization of vision in pediatric retinoblastoma survivors beyond visual acuity. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2023-09-12;27(4):188.e1-188.e6
doi: 10.1016/j.jaapos.2023.06.003
Riazi-Esfahani H., Masoomian B., Ghassemi F. Intra-Arterial Chemotherapy: New Hope for Adult Retinoblastoma Treatment-A Case Report and Brief Review. Case reports in ophthalmological medicine. 2021 Jul 9;2021:6639900. PMID: 34336323; PMCID: PMC8289600.
doi: 10.1155/2021/6639900
Riazi-Esfahani H., Masoomian B., Khodabandeh A. et al. Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2022-11-19
doi: 10.1007/s00417-022-05903-3
Riazi-Esfahani H., Shamouli H., Pour E.K. et al. Retinal Optical Coherence Tomography Angiography Findings following Retinoblastoma Treatment by Chemotherapy. Journal of current ophthalmology. 2023-05-16;34(4):452-459
doi: 10.4103/joco.joco_323_21
Ribeiro KB, Veiga LHS, Carvalho Filho NP, Morton LM, Kleinerman RA, Antoneli CBG. Overall survival and cause-specific mortality in a hospital-based cohort of retinoblastoma patients in São Paulo, Brazil. Int J Cancer. 2025 Jan 1;156(1):69-78. Epub 2024 Aug 13. PMID: 39138799; PMCID: PMC11537822.
doi: 10.1002/ijc.35127
Rich V., Plummer K., Padhy S. et al. Captains on call: A qualitative investigation of an intervention to support children with retinoblastoma undergoing regular eye examinations. Psycho-oncology. 2024-03-04;33(3):e6315
doi: 10.1002/pon.6315
Rishi P. Commentary: Current standards in retinoblastoma care. Indian journal of ophthalmology. 2020 Nov;68(11):2367.
doi: 10.4103/ijo.IJO_3198_20
Ristevski I., Flegg K., Al-Hammadi M. et al. Development of a Patient-Centered Pathway of Care for Retinoblastoma Patients: A Mixed-Methods Pilot Study. Oncology. 2024-07-02
doi: 10.1159/000540055
Ristevski I., Kiew J., Hendry M., Prunier M., Noronha R., Al-Hammadi M., Flegg K., Gallie B.L., Paton K., Dimaras H.; Canadian Retinoblastoma Research Advisory Board. The Retinoblastoma Research Booklet: A Catalyst for Patient Involvement in Retinoblastoma Research. Healthc Q. 2022 Apr;24(SP):61-68. PMID: 35467513.
doi: 10.12927/hcq.2022.26772
Ristevski I., Robert J., Baddeliyanage R., Noronha R., Gelkopf M., Flegg K., Low L., Steeves J., Crooks B., Gallie B.L., Dimaras H.; Canadian Retinoblastoma Research Advisory Board. EMPOWER Retinoblastoma: Engaging Patient Partners in Solving the Top 10 Priorities for Eye Cancer Research in Canada. Healthc Q. 2022 Apr;24(SP):11-17. PMID: 35467505
doi: 10.12927/hcq.2022.26780
DOI:https://doi.org/10.1016/j.ophtha.2020.05.024
Reddy M.A., Butt M., Hinds A.M., Duncan C., Price E.A., Sagoo M.S., Onadim Z. Prognostic information for known genetic carriers of RB1 pathogenic variants (germline and mosaic).
Ophthalmology. Retina. 2020 Aug 21
doi: 10.1016/j.oret.2020.08.010
Reedy-Cooper A., Scartozzi C., Yurkonis T. et al. Childhood Eye Examination in Primary Care. American family physician. 2023-11-16;108(1):40-50
Reinhard J., Wagner N., Krämer M.M., Jarocki M., Joachim S.C., Dick H.B., Faissner A., Kakkassery V. Expression Changes and Impact of the Extracellular Matrix on Etoposide Resistant Human Retinoblastoma Cell Lines. International journal of molecular sciences. 2020 Jun 17.
doi: 10.3390/ijms21124322
Ren H., Guo X., Li F., Xia Q., Chen Z., Xing Y. Four Autophagy-Related Long Noncoding RNAs Provide Coexpression and ceRNA Mechanisms in Retinoblastoma through Bioinformatics and Experimental Evidence. ACS Omega. 2021 Nov 29;6(49):33976-33984.
doi: 10.1021/acsomega.1c05259
Ren R., Gao L., Li G. et al. 2D, 3D-QSAR study and docking of vascular endothelial growth factor receptor 3 (VEGFR3) inhibitors for potential treatment of retinoblastoma. Frontiers in pharmacology. 2023-04-25;14(14):1177282
doi: 10.3389/fphar.2023.1177282
Reschke M.; Biewald E.; Bronstein L.; Brecht I.B.; Dittner-Moormann S.; Driever F.; Ebinger M.; Fleischhack G.; Grabow D.; Geismar D. et al. Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria. Special Issue Retinoblastoma - Current Therapeutic Challenges and Promising New Approaches. Cancers 2021, 13, 1876.
Retinoblastoma Treatment (PDQ®): Health Professional Version.
https://pubmed.ncbi.nlm.nih.gov/26389442
Requejo F., Opezzo J., Vater A. et al. Pharmacokinetics of Orbital Topotecan After Ophthalmic Artery Chemosurgery and Intravenous Infusion in the Swine Model. Investigative ophthalmology & visual science. 2023-11-21;64(12):3
doi: 10.1167/iovs.64.12.3
Reynolds M., Lueder G., Gordon M., Hayashi R.J. Developmental Delay and School Performance Among Retinoblastoma Survivors: Development/school morbidity among retinoblastoma survivors. American journal of ophthalmology. 2021 May 6:S0002-9394(21)00224-5.
doi: 10.1016/j.ajo.2021.04.025
Reynolds M.M., Sein J., Hayashi R., Lueder G. Treatment of small and medium retinoblastoma tumors with Iris diode laser. European journal of ophthalmology. 2021 Feb 2:1120672121991390.
doi: 10.1177/1120672121991390
Reynolds M., Wise J., Wu T. et al. Characterization of vision in pediatric retinoblastoma survivors beyond visual acuity. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2023-09-12;27(4):188.e1-188.e6
doi: 10.1016/j.jaapos.2023.06.003
Riazi-Esfahani H., Masoomian B., Ghassemi F. Intra-Arterial Chemotherapy: New Hope for Adult Retinoblastoma Treatment-A Case Report and Brief Review. Case reports in ophthalmological medicine. 2021 Jul 9;2021:6639900. PMID: 34336323; PMCID: PMC8289600.
doi: 10.1155/2021/6639900
Riazi-Esfahani H., Masoomian B., Khodabandeh A. et al. Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2022-11-19
doi: 10.1007/s00417-022-05903-3
Riazi-Esfahani H., Shamouli H., Pour E.K. et al. Retinal Optical Coherence Tomography Angiography Findings following Retinoblastoma Treatment by Chemotherapy. Journal of current ophthalmology. 2023-05-16;34(4):452-459
doi: 10.4103/joco.joco_323_21
Ribeiro KB, Veiga LHS, Carvalho Filho NP, Morton LM, Kleinerman RA, Antoneli CBG. Overall survival and cause-specific mortality in a hospital-based cohort of retinoblastoma patients in São Paulo, Brazil. Int J Cancer. 2025 Jan 1;156(1):69-78. Epub 2024 Aug 13. PMID: 39138799; PMCID: PMC11537822.
doi: 10.1002/ijc.35127
Rich V., Plummer K., Padhy S. et al. Captains on call: A qualitative investigation of an intervention to support children with retinoblastoma undergoing regular eye examinations. Psycho-oncology. 2024-03-04;33(3):e6315
doi: 10.1002/pon.6315
Rishi P. Commentary: Current standards in retinoblastoma care. Indian journal of ophthalmology. 2020 Nov;68(11):2367.
doi: 10.4103/ijo.IJO_3198_20
Ristevski I., Flegg K., Al-Hammadi M. et al. Development of a Patient-Centered Pathway of Care for Retinoblastoma Patients: A Mixed-Methods Pilot Study. Oncology. 2024-07-02
doi: 10.1159/000540055
Ristevski I., Kiew J., Hendry M., Prunier M., Noronha R., Al-Hammadi M., Flegg K., Gallie B.L., Paton K., Dimaras H.; Canadian Retinoblastoma Research Advisory Board. The Retinoblastoma Research Booklet: A Catalyst for Patient Involvement in Retinoblastoma Research. Healthc Q. 2022 Apr;24(SP):61-68. PMID: 35467513.
doi: 10.12927/hcq.2022.26772
Ristevski I., Robert J., Baddeliyanage R., Noronha R., Gelkopf M., Flegg K., Low L., Steeves J., Crooks B., Gallie B.L., Dimaras H.; Canadian Retinoblastoma Research Advisory Board. EMPOWER Retinoblastoma: Engaging Patient Partners in Solving the Top 10 Priorities for Eye Cancer Research in Canada. Healthc Q. 2022 Apr;24(SP):11-17. PMID: 35467505
doi: 10.12927/hcq.2022.26780
Roble A.A., Mohamed H.M., Bekdemir Ş. et al. Case report from Somalia: access to diagnose retinoblastoma among children in a resource-limited country. Journal of surgical case reports. 2024-09-25;2024(9):rjae593
doi: 10.1093/jscr/rjae593
Roca-Cabau M., Peralta Calvo J., García Martínez F. et al. Choroidal occlusive vasculopathy after intraarterial chemotherapy: MRI findings. Archivos de la Sociedad Espanola de Oftalmologia. 2022-07-25
doi: 10.1016/j.oftale.2022.06.015
Rodriguez A., Abruzzo T., Williams J.A. et al. Audiology evaluation following intra-arterial carboplatin for retinoblastoma. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024-02-28
doi: 10.1016/j.jcjo.2024.01.014
Rodriguez A., Kelley C., Patel A. et al. Prenatal Diagnosis of Retinoblastomas: A Scoping Review. International journal of general medicine. 2023-04-04;16(16):1101-1110
doi: 10.2147/IJGM.S380634
Rodriguez Barreto A.M., Walsh M.F., Robbins M.A. et al. Non-RB1 germline cancer predisposing variants found in retinoblastoma patients. Genetics in medicine open. 2024-12-14;2(2):101836
doi: 10.1016/j.gimo.2024.101836
Rojanaporn D., Chitphuk S., Iemwimangsa N. et al. Germline RB1 Mutation in Retinoblastoma Patients: Detection Methods and Implication in Tumor Focality. Translational vision science & technology. 2022-09-30;11(9):30
doi: 10.1167/tvst.11.9.30
Rokaya D., Kritsana J., Amornvit P., Dhakal N., Khurshid Z., Zafar M.S., Saonanon P. Magnification of Iris through Clear Acrylic Resin in Ocular Prosthesis. J Funct Biomater. 2022 Mar 11;13(1):29. PMID: 35323229; PMCID: PMC8952227.
doi: 10.3390/jfb13010029
Rollins N.K. et al. Association between MRI Findings and Causative Variations in Unilateral Retinoblastoma. Radiology. 2023-05-16:230852
doi: 10.1148/radiol.230852
Romani A., Zauli E., Zauli G. et al. MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma. Frontiers in oncology. 2022-11-08;12(12):1000677
doi: 10.3389/fonc.2022.1000677
Rong J., Li Z., Xu L., Lang L., Zheng G. microRNA-362-3p targets USP22 to retard retinoblastoma growth via reducing deubiquitination of LSD1. Cell Cycle. 2021 Feb;20(3):298-307. Epub 2021 Jan 21.
doi: 10.1080/15384101.2021.1874685
Roohollahi K., de Jong Y., van Mil SE. et al. High-Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures. Ophthalmology science. 2022-10-19;2(3):100188.
doi: 10.1016/j.xops.2022.100188
Roufayel R., Mezher R., Storey K.B. The Role of Retinoblastoma Protein in Cell Cycle Regulation: An Updated Review. Current molecular medicine. 2021 Jan 3.
doi: 10.2174/1566524020666210104113003
Roy P.S., Muhammed S., Singh U. et al. A single-blinded, randomized controlled trial of standard versus higher dose carboplatin-based intravenous chemotherapy for group D and E retinoblastoma. Pediatric blood & cancer. 2023-05-27:e30444
doi: 10.1002/pbc.30444
Roy SR, Huque F, Nuruddin M. Adult Onset Retinoblastoma: Two Rare Case Reports. Mymensingh Med J. 2025 Apr;34(2):576-579. PMID: 40160080.
Roy S.R., Kaliki S. Retinoblastoma: A Major Review. Mymensingh Med J. 2021 Jul;30(3):881-895.
Rozanska A., Cerna-Chavez R., Queen R., Collin J., Zerti D., Dorgau B., Beh C.S., Davey T., Coxhead J., Hussain R., Al-Aama J., Steel D.H., Benvenisty N., Armstrong L., Parulekar M., Lako M. pRB-Depleted pluripotent stem cell retinal organoids recapitulate cell state transitions of retinoblastoma development and suggest an important role for pRB in retinal cell differentiation. Stem Cells Transl Med. 2022 Mar 23:szac008. PMID: 35325233. Epub ahead of print.
doi: 10.1093/stcltm/szac008
Ruben M., Eiger-Moscovich M., Yaghy A., Tadepalli S., Shields C.L. Iodine-125 Plaque Radiotherapy for Retinoblastoma Recurrence Following Intra-arterial Chemotherapy. J Pediatr Ophthalmol Strabismus. 2021 Dec 20:1-8.
doi: 10.3928/01913913-20210903-01
Ruben M., Yaghy A., Shields C.L. Retinoblastoma Vitreous Seeds Captured on OCT. Ophthalmology. Retina. 2020 Nov;4(11):1117.
doi: 10.1016/j.oret.2020.05.004
Rumboldt Z, Dodig D, Galluzzi P, Brumini I, Clarke R, Singh S, Rossi A. Retinoblastoma and beyond: pediatric orbital mass lesions. Neuroradiology. 2025 Feb;67(2):469-492. Epub 2024 Dec 27. PMID: 39729290; PMCID: PMC11893699.
doi: 10.1007/s00234-024-03517-6
Runnels J., Acosta G., Rose A., Haynes M., Nikolaidis D., Wong A., Fiani B. The role for intra-arterial chemotherapy for refractory retinoblastoma: a systematic review. Clin Transl Oncol. 2021 Oct;23(10):2066-2077.
doi: 10.1007/s12094-021-02610-z
Rusakevich A.M., Nahhas M.I., Zhou B. et al. Angiographic characteristics and treatment approach in patients undergoing intra-arterial chemotherapy for retinoblastoma. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2023-11-30
doi: 10.1007/s00417-023-06279-8
Russo E., Spallarossa A., Tasso B. et al. Nanotechnology for Pediatric Retinoblastoma Therapy. Pharmaceuticals (Basel, Switzerland). 2022-09-28;15(9)
doi: 10.3390/ph15091087
Russo I., Levy-Gabriel C., Dupont A., Lumbroso-Le Rouic L., Cassoux N., Desjardins L., Bertozzi A.I., Coze C., Doz F., Savignoni A., Aerts I. Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome. Pediatric blood & cancer. 2020 Oct 24
doi: 10.1002/pbc.28721
Ryl T., Afanasyeva E., Hartmann T. et al. A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma. Communications biology. 2024-09-12;7(1):919
doi: 10.1038/s42003-024-06596-6
doi: 10.1093/jscr/rjae593
Roca-Cabau M., Peralta Calvo J., García Martínez F. et al. Choroidal occlusive vasculopathy after intraarterial chemotherapy: MRI findings. Archivos de la Sociedad Espanola de Oftalmologia. 2022-07-25
doi: 10.1016/j.oftale.2022.06.015
Rodriguez A., Abruzzo T., Williams J.A. et al. Audiology evaluation following intra-arterial carboplatin for retinoblastoma. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024-02-28
doi: 10.1016/j.jcjo.2024.01.014
Rodriguez A., Kelley C., Patel A. et al. Prenatal Diagnosis of Retinoblastomas: A Scoping Review. International journal of general medicine. 2023-04-04;16(16):1101-1110
doi: 10.2147/IJGM.S380634
Rodriguez Barreto A.M., Walsh M.F., Robbins M.A. et al. Non-RB1 germline cancer predisposing variants found in retinoblastoma patients. Genetics in medicine open. 2024-12-14;2(2):101836
doi: 10.1016/j.gimo.2024.101836
Rojanaporn D., Chitphuk S., Iemwimangsa N. et al. Germline RB1 Mutation in Retinoblastoma Patients: Detection Methods and Implication in Tumor Focality. Translational vision science & technology. 2022-09-30;11(9):30
doi: 10.1167/tvst.11.9.30
Rokaya D., Kritsana J., Amornvit P., Dhakal N., Khurshid Z., Zafar M.S., Saonanon P. Magnification of Iris through Clear Acrylic Resin in Ocular Prosthesis. J Funct Biomater. 2022 Mar 11;13(1):29. PMID: 35323229; PMCID: PMC8952227.
doi: 10.3390/jfb13010029
Rollins N.K. et al. Association between MRI Findings and Causative Variations in Unilateral Retinoblastoma. Radiology. 2023-05-16:230852
doi: 10.1148/radiol.230852
Romani A., Zauli E., Zauli G. et al. MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma. Frontiers in oncology. 2022-11-08;12(12):1000677
doi: 10.3389/fonc.2022.1000677
Rong J., Li Z., Xu L., Lang L., Zheng G. microRNA-362-3p targets USP22 to retard retinoblastoma growth via reducing deubiquitination of LSD1. Cell Cycle. 2021 Feb;20(3):298-307. Epub 2021 Jan 21.
doi: 10.1080/15384101.2021.1874685
Roohollahi K., de Jong Y., van Mil SE. et al. High-Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures. Ophthalmology science. 2022-10-19;2(3):100188.
doi: 10.1016/j.xops.2022.100188
Roufayel R., Mezher R., Storey K.B. The Role of Retinoblastoma Protein in Cell Cycle Regulation: An Updated Review. Current molecular medicine. 2021 Jan 3.
doi: 10.2174/1566524020666210104113003
Roy P.S., Muhammed S., Singh U. et al. A single-blinded, randomized controlled trial of standard versus higher dose carboplatin-based intravenous chemotherapy for group D and E retinoblastoma. Pediatric blood & cancer. 2023-05-27:e30444
doi: 10.1002/pbc.30444
Roy SR, Huque F, Nuruddin M. Adult Onset Retinoblastoma: Two Rare Case Reports. Mymensingh Med J. 2025 Apr;34(2):576-579. PMID: 40160080.
Roy S.R., Kaliki S. Retinoblastoma: A Major Review. Mymensingh Med J. 2021 Jul;30(3):881-895.
Rozanska A., Cerna-Chavez R., Queen R., Collin J., Zerti D., Dorgau B., Beh C.S., Davey T., Coxhead J., Hussain R., Al-Aama J., Steel D.H., Benvenisty N., Armstrong L., Parulekar M., Lako M. pRB-Depleted pluripotent stem cell retinal organoids recapitulate cell state transitions of retinoblastoma development and suggest an important role for pRB in retinal cell differentiation. Stem Cells Transl Med. 2022 Mar 23:szac008. PMID: 35325233. Epub ahead of print.
doi: 10.1093/stcltm/szac008
Ruben M., Eiger-Moscovich M., Yaghy A., Tadepalli S., Shields C.L. Iodine-125 Plaque Radiotherapy for Retinoblastoma Recurrence Following Intra-arterial Chemotherapy. J Pediatr Ophthalmol Strabismus. 2021 Dec 20:1-8.
doi: 10.3928/01913913-20210903-01
Ruben M., Yaghy A., Shields C.L. Retinoblastoma Vitreous Seeds Captured on OCT. Ophthalmology. Retina. 2020 Nov;4(11):1117.
doi: 10.1016/j.oret.2020.05.004
Rumboldt Z, Dodig D, Galluzzi P, Brumini I, Clarke R, Singh S, Rossi A. Retinoblastoma and beyond: pediatric orbital mass lesions. Neuroradiology. 2025 Feb;67(2):469-492. Epub 2024 Dec 27. PMID: 39729290; PMCID: PMC11893699.
doi: 10.1007/s00234-024-03517-6
Runnels J., Acosta G., Rose A., Haynes M., Nikolaidis D., Wong A., Fiani B. The role for intra-arterial chemotherapy for refractory retinoblastoma: a systematic review. Clin Transl Oncol. 2021 Oct;23(10):2066-2077.
doi: 10.1007/s12094-021-02610-z
Rusakevich A.M., Nahhas M.I., Zhou B. et al. Angiographic characteristics and treatment approach in patients undergoing intra-arterial chemotherapy for retinoblastoma. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2023-11-30
doi: 10.1007/s00417-023-06279-8
Russo E., Spallarossa A., Tasso B. et al. Nanotechnology for Pediatric Retinoblastoma Therapy. Pharmaceuticals (Basel, Switzerland). 2022-09-28;15(9)
doi: 10.3390/ph15091087
Russo I., Levy-Gabriel C., Dupont A., Lumbroso-Le Rouic L., Cassoux N., Desjardins L., Bertozzi A.I., Coze C., Doz F., Savignoni A., Aerts I. Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome. Pediatric blood & cancer. 2020 Oct 24
doi: 10.1002/pbc.28721
Ryl T., Afanasyeva E., Hartmann T. et al. A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma. Communications biology. 2024-09-12;7(1):919
doi: 10.1038/s42003-024-06596-6
S
Saakyan S.V., Myakoshina E.B., Tatskov R.A. et al. [Angioarchitecture of small retinoblastomas: the role of optical coherence tomography angiography]. Vestnik oftalmologii. 2023-08-29;139(4):5-11
doi: 10.17116/oftalma20231390415
Saakyan SV, Tatskov RA, Myakoshina EB, Tsygankov AY, Ushakova TL. Effektivnost' primeneniya transpupillyarnoi termoterapii na fone kombinirovannoi khimioterapii retinoblastom [Effectiveness of transpupillary thermotherapy in addition to combination chemotherapy for retinoblastoma]. Vestn Oftalmol. 2025;141(3):13-19. Russian. PMID: 40591380.
doi: 10.17116/oftalma202514103113
Saal-Zapata G., Rodríguez R., Rodriguez-Calienes A., Cordero R. Contralateral catheterization of the ophthalmic artery to deliver intra-arterial chemotherapy in retinoblastoma. The neuroradiology journal. 2021 Jun 13:19714009211024632.
doi: 10.1177/19714009211024632
Sabbagh MA, Munro MP, Mieler WF. Radiation retinopathy and benign lymphoproliferative orbital tumour presenting 47 years after treatment of hereditary retinoblastoma. Retin Cases Brief Rep. 2025 Jan 1;19(1):19-22. PMID: 38055910.
doi: 10.1097/ICB.0000000000001521
Sadeghi R., Pirankuraim H., Javanshir ST. et al. Risk of secondary tumours in patients with non-metastatic and metastatic human retinoblastoma. Eye (London, England). 2022-12-17
doi: 10.1038/s41433-022-02345-3
Sadri E., Khoee S., Moayeri S. et al. Enhanced anti-tumor activity of transferrin/folate dual-targeting magnetic nanoparticles using chemo-thermo therapy on retinoblastoma cancer cells Y79. Scientific reports. 2023-12-27;13(1):22358
doi: 10.1038/s41598-023-49171-5
Saengwimol D., Chittavanich P., Laosillapacharoen N., Srimongkol A., Chaitankar V., Rojanaporn D., Aroonroch R., Suktitipat B., Saisawang C., Svasti S., Hongeng S., Kaewkhaw R. Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation. Investigative ophthalmology & visual science. 2020 Dec 1;61(14):8.
doi: 10.1167/iovs.61.14.8
Sai M., Niizuma H., Yagi K. et al. Comprehensive genomic profiling suggested multifocal development of retinoblastoma in a single eye. Pediatric blood & cancer. 2022-10-02:e30031.
doi: 10.1002/pbc.30031
Sait S.F., Kernan N.A., Klein E. et al. Craniospinal irradiation and/or intraventricular radioimmunotherapy after high-dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma-Safety and outcomes. Pediatric blood & cancer. 2024-10-09;71(11):e31297
doi: 10.1002/pbc.31297
Sakaria R.P., Davidson J.M., Coleman N. et al. Improving Red Reflex Screening in a Level III NICU Through a Quality Improvement-based Approach. Hospital pediatrics. 2022-11-30;12(12):1093-1100
doi: 10.1542/hpeds.2022-006520
Saluja G., Lomi N., Kashyap S. Unilateral retinal dysplasia simulating retinoblastoma. BMJ case reports. 2020 Sep 16;
doi: 10.1136/bcr-2020-238463
Salviat F., Gauthier-Villars M., Carton M., Cassoux N., Lumbroso-Le Rouic L., Dehainault C., Levy C., Golmard L., Aerts I., Doz F., Bonnet-Serrano F., Hayek S., Savignoni A., Stoppa-Lyonnet D., Houdayer C. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma. JAMA ophthalmology. 2020 Jun 18
doi: 10.1001/jamaophthalmol.2020.2100
Samuel J., Singh N., Kanwar J.R., Krishnakumar S., Kanwar R.K..
Corrigendum to Upregulation of sodium iodide symporter (NIS) protein expression by an innate immunity component: Promising potential for targeting radiosensitive retinoblastoma [Exp. Eye Res. 139 (2015) 108e114]. Experimental eye research. 2020 Aug 11
doi: 10.1016/j.exer.2020.108145
Sanati-Mehrizy A., Ghosh T., Peterson E., Starke R.M., Harbour J.W., Corrales-Medina F.F. Hematologic Complications Associated With Intra-arterial Chemotherapy for Retinoblastoma Treatment: A Single Institution Experience. J Pediatr Hematol Oncol. 2022 May 1;44(4):181-185.
doi: 10.1097/MPH.0000000000002451
Sanchez GM, Chigane D, Lin M, Xu L, Yellapantula V, Berry JL. Retinoblastoma: Aqueous humor liquid biopsy. Taiwan J Ophthalmol. 2025 Mar 20;15(1):55-61. doi: 10.4103/tjo.TJO-D-24-00133. PMID: 40213298; PMCID:
PMC11981557.
Sánchez-Cañal B., Bosch Canto V. et al. Presence of cataract in patients treated for retinoblastoma at the national institute of pediatrics in Mexico (2011-2021). Journal francais d'ophtalmologie. 2023-01-15
doi: 10.1016/j.jfo.2022.06.018
Sanfilippo C.J., Javaheri M., Handler S. et al. Benign Lobular Inner Nuclear Layer Proliferations (BLIPs) of the Retina Associated with Congenital Hypertrophy of the Retinal Pigment Epithelium. Ophthalmology. 2022-10-21.
doi: 10.1016/j.ophtha.2022.10.011
Santamaría Álvarez J., Català-Mora J., Barraso Rodrigo M. et al. Intraoperative OCT assessment of retinal vascular complications secondary to intraarterial chemotherapy for retinoblastoma. Journal francais d'ophtalmologie. 2023-05-30;46(5):e132-e134
doi: 10.1016/j.jfo.2022.07.017
Santapuram P.R., Schremp E.A., Friedman D.L., Koyama T., Froehler M.T., Daniels A.B. Adverse Events, Burden and Outcomes of IV vs. Intra-arterial Chemotherapy for RB. Ophthalmology Retina. 2020 Sep 10
doi: 10.1016/j.oret.2020.09.006
Santos Oliveira J., Catarino S., Magalhães A. et al. The Red Reflex Test and Leukocoria in Childhood. Acta medica portuguesa. 2024-09-03;37(9):638-646
doi: 10.20344/amp.21367
Sari N.M., Hadiputri R., Kuntorini M.S., Agustina H., Mardianty F. High-Risk Histopathologic Features of Retinoblastoma Treated at a Tertiary Hospital in West Java, Indonesia. Ocul Oncol Pathol. 2021 Oct;7(5):353-360.
doi: 10.1159/000517100
Saroya K.K., Singh K., Sethi N., Suman N., Kaur S., Bawa R. Orbital prosthesis- An innovative approach. J Family Med Prim Care. 2022 Mar;11(3):1188-1190. Epub 2022 Mar 10. PMID: 35495812; PMCID: PMC9051687
doi: 10.4103/jfmpc.jfmpc_988_21
Sarver A.L., Xie C., Riddle M.J., Forster C.L., Wang X., Lu H., Wagner W., Tolar J., Hallstrom T.C. Retinoblastoma tumor cell proliferation is negatively associated with an immune gene expression signature and increased immune cells. Laboratory investigation; a journal of technical methods and pathology. 2021 Mar 3.
doi: 10.1038/s41374-021-00573-x
Sarwar S., Riaz U., Ali A. et al. Adverse events associated with chimeric antigen receptor T-cell therapy in ophthalmology: a narrative review. Annals of medicine and surgery (2012). 2024-07-12;86(7):4035-4041
doi: 10.1097/MS9.0000000000002188
Saakyan S.V., Myakoshina E.B., Tatskov R.A. et al. [Angioarchitecture of small retinoblastomas: the role of optical coherence tomography angiography]. Vestnik oftalmologii. 2023-08-29;139(4):5-11
doi: 10.17116/oftalma20231390415
Saakyan SV, Tatskov RA, Myakoshina EB, Tsygankov AY, Ushakova TL. Effektivnost' primeneniya transpupillyarnoi termoterapii na fone kombinirovannoi khimioterapii retinoblastom [Effectiveness of transpupillary thermotherapy in addition to combination chemotherapy for retinoblastoma]. Vestn Oftalmol. 2025;141(3):13-19. Russian. PMID: 40591380.
doi: 10.17116/oftalma202514103113
Saal-Zapata G., Rodríguez R., Rodriguez-Calienes A., Cordero R. Contralateral catheterization of the ophthalmic artery to deliver intra-arterial chemotherapy in retinoblastoma. The neuroradiology journal. 2021 Jun 13:19714009211024632.
doi: 10.1177/19714009211024632
Sabbagh MA, Munro MP, Mieler WF. Radiation retinopathy and benign lymphoproliferative orbital tumour presenting 47 years after treatment of hereditary retinoblastoma. Retin Cases Brief Rep. 2025 Jan 1;19(1):19-22. PMID: 38055910.
doi: 10.1097/ICB.0000000000001521
Sadeghi R., Pirankuraim H., Javanshir ST. et al. Risk of secondary tumours in patients with non-metastatic and metastatic human retinoblastoma. Eye (London, England). 2022-12-17
doi: 10.1038/s41433-022-02345-3
Sadri E., Khoee S., Moayeri S. et al. Enhanced anti-tumor activity of transferrin/folate dual-targeting magnetic nanoparticles using chemo-thermo therapy on retinoblastoma cancer cells Y79. Scientific reports. 2023-12-27;13(1):22358
doi: 10.1038/s41598-023-49171-5
Saengwimol D., Chittavanich P., Laosillapacharoen N., Srimongkol A., Chaitankar V., Rojanaporn D., Aroonroch R., Suktitipat B., Saisawang C., Svasti S., Hongeng S., Kaewkhaw R. Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation. Investigative ophthalmology & visual science. 2020 Dec 1;61(14):8.
doi: 10.1167/iovs.61.14.8
Sai M., Niizuma H., Yagi K. et al. Comprehensive genomic profiling suggested multifocal development of retinoblastoma in a single eye. Pediatric blood & cancer. 2022-10-02:e30031.
doi: 10.1002/pbc.30031
Sait S.F., Kernan N.A., Klein E. et al. Craniospinal irradiation and/or intraventricular radioimmunotherapy after high-dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma-Safety and outcomes. Pediatric blood & cancer. 2024-10-09;71(11):e31297
doi: 10.1002/pbc.31297
Sakaria R.P., Davidson J.M., Coleman N. et al. Improving Red Reflex Screening in a Level III NICU Through a Quality Improvement-based Approach. Hospital pediatrics. 2022-11-30;12(12):1093-1100
doi: 10.1542/hpeds.2022-006520
Saluja G., Lomi N., Kashyap S. Unilateral retinal dysplasia simulating retinoblastoma. BMJ case reports. 2020 Sep 16;
doi: 10.1136/bcr-2020-238463
Salviat F., Gauthier-Villars M., Carton M., Cassoux N., Lumbroso-Le Rouic L., Dehainault C., Levy C., Golmard L., Aerts I., Doz F., Bonnet-Serrano F., Hayek S., Savignoni A., Stoppa-Lyonnet D., Houdayer C. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma. JAMA ophthalmology. 2020 Jun 18
doi: 10.1001/jamaophthalmol.2020.2100
Samuel J., Singh N., Kanwar J.R., Krishnakumar S., Kanwar R.K..
Corrigendum to Upregulation of sodium iodide symporter (NIS) protein expression by an innate immunity component: Promising potential for targeting radiosensitive retinoblastoma [Exp. Eye Res. 139 (2015) 108e114]. Experimental eye research. 2020 Aug 11
doi: 10.1016/j.exer.2020.108145
Sanati-Mehrizy A., Ghosh T., Peterson E., Starke R.M., Harbour J.W., Corrales-Medina F.F. Hematologic Complications Associated With Intra-arterial Chemotherapy for Retinoblastoma Treatment: A Single Institution Experience. J Pediatr Hematol Oncol. 2022 May 1;44(4):181-185.
doi: 10.1097/MPH.0000000000002451
Sanchez GM, Chigane D, Lin M, Xu L, Yellapantula V, Berry JL. Retinoblastoma: Aqueous humor liquid biopsy. Taiwan J Ophthalmol. 2025 Mar 20;15(1):55-61. doi: 10.4103/tjo.TJO-D-24-00133. PMID: 40213298; PMCID:
PMC11981557.
Sánchez-Cañal B., Bosch Canto V. et al. Presence of cataract in patients treated for retinoblastoma at the national institute of pediatrics in Mexico (2011-2021). Journal francais d'ophtalmologie. 2023-01-15
doi: 10.1016/j.jfo.2022.06.018
Sanfilippo C.J., Javaheri M., Handler S. et al. Benign Lobular Inner Nuclear Layer Proliferations (BLIPs) of the Retina Associated with Congenital Hypertrophy of the Retinal Pigment Epithelium. Ophthalmology. 2022-10-21.
doi: 10.1016/j.ophtha.2022.10.011
Santamaría Álvarez J., Català-Mora J., Barraso Rodrigo M. et al. Intraoperative OCT assessment of retinal vascular complications secondary to intraarterial chemotherapy for retinoblastoma. Journal francais d'ophtalmologie. 2023-05-30;46(5):e132-e134
doi: 10.1016/j.jfo.2022.07.017
Santapuram P.R., Schremp E.A., Friedman D.L., Koyama T., Froehler M.T., Daniels A.B. Adverse Events, Burden and Outcomes of IV vs. Intra-arterial Chemotherapy for RB. Ophthalmology Retina. 2020 Sep 10
doi: 10.1016/j.oret.2020.09.006
Santos Oliveira J., Catarino S., Magalhães A. et al. The Red Reflex Test and Leukocoria in Childhood. Acta medica portuguesa. 2024-09-03;37(9):638-646
doi: 10.20344/amp.21367
Sari N.M., Hadiputri R., Kuntorini M.S., Agustina H., Mardianty F. High-Risk Histopathologic Features of Retinoblastoma Treated at a Tertiary Hospital in West Java, Indonesia. Ocul Oncol Pathol. 2021 Oct;7(5):353-360.
doi: 10.1159/000517100
Saroya K.K., Singh K., Sethi N., Suman N., Kaur S., Bawa R. Orbital prosthesis- An innovative approach. J Family Med Prim Care. 2022 Mar;11(3):1188-1190. Epub 2022 Mar 10. PMID: 35495812; PMCID: PMC9051687
doi: 10.4103/jfmpc.jfmpc_988_21
Sarver A.L., Xie C., Riddle M.J., Forster C.L., Wang X., Lu H., Wagner W., Tolar J., Hallstrom T.C. Retinoblastoma tumor cell proliferation is negatively associated with an immune gene expression signature and increased immune cells. Laboratory investigation; a journal of technical methods and pathology. 2021 Mar 3.
doi: 10.1038/s41374-021-00573-x
Sarwar S., Riaz U., Ali A. et al. Adverse events associated with chimeric antigen receptor T-cell therapy in ophthalmology: a narrative review. Annals of medicine and surgery (2012). 2024-07-12;86(7):4035-4041
doi: 10.1097/MS9.0000000000002188
Scarborough M.T. et al. CORR Insights®: Does the Clinical Presentation of Secondary Osteosarcoma in Patients Who Survive Retinoblastoma Differ From That of Conventional Osteosarcoma and How Do We Detect Them? Clinical orthopaedics and related research. 2023-10-23;481(11):2164-2166
doi: 10.1097/CORR.0000000000002745
Schaiquevich P., Francis J.H., Cancela M.B., Carcaboso A.M., Chantada G.L., Abramson D.H. Treatment of Retinoblastoma: What Is the Latest and What Is the Future. Front Oncol. 2022 Apr 1;12:822330. PMID: 35433448; PMCID: PMC9010858.
doi: 10.3389/fonc.2022.822330
Schefler A.C., Kim R.S. Recent advancements in the management of retinoblastoma and uveal melanoma. Fac Rev. 2021 May 28;10:51.
doi: 10.12703/r/10-51
Schieffer K.M., Feldman A.Z., Kautto E.A., McGrath S., Miller A.R., Hernandez-Gonzalez M.E., LaHaye S., Miller K.E., Koboldt D.C., Brennan P., Kelly B., Wetzel A., Agarwal V., Shatara M., Conley S., Rodriguez D.P., Abu-Arja R., Shaikhkhalil A., Snuderl M., Orr B.A., Finlay J.L., Osorio D.S., Drapeau A.I., Leonard J.R., Pierson C.R., White P., Magrini V., Mardis E.R., Wilson R.K., Cottrell C.E., Boué D.R. Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma. Acta neuropathologica communications. 2021 Apr 7;9(1):61.
doi: 10.1186/s40478-021-01164-z
Schiller E., Kalafatis N.E., Shields C.L. et al. Retinal cavernous hemangioma in a newborn: an unusual presentation of a rare tumor. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2022-09-20
doi: 10.1016/j.jaapos.2022.08.260
Schittkowski M.P., Weiss N. et al. [Ocular prosthetics in children-Possibilities and challenges]. Die Ophthalmologie. 2023-02-07;120(2):139-149
doi: 10.1007/s00347-022-01794-1
Schmidt M.J., Prabakar R.K., Pike S. et al. Simultaneous Copy Number Alteration and Single-Nucleotide Variation Analysis in Matched Aqueous Humor and Tumor Samples in Children with Retinoblastoma. International journal of molecular sciences. 2023-05-29;24(10)
doi: 10.3390/ijms24108606
Schofield D., Zeppel M.J.B, Staffieri S., Shrestha R.N., Jelovic D., Lee E., Jamieson R.V. Preimplantation genetic diagnosis for retinoblastoma survivors: a cost-effectiveness study. Reproductive biomedicine & society online. 2020 May 11.
doi: 10.1016/j.rbms.2020.03.001
Schonfeld S.J, Kleinerman R.A., Abramson D.H., Seddon J.M., Tucker M.A., Morton L.M. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors.
British journal of cancer. 2021 Jan 21.
doi: 10.1038/s41416-020-01248-y
Schreiber C, Kocharian G, Kharas N, Knopman J, Francis JH, Abramson DH, Gobin YP. Catheterization complications of intra-arterial chemotherapy for retinoblastoma. J Neurointerv Surg. 2025 Feb 25:jnis-2024-022881. Epub ahead of print. PMID: 40010848.
doi: 10.1136/jnis-2024-022881
Schroeder C., Faust U., Krauße L. et al. Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients. European journal of human genetics : EJHG. 2023-10-05;31(10):1139-1146.
doi: 10.1038/s41431-023-01423-8
Schultz K.A.P., Chintagumpala M., Piao J. et al. Children's Oncology Group's 2023 blueprint for research: Rare tumors. Pediatric blood & cancer. 2023-10-03;70 Suppl 6(Suppl 6):e30574
doi: 10.1002/pbc.30574.
Schultz KAP., Chintagumpala M., Piao J. et al. Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective. EJC paediatric oncology. 2023-12-02;2(2).
doi: 10.1016/j.ejcped.2023.100024
Schweiger B., Göricke S., Ketteler P. et al. [Imaging of retinoblastoma: Current state-of-the-art and future prospects]. Radiologie (Heidelberg, Germany). 2022-08-15.
doi: 10.1007/s00117-022-01052-0
Sedaghat A., Raval V., Jia R. et al. Advanced intraocular retinoblastoma: evolving criteria for group E disease. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024-05-11.
doi: 10.1016/j.jcjo.2024.03.005
Selvarajah A., Flegg K., Sim W., Hu J.B., Gallie B.L., Shaikh F., Soliman S.E., Dimaras H. Clinical audit of retinoblastoma management: a retrospective single-institution study. Canadian journal of ophthalmology. 2021 May 30:S0008-4182(21)00163-0.
doi: 10.1016/j.jcjo.2021.04.019
Selvin S.S.T., Kuriakose T. An uncommon presentation of a refractory case of retinoblastoma. Orbit. 2020 Sep 2.
doi: 10.1080/01676830.2020.1817950
Sen M., Rao R., Mulay K. et al. Intravitreal Topotecan for Vitreous Seeds in Retinoblastoma: A Long-term Review of 91 Eyes. Ophthalmology. 2024-06-15
doi: 10.1016/j.ophtha.2024.04.022
Sepúlveda-Sánchez J.M., Gil-Gil M., Alonso-García M., Vaz Salgado M.Á., Vicente E., Mesía Barroso C., Rodríguez Sánchez Á., Durán G., De Las Peñas R., Muñoz-Langa J., Velasco G., Hernández-Laín A., Hilario A., Navarro Martín M., Benavides M., Oleaga L., Cantero Montenegro D., Ruano Y., Sánchez-Gómez P., Martín-Soberón M.C., Morales-Llombart R., Pachón V., Pineda E. Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO). Targeted oncology. 2020 Oct;15(5):613-622.
doi: 10.1007/s11523-020-00754-6
Sergeenko K.A., Dokuchaeva Y.Y., Kostareva I.O. Aliev T.Z., Elfimova A.Yu., Stepanian N.G., Lozovan Y.V., Burlaka N.A., Sidorova N.V., Machneva E.B., Gorbunova T.V., Ushakova T.L., Polyakov V.G., Kirgizov K.I., Varfolomeeva S.R. High-dose chemotherapy with autologous hemopoietic stem cell transplantation in children with retinoblastoma. Literature review and case series // Cellular Therapy and Transplantation. 2022. Vol. 11. No 1. P. 6-12.
doi: 10.18620/ctt-1866-8836-2022-11-1-6-12
Sethu Nagarajan R, Kim U, Shanthi R, Vanniarajan A. Investigation of GD2 synthase as a potential marker for retinoblastoma poor prognosis. Mol Biol Rep. 2025 Apr 9;52(1):372. PMID: 40202619.
doi: 10.1007/s11033-025-10475-6
Seydi E., Tahmasebi G., Arjmand A. et al. Toxicity of superparamagnetic iron oxide nanoparticles on retinoblastoma mitochondria. Cutaneous and ocular toxicology. 2023-11-01:1-6.
doi: 10.1080/15569527.2023.2275030
Shah A., Shrestha M., Shrestha S.M., Khatri A., Shrestha P.K. Pathologic Risk Factor in Retinoblastoma: An Institutional Experience Based on Analysis of Enucleated Eyes. Nepal J Ophthalmol. 2021 Jan;13(25):91-97.
doi: 10.3126/nepjoph.v13i1.31139
PMID: 33981102.
Shahin M.N., Fecker A.L., Gale M. et al. Concurrent Unilateral Retinoblastoma and Giant Suprasellar Pilomyxoid Astrocytoma. Pediatric blood & cancer. 2024-12-23;72(2):e31455
doi: 10.1002/pbc.31455
Shahraki K., Najafi A., Ilkhani Pak V. et al. The Traces of Dysregulated lncRNAs-Associated ceRNA Axes in Retinoblastoma: A Systematic Scope Review. Current eye research. 2024-02-01:1-14.
doi: 10.1080/02713683.2024.2306859
Shakarchi F., Grigorian F. et al. Retinoblastoma vitreous seeding underestimation on ophthalmoscopy. Eye (London, England). 2024-12-16
doi: 10.1038/s41433-024-03536-w
Shakeel O., Pace N., Chambers T.M., Scheurer M.E., Ganguly A.A., Lupo P.J., Bunin G.R. Medical radiation exposure and risk of sporadic retinoblastoma. Pediatric blood & cancer. 2020 Aug 2
doi: 10.1002/pbc.28633
Shanmugam P.M. Commentary: Retinoblastoma management-Where are we and where do we go from here? Indian journal of ophthalmology. 2020 Nov;68(11):2365-2366.
doi: 10.4103/ijo.IJO_1954_20
Shanmugam MP., Simakurthy S., Dubey D. et al. Role of optical coherence tomography angiography in retinal tumors: A narrative review. Indian journal of ophthalmology. 2024-07-30;72(8):1082-1090.
doi: 10.4103/IJO.IJO_29_24
Shanthini T., Balaji S., Kim U., Muthukkaruppan V., Vanniarajan A. Genetic characterization of a patient with an unusual presentation of Waardenburg syndrome Type 4 and retinoblastoma. Pediatric blood & cancer. 2020 Jul 16.
doi: 10.1002/pbc.28553
Shapira Y., Worrell E., Litwin A.S., Malhotra R. The UK National Artificial Eye Questionnaire Study: predictors of artificial eye wearers' experience Part 2: visual function and quality of life. Eye (Lond). 2022 Jan;36(1):140-147. Epub 2021 Mar 1.
doi: 10.1038/s41433-021-01459-4
Shapira Y., Worrell E., Ullrich K., Litwin A., Malhotra R. UK National Artificial Eye Questionnaire study: comparisons between cosmetic shell and artificial eye users. Part 1: demographics, comfort and satisfaction. Br J Ophthalmol. 2021 Oct;105(10):1346-1351.
doi: 10.1136/bjophthalmol-2020-317015
Sharma M., Gupta A., Jana M. et al. Comparison of HASTE versus EPI-Based DWI for Retinoblastoma and Correlation with Prognostic Histopathologic Parameters. AJNR. American journal of neuroradiology. 2024-02-14;45(2):198-204.
doi: 10.3174/ajnr.A8084
Sheehan A.P. Retinoblastoma: Early Diagnosis is Crucial. Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners. 2020 Aug 24
doi: 10.1016/j.pedhc.2020.06.006
Shemesh R., Sandler H., Dichter S. et al. The Most-Cited Articles on Retinoblastoma: A Fifty-Year Perspective. Vision (Basel, Switzerland). 2023-04-26;7(2)
doi: 10.3390/vision7020033
Sheng J., Kohno S., Okada N., Okahashi N., Teranishi K., Matsuda F., Shimizu H., Linn P., Nagatani N., Yamamura M., Harada K., Horike SI., Inoue H., Yano S., Kumar S., Kitajima S., Ajioka I., Takahashi C. Treatment of Retinoblastoma 1-Intact Hepatocellular Carcinoma With Cyclin-Dependent Kinase 4/6 Inhibitor Combination Therapy. Hepatology. 2021 Oct;74(4):1971-1993.
doi: 10.1002/hep.31872
Sherief S.T., Asfaw G., Abateneh A. et al. Incidence and geographic distribution of retinoblastoma in Ethiopia. BMC ophthalmology. 2023-05-27;23(1):231
doi: 10.1186/s12886-023-02980-8
Sherief ST., Girma E., Wu F. et al. Caring for a child with retinoblastoma: Experience of Ethiopian parents. Pediatric blood & cancer. 2022-12-22:e30163.
doi: 10.1002/pbc.30163
Sherief S.T., Mulatu D.G., Wu F. et al. Clinicopathological Presentation of Retinoblastoma in Ethiopia. Ocular oncology and pathology. 2023-03-21;8(3):168-174.
doi: 10.1159/000525113
Sherief S.T., Wu F., O'Banion J. et al. Health Services Needs Assessment for Retinoblastoma in Ethiopia. JCO global oncology. 2023-11-16;9(9):e2200445.
doi: 10.1200/GO.22.00445
Sherief S.T., Wu F., O'Banion J. et al. Referral patterns for retinoblastoma patients in Ethiopia. BMC health services research. 2023-02-24;23(1):172.
doi: 10.1186/s12913-023-09137-9
Shi C., Huang K., Soto J. et al. Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular vesicles. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023-04-03;161(161):114554.
doi: 10.1016/j.biopha.2023.114554
Shi H., He X., Yang Z. et al. The Use of rAAV2-RB1-Mediated Gene Therapy in Retinoblastoma. Investigative ophthalmology & visual science. 2023-12-25;64(15):31.
doi: 10.1167/iovs.64.15.31
Shi J., Sun J., Liu L., Shan T., Meng H., Yang T., Wang S., Wei T., Chen B., Ma Y., Wang Q., Wang H., Liu J., Wang L. P16ink4a overexpression ameliorates cardiac remodeling of mouse following myocardial infarction via CDK4/pRb pathway. Biochem Biophys Res Commun. 2022 Jan 22;595:62-68. Epub ahead of print.
doi: 10.1016/j.bbrc.2022.01.077
Shi K., Zhu X., Wu J., Chen Y., Zhang J., Sun X. Centromere protein E as a novel biomarker and potential therapeutic target for retinoblastoma. Bioengineered. 2021 Dec;12(1):5950-5970.
doi: 10.1080/21655979.2021.1972080
Shields C.L., Bas Z., Laiton A., Silva A.M.V., Sheikh A., Lally S.E., Shields J.A. Retinoblastoma: emerging concepts in genetics, global disease burden, chemotherapy outcomes, and psychological impact. Eye (Lond). 2022 Feb 25:1–8. Epub ahead of print.
doi: 10.1038/s41433-022-01980-0
Shields C.L., Bas Z., Tadepalli S., Dalvin L.A., Rao R., Schwendeman R., Lally S.E., Shields J.A., Shah A., Leahey A. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre. Br J Ophthalmol. 2020 Feb 12.
doi: 10.1136/bjophthalmol-2019-315572
Shields C.L., Dockery P., Ruben M., Yaghy A., Sunday M.A., Duffner E.R., Levin H.J., Taylor O.S., Calotti M., Lally S.E., Shields J.A. Likelihood of Germline Mutation With Solitary Unilateral Retinoblastoma Based on Patient Age at Presentation: Analysis of 482 Consecutive Patients. Journal of pediatric ophthalmology and strabismus. 2021 Jun 1:1-10.
doi: 10.3928/01913913-20210414-02
Shields C.L., Dockery P.W., Ruben M. et al. Conditional analysis on new tumor formation with solitary unilateral retinoblastoma in 482 consecutive patients. Saudi journal of ophthalmology: official journal of the Saudi Ophthalmological Society. 2022-07-16;35(4):279-285
doi: 10.4103/sjopt.sjopt_146_21
Shields C.L., Dockery P.W., Yaghy A., Duffner E.R., Levin H.J., Taylor O.S., Sajjadi Z., Lally S.E., Shields J.A., Rosenwasser R., Tjoumakaris S., Jabbour P. Intra-arterial chemotherapy for retinoblastoma in 341 consecutive eyes (1,292 infusions): comparative analysis of outcomes based on patient age, race, and sex. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, S1091-8531(21)00112-9. 24 May. 2021. doi:10.1016/j.jaapos.2020.12.006
Shields C.L., Srinivasan A., Lucio-Alvarez J.A., Shields J.A. Retinocytoma/retinoma: comparative analysis of clinical features in 78 tumors and rate of transformation into retinoblastoma over 20 years. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2021 May 26:S1091-8531(21)00132-4.
doi: 10.1016/j.jaapos.2020.11.024
Shields CL, Medina R, Evans H, Valdes-Perez N, Burak Acar A, Bansal R, Lally SE, Shields JA. High-dose intravitreal topotecan for recurrent retinoblastoma, subretinal seeds, and vitreous seeds. Retina. 2025 Jan 1;45(1):1-6. PMID: 39378373.
doi: 10.1097/IAE.0000000000004283
doi: 10.1097/CORR.0000000000002745
Schaiquevich P., Francis J.H., Cancela M.B., Carcaboso A.M., Chantada G.L., Abramson D.H. Treatment of Retinoblastoma: What Is the Latest and What Is the Future. Front Oncol. 2022 Apr 1;12:822330. PMID: 35433448; PMCID: PMC9010858.
doi: 10.3389/fonc.2022.822330
Schefler A.C., Kim R.S. Recent advancements in the management of retinoblastoma and uveal melanoma. Fac Rev. 2021 May 28;10:51.
doi: 10.12703/r/10-51
Schieffer K.M., Feldman A.Z., Kautto E.A., McGrath S., Miller A.R., Hernandez-Gonzalez M.E., LaHaye S., Miller K.E., Koboldt D.C., Brennan P., Kelly B., Wetzel A., Agarwal V., Shatara M., Conley S., Rodriguez D.P., Abu-Arja R., Shaikhkhalil A., Snuderl M., Orr B.A., Finlay J.L., Osorio D.S., Drapeau A.I., Leonard J.R., Pierson C.R., White P., Magrini V., Mardis E.R., Wilson R.K., Cottrell C.E., Boué D.R. Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma. Acta neuropathologica communications. 2021 Apr 7;9(1):61.
doi: 10.1186/s40478-021-01164-z
Schiller E., Kalafatis N.E., Shields C.L. et al. Retinal cavernous hemangioma in a newborn: an unusual presentation of a rare tumor. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2022-09-20
doi: 10.1016/j.jaapos.2022.08.260
Schittkowski M.P., Weiss N. et al. [Ocular prosthetics in children-Possibilities and challenges]. Die Ophthalmologie. 2023-02-07;120(2):139-149
doi: 10.1007/s00347-022-01794-1
Schmidt M.J., Prabakar R.K., Pike S. et al. Simultaneous Copy Number Alteration and Single-Nucleotide Variation Analysis in Matched Aqueous Humor and Tumor Samples in Children with Retinoblastoma. International journal of molecular sciences. 2023-05-29;24(10)
doi: 10.3390/ijms24108606
Schofield D., Zeppel M.J.B, Staffieri S., Shrestha R.N., Jelovic D., Lee E., Jamieson R.V. Preimplantation genetic diagnosis for retinoblastoma survivors: a cost-effectiveness study. Reproductive biomedicine & society online. 2020 May 11.
doi: 10.1016/j.rbms.2020.03.001
Schonfeld S.J, Kleinerman R.A., Abramson D.H., Seddon J.M., Tucker M.A., Morton L.M. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors.
British journal of cancer. 2021 Jan 21.
doi: 10.1038/s41416-020-01248-y
Schreiber C, Kocharian G, Kharas N, Knopman J, Francis JH, Abramson DH, Gobin YP. Catheterization complications of intra-arterial chemotherapy for retinoblastoma. J Neurointerv Surg. 2025 Feb 25:jnis-2024-022881. Epub ahead of print. PMID: 40010848.
doi: 10.1136/jnis-2024-022881
Schroeder C., Faust U., Krauße L. et al. Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients. European journal of human genetics : EJHG. 2023-10-05;31(10):1139-1146.
doi: 10.1038/s41431-023-01423-8
Schultz K.A.P., Chintagumpala M., Piao J. et al. Children's Oncology Group's 2023 blueprint for research: Rare tumors. Pediatric blood & cancer. 2023-10-03;70 Suppl 6(Suppl 6):e30574
doi: 10.1002/pbc.30574.
Schultz KAP., Chintagumpala M., Piao J. et al. Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective. EJC paediatric oncology. 2023-12-02;2(2).
doi: 10.1016/j.ejcped.2023.100024
Schweiger B., Göricke S., Ketteler P. et al. [Imaging of retinoblastoma: Current state-of-the-art and future prospects]. Radiologie (Heidelberg, Germany). 2022-08-15.
doi: 10.1007/s00117-022-01052-0
Sedaghat A., Raval V., Jia R. et al. Advanced intraocular retinoblastoma: evolving criteria for group E disease. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024-05-11.
doi: 10.1016/j.jcjo.2024.03.005
Selvarajah A., Flegg K., Sim W., Hu J.B., Gallie B.L., Shaikh F., Soliman S.E., Dimaras H. Clinical audit of retinoblastoma management: a retrospective single-institution study. Canadian journal of ophthalmology. 2021 May 30:S0008-4182(21)00163-0.
doi: 10.1016/j.jcjo.2021.04.019
Selvin S.S.T., Kuriakose T. An uncommon presentation of a refractory case of retinoblastoma. Orbit. 2020 Sep 2.
doi: 10.1080/01676830.2020.1817950
Sen M., Rao R., Mulay K. et al. Intravitreal Topotecan for Vitreous Seeds in Retinoblastoma: A Long-term Review of 91 Eyes. Ophthalmology. 2024-06-15
doi: 10.1016/j.ophtha.2024.04.022
Sepúlveda-Sánchez J.M., Gil-Gil M., Alonso-García M., Vaz Salgado M.Á., Vicente E., Mesía Barroso C., Rodríguez Sánchez Á., Durán G., De Las Peñas R., Muñoz-Langa J., Velasco G., Hernández-Laín A., Hilario A., Navarro Martín M., Benavides M., Oleaga L., Cantero Montenegro D., Ruano Y., Sánchez-Gómez P., Martín-Soberón M.C., Morales-Llombart R., Pachón V., Pineda E. Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO). Targeted oncology. 2020 Oct;15(5):613-622.
doi: 10.1007/s11523-020-00754-6
Sergeenko K.A., Dokuchaeva Y.Y., Kostareva I.O. Aliev T.Z., Elfimova A.Yu., Stepanian N.G., Lozovan Y.V., Burlaka N.A., Sidorova N.V., Machneva E.B., Gorbunova T.V., Ushakova T.L., Polyakov V.G., Kirgizov K.I., Varfolomeeva S.R. High-dose chemotherapy with autologous hemopoietic stem cell transplantation in children with retinoblastoma. Literature review and case series // Cellular Therapy and Transplantation. 2022. Vol. 11. No 1. P. 6-12.
doi: 10.18620/ctt-1866-8836-2022-11-1-6-12
Sethu Nagarajan R, Kim U, Shanthi R, Vanniarajan A. Investigation of GD2 synthase as a potential marker for retinoblastoma poor prognosis. Mol Biol Rep. 2025 Apr 9;52(1):372. PMID: 40202619.
doi: 10.1007/s11033-025-10475-6
Seydi E., Tahmasebi G., Arjmand A. et al. Toxicity of superparamagnetic iron oxide nanoparticles on retinoblastoma mitochondria. Cutaneous and ocular toxicology. 2023-11-01:1-6.
doi: 10.1080/15569527.2023.2275030
Shah A., Shrestha M., Shrestha S.M., Khatri A., Shrestha P.K. Pathologic Risk Factor in Retinoblastoma: An Institutional Experience Based on Analysis of Enucleated Eyes. Nepal J Ophthalmol. 2021 Jan;13(25):91-97.
doi: 10.3126/nepjoph.v13i1.31139
PMID: 33981102.
Shahin M.N., Fecker A.L., Gale M. et al. Concurrent Unilateral Retinoblastoma and Giant Suprasellar Pilomyxoid Astrocytoma. Pediatric blood & cancer. 2024-12-23;72(2):e31455
doi: 10.1002/pbc.31455
Shahraki K., Najafi A., Ilkhani Pak V. et al. The Traces of Dysregulated lncRNAs-Associated ceRNA Axes in Retinoblastoma: A Systematic Scope Review. Current eye research. 2024-02-01:1-14.
doi: 10.1080/02713683.2024.2306859
Shakarchi F., Grigorian F. et al. Retinoblastoma vitreous seeding underestimation on ophthalmoscopy. Eye (London, England). 2024-12-16
doi: 10.1038/s41433-024-03536-w
Shakeel O., Pace N., Chambers T.M., Scheurer M.E., Ganguly A.A., Lupo P.J., Bunin G.R. Medical radiation exposure and risk of sporadic retinoblastoma. Pediatric blood & cancer. 2020 Aug 2
doi: 10.1002/pbc.28633
Shanmugam P.M. Commentary: Retinoblastoma management-Where are we and where do we go from here? Indian journal of ophthalmology. 2020 Nov;68(11):2365-2366.
doi: 10.4103/ijo.IJO_1954_20
Shanmugam MP., Simakurthy S., Dubey D. et al. Role of optical coherence tomography angiography in retinal tumors: A narrative review. Indian journal of ophthalmology. 2024-07-30;72(8):1082-1090.
doi: 10.4103/IJO.IJO_29_24
Shanthini T., Balaji S., Kim U., Muthukkaruppan V., Vanniarajan A. Genetic characterization of a patient with an unusual presentation of Waardenburg syndrome Type 4 and retinoblastoma. Pediatric blood & cancer. 2020 Jul 16.
doi: 10.1002/pbc.28553
Shapira Y., Worrell E., Litwin A.S., Malhotra R. The UK National Artificial Eye Questionnaire Study: predictors of artificial eye wearers' experience Part 2: visual function and quality of life. Eye (Lond). 2022 Jan;36(1):140-147. Epub 2021 Mar 1.
doi: 10.1038/s41433-021-01459-4
Shapira Y., Worrell E., Ullrich K., Litwin A., Malhotra R. UK National Artificial Eye Questionnaire study: comparisons between cosmetic shell and artificial eye users. Part 1: demographics, comfort and satisfaction. Br J Ophthalmol. 2021 Oct;105(10):1346-1351.
doi: 10.1136/bjophthalmol-2020-317015
Sharma M., Gupta A., Jana M. et al. Comparison of HASTE versus EPI-Based DWI for Retinoblastoma and Correlation with Prognostic Histopathologic Parameters. AJNR. American journal of neuroradiology. 2024-02-14;45(2):198-204.
doi: 10.3174/ajnr.A8084
Sheehan A.P. Retinoblastoma: Early Diagnosis is Crucial. Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners. 2020 Aug 24
doi: 10.1016/j.pedhc.2020.06.006
Shemesh R., Sandler H., Dichter S. et al. The Most-Cited Articles on Retinoblastoma: A Fifty-Year Perspective. Vision (Basel, Switzerland). 2023-04-26;7(2)
doi: 10.3390/vision7020033
Sheng J., Kohno S., Okada N., Okahashi N., Teranishi K., Matsuda F., Shimizu H., Linn P., Nagatani N., Yamamura M., Harada K., Horike SI., Inoue H., Yano S., Kumar S., Kitajima S., Ajioka I., Takahashi C. Treatment of Retinoblastoma 1-Intact Hepatocellular Carcinoma With Cyclin-Dependent Kinase 4/6 Inhibitor Combination Therapy. Hepatology. 2021 Oct;74(4):1971-1993.
doi: 10.1002/hep.31872
Sherief S.T., Asfaw G., Abateneh A. et al. Incidence and geographic distribution of retinoblastoma in Ethiopia. BMC ophthalmology. 2023-05-27;23(1):231
doi: 10.1186/s12886-023-02980-8
Sherief ST., Girma E., Wu F. et al. Caring for a child with retinoblastoma: Experience of Ethiopian parents. Pediatric blood & cancer. 2022-12-22:e30163.
doi: 10.1002/pbc.30163
Sherief S.T., Mulatu D.G., Wu F. et al. Clinicopathological Presentation of Retinoblastoma in Ethiopia. Ocular oncology and pathology. 2023-03-21;8(3):168-174.
doi: 10.1159/000525113
Sherief S.T., Wu F., O'Banion J. et al. Health Services Needs Assessment for Retinoblastoma in Ethiopia. JCO global oncology. 2023-11-16;9(9):e2200445.
doi: 10.1200/GO.22.00445
Sherief S.T., Wu F., O'Banion J. et al. Referral patterns for retinoblastoma patients in Ethiopia. BMC health services research. 2023-02-24;23(1):172.
doi: 10.1186/s12913-023-09137-9
Shi C., Huang K., Soto J. et al. Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular vesicles. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023-04-03;161(161):114554.
doi: 10.1016/j.biopha.2023.114554
Shi H., He X., Yang Z. et al. The Use of rAAV2-RB1-Mediated Gene Therapy in Retinoblastoma. Investigative ophthalmology & visual science. 2023-12-25;64(15):31.
doi: 10.1167/iovs.64.15.31
Shi J., Sun J., Liu L., Shan T., Meng H., Yang T., Wang S., Wei T., Chen B., Ma Y., Wang Q., Wang H., Liu J., Wang L. P16ink4a overexpression ameliorates cardiac remodeling of mouse following myocardial infarction via CDK4/pRb pathway. Biochem Biophys Res Commun. 2022 Jan 22;595:62-68. Epub ahead of print.
doi: 10.1016/j.bbrc.2022.01.077
Shi K., Zhu X., Wu J., Chen Y., Zhang J., Sun X. Centromere protein E as a novel biomarker and potential therapeutic target for retinoblastoma. Bioengineered. 2021 Dec;12(1):5950-5970.
doi: 10.1080/21655979.2021.1972080
Shields C.L., Bas Z., Laiton A., Silva A.M.V., Sheikh A., Lally S.E., Shields J.A. Retinoblastoma: emerging concepts in genetics, global disease burden, chemotherapy outcomes, and psychological impact. Eye (Lond). 2022 Feb 25:1–8. Epub ahead of print.
doi: 10.1038/s41433-022-01980-0
Shields C.L., Bas Z., Tadepalli S., Dalvin L.A., Rao R., Schwendeman R., Lally S.E., Shields J.A., Shah A., Leahey A. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre. Br J Ophthalmol. 2020 Feb 12.
doi: 10.1136/bjophthalmol-2019-315572
Shields C.L., Dockery P., Ruben M., Yaghy A., Sunday M.A., Duffner E.R., Levin H.J., Taylor O.S., Calotti M., Lally S.E., Shields J.A. Likelihood of Germline Mutation With Solitary Unilateral Retinoblastoma Based on Patient Age at Presentation: Analysis of 482 Consecutive Patients. Journal of pediatric ophthalmology and strabismus. 2021 Jun 1:1-10.
doi: 10.3928/01913913-20210414-02
Shields C.L., Dockery P.W., Ruben M. et al. Conditional analysis on new tumor formation with solitary unilateral retinoblastoma in 482 consecutive patients. Saudi journal of ophthalmology: official journal of the Saudi Ophthalmological Society. 2022-07-16;35(4):279-285
doi: 10.4103/sjopt.sjopt_146_21
Shields C.L., Dockery P.W., Yaghy A., Duffner E.R., Levin H.J., Taylor O.S., Sajjadi Z., Lally S.E., Shields J.A., Rosenwasser R., Tjoumakaris S., Jabbour P. Intra-arterial chemotherapy for retinoblastoma in 341 consecutive eyes (1,292 infusions): comparative analysis of outcomes based on patient age, race, and sex. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, S1091-8531(21)00112-9. 24 May. 2021. doi:10.1016/j.jaapos.2020.12.006
Shields C.L., Srinivasan A., Lucio-Alvarez J.A., Shields J.A. Retinocytoma/retinoma: comparative analysis of clinical features in 78 tumors and rate of transformation into retinoblastoma over 20 years. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2021 May 26:S1091-8531(21)00132-4.
doi: 10.1016/j.jaapos.2020.11.024
Shields CL, Medina R, Evans H, Valdes-Perez N, Burak Acar A, Bansal R, Lally SE, Shields JA. High-dose intravitreal topotecan for recurrent retinoblastoma, subretinal seeds, and vitreous seeds. Retina. 2025 Jan 1;45(1):1-6. PMID: 39378373.
doi: 10.1097/IAE.0000000000004283
Sidipratomo P., Pandelaki J., Matondang S.B.R.E. et al. Intra-arterial chemotherapy for retinoblastoma: Our first experience in Indonesia. Radiology case reports. 2022-10-07;17(12):4713-4716.
doi: 10.1016/j.radcr.2022.09.004
Silva F.N., Kora L.X., Elongo T. et al. Anatomo-Clinical Aspects of Retinoblastoma: A Series of 144 Cases. Cureus. 2022-07-16;14(5):e25422.
doi: 10.7759/cureus.25422
Silva-Teixeira R., Laranjo M., Lopes B., Almeida-Ferreira C., Gonçalves A.C., Rodrigues T., Matafome P., Sarmento-Ribeiro A.B., Caramelo F., Botelho M.F. Plasma activated media and direct exposition can selectively ablate retinoblastoma cells. Free Radic Biol Med. 2021 Aug 1;171:302-313.
doi: 10.1016/j.freeradbiomed.2021.05.027
Silvera V.M., Guerin J.B., Brinjikji W., Dalvin L.A. Retinoblastoma: What the Neuroradiologist Needs to Know. AJNR. American journal of neuroradiology. 2021 Jan 28.
doi: 10.3174/ajnr.A6949
Silverman R.F., Francis J.H., Robbins M.A. et al. RB1 circulating-tumor DNA in the blood of Retinoblastoma patients increases in untreated patients. Retina (Philadelphia, Pa.). 2024-08-01.
doi: 10.1097/IAE.0000000000004224
Sinenko I.L., Kuttler F., Simeonov V. et al. Translational screening platform to evaluate chemotherapy in combination with focal therapy for retinoblastoma. Cancer science. 2023-09-06;114(9):3728-3739.
doi: 10.1111/cas.15878
Sinenko I.L., Turnell-Ritson R.C., Munier F.L. et al. The predictive capacity of in vitro preclinical models to evaluate drugs for the treatment of retinoblastoma. Experimental eye research. 2023-03-25;230(230):109447.
doi: 10.1016/j.exer.2023.109447
Singh A., Raval V., Sedaghat A. et al. Evolving criteria for group E retinoblastoma: impact on outcomes. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024-06-27.
doi: 10.1016/j.jcjo.2024.05.001
Singh H.P., Shayler D.W.H., Fernandez G.E. et al. An immature, dedifferentiated, and lineage-deconstrained cone precursor origin of N-Myc-initiated retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America. 2022-08-24;119(28):e2200721119.
doi: 10.1073/pnas.2200721119
Singh L., Chinnaswamy G., Meel R. et al. Epidemiology, Diagnosis and Genetics of Retinoblastoma: ICMR Consensus Guidelines. Indian journal of pediatrics. 2024-03-16.
doi: 10.1007/s12098-024-05085-2
Singh L., Singh M.K., Rizvi M.A., Bakhshi S., Meel R., Lomi N., Sen S., Kashyap S. Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma.
doi: 10.1007/s00262-020-02529-4
Singh N., DeBenedictis M.J., Singh A.D. An Online Application for Retinoblastoma Surveillance. Ocular oncology and pathology. 2020 Oct; 6.
doi: 10.1159/000505751
Singh S., Nishath T., Fabian I.D. et al. Seasonal variation in the diagnosis of retinoblastoma. Ophthalmic epidemiology. 2022-12-12:1-6.
doi: 10.1080/09286586.2022.2153872
Sirivolu S., Schmidt M.J., Prabakar R.K. et al. Single-cell somatic copy number alteration profiling of vitreous humor seeds in retinoblastoma. Ophthalmic genetics. 2024-07-17:1-4.
doi: 10.1080/13816810.2024.2374886
Sirivolu S., Xu L., Warren M. et al. Chromosome 6p amplification detected in blood cell-free DNA in advanced intraocular retinoblastoma. Ophthalmic genetics. 2022-11-29:1-5.
doi: 10.1080/13816810.2022.2142246
Skalet A.H., Allen R.C., Shields C.L., Wilson M.W., Mruthyunjaya P., Gombos D.S. Considerations for the Management and Triage of Ocular Oncology Cases during the COVID-19 Pandemic. Ocular oncology and pathology. 2020 Apr 21.
doi: 10.1159/000507734
Skalet A.H., Campbell J.P., Jian Y. Ultrawide-field OCT for Retinoblastoma. Ophthalmology. 2022 Jun;129(6):718. PMID: 35598905.
doi: 10.1016/j.ophtha.2021.11.012
Skilton A.M., Low L.G., Dimaras H. Patients, Public and Service Users are Experts by Experience: An Overview from Ophthalmology Research in Canada, UK and Beyond. Ophthalmol Ther. 2020 Feb 29.
doi: 10.1007/s40123-020-00237-x
Smith T., Kritzmire S., Tejada J.G. et al. Urinary bladder retention secondary to intranasal administration of oxymetazoline "Afrin" for intra-arterial chemotherapy. Interventional neuroradiology: journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2023-10-03:15910199231204924.
doi: 10.1177/15910199231204924
So JY, Pershing S, Pollom EL, Hiniker SM, Afshar AR. Disparities in United States Retinoblastoma Presentation, Management, and Local Recurrence in theNational Cancer Database, 2004-2016. Ophthalmol Retina. 2025 May;9(5):465-475. Epub 2024 Nov 12. PMID: 39536804.
doi: 10.1016/j.oret.2024.11.005
Solana-Altabella A., Valero S., Balaguer J., Escobar-Cava P., Barranco H., López E., Ribes-Artero H., Poveda J.L. Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol. J Oncol Pharm Pract. 2020 Feb 17:1078155220904410.
DOI: 10.1177/1078155220904410
Solaz-Ruiz M.G., Pérez L.A., Cauto-Picazo C. et al. Toxicity to intravitreal melphalan in a patient with retinoblastoma. Romanian journal of ophthalmology. 2023-11-02;67(3):305-308.
doi: 10.22336/rjo.2023.49
Soliman S.E., Martínez S., De Nicola M.L., Kiehl R., Krema H. Molecular analysis confirms retinoblastoma diagnosis in a histologically undifferentiated retinal tumor in an adult. Ophthalmic genetics. 2020 Jun 16.
doi: 10.1080/13816810.2020.1765398
Soliman S.E., Bansal A., De Nicola M.L., Bhambhwani V., Laperriere N., Gallie B.L., Krema H. Applications of iodine-125 plaque radiotherapy for residual or recurrent retinoblastoma. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2021 Jan 23:S0008-4182(21)00001-6.
doi: 10.1016/j.jcjo.2020.12.016
Soliman S., Feng Z.X., Gallie B. Primary laser therapy as monotherapy for discrete retinoblastoma. The British journal of ophthalmology. 2021 Feb 3:bjophthalmol-2020-317885.
doi: 10.1136/bjophthalmol-2020-317885
Soliman S.E., Vanden Hoven C., MacKeen L.D., Gallie B.L. Secondary Prevention of Retinoblastoma Revisited: Laser Photocoagulation of Invisible New Retinoblastoma. Ophthalmology. 2020 Jan;127(1):122-127.
DOI: 10.1016/j.ophtha.2019.08.011
Soltani S., Tabibzadeh A., Yousefi P., Zandi M., Zakeri A., Akhavan Rezayat S., Ramezani A., Esghaei M., Farahani A. HPV infections in retinoblastoma: a systematic review. J Clin Lab Anal. 2021 Aug 30:e23981.
doi: 10.1002/jcla.23981
Song J., Zhang Z. Long non‑coding RNA SNHG20 promotes cell proliferation, migration and invasion in retinoblastoma via the miR‑335‑5p/E2F3 axis. Mol Med Rep. 2021 Aug;24(2):543.
doi: 10.3892/mmr.2021.12182
Song K., Li B., Chen Y.Y., Wang H., Liu K.C., Tan W., Zou J. LRPPRC regulates metastasis and glycolysis by modulating autophagy and the ROS/HIF1-α pathway in retinoblastoma. Mol Ther Oncolytics. 2021 Jun 24;22:582-591.
doi: 10.1016/j.omto.2021.06.009
Song L., Huang Y., Zhang X., Han S., Hou M., Li H. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2. Investigative Ophthalmology & Visual Science.. 2020 Mar 9.
DOI: 10.1167/iovs.61.3.32
Song L., Wang Y., Cui J., Zhang W., Zhang D., Wang X., Wang Z., Zhao Y., Zhang C., Duan C., Sun T., Zhang L., Yang X. Characteristics of Myelogram in Patients with Extraocular Metastatic Retinoblastoma and Morphological Analysis of Tumor Cells in Bone Marrow and Cerebrospinal Fluid.
Ophthalmologica. 2020 Oct 12.
doi: 10.1159/000512193
Song W.P., Zheng S., Yao H.J., Zhou X.F., Li R., Zhang C.Y., Zhao J.Y., Wang L.W., Shao R.G., Li L. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism. // BMC Ophthalmology. 2020 Mar 6.
DOI: 10.1186/s12886-020-01348-6
Sonkeshri A., Biswas S., Tripathy D. et al. Metastatic neuroblastoma masquerading as orbital retinoblastoma. Orbit (Amsterdam, Netherlands). 2022-12-05:1.
doi: 10.1080/01676830.2022.2151631
Spadoni VS., Conceição TMBD., Schaefer FDC. et al. Role of apparent diffusion map in the evaluation of retinoblastoma. Arquivos brasileiros de oftalmologia. 2024-03-04;87(2):e20210435
doi: 10.5935/0004-2749.2021-0435
doi: 10.1016/j.radcr.2022.09.004
Silva F.N., Kora L.X., Elongo T. et al. Anatomo-Clinical Aspects of Retinoblastoma: A Series of 144 Cases. Cureus. 2022-07-16;14(5):e25422.
doi: 10.7759/cureus.25422
Silva-Teixeira R., Laranjo M., Lopes B., Almeida-Ferreira C., Gonçalves A.C., Rodrigues T., Matafome P., Sarmento-Ribeiro A.B., Caramelo F., Botelho M.F. Plasma activated media and direct exposition can selectively ablate retinoblastoma cells. Free Radic Biol Med. 2021 Aug 1;171:302-313.
doi: 10.1016/j.freeradbiomed.2021.05.027
Silvera V.M., Guerin J.B., Brinjikji W., Dalvin L.A. Retinoblastoma: What the Neuroradiologist Needs to Know. AJNR. American journal of neuroradiology. 2021 Jan 28.
doi: 10.3174/ajnr.A6949
Silverman R.F., Francis J.H., Robbins M.A. et al. RB1 circulating-tumor DNA in the blood of Retinoblastoma patients increases in untreated patients. Retina (Philadelphia, Pa.). 2024-08-01.
doi: 10.1097/IAE.0000000000004224
Sinenko I.L., Kuttler F., Simeonov V. et al. Translational screening platform to evaluate chemotherapy in combination with focal therapy for retinoblastoma. Cancer science. 2023-09-06;114(9):3728-3739.
doi: 10.1111/cas.15878
Sinenko I.L., Turnell-Ritson R.C., Munier F.L. et al. The predictive capacity of in vitro preclinical models to evaluate drugs for the treatment of retinoblastoma. Experimental eye research. 2023-03-25;230(230):109447.
doi: 10.1016/j.exer.2023.109447
Singh A., Raval V., Sedaghat A. et al. Evolving criteria for group E retinoblastoma: impact on outcomes. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024-06-27.
doi: 10.1016/j.jcjo.2024.05.001
Singh H.P., Shayler D.W.H., Fernandez G.E. et al. An immature, dedifferentiated, and lineage-deconstrained cone precursor origin of N-Myc-initiated retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America. 2022-08-24;119(28):e2200721119.
doi: 10.1073/pnas.2200721119
Singh L., Chinnaswamy G., Meel R. et al. Epidemiology, Diagnosis and Genetics of Retinoblastoma: ICMR Consensus Guidelines. Indian journal of pediatrics. 2024-03-16.
doi: 10.1007/s12098-024-05085-2
Singh L., Singh M.K., Rizvi M.A., Bakhshi S., Meel R., Lomi N., Sen S., Kashyap S. Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma.
doi: 10.1007/s00262-020-02529-4
Singh N., DeBenedictis M.J., Singh A.D. An Online Application for Retinoblastoma Surveillance. Ocular oncology and pathology. 2020 Oct; 6.
doi: 10.1159/000505751
Singh S., Nishath T., Fabian I.D. et al. Seasonal variation in the diagnosis of retinoblastoma. Ophthalmic epidemiology. 2022-12-12:1-6.
doi: 10.1080/09286586.2022.2153872
Sirivolu S., Schmidt M.J., Prabakar R.K. et al. Single-cell somatic copy number alteration profiling of vitreous humor seeds in retinoblastoma. Ophthalmic genetics. 2024-07-17:1-4.
doi: 10.1080/13816810.2024.2374886
Sirivolu S., Xu L., Warren M. et al. Chromosome 6p amplification detected in blood cell-free DNA in advanced intraocular retinoblastoma. Ophthalmic genetics. 2022-11-29:1-5.
doi: 10.1080/13816810.2022.2142246
Skalet A.H., Allen R.C., Shields C.L., Wilson M.W., Mruthyunjaya P., Gombos D.S. Considerations for the Management and Triage of Ocular Oncology Cases during the COVID-19 Pandemic. Ocular oncology and pathology. 2020 Apr 21.
doi: 10.1159/000507734
Skalet A.H., Campbell J.P., Jian Y. Ultrawide-field OCT for Retinoblastoma. Ophthalmology. 2022 Jun;129(6):718. PMID: 35598905.
doi: 10.1016/j.ophtha.2021.11.012
Skilton A.M., Low L.G., Dimaras H. Patients, Public and Service Users are Experts by Experience: An Overview from Ophthalmology Research in Canada, UK and Beyond. Ophthalmol Ther. 2020 Feb 29.
doi: 10.1007/s40123-020-00237-x
Smith T., Kritzmire S., Tejada J.G. et al. Urinary bladder retention secondary to intranasal administration of oxymetazoline "Afrin" for intra-arterial chemotherapy. Interventional neuroradiology: journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2023-10-03:15910199231204924.
doi: 10.1177/15910199231204924
So JY, Pershing S, Pollom EL, Hiniker SM, Afshar AR. Disparities in United States Retinoblastoma Presentation, Management, and Local Recurrence in theNational Cancer Database, 2004-2016. Ophthalmol Retina. 2025 May;9(5):465-475. Epub 2024 Nov 12. PMID: 39536804.
doi: 10.1016/j.oret.2024.11.005
Solana-Altabella A., Valero S., Balaguer J., Escobar-Cava P., Barranco H., López E., Ribes-Artero H., Poveda J.L. Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol. J Oncol Pharm Pract. 2020 Feb 17:1078155220904410.
DOI: 10.1177/1078155220904410
Solaz-Ruiz M.G., Pérez L.A., Cauto-Picazo C. et al. Toxicity to intravitreal melphalan in a patient with retinoblastoma. Romanian journal of ophthalmology. 2023-11-02;67(3):305-308.
doi: 10.22336/rjo.2023.49
Soliman S.E., Martínez S., De Nicola M.L., Kiehl R., Krema H. Molecular analysis confirms retinoblastoma diagnosis in a histologically undifferentiated retinal tumor in an adult. Ophthalmic genetics. 2020 Jun 16.
doi: 10.1080/13816810.2020.1765398
Soliman S.E., Bansal A., De Nicola M.L., Bhambhwani V., Laperriere N., Gallie B.L., Krema H. Applications of iodine-125 plaque radiotherapy for residual or recurrent retinoblastoma. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2021 Jan 23:S0008-4182(21)00001-6.
doi: 10.1016/j.jcjo.2020.12.016
Soliman S., Feng Z.X., Gallie B. Primary laser therapy as monotherapy for discrete retinoblastoma. The British journal of ophthalmology. 2021 Feb 3:bjophthalmol-2020-317885.
doi: 10.1136/bjophthalmol-2020-317885
Soliman S.E., Vanden Hoven C., MacKeen L.D., Gallie B.L. Secondary Prevention of Retinoblastoma Revisited: Laser Photocoagulation of Invisible New Retinoblastoma. Ophthalmology. 2020 Jan;127(1):122-127.
DOI: 10.1016/j.ophtha.2019.08.011
Soltani S., Tabibzadeh A., Yousefi P., Zandi M., Zakeri A., Akhavan Rezayat S., Ramezani A., Esghaei M., Farahani A. HPV infections in retinoblastoma: a systematic review. J Clin Lab Anal. 2021 Aug 30:e23981.
doi: 10.1002/jcla.23981
Song J., Zhang Z. Long non‑coding RNA SNHG20 promotes cell proliferation, migration and invasion in retinoblastoma via the miR‑335‑5p/E2F3 axis. Mol Med Rep. 2021 Aug;24(2):543.
doi: 10.3892/mmr.2021.12182
Song K., Li B., Chen Y.Y., Wang H., Liu K.C., Tan W., Zou J. LRPPRC regulates metastasis and glycolysis by modulating autophagy and the ROS/HIF1-α pathway in retinoblastoma. Mol Ther Oncolytics. 2021 Jun 24;22:582-591.
doi: 10.1016/j.omto.2021.06.009
Song L., Huang Y., Zhang X., Han S., Hou M., Li H. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2. Investigative Ophthalmology & Visual Science.. 2020 Mar 9.
DOI: 10.1167/iovs.61.3.32
Song L., Wang Y., Cui J., Zhang W., Zhang D., Wang X., Wang Z., Zhao Y., Zhang C., Duan C., Sun T., Zhang L., Yang X. Characteristics of Myelogram in Patients with Extraocular Metastatic Retinoblastoma and Morphological Analysis of Tumor Cells in Bone Marrow and Cerebrospinal Fluid.
Ophthalmologica. 2020 Oct 12.
doi: 10.1159/000512193
Song W.P., Zheng S., Yao H.J., Zhou X.F., Li R., Zhang C.Y., Zhao J.Y., Wang L.W., Shao R.G., Li L. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism. // BMC Ophthalmology. 2020 Mar 6.
DOI: 10.1186/s12886-020-01348-6
Sonkeshri A., Biswas S., Tripathy D. et al. Metastatic neuroblastoma masquerading as orbital retinoblastoma. Orbit (Amsterdam, Netherlands). 2022-12-05:1.
doi: 10.1080/01676830.2022.2151631
Spadoni VS., Conceição TMBD., Schaefer FDC. et al. Role of apparent diffusion map in the evaluation of retinoblastoma. Arquivos brasileiros de oftalmologia. 2024-03-04;87(2):e20210435
doi: 10.5935/0004-2749.2021-0435
Sradhanjali S., Rout P., Tripathy D., Kaliki S., Rath S., Modak R., Mittal R., Chowdary T.K., Reddy M.M.. The Oncogene MYCN Modulates Glycolytic and Invasive Genes to Enhance Cell Viability and Migration in Human Retinoblastoma. Cancers (Basel). 2021 Oct 19;13(20):5248. PMID: 34680394; PMCID: PMC8533785.
doi: 10.3390/cancers13205248
Srimongkol A., Laosillapacharoen N., Saengwimol D. et al. Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids. Journal of experimental & clinical cancer research: CR. 2023-02-04;42(1):39.
doi: 10.1186/s13046-023-02608-1
Stacey A.W., Bowman R., Foster A., Kivelä T.T., Munier F.L., Cassoux N., Fabian I.D.; Global Retinoblastoma Study Group, Al Harby L., Alarcón Portabella S., Alia D.B., All-Eriksson C., Antonino R., Astbury N.J., Balaguer J., Balwierz W., Barranco H., Bascaran C., Beck Popovic M., Biewald E.M., Bobrova N., Bornfeld N., Brichard B.G., Blum S., Capra M., Castela G., Català-Mora J., Chantada G.L., Chernodrinska V.S., Cieslik K., Comsa C., Correa Llano M.G., Csóka M., De Potter P., Desjardins L., Dragomir M.D., Fernández-Teijeiro A., García Aldana D., Gregersen P.A., Gomel N., Hadjistilianou T., Hederova S., Hummlen M., Husakova K., Ida R., Ilic V.R., Jenkinson H., Kapelushnik N., Kardava T., Keren-Froim N., Kepak T., Khotenashvili Z., Klett A., Krivaitiene D., Latinović S., Lumbroso L., Lysytsia L., Maka E., Martín Begue N., Midena E., Moll A.C., Murgoi G., Naumenko L., Neroev V., Nikitovic M., Olechowski A., Papyan R., Parrozzani R., Parulekar M.V., Pawinska-Wasikowska K., Perić S., Pochop P., Polyakov V.G., Reddy M.A., Ritter-Sovinz P., Saakyan S., Sagoo M.S., San Román Pacheco S., Seregard S., Silva S., Sorochynska T., Stathopoulos C., Stirn Kranjc B., Svojgr K., Tamamyan G., Tandili A., Tateshi B., Tekavcic Pompe M., Urbak S.F., Ushakova T.L., Valeina S., van Hoefen Wijsard M., Veleva-Krasteva N.V., Viksnins M., Wackernagel W., Wolley Dod C., Yarovaya V.A., Yarovoy A.A., Zhilyaeva K., Zondervan M. Incidence of retinoblastoma has increased: results from 40 European countries. Ophthalmology. 2021 Jan 25:S0161-6420(21)00072-5.
doi: 10.1016/j.ophtha.2021.01.024
Stacey A.W., Bowman R., Foster A., Kivelä T.T., Munier F.L., Cassoux N., Fabian I.D.; Global Retinoblastoma Study Group. Incidence of Retinoblastoma Has Increased: Results from 40 European Countries. Ophthalmology. 2021 Sep;128(9):1369-1371.
doi: 10.1016/j.ophtha.2021.01.024
Stacey A.W., De Francesco S., Borri M., Hadjistilianou T. The addition of topotecan to melphalan in the treatment of retinoblastoma with intra-arterial chemotherapy. Ophthalmology. Retina. 2020 Nov 19:S2468-6530(20)30459-0.
doi: 10.1016/j.oret.2020.11.007
Stacey A.W., De Francesco S., Borri M., Hadjistilianou T. The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy. Ophthalmol Retina. 2021 Aug; 5(8):824-830.
doi: 10.1016/j.oret.2020.11.007
Stacey A.W., Nakamichi K., Huey J. et al. Prognostic importance of direct assignment of parent-of-origin via long-read genome and epigenome sequencing in retinoblastoma. JCI insight. 2024-12-26
doi: 10.1172/jci.insight.188216
Stacey A.W., Tsukikawa M., Fabian I.D., Turner S., Jenkinson H., Smith V., Naeem Z., Morland B., Ainsworth J.R., Reddy M.A., Parulekar M., Sagoo M.S. Adjuvant use of laser in eyes with macular retinoblastoma treated with primary intravenous chemotherapy. The British journal of ophthalmology. 2020 Sep 15.
doi: 10.1136/bjophthalmol-2020-316862
Stachelek K., Harutyunyan N., Lee S. et al. Non-synonymous, synonymous, and non-coding nucleotide variants contribute to recurrently altered biological processes during retinoblastoma progression. Genes, chromosomes & cancer. 2023-01-05.
doi: 10.1002/gcc.23120
Stalhammar G., Yeung A., Mendoza P. et al. Gain of Chromosome 6p Correlates with Severe Anaplasia, Cellular Hyperchromasia, and Extraocular Spread of Retinoblastoma. Ophthalmology science. 2022-10-19;2(1):100089.
doi: 10.1016/j.xops.2021.100089
Stathopoulos C., Bartolini B., Marie G., Beck-Popovic M., Saliou G., Munier F.L. Risk factors for acute choroidal ischemia after intra-arterial melphalan for retinoblastoma: the role of the catheterization approach. Ophthalmology. 2020 Sep 18.
doi: 10.1016/j.ophtha.2020.09.021
Stathopoulos C., Beck-Popovic M., Moulin AP. et al. Ten-year experience with intracameral chemotherapy for aqueous seeding in retinoblastoma: long-term efficacy, safety and toxicity. The British journal of ophthalmology. 2022-11-15.
doi: 10.1136/bjo-2022-322492
Stathopoulos C., Lumbroso-Le Rouic L., Moll A.C., Parulekar M., Maeder P., Doz F., Jenkinson H., Beck Popovic M., Chantada G., Munier F.L. Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG). Cancers (Basel). 2021 Jul 6;13(14):3392. PMID: 34298608; PMCID: PMC8303810.
Stathopoulos C., Munier F.L. et al. In vivo incipient retinoblastoma growth rate estimation using optic coherence tomography. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024-06-28.
doi: 10.1016/j.jcjo.2024.04.012
Stathopoulos C., Saliou G., Moulin A. et al. Intra-arterial Chemotherapy for Retinoblastoma: 15-Year Experience. Klinische Monatsblatter fur Augenheilkunde. 2024-04-23;241(4):500-505.
doi: 10.1055/a-2237-2943
Stathopoulos C., Sergenti J., Gaillard M.C., Munier F.L., Daruich A. Pars plana vitrectomy under melphalan irrigation for recurrent retinal detachment in eyes treated for retinoblastoma: a case report. BMC Ophthalmol. 2020 Jan 28;20(1):34.
doi: 10.1186/s12886-020-1315-7
Stathopoulos C., Sharkawi E., Stappler T. et al. Goniosynechialysis for the treatment of angle-closure glaucoma in retinoblastoma. Clinical & experimental ophthalmology. 2023-11-08;51(7):739-742.
doi: 10.1111/ceo.14271
Stathopoulos C., Tripathy D., Moulin A. et al. Retinal and optic nerve relapse in retinoblastoma secondary to epiretinal and epipapillary vitreous seeds implantation documented by optical coherence tomography. Ophthalmic genetics. 2022-11-03:1-5.
doi: 10.1080/13816810.2022.2141801
Sthapit P.R., Amatya M., Gurung H.B. et al. Clinicopathologic Presentation and Management of Malignant Orbito-ocular Tumors at a Tertiary Care Hospital in Nepal. Nepalese journal of ophthalmology: a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society: NEPJOPH. 2022-08-24;13(24):11-20.
doi: 10.3126/nepjoph.v13i2.32865
Strijbis V.I.J., de Bloeme C.M., Jansen R.W., Kebiri H., Nguyen H.G., de Jong M.C., Moll A.C., Bach-Cuadra M., de Graaf P., Steenwijk M.D. Multi-view convolutional neural networks for automated ocular structure and tumor segmentation in retinoblastoma. Sci Rep. 2021 Jul 16;11(1):14590.
doi: 10.1038/s41598-021-93905-2
Struckmeier AK, Gosau M, Smeets R. Radiation-induced sarcomas of the craniofacial region: A systematic review. Oral Oncol. 2025 May;164:107282.2025.107282. Epub 2025 Mar 29. PMID: 40158265.
doi: 10.1016/j.oraloncology
Stuart K.V., Shepherd D.J., Kruger M., Singh E. The Incidence of Retinoblastoma in South Africa: Findings from the South African National Cancer Registry (2004-2018). Ophthalmic Epidemiol. 2021 Dec 22:1-7.
doi: 10.1080/09286586.2021.2013900
Subramanian S., Shetty D., Dudeja G. et al. Median effective dose of intranasal dexmedetomidine for satisfactory mask induction in children undergoing examination under anaesthesia for retinoblastoma - A prospective up and down sequential allocation study. Indian journal of anaesthesia. 2024-03-05;68(2):165-169.
doi: 10.4103/ija.ija_496_23
Supriya M, Singh MK, Singh L, Sharma S, Meel R, Lomi N, Sen S, Kashyap S. Exploring metabolic biomarkers in primary and chemoreduced retinoblastoma with patient outcome. Br J Ophthalmol. 2025 Apr 21:bjo-2024-326495. Epub ahead of print. PMID: 40216531.
doi: 10.1136/bjo-2024-326495
doi: 10.3390/cancers13205248
Srimongkol A., Laosillapacharoen N., Saengwimol D. et al. Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids. Journal of experimental & clinical cancer research: CR. 2023-02-04;42(1):39.
doi: 10.1186/s13046-023-02608-1
Stacey A.W., Bowman R., Foster A., Kivelä T.T., Munier F.L., Cassoux N., Fabian I.D.; Global Retinoblastoma Study Group, Al Harby L., Alarcón Portabella S., Alia D.B., All-Eriksson C., Antonino R., Astbury N.J., Balaguer J., Balwierz W., Barranco H., Bascaran C., Beck Popovic M., Biewald E.M., Bobrova N., Bornfeld N., Brichard B.G., Blum S., Capra M., Castela G., Català-Mora J., Chantada G.L., Chernodrinska V.S., Cieslik K., Comsa C., Correa Llano M.G., Csóka M., De Potter P., Desjardins L., Dragomir M.D., Fernández-Teijeiro A., García Aldana D., Gregersen P.A., Gomel N., Hadjistilianou T., Hederova S., Hummlen M., Husakova K., Ida R., Ilic V.R., Jenkinson H., Kapelushnik N., Kardava T., Keren-Froim N., Kepak T., Khotenashvili Z., Klett A., Krivaitiene D., Latinović S., Lumbroso L., Lysytsia L., Maka E., Martín Begue N., Midena E., Moll A.C., Murgoi G., Naumenko L., Neroev V., Nikitovic M., Olechowski A., Papyan R., Parrozzani R., Parulekar M.V., Pawinska-Wasikowska K., Perić S., Pochop P., Polyakov V.G., Reddy M.A., Ritter-Sovinz P., Saakyan S., Sagoo M.S., San Román Pacheco S., Seregard S., Silva S., Sorochynska T., Stathopoulos C., Stirn Kranjc B., Svojgr K., Tamamyan G., Tandili A., Tateshi B., Tekavcic Pompe M., Urbak S.F., Ushakova T.L., Valeina S., van Hoefen Wijsard M., Veleva-Krasteva N.V., Viksnins M., Wackernagel W., Wolley Dod C., Yarovaya V.A., Yarovoy A.A., Zhilyaeva K., Zondervan M. Incidence of retinoblastoma has increased: results from 40 European countries. Ophthalmology. 2021 Jan 25:S0161-6420(21)00072-5.
doi: 10.1016/j.ophtha.2021.01.024
Stacey A.W., Bowman R., Foster A., Kivelä T.T., Munier F.L., Cassoux N., Fabian I.D.; Global Retinoblastoma Study Group. Incidence of Retinoblastoma Has Increased: Results from 40 European Countries. Ophthalmology. 2021 Sep;128(9):1369-1371.
doi: 10.1016/j.ophtha.2021.01.024
Stacey A.W., De Francesco S., Borri M., Hadjistilianou T. The addition of topotecan to melphalan in the treatment of retinoblastoma with intra-arterial chemotherapy. Ophthalmology. Retina. 2020 Nov 19:S2468-6530(20)30459-0.
doi: 10.1016/j.oret.2020.11.007
Stacey A.W., De Francesco S., Borri M., Hadjistilianou T. The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy. Ophthalmol Retina. 2021 Aug; 5(8):824-830.
doi: 10.1016/j.oret.2020.11.007
Stacey A.W., Nakamichi K., Huey J. et al. Prognostic importance of direct assignment of parent-of-origin via long-read genome and epigenome sequencing in retinoblastoma. JCI insight. 2024-12-26
doi: 10.1172/jci.insight.188216
Stacey A.W., Tsukikawa M., Fabian I.D., Turner S., Jenkinson H., Smith V., Naeem Z., Morland B., Ainsworth J.R., Reddy M.A., Parulekar M., Sagoo M.S. Adjuvant use of laser in eyes with macular retinoblastoma treated with primary intravenous chemotherapy. The British journal of ophthalmology. 2020 Sep 15.
doi: 10.1136/bjophthalmol-2020-316862
Stachelek K., Harutyunyan N., Lee S. et al. Non-synonymous, synonymous, and non-coding nucleotide variants contribute to recurrently altered biological processes during retinoblastoma progression. Genes, chromosomes & cancer. 2023-01-05.
doi: 10.1002/gcc.23120
Stalhammar G., Yeung A., Mendoza P. et al. Gain of Chromosome 6p Correlates with Severe Anaplasia, Cellular Hyperchromasia, and Extraocular Spread of Retinoblastoma. Ophthalmology science. 2022-10-19;2(1):100089.
doi: 10.1016/j.xops.2021.100089
Stathopoulos C., Bartolini B., Marie G., Beck-Popovic M., Saliou G., Munier F.L. Risk factors for acute choroidal ischemia after intra-arterial melphalan for retinoblastoma: the role of the catheterization approach. Ophthalmology. 2020 Sep 18.
doi: 10.1016/j.ophtha.2020.09.021
Stathopoulos C., Beck-Popovic M., Moulin AP. et al. Ten-year experience with intracameral chemotherapy for aqueous seeding in retinoblastoma: long-term efficacy, safety and toxicity. The British journal of ophthalmology. 2022-11-15.
doi: 10.1136/bjo-2022-322492
Stathopoulos C., Lumbroso-Le Rouic L., Moll A.C., Parulekar M., Maeder P., Doz F., Jenkinson H., Beck Popovic M., Chantada G., Munier F.L. Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG). Cancers (Basel). 2021 Jul 6;13(14):3392. PMID: 34298608; PMCID: PMC8303810.
Stathopoulos C., Munier F.L. et al. In vivo incipient retinoblastoma growth rate estimation using optic coherence tomography. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024-06-28.
doi: 10.1016/j.jcjo.2024.04.012
Stathopoulos C., Saliou G., Moulin A. et al. Intra-arterial Chemotherapy for Retinoblastoma: 15-Year Experience. Klinische Monatsblatter fur Augenheilkunde. 2024-04-23;241(4):500-505.
doi: 10.1055/a-2237-2943
Stathopoulos C., Sergenti J., Gaillard M.C., Munier F.L., Daruich A. Pars plana vitrectomy under melphalan irrigation for recurrent retinal detachment in eyes treated for retinoblastoma: a case report. BMC Ophthalmol. 2020 Jan 28;20(1):34.
doi: 10.1186/s12886-020-1315-7
Stathopoulos C., Sharkawi E., Stappler T. et al. Goniosynechialysis for the treatment of angle-closure glaucoma in retinoblastoma. Clinical & experimental ophthalmology. 2023-11-08;51(7):739-742.
doi: 10.1111/ceo.14271
Stathopoulos C., Tripathy D., Moulin A. et al. Retinal and optic nerve relapse in retinoblastoma secondary to epiretinal and epipapillary vitreous seeds implantation documented by optical coherence tomography. Ophthalmic genetics. 2022-11-03:1-5.
doi: 10.1080/13816810.2022.2141801
Sthapit P.R., Amatya M., Gurung H.B. et al. Clinicopathologic Presentation and Management of Malignant Orbito-ocular Tumors at a Tertiary Care Hospital in Nepal. Nepalese journal of ophthalmology: a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society: NEPJOPH. 2022-08-24;13(24):11-20.
doi: 10.3126/nepjoph.v13i2.32865
Strijbis V.I.J., de Bloeme C.M., Jansen R.W., Kebiri H., Nguyen H.G., de Jong M.C., Moll A.C., Bach-Cuadra M., de Graaf P., Steenwijk M.D. Multi-view convolutional neural networks for automated ocular structure and tumor segmentation in retinoblastoma. Sci Rep. 2021 Jul 16;11(1):14590.
doi: 10.1038/s41598-021-93905-2
Struckmeier AK, Gosau M, Smeets R. Radiation-induced sarcomas of the craniofacial region: A systematic review. Oral Oncol. 2025 May;164:107282.2025.107282. Epub 2025 Mar 29. PMID: 40158265.
doi: 10.1016/j.oraloncology
Stuart K.V., Shepherd D.J., Kruger M., Singh E. The Incidence of Retinoblastoma in South Africa: Findings from the South African National Cancer Registry (2004-2018). Ophthalmic Epidemiol. 2021 Dec 22:1-7.
doi: 10.1080/09286586.2021.2013900
Subramanian S., Shetty D., Dudeja G. et al. Median effective dose of intranasal dexmedetomidine for satisfactory mask induction in children undergoing examination under anaesthesia for retinoblastoma - A prospective up and down sequential allocation study. Indian journal of anaesthesia. 2024-03-05;68(2):165-169.
doi: 10.4103/ija.ija_496_23
Supriya M, Singh MK, Singh L, Sharma S, Meel R, Lomi N, Sen S, Kashyap S. Exploring metabolic biomarkers in primary and chemoreduced retinoblastoma with patient outcome. Br J Ophthalmol. 2025 Apr 21:bjo-2024-326495. Epub ahead of print. PMID: 40216531.
doi: 10.1136/bjo-2024-326495
Sujjitjoon J., Sayour E., Tsao S.T., Uiprasertkul M., Sanpakit K., Buaboonnam J., Yenchitsomanus P.T., Atchaneeyasakul L.O., Chang L.J. GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma - assessing tumor and T cell interaction. Translational oncology. 2020 Dec 12;14(2):100971.
doi: 10.1016/j.tranon.2020.100971
Suleiman D.E., Iliyasu Y., Ahmed S.A., Liman A.A. Histopathologic spectrum of paediatric eye and ocular adnexal tumours: A 10-year review from a referral centre in Nigeria. Nigerian journal of clinical practice. 2020 May;23.
doi: 10.4103/njcp.njcp_389_19
Sun J., Feng D., Xi H., Luo J., Zhou Z., Liu Q., Chen Y., Shao Q. CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy. Molecular oncology. 2020 May 12.
doi: 10.1002/1878-0261.12708
Sun J., Gan L., Ding J. et al. Identification of non-coding RNAs and their functional network associated with optic nerve invasion in retinoblastoma. Heliyon. 2023-03-01;9(2):e13813.
doi: 10.1016/j.heliyon.2023.e13813
Sun J., Gu X., Wang L. et al. Incidence of second primary cancers in patients with retinoblastoma: a systematic review and meta-analysis. Frontiers in oncology. 2024-04-25;14(14):1372548.
doi: 10.3389/fonc.2024.1372548
Sun J., Xi H.Y., Shao Q., Liu Q.H. Biomarkers in retinoblastoma Int J Ophthalmol. 2020 Feb 18;13(2):325-341.
doi: 10.18240/ijo.2020.02.18. eCollection 2020.
Sun S., Wang R., Yi S., Li S., Wang L., Wang J. Roles of the microRNA‑338‑3p/NOVA1 axis in retinoblastoma. Molecular medicine reports. 2021 May;23(5):394.
doi: 10.3892/mmr.2021.12033
Sun X., Shen H., Liu S., Gao J., Zhang S. Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA‑124 and thereby upregulating STAT3.International Journal of Molecular Medicine. 2020 Mar 20.
doi: 10.3892/ijmm.2020.4547
Sun Z., Zhang A., Hou M., Jiang T. Circular RNA hsa_circ_0000034 promotes the progression of retinoblastoma via sponging microRNA-361-3p. Bioengineered. 2020 Dec;11(1):949-957.
doi: 10.1080/21655979.2020.1814670
Sunwoo Y., Choi J.Y., Park H.J. et al. Twenty-year retrospective study of post-enucleation chemotherapy in high-risk patients with unilateral retinoblastoma. Children (Basel, Switzerland). 2022-12-25;9(12).
doi: 10.3390/children9121983
Suresh Babu V., Bisht A., Mallipatna A. et al. Enhanced Epithelial-to-Mesenchymal Transition and Chemoresistance in Advanced Retinoblastoma Tumors Is Driven by miR-181a. Cancers. 2022-10-30;14(20).
doi: 10.3390/cancers14205124
Surukrattanaskul S., Keyurapan B., Wangtiraumnuay N. et al. Correlation between clinical presentations, radiological findings and high risk histopathological features of primary enucleated eyes with advanced retinoblastoma at Queen Sirikit National Institute of Child Health: 5 years result. PloS one. 2022-07-25;17(7):e0270362.
doi: 10.1371/journal.pone.0270362
Sweid A., El Naamani K., Sajja K.C., Hammoud B., Knapp M.D., Moylan D.D., Joffe D., Morse C.E., Habbal D., Weinberg J.H., Tjoumakaris S.I., Shields C.L., Lezama D.A., Lim L.S., Dalvin L.A., Rosenwasser R., Jabbour P. Incidence and predictors of ophthalmic artery occlusion in intra-arterial chemotherapy for retinoblastoma. Journal of neurointerventional surgery. 2020 Oct 29.
doi: 10.1136/neurintsurg-2020-016759
Sweid A., Hammoud B., Texakalidis P., Xu V., Shivashankar K., Baldassari M.P., Das S., Tjoumakaris S., Shields C.L., Ancona-Lezama D., Lim L.S., Dalvin L.A., Maamari D.J., Jabbour P. The Use of Alternative Routes for the Delivery of Intra-Arterial Chemotherapy for Retinoblastoma. Neurosurgery online. 2020 May 12.
doi: 10.1093/neuros/nyaa142
Sweid A., Hammoud B., Weinberg J.H., Texakalidis P., Xu V., Shivashankar K., Baldassari M.P., Das S., Ramesh S., Tjoumakaris S., Shields C.L., Ancona-Lezama D., Lim L.S., Dalvin L.A., Jabbour P. Intra-Arterial Chemotherapy for Retinoblastoma in Infants ≤10 Kg: 74 Treated Eyes With 222 IAC Sessions. American journal of neuroradiology. 2020 June 25.
doi: 10.3174/ajnr.A6590
Sweid A., Hammoud B., Weinberg J.H., Texakalidis P., Xu V., Shivashankar K., Baldassari M.P., Das S., Tjoumakaris S.I., Shields C.L., Lezama D.A., Lim L.S., Dalvin L.A., El Naamani K., Jabbour P. Ophthalmic artery catheterization for retinoblastoma treatment: does reflux affect tumor response? Journal of NeuroInterventional Surgery. 2020 Apr 9.
doi: 10.1136/neurintsurg-2019-015597
Sweid A., Jabbour P. Intra-arterial chemotherapy for retinoblastoma: transradial and transfemoral approach. Journal of neurointerventional surgery. 2020 May 15.
doi: 10.1136/neurintsurg-2019-015627
doi: 10.1016/j.tranon.2020.100971
Suleiman D.E., Iliyasu Y., Ahmed S.A., Liman A.A. Histopathologic spectrum of paediatric eye and ocular adnexal tumours: A 10-year review from a referral centre in Nigeria. Nigerian journal of clinical practice. 2020 May;23.
doi: 10.4103/njcp.njcp_389_19
Sun J., Feng D., Xi H., Luo J., Zhou Z., Liu Q., Chen Y., Shao Q. CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy. Molecular oncology. 2020 May 12.
doi: 10.1002/1878-0261.12708
Sun J., Gan L., Ding J. et al. Identification of non-coding RNAs and their functional network associated with optic nerve invasion in retinoblastoma. Heliyon. 2023-03-01;9(2):e13813.
doi: 10.1016/j.heliyon.2023.e13813
Sun J., Gu X., Wang L. et al. Incidence of second primary cancers in patients with retinoblastoma: a systematic review and meta-analysis. Frontiers in oncology. 2024-04-25;14(14):1372548.
doi: 10.3389/fonc.2024.1372548
Sun J., Xi H.Y., Shao Q., Liu Q.H. Biomarkers in retinoblastoma Int J Ophthalmol. 2020 Feb 18;13(2):325-341.
doi: 10.18240/ijo.2020.02.18. eCollection 2020.
Sun S., Wang R., Yi S., Li S., Wang L., Wang J. Roles of the microRNA‑338‑3p/NOVA1 axis in retinoblastoma. Molecular medicine reports. 2021 May;23(5):394.
doi: 10.3892/mmr.2021.12033
Sun X., Shen H., Liu S., Gao J., Zhang S. Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA‑124 and thereby upregulating STAT3.International Journal of Molecular Medicine. 2020 Mar 20.
doi: 10.3892/ijmm.2020.4547
Sun Z., Zhang A., Hou M., Jiang T. Circular RNA hsa_circ_0000034 promotes the progression of retinoblastoma via sponging microRNA-361-3p. Bioengineered. 2020 Dec;11(1):949-957.
doi: 10.1080/21655979.2020.1814670
Sunwoo Y., Choi J.Y., Park H.J. et al. Twenty-year retrospective study of post-enucleation chemotherapy in high-risk patients with unilateral retinoblastoma. Children (Basel, Switzerland). 2022-12-25;9(12).
doi: 10.3390/children9121983
Suresh Babu V., Bisht A., Mallipatna A. et al. Enhanced Epithelial-to-Mesenchymal Transition and Chemoresistance in Advanced Retinoblastoma Tumors Is Driven by miR-181a. Cancers. 2022-10-30;14(20).
doi: 10.3390/cancers14205124
Surukrattanaskul S., Keyurapan B., Wangtiraumnuay N. et al. Correlation between clinical presentations, radiological findings and high risk histopathological features of primary enucleated eyes with advanced retinoblastoma at Queen Sirikit National Institute of Child Health: 5 years result. PloS one. 2022-07-25;17(7):e0270362.
doi: 10.1371/journal.pone.0270362
Sweid A., El Naamani K., Sajja K.C., Hammoud B., Knapp M.D., Moylan D.D., Joffe D., Morse C.E., Habbal D., Weinberg J.H., Tjoumakaris S.I., Shields C.L., Lezama D.A., Lim L.S., Dalvin L.A., Rosenwasser R., Jabbour P. Incidence and predictors of ophthalmic artery occlusion in intra-arterial chemotherapy for retinoblastoma. Journal of neurointerventional surgery. 2020 Oct 29.
doi: 10.1136/neurintsurg-2020-016759
Sweid A., Hammoud B., Texakalidis P., Xu V., Shivashankar K., Baldassari M.P., Das S., Tjoumakaris S., Shields C.L., Ancona-Lezama D., Lim L.S., Dalvin L.A., Maamari D.J., Jabbour P. The Use of Alternative Routes for the Delivery of Intra-Arterial Chemotherapy for Retinoblastoma. Neurosurgery online. 2020 May 12.
doi: 10.1093/neuros/nyaa142
Sweid A., Hammoud B., Weinberg J.H., Texakalidis P., Xu V., Shivashankar K., Baldassari M.P., Das S., Ramesh S., Tjoumakaris S., Shields C.L., Ancona-Lezama D., Lim L.S., Dalvin L.A., Jabbour P. Intra-Arterial Chemotherapy for Retinoblastoma in Infants ≤10 Kg: 74 Treated Eyes With 222 IAC Sessions. American journal of neuroradiology. 2020 June 25.
doi: 10.3174/ajnr.A6590
Sweid A., Hammoud B., Weinberg J.H., Texakalidis P., Xu V., Shivashankar K., Baldassari M.P., Das S., Tjoumakaris S.I., Shields C.L., Lezama D.A., Lim L.S., Dalvin L.A., El Naamani K., Jabbour P. Ophthalmic artery catheterization for retinoblastoma treatment: does reflux affect tumor response? Journal of NeuroInterventional Surgery. 2020 Apr 9.
doi: 10.1136/neurintsurg-2019-015597
Sweid A., Jabbour P. Intra-arterial chemotherapy for retinoblastoma: transradial and transfemoral approach. Journal of neurointerventional surgery. 2020 May 15.
doi: 10.1136/neurintsurg-2019-015627
T
Talapatra J., Reddy M.M. et al. Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification. Cancers. 2023-04-15;15(7).
doi: 10.3390/cancers15072144
Tan R.J.D., Ballesteros K.F.B. et al. Retinoblastoma outcomes in a tertiary hospital in Northern Luzon, the Philippines: A 15-Year Experience. South Asian journal of cancer. 2022-12-06;11(2):160-163.
doi: 10.1055/s-0041-1739179
Tan R.J.D., Mercado G.J.V., Cabrera P.E. et al. Philippine retinoblastoma initiative multi-eye center study 2010-2020. International journal of ophthalmology. 2024-01-21;17(1):144-156.
doi: 10.18240/ijo.2024.01.20
Tandon S., Prasad M., Vora T., Chinnaswamy G., Shetye N. A Rare Association of Retinoblastoma With Incontinentia Pigmenti. Journal of Pediatric Hematology/Oncology. 2020 Apr 13.
doiI: 10.1097/MPH.0000000000001797
Taneja S., Aldoais T., Kaliki S. Primary Orbital Polymethylmethacrylate Implant Following Primary Enucleation for Retinoblastoma: A Study of 321 Cases. Orbit. 2020 Apr 7.
doi: 10.1080/01676830.2020.1750040
Taneja S., Aldoais T., Kaliki S. Primary orbital polymethylmethacrylate implant following primary enucleation for retinoblastoma: a study of 321 cases. Orbit. 2021 Apr;40(2):127-132.
doi: 10.1080/01676830.2020.1750040
Tang H., Long Q., Zhuang K., Han K., Zhang X., Guo H., Lu X. Retinoblastoma tumor suppressor gene 1 enhances 5-Fluorouracil chemosensitivity through SDF-1/CXCR4 axis by regulating autophagy in gastric cancer. Pathol Res Pract. 2021 Aug;224:153532.
doi: 10.1016/j.prp.2021.153532
Tang J., Liu Y., Wang Y. et al. Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression. Biomarker research. 2024-05-13;12(1):48.
doi: 10.1186/s40364-024-00596-8
Tang J., Liu Y., Zhang Z. et al. Heterogeneous Expression Patterns of the Minichromosome Maintenance Complex Members in Retinoblastoma Unveil Its Clinical Significance. Investigative ophthalmology & visual science. 2024-01-31;65(1):31.
doi: 10.1167/iovs.65.1.31
Tang L., Fu Y., Song J., Hu T, Li K, Li Z. mTOR inhibition by TAK-228 is effective against growth, survival and angiogenesis in preclinical retinoblastoma models. Pharmacol Res Perspect. 2022 Feb;10(1):e00930. PMID: 35142090.
doi: 10.1002/prp2.930
Tang Q., Xu F., Lin J. et al. Legumain affects the PI3K/AKT tumor progression pathway in retinoblastoma. Experimental eye research. 2022-09-27;224(224):109221
doi: 10.1016/j.exer.2022.109221
Tang W., Zhang L., Li J. et al. KCNQ1OT1 promotes retinoblastoma progression by targeting miR-339-3p that suppresses KIF23. International ophthalmology. 2023-07-03;43(7):2419-2432
doi: 10.1007/s10792-023-02641-1
Tang W., Zhang L., Li J., Guan Y. AFAP1 antisense RNA 1 promotes retinoblastoma progression by sponging microRNA miR-545-3p that targets G protein subunit beta 1. Bioengineered. 2022 Mar;13(3):5638-5652. PMID: 35193469.
doi: 10.1080/21655979.2022.2033464
Tangella A.V. et al. The Evolving Role of Intra-arterial Chemotherapy in Adult and Pediatric Cancers: A Comprehensive Review. Cureus. 2023-10-31;15(10):e46631.
doi: 10.7759/cureus.46631
Tanveer S., Zafar F., Bibi H. et al. Advancements in Retinoblastoma Treatment: Unraveling the Potential of Intravitreal Chemotherapy. Cureus. 2024-02-29;16(1):e53012.
doi: 10.7759/cureus.53012
Tanwar M., Balaji S., Vanniarajan A., Kim U., Chowdhury G. Parental age and retinoblastoma-a retrospective study of demographic data and genetic analysis. Eye (Lond). 2021 Nov 19.
doi: 10.1038/s41433-021-01771-z
Tarlan B., Gunaydin B., Veyselov O., Gungor I., Konuk O. Surgical treatment of huge orbital retinoblastoma under general anesthesia in a three-year old child. Braz J Anesthesiol. 2022 Apr 6:S0104-0014(22)00039-2. Epub ahead of print. PMID: 35398150.
doi: 10.1016/j.bjane.2022.03.009
Tetik D., Kaan Gündüz A., Heper A.O. et al. Orbital pseudocellulitis following systemic chemotherapy in a case of congenital retinoblastoma. Journal francais d'ophtalmologie. 2024-04-04:104172.
doi: 10.1016/j.jfo.2024.104172
Thaker S.K., Shah P.K., Das A. et al. Management of Recurrence in Retinoblastoma Based on the Source of Tumor Cells. Middle East African journal of ophthalmology. 2024-03-05;30(1):24-30.
doi: 10.4103/meajo.meajo_112_23
Thakur S., Basnet R., Bajracharya K. et al. Multidisciplinary Approach for Retinoblastoma Management. Nepalese journal of ophthalmology: a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society: NEPJOPH. 2022-08-24;13(24):234-236
doi: 10.3126/nepjoph.v13i2.39752
Thomas G.N., Vempuluru V.S., Shields C.L. et al. Disappearing retinoblastoma. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2023-07-22.
doi: 10.1016/j.jcjo.2023.06.008
Thompson S., Ritz B., Cockburn M. et al. Prenatal ambient pesticide exposure and childhood retinoblastoma. International journal of hygiene and environmental health. 2022-09-20;245(245):114025.
doi: 10.1016/j.ijheh.2022.114025
Thongkumkoon P., Sangphukieo A., Tongjai S. et al. Establishment, characterization, and genetic profiling of patient-derived osteosarcoma cells from a patient with retinoblastoma. Scientific reports. 2024-09-12;14(1):11056.
doi: 10.1038/s41598-024-60628-z
Thuma T.B.T., Silverman R.F., Francis J.H. et al. Capturing Bilateral Retinoblastoma. Journal of pediatric ophthalmology and strabismus. 2024-05-30:1.
doi: 10.3928/01913913-20240508-07
Ting S.C., Kiefer T., Ehlert K., Goericke S.L., Hinze R., Ketteler P., Bechrakis N.E., Schildhaus H.U. Bone metastasis of retinoblastoma five years after primary treatment. American journal of ophthalmology case reports. 2020 Jul 17.
doi: 10.1016/j.ajoc.2020.100834
Tohidian M, Esmaeil N, Soleimani M, Khanehzad M, Naderi Majd AH, Zarinfard G. The niosomal nelarabine as a promising nano combination for retinoblastoma treatment: an in vitro study-experimental research. Ann Med Surg (Lond). 2025 Jan 9;87(1):121-129. PMID: 40109588; PMCID: PMC11918550.
doi: 10.1097/MS9.0000000000002821
Toki H, Yonekura Y, Tsunoyama Y, Bando M. Theoretical Study of Retinoblastoma in the Hereditary and Non-hereditary Processes Including the Cancer Growth. Bull Math Biol. 2025 Jun 26;87(8):103. PMID: 40569505; PMCID: PMC12202645.
doi: 10.1007/s11538-025-01483-5
Toli A., Perente A., Labiris G. Evaluation of the red reflex: An overview for the pediatrician. World J Methodol. 2021 Sep 20;11(5):263-277.
doi: 10.5662/wjm.v11.i5.263
Tomar A.S., Finger P.T., Gallie B., Kivelä T.T., Mallipatna A., Zhang C., Zhao J., Wilson M.W., Brenna R.C., Burges M., Kim J., Khetan V., Ganesan S., Yarovoy A., Yarovaya V., Kotova E., Yousef Y.A., Nummi K., Ushakova T.L., Yugay O.V., Polyakov V.G., Ramirez-Ortiz M.A., Esparza-Aguiar E., Chantada G., Schaiquevich P., Fandino A., Yam J.C., Lau W.W., Lam C.P., Sharwood P., Moorthy S., Long Q.B., Essuman V.A., Renner L.A., Semenova E., Català J., Correa-Llano G., Carreras E.; American Joint Committee on Cancer Ophthalmic Oncology Task Force.
Global Retinoblastoma Treatment Outcomes: Association with National Income Level. Ophthalmology. 2021 May;128(5):740-753.
doi: 10.1016/j.ophtha.2020.09.032
Tomar A.S., Finger P.T., Gallie B., Kivelä T., Mallipatna A., Zhang C., Zhao J., Wilson M., Brennan R., Burges M., Kim J., Berry J.L., Jubran R., Khetan V., Ganeshan S., Yarovoy A., Yarovaya V., Kotova E., Volodin D., Yousef Y., Nummi K., Ushakova T.L., Yugay O.V., Polyakov V.G., Ramirez-Ortiz M.A., Esparza-Aguiar E., Chantada G.L., Schaiquevich P., Fandiño A.C., Yam J.C., Lau W.W., Lam C.P., Sharwood P., Moorthy S., Long Q.B., Essuman V.A., Renner L.A., Semenova E., Català-Mora J., Correa Llano M., Carreras E.; American Joint Committee on Cancer Ophthalmic Oncology Task Force; American Joint Committee on Cancer Ophthalmic Oncology Task.
Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging. Br J Ophthalmol. 2021 Aug 2:bjophthalmol-2021-318892.
doi: 10.1136/bjophthalmol-2021-318892
https://bjo.bmj.com/content/early/2021/08/01/bjophthalmol-2021-318892.long
Tomar A.S., Finger P.T., Gallie B., Mallipatna A., Kivelä T.T., Zhang C., Zhao J., Wilson M.W., Brenna R.C., Burges M., Kim J., Khetan V., Ganesan S., Yarovoy A., Yarovaya V., Kotova E., Yousef Y.A., Nummi K, Ushakova T.L., Yugay O.V., Polyakov V.G., Ramirez-Ortiz M.A., Esparza-Aguiar E., Chantada G., Schaiquevich P., Fandino A., Yam J.C., Lau W.W., Lam C.P., Sharwood P., Moorthy S., Long Q.B., Essuman V.A., Renner L.A., Semenova E., Català J., Correa-Llano G., Carreras-Bertran E.; American Joint Committee on Cancer Ophthalmic Oncology Task Force.
A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Treatment Success and Globe Salvage. Ophthalmology. 2020 Jun 8.
doi: 10.1016/j.ophtha.2020.05.051
Tomar A.S., Finger P.T., Gallie B., Kivelä T.T., Mallipatna A., Zhang C., Zhao J., Wilson M.W., Brennan R.C., Burges M., Kim J., Berry J.L., Jubran R., Khetan V., Ganesan S., Yarovoy A., Yarovaya V., Kotova E., Volodin D., Yousef Y.A., Nummi K., Ushakova T.L., Yugay O.V., Polyakov V.G., Ramirez-Ortiz M.A., Esparza-Aguiar E., Chantada G., Schaiquevich P., Fandino A., Yam J.C., Lau W.W., Lam C.P., Sharwood P., Moorthy S., Long Q.B., Essuman V.A., Renner L.A., Semenova E., Català-Mora J., Correa-Llano G., Carreras E.; American Joint Committee on Cancer Ophthalmic Oncology Task Force. High-Risk Pathology Based on Presenting Features in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing AJCC Study. Ophthalmology. 2022 Apr 15:S0161-6420(22)00284-6. Epub ahead of print. PMID: 35436535.
doi: 10.1016/j.ophtha.2022.04.006
Tomita T., Huibregtse J.M., Matouschek A. A Masked Initiation Region in Retinoblastoma Protein Regulates Its Proteasomal Degradation. Nature Communications. 2020 Apr 24
DOI: 10.1038/s41467-020-16003-3
Tonorezos E.S., Friedman D.N., Barnea D., Bosscha M.I., Chantada G., Dommering C.J., de Graaf P., Dunkel I.J., Fabius A.W.M., Francis J.H., Greer M.C., Kleinerman R.A., Kors W.A., Laughlin S., Moll A.C., Morton L.M., Temming P., Tucker M.A., van Leeuwen F.E., Walsh M.F., Oeffinger K.C., Abramson D.H. Recommendations for long-term follow-up of adults with heritable retinoblastoma. Ophthalmology. 2020 May 15.
DOI: 10.1016/j.ophtha.2020.05.024
Toret E., Ozdemir Z.C., Zengin Ersoy G. et al. Tandem high-dose chemotherapy followed by autologous stem cell transplantation: An infant with trilateral retinoblastoma. Pediatric transplantation. 2023-03-15:e14504.
doi: 10.1111/petr.14504
Tóth D., Fábián E., Szabó E. et al. Investigation of PACAP38 and PAC1 Receptor Expression in Human Retinoblastoma and the Effect of PACAP38 Administration on Human Y-79 Retinoblastoma Cells. Life (Basel, Switzerland). 2024-02-27;14(2).
doi: 10.3390/life14020185
Toumasis PN, Mallipatna A, Corson TW, Dimaras H. Retinoma: An overview. Pediatr Investig. 2025 Mar 10;9(2):139-149. PMID: 40539010; PMCID: PMC12175641.
doi: 10.1002/ped4.12472
Trauernicht C.J., van Eeden D., du Plessis F.C.P. et al. Measured, calculated, and egs_brachy I-125 dose distributions in a gold plaque for retinoblastoma treatment. Medical physics. 2022-09-14;49(9):6183-6194.
doi: 10.1002/mp.15845
Tripathy D., Moulin A., Bijon J. et al. When the second comes first- rhabdomyosarcoma preceding heritable retinoblastoma- a case report. BMC ophthalmology. 2024-02-08;24(1):47.
doi: 10.1186/s12886-024-03307-x
Tsimpida M., Dharmaraj S., Luthert P.J., Reddy M.A., Sagoo M.S. Retinal neuronal ectopia: a new entity in the differential diagnosis of retinoblastoma. Retin Cases Brief Rep. 2022 Mar 1;16(2):204-206. PMID: 31800504.
doi: 10.1097/ICB.0000000000000950
Tu J., Huo Z., Yu Y., Zhu D., Xu A., Huang M.F., Hu R., Wang R., Gingold J.A., Chen Y.H., Tsai K.L., Forcioli-Conti N.R., Huang S.X.L., Webb T.R., Su J., Bazer D.A., Jia P. etc. Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies. Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2117857119. Epub 2022 Apr 11. PMID: 35412907.
doi: 10.1073/pnas.2117857119
Turchiello R.F., Oliveira C.S., Fernandes A.U., Gómez S.L., Baptista M.S. Methylene blue-mediated Photodynamic Therapy in human retinoblastoma cell lines. Journal of photochemistry and photobiology. B, Biology. 2021 Jul 16;222:112260. PMID: 34304071.
doi: 10.1016/j.jphotobiol.2021.112260.
Turchiello R.F., Oliveira C.S., Fernandes A.U., Gómez S.L., Baptista M.S. Methylene blue-mediated Photodynamic Therapy in human retinoblastoma cell lines. J Photochem Photobiol B. 2021 Sep;222:112260.
doi: 10.1016/j.jphotobiol.2021.112260
Turkoglu E.B., Erol M.K., Karaca B.O. Coexistence of torpedo maculopathy and retinoblastoma: Differentiation the lesions with hand-held optical coherence tomography. Photodiagnosis and photodynamic therapy. 2021 May 4;34:102331.
doi: 10.1016/j.pdpdt.2021.102331
Turkoglu E.B., Erol M.K. Optical coherence tomography findings in a case with cavitary retinoblastoma. Journal français d'ophtalmologie. 2020 Dec 1:S0181-5512(20)30536-2.
doi: 10.1016/j.jfo.2020.05.008
Twelve-month observational study of children with cancer in 41 countries during the COVID-19 pandemic. BMJ global health. 2022-10-21;7(10).
doi: 10.1136/bmjgh-2022-008797
Talapatra J., Reddy M.M. et al. Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification. Cancers. 2023-04-15;15(7).
doi: 10.3390/cancers15072144
Tan R.J.D., Ballesteros K.F.B. et al. Retinoblastoma outcomes in a tertiary hospital in Northern Luzon, the Philippines: A 15-Year Experience. South Asian journal of cancer. 2022-12-06;11(2):160-163.
doi: 10.1055/s-0041-1739179
Tan R.J.D., Mercado G.J.V., Cabrera P.E. et al. Philippine retinoblastoma initiative multi-eye center study 2010-2020. International journal of ophthalmology. 2024-01-21;17(1):144-156.
doi: 10.18240/ijo.2024.01.20
Tandon S., Prasad M., Vora T., Chinnaswamy G., Shetye N. A Rare Association of Retinoblastoma With Incontinentia Pigmenti. Journal of Pediatric Hematology/Oncology. 2020 Apr 13.
doiI: 10.1097/MPH.0000000000001797
Taneja S., Aldoais T., Kaliki S. Primary Orbital Polymethylmethacrylate Implant Following Primary Enucleation for Retinoblastoma: A Study of 321 Cases. Orbit. 2020 Apr 7.
doi: 10.1080/01676830.2020.1750040
Taneja S., Aldoais T., Kaliki S. Primary orbital polymethylmethacrylate implant following primary enucleation for retinoblastoma: a study of 321 cases. Orbit. 2021 Apr;40(2):127-132.
doi: 10.1080/01676830.2020.1750040
Tang H., Long Q., Zhuang K., Han K., Zhang X., Guo H., Lu X. Retinoblastoma tumor suppressor gene 1 enhances 5-Fluorouracil chemosensitivity through SDF-1/CXCR4 axis by regulating autophagy in gastric cancer. Pathol Res Pract. 2021 Aug;224:153532.
doi: 10.1016/j.prp.2021.153532
Tang J., Liu Y., Wang Y. et al. Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression. Biomarker research. 2024-05-13;12(1):48.
doi: 10.1186/s40364-024-00596-8
Tang J., Liu Y., Zhang Z. et al. Heterogeneous Expression Patterns of the Minichromosome Maintenance Complex Members in Retinoblastoma Unveil Its Clinical Significance. Investigative ophthalmology & visual science. 2024-01-31;65(1):31.
doi: 10.1167/iovs.65.1.31
Tang L., Fu Y., Song J., Hu T, Li K, Li Z. mTOR inhibition by TAK-228 is effective against growth, survival and angiogenesis in preclinical retinoblastoma models. Pharmacol Res Perspect. 2022 Feb;10(1):e00930. PMID: 35142090.
doi: 10.1002/prp2.930
Tang Q., Xu F., Lin J. et al. Legumain affects the PI3K/AKT tumor progression pathway in retinoblastoma. Experimental eye research. 2022-09-27;224(224):109221
doi: 10.1016/j.exer.2022.109221
Tang W., Zhang L., Li J. et al. KCNQ1OT1 promotes retinoblastoma progression by targeting miR-339-3p that suppresses KIF23. International ophthalmology. 2023-07-03;43(7):2419-2432
doi: 10.1007/s10792-023-02641-1
Tang W., Zhang L., Li J., Guan Y. AFAP1 antisense RNA 1 promotes retinoblastoma progression by sponging microRNA miR-545-3p that targets G protein subunit beta 1. Bioengineered. 2022 Mar;13(3):5638-5652. PMID: 35193469.
doi: 10.1080/21655979.2022.2033464
Tangella A.V. et al. The Evolving Role of Intra-arterial Chemotherapy in Adult and Pediatric Cancers: A Comprehensive Review. Cureus. 2023-10-31;15(10):e46631.
doi: 10.7759/cureus.46631
Tanveer S., Zafar F., Bibi H. et al. Advancements in Retinoblastoma Treatment: Unraveling the Potential of Intravitreal Chemotherapy. Cureus. 2024-02-29;16(1):e53012.
doi: 10.7759/cureus.53012
Tanwar M., Balaji S., Vanniarajan A., Kim U., Chowdhury G. Parental age and retinoblastoma-a retrospective study of demographic data and genetic analysis. Eye (Lond). 2021 Nov 19.
doi: 10.1038/s41433-021-01771-z
Tarlan B., Gunaydin B., Veyselov O., Gungor I., Konuk O. Surgical treatment of huge orbital retinoblastoma under general anesthesia in a three-year old child. Braz J Anesthesiol. 2022 Apr 6:S0104-0014(22)00039-2. Epub ahead of print. PMID: 35398150.
doi: 10.1016/j.bjane.2022.03.009
Tetik D., Kaan Gündüz A., Heper A.O. et al. Orbital pseudocellulitis following systemic chemotherapy in a case of congenital retinoblastoma. Journal francais d'ophtalmologie. 2024-04-04:104172.
doi: 10.1016/j.jfo.2024.104172
Thaker S.K., Shah P.K., Das A. et al. Management of Recurrence in Retinoblastoma Based on the Source of Tumor Cells. Middle East African journal of ophthalmology. 2024-03-05;30(1):24-30.
doi: 10.4103/meajo.meajo_112_23
Thakur S., Basnet R., Bajracharya K. et al. Multidisciplinary Approach for Retinoblastoma Management. Nepalese journal of ophthalmology: a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society: NEPJOPH. 2022-08-24;13(24):234-236
doi: 10.3126/nepjoph.v13i2.39752
Thomas G.N., Vempuluru V.S., Shields C.L. et al. Disappearing retinoblastoma. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2023-07-22.
doi: 10.1016/j.jcjo.2023.06.008
Thompson S., Ritz B., Cockburn M. et al. Prenatal ambient pesticide exposure and childhood retinoblastoma. International journal of hygiene and environmental health. 2022-09-20;245(245):114025.
doi: 10.1016/j.ijheh.2022.114025
Thongkumkoon P., Sangphukieo A., Tongjai S. et al. Establishment, characterization, and genetic profiling of patient-derived osteosarcoma cells from a patient with retinoblastoma. Scientific reports. 2024-09-12;14(1):11056.
doi: 10.1038/s41598-024-60628-z
Thuma T.B.T., Silverman R.F., Francis J.H. et al. Capturing Bilateral Retinoblastoma. Journal of pediatric ophthalmology and strabismus. 2024-05-30:1.
doi: 10.3928/01913913-20240508-07
Ting S.C., Kiefer T., Ehlert K., Goericke S.L., Hinze R., Ketteler P., Bechrakis N.E., Schildhaus H.U. Bone metastasis of retinoblastoma five years after primary treatment. American journal of ophthalmology case reports. 2020 Jul 17.
doi: 10.1016/j.ajoc.2020.100834
Tohidian M, Esmaeil N, Soleimani M, Khanehzad M, Naderi Majd AH, Zarinfard G. The niosomal nelarabine as a promising nano combination for retinoblastoma treatment: an in vitro study-experimental research. Ann Med Surg (Lond). 2025 Jan 9;87(1):121-129. PMID: 40109588; PMCID: PMC11918550.
doi: 10.1097/MS9.0000000000002821
Toki H, Yonekura Y, Tsunoyama Y, Bando M. Theoretical Study of Retinoblastoma in the Hereditary and Non-hereditary Processes Including the Cancer Growth. Bull Math Biol. 2025 Jun 26;87(8):103. PMID: 40569505; PMCID: PMC12202645.
doi: 10.1007/s11538-025-01483-5
Toli A., Perente A., Labiris G. Evaluation of the red reflex: An overview for the pediatrician. World J Methodol. 2021 Sep 20;11(5):263-277.
doi: 10.5662/wjm.v11.i5.263
Tomar A.S., Finger P.T., Gallie B., Kivelä T.T., Mallipatna A., Zhang C., Zhao J., Wilson M.W., Brenna R.C., Burges M., Kim J., Khetan V., Ganesan S., Yarovoy A., Yarovaya V., Kotova E., Yousef Y.A., Nummi K., Ushakova T.L., Yugay O.V., Polyakov V.G., Ramirez-Ortiz M.A., Esparza-Aguiar E., Chantada G., Schaiquevich P., Fandino A., Yam J.C., Lau W.W., Lam C.P., Sharwood P., Moorthy S., Long Q.B., Essuman V.A., Renner L.A., Semenova E., Català J., Correa-Llano G., Carreras E.; American Joint Committee on Cancer Ophthalmic Oncology Task Force.
Global Retinoblastoma Treatment Outcomes: Association with National Income Level. Ophthalmology. 2021 May;128(5):740-753.
doi: 10.1016/j.ophtha.2020.09.032
Tomar A.S., Finger P.T., Gallie B., Kivelä T., Mallipatna A., Zhang C., Zhao J., Wilson M., Brennan R., Burges M., Kim J., Berry J.L., Jubran R., Khetan V., Ganeshan S., Yarovoy A., Yarovaya V., Kotova E., Volodin D., Yousef Y., Nummi K., Ushakova T.L., Yugay O.V., Polyakov V.G., Ramirez-Ortiz M.A., Esparza-Aguiar E., Chantada G.L., Schaiquevich P., Fandiño A.C., Yam J.C., Lau W.W., Lam C.P., Sharwood P., Moorthy S., Long Q.B., Essuman V.A., Renner L.A., Semenova E., Català-Mora J., Correa Llano M., Carreras E.; American Joint Committee on Cancer Ophthalmic Oncology Task Force; American Joint Committee on Cancer Ophthalmic Oncology Task.
Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging. Br J Ophthalmol. 2021 Aug 2:bjophthalmol-2021-318892.
doi: 10.1136/bjophthalmol-2021-318892
https://bjo.bmj.com/content/early/2021/08/01/bjophthalmol-2021-318892.long
Tomar A.S., Finger P.T., Gallie B., Mallipatna A., Kivelä T.T., Zhang C., Zhao J., Wilson M.W., Brenna R.C., Burges M., Kim J., Khetan V., Ganesan S., Yarovoy A., Yarovaya V., Kotova E., Yousef Y.A., Nummi K, Ushakova T.L., Yugay O.V., Polyakov V.G., Ramirez-Ortiz M.A., Esparza-Aguiar E., Chantada G., Schaiquevich P., Fandino A., Yam J.C., Lau W.W., Lam C.P., Sharwood P., Moorthy S., Long Q.B., Essuman V.A., Renner L.A., Semenova E., Català J., Correa-Llano G., Carreras-Bertran E.; American Joint Committee on Cancer Ophthalmic Oncology Task Force.
A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Treatment Success and Globe Salvage. Ophthalmology. 2020 Jun 8.
doi: 10.1016/j.ophtha.2020.05.051
Tomar A.S., Finger P.T., Gallie B., Kivelä T.T., Mallipatna A., Zhang C., Zhao J., Wilson M.W., Brennan R.C., Burges M., Kim J., Berry J.L., Jubran R., Khetan V., Ganesan S., Yarovoy A., Yarovaya V., Kotova E., Volodin D., Yousef Y.A., Nummi K., Ushakova T.L., Yugay O.V., Polyakov V.G., Ramirez-Ortiz M.A., Esparza-Aguiar E., Chantada G., Schaiquevich P., Fandino A., Yam J.C., Lau W.W., Lam C.P., Sharwood P., Moorthy S., Long Q.B., Essuman V.A., Renner L.A., Semenova E., Català-Mora J., Correa-Llano G., Carreras E.; American Joint Committee on Cancer Ophthalmic Oncology Task Force. High-Risk Pathology Based on Presenting Features in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing AJCC Study. Ophthalmology. 2022 Apr 15:S0161-6420(22)00284-6. Epub ahead of print. PMID: 35436535.
doi: 10.1016/j.ophtha.2022.04.006
Tomita T., Huibregtse J.M., Matouschek A. A Masked Initiation Region in Retinoblastoma Protein Regulates Its Proteasomal Degradation. Nature Communications. 2020 Apr 24
DOI: 10.1038/s41467-020-16003-3
Tonorezos E.S., Friedman D.N., Barnea D., Bosscha M.I., Chantada G., Dommering C.J., de Graaf P., Dunkel I.J., Fabius A.W.M., Francis J.H., Greer M.C., Kleinerman R.A., Kors W.A., Laughlin S., Moll A.C., Morton L.M., Temming P., Tucker M.A., van Leeuwen F.E., Walsh M.F., Oeffinger K.C., Abramson D.H. Recommendations for long-term follow-up of adults with heritable retinoblastoma. Ophthalmology. 2020 May 15.
DOI: 10.1016/j.ophtha.2020.05.024
Toret E., Ozdemir Z.C., Zengin Ersoy G. et al. Tandem high-dose chemotherapy followed by autologous stem cell transplantation: An infant with trilateral retinoblastoma. Pediatric transplantation. 2023-03-15:e14504.
doi: 10.1111/petr.14504
Tóth D., Fábián E., Szabó E. et al. Investigation of PACAP38 and PAC1 Receptor Expression in Human Retinoblastoma and the Effect of PACAP38 Administration on Human Y-79 Retinoblastoma Cells. Life (Basel, Switzerland). 2024-02-27;14(2).
doi: 10.3390/life14020185
Toumasis PN, Mallipatna A, Corson TW, Dimaras H. Retinoma: An overview. Pediatr Investig. 2025 Mar 10;9(2):139-149. PMID: 40539010; PMCID: PMC12175641.
doi: 10.1002/ped4.12472
Trauernicht C.J., van Eeden D., du Plessis F.C.P. et al. Measured, calculated, and egs_brachy I-125 dose distributions in a gold plaque for retinoblastoma treatment. Medical physics. 2022-09-14;49(9):6183-6194.
doi: 10.1002/mp.15845
Tripathy D., Moulin A., Bijon J. et al. When the second comes first- rhabdomyosarcoma preceding heritable retinoblastoma- a case report. BMC ophthalmology. 2024-02-08;24(1):47.
doi: 10.1186/s12886-024-03307-x
Tsimpida M., Dharmaraj S., Luthert P.J., Reddy M.A., Sagoo M.S. Retinal neuronal ectopia: a new entity in the differential diagnosis of retinoblastoma. Retin Cases Brief Rep. 2022 Mar 1;16(2):204-206. PMID: 31800504.
doi: 10.1097/ICB.0000000000000950
Tu J., Huo Z., Yu Y., Zhu D., Xu A., Huang M.F., Hu R., Wang R., Gingold J.A., Chen Y.H., Tsai K.L., Forcioli-Conti N.R., Huang S.X.L., Webb T.R., Su J., Bazer D.A., Jia P. etc. Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies. Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2117857119. Epub 2022 Apr 11. PMID: 35412907.
doi: 10.1073/pnas.2117857119
Turchiello R.F., Oliveira C.S., Fernandes A.U., Gómez S.L., Baptista M.S. Methylene blue-mediated Photodynamic Therapy in human retinoblastoma cell lines. Journal of photochemistry and photobiology. B, Biology. 2021 Jul 16;222:112260. PMID: 34304071.
doi: 10.1016/j.jphotobiol.2021.112260.
Turchiello R.F., Oliveira C.S., Fernandes A.U., Gómez S.L., Baptista M.S. Methylene blue-mediated Photodynamic Therapy in human retinoblastoma cell lines. J Photochem Photobiol B. 2021 Sep;222:112260.
doi: 10.1016/j.jphotobiol.2021.112260
Turkoglu E.B., Erol M.K., Karaca B.O. Coexistence of torpedo maculopathy and retinoblastoma: Differentiation the lesions with hand-held optical coherence tomography. Photodiagnosis and photodynamic therapy. 2021 May 4;34:102331.
doi: 10.1016/j.pdpdt.2021.102331
Turkoglu E.B., Erol M.K. Optical coherence tomography findings in a case with cavitary retinoblastoma. Journal français d'ophtalmologie. 2020 Dec 1:S0181-5512(20)30536-2.
doi: 10.1016/j.jfo.2020.05.008
Twelve-month observational study of children with cancer in 41 countries during the COVID-19 pandemic. BMJ global health. 2022-10-21;7(10).
doi: 10.1136/bmjgh-2022-008797
U
Ueda T., Koga Y., Yoshikawa H., Tanabe M., Yamana K., Oba U., Nakashima K., Ono H., Ichimura T., Hasegawa S., Kato W., Kobayashi T., Nakayama H., Sakai Y., Yoshitake T., Ohga S., Oda Y., Suzuki S., Sonoda K.H., Ohga S. Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma. BMC Pediatr. 2020 Jan 28;20(1):37.
DOI: 10.1186/s12887-020-1923-7
Ustaoglu M., Eagle R.J., Bloom S.M. et al. Unilateral, Sectoral Retinal Metastasis of Small-Cell Lung Cancer Mimicking Viral Retinitis. Retinal cases & brief reports. 2023-04-27
doi: 10.1097/ICB.0000000000001415
Utomo PT., Respatika D., Ardianto B. et al. Lag time, high-risk histopathological features, metastasis, and survival interrelation in retinoblastoma: a perspective from lower-middle income country. International journal of ophthalmology. 2022-12-22;15(12):1994-2000
doi: 10.18240/ijo.2022.12.15
V
Vaithialingam B., Gopal S., Chandrashekhar S. et al. Anesthetic management of super-selective intra-arterial Melphalan injection in an infant with retinoblastoma. Saudi journal of anaesthesia. 2023-10-31;17(3):434-436.
doi: 10.4103/sja.sja_236_23
Vaithialingam B., Gopal S., Chandrashekhar S. et al. Severe Oculorespiratory Reflex during Ophthalmic Artery Catheterization in an Infant with Retinoblastoma. The Indian journal of radiology & imaging. 2023-10-10;33(4):574-575.
doi: 10.1055/s-0043-1770084
Valve A, Reijonen V, Rintala A, Strengell S, Nousiainen K, Tenhunen M. Dose measurement of ophthalmic Ru-106/Rh-106 applicators with a diamond detector calibrated in a clinical megavoltage electron beam. Phys Med Biol. 2025 Mar 10;70(6). PMID: 39993378.
doi: 10.1088/1361-6560/adb9b1
van Elst S., de Bloeme C.M., Noteboom S. et al. Automatic segmentation and quantification of the optic nerve on MRI using a 3D U-Net. Journal of medical imaging (Bellingham, Wash.). 2023-05-19;10(3):034501.
doi: 10.1117/1.JMI.10.3.034501
van Hoefen Wijsard M., Serné S.H., Otten R.H., Bosscha M.I., Dommering C.J., Fabius A.W., Moll A.C. At What Age Could Screening for Familial Retinoblastoma Be Discontinued? A Systematic Review. Cancers. 2021 Apr 17;13(8):1942.
doi: 10.3390/cancers13081942
van Hoefen Wijsard M., Schonfeld S.J., van Leeuwen F.E., Moll A.C., Fabius A.W., Abramson D.H., Seddon J.M., Francis J.H., Tucker M.A., Kleinerman R.A., Morton L.M. Benign Tumors in Long-Term Survivors of Retinoblastoma. Cancers. 2021 Apr 8;13(8):1773.
doi: 10.3390/cancers13081773
Vanniarajan A., Maitra P., Saraswathi K.K. et al. Impact of RB1 gene screening from blood collected on a single day from 411 family members of 113 Retinoblastoma survivors in India. Eye (London, England). 2024-02-10.
doi: 10.1038/s41433-024-02955-z
Van Meenen D., Doege A., Alefeld E. et al. ADAM10 and ADAM17-Novel Players in Retinoblastoma Carcinogenesis. International journal of molecular sciences. 2022-10-30;23(20).
doi: 10.3390/ijms232012621
Varkaris A, Wang K, Nouri M, Kozlova N, Schmidt DR, Stavridi A, Arai S, Ambrosio N, Poluben L, Jimenez-Vacas JM, Westaby D, Carmichael J, Xie F, Figueiredo I, Buroni L, Neeb A, Gurel B, Chevalier N, Brown L, Voznesensky O, Chen SY, Russo JW, Yuan X, Juric D, Beltran H, De Bono JS, Vander Heiden MG, Einstein DJ, Muranen T, Corey E, Sharp A, Balk SP. BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress. Nat Commun. 2025 May 28;16(1):4931. PMID: 40436896; PMCID: PMC12119881.
doi: 10.1038/s41467-025-60238-x
Vasiljevic A. et al. Histopathology and molecular pathology of pediatric pineal parenchymal tumors. Child's nervous system: ChNS: official journal of the International Society for Pediatric Neurosurgery. 2022-08-16.
doi: 10.1007/s00381-022-05637-x
Vaz M., Fahrenkrog B. The Retinoblastoma Tumor Suppressor Is Required for the NUP98-HOXA9-Induced Aberrant Nuclear Envelope Phenotype. Cells. 2021 Oct 22;10(11):2851.
doi: 10.3390/cells10112851
Velasco-Hidalgo L., González-Garay A., Rizzoli-Córdoba A. et al. Risk of alterations in neurodevelopment in infants and preschool children with cancer. Boletin medico del Hospital Infantil de Mexico. 2024-09-05;81(4):217-224
doi: 10.24875/BMHIM.24000011
Vempuluru VS, Bakal K, Agarwal P, Kaur G, Kaliki S. Secondary Enucleation in Retinoblastoma: Clinical features predictive of high-risk histopathology Features in 295 Eyes. Retina. 2025 May 6. Epub ahead of print. PMID: 40334128.
doi: 10.1097/IAE.0000000000004504
Vempuluru V.S., Jakati S., Kaliki S. Delayed metastasis in patients with intraocular retinoblastoma: A review of three cases. European journal of ophthalmology. 2020 Jul 24.
doi: 10.1177/1120672120946285
Vempuluru V.S, Jakati S., Krishnamurthy R., Senthil S., Kaliki S. Glaucoma as the presenting sign of intraocular tumors: beware of the masquerading sign. // International Ophthalmology. 2020 Mar 20.
doi: 10.1007/s10792-020-01348-x
Vempuluru V.S., Kaliki S. Screening for Retinoblastoma: A Systematic Review of Current Strategies. Asia-Pacific journal of ophthalmology. 2021 Mar-Apr 01;10(2):192-199.
doi: 10.1097/APO.0000000000000378
Vempuluru V.S., Maniar A., Bakal K. et al. Role of MYCN in retinoblastoma: A review of current literature. Survey of ophthalmology. 2024-09-06;69(5):697-706.
doi: 10.1016/j.survophthal.2024.05.009
Vempuluru V.S., Maniar A., Kaliki S. et al. Global retinoblastoma studies: A review. Clinical & experimental ophthalmology. 2024-01-24.
doi: 10.1111/ceo.14357
Vempuluru VS, Mishra DK, Kaliki S. Intravitreal topotecan injection-induced conjunctival fibrosis mimicking extraocular extension of retinoblastoma: a rare complication. J AAPOS. 2025 Feb;29(1):104099.104099. Epub 2024 Dec 31. PMID: 39746534.
doi: 10.1016/j.jaapos.2024
Vempuluru VS, Patil G, Viriyala R, Dhara KK, Kaliki S. Artificial intelligence and machine learning in ocular oncology, retinoblastoma (ArMOR). Indian J Ophthalmol. 2025 May 1;73(5):741-743. Epub 2025 Apr 24. PMID: 40272303; PMCID: PMC12121871.
doi: 10.4103/IJO.IJO_1768_24
Vempuluru VS, Shields CL, Berry JL, Kaliki S; High-Risk Retinoblastoma Collaborative Study Group. Retinoblastoma Outcomes Based on the 8th Edition American Joint Committee on Cancer Pathological Classification in 1411 Patients. Ophthalmology. 2025 Mar; 132(3):317-326. Epub 2024 Sep 7. PMID: 39245078.
doi: 10.1016/j.ophtha.2024.08.037
Vempuluru V.S., Viriyala R., Ayyagari V. et al. Artificial Intelligence and Machine Learning in Ocular Oncology, Retinoblastoma (ArMOR): Experience with a Multiracial Cohort. Cancers. 2024-10-28;16(20)
doi: 10.3390/cancers16203516
Vemuganti G.K. Viral etiology in retinoblastoma. Indian J Ophthalmol. 2021 Aug;69(8):1990.
doi: 10.4103/ijo.IJO_1801_21 г
Venkatesh R., Agrawal S., Reddy N.G., Pereira A. Multimodal imaging in a classic case of unilateral retinocytoma. BMJ Case Rep. 2021 Aug 5;14(8):e244167.
doi: 10.1136/bcr-2021-244167
Ventura E., Iannuzzi C.A., Pentimalli F., Giordano A., Morrione A. RBL1/p107 Expression Levels Are Modulated by Multiple Signaling Pathways. Cancers (Basel). 2021 Oct 8;13(19):5025.
doi: 10.3390/cancers13195025
Verma R., Adewara BA., Palkonda VAR. et al. Salvage intra-arterial chemotherapy for recurrent or persistent intraocular retinoblastoma: A study of 24 eyes. Ophthalmology. Retina. 2022-10-04.
doi: 10.1016/j.oret.2022.09.006
Verma R., Singh A., Chopra S. et al. Adult-onset retinoblastoma: An uncommon and challenging diagnosis. Oman journal of ophthalmology. 2023-08-23;16(2):382-384.
doi: 10.4103/ojo.ojo_296_22
Vijayan A., Aggarwal A., S. Khurana P.R., Sinha T. Rehabilitation of Phthisis Bulbi using Thick Scleral Shell Prosthesis. Int J Appl Basic Med Res. 2022 Jul-Sep;12(3):217-219. Epub 2022 Jul 26. PMID: 36131853; PMCID: PMC9484514.
doi: 10.4103/ijabmr.ijabmr_699_21
Villanueva G., Sampor C., Moreno F., Alderete D., Moresco A., Pinto N., Szijan I., Schaiquevich P., Felice M.S., Rose A., Zubizarreta P., Sgroi M., Fandiño A., Chantada G. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina. Pediatr Blood Cancer. 2022 Apr 21:e29710. PMID: 35451226.
doi: 10.1002/pbc.29710
Vincent A., Natarajan V., Khetan V., Krishnakumar S., Parameswaran S. Retinoblastoma patient-derived stem cells-an in vivo model to study the role of RB1 in adipogenesis. Histochem Cell Biol. 2022 Apr 21. Epub ahead of print. PMID: 35445864.
doi: 10.1007/s00418-022-02105-0
Virgili G., Capocaccia R., Botta L. et al. Survival and Health Care Burden of Children With Retinoblastoma in Europe. JAMA ophthalmology. 2024-11-23;142(11):1062-70
doi: 10.1001/jamaophthalmol.2024.4140
Vishwanath, Swamy D.T., Gaddi D.S. et al. Smartphone for retinal imaging - Case series in resource-limited rural settings. Indian journal of ophthalmology. 2023-05-22;71(5):2008-2013.
doi: 10.4103/ijo.IJO_2077_22
Vural Ö., Atalay H.T., Kayhan G. et al. Clinical and genetic characteristics of retinoblastoma patients in a single center with four novel RB1 variants. International journal of ophthalmology. 2023-08-23;16(8):1274-1279.
doi: 10.18240/ijo.2023.08.13
Ueda T., Koga Y., Yoshikawa H., Tanabe M., Yamana K., Oba U., Nakashima K., Ono H., Ichimura T., Hasegawa S., Kato W., Kobayashi T., Nakayama H., Sakai Y., Yoshitake T., Ohga S., Oda Y., Suzuki S., Sonoda K.H., Ohga S. Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma. BMC Pediatr. 2020 Jan 28;20(1):37.
DOI: 10.1186/s12887-020-1923-7
Ustaoglu M., Eagle R.J., Bloom S.M. et al. Unilateral, Sectoral Retinal Metastasis of Small-Cell Lung Cancer Mimicking Viral Retinitis. Retinal cases & brief reports. 2023-04-27
doi: 10.1097/ICB.0000000000001415
Utomo PT., Respatika D., Ardianto B. et al. Lag time, high-risk histopathological features, metastasis, and survival interrelation in retinoblastoma: a perspective from lower-middle income country. International journal of ophthalmology. 2022-12-22;15(12):1994-2000
doi: 10.18240/ijo.2022.12.15
V
Vaithialingam B., Gopal S., Chandrashekhar S. et al. Anesthetic management of super-selective intra-arterial Melphalan injection in an infant with retinoblastoma. Saudi journal of anaesthesia. 2023-10-31;17(3):434-436.
doi: 10.4103/sja.sja_236_23
Vaithialingam B., Gopal S., Chandrashekhar S. et al. Severe Oculorespiratory Reflex during Ophthalmic Artery Catheterization in an Infant with Retinoblastoma. The Indian journal of radiology & imaging. 2023-10-10;33(4):574-575.
doi: 10.1055/s-0043-1770084
Valve A, Reijonen V, Rintala A, Strengell S, Nousiainen K, Tenhunen M. Dose measurement of ophthalmic Ru-106/Rh-106 applicators with a diamond detector calibrated in a clinical megavoltage electron beam. Phys Med Biol. 2025 Mar 10;70(6). PMID: 39993378.
doi: 10.1088/1361-6560/adb9b1
van Elst S., de Bloeme C.M., Noteboom S. et al. Automatic segmentation and quantification of the optic nerve on MRI using a 3D U-Net. Journal of medical imaging (Bellingham, Wash.). 2023-05-19;10(3):034501.
doi: 10.1117/1.JMI.10.3.034501
van Hoefen Wijsard M., Serné S.H., Otten R.H., Bosscha M.I., Dommering C.J., Fabius A.W., Moll A.C. At What Age Could Screening for Familial Retinoblastoma Be Discontinued? A Systematic Review. Cancers. 2021 Apr 17;13(8):1942.
doi: 10.3390/cancers13081942
van Hoefen Wijsard M., Schonfeld S.J., van Leeuwen F.E., Moll A.C., Fabius A.W., Abramson D.H., Seddon J.M., Francis J.H., Tucker M.A., Kleinerman R.A., Morton L.M. Benign Tumors in Long-Term Survivors of Retinoblastoma. Cancers. 2021 Apr 8;13(8):1773.
doi: 10.3390/cancers13081773
Vanniarajan A., Maitra P., Saraswathi K.K. et al. Impact of RB1 gene screening from blood collected on a single day from 411 family members of 113 Retinoblastoma survivors in India. Eye (London, England). 2024-02-10.
doi: 10.1038/s41433-024-02955-z
Van Meenen D., Doege A., Alefeld E. et al. ADAM10 and ADAM17-Novel Players in Retinoblastoma Carcinogenesis. International journal of molecular sciences. 2022-10-30;23(20).
doi: 10.3390/ijms232012621
Varkaris A, Wang K, Nouri M, Kozlova N, Schmidt DR, Stavridi A, Arai S, Ambrosio N, Poluben L, Jimenez-Vacas JM, Westaby D, Carmichael J, Xie F, Figueiredo I, Buroni L, Neeb A, Gurel B, Chevalier N, Brown L, Voznesensky O, Chen SY, Russo JW, Yuan X, Juric D, Beltran H, De Bono JS, Vander Heiden MG, Einstein DJ, Muranen T, Corey E, Sharp A, Balk SP. BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress. Nat Commun. 2025 May 28;16(1):4931. PMID: 40436896; PMCID: PMC12119881.
doi: 10.1038/s41467-025-60238-x
Vasiljevic A. et al. Histopathology and molecular pathology of pediatric pineal parenchymal tumors. Child's nervous system: ChNS: official journal of the International Society for Pediatric Neurosurgery. 2022-08-16.
doi: 10.1007/s00381-022-05637-x
Vaz M., Fahrenkrog B. The Retinoblastoma Tumor Suppressor Is Required for the NUP98-HOXA9-Induced Aberrant Nuclear Envelope Phenotype. Cells. 2021 Oct 22;10(11):2851.
doi: 10.3390/cells10112851
Velasco-Hidalgo L., González-Garay A., Rizzoli-Córdoba A. et al. Risk of alterations in neurodevelopment in infants and preschool children with cancer. Boletin medico del Hospital Infantil de Mexico. 2024-09-05;81(4):217-224
doi: 10.24875/BMHIM.24000011
Vempuluru VS, Bakal K, Agarwal P, Kaur G, Kaliki S. Secondary Enucleation in Retinoblastoma: Clinical features predictive of high-risk histopathology Features in 295 Eyes. Retina. 2025 May 6. Epub ahead of print. PMID: 40334128.
doi: 10.1097/IAE.0000000000004504
Vempuluru V.S., Jakati S., Kaliki S. Delayed metastasis in patients with intraocular retinoblastoma: A review of three cases. European journal of ophthalmology. 2020 Jul 24.
doi: 10.1177/1120672120946285
Vempuluru V.S, Jakati S., Krishnamurthy R., Senthil S., Kaliki S. Glaucoma as the presenting sign of intraocular tumors: beware of the masquerading sign. // International Ophthalmology. 2020 Mar 20.
doi: 10.1007/s10792-020-01348-x
Vempuluru V.S., Kaliki S. Screening for Retinoblastoma: A Systematic Review of Current Strategies. Asia-Pacific journal of ophthalmology. 2021 Mar-Apr 01;10(2):192-199.
doi: 10.1097/APO.0000000000000378
Vempuluru V.S., Maniar A., Bakal K. et al. Role of MYCN in retinoblastoma: A review of current literature. Survey of ophthalmology. 2024-09-06;69(5):697-706.
doi: 10.1016/j.survophthal.2024.05.009
Vempuluru V.S., Maniar A., Kaliki S. et al. Global retinoblastoma studies: A review. Clinical & experimental ophthalmology. 2024-01-24.
doi: 10.1111/ceo.14357
Vempuluru VS, Mishra DK, Kaliki S. Intravitreal topotecan injection-induced conjunctival fibrosis mimicking extraocular extension of retinoblastoma: a rare complication. J AAPOS. 2025 Feb;29(1):104099.104099. Epub 2024 Dec 31. PMID: 39746534.
doi: 10.1016/j.jaapos.2024
Vempuluru VS, Patil G, Viriyala R, Dhara KK, Kaliki S. Artificial intelligence and machine learning in ocular oncology, retinoblastoma (ArMOR). Indian J Ophthalmol. 2025 May 1;73(5):741-743. Epub 2025 Apr 24. PMID: 40272303; PMCID: PMC12121871.
doi: 10.4103/IJO.IJO_1768_24
Vempuluru VS, Shields CL, Berry JL, Kaliki S; High-Risk Retinoblastoma Collaborative Study Group. Retinoblastoma Outcomes Based on the 8th Edition American Joint Committee on Cancer Pathological Classification in 1411 Patients. Ophthalmology. 2025 Mar; 132(3):317-326. Epub 2024 Sep 7. PMID: 39245078.
doi: 10.1016/j.ophtha.2024.08.037
Vempuluru V.S., Viriyala R., Ayyagari V. et al. Artificial Intelligence and Machine Learning in Ocular Oncology, Retinoblastoma (ArMOR): Experience with a Multiracial Cohort. Cancers. 2024-10-28;16(20)
doi: 10.3390/cancers16203516
Vemuganti G.K. Viral etiology in retinoblastoma. Indian J Ophthalmol. 2021 Aug;69(8):1990.
doi: 10.4103/ijo.IJO_1801_21 г
Venkatesh R., Agrawal S., Reddy N.G., Pereira A. Multimodal imaging in a classic case of unilateral retinocytoma. BMJ Case Rep. 2021 Aug 5;14(8):e244167.
doi: 10.1136/bcr-2021-244167
Ventura E., Iannuzzi C.A., Pentimalli F., Giordano A., Morrione A. RBL1/p107 Expression Levels Are Modulated by Multiple Signaling Pathways. Cancers (Basel). 2021 Oct 8;13(19):5025.
doi: 10.3390/cancers13195025
Verma R., Adewara BA., Palkonda VAR. et al. Salvage intra-arterial chemotherapy for recurrent or persistent intraocular retinoblastoma: A study of 24 eyes. Ophthalmology. Retina. 2022-10-04.
doi: 10.1016/j.oret.2022.09.006
Verma R., Singh A., Chopra S. et al. Adult-onset retinoblastoma: An uncommon and challenging diagnosis. Oman journal of ophthalmology. 2023-08-23;16(2):382-384.
doi: 10.4103/ojo.ojo_296_22
Vijayan A., Aggarwal A., S. Khurana P.R., Sinha T. Rehabilitation of Phthisis Bulbi using Thick Scleral Shell Prosthesis. Int J Appl Basic Med Res. 2022 Jul-Sep;12(3):217-219. Epub 2022 Jul 26. PMID: 36131853; PMCID: PMC9484514.
doi: 10.4103/ijabmr.ijabmr_699_21
Villanueva G., Sampor C., Moreno F., Alderete D., Moresco A., Pinto N., Szijan I., Schaiquevich P., Felice M.S., Rose A., Zubizarreta P., Sgroi M., Fandiño A., Chantada G. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina. Pediatr Blood Cancer. 2022 Apr 21:e29710. PMID: 35451226.
doi: 10.1002/pbc.29710
Vincent A., Natarajan V., Khetan V., Krishnakumar S., Parameswaran S. Retinoblastoma patient-derived stem cells-an in vivo model to study the role of RB1 in adipogenesis. Histochem Cell Biol. 2022 Apr 21. Epub ahead of print. PMID: 35445864.
doi: 10.1007/s00418-022-02105-0
Virgili G., Capocaccia R., Botta L. et al. Survival and Health Care Burden of Children With Retinoblastoma in Europe. JAMA ophthalmology. 2024-11-23;142(11):1062-70
doi: 10.1001/jamaophthalmol.2024.4140
Vishwanath, Swamy D.T., Gaddi D.S. et al. Smartphone for retinal imaging - Case series in resource-limited rural settings. Indian journal of ophthalmology. 2023-05-22;71(5):2008-2013.
doi: 10.4103/ijo.IJO_2077_22
Vural Ö., Atalay H.T., Kayhan G. et al. Clinical and genetic characteristics of retinoblastoma patients in a single center with four novel RB1 variants. International journal of ophthalmology. 2023-08-23;16(8):1274-1279.
doi: 10.18240/ijo.2023.08.13
W
Waddell K., Matua M., Bidwell C., Atwine R., Onyango J., Picton S.V., Simmons I., Stahlschmidt J., Johnston W.T., Newton R. A ten-year study of Retinoblastoma in Uganda: An approach to improving outcome with limited resources. Cancer Epidemiology. 2021 Apr;71(Pt B):101777.
doi: 10.1016/j.canep.2020.101777
Wagner R.S. The Genetics of Unilateral Retinoblastoma Clarified. J Pediatr Ophthalmol Strabismus. 2021 Nov-Dec;58(6):344.
doi: 10.3928/01913913-20211012-01
Wai Y.Z., Radhakrishnan D.M., Lingam G. et al. Intra-arterial chemotherapy for retinoblastoma: Experience from the pediatric ophthalmology referral center in Malaysia with literature review. Taiwan journal of ophthalmology. 2024-01-23;13(4):527-534.
doi: 10.4103/tjo.TJO-D-22-00162
Wakankar R. et al. An Interesting Case of Post-enucleation Retinoblastoma Presenting With Distant Liver and Skeletal Metastases Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography. Cureus. 2023-12-07;15(11):e48249.
doi: 10.7759/cureus.48249
Walker JK, Nair D, Mongan AM, Parulekar M, Cole T, Abbott J. Age distribution of retinoblastoma tumours in familial disease. Eye (Lond). 2025 Apr;39(6):1093-1098. Epub 2024 Dec 11. PMID: 39663399; PMCID: PMC11978979.
doi: 10.1038/s41433-024-03499-y
Wallace W.H., Kelsey T.W., Morrison D. et al. Live birth and maternity outcome in childhood and adolescent cancer survivors under 18 years at diagnosis: a 40-year population-based cohort study. British journal of cancer. 2024-10-21;131(8):1309-1319
doi: 10.1038/s41416-024-02818-0
Wan T., Fu M., Wu Z., Gao X., Zhou S. Advances in the role of autophagy in the development of retinoblastoma. Oncol Lett. 2021 Aug;22(2):632.
doi: 10.3892/ol.2021.12893
Wang F, Wang J. Establishment and validation of a prognostic risk early-warning model for retinoblastoma based on XGBoost. Am J Cancer Res. 2025 Jan 15;15(1):99-112. doi: 10.62347/WHUQ1208. PMID: 39949950; PMCID: PMC11815383.
Wang H., Li M., Cui H., Song X., Sha Q. CircDHDDS/miR-361-3p/WNT3A Axis Promotes the Development of Retinoblastoma by Regulating Proliferation, Cell Cycle, Migration, and Invasion of Retinoblastoma Cells. Neurochemical research. 2020 Aug 31.
doi: 10.1007/s11064-020-03112-0
Wang H., Liu Z., Sun Z., Zhou D., Mao H., Deng G. Ubiquitin specific peptidase 33 promotes cell proliferation and reduces apoptosis through regulation of the SP1/PI3K/AKT pathway in retinoblastoma. Cell Cycle. 2021 Sep 1:1-11.
doi: 10.1080/15384101.2021.1970305
Wang H, Wang W, Tang Q, Liu X, Zhu L, Sun D, Lin T. Enzyme-sensitive peptide KC26 modifies milk exosomes encapsulating carboplatin for the treatment of retinoblastoma. Pharm Dev Technol. 2025 Jun;30(5):621-631. Epub 2025 May 22. PMID: 40356530.
doi: 10.1080/10837450.2025.2505005
Wang H., Yang J., Pan H., Tai M.C., Maher M.H., Jia R., Ge S., Lu L. Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway. OncoTargets and therapy.2020 May 8.
doi: 10.2147/OTT.S228532
Wang J., Dong Y., Li Q. Neferine induces mitochondrial dysfunction to exert anti-proliferative and anti-invasive activities on retinoblastoma. Experimental biology and medicine / Society for Experimental Biology and Medicine. 2020 May 28.
doi: 10.1177/1535370220928933
Wang J., Wang S., Chen L., Tan J. SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway.Molecular medicine reports. 2021 Mar;23(3):202.
doi: 10.3892/mmr.2021.11841. Epub 2021 Jan 26
Wang J., Zhang C., Zhang L. et al. Comparative study on genomic and epigenomic profiles of retinoblastoma or tuberous sclerosis complex via nanopore sequencing and a joint screening framework. Cancer gene therapy. 2023-12-25.
doi: 10.1038/s41417-023-00714-y
Wang L., Chen J., Shen Y. et al. Incidence, mortality, and global burden of retinoblastoma in 204 countries worldwide from 1990 to 2021: Data and systematic analysis from the Global Burden of Disease Study 2021. Neoplasia (New York, N.Y.). 2024-12-26;60(60):101107
doi: 10.1016/j.neo.2024.101107
Wang L., Chen N., Cheng H. Fisetin inhibits vascular endothelial growth factor-induced angiogenesis in retinoblastoma cells. Oncology letters. 2020 Aug.
doi: 10.3892/ol.2020.11679
Wang L., Li S., Mei J. et al. Immunotherapies of retinoblastoma: Effective methods for preserving vision in the future. Frontiers in oncology. 2022-09-24;12(12):949193.
doi: 10.3389/fonc.2022.949193
Wang L., Wang C., Wu T., Sun F. Long non-coding RNA TP73-AS1 promotes TFAP2B-mediated proliferation, metastasis and invasion in retinoblastoma via decoying of miRNA-874-3p. Journal of Cell Communication and Signaling. Feb-2020.
doi: 10.1007/s12079-020-00550-x
Wang L., Zhang Y., Xin X. Long Non-Coding RNA MALAT1 Aggravates Human Retinoblastoma by Sponging miR-20b-5p to Upregulate STAT3. Pathology, Research and Practice. 2020 Apr 18.
doi: 10.1016/j.prp.2020.152977
https://pubmed.ncbi.nlm.nih.gov/32336590/?from_term=retinoblastoma&from_sort=date&from_pos=5
Wang N., Liu R., Li J. et al. Long-term efficacy of enucleation combined with primary orbital implantation in children with retinoblastoma histopathological invasion of optic nerve. Frontiers in neurology. 2022-10-28;13(13):1013523.
doi: 10.3389/fneur.2022.1013523
Wang N., Ma J.M. et al. Progress of Cancer Stem Cells in Retinoblastoma. Current stem cell research & therapy. 2023-10-10.
doi: 10.2174/011574888X252989230921065809
Wang X., Su Y., Yin C. Long non-coding RNA (lncRNA) five prime to Xist (FTX) promotes retinoblastoma progression by regulating the microRNA-320a/with-nolysine kinases 1 (WNK1) axis. Bioengineered. 2021 Nov 1.
doi: 10.1080/21655979.2021.1994718
Wang X., Su Y., Yin C. Long non-coding RNA (lncRNA) five prime to Xist (FTX) promotes retinoblastoma progression by regulating the microRNA-320a/with-no-lysine kinases 1 (WNK1) axis. Bioengineered. 2021 Dec;12(2):11622-11633.
doi: 10.1080/21655979.2021.1994718
Wang Y., Sun D., Sheng Y., Guo H., Meng F., Song T. XIST promotes cell proliferation and invasion by regulating miR-140-5p and SOX4 in retinoblastoma // World Journal of Surgical Oncology. 2020 Mar 3.
DOI: 10.1186/s12957-020-01825-8
Wang Y., Tang J., Liu Y. et al. Targeting ALDOA to modulate tumorigenesis and energy metabolism in retinoblastoma. iScience. 2024-09-14;27(9):110725
doi: 10.1016/j.isci.2024.110725
Wang Y., Wang J., Hao H., Luo X. lncRNA KCNQ1OT1 promotes the proliferation, migration and invasion of retinoblastoma cells by upregulating HIF-1alpha via sponging miR-153-3p. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 2020 Dec;68(8):1349-1356.
doi: 10.1136/jim-2020-001431
Wang Y., Xin D., Zhou L. LncRNA LINC00152 Increases the Aggressiveness of Human Retinoblastoma and Enhances Carboplatin and Adriamycin Resistance by Regulating MiR-613/Yes-Associated Protein 1 (YAP1) Axis. Medical science monitor : international medical journal of experimental and clinical research.2020 Jun 15.
doi: 10.12659/MSM.920886
Wang Y.Z., Hu H.M., Zhang Y. et al. Clinical Characteristics and Prognosis of 39 Cases of Retinoblastoma With Optic Nerve Stump Involvement. American journal of therapeutics. 2024-10-18
doi: 10.1097/MJT.0000000000001794
Wang Y.Z., Zhang Y., Huang D.S., Shi J.T., Ma J.M., Li B., Xu X.L., Zhou Y., Gu H.L.
Clinical characteristics, treatment and prognosis of children with unilateral retinoblastoma and intracranial segment of Retrobulbar optic nerve invasion. BMC Ophthalmol. 2021 Jan 14;21(1):38.
doi: 10.1186/s12886-020-01768-4
Wang Z., Chen N., Liu C., Cao G., Ji Y., Yang W., Jiang Q. UBE2T is a prognostic biomarker and correlated with Th2 cell infiltrates in retinoblastoma. Biochem Biophys Res Commun. 2022 May 6;614:138-144.
doi: 10.1016/j.bbrc.2022.04.096
Wang Z., Liang X., Yi G. et al. Bioinformatics analysis proposes a possible role for long noncoding RNA MIR17HG in retinoblastoma. Cancer reports (Hoboken, N.J.). 2024-03-14;7(2):e1933.
doi: 10.1002/cnr2.1933
Wangtiraumnuay N., Surakrattanaskul S., Wangkittikul C. et al. Digital Gangrene and Antiphospholipid Syndrome in a Retinoblastoma Patient with Chromosome 13q Deletion: A Case Report. Case reports in oncology. 2023-05-02;16(1):287-293.
doi: 10.1159/000530182
Warda O., Naeem Z., Roelofs K.A., Sagoo M.S., Reddy M.A. Retinoblastoma and vision. Eye (Lond). 2022 Jan 5. Epub ahead of print.
doi: 10.1038/s41433-021-01845-y
Warkad V., Tripathy D. et al. Intravitreal chemotherapy-induced cataract in retinoblastoma: challenges and outcome. BMJ case reports. 2022-12-22;15(12)
doi: 10.1136/bcr-2022-250617
Watts-Santos A., Ancona-Lezama D.A., Figueroa-Sanchez J.A. et al. Ciliary Madarosis Secondary to Intra-Arterial Chemotherapy for Retinoblastoma Treatment. Skin appendage disorders. 2024-06-07;10(3):167-171.
doi: 10.1159/000535826
Wei D., Pu N., Li S.Y. et al. Application of iontophoresis in ophthalmic practice: an innovative strategy to deliver drugs into the eye. Drug delivery. 2023-01-21;30(1):2165736.
doi: 10.1080/10717544.2023.2165736
Wei T., Grace M., Uberoi A., Romero-Masters J.C., Lee D., Lambert P.F., Munger K. The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis. mBio. 2021 Aug 31;12(4):e0227721.
doi: 10.1128/mBio.02277-21
Wen S., Hu M., Xiong Y. Effect of Eriodictyol on Retinoblastoma via the PI3K/Akt Pathway. J Healthc Eng. 2021 Nov 11;2021:6091585.
doi: 10.1155/2021/6091585
Wen X., Fan J., Jin M. et al. Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial. The Lancet. Child & adolescent health. 2023-10-11;7(9):613-620.
doi: 10.1016/S2352-4642(23)00141-4
Wen Y., Zhu M., Zhang X. et al. Integrated analysis of multiple bioinformatics studies to identify microRNA-target gene-transcription factor regulatory networks in retinoblastoma. Translational cancer research. 2022-08-16;11(7):2225-2237.
doi: 10.21037/tcr-21-1748
Wendt S.P., Barrett D.A., Chang E.Y., Schefler A.C. Segmental Scleral Buckle Surgical Technique for Repair of a Rhegmatogenous Retinal Detachment in Retinoblastoma: A Case and Review of the Literature. Ocul Oncol Pathol. 2021 Mar;7(2):91-96.
doi: 10.1159/000508721
Weng P.Y., Chen S.H., Kao L.Y., Tsai Y.J., Yang S.H., Tseng C.K., Tsay P.K., Jaing T.H. Clinical spectrum and treatment outcome of retinoblastoma with Group D and E diseases: A single institution retrospective review. Medicine. 2020 Sep 18;
doi: 10.1097/MD.0000000000022201
Waddell K., Matua M., Bidwell C., Atwine R., Onyango J., Picton S.V., Simmons I., Stahlschmidt J., Johnston W.T., Newton R. A ten-year study of Retinoblastoma in Uganda: An approach to improving outcome with limited resources. Cancer Epidemiology. 2021 Apr;71(Pt B):101777.
doi: 10.1016/j.canep.2020.101777
Wagner R.S. The Genetics of Unilateral Retinoblastoma Clarified. J Pediatr Ophthalmol Strabismus. 2021 Nov-Dec;58(6):344.
doi: 10.3928/01913913-20211012-01
Wai Y.Z., Radhakrishnan D.M., Lingam G. et al. Intra-arterial chemotherapy for retinoblastoma: Experience from the pediatric ophthalmology referral center in Malaysia with literature review. Taiwan journal of ophthalmology. 2024-01-23;13(4):527-534.
doi: 10.4103/tjo.TJO-D-22-00162
Wakankar R. et al. An Interesting Case of Post-enucleation Retinoblastoma Presenting With Distant Liver and Skeletal Metastases Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography. Cureus. 2023-12-07;15(11):e48249.
doi: 10.7759/cureus.48249
Walker JK, Nair D, Mongan AM, Parulekar M, Cole T, Abbott J. Age distribution of retinoblastoma tumours in familial disease. Eye (Lond). 2025 Apr;39(6):1093-1098. Epub 2024 Dec 11. PMID: 39663399; PMCID: PMC11978979.
doi: 10.1038/s41433-024-03499-y
Wallace W.H., Kelsey T.W., Morrison D. et al. Live birth and maternity outcome in childhood and adolescent cancer survivors under 18 years at diagnosis: a 40-year population-based cohort study. British journal of cancer. 2024-10-21;131(8):1309-1319
doi: 10.1038/s41416-024-02818-0
Wan T., Fu M., Wu Z., Gao X., Zhou S. Advances in the role of autophagy in the development of retinoblastoma. Oncol Lett. 2021 Aug;22(2):632.
doi: 10.3892/ol.2021.12893
Wang F, Wang J. Establishment and validation of a prognostic risk early-warning model for retinoblastoma based on XGBoost. Am J Cancer Res. 2025 Jan 15;15(1):99-112. doi: 10.62347/WHUQ1208. PMID: 39949950; PMCID: PMC11815383.
Wang H., Li M., Cui H., Song X., Sha Q. CircDHDDS/miR-361-3p/WNT3A Axis Promotes the Development of Retinoblastoma by Regulating Proliferation, Cell Cycle, Migration, and Invasion of Retinoblastoma Cells. Neurochemical research. 2020 Aug 31.
doi: 10.1007/s11064-020-03112-0
Wang H., Liu Z., Sun Z., Zhou D., Mao H., Deng G. Ubiquitin specific peptidase 33 promotes cell proliferation and reduces apoptosis through regulation of the SP1/PI3K/AKT pathway in retinoblastoma. Cell Cycle. 2021 Sep 1:1-11.
doi: 10.1080/15384101.2021.1970305
Wang H, Wang W, Tang Q, Liu X, Zhu L, Sun D, Lin T. Enzyme-sensitive peptide KC26 modifies milk exosomes encapsulating carboplatin for the treatment of retinoblastoma. Pharm Dev Technol. 2025 Jun;30(5):621-631. Epub 2025 May 22. PMID: 40356530.
doi: 10.1080/10837450.2025.2505005
Wang H., Yang J., Pan H., Tai M.C., Maher M.H., Jia R., Ge S., Lu L. Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway. OncoTargets and therapy.2020 May 8.
doi: 10.2147/OTT.S228532
Wang J., Dong Y., Li Q. Neferine induces mitochondrial dysfunction to exert anti-proliferative and anti-invasive activities on retinoblastoma. Experimental biology and medicine / Society for Experimental Biology and Medicine. 2020 May 28.
doi: 10.1177/1535370220928933
Wang J., Wang S., Chen L., Tan J. SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway.Molecular medicine reports. 2021 Mar;23(3):202.
doi: 10.3892/mmr.2021.11841. Epub 2021 Jan 26
Wang J., Zhang C., Zhang L. et al. Comparative study on genomic and epigenomic profiles of retinoblastoma or tuberous sclerosis complex via nanopore sequencing and a joint screening framework. Cancer gene therapy. 2023-12-25.
doi: 10.1038/s41417-023-00714-y
Wang L., Chen J., Shen Y. et al. Incidence, mortality, and global burden of retinoblastoma in 204 countries worldwide from 1990 to 2021: Data and systematic analysis from the Global Burden of Disease Study 2021. Neoplasia (New York, N.Y.). 2024-12-26;60(60):101107
doi: 10.1016/j.neo.2024.101107
Wang L., Chen N., Cheng H. Fisetin inhibits vascular endothelial growth factor-induced angiogenesis in retinoblastoma cells. Oncology letters. 2020 Aug.
doi: 10.3892/ol.2020.11679
Wang L., Li S., Mei J. et al. Immunotherapies of retinoblastoma: Effective methods for preserving vision in the future. Frontiers in oncology. 2022-09-24;12(12):949193.
doi: 10.3389/fonc.2022.949193
Wang L., Wang C., Wu T., Sun F. Long non-coding RNA TP73-AS1 promotes TFAP2B-mediated proliferation, metastasis and invasion in retinoblastoma via decoying of miRNA-874-3p. Journal of Cell Communication and Signaling. Feb-2020.
doi: 10.1007/s12079-020-00550-x
Wang L., Zhang Y., Xin X. Long Non-Coding RNA MALAT1 Aggravates Human Retinoblastoma by Sponging miR-20b-5p to Upregulate STAT3. Pathology, Research and Practice. 2020 Apr 18.
doi: 10.1016/j.prp.2020.152977
https://pubmed.ncbi.nlm.nih.gov/32336590/?from_term=retinoblastoma&from_sort=date&from_pos=5
Wang N., Liu R., Li J. et al. Long-term efficacy of enucleation combined with primary orbital implantation in children with retinoblastoma histopathological invasion of optic nerve. Frontiers in neurology. 2022-10-28;13(13):1013523.
doi: 10.3389/fneur.2022.1013523
Wang N., Ma J.M. et al. Progress of Cancer Stem Cells in Retinoblastoma. Current stem cell research & therapy. 2023-10-10.
doi: 10.2174/011574888X252989230921065809
Wang X., Su Y., Yin C. Long non-coding RNA (lncRNA) five prime to Xist (FTX) promotes retinoblastoma progression by regulating the microRNA-320a/with-nolysine kinases 1 (WNK1) axis. Bioengineered. 2021 Nov 1.
doi: 10.1080/21655979.2021.1994718
Wang X., Su Y., Yin C. Long non-coding RNA (lncRNA) five prime to Xist (FTX) promotes retinoblastoma progression by regulating the microRNA-320a/with-no-lysine kinases 1 (WNK1) axis. Bioengineered. 2021 Dec;12(2):11622-11633.
doi: 10.1080/21655979.2021.1994718
Wang Y., Sun D., Sheng Y., Guo H., Meng F., Song T. XIST promotes cell proliferation and invasion by regulating miR-140-5p and SOX4 in retinoblastoma // World Journal of Surgical Oncology. 2020 Mar 3.
DOI: 10.1186/s12957-020-01825-8
Wang Y., Tang J., Liu Y. et al. Targeting ALDOA to modulate tumorigenesis and energy metabolism in retinoblastoma. iScience. 2024-09-14;27(9):110725
doi: 10.1016/j.isci.2024.110725
Wang Y., Wang J., Hao H., Luo X. lncRNA KCNQ1OT1 promotes the proliferation, migration and invasion of retinoblastoma cells by upregulating HIF-1alpha via sponging miR-153-3p. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 2020 Dec;68(8):1349-1356.
doi: 10.1136/jim-2020-001431
Wang Y., Xin D., Zhou L. LncRNA LINC00152 Increases the Aggressiveness of Human Retinoblastoma and Enhances Carboplatin and Adriamycin Resistance by Regulating MiR-613/Yes-Associated Protein 1 (YAP1) Axis. Medical science monitor : international medical journal of experimental and clinical research.2020 Jun 15.
doi: 10.12659/MSM.920886
Wang Y.Z., Hu H.M., Zhang Y. et al. Clinical Characteristics and Prognosis of 39 Cases of Retinoblastoma With Optic Nerve Stump Involvement. American journal of therapeutics. 2024-10-18
doi: 10.1097/MJT.0000000000001794
Wang Y.Z., Zhang Y., Huang D.S., Shi J.T., Ma J.M., Li B., Xu X.L., Zhou Y., Gu H.L.
Clinical characteristics, treatment and prognosis of children with unilateral retinoblastoma and intracranial segment of Retrobulbar optic nerve invasion. BMC Ophthalmol. 2021 Jan 14;21(1):38.
doi: 10.1186/s12886-020-01768-4
Wang Z., Chen N., Liu C., Cao G., Ji Y., Yang W., Jiang Q. UBE2T is a prognostic biomarker and correlated with Th2 cell infiltrates in retinoblastoma. Biochem Biophys Res Commun. 2022 May 6;614:138-144.
doi: 10.1016/j.bbrc.2022.04.096
Wang Z., Liang X., Yi G. et al. Bioinformatics analysis proposes a possible role for long noncoding RNA MIR17HG in retinoblastoma. Cancer reports (Hoboken, N.J.). 2024-03-14;7(2):e1933.
doi: 10.1002/cnr2.1933
Wangtiraumnuay N., Surakrattanaskul S., Wangkittikul C. et al. Digital Gangrene and Antiphospholipid Syndrome in a Retinoblastoma Patient with Chromosome 13q Deletion: A Case Report. Case reports in oncology. 2023-05-02;16(1):287-293.
doi: 10.1159/000530182
Warda O., Naeem Z., Roelofs K.A., Sagoo M.S., Reddy M.A. Retinoblastoma and vision. Eye (Lond). 2022 Jan 5. Epub ahead of print.
doi: 10.1038/s41433-021-01845-y
Warkad V., Tripathy D. et al. Intravitreal chemotherapy-induced cataract in retinoblastoma: challenges and outcome. BMJ case reports. 2022-12-22;15(12)
doi: 10.1136/bcr-2022-250617
Watts-Santos A., Ancona-Lezama D.A., Figueroa-Sanchez J.A. et al. Ciliary Madarosis Secondary to Intra-Arterial Chemotherapy for Retinoblastoma Treatment. Skin appendage disorders. 2024-06-07;10(3):167-171.
doi: 10.1159/000535826
Wei D., Pu N., Li S.Y. et al. Application of iontophoresis in ophthalmic practice: an innovative strategy to deliver drugs into the eye. Drug delivery. 2023-01-21;30(1):2165736.
doi: 10.1080/10717544.2023.2165736
Wei T., Grace M., Uberoi A., Romero-Masters J.C., Lee D., Lambert P.F., Munger K. The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis. mBio. 2021 Aug 31;12(4):e0227721.
doi: 10.1128/mBio.02277-21
Wen S., Hu M., Xiong Y. Effect of Eriodictyol on Retinoblastoma via the PI3K/Akt Pathway. J Healthc Eng. 2021 Nov 11;2021:6091585.
doi: 10.1155/2021/6091585
Wen X., Fan J., Jin M. et al. Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial. The Lancet. Child & adolescent health. 2023-10-11;7(9):613-620.
doi: 10.1016/S2352-4642(23)00141-4
Wen Y., Zhu M., Zhang X. et al. Integrated analysis of multiple bioinformatics studies to identify microRNA-target gene-transcription factor regulatory networks in retinoblastoma. Translational cancer research. 2022-08-16;11(7):2225-2237.
doi: 10.21037/tcr-21-1748
Wendt S.P., Barrett D.A., Chang E.Y., Schefler A.C. Segmental Scleral Buckle Surgical Technique for Repair of a Rhegmatogenous Retinal Detachment in Retinoblastoma: A Case and Review of the Literature. Ocul Oncol Pathol. 2021 Mar;7(2):91-96.
doi: 10.1159/000508721
Weng P.Y., Chen S.H., Kao L.Y., Tsai Y.J., Yang S.H., Tseng C.K., Tsay P.K., Jaing T.H. Clinical spectrum and treatment outcome of retinoblastoma with Group D and E diseases: A single institution retrospective review. Medicine. 2020 Sep 18;
doi: 10.1097/MD.0000000000022201
Willard V.W., Qaddoumi I., Pan H., Hsu C.W., Brennan R.C., Wilson M.W., Rodriguez-Galindo C., Goode K., Parris K., Phipps S. Cognitive and Adaptive Functioning in Youth With Retinoblastoma: A Longitudinal Investigation Through 10 Years of Age. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021 Apr 23:JCO2003422.
doi: 10.1200/JCO.20.03422
Wimberly C.E., Gulrajani N.B., Russ JB. et al. Maternal prenatal use of alcohol, tobacco, and illicit drugs and associations with childhood cancer subtypes. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2023-12-19
doi: 10.1158/1055-9965.EPI-23-1027
Winter U., Ganiewich D., Ottaviani D., Zugbi S., Aschero R., Sendoya J.M., Cafferata E.G., Mena M., Sgroi M., Sampor C., Lubieniecki F., Fandiño A., Abba M.C., Doz F., Podhjacer O., Montero Carcaboso A., Letouzé E., Radvanyi F., Chantada G.L., Llera A.S., Schaiquevich P. Genomic and Transcriptomic Tumor Heterogeneity in Bilateral Retinoblastoma // JAMA Ophthalmology. 2020 Mar 19.
DOI: 10.1001/jamaophthalmol.2020.0427
Wise J., Hayashi R., Wu T. et al. Eye-related quality of life and activities of daily living in pediatric retinoblastoma patients: A single-center, non-controlled, cross-sectional analysis. Pediatric blood & cancer. 2023-11-16;70(8):e30479.
doi: 10.1002/pbc.30479
Wiseman M.T., Ebert J.J., Augsburger J.J. et al. Second Primary Malignant Neoplasms in Survivors of Retinoblastoma in a Single Ocular Oncology Practice. Clinical ophthalmology (Auckland, N.Z.). 2024-11-05;18(18):3103-3109
doi: 10.2147/OPTH.S484968
Wiwatwongwana D., Kulniwatcharoen P., Mahanupab P., Visrutaratna P., Wiwatwongwana A. Accuracy of Computed Tomography and Magnetic Resonance Imaging for Detection of Pathologic Risk Factors in Patients Diagnosed with Retinoblastoma. Current eye research. 2021 Mar 22:1-7.
doi: 10.1080/02713683.2021.1901938
Woldeyohannes A.M., Wondimu B.A., Kefenie D.H. et al. Retinoblastoma in Ethiopian Children: Imaging Findings and Staging. Ethiopian journal of health sciences. 2025-01-04;34(Spec Iss 1):39-46
doi: 10.4314/ejhs.v34i1.7S
Wolf J, Hajdu RI, Boneva S, Godbole I, Stürzbecher L, Auw-Haedrich C, Lagrèze WA, Agostini H, Reinhard T, Tholen S, Schilling O, Schlunck G, Bengsch B, Lange C. A proteotranscriptomic approach to dissect the molecular landscape of human retinoblastoma. Front Oncol. 2025 May 6;15:1571702. PMID: 40395327; PMCID: PMC12088971.
doi: 10.3389/fonc.2025.1571702
Wong E.S., Choy R.W., Zhang Y., Chu W.K., Chen L.J., Pang C.P., Yam J.C. Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors. Lancet Glob Health. Epub ahead of print. 2022 Jan 27:S2214-109X(21)00555-6.
doi: 10.1016/S2214-109X(21)00555-6.
Wong E.Y., Xu L., Shen L., Kim M.E., Polski A., Prabakar R.K., Shah R., Jubran R., Kim J.W., Biegel J.A., Gai X., Kuhn P., Hicks J., Berry J.L. Inter-eye genomic heterogeneity in bilateral retinoblastoma via aqueous humor liquid biopsy. NPJ precision oncology. 2021 Jul 27;5(1):73. PMID: 34316014; PMCID: PMC8316348.
doi: 10.1038/s41698-021-00212-0
Wong K.M., King D.A., Schwartz E.K., Herrera R.E, Morrison A.J. Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci. Life Sci Alliance. 2022 Jan 4;5(4):e202101134. PMID: 34983823; PMCID: PMC8739494.
doi: 10.26508/lsa.202101134
Woods M.M., Bansal R., Shields C.L. et al. High-dose Intravitreal Topotecan for Perifoveal Recurrence of Retinoblastoma. Ophthalmology. Retina. 2024-11-18
doi: 10.1016/j.oret.2024.10.010
Wu C., Shang X.Q., You Z.P., Jin Q.F., Zhang Y.L., Zhou Y., Zhang Y.Z., Shi K. TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway. Investigative ophthalmology & visual science. 2020 Aug 3.
doi: 10.1167/iovs.61.10.2
Wu C., Yang J., Xiao W., Jiang Z., Chen S., Guo D., Zhang P., Liu C., Yang H., Xie Z. Single-cell characterization of malignant phenotypes and microenvironment alteration in retinoblastoma. Cell Death Dis. 2022 May 6;13(5):438. PMID: 35523772; PMCID: PMC9076657.
doi: 10.1038/s41419-022-04904-8
Wu C., Zheng W., Zhang J. et al. Exploring the Mechanism of Curcumin on Retinoblastoma Based on Network Pharmacology and Molecular Docking. Evidence-based complementary and alternative medicine : eCAM. 2022-08-02;2022(2022):2407462.
doi: 10.1155/2022/2407462
Wu J., Qian D., Sun X. Long noncoding RNAs as potential biomarkers in retinoblastoma: a systematic review and meta-analysis. Cancer cell international. 2020 May 29.
doi: 10.1186/s12935-020-01281-0
Wu K.Y., Wang X.C., Anderson M. et al. Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma. Molecules (Basel, Switzerland). 2024-05-27;29(10).
doi: 10.3390/molecules29102263
Wu L., Huang G., Hong H. et al. MiR-452-5p facilitates retinoblastoma cell growth and invasion via the SOCS3/JAK2/STAT3 pathway. Journal of biochemical and molecular toxicology. 2023-12-16;37(12):e23501.
doi: 10.1002/jbt.23501
Wu L., Xiang X., Guo H., Tan H. The effect of non-pharmacological interventions on psychological stress and quality of life of parents of children with retinoblastoma: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021 Dec 23;100(51):e28148.
doi: 10.1097/MD.0000000000028148
Wu N., Chen S., Luo Q., Jiang Z., Wang X., Li Y., Qiu J., Yu K., Yang Y., Zhuang J. Kruppel-like factor 2 acts as a tumor suppressor in human retinoblastoma. Exp Eye Res. 2022 Jan 21:108955.
doi: 10.1016/j.exer.2022.108955
Wu W., Zhang Y., Xu C. et al. LncRNA LOXL1-AS1 promotes proliferation and invasion and inhibits apoptosis in retinoblastoma by regulating the MAPK signaling pathway. Molecular and cellular biochemistry. 2023-06-05.
doi: 10.1007/s11010-023-04774-4
Wu W., Zhang Y., Yang M. et al. Emerging role of circular RNAs in the pathogenesis of retinoblastoma. Ophthalmic research. 2023-12-18.
doi: 10.1159/000535329
Wu Z., Chen L., Zhang C., Liu Y. miR-4319 inhibited retinoblastoma cells proliferation, migration, invasion and EMT progress via suppressing CD147 mediated MMPs expression. Journal of molecular histology. 2021 Jan 20.
doi: 10.1007/s10735-020-09946-w
doi: 10.1200/JCO.20.03422
Wimberly C.E., Gulrajani N.B., Russ JB. et al. Maternal prenatal use of alcohol, tobacco, and illicit drugs and associations with childhood cancer subtypes. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2023-12-19
doi: 10.1158/1055-9965.EPI-23-1027
Winter U., Ganiewich D., Ottaviani D., Zugbi S., Aschero R., Sendoya J.M., Cafferata E.G., Mena M., Sgroi M., Sampor C., Lubieniecki F., Fandiño A., Abba M.C., Doz F., Podhjacer O., Montero Carcaboso A., Letouzé E., Radvanyi F., Chantada G.L., Llera A.S., Schaiquevich P. Genomic and Transcriptomic Tumor Heterogeneity in Bilateral Retinoblastoma // JAMA Ophthalmology. 2020 Mar 19.
DOI: 10.1001/jamaophthalmol.2020.0427
Wise J., Hayashi R., Wu T. et al. Eye-related quality of life and activities of daily living in pediatric retinoblastoma patients: A single-center, non-controlled, cross-sectional analysis. Pediatric blood & cancer. 2023-11-16;70(8):e30479.
doi: 10.1002/pbc.30479
Wiseman M.T., Ebert J.J., Augsburger J.J. et al. Second Primary Malignant Neoplasms in Survivors of Retinoblastoma in a Single Ocular Oncology Practice. Clinical ophthalmology (Auckland, N.Z.). 2024-11-05;18(18):3103-3109
doi: 10.2147/OPTH.S484968
Wiwatwongwana D., Kulniwatcharoen P., Mahanupab P., Visrutaratna P., Wiwatwongwana A. Accuracy of Computed Tomography and Magnetic Resonance Imaging for Detection of Pathologic Risk Factors in Patients Diagnosed with Retinoblastoma. Current eye research. 2021 Mar 22:1-7.
doi: 10.1080/02713683.2021.1901938
Woldeyohannes A.M., Wondimu B.A., Kefenie D.H. et al. Retinoblastoma in Ethiopian Children: Imaging Findings and Staging. Ethiopian journal of health sciences. 2025-01-04;34(Spec Iss 1):39-46
doi: 10.4314/ejhs.v34i1.7S
Wolf J, Hajdu RI, Boneva S, Godbole I, Stürzbecher L, Auw-Haedrich C, Lagrèze WA, Agostini H, Reinhard T, Tholen S, Schilling O, Schlunck G, Bengsch B, Lange C. A proteotranscriptomic approach to dissect the molecular landscape of human retinoblastoma. Front Oncol. 2025 May 6;15:1571702. PMID: 40395327; PMCID: PMC12088971.
doi: 10.3389/fonc.2025.1571702
Wong E.S., Choy R.W., Zhang Y., Chu W.K., Chen L.J., Pang C.P., Yam J.C. Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors. Lancet Glob Health. Epub ahead of print. 2022 Jan 27:S2214-109X(21)00555-6.
doi: 10.1016/S2214-109X(21)00555-6.
Wong E.Y., Xu L., Shen L., Kim M.E., Polski A., Prabakar R.K., Shah R., Jubran R., Kim J.W., Biegel J.A., Gai X., Kuhn P., Hicks J., Berry J.L. Inter-eye genomic heterogeneity in bilateral retinoblastoma via aqueous humor liquid biopsy. NPJ precision oncology. 2021 Jul 27;5(1):73. PMID: 34316014; PMCID: PMC8316348.
doi: 10.1038/s41698-021-00212-0
Wong K.M., King D.A., Schwartz E.K., Herrera R.E, Morrison A.J. Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci. Life Sci Alliance. 2022 Jan 4;5(4):e202101134. PMID: 34983823; PMCID: PMC8739494.
doi: 10.26508/lsa.202101134
Woods M.M., Bansal R., Shields C.L. et al. High-dose Intravitreal Topotecan for Perifoveal Recurrence of Retinoblastoma. Ophthalmology. Retina. 2024-11-18
doi: 10.1016/j.oret.2024.10.010
Wu C., Shang X.Q., You Z.P., Jin Q.F., Zhang Y.L., Zhou Y., Zhang Y.Z., Shi K. TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway. Investigative ophthalmology & visual science. 2020 Aug 3.
doi: 10.1167/iovs.61.10.2
Wu C., Yang J., Xiao W., Jiang Z., Chen S., Guo D., Zhang P., Liu C., Yang H., Xie Z. Single-cell characterization of malignant phenotypes and microenvironment alteration in retinoblastoma. Cell Death Dis. 2022 May 6;13(5):438. PMID: 35523772; PMCID: PMC9076657.
doi: 10.1038/s41419-022-04904-8
Wu C., Zheng W., Zhang J. et al. Exploring the Mechanism of Curcumin on Retinoblastoma Based on Network Pharmacology and Molecular Docking. Evidence-based complementary and alternative medicine : eCAM. 2022-08-02;2022(2022):2407462.
doi: 10.1155/2022/2407462
Wu J., Qian D., Sun X. Long noncoding RNAs as potential biomarkers in retinoblastoma: a systematic review and meta-analysis. Cancer cell international. 2020 May 29.
doi: 10.1186/s12935-020-01281-0
Wu K.Y., Wang X.C., Anderson M. et al. Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma. Molecules (Basel, Switzerland). 2024-05-27;29(10).
doi: 10.3390/molecules29102263
Wu L., Huang G., Hong H. et al. MiR-452-5p facilitates retinoblastoma cell growth and invasion via the SOCS3/JAK2/STAT3 pathway. Journal of biochemical and molecular toxicology. 2023-12-16;37(12):e23501.
doi: 10.1002/jbt.23501
Wu L., Xiang X., Guo H., Tan H. The effect of non-pharmacological interventions on psychological stress and quality of life of parents of children with retinoblastoma: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021 Dec 23;100(51):e28148.
doi: 10.1097/MD.0000000000028148
Wu N., Chen S., Luo Q., Jiang Z., Wang X., Li Y., Qiu J., Yu K., Yang Y., Zhuang J. Kruppel-like factor 2 acts as a tumor suppressor in human retinoblastoma. Exp Eye Res. 2022 Jan 21:108955.
doi: 10.1016/j.exer.2022.108955
Wu W., Zhang Y., Xu C. et al. LncRNA LOXL1-AS1 promotes proliferation and invasion and inhibits apoptosis in retinoblastoma by regulating the MAPK signaling pathway. Molecular and cellular biochemistry. 2023-06-05.
doi: 10.1007/s11010-023-04774-4
Wu W., Zhang Y., Yang M. et al. Emerging role of circular RNAs in the pathogenesis of retinoblastoma. Ophthalmic research. 2023-12-18.
doi: 10.1159/000535329
Wu Z., Chen L., Zhang C., Liu Y. miR-4319 inhibited retinoblastoma cells proliferation, migration, invasion and EMT progress via suppressing CD147 mediated MMPs expression. Journal of molecular histology. 2021 Jan 20.
doi: 10.1007/s10735-020-09946-w
X
Xia Y., Deng Y., Zhou Y., Li D., Sun X., Gu L., Chen Z., Zhao Q. TSPAN31 suppresses cell proliferation in human cervical cancer through down-regulation of its antisense pairing with CDK4. // Cell Biochemistry & Function. 2020 Mar 23.
doi: 10.1002/cbf.3526
Xiao W., Ji X., Ye H., Zeng H., Gao Y., Chen R., Chen X., Mao Y., Yang H. Parent Knowledge of Screening and Genetic Testing in Retinoblastoma. Journal of ophthalmology. 2020 Apr 8.
doi: 10.1155/2020/3839792
Xie W., Shao Y., Bo Q. et al. FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3. Molecular carcinogenesis. 2024-02-21.
doi: 10.1002/mc.23698
Xie Y., Xu X.L., Wei W.B. The RB1 Mutation Spectrum and Genetic Management Consultation in Pediatric Patients with Retinoblastoma in Beijing, China. Risk Manag Healthc Policy. 2021 Aug 21;14:3453-3463.
doi: 10.2147/RMHP.S322373
Xu H.K., Wang X.D., Wang D.G., Wei D.D., Liang L., Liu CH. miR-340 Exerts Suppressive Effect on Retinoblastoma Progression by Targeting KIF14. Curr Eye Res. 2021 Feb;46(2):232-238.
doi: 10.1080/02713683.2020.1795202
Xu H., Xiao L., Chen Y. et al. Effect of CDK7 inhibitor on MYCN-amplified retinoblastoma. Biochimica et biophysica acta. Gene regulatory mechanisms. 2023-08-22;1866(3):194964.
doi: 10.1016/j.bbagrm.2023.194964
Xu J., Yu SJ., Sun S. et al. Enhanced innate responses in microglia derived from retinoblastoma patient-specific iPSCs. Glia. 2024-03-20;72(5):872-884.
doi: 10.1002/glia.24507
Xu K., Liu J., Zhang C. Intra-arterial chemotherapy combined with VEC intravenous chemotherapy in the treatment of advanced retinoblastoma. Journal of B.U.ON.: official journal of the Balkan Union of Oncology. Mar-Apr 2020.
Xu K., Nie W., Tong Q. et al. [Analysis of progress characteristics of retinoblastoma based on single cell transcriptome sequencing]. Chinese journal of biotechnology. 2022-10-31;38(10):3809-3824.
doi: 10.13345/j.cjb.220491
Xu L., Kim M.E., Polski A., Prabakar R.K., Shen L., Peng C.C., Reid M.W, Chévez-Barrios P, Kim J.W., Shah R., Jubran R., Kuhn P., Cobrinik D., Biegel J.A., Gai X., Hicks J., Berry J.L. Establishing the Clinical Utility of ctDNA Analysis for Diagnosis, Prognosis, and Treatment Monitoring of Retinoblastoma: The Aqueous Humor Liquid Biopsy. Cancers. 2021 Mar 13;13(6):1282.
doi: 10.3390/cancers13061282
Xu L., Long H., Zhou B., Jiang H., Cai M. CircMKLN1 Suppresses the Progression of Human Retinoblastoma by Modulation of miR-425-5p/PDCD4 Axis. Current eye research. 2021 May 14:1-11.
doi: 10.1080/02713683.2021.1927110
Xu L., Polski A., Prabakar R.K., Reid M.W., Chevez-Barrios P., Jubran R., Kim J.W., Kuhn P., Cobrinik D., Hicks J., Berry J.L. Chromosome 6p amplification in aqueous humor cell-free DNA is a prognostic biomarker for retinoblastoma ocular survival. Molecular cancer research : MCR. 2020 May 20.
doi: 10.1158/1541-7786.MCR-19-1262
Xu L., Shen L., Polski A., Prabakar R.K., Shah R., Jubran R., Kim J.W., Biegel J., Kuhn P., Cobrinik D., Hicks J., Gai X., Berry J.L. Simultaneous identification of clinically relevant RB1 mutations and copy number alterations in aqueous humor of retinoblastoma eyes. Ophthalmic genetics. 2020 Aug 17.
doi: 10.1080/13816810.2020.1799417
Xu L., Zhu S., Tang A., Liu W. LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/beta-catenin signaling pathway. Inflammation research: official journal of the European Histamine Research Society ... [et al.].. 2021 Jan 16.
doi: 10.1007/s00011-020-01432-z
Xu M, Shi H, Shen Y, Yang L, Luan Y, Gu X, Wen X, Zhou C, Jia R, Ji X, Zhao P, Han M, Fan J, Chai P. Diminished MYCN Dosage Endows Cavitary Transformation in Retinoblastoma. Ophthalmol Sci. 2025 May 6;5(5):100820. PMID: 40529103; PMCID: PMC12173066.
doi: 10.1016/j.xops.2025.100820
Xu P., Guo F., Xiao W. et al. Generation and characterization of two induced pluripotent stem cell lines from conjunctiva of a retinoblastoma patient. Stem cell research. 2023-11-06;72(72):103200.
doi: 10.1016/j.scr.2023.103200
Xu Q. The Potential Tumor Promotional Role of circVAPA in Retinoblastoma via Regulating miR-615-3p and SMARCE1. OncoTargets and therapy. 2020 Aug 5.
doi: 10.2147/OTT.S254925
Xu X., Zhao Y., Duan G., Du B. Downregulation of MIAT reduces the proliferation and migratory and invasive abilities of retinoblastoma cells by sponging miR-665 and regulating LASP1. Exp Ther Med. 2021 Nov;22(5):1342.
doi: 10.3892/etm.2021.10777
Xu Y., Fu Z., Gao X., Wang R., Li Q. Long non-coding RNA XIST promotes retinoblastoma cell proliferation, migration, and invasion by modulating microRNA-191-5p/brain derived neurotrophic factor. Bioengineered. 2021 Dec;12(1):1587-1598.
doi: 10.1080/21655979.2021.1918991
Xia Y., Deng Y., Zhou Y., Li D., Sun X., Gu L., Chen Z., Zhao Q. TSPAN31 suppresses cell proliferation in human cervical cancer through down-regulation of its antisense pairing with CDK4. // Cell Biochemistry & Function. 2020 Mar 23.
doi: 10.1002/cbf.3526
Xiao W., Ji X., Ye H., Zeng H., Gao Y., Chen R., Chen X., Mao Y., Yang H. Parent Knowledge of Screening and Genetic Testing in Retinoblastoma. Journal of ophthalmology. 2020 Apr 8.
doi: 10.1155/2020/3839792
Xie W., Shao Y., Bo Q. et al. FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3. Molecular carcinogenesis. 2024-02-21.
doi: 10.1002/mc.23698
Xie Y., Xu X.L., Wei W.B. The RB1 Mutation Spectrum and Genetic Management Consultation in Pediatric Patients with Retinoblastoma in Beijing, China. Risk Manag Healthc Policy. 2021 Aug 21;14:3453-3463.
doi: 10.2147/RMHP.S322373
Xu H.K., Wang X.D., Wang D.G., Wei D.D., Liang L., Liu CH. miR-340 Exerts Suppressive Effect on Retinoblastoma Progression by Targeting KIF14. Curr Eye Res. 2021 Feb;46(2):232-238.
doi: 10.1080/02713683.2020.1795202
Xu H., Xiao L., Chen Y. et al. Effect of CDK7 inhibitor on MYCN-amplified retinoblastoma. Biochimica et biophysica acta. Gene regulatory mechanisms. 2023-08-22;1866(3):194964.
doi: 10.1016/j.bbagrm.2023.194964
Xu J., Yu SJ., Sun S. et al. Enhanced innate responses in microglia derived from retinoblastoma patient-specific iPSCs. Glia. 2024-03-20;72(5):872-884.
doi: 10.1002/glia.24507
Xu K., Liu J., Zhang C. Intra-arterial chemotherapy combined with VEC intravenous chemotherapy in the treatment of advanced retinoblastoma. Journal of B.U.ON.: official journal of the Balkan Union of Oncology. Mar-Apr 2020.
Xu K., Nie W., Tong Q. et al. [Analysis of progress characteristics of retinoblastoma based on single cell transcriptome sequencing]. Chinese journal of biotechnology. 2022-10-31;38(10):3809-3824.
doi: 10.13345/j.cjb.220491
Xu L., Kim M.E., Polski A., Prabakar R.K., Shen L., Peng C.C., Reid M.W, Chévez-Barrios P, Kim J.W., Shah R., Jubran R., Kuhn P., Cobrinik D., Biegel J.A., Gai X., Hicks J., Berry J.L. Establishing the Clinical Utility of ctDNA Analysis for Diagnosis, Prognosis, and Treatment Monitoring of Retinoblastoma: The Aqueous Humor Liquid Biopsy. Cancers. 2021 Mar 13;13(6):1282.
doi: 10.3390/cancers13061282
Xu L., Long H., Zhou B., Jiang H., Cai M. CircMKLN1 Suppresses the Progression of Human Retinoblastoma by Modulation of miR-425-5p/PDCD4 Axis. Current eye research. 2021 May 14:1-11.
doi: 10.1080/02713683.2021.1927110
Xu L., Polski A., Prabakar R.K., Reid M.W., Chevez-Barrios P., Jubran R., Kim J.W., Kuhn P., Cobrinik D., Hicks J., Berry J.L. Chromosome 6p amplification in aqueous humor cell-free DNA is a prognostic biomarker for retinoblastoma ocular survival. Molecular cancer research : MCR. 2020 May 20.
doi: 10.1158/1541-7786.MCR-19-1262
Xu L., Shen L., Polski A., Prabakar R.K., Shah R., Jubran R., Kim J.W., Biegel J., Kuhn P., Cobrinik D., Hicks J., Gai X., Berry J.L. Simultaneous identification of clinically relevant RB1 mutations and copy number alterations in aqueous humor of retinoblastoma eyes. Ophthalmic genetics. 2020 Aug 17.
doi: 10.1080/13816810.2020.1799417
Xu L., Zhu S., Tang A., Liu W. LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/beta-catenin signaling pathway. Inflammation research: official journal of the European Histamine Research Society ... [et al.].. 2021 Jan 16.
doi: 10.1007/s00011-020-01432-z
Xu M, Shi H, Shen Y, Yang L, Luan Y, Gu X, Wen X, Zhou C, Jia R, Ji X, Zhao P, Han M, Fan J, Chai P. Diminished MYCN Dosage Endows Cavitary Transformation in Retinoblastoma. Ophthalmol Sci. 2025 May 6;5(5):100820. PMID: 40529103; PMCID: PMC12173066.
doi: 10.1016/j.xops.2025.100820
Xu P., Guo F., Xiao W. et al. Generation and characterization of two induced pluripotent stem cell lines from conjunctiva of a retinoblastoma patient. Stem cell research. 2023-11-06;72(72):103200.
doi: 10.1016/j.scr.2023.103200
Xu Q. The Potential Tumor Promotional Role of circVAPA in Retinoblastoma via Regulating miR-615-3p and SMARCE1. OncoTargets and therapy. 2020 Aug 5.
doi: 10.2147/OTT.S254925
Xu X., Zhao Y., Duan G., Du B. Downregulation of MIAT reduces the proliferation and migratory and invasive abilities of retinoblastoma cells by sponging miR-665 and regulating LASP1. Exp Ther Med. 2021 Nov;22(5):1342.
doi: 10.3892/etm.2021.10777
Xu Y., Fu Z., Gao X., Wang R., Li Q. Long non-coding RNA XIST promotes retinoblastoma cell proliferation, migration, and invasion by modulating microRNA-191-5p/brain derived neurotrophic factor. Bioengineered. 2021 Dec;12(1):1587-1598.
doi: 10.1080/21655979.2021.1918991
Y
Yadav G., Singh A., Kushwaha R. et al. Utility of bone marrow examination in retinoblastoma and their correlation with hematological features. Journal of medicine and life. 2023-12-17;16(8):1245-1250.
doi: 10.25122/jml-2023-0156
Yagi T., Nakamura H., Kukita Y. et al. Secondary leiomyosarcoma of the nasal cavity in a treated patient with possible hereditary retinoblastoma with germline reciprocal translocation of RB1 and DMXL1 and somatic TP53 mutation: A case report. Molecular and clinical oncology. 2023-08-11;19(2):65.
doi: 10.3892/mco.2023.2661
Yan J., Deng Y.X., Cai Y.L., Cong W.D. LncRNA MIR17HG promotes the proliferation, migration, and invasion of retinoblastoma cells by up-regulating HIF-1α expression via sponging miR-155-5p. Kaohsiung J Med Sci. 2022 Mar 7. Epub ahead of print. PMID: 35253975.
doi: 10.1002/kjm2.12523
Yan L.J., Lin H.B., Yu H.Q. et al. The clinical diagnostic value of plasma miR-592 and miR-217-3p levels in retinoblastoma. Journal of medical biochemistry. 2022-11-17;41(4):497-505
doi: 10.5937/jomb0-34794
Yan Q., He D., Walker DI. et al. The neonatal blood spot metabolome in retinoblastoma. EJC paediatric oncology. 2023-12-24;2(2)
doi: 10.1016/j.ejcped.2023.100123
Yan S., Yang W., You W. et al. Resurrecting p53 by an Artificial Nano-Protein for Potent Photodynamic Retinoblastoma Therapy. Small (Weinheim an der Bergstrasse, Germany). 2024-11-30:e2401260
doi: 10.1002/smll.202401260
Yan X., Jia H., Zhao J. et al. LncRNA MEG3 attenuates the malignancy of retinoblastoma cells through inactivating PI3K /Akt/mTOR signaling pathway. Experimental eye research. 2023-01-10;226(226):109340
doi: 10.1016/j.exer.2022.109340
Yanagihara RT, Takayesu JSK, Crotty EE, Ji X, Zou Y, Sultana S, Rashid R, Sherief ST, Cassoux N, Garcia Leon JL, Diaz Coronado RY, Zapata López AM, Ushakova TL, Polyakov VG, Roy SR, Ahmad A, Reddy MA, Sagoo MS, Al Harby L, Berry JL, Polski A, Astbury NJ, Bascaran C, Blum S, Bowman R, Burton MJ, Foster A, Gomel N, Keren-Froim N, Madgar S, Zondervan M, Kaliki S, Fabian ID, Stacey AW. Clinical Stage of Retinoblastoma Based on Presenting Signs of 4578 Patients from 121 Countries. Ophthalmology. 2025 May 5:S0161-6420(25)00282-9. Epub ahead of print. PMID: 40334716.
doi: 10.1016/j.ophtha.2025.04.030
Yang G., Zeng C., Liu Y., Li D., Cui J. ZNRD1-AS1 knockdown alleviates malignant phenotype of retinoblastoma through miR-128-3p/BMI1 axis. Am J Transl Res. 2021 Jun 15;13(6):5866-5879.
Yang H., Huang Y., He J., Chai G., Di Y., Wang A., Gui D. MiR-486-3p Inhibits the Proliferation, Migration and Invasion of Retinoblastoma Cells by Targeting ECM1.2020 May 13. Bioscience reports.
doi: 10.1042/BSR20200392
Yang J., Li Y., Han Y., Feng Y., Zhou M., Zong C., He X., Jia R., Xu X., Fan J. Single-cell transcriptome profiling reveals intratumoural heterogeneity and malignant progression in retinoblastoma. Cell Death Dis. 2021 Nov 23;12(12):1100.
doi: 10.1038/s41419-021-04390-4
Yang J., Li Y., Zong C., Zhang Q., Ge S., Ma L., Fan J., Zhang J., Jia R. Xanthatin Selectively Targets Retinoblastoma by Inhibiting the PLK1-Mediated Cell Cycle. Invest Ophthalmol Vis Sci. 2021 Dec 1;62(15):11.
doi: 10.1167/iovs.62.15.11
Yang L., Fang X., Jin M., Chen J., Zhang C., Mou J., Zhao J., Ni X. Analysis of Cause-Specific Mortality in Patients with Retinoblastoma. J Ophthalmol. 2022 Mar 4;2022:2470890. PMID: 35282141; PMCID: PMC8916902.
doi: 10.1155/2022/2470890
Yang L., Zhang L., Lu L., Wang Y. miR-214-3p Regulates Multi-Drug Resistance and Apoptosis in Retinoblastoma Cells by Targeting ABCB1 and XIAP. Onco Targets Ther. 2020 Jan 28;13:803-811.
doi: 10.2147/OTT.S235862
Yang L, Zuo S, Jia R, Gu X, Liao Q, Hua Y, Ge S, He M, Fan J, Tong X, Yuan T, Jia R, Fan X, Chai P, Wen X. Lactylation-boosted polycomb repression of KLF4 elicits glycolysis in retinoblastoma: A positive feedback circuit between histone modifications. Cancer Lett. 2025 Aug 10;625:217804. Epub 2025 May 16. PMID: 40383410.
doi: 10.1016/j.canlet.2025.217804
Yang M.K., Lee M.J., Kim N., Choung H., Khwarg S.I. Outcomes of enucleation and porous polyethylene orbital implant insertion in patients with paediatric retinoblastoma: a long-term follow-up study. The British journal of ophthalmology. 2020 Dec 8:bjophthalmol-2020-317934.
doi: 10.1136/bjophthalmol-2020-317934
Yang M., Yao P., Lang X., Li X., Zhang D. Ribonucleotide reductase subunit M2 promotes proliferation and epithelial-mesenchymal transition via the JAK2/STAT3 signaling pathway in retinoblastoma. Bioengineered. 2021 Dec;12(2):12800-12811.
doi: 10.1080/21655979.2021.2001241
Yang W., Jiang X.X., Zhao X.Y., Mao P.A. Treatment of RB-deficient retinoblastoma with Aurora-A kinase inhibitor. Kaohsiung J Med Sci. 2021 Nov 6.
doi: 10.1002/kjm2.12469
Yang X.L., Hao Y.J., Wang B., Gu X.L., Wang X.X., Sun J.F. Long noncoding RNA NORAD promotes the progression of retinoblastoma by sponging miR-136-5p/PBX3 axis. Eur Rev Med Pharmacol Sci. 2020 Jan;24(3):1278-1287.
doi: 10.26355/eurrev_202001_20185
Yang X., Sun H., Tang T., Zhang W., Li Y. Netrin-1 promotes retinoblastoma-associated angiogenesis. Ann Transl Med. 2021 Nov;9(22):1683.
doi: 10.21037/atm-21-5560
Yang Y.L., Zhou H., Yue L.R., Shen H. Spleen tyrosine kinase expression and its correlation with necrosis and high-risk histopathologic features in retinoblastoma. Chinese medical journal. 2020 Jul 20.
doi: 10.1097/CM9.0000000000000889
Yao L., Yang L., Song H., Liu T.G., Yan H. Silencing of lncRNA XIST Suppresses Proliferation and Autophagy and Enhances Vincristine Sensitivity in Retinoblastoma Cells by Sponging miR-204-5p. European review for medical and pharmacological sciences. 2020 Apr 24.
DOI: 10.26355/eurrev_202004_20812
Yao X., Shen H., Peng Q., Yu J. TP53/miR-129/MDM2/4/TP53 feedback loop modulates cell proliferation and apoptosis in retinoblastoma. Cell Cycle. 2021 Mar-Mar;20(5-6):603-615.
doi: 10.1080/15384101.2021.1892321
Yaqoob N., Zia N., Hamid A., Kaleem B., Jamal S., Amin S., Qaddoumi I., Jamal S. Correlation of clinical and radiological predictors of retinoblastoma with high-risk histopathological features. Pediatr Blood Cancer. 2022 May;69(5):e29625. Epub 2022 Mar 6. PMID: 35253344.
doi: 10.1002/pbc.29625
Yarovoy A.A., Golanov A.V., Yarovaya V.A. et al. Stereotactic Gamma Knife® Radiosurgery of Intraocular Retinoblastoma: Six-Year Experience. Cureus. 2022-10-11;14(9):e28751.
doi: 10.7759/cureus.28751
Yarovoy AA, Volodin DP, Yarovaya VA. A retrospective study on ruthenium-106 and strontium-90 eye-plaques treatment for retinoblastoma: 16-years clinical experience. Brachytherapy. 2025 Mar-Apr;24(2):265-272. Epub 2025 Jan 9. PMID: 39788791.
doi: 10.1016/j.brachy.2024.11.008
Yazici H., Wu H.C., Tigli H., Yilmaz E.Z., Kebudi R., Santella R.M. High levels of global genome methylation in patients with retinoblastoma. Oncology letters. 2020 Jul.
doi: 10.3892/ol.2020.11613
Ye H., Chen R., Xiao W. et al. Polyester 5-0 suture for porous implant placement after retinoblastoma enucleation: analysis of 120 sockets. BMC ophthalmology. 2023-02-02;23(1):30.
doi: 10.1186/s12886-023-02787-7
Ye H., Xue K., Zhang P. et al. Three vs 6 Cycles of Chemotherapy for High-Risk Retinoblastoma: A Randomized Clinical Trial. JAMA. 2024-12-19;332(19):1634-1641
doi: 10.1001/jama.2024.19981
Ye Q., Zeng Z., Liang X. et al. Quercetin suppresses retinoblastoma cell proliferation and invasion and facilitates oxidative stress-induced apoptosis through the miR-137/FNDC5 axis. Environmental research. 2023-10-22;237(Pt 2):116934.
doi: 10.1016/j.envres.2023.116934
Ye R, Yuan Q, You W, Huang Y, Lin Z, Tang H, Zeng R. Identification of the shared gene signatures in retinoblastoma and osteosarcoma by machine learning. Sci Rep. 2024 Dec 28;14(1):31355. PMID: 39733097; PMCID: PMC11682156.
doi: 10.1038/s41598-024-82789-7
Yi X., Lin X., Fang C. et al. Assessment of Retinal Microvasculature and Choroidal Vascularity After Intra-arterial Chemotherapy for Retinoblastoma. American journal of ophthalmology. 2024-06-06;266(266):10-16.
doi: 10.1016/j.ajo.2024.04.007
Yin D.F., Zhou X.J., Li N., Liu H.J., Yuan H. Long non-coding RNA SND1-IT1 accelerates cell proliferation, invasion and migration via regulating miR-132-3p/SMAD2 axis in retinoblastoma. Bioengineered. 2021 Dec;12(1):1189-1201.
doi: 10.1080/21655979.2021.1909962
Yin F., Guo Z., Sun W. et al. Overall survival comparison between pediatric and adult retinoblastoma and adult nomogram construction: A SEER population-based analysis. Asian journal of surgery. 2024-02-23.
doi: 10.1016/j.asjsur.2024.02.046
Yin J., Zhang F., Cao J. et al. Gentiopicroside inhibits retinoblastoma cell proliferation, invasion, and tumorigenesis in nude mice by suppressing the PI3K/AKT pathway. Naunyn-Schmiedeberg's archives of pharmacology. 2023-08-09.
doi: 10.1007/s00210-023-02646-8
Yin W., Gao F., Zhang S. MicroRNA‑34a inhibits the proliferation and promotes the chemosensitivity of retinoblastoma cells by downregulating Notch1 expression. Molecular medicine reports. 2020 Aug;22
doi: 10.3892/mmr.2020.11238
Yi X., Sun J., Qian J., Guo J., Xue K. Quantitative evaluation of retinal microvasculature and retrobulbar vessels after intravenous chemotherapy for retinoblastoma. BMC Ophthalmol. 2021 Nov 26;21(1):405.
doi: 10.1186/s12886-021-02170-4
Youlden D.R., Baade P.D., Frazier A.L. et al. Temporal changes in childhood cancer incidence and survival by stage at diagnosis in Australia, 2000-2017. Acta oncologica (Stockholm, Sweden). 2023-11-08;62(10):1256-1264
doi: 10.1080/0284186X.2023.2251668
Yousef Y.A., Abu Salim Q.F., Mohammad M. et al. Presentation and management outcomes of Retinoblastoma among Syrian refugees in Jordan. Frontiers in oncology. 2023-02-02;12(12):1056963
doi: 10.3389/fonc.2022.1056963
Yousef Y.A., Al Jboor M., Mohammad M., Mehyar M., Toro M.D., Nazzal R., Alzureikat Q.H., Rejdak M., Elfalah M., Sultan I., Rejdak R., Al-Hussaini M., Al-Nawaiseh I. Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma. Frontiers in pharmacology. 2021 Jul 12;12:696787. PMID: 34322023; PMCID: PMC8311556.
doi: 10.3389/fphar.2021.696787
Yousef Y.A., AlHabahbeh O., Mohammad M. et al. Optimizing Surgical Management for Rhegmatogenous Retinal Detachment in Eyes with Active Retinoblastoma: A Safety-Driven Approach. Journal of clinical medicine. 2024-05-14;13(9).
doi: 10.3390/jcm13092511
Yousef YA, Halawa F, Mohammad M, Al-Fahoum L, Soudi R, Mehyar M, AlJabari R, Halalsheh H, AlNawaiseh I, Jaradat I. Outcomes and Predictive Factors of I-125 Plaque Therapy for Refractory Retinoblastoma. J Clin Med. 2025 Mar 6;14(5):1778. PMID: 40095901; PMCID: PMC11901221.
doi: 10.3390/jcm14051778
Yousef YA, Mohammad M, Al-Jabari O, Halawa F, Al-Fahoum L, Halalsheh H, Khzouz J, Al-Hussaini M, Jaradat I, Mehyar M, Rejdak R, Toro MD, Haboob H, Al-Nawaiseh I. Intra-Arterial Melphalan Chemotherapy for Retinoblastoma in a Developing Nation: Real-World Outcomes and Prognostic Factors. Cancers (Basel). 2025 Jun 12;17(12):1955. PMID: 40563605; PMCID: PMC12190955.
doi: 10.3390/cancers17121955
Yousef Y.A., Mohammad M., Al-Nawaiseh I. et al. Retinoblastoma and uveal melanoma in Jordan: incidence, demographics, and survival (2011-2020). Ophthalmic genetics. 2022-07-18:1-8.
doi: 10.1080/13816810.2022.2090008
Yousef Y.A., Mohammad M., Baqain L. et al. Mutational analysis of the RB1 gene in patients with unilateral retinoblastoma. Frontiers in medicine. 2024-09-07;11(11):1406215
doi: 10.3389/fmed.2024.1406215
Yousef Y.A., Mohammad M., Mehyar M., Sultan I., Al-Hussaini M., Alhourani J., Halalsheh H., Khzouz J., Jaradat I., Qaddoumi I., Al-Nawaiseh I. The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy. J Pediatr Hematol Oncol. 2021 Aug 1;43(6):e841-e847.
doi: 10.1097/MPH.0000000000002144
Yu B., Zhao J., Dong Y. Circ_0000527 Promotes Retinoblastoma Progression through Modulating miR-98-5p/XIAP Pathway. Curr Eye Res. 2021 Sep;46(9):1414-1423.
doi: 10.1080/02713683.2021.1891255
Yu G., Zhou X., Li J. et al. A meta-analysis of the efficacy of intra-arterial chemotherapy for the management of retinoblastoma patients. Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 2023-07-24.
doi: 10.17219/acem/166664
Yu X., Li X., Xing Y., Lu S., Tanumiharjo S., Ma J. Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma. BMC Cancer. 2020 Aug 26.
doi: 10.1186/s12885-020-07314-1
Yin X., Liao Y., Xiong W., Zhang Y., Zhou Y., Yang Y. Hypoxia-induced lncRNA ANRIL promotes cisplatin resistance in retinoblastoma cells through regulating ABCG2 expression. Clinical and Experimental Pharmacology & Physiology.. 2020 Mar 15.
doi: 10.1111/1440-1681.13279
Yousef Y.A., Alkhoms A., AlJabari R., AlJboor M., Mohammad M., Lahlouh M, Deebajah R, Halalsheh H, Al-Hussaini M, Jaradat I, Shawagfeh M, Sultan I, Mehyar M, AlNawaiseh I. Programmed screening for retinoblastoma enhances early diagnosis and improves management outcome for high-risk children. Ophthalmic genetics. 2020 May 20.
doi: 10.1080/13816810.2020.1766085
Yousef Y.A., Al-Nawaiseh I., Mehyar M, Sultan I., Al-Hussaini M., Jaradat I., Mohammad M., AlJabari R., Abu-Yaghi N., Rodriguez-Galindo C., Qaddoumi I., Wilson M. How Telemedicine and Centralized Care Changed the Natural History of Retinoblastoma in a Developing Country: Analysis of 478 Patients. Ophthalmology. 2020 Jul 16.
doi: 10.1016/j.ophtha.2020.07.026
Yousef Y.A., Mohammad M., Jaradat I., Shatnawi R., Banat S., Mehyar M., Al-Nawaiseh I. The role of external beam radiation therapy for retinoblastoma after failure of combined chemoreduction and focal consolidation therapy. Ophthalmic Genet. 2020 Feb 19:1-6.
doi: 10.1080/13816810.2020.1719519
Yousef Y.A., Mohammad M., Mehyar M., Sultan I., Al-Hussaini M., Alhourani J., Halalsheh H, Khzouz J., Jaradat I., Qaddoumi I., Al-Nawaiseh I. The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy. Journal of pediatric hematology/oncology. 2021 Mar 23.
doi: 10.1097/MPH.0000000000002144
Yu B., Zhao J., Dong Y. Circ_0000527 Promotes Retinoblastoma Progression through Modulating miR-98-5p/XIAP Pathway. Current eye research. 2021 Feb 25:1-10.
doi: 10.1080/02713683.2021.1891255
Yadav G., Singh A., Kushwaha R. et al. Utility of bone marrow examination in retinoblastoma and their correlation with hematological features. Journal of medicine and life. 2023-12-17;16(8):1245-1250.
doi: 10.25122/jml-2023-0156
Yagi T., Nakamura H., Kukita Y. et al. Secondary leiomyosarcoma of the nasal cavity in a treated patient with possible hereditary retinoblastoma with germline reciprocal translocation of RB1 and DMXL1 and somatic TP53 mutation: A case report. Molecular and clinical oncology. 2023-08-11;19(2):65.
doi: 10.3892/mco.2023.2661
Yan J., Deng Y.X., Cai Y.L., Cong W.D. LncRNA MIR17HG promotes the proliferation, migration, and invasion of retinoblastoma cells by up-regulating HIF-1α expression via sponging miR-155-5p. Kaohsiung J Med Sci. 2022 Mar 7. Epub ahead of print. PMID: 35253975.
doi: 10.1002/kjm2.12523
Yan L.J., Lin H.B., Yu H.Q. et al. The clinical diagnostic value of plasma miR-592 and miR-217-3p levels in retinoblastoma. Journal of medical biochemistry. 2022-11-17;41(4):497-505
doi: 10.5937/jomb0-34794
Yan Q., He D., Walker DI. et al. The neonatal blood spot metabolome in retinoblastoma. EJC paediatric oncology. 2023-12-24;2(2)
doi: 10.1016/j.ejcped.2023.100123
Yan S., Yang W., You W. et al. Resurrecting p53 by an Artificial Nano-Protein for Potent Photodynamic Retinoblastoma Therapy. Small (Weinheim an der Bergstrasse, Germany). 2024-11-30:e2401260
doi: 10.1002/smll.202401260
Yan X., Jia H., Zhao J. et al. LncRNA MEG3 attenuates the malignancy of retinoblastoma cells through inactivating PI3K /Akt/mTOR signaling pathway. Experimental eye research. 2023-01-10;226(226):109340
doi: 10.1016/j.exer.2022.109340
Yanagihara RT, Takayesu JSK, Crotty EE, Ji X, Zou Y, Sultana S, Rashid R, Sherief ST, Cassoux N, Garcia Leon JL, Diaz Coronado RY, Zapata López AM, Ushakova TL, Polyakov VG, Roy SR, Ahmad A, Reddy MA, Sagoo MS, Al Harby L, Berry JL, Polski A, Astbury NJ, Bascaran C, Blum S, Bowman R, Burton MJ, Foster A, Gomel N, Keren-Froim N, Madgar S, Zondervan M, Kaliki S, Fabian ID, Stacey AW. Clinical Stage of Retinoblastoma Based on Presenting Signs of 4578 Patients from 121 Countries. Ophthalmology. 2025 May 5:S0161-6420(25)00282-9. Epub ahead of print. PMID: 40334716.
doi: 10.1016/j.ophtha.2025.04.030
Yang G., Zeng C., Liu Y., Li D., Cui J. ZNRD1-AS1 knockdown alleviates malignant phenotype of retinoblastoma through miR-128-3p/BMI1 axis. Am J Transl Res. 2021 Jun 15;13(6):5866-5879.
Yang H., Huang Y., He J., Chai G., Di Y., Wang A., Gui D. MiR-486-3p Inhibits the Proliferation, Migration and Invasion of Retinoblastoma Cells by Targeting ECM1.2020 May 13. Bioscience reports.
doi: 10.1042/BSR20200392
Yang J., Li Y., Han Y., Feng Y., Zhou M., Zong C., He X., Jia R., Xu X., Fan J. Single-cell transcriptome profiling reveals intratumoural heterogeneity and malignant progression in retinoblastoma. Cell Death Dis. 2021 Nov 23;12(12):1100.
doi: 10.1038/s41419-021-04390-4
Yang J., Li Y., Zong C., Zhang Q., Ge S., Ma L., Fan J., Zhang J., Jia R. Xanthatin Selectively Targets Retinoblastoma by Inhibiting the PLK1-Mediated Cell Cycle. Invest Ophthalmol Vis Sci. 2021 Dec 1;62(15):11.
doi: 10.1167/iovs.62.15.11
Yang L., Fang X., Jin M., Chen J., Zhang C., Mou J., Zhao J., Ni X. Analysis of Cause-Specific Mortality in Patients with Retinoblastoma. J Ophthalmol. 2022 Mar 4;2022:2470890. PMID: 35282141; PMCID: PMC8916902.
doi: 10.1155/2022/2470890
Yang L., Zhang L., Lu L., Wang Y. miR-214-3p Regulates Multi-Drug Resistance and Apoptosis in Retinoblastoma Cells by Targeting ABCB1 and XIAP. Onco Targets Ther. 2020 Jan 28;13:803-811.
doi: 10.2147/OTT.S235862
Yang L, Zuo S, Jia R, Gu X, Liao Q, Hua Y, Ge S, He M, Fan J, Tong X, Yuan T, Jia R, Fan X, Chai P, Wen X. Lactylation-boosted polycomb repression of KLF4 elicits glycolysis in retinoblastoma: A positive feedback circuit between histone modifications. Cancer Lett. 2025 Aug 10;625:217804. Epub 2025 May 16. PMID: 40383410.
doi: 10.1016/j.canlet.2025.217804
Yang M.K., Lee M.J., Kim N., Choung H., Khwarg S.I. Outcomes of enucleation and porous polyethylene orbital implant insertion in patients with paediatric retinoblastoma: a long-term follow-up study. The British journal of ophthalmology. 2020 Dec 8:bjophthalmol-2020-317934.
doi: 10.1136/bjophthalmol-2020-317934
Yang M., Yao P., Lang X., Li X., Zhang D. Ribonucleotide reductase subunit M2 promotes proliferation and epithelial-mesenchymal transition via the JAK2/STAT3 signaling pathway in retinoblastoma. Bioengineered. 2021 Dec;12(2):12800-12811.
doi: 10.1080/21655979.2021.2001241
Yang W., Jiang X.X., Zhao X.Y., Mao P.A. Treatment of RB-deficient retinoblastoma with Aurora-A kinase inhibitor. Kaohsiung J Med Sci. 2021 Nov 6.
doi: 10.1002/kjm2.12469
Yang X.L., Hao Y.J., Wang B., Gu X.L., Wang X.X., Sun J.F. Long noncoding RNA NORAD promotes the progression of retinoblastoma by sponging miR-136-5p/PBX3 axis. Eur Rev Med Pharmacol Sci. 2020 Jan;24(3):1278-1287.
doi: 10.26355/eurrev_202001_20185
Yang X., Sun H., Tang T., Zhang W., Li Y. Netrin-1 promotes retinoblastoma-associated angiogenesis. Ann Transl Med. 2021 Nov;9(22):1683.
doi: 10.21037/atm-21-5560
Yang Y.L., Zhou H., Yue L.R., Shen H. Spleen tyrosine kinase expression and its correlation with necrosis and high-risk histopathologic features in retinoblastoma. Chinese medical journal. 2020 Jul 20.
doi: 10.1097/CM9.0000000000000889
Yao L., Yang L., Song H., Liu T.G., Yan H. Silencing of lncRNA XIST Suppresses Proliferation and Autophagy and Enhances Vincristine Sensitivity in Retinoblastoma Cells by Sponging miR-204-5p. European review for medical and pharmacological sciences. 2020 Apr 24.
DOI: 10.26355/eurrev_202004_20812
Yao X., Shen H., Peng Q., Yu J. TP53/miR-129/MDM2/4/TP53 feedback loop modulates cell proliferation and apoptosis in retinoblastoma. Cell Cycle. 2021 Mar-Mar;20(5-6):603-615.
doi: 10.1080/15384101.2021.1892321
Yaqoob N., Zia N., Hamid A., Kaleem B., Jamal S., Amin S., Qaddoumi I., Jamal S. Correlation of clinical and radiological predictors of retinoblastoma with high-risk histopathological features. Pediatr Blood Cancer. 2022 May;69(5):e29625. Epub 2022 Mar 6. PMID: 35253344.
doi: 10.1002/pbc.29625
Yarovoy A.A., Golanov A.V., Yarovaya V.A. et al. Stereotactic Gamma Knife® Radiosurgery of Intraocular Retinoblastoma: Six-Year Experience. Cureus. 2022-10-11;14(9):e28751.
doi: 10.7759/cureus.28751
Yarovoy AA, Volodin DP, Yarovaya VA. A retrospective study on ruthenium-106 and strontium-90 eye-plaques treatment for retinoblastoma: 16-years clinical experience. Brachytherapy. 2025 Mar-Apr;24(2):265-272. Epub 2025 Jan 9. PMID: 39788791.
doi: 10.1016/j.brachy.2024.11.008
Yazici H., Wu H.C., Tigli H., Yilmaz E.Z., Kebudi R., Santella R.M. High levels of global genome methylation in patients with retinoblastoma. Oncology letters. 2020 Jul.
doi: 10.3892/ol.2020.11613
Ye H., Chen R., Xiao W. et al. Polyester 5-0 suture for porous implant placement after retinoblastoma enucleation: analysis of 120 sockets. BMC ophthalmology. 2023-02-02;23(1):30.
doi: 10.1186/s12886-023-02787-7
Ye H., Xue K., Zhang P. et al. Three vs 6 Cycles of Chemotherapy for High-Risk Retinoblastoma: A Randomized Clinical Trial. JAMA. 2024-12-19;332(19):1634-1641
doi: 10.1001/jama.2024.19981
Ye Q., Zeng Z., Liang X. et al. Quercetin suppresses retinoblastoma cell proliferation and invasion and facilitates oxidative stress-induced apoptosis through the miR-137/FNDC5 axis. Environmental research. 2023-10-22;237(Pt 2):116934.
doi: 10.1016/j.envres.2023.116934
Ye R, Yuan Q, You W, Huang Y, Lin Z, Tang H, Zeng R. Identification of the shared gene signatures in retinoblastoma and osteosarcoma by machine learning. Sci Rep. 2024 Dec 28;14(1):31355. PMID: 39733097; PMCID: PMC11682156.
doi: 10.1038/s41598-024-82789-7
Yi X., Lin X., Fang C. et al. Assessment of Retinal Microvasculature and Choroidal Vascularity After Intra-arterial Chemotherapy for Retinoblastoma. American journal of ophthalmology. 2024-06-06;266(266):10-16.
doi: 10.1016/j.ajo.2024.04.007
Yin D.F., Zhou X.J., Li N., Liu H.J., Yuan H. Long non-coding RNA SND1-IT1 accelerates cell proliferation, invasion and migration via regulating miR-132-3p/SMAD2 axis in retinoblastoma. Bioengineered. 2021 Dec;12(1):1189-1201.
doi: 10.1080/21655979.2021.1909962
Yin F., Guo Z., Sun W. et al. Overall survival comparison between pediatric and adult retinoblastoma and adult nomogram construction: A SEER population-based analysis. Asian journal of surgery. 2024-02-23.
doi: 10.1016/j.asjsur.2024.02.046
Yin J., Zhang F., Cao J. et al. Gentiopicroside inhibits retinoblastoma cell proliferation, invasion, and tumorigenesis in nude mice by suppressing the PI3K/AKT pathway. Naunyn-Schmiedeberg's archives of pharmacology. 2023-08-09.
doi: 10.1007/s00210-023-02646-8
Yin W., Gao F., Zhang S. MicroRNA‑34a inhibits the proliferation and promotes the chemosensitivity of retinoblastoma cells by downregulating Notch1 expression. Molecular medicine reports. 2020 Aug;22
doi: 10.3892/mmr.2020.11238
Yi X., Sun J., Qian J., Guo J., Xue K. Quantitative evaluation of retinal microvasculature and retrobulbar vessels after intravenous chemotherapy for retinoblastoma. BMC Ophthalmol. 2021 Nov 26;21(1):405.
doi: 10.1186/s12886-021-02170-4
Youlden D.R., Baade P.D., Frazier A.L. et al. Temporal changes in childhood cancer incidence and survival by stage at diagnosis in Australia, 2000-2017. Acta oncologica (Stockholm, Sweden). 2023-11-08;62(10):1256-1264
doi: 10.1080/0284186X.2023.2251668
Yousef Y.A., Abu Salim Q.F., Mohammad M. et al. Presentation and management outcomes of Retinoblastoma among Syrian refugees in Jordan. Frontiers in oncology. 2023-02-02;12(12):1056963
doi: 10.3389/fonc.2022.1056963
Yousef Y.A., Al Jboor M., Mohammad M., Mehyar M., Toro M.D., Nazzal R., Alzureikat Q.H., Rejdak M., Elfalah M., Sultan I., Rejdak R., Al-Hussaini M., Al-Nawaiseh I. Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma. Frontiers in pharmacology. 2021 Jul 12;12:696787. PMID: 34322023; PMCID: PMC8311556.
doi: 10.3389/fphar.2021.696787
Yousef Y.A., AlHabahbeh O., Mohammad M. et al. Optimizing Surgical Management for Rhegmatogenous Retinal Detachment in Eyes with Active Retinoblastoma: A Safety-Driven Approach. Journal of clinical medicine. 2024-05-14;13(9).
doi: 10.3390/jcm13092511
Yousef YA, Halawa F, Mohammad M, Al-Fahoum L, Soudi R, Mehyar M, AlJabari R, Halalsheh H, AlNawaiseh I, Jaradat I. Outcomes and Predictive Factors of I-125 Plaque Therapy for Refractory Retinoblastoma. J Clin Med. 2025 Mar 6;14(5):1778. PMID: 40095901; PMCID: PMC11901221.
doi: 10.3390/jcm14051778
Yousef YA, Mohammad M, Al-Jabari O, Halawa F, Al-Fahoum L, Halalsheh H, Khzouz J, Al-Hussaini M, Jaradat I, Mehyar M, Rejdak R, Toro MD, Haboob H, Al-Nawaiseh I. Intra-Arterial Melphalan Chemotherapy for Retinoblastoma in a Developing Nation: Real-World Outcomes and Prognostic Factors. Cancers (Basel). 2025 Jun 12;17(12):1955. PMID: 40563605; PMCID: PMC12190955.
doi: 10.3390/cancers17121955
Yousef Y.A., Mohammad M., Al-Nawaiseh I. et al. Retinoblastoma and uveal melanoma in Jordan: incidence, demographics, and survival (2011-2020). Ophthalmic genetics. 2022-07-18:1-8.
doi: 10.1080/13816810.2022.2090008
Yousef Y.A., Mohammad M., Baqain L. et al. Mutational analysis of the RB1 gene in patients with unilateral retinoblastoma. Frontiers in medicine. 2024-09-07;11(11):1406215
doi: 10.3389/fmed.2024.1406215
Yousef Y.A., Mohammad M., Mehyar M., Sultan I., Al-Hussaini M., Alhourani J., Halalsheh H., Khzouz J., Jaradat I., Qaddoumi I., Al-Nawaiseh I. The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy. J Pediatr Hematol Oncol. 2021 Aug 1;43(6):e841-e847.
doi: 10.1097/MPH.0000000000002144
Yu B., Zhao J., Dong Y. Circ_0000527 Promotes Retinoblastoma Progression through Modulating miR-98-5p/XIAP Pathway. Curr Eye Res. 2021 Sep;46(9):1414-1423.
doi: 10.1080/02713683.2021.1891255
Yu G., Zhou X., Li J. et al. A meta-analysis of the efficacy of intra-arterial chemotherapy for the management of retinoblastoma patients. Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 2023-07-24.
doi: 10.17219/acem/166664
Yu X., Li X., Xing Y., Lu S., Tanumiharjo S., Ma J. Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma. BMC Cancer. 2020 Aug 26.
doi: 10.1186/s12885-020-07314-1
Yin X., Liao Y., Xiong W., Zhang Y., Zhou Y., Yang Y. Hypoxia-induced lncRNA ANRIL promotes cisplatin resistance in retinoblastoma cells through regulating ABCG2 expression. Clinical and Experimental Pharmacology & Physiology.. 2020 Mar 15.
doi: 10.1111/1440-1681.13279
Yousef Y.A., Alkhoms A., AlJabari R., AlJboor M., Mohammad M., Lahlouh M, Deebajah R, Halalsheh H, Al-Hussaini M, Jaradat I, Shawagfeh M, Sultan I, Mehyar M, AlNawaiseh I. Programmed screening for retinoblastoma enhances early diagnosis and improves management outcome for high-risk children. Ophthalmic genetics. 2020 May 20.
doi: 10.1080/13816810.2020.1766085
Yousef Y.A., Al-Nawaiseh I., Mehyar M, Sultan I., Al-Hussaini M., Jaradat I., Mohammad M., AlJabari R., Abu-Yaghi N., Rodriguez-Galindo C., Qaddoumi I., Wilson M. How Telemedicine and Centralized Care Changed the Natural History of Retinoblastoma in a Developing Country: Analysis of 478 Patients. Ophthalmology. 2020 Jul 16.
doi: 10.1016/j.ophtha.2020.07.026
Yousef Y.A., Mohammad M., Jaradat I., Shatnawi R., Banat S., Mehyar M., Al-Nawaiseh I. The role of external beam radiation therapy for retinoblastoma after failure of combined chemoreduction and focal consolidation therapy. Ophthalmic Genet. 2020 Feb 19:1-6.
doi: 10.1080/13816810.2020.1719519
Yousef Y.A., Mohammad M., Mehyar M., Sultan I., Al-Hussaini M., Alhourani J., Halalsheh H, Khzouz J., Jaradat I., Qaddoumi I., Al-Nawaiseh I. The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy. Journal of pediatric hematology/oncology. 2021 Mar 23.
doi: 10.1097/MPH.0000000000002144
Yu B., Zhao J., Dong Y. Circ_0000527 Promotes Retinoblastoma Progression through Modulating miR-98-5p/XIAP Pathway. Current eye research. 2021 Feb 25:1-10.
doi: 10.1080/02713683.2021.1891255
Z
Zanolli M., Oporto J.I., Verdaguer J.I., López J.P., Zacharías S., Romero P., Ossandón D., Denk O., Acuña O., López J.M., Stevenson R., Álamos B., Iturriaga H. Genetic testing for inherited ocular conditions in a developing country. // Ophthalmic Genetics. 2020 Mar 6.
doi: 10.1080/13816810.2020.1734944
Zamani Sani M, Mirzaei M, Mota A, Mohammadian J, Aboutalebi Vand Beilankouhi E, Rahmati M. MicroRNAs' Significance in Retinoblastoma Diagnosis and Treatment: The Little Heroes. Biochem Genet. 2025 Apr;63(2):1176-1197. Epub 2025 Jan 25. PMID: 39862293.
doi: 10.1007/s10528-024-10976-2
Zebret S., Hadiji M., Romano-deGea J. et al. New melphalan derivatives for the treatment of retinoblastoma in combination with thermotherapy. RSC medicinal chemistry. 2024-07-20;15(7):2300-2304.
doi: 10.1039/d4md00211c
Zeng C., Cao W., Zhao T., Li L., Hou L. Hope level and associated factors among parents of retinoblastoma patients during COVID-19 pandemic: a cross-sectional study. BMC Psychiatry. 2021 Aug 6;21(1):391.
doi: 10.1186/s12888-021-03401-0
Zeng C., Du N., He L. et al. Factors influencing parental fatigue in children with retinoblastoma based on the unpleasant symptoms theory. Scientific reports. 2024-08-06;14(1):17389.
doi: 10.1038/s41598-024-67155-x
Zeng C., Han M., Fan J. et al. Anemia and Bone Marrow Suppression After Intra-Arterial Chemotherapy in Children With Retinoblastoma: A Retrospective Analysis. Frontiers in oncology. 2022-08-13;12(12):848877.
doi: 10.3389/fonc.2022.848877
Zeng C., Wu Y., He Y. et al. Hemostatic effect of 3D-printed hip fixators in children with retinoblastoma after intra-arterial chemotherapy: a non-randomized controlled trial. Scientific reports. 2024-11-22;14(1):27613
doi: 10.1038/s41598-024-78829-x
Zeng Q., Wang S., Chen L. et al. Transcriptome analysis reveals molecularly distinct subtypes in retinoblastoma. Scientific reports. 2023-11-21;13(1):16475.
doi: 10.1038/s41598-023-42253-4
Zeng Q., Wang S., Tan J., Chen L., Wang J. The methylation level of TFAP2A is a potential diagnostic biomarker for retinoblastoma: an analytical validation study. PeerJ. 2021 Mar 2;9:e10830.
doi: 10.7717/peerj.10830
Zeng Y., He T., Liu J., Li Z., Xie F., Chen C. Xing Y. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma. Medicine. 2020 Nov 20;99(47):e23314.
doi: 10.1097/MD.0000000000023314
Zhang C., Feng Z.X., Li L., Solarte C.E., Ma X. Retinoblastoma in a child with tuberous sclerosis complex. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2020 Aug 18.
doi: 10.1016/j.jcjo.2020.05.014
Zhang C., Wu S. MicroRNA -378a-3p Restrains the Proliferation of Retinoblastoma Cells but Promotes Apoptosis of Retinoblastoma Cells via Inhibition of FOXG1.
Investigative ophthalmology & visual science. 2020 May 11
DOI: 10.1167/iovs.61.5.31
Zhang D.L., French D.D., Rossen J.L. et al. Direct medical costs of globe salvage in group C-E retinoblastoma and implications for cost-effectiveness. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2024-08-28;27(6):338.e1-338.e6.
doi: 10.1016/j.jaapos.2023.08.013
Zhang G., Yang W., Li D., Li X., Huang J., Huang R., Luo J. lncRNA FEZF1‑AS1 promotes migration, invasion and epithelial‑mesenchymal transition of retinoblastoma cells by targeting miR‑1236‑3p. Molecular medicine reports. 2020 Sep 2.
doi: 10.3892/mmr.2020.11478
Zhang H., Konjusha D., Rafati N. et al. Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour. Cellular oncology (Dordrecht). 2023-08-22
doi: 10.1007/s13402-023-00863-0
Zhang H., Qiu X., Song Z., Lan L., Ren X., Ye B. CircCUL2 suppresses retinoblastoma cells by regulating miR-214-5p/E2F2 Axis. Anticancer Drugs. 2021 Aug 11.
doi: 10.1097/CAD.0000000000001190
Zhang H., Yang X., Xu Y., Li H. KCNQ1OT1 regulates the retinoblastoma cell proliferation, migration and SIRT1/JNK signaling pathway by targeting miR-124/SP1 axis. Bioscience reports. 2020 Dec 21:BSR20201626.
doi: 10.1042/BSR20201626
Zhang H., Zhang P., Long C., Ma X., Huang H., Kuang X., Du H., Tang H., Ling X., Ning J., Liu H., Deng X., Zou Y., Wang R., Cheng H., Lin S., Zhang Q., Yan J., Shen H. m(6)A methyltransferase METTL3 promotes retinoblastoma progression via PI3K/AKT/mTOR pathway. Journal of cellular and molecular medicine. 2020 Oct 8.
doi: 10.1111/jcmm.15736
Zhang H.L., Li N., Dong L. et al. Prox1 Suppresses Proliferation and Drug Resistance of Retinoblastoma Cells via Targeting Notch1. Current medical science. 2024-02-27;44(1):223-231.
doi: 10.1007/s11596-023-2803-9.
Zhang J., Liu Z.N., Deng G.H. Anticancer Activity of New Na(I) Complex on Retinoblastoma Cells via Inhibiting PI3K/AKT/mTOR Pathway. J Oncol. 2021 Nov 18;2021:9403333.
doi: 10.1155/2021/9403333
Zhang L.J., Wang F., Qi P.Y., Zhou W.Y., Wang B. miR-513b-5p inhibits the proliferation and promotes apoptosis of retinoblastoma cells by targeting TRIB1. Open Med (Wars). 2021 Sep 9;16(1):1364-1371.
doi: 10.1515/med-2021-0343.
Zhang L., Wu J., Li Y., Jiang Y., Wang L., Chen Y., Lv Y., Zou Y., Ding X.
Circ_0000527 promotes the progression of retinoblastoma by regulating miR-646/LRP6 axis. Cancer cell international. 2020 Jul 10.
doi: 10.1186/s12935-020-01396-4
Zhang M.G., Kuznetsoff J.N., Owens D.A. et al. Early Mechanisms of Chemoresistance in Retinoblastoma. Cancers. 2022-10-17;14(19).
doi: 10.3390/cancers14194966
Zhang Q., Zhong C., Duan S. The tumorigenic function of LINC00858 in cancer. Biomed Pharmacother. 2021 Nov;143:112235.
doi: 10.1016/j.biopha.2021.112235
Zhang R., Dong L., Li R. et al. Automatic retinoblastoma screening and surveillance using deep learning. British journal of cancer. 2023-08-09;129(3):466-474.
doi: 10.1038/s41416-023-02320-z
Zhang R., Song Y.N., Duo X., Guo Z., Sun Y., Zhang Z., Lu Y., Miao B., Yang P.C., Nie G. Retinoblastoma cell-derived Twist protein promotes regulatory T-cell development. Cancer immunology, immunotherapy: CII. 2020 Oct 27.
doi: 10.1007/s00262-020-02744-z
Zhang S., Long J., Hu Y. Long noncoding RNA LINC00205 enhances the malignant characteristics of retinoblastoma by acting as a molecular sponge of microRNA-665 and consequently increasing HMGB1 expression. // Biochemical and Biophysical Research Communication. 2020 Mar 26.
doi: 10.1016/j.bbrc.2020.03.083
Zhang S., Xu H., Li W. et al. MDM2 promotes cancer cell survival through regulating the expression of HIF-1α and pVHL in retinoblastoma. Pathology oncology research: POR. 2023-02-08;29(29):1610801.
doi: 10.3389/pore.2023.1610801
Zhang T., Yang J., Gong F., Li L., Li A. Long non-coding RNA CASC9 promotes the progression of retinoblastoma via interacting with miR-145-5p. Cell Cycle. 2020 Aug 10.
doi: 10.1080/15384101.2020.1802813
Zhang W.X., Shimony J.S., Lueder GT. et al. Apparent Diffusion Coefficient (ADC) Differentiates Retinoblastoma from Coats Disease on MRI. American journal of ophthalmology. 2024-07-14;267(267):8-12.
doi: 10.1016/j.ajo.2024.05.023
Zhang X., Jiang Y., Cai Y. et al. Epigenetics research in eye diseases: a bibliometric analysis from 2000 to 2023. Clinical & experimental optometry. 2023-10-24:1-8.
doi: 10.1080/08164622.2023.2261929
Zhang X., Jin Z.B. et al. Reconstruct Human Retinoblastoma In Vitro. Journal of visualized experiments : JoVE. 2022-11-02(188).
doi: 10.3791/62629
Zhang X., Song L., Huang Y., Han S., Hou M., Li H. Downregulation of MST4 Underlies a Novel Inhibitory Role of MicroRNA Let-7a in the Progression of Retinoblastoma. Investigative ophthalmology & visual science. 2020 Jun 3.
doi: 10.1167/iovs.61.6.28
Zhang X., You W., Wang Y. et al. Prospects of anti-GD2 immunotherapy for retinoblastoma. Frontiers in immunology. 2024-12-10;15(15):1499700
doi: 10.3389/fimmu.2024.1499700
Zhang Y., Dou X., Kong Q., Li Y., Zhou X. Circ_0075804 promotes the malignant behaviors of retinoblastoma cells by binding to miR-138-5p to induce PEG10 expression. Int Ophthalmol. 2021 Oct 11.
doi: 10.1007/s10792-021-02067-7
Zhang Y., Duan S., Jang A., Mao L., Liu X., Huang G. JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis. Experimental eye research. 2020 Oct 17.
doi: 10.1016/j.exer.2020.108304
Zhang Y., Jing X., Li Z., Tian Q., Wang Q., Chen X. Investigation of the role of the miR17-92 cluster in BMP9-induced osteoblast lineage commitment. J Orthop Surg Res. 2021 Oct 30;16(1):652.
doi: 10.1186/s13018-021-02804-9.
Zhang Y., Mao L., Jiang A. et al. PRMT1 mediates the proliferation of Y79 retinoblastoma cells by regulating the p53/p21/CDC2/cyclin B pathway. Experimental eye research. 2024-09-12;247(247):110040.
doi: 10.1016/j.exer.2024.110040
Zhang Y., Tang L. et al. Retinoblastoma in an older child with secondary glaucoma as the first clinical presenting symptom: A case report. World journal of clinical cases. 2022-09-28;10(24):8695-8702.
doi: 10.12998/wjcc.v10.i24.8695
Zhang Y., Wang Y., Huang D., Ma J., Zhang W., Gu H., Zhou Y., Yi Y., Zhang P. Correlation between Family RB1 Gene Pathogenic Variant with Clinical Features and Prognosis of Retinoblastoma under 5 Years Old. Disease markers. 2021 Jul 12;2021:9981028. PMID: 34336010; PMCID: PMC8292087.
doi: 10.1155/2021/9981028
Zhang Y., Wang Y., Zhi T. et al. Clinical characteristics, treatment and prognosis of infants with retinoblastoma: a multicenter, 10-year retrospective analysis. BMC pediatrics. 2023-05-13;23(1):229.
doi: 10.1186/s12887-023-03984-5
Zhang Y., Wang Y.Z., Shi J.T. et al. Clinical analysis of 2790 children with retinoblastoma: a single-center experience in China. World journal of pediatrics : WJP. 2023-10-21;19(12):1169-1180.
doi: 10.1007/s12519-023-00719-5
Zhang Y., Wei W.B., Zhao J. et al. Spectrum and tissue distribution of RB1 pathogenic alleles in mosaic retinoblastoma patients. Ophthalmic genetics. 2022-08-08:1-11.
doi: 10.1080/13816810.2022.2098985
Zhang Y., Zheng A. MiR-142-5p promotes retinoblastoma cell proliferation, migration and invasion by targeting PTEN. J Biochem. 2021 Oct 11;170(2):195-202.
doi: 10.1093/jb/mvaa121
Zhang Z, Li M, Guo Q, Wang X. Prediction of mortality in patients with retinoblastoma based on random survival forest: a retrospective cohort analysis using SEER database. Transl Cancer Res. 2025 Apr 30;14(4):2343-2353. Epub 2025 Apr 16. PMID: 40386278; PMCID: PMC12079209.
doi: 10.21037/tcr-24-1760
Zhang Z., Xiao Y.S., Shen R., Jiang H.C., Tan L., Li R.Q., Yang X.H., Gu H.Y., He W.J., Ma J. Next generation sequencing of RB1gene for the molecular diagnosis of ethnic minority with retinoblastoma in Yunnan. BMC medical genetics. 2020 Nov 23;21(1):230.
doi: 10.1186/s12881-020-01150-7
Zhao H.S., Wei W.B., Shi J.T. et al. [A retrospective analysis of 147 cases of orbital exenteration]. [Zhonghua yan ke za zhi] Chinese journal of ophthalmology. 2023-05-09;59(5):388-397.
doi: 10.3760/cma.j.cn112142-20221107-00577
Zhao H., Wan J., Zhu Y. Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis. Drug design, development and therapy. 2020 Aug 21
doi: 10.2147/DDDT.S256813
Zhao J., Cui R., Li L. et al. Multimodal imaging for the differential diagnosis and efficacy evaluation of intraocular retinoblastoma in children with selective ophthalmic artery infusion. Translational pediatrics. 2024-08-16;13(7):1022-1032.
doi: 10.21037/tp-24-2
Zhao J., Feng Z., Gallie B.L. Natural History of Untreated Retinoblastoma. Cancers (Basel). 2021 Jul 21;13(15):3646.
doi: 10.3390/cancers13153646
Zhao J., Feng Z., Leung G., Gallie B.L. Retinoblastoma Survival Following Primary Enucleation by AJCC Staging. Cancers (Basel). 2021 Dec 13;13(24):6240.
doi: 10.3390/cancers13246240
Zhao J., Li Q., Feng Z.X., Zhang J., Wu S., Jin L., Gallie B.L. Tylectomy Safety in Salvage of Eyes with Retinoblastoma. Cancers (Basel). 2021 Nov 22;13(22):5862.
doi: 10.3390/cancers13225862
Zhao N.O., Pak D., El-Hadad C., Debnam J.M., Ning J., Esmaeli B. Characteristics and Survival Outcomes of Second Primary Cancers in Long-term Retinoblastoma Survivors. Asia-Pacific journal of ophthalmology. 2021 Jan 19.
doi: 10.1097/APO.0000000000000361
Zhao N., Zhou L., Lu Q., Wang S., Sun Y., Ding Y., Liu M., He H., Lang T. SOX2 maintains the stemness of retinoblastoma stem-like cells through Hippo/YAP signaling pathway. Exp Eye Res. 2021 Dec 7;214:108887.
doi: 10.1016/j.exer.2021.108887
Zhao X.M., Li Y.B., Sun P., Pu Y.D., Shan M.J., Zhang Y.M. Bioinformatics analysis of key biomarkers for retinoblastoma. The Journal of international medical research. 2021 Jun;49(6):3000605211022210.
doi: 10.1177/03000605211022210
Zhao Y., Cheng Y., Qu Y. et al. The role of EZH2 as a potential therapeutic target in retinoblastoma. Experimental eye research. 2023-01-27;227(227):109389.
doi: 10.1016/j.exer.2023.109389
Zhao Y, Wang Y, Wang Y, Li J, Li H, Zhao H. Retinoblastoma research trends from 1980 to 2023: a 44-year bibliometric study. Front Oncol. 2025 May 28;15:1549387. PMID: 40502639; PMCID: PMC12151829.
doi: 10.3389/fonc.2025.1549387
Zhao Y, Wang Z, Gao M, Wang X, Feng H, Cui Y, Tian X. lncRNA MALAT1 regulated ATAD2 to facilitate retinoblastoma progression via miR-655-3p. Open Med (Wars). 2021 Jun 24;16(1):931-943.
doi: 10.1515/med-2021-0290
Zheng J., Li T., Ye H. et al. Comprehensive identification of pathogenic variants in retinoblastoma by long- and short-read sequencing. Cancer letters. 2024-08-15;598(598):217121.
doi: 10.1016/j.canlet.2024.217121
Zheng T., Chen W., Wang X., Cai W., Wu F., Lin C. Circular RNA circ-FAM158A promotes retinoblastoma progression by regulating miR-138-5p/SLC7A5 axis. Experimental eye research. 2021 Jun 5:108650.
doi: 10.1016/j.exer.2021.108650
Zheng Q., Zhu Q., Li C., Hao S., Li J., Yu X., Qi D., Pan Y. Sinomenine can inhibit the growth and invasion ability of retinoblastoma cell through regulating PI3k/AKT signaling pathway. Biological & pharmaceutical bulletin. 2020 Aug 4.
doi: 10.1248/bpb.b20-00387
Zheng W., Li X., Zou H. et al. Dual-Target Multifunctional Superparamagnetic Cationic Nanoliposomes for Multimodal Imaging-Guided Synergistic Photothermal/Photodynamic Therapy of Retinoblastoma. International journal of nanomedicine. 2022-08-05;17(17):3217-3237ю
doi: 10.2147/IJN.S364264
Zheng Y., Froehler M.T., Friedman D., Daniels A. Intra-arterial chemotherapy (IAC) as primary treatment for cavitary retinoblastoma: Excellent response in 8 tumors. Ophthalmology. Retina. 2020 Aug 24ю
doi: 10.1016/j.oret.2020.08.011
Zheng Y., Froehler M.T., Friedman D.L., Daniels A.B. Intra-arterial Chemotherapy as Primary Treatment for Cavitary Retinoblastoma: Excellent Response in Eight Tumors. Ophthalmology Retina. 2021 May;5(5):479-485.
doi: 10.1016/j.oret.2020.08.011
Zheng Q., Zhu Q., Li C., Hao S., Li J., Yu X., Qi D., Pan Y. microRNA-144 functions as a diagnostic and prognostic marker for retinoblastoma. Clinics. 2020 Aug 19.
doi: 10.6061/clinics/2020/e1804
Zhou C., Wen X., Ding Y., Ding J., Jin M., Liu Z., Wang S., Han M., Yuan H., Xiao Y., Wu L., Wang J., Li Y., Yu J., Wen Y., Ye J., Liu R., Chen Z., Xue S., Lu W., Liao H., Cui J., Zhu D., Lu F., Tang S., Wu Y., Yangkyi T., Zhang G., Wubuli M., Guo H., Wang X., He Y., Sheng X., Wang Q., Luo Y., Fan J., Qi J., Yu Z., Tan J., Liang J., Sun X., Jin L., Yang X., Zhang J., Ji X., Zhao J., Jia R., Fan X. Eye-preserving therapies for advanced retinoblastoma: a multicenter cohort of 1678 patients in China. Ophthalmology. 2021 Sep 15:S0161-6420(21)00683-7.
doi: 10.1016/j.ophtha.2021.09.002
Zhou L., Chen L., Chen S. et al. Highly Efficient Photodynamic Therapy with Mitochondria-Targeting Aggregation-induced Emission Photosensitizer for Retinoblastoma. Advanced healthcare materials. 2022-10-22:e2202219.
doi: 10.1002/adhm.202202219
Zhou L., Ng D.S., Yam J.C., Chen L.J., Tham C.C., Pang C.P., Chu W.K. Post-translational modifications on the retinoblastoma protein. J Biomed Sci. 2022 Jun 1;29(1):33. PMID: 35650644; PMCID: PMC9161509.
doi: 10.1186/s12929-022-00818-x
Zhou L., Tong Y., Ho B.M. et al. Etiology including epigenetic defects of retinoblastoma. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2024-06-07;13(3):100072.
doi: 10.1016/j.apjo.2024.100072
Zhou L., Zhu X.H., Zhang K., Hu R., Myers F. Case Report: Adult Retinoblastoma Progression in 19 Months. Optometry and vision science: official publication of the American Academy of Optometry. 2020 Oct 26.
doi: 10.1097/OPX.0000000000001602
Zhou M., Tang J., Fan J. et al. Recent progress in retinoblastoma: Pathogenesis, presentation, diagnosis and management. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2024-05-21;13(2):100058.
doi: 10.1016/j.apjo.2024.100058
Zhou M., Wen X., Jia S., Han Y., He X., Han M., Xu W., Fan J., Jia R., Fan X. Risk factors for ophthalmic artery stenosis and occlusion in patients with retinoblastoma treated with intra-arterial chemotherapy. The British journal of ophthalmology. 26 May. 2021
doi:10.1136/bjophthalmol-2021-319118
Zhou N., Yang L., Xu X. et al. Retinoblastoma in Adults: Clinical Features, Gene Mutations and Treatment Outcomes: A Study of Six Cases. Frontiers in oncology. 2022-08-20;12(12):835965
doi: 10.3389/fonc.2022.835965
Zhou S., Lu S., Guo S., Zhao L., Han Z., Li Z. Protective Effect of Ginsenoside Rb1 Nanoparticles Against Contrast-Induced Nephropathy by Inhibiting High Mobility Group Box 1 Gene/Toll-Like Receptor 4/NF-κB Signaling Pathway. J Biomed Nanotechnol. 2021 Oct 1;17(10):2085-2098.
doi: 10.1166/jbn.2021.3163
Zhou W., Guan W., Zhou Y., Rao Y., Ji X., Li J. Weighted genes associated with the progression of retinoblastoma: Evidence from bioinformatic analysis. Exp Eye Res. 2021 Oct;211:108730.
doi: 10.1016/j.exer.2021.108730
Zhou Y., Cai S., Jin M., Jiang C., Xu N., Duan C., Peng X., Zhao J., Ma X. Economic burden for retinoblastoma patients in China. Journal of medical economics. 2020 Oct 27:1-5.
doi: 10.1080/13696998.2020.1831518
Zhou Z., Jiang H., Xia J., Zhang J. Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo. International journal of oncology. 2020 Jun 22.
doi: 10.3892/ijo.2020.5085
Zhu H, Zhao M, Zheng J. Global, regional, and national burden of retinoblastoma in children aged under 10 years from 1990 to 2021 and projections for future disease burden. Sci Rep. 2025 Mar 3;15(1):7488. PMID: 40032986; PMCID: PMC11876563.
doi: 10.1038/s41598-025-91289-1
Zhu X.Y., Li J., Guan W.B., Chen C.L., Ji X.D., Zhao P.Q. Pathologic comparisons of enucleated eyes with retinoblastoma after superselective ophthalmic arterial chemotherapy with or without intravenous chemotherapy. International journal of ophthalmology. 2020 Nov 18;13(11):1794-1799.
doi: 10.18240/ijo.2020.11.17
Zhu X., Li Z., Liu J. et al. MRI features for prediction of the intravenous chemotherapy effect in patients with retinoblastoma. Clinical radiology. 2023-10-12;78(11):e864-e871
doi: 10.1016/j.crad.2023.07.013
Zhu X., Yu M., Wang K., Zou W., Zhu L. FoxM1 affects adhesive, migratory, and invasive abilities of human retinoblastoma Y-79 cells by targeting matrix metalloproteinase 2. // Acta Biochimica et Biophysica Sinica. 2020 Mar 10.
DOI: 10.1093/abbs/gmz160
Zhu Y., Hao F. Knockdown of long non‑coding RNA HCP5 suppresses the malignant behavior of retinoblastoma by sponging miR‑3619‑5p to target HDAC9. International journal of molecular medicine. 2021 May;47(5):74.
doi: 10.3892/ijmm.2021.4907
Zhuang H., Xu Y.N., Zheng H.H., Huan Y.R., Zheng N.X., Lin L., Zhang W.Z., Xu W. Carboplatin-loaded surface modified-PLGA nanoparticles confer sustained inhibitory effect against retinoblastoma cell in vitro. Arq Bras Oftalmol. 2022 Feb 14:S0004-27492022005002204. PMID: 35170632.
doi: 10.5935/0004-2749.20220075
Zluhan-Martínez E., Pérez-Koldenkova V., Ponce-Castañeda M.V., Sánchez M.P., García-Ponce B., Miguel-Hernández S., Álvarez-Buylla E.R., Garay-Arroyo A. Beyond What Your Retina Can See: Similarities of Retinoblastoma Function between Plants and Animals, from Developmental Processes to Epigenetic Regulation. International journal of molecular sciences. 2020 Jul 12.
doi: 10.3390/ijms21144925
Zocchi L., Wu S.C., Benavente C.A. Heavenly HELLS? A potential new therapeutic target for retinoblastoma. Oncoscience. 2020 May 1.
doi: 10.18632/oncoscience.502
Zomor El. H., Nour R., Saad A., Taha H., Shelil AE., Aleieldin A., Saad Zaghloul M., Alfaar AS. Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients. Eye (Lond). 2021 Sep;35(9):2564-2572. Epub 2020 Nov 13. PMID: 33188294; PMCID: PMC8377076.
doi: 10.1038/s41433-020-01275-2
Zou Y., Li J., Hua P., Liang T., Ji X., Zhao P. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing. Molecular vision. 2021 Jan 6;27:1-16.
Zschoche M., Skosyrski S., Babst N., Ranjbar M., Rommel F., Kurz M., Tura A., Joachim S.C., Kociok N., Kakkassey V. Islet Co-Expression of CD133 and ABCB5 in Human Retinoblastoma Specimens. Klin Monbl Augenheilkd. 2021 Sep 27.
doi: 10.1055/a-1525-2588
Zugbi S., Aschero R., Ganiewich D. et al. Establishment and Comprehensive Characterization of a Novel Preclinical Platform of Metastatic Retinoblastoma for Therapeutic Developments. Investigative ophthalmology & visual science. 2023-12-24;64(15):27.
doi: 10.1167/iovs.64.15.27
Zugbi S., Ganiewich D., Bhattacharyya A., Aschero R., Ottaviani D., Sampor C., Cafferata E.G. etc. Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma. Cancers. 2020 Sep 22
doi: 10.3390/cancers12092714
Zuo X., Fu C., Xie J., Wang X., Yan Z. Hsa_circ_0000527 Downregulation Suppresses the Development of Retinoblastoma by Modulating the miR-27a-3p/HDAC9 Pathway. Curr Eye Res. 2021 Nov 25:1-12.
doi: 10.1080/02713683.2021.1925697
Zanolli M., Oporto J.I., Verdaguer J.I., López J.P., Zacharías S., Romero P., Ossandón D., Denk O., Acuña O., López J.M., Stevenson R., Álamos B., Iturriaga H. Genetic testing for inherited ocular conditions in a developing country. // Ophthalmic Genetics. 2020 Mar 6.
doi: 10.1080/13816810.2020.1734944
Zamani Sani M, Mirzaei M, Mota A, Mohammadian J, Aboutalebi Vand Beilankouhi E, Rahmati M. MicroRNAs' Significance in Retinoblastoma Diagnosis and Treatment: The Little Heroes. Biochem Genet. 2025 Apr;63(2):1176-1197. Epub 2025 Jan 25. PMID: 39862293.
doi: 10.1007/s10528-024-10976-2
Zebret S., Hadiji M., Romano-deGea J. et al. New melphalan derivatives for the treatment of retinoblastoma in combination with thermotherapy. RSC medicinal chemistry. 2024-07-20;15(7):2300-2304.
doi: 10.1039/d4md00211c
Zeng C., Cao W., Zhao T., Li L., Hou L. Hope level and associated factors among parents of retinoblastoma patients during COVID-19 pandemic: a cross-sectional study. BMC Psychiatry. 2021 Aug 6;21(1):391.
doi: 10.1186/s12888-021-03401-0
Zeng C., Du N., He L. et al. Factors influencing parental fatigue in children with retinoblastoma based on the unpleasant symptoms theory. Scientific reports. 2024-08-06;14(1):17389.
doi: 10.1038/s41598-024-67155-x
Zeng C., Han M., Fan J. et al. Anemia and Bone Marrow Suppression After Intra-Arterial Chemotherapy in Children With Retinoblastoma: A Retrospective Analysis. Frontiers in oncology. 2022-08-13;12(12):848877.
doi: 10.3389/fonc.2022.848877
Zeng C., Wu Y., He Y. et al. Hemostatic effect of 3D-printed hip fixators in children with retinoblastoma after intra-arterial chemotherapy: a non-randomized controlled trial. Scientific reports. 2024-11-22;14(1):27613
doi: 10.1038/s41598-024-78829-x
Zeng Q., Wang S., Chen L. et al. Transcriptome analysis reveals molecularly distinct subtypes in retinoblastoma. Scientific reports. 2023-11-21;13(1):16475.
doi: 10.1038/s41598-023-42253-4
Zeng Q., Wang S., Tan J., Chen L., Wang J. The methylation level of TFAP2A is a potential diagnostic biomarker for retinoblastoma: an analytical validation study. PeerJ. 2021 Mar 2;9:e10830.
doi: 10.7717/peerj.10830
Zeng Y., He T., Liu J., Li Z., Xie F., Chen C. Xing Y. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma. Medicine. 2020 Nov 20;99(47):e23314.
doi: 10.1097/MD.0000000000023314
Zhang C., Feng Z.X., Li L., Solarte C.E., Ma X. Retinoblastoma in a child with tuberous sclerosis complex. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2020 Aug 18.
doi: 10.1016/j.jcjo.2020.05.014
Zhang C., Wu S. MicroRNA -378a-3p Restrains the Proliferation of Retinoblastoma Cells but Promotes Apoptosis of Retinoblastoma Cells via Inhibition of FOXG1.
Investigative ophthalmology & visual science. 2020 May 11
DOI: 10.1167/iovs.61.5.31
Zhang D.L., French D.D., Rossen J.L. et al. Direct medical costs of globe salvage in group C-E retinoblastoma and implications for cost-effectiveness. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2024-08-28;27(6):338.e1-338.e6.
doi: 10.1016/j.jaapos.2023.08.013
Zhang G., Yang W., Li D., Li X., Huang J., Huang R., Luo J. lncRNA FEZF1‑AS1 promotes migration, invasion and epithelial‑mesenchymal transition of retinoblastoma cells by targeting miR‑1236‑3p. Molecular medicine reports. 2020 Sep 2.
doi: 10.3892/mmr.2020.11478
Zhang H., Konjusha D., Rafati N. et al. Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour. Cellular oncology (Dordrecht). 2023-08-22
doi: 10.1007/s13402-023-00863-0
Zhang H., Qiu X., Song Z., Lan L., Ren X., Ye B. CircCUL2 suppresses retinoblastoma cells by regulating miR-214-5p/E2F2 Axis. Anticancer Drugs. 2021 Aug 11.
doi: 10.1097/CAD.0000000000001190
Zhang H., Yang X., Xu Y., Li H. KCNQ1OT1 regulates the retinoblastoma cell proliferation, migration and SIRT1/JNK signaling pathway by targeting miR-124/SP1 axis. Bioscience reports. 2020 Dec 21:BSR20201626.
doi: 10.1042/BSR20201626
Zhang H., Zhang P., Long C., Ma X., Huang H., Kuang X., Du H., Tang H., Ling X., Ning J., Liu H., Deng X., Zou Y., Wang R., Cheng H., Lin S., Zhang Q., Yan J., Shen H. m(6)A methyltransferase METTL3 promotes retinoblastoma progression via PI3K/AKT/mTOR pathway. Journal of cellular and molecular medicine. 2020 Oct 8.
doi: 10.1111/jcmm.15736
Zhang H.L., Li N., Dong L. et al. Prox1 Suppresses Proliferation and Drug Resistance of Retinoblastoma Cells via Targeting Notch1. Current medical science. 2024-02-27;44(1):223-231.
doi: 10.1007/s11596-023-2803-9.
Zhang J., Liu Z.N., Deng G.H. Anticancer Activity of New Na(I) Complex on Retinoblastoma Cells via Inhibiting PI3K/AKT/mTOR Pathway. J Oncol. 2021 Nov 18;2021:9403333.
doi: 10.1155/2021/9403333
Zhang L.J., Wang F., Qi P.Y., Zhou W.Y., Wang B. miR-513b-5p inhibits the proliferation and promotes apoptosis of retinoblastoma cells by targeting TRIB1. Open Med (Wars). 2021 Sep 9;16(1):1364-1371.
doi: 10.1515/med-2021-0343.
Zhang L., Wu J., Li Y., Jiang Y., Wang L., Chen Y., Lv Y., Zou Y., Ding X.
Circ_0000527 promotes the progression of retinoblastoma by regulating miR-646/LRP6 axis. Cancer cell international. 2020 Jul 10.
doi: 10.1186/s12935-020-01396-4
Zhang M.G., Kuznetsoff J.N., Owens D.A. et al. Early Mechanisms of Chemoresistance in Retinoblastoma. Cancers. 2022-10-17;14(19).
doi: 10.3390/cancers14194966
Zhang Q., Zhong C., Duan S. The tumorigenic function of LINC00858 in cancer. Biomed Pharmacother. 2021 Nov;143:112235.
doi: 10.1016/j.biopha.2021.112235
Zhang R., Dong L., Li R. et al. Automatic retinoblastoma screening and surveillance using deep learning. British journal of cancer. 2023-08-09;129(3):466-474.
doi: 10.1038/s41416-023-02320-z
Zhang R., Song Y.N., Duo X., Guo Z., Sun Y., Zhang Z., Lu Y., Miao B., Yang P.C., Nie G. Retinoblastoma cell-derived Twist protein promotes regulatory T-cell development. Cancer immunology, immunotherapy: CII. 2020 Oct 27.
doi: 10.1007/s00262-020-02744-z
Zhang S., Long J., Hu Y. Long noncoding RNA LINC00205 enhances the malignant characteristics of retinoblastoma by acting as a molecular sponge of microRNA-665 and consequently increasing HMGB1 expression. // Biochemical and Biophysical Research Communication. 2020 Mar 26.
doi: 10.1016/j.bbrc.2020.03.083
Zhang S., Xu H., Li W. et al. MDM2 promotes cancer cell survival through regulating the expression of HIF-1α and pVHL in retinoblastoma. Pathology oncology research: POR. 2023-02-08;29(29):1610801.
doi: 10.3389/pore.2023.1610801
Zhang T., Yang J., Gong F., Li L., Li A. Long non-coding RNA CASC9 promotes the progression of retinoblastoma via interacting with miR-145-5p. Cell Cycle. 2020 Aug 10.
doi: 10.1080/15384101.2020.1802813
Zhang W.X., Shimony J.S., Lueder GT. et al. Apparent Diffusion Coefficient (ADC) Differentiates Retinoblastoma from Coats Disease on MRI. American journal of ophthalmology. 2024-07-14;267(267):8-12.
doi: 10.1016/j.ajo.2024.05.023
Zhang X., Jiang Y., Cai Y. et al. Epigenetics research in eye diseases: a bibliometric analysis from 2000 to 2023. Clinical & experimental optometry. 2023-10-24:1-8.
doi: 10.1080/08164622.2023.2261929
Zhang X., Jin Z.B. et al. Reconstruct Human Retinoblastoma In Vitro. Journal of visualized experiments : JoVE. 2022-11-02(188).
doi: 10.3791/62629
Zhang X., Song L., Huang Y., Han S., Hou M., Li H. Downregulation of MST4 Underlies a Novel Inhibitory Role of MicroRNA Let-7a in the Progression of Retinoblastoma. Investigative ophthalmology & visual science. 2020 Jun 3.
doi: 10.1167/iovs.61.6.28
Zhang X., You W., Wang Y. et al. Prospects of anti-GD2 immunotherapy for retinoblastoma. Frontiers in immunology. 2024-12-10;15(15):1499700
doi: 10.3389/fimmu.2024.1499700
Zhang Y., Dou X., Kong Q., Li Y., Zhou X. Circ_0075804 promotes the malignant behaviors of retinoblastoma cells by binding to miR-138-5p to induce PEG10 expression. Int Ophthalmol. 2021 Oct 11.
doi: 10.1007/s10792-021-02067-7
Zhang Y., Duan S., Jang A., Mao L., Liu X., Huang G. JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis. Experimental eye research. 2020 Oct 17.
doi: 10.1016/j.exer.2020.108304
Zhang Y., Jing X., Li Z., Tian Q., Wang Q., Chen X. Investigation of the role of the miR17-92 cluster in BMP9-induced osteoblast lineage commitment. J Orthop Surg Res. 2021 Oct 30;16(1):652.
doi: 10.1186/s13018-021-02804-9.
Zhang Y., Mao L., Jiang A. et al. PRMT1 mediates the proliferation of Y79 retinoblastoma cells by regulating the p53/p21/CDC2/cyclin B pathway. Experimental eye research. 2024-09-12;247(247):110040.
doi: 10.1016/j.exer.2024.110040
Zhang Y., Tang L. et al. Retinoblastoma in an older child with secondary glaucoma as the first clinical presenting symptom: A case report. World journal of clinical cases. 2022-09-28;10(24):8695-8702.
doi: 10.12998/wjcc.v10.i24.8695
Zhang Y., Wang Y., Huang D., Ma J., Zhang W., Gu H., Zhou Y., Yi Y., Zhang P. Correlation between Family RB1 Gene Pathogenic Variant with Clinical Features and Prognosis of Retinoblastoma under 5 Years Old. Disease markers. 2021 Jul 12;2021:9981028. PMID: 34336010; PMCID: PMC8292087.
doi: 10.1155/2021/9981028
Zhang Y., Wang Y., Zhi T. et al. Clinical characteristics, treatment and prognosis of infants with retinoblastoma: a multicenter, 10-year retrospective analysis. BMC pediatrics. 2023-05-13;23(1):229.
doi: 10.1186/s12887-023-03984-5
Zhang Y., Wang Y.Z., Shi J.T. et al. Clinical analysis of 2790 children with retinoblastoma: a single-center experience in China. World journal of pediatrics : WJP. 2023-10-21;19(12):1169-1180.
doi: 10.1007/s12519-023-00719-5
Zhang Y., Wei W.B., Zhao J. et al. Spectrum and tissue distribution of RB1 pathogenic alleles in mosaic retinoblastoma patients. Ophthalmic genetics. 2022-08-08:1-11.
doi: 10.1080/13816810.2022.2098985
Zhang Y., Zheng A. MiR-142-5p promotes retinoblastoma cell proliferation, migration and invasion by targeting PTEN. J Biochem. 2021 Oct 11;170(2):195-202.
doi: 10.1093/jb/mvaa121
Zhang Z, Li M, Guo Q, Wang X. Prediction of mortality in patients with retinoblastoma based on random survival forest: a retrospective cohort analysis using SEER database. Transl Cancer Res. 2025 Apr 30;14(4):2343-2353. Epub 2025 Apr 16. PMID: 40386278; PMCID: PMC12079209.
doi: 10.21037/tcr-24-1760
Zhang Z., Xiao Y.S., Shen R., Jiang H.C., Tan L., Li R.Q., Yang X.H., Gu H.Y., He W.J., Ma J. Next generation sequencing of RB1gene for the molecular diagnosis of ethnic minority with retinoblastoma in Yunnan. BMC medical genetics. 2020 Nov 23;21(1):230.
doi: 10.1186/s12881-020-01150-7
Zhao H.S., Wei W.B., Shi J.T. et al. [A retrospective analysis of 147 cases of orbital exenteration]. [Zhonghua yan ke za zhi] Chinese journal of ophthalmology. 2023-05-09;59(5):388-397.
doi: 10.3760/cma.j.cn112142-20221107-00577
Zhao H., Wan J., Zhu Y. Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis. Drug design, development and therapy. 2020 Aug 21
doi: 10.2147/DDDT.S256813
Zhao J., Cui R., Li L. et al. Multimodal imaging for the differential diagnosis and efficacy evaluation of intraocular retinoblastoma in children with selective ophthalmic artery infusion. Translational pediatrics. 2024-08-16;13(7):1022-1032.
doi: 10.21037/tp-24-2
Zhao J., Feng Z., Gallie B.L. Natural History of Untreated Retinoblastoma. Cancers (Basel). 2021 Jul 21;13(15):3646.
doi: 10.3390/cancers13153646
Zhao J., Feng Z., Leung G., Gallie B.L. Retinoblastoma Survival Following Primary Enucleation by AJCC Staging. Cancers (Basel). 2021 Dec 13;13(24):6240.
doi: 10.3390/cancers13246240
Zhao J., Li Q., Feng Z.X., Zhang J., Wu S., Jin L., Gallie B.L. Tylectomy Safety in Salvage of Eyes with Retinoblastoma. Cancers (Basel). 2021 Nov 22;13(22):5862.
doi: 10.3390/cancers13225862
Zhao N.O., Pak D., El-Hadad C., Debnam J.M., Ning J., Esmaeli B. Characteristics and Survival Outcomes of Second Primary Cancers in Long-term Retinoblastoma Survivors. Asia-Pacific journal of ophthalmology. 2021 Jan 19.
doi: 10.1097/APO.0000000000000361
Zhao N., Zhou L., Lu Q., Wang S., Sun Y., Ding Y., Liu M., He H., Lang T. SOX2 maintains the stemness of retinoblastoma stem-like cells through Hippo/YAP signaling pathway. Exp Eye Res. 2021 Dec 7;214:108887.
doi: 10.1016/j.exer.2021.108887
Zhao X.M., Li Y.B., Sun P., Pu Y.D., Shan M.J., Zhang Y.M. Bioinformatics analysis of key biomarkers for retinoblastoma. The Journal of international medical research. 2021 Jun;49(6):3000605211022210.
doi: 10.1177/03000605211022210
Zhao Y., Cheng Y., Qu Y. et al. The role of EZH2 as a potential therapeutic target in retinoblastoma. Experimental eye research. 2023-01-27;227(227):109389.
doi: 10.1016/j.exer.2023.109389
Zhao Y, Wang Y, Wang Y, Li J, Li H, Zhao H. Retinoblastoma research trends from 1980 to 2023: a 44-year bibliometric study. Front Oncol. 2025 May 28;15:1549387. PMID: 40502639; PMCID: PMC12151829.
doi: 10.3389/fonc.2025.1549387
Zhao Y, Wang Z, Gao M, Wang X, Feng H, Cui Y, Tian X. lncRNA MALAT1 regulated ATAD2 to facilitate retinoblastoma progression via miR-655-3p. Open Med (Wars). 2021 Jun 24;16(1):931-943.
doi: 10.1515/med-2021-0290
Zheng J., Li T., Ye H. et al. Comprehensive identification of pathogenic variants in retinoblastoma by long- and short-read sequencing. Cancer letters. 2024-08-15;598(598):217121.
doi: 10.1016/j.canlet.2024.217121
Zheng T., Chen W., Wang X., Cai W., Wu F., Lin C. Circular RNA circ-FAM158A promotes retinoblastoma progression by regulating miR-138-5p/SLC7A5 axis. Experimental eye research. 2021 Jun 5:108650.
doi: 10.1016/j.exer.2021.108650
Zheng Q., Zhu Q., Li C., Hao S., Li J., Yu X., Qi D., Pan Y. Sinomenine can inhibit the growth and invasion ability of retinoblastoma cell through regulating PI3k/AKT signaling pathway. Biological & pharmaceutical bulletin. 2020 Aug 4.
doi: 10.1248/bpb.b20-00387
Zheng W., Li X., Zou H. et al. Dual-Target Multifunctional Superparamagnetic Cationic Nanoliposomes for Multimodal Imaging-Guided Synergistic Photothermal/Photodynamic Therapy of Retinoblastoma. International journal of nanomedicine. 2022-08-05;17(17):3217-3237ю
doi: 10.2147/IJN.S364264
Zheng Y., Froehler M.T., Friedman D., Daniels A. Intra-arterial chemotherapy (IAC) as primary treatment for cavitary retinoblastoma: Excellent response in 8 tumors. Ophthalmology. Retina. 2020 Aug 24ю
doi: 10.1016/j.oret.2020.08.011
Zheng Y., Froehler M.T., Friedman D.L., Daniels A.B. Intra-arterial Chemotherapy as Primary Treatment for Cavitary Retinoblastoma: Excellent Response in Eight Tumors. Ophthalmology Retina. 2021 May;5(5):479-485.
doi: 10.1016/j.oret.2020.08.011
Zheng Q., Zhu Q., Li C., Hao S., Li J., Yu X., Qi D., Pan Y. microRNA-144 functions as a diagnostic and prognostic marker for retinoblastoma. Clinics. 2020 Aug 19.
doi: 10.6061/clinics/2020/e1804
Zhou C., Wen X., Ding Y., Ding J., Jin M., Liu Z., Wang S., Han M., Yuan H., Xiao Y., Wu L., Wang J., Li Y., Yu J., Wen Y., Ye J., Liu R., Chen Z., Xue S., Lu W., Liao H., Cui J., Zhu D., Lu F., Tang S., Wu Y., Yangkyi T., Zhang G., Wubuli M., Guo H., Wang X., He Y., Sheng X., Wang Q., Luo Y., Fan J., Qi J., Yu Z., Tan J., Liang J., Sun X., Jin L., Yang X., Zhang J., Ji X., Zhao J., Jia R., Fan X. Eye-preserving therapies for advanced retinoblastoma: a multicenter cohort of 1678 patients in China. Ophthalmology. 2021 Sep 15:S0161-6420(21)00683-7.
doi: 10.1016/j.ophtha.2021.09.002
Zhou L., Chen L., Chen S. et al. Highly Efficient Photodynamic Therapy with Mitochondria-Targeting Aggregation-induced Emission Photosensitizer for Retinoblastoma. Advanced healthcare materials. 2022-10-22:e2202219.
doi: 10.1002/adhm.202202219
Zhou L., Ng D.S., Yam J.C., Chen L.J., Tham C.C., Pang C.P., Chu W.K. Post-translational modifications on the retinoblastoma protein. J Biomed Sci. 2022 Jun 1;29(1):33. PMID: 35650644; PMCID: PMC9161509.
doi: 10.1186/s12929-022-00818-x
Zhou L., Tong Y., Ho B.M. et al. Etiology including epigenetic defects of retinoblastoma. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2024-06-07;13(3):100072.
doi: 10.1016/j.apjo.2024.100072
Zhou L., Zhu X.H., Zhang K., Hu R., Myers F. Case Report: Adult Retinoblastoma Progression in 19 Months. Optometry and vision science: official publication of the American Academy of Optometry. 2020 Oct 26.
doi: 10.1097/OPX.0000000000001602
Zhou M., Tang J., Fan J. et al. Recent progress in retinoblastoma: Pathogenesis, presentation, diagnosis and management. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2024-05-21;13(2):100058.
doi: 10.1016/j.apjo.2024.100058
Zhou M., Wen X., Jia S., Han Y., He X., Han M., Xu W., Fan J., Jia R., Fan X. Risk factors for ophthalmic artery stenosis and occlusion in patients with retinoblastoma treated with intra-arterial chemotherapy. The British journal of ophthalmology. 26 May. 2021
doi:10.1136/bjophthalmol-2021-319118
Zhou N., Yang L., Xu X. et al. Retinoblastoma in Adults: Clinical Features, Gene Mutations and Treatment Outcomes: A Study of Six Cases. Frontiers in oncology. 2022-08-20;12(12):835965
doi: 10.3389/fonc.2022.835965
Zhou S., Lu S., Guo S., Zhao L., Han Z., Li Z. Protective Effect of Ginsenoside Rb1 Nanoparticles Against Contrast-Induced Nephropathy by Inhibiting High Mobility Group Box 1 Gene/Toll-Like Receptor 4/NF-κB Signaling Pathway. J Biomed Nanotechnol. 2021 Oct 1;17(10):2085-2098.
doi: 10.1166/jbn.2021.3163
Zhou W., Guan W., Zhou Y., Rao Y., Ji X., Li J. Weighted genes associated with the progression of retinoblastoma: Evidence from bioinformatic analysis. Exp Eye Res. 2021 Oct;211:108730.
doi: 10.1016/j.exer.2021.108730
Zhou Y., Cai S., Jin M., Jiang C., Xu N., Duan C., Peng X., Zhao J., Ma X. Economic burden for retinoblastoma patients in China. Journal of medical economics. 2020 Oct 27:1-5.
doi: 10.1080/13696998.2020.1831518
Zhou Z., Jiang H., Xia J., Zhang J. Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo. International journal of oncology. 2020 Jun 22.
doi: 10.3892/ijo.2020.5085
Zhu H, Zhao M, Zheng J. Global, regional, and national burden of retinoblastoma in children aged under 10 years from 1990 to 2021 and projections for future disease burden. Sci Rep. 2025 Mar 3;15(1):7488. PMID: 40032986; PMCID: PMC11876563.
doi: 10.1038/s41598-025-91289-1
Zhu X.Y., Li J., Guan W.B., Chen C.L., Ji X.D., Zhao P.Q. Pathologic comparisons of enucleated eyes with retinoblastoma after superselective ophthalmic arterial chemotherapy with or without intravenous chemotherapy. International journal of ophthalmology. 2020 Nov 18;13(11):1794-1799.
doi: 10.18240/ijo.2020.11.17
Zhu X., Li Z., Liu J. et al. MRI features for prediction of the intravenous chemotherapy effect in patients with retinoblastoma. Clinical radiology. 2023-10-12;78(11):e864-e871
doi: 10.1016/j.crad.2023.07.013
Zhu X., Yu M., Wang K., Zou W., Zhu L. FoxM1 affects adhesive, migratory, and invasive abilities of human retinoblastoma Y-79 cells by targeting matrix metalloproteinase 2. // Acta Biochimica et Biophysica Sinica. 2020 Mar 10.
DOI: 10.1093/abbs/gmz160
Zhu Y., Hao F. Knockdown of long non‑coding RNA HCP5 suppresses the malignant behavior of retinoblastoma by sponging miR‑3619‑5p to target HDAC9. International journal of molecular medicine. 2021 May;47(5):74.
doi: 10.3892/ijmm.2021.4907
Zhuang H., Xu Y.N., Zheng H.H., Huan Y.R., Zheng N.X., Lin L., Zhang W.Z., Xu W. Carboplatin-loaded surface modified-PLGA nanoparticles confer sustained inhibitory effect against retinoblastoma cell in vitro. Arq Bras Oftalmol. 2022 Feb 14:S0004-27492022005002204. PMID: 35170632.
doi: 10.5935/0004-2749.20220075
Zluhan-Martínez E., Pérez-Koldenkova V., Ponce-Castañeda M.V., Sánchez M.P., García-Ponce B., Miguel-Hernández S., Álvarez-Buylla E.R., Garay-Arroyo A. Beyond What Your Retina Can See: Similarities of Retinoblastoma Function between Plants and Animals, from Developmental Processes to Epigenetic Regulation. International journal of molecular sciences. 2020 Jul 12.
doi: 10.3390/ijms21144925
Zocchi L., Wu S.C., Benavente C.A. Heavenly HELLS? A potential new therapeutic target for retinoblastoma. Oncoscience. 2020 May 1.
doi: 10.18632/oncoscience.502
Zomor El. H., Nour R., Saad A., Taha H., Shelil AE., Aleieldin A., Saad Zaghloul M., Alfaar AS. Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients. Eye (Lond). 2021 Sep;35(9):2564-2572. Epub 2020 Nov 13. PMID: 33188294; PMCID: PMC8377076.
doi: 10.1038/s41433-020-01275-2
Zou Y., Li J., Hua P., Liang T., Ji X., Zhao P. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing. Molecular vision. 2021 Jan 6;27:1-16.
Zschoche M., Skosyrski S., Babst N., Ranjbar M., Rommel F., Kurz M., Tura A., Joachim S.C., Kociok N., Kakkassey V. Islet Co-Expression of CD133 and ABCB5 in Human Retinoblastoma Specimens. Klin Monbl Augenheilkd. 2021 Sep 27.
doi: 10.1055/a-1525-2588
Zugbi S., Aschero R., Ganiewich D. et al. Establishment and Comprehensive Characterization of a Novel Preclinical Platform of Metastatic Retinoblastoma for Therapeutic Developments. Investigative ophthalmology & visual science. 2023-12-24;64(15):27.
doi: 10.1167/iovs.64.15.27
Zugbi S., Ganiewich D., Bhattacharyya A., Aschero R., Ottaviani D., Sampor C., Cafferata E.G. etc. Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma. Cancers. 2020 Sep 22
doi: 10.3390/cancers12092714
Zuo X., Fu C., Xie J., Wang X., Yan Z. Hsa_circ_0000527 Downregulation Suppresses the Development of Retinoblastoma by Modulating the miR-27a-3p/HDAC9 Pathway. Curr Eye Res. 2021 Nov 25:1-12.
doi: 10.1080/02713683.2021.1925697
Вам понравилась страница?